{"numRecords":"2569","DataElementQueryResults":[{"publicId":"5625","version":"2.31","preferredName":"Toxic Exposure Specify","preferredDefinition":"The type of exposure if not listed. Free Form Text","longName":"TOXIC_EXP_TYPE_OTHR","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"99BA9DC8-3124-4E69-E034-080020C9C0E0","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"GDEEN","dateModified":"2023-10-17","changeNote":"Retired due to lack of use since the time of curation.  No additional use in classifications or CRFs since created.dmr4.7.2015","administrativeNotes":"10.17.23_Transferred ownership to support Protocol 000302-C (Natural History Study)_ghd","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2002895","version":"4","preferredName":"Body System Type","preferredDefinition":"Text term to identify a Review of Systems (ROS) component that consists of one or all members of an organ system, and/or additional medical questions.","longName":"BDY_SYS_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Standard","id":"CEDC2945-2E10-2C7C-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-12-22","endDate":null,"createdBy":"REEVESD","dateCreated":"2003-12-22","modifiedBy":"HARTLEYG","dateModified":"2021-06-17","changeNote":"New version with expanded VD and DE using naming standards.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2002913","version":"4","preferredName":"Total Dose Value","preferredDefinition":"Numeric value for the amount of medicine taken, or radiation given, during a period of time.","longName":"TTL_DOSE_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"BA9829CA-A35A-531B-E040-BB89AD432A45","latestVersionIndicator":"Yes","beginDate":"2012-03-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-03-06","modifiedBy":"FORMBUILDER","dateModified":"2012-05-14","changeNote":"v4.0 replaces v3.0 of the CDE with updated DEC and VD. v3.0 was incorrectly in use as a numeric datatype, but was paired with a (later retired) character VD.  This version pairs the correct VD which is not retired.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2003300","version":"4","preferredName":"Protocol Number","preferredDefinition":"The numeric or alphanumeric identification assigned to the study by the NCI. Inter-Group protocols should use the lead Groups protocol number.","longName":"PROT_NUM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"BFEDE733-ABF5-1556-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-06-12","endDate":null,"createdBy":"JASUR","dateCreated":"2003-06-12","modifiedBy":"REEVESD","dateModified":"2011-03-18","changeNote":"CCR CCMG approval of Released status 3/17/2004.  CDE supports DICOM Standard PS 3 - 204.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2003301","version":"4","preferredName":"Patient Identifier","preferredDefinition":"The unique numeric or alphanumeric identification assigned to a participant in a clinical trial or research study.","longName":"PT_ID","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Standard","id":"BBD6F1B4-3D25-B65B-E040-BB89AD432DD1","latestVersionIndicator":"Yes","beginDate":"2002-07-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-03-22","modifiedBy":"TSESU","dateModified":"2023-05-17","changeNote":"05/25/2016 wz added NWU CS/CSI.5/18/16 jk moved to MCL context CSIs. 3/7/16 jk added MCL Clinical CSI. 12/11/14 jc added Exceptional Responder CSI. 12/10/14 jc added CDUS Rave Integration CSI.  CDE supports DICOM Standard PS 3 - 2004. v4.0 replaces v3.0 to use a version VD that increases max length from 12 to 20 characters","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2003303","version":"3","preferredName":"Body Weight in Kilograms","preferredDefinition":"Measurement of an individual's weight in kilograms.","longName":"BDY_WT_KG","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"A55B8F01-7C9A-6305-E034-080020C9C0E0","latestVersionIndicator":"Yes","beginDate":"2002-07-09","endDate":null,"createdBy":"JASUR","dateCreated":"2002-07-09","modifiedBy":"DWARZEL","dateModified":"2023-04-12","changeNote":"CDE supports DICOM Standard PS 3 - 2004","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2003304","version":"4","preferredName":"Person Height Measurement","preferredDefinition":"Value for an individual's height measured in centimeters.","longName":"PERS_HT_CM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"76FB6357-F3E4-3688-E040-BB89AD437ED0","latestVersionIndicator":"Yes","beginDate":"2009-10-26","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-10-28","modifiedBy":"KUMMEROA","dateModified":"2021-09-17","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2003305","version":"5","preferredName":"Patient Subgroup Assignment","preferredDefinition":"Subgroup assignment given to a participant on a protocol.","longName":"PT_SUBGRP_ASSIGN_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E97E4098-B159-CA79-E040-BB89AD4371C0","latestVersionIndicator":"Yes","beginDate":"2013-10-24","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-10-24","modifiedBy":"FORMBUILDER","dateModified":"2014-07-14","changeNote":"Replaces v4.0 with a new version of the VD with extended field length from 10 to 40 characters.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2003306","version":"3","preferredName":"Registering Group","preferredDefinition":"Name of the practice group where the patient was originally registered on study.","longName":"REG_GP_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"A55B8F01-7CB1-6305-E034-080020C9C0E0","latestVersionIndicator":"Yes","beginDate":"2002-07-09","endDate":null,"createdBy":"JASUR","dateCreated":"2002-07-09","modifiedBy":"FORMBUILDER","dateModified":"2014-07-14","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2003307","version":"4","preferredName":"Registering Institution Identification Code","preferredDefinition":"Code that uniquely identifies the institution where the research participant was registered in a clinical trial.","longName":"REG_INST_ID_CD","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Standard","id":"EBC26768-095F-5C79-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-12-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-12-27","modifiedBy":"FINCHAMB","dateModified":"2023-03-20","changeNote":"05/25/2016 wz added NWU CS/CSI.5/18/16 jk moved from EDRN to MCL context CSI.  3/7/16 jk added MCL Clinical CSI.7/20/2016 Removed ' [Manually-curated]' from CDE definition, wz.","administrativeNotes":"02.13.23_Set Reg Status to Standard for all CDISC Aligned content_ghd","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2003308","version":"5","preferredName":"Country Code","preferredDefinition":"Two character coded value to represent a collective generic term \"Country\", referring to a wide variety of dependencies, areas of special sovereignty, uninhabited islands, and other entities in addition to the traditional countries.","longName":"CNTRY_CD","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7B9943B3-6F29-1292-E053-F662850AF731","latestVersionIndicator":"Yes","beginDate":"2018-11-27","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-11-27","modifiedBy":"COOPERM","dateModified":"2018-11-27","changeNote":"Version 4.0 includes enumerated VD from CTEP with all permissible country codes from CTEP. Versioned to use latest version of VD. mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2003309","version":"4","preferredName":"Payment Method","preferredDefinition":"Primary payer/insurance carrier information at the time of treatment on a protocol.","longName":"PYMT_METH","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"96DCD154-DEA9-2B9E-E053-F662850A50A3","latestVersionIndicator":"Yes","beginDate":"2002-07-09","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-11-08","modifiedBy":"COOPERM","dateModified":"2020-10-21","changeNote":"Versioned to use new version DEC. mc 11/8/19","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2003310","version":"3","preferredName":"Disease Stage TNM","preferredDefinition":"TNM value used to express the extent of a cancer within the body, citing disease extent in the primary tumor (T), lymph nodes (N), and metastatic sites (M).  ","longName":"DZ_STG_TNM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"A55B8F01-7CDF-6305-E034-080020C9C0E0","latestVersionIndicator":"Yes","beginDate":"2002-07-09","endDate":null,"createdBy":"JASUR","dateCreated":"2002-07-09","modifiedBy":"REEVESD","dateModified":"2011-03-18","changeNote":"TNM added to preferred name to differentiate from Numeric values.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2003311","version":"3","preferredName":"Disease CDUS Code","preferredDefinition":"The unique number assigned to a disease based on Clinical Data Update System (CDUS) Disease Coding.","longName":"DZ_CDUS_CD","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"A55B8F01-7CE6-6305-E034-080020C9C0E0","latestVersionIndicator":"Yes","beginDate":"2002-07-09","endDate":null,"createdBy":"JASUR","dateCreated":"2002-07-09","modifiedBy":"REEVESD","dateModified":"2011-06-28","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2003312","version":"3","preferredName":"Histology/Cytopathology Description","preferredDefinition":"The free-text description of a histological and/or cytopathological type present in a pathology specimen, commonly referred to as the diagnosis.","longName":"HIST_CYTPATH_DESC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"A55B8F01-7CED-6305-E034-080020C9C0E0","latestVersionIndicator":"Yes","beginDate":"2002-07-09","endDate":null,"createdBy":"JASUR","dateCreated":"2002-07-09","modifiedBy":"SOKKERL","dateModified":"2017-07-18","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2003313","version":"3","preferredName":"Histologic Confirmation Date","preferredDefinition":"The date when a pathologic diagnosis is verified and confirmed.","longName":"HIST_CONF_DT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"A55B8F01-7CF4-6305-E034-080020C9C0E0","latestVersionIndicator":"Yes","beginDate":"2002-07-09","endDate":null,"createdBy":"JASUR","dateCreated":"2002-07-09","modifiedBy":"KUMMEROA","dateModified":"2022-11-15","changeNote":"CCR CCMG approval of Released status on 1/7/2004.","administrativeNotes":"2022.11.15 AQT added for ticket request CADSR0001697. ak","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2003314","version":"4","preferredName":"Informed Consent Version","preferredDefinition":"The version of the consent document in which the patient acknowledged participation on the protocol by signing the document.","longName":"PROT_INF_CONS_VER","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"FA7C1A6F-1B3E-C2AB-E040-BB89AD436686","latestVersionIndicator":"Yes","beginDate":"2014-05-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-05-28","modifiedBy":"HARTLEYG","dateModified":"2021-01-25","changeNote":"05/25/2016 wz added NWU CS/CSI.New version created to replaced retired VD.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2003315","version":"4.2","preferredName":"Zubrod Performance Status Score","preferredDefinition":"The functional level of the patient based on the Zubrod performance scale.","longName":"ZUBROD_PERF_STAT_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F2C45BCA-7A30-7026-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-03-23","modifiedBy":"HARTLEYG","dateModified":"2021-06-17","changeNote":"12/10/14 jc added CDUS Rave Integration CSI.  New version uses semantically complete and versioned DEC.  Standard registration status approved by VCDE 5/17/2005.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2003316","version":"4","preferredName":"Enrollment Treatment Study Assignment Code","preferredDefinition":"Code delivered at the time of patient enrollment onto a clinical trial to denote the treatment assignment.","longName":"ENROLL_TX_ASSIGN_CD","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"22B16A2D-EEE6-664F-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-11-20","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-11-20","modifiedBy":"SOKKERL","dateModified":"2019-10-02","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2003319","version":"3","preferredName":"Prior Therapy Type Indicator","preferredDefinition":"Yes or No response to signify if a patient received any of the prior therapy treatment.","longName":"PRIOR_TX_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"A55B8F01-7D3E-6305-E034-080020C9C0E0","latestVersionIndicator":"Yes","beginDate":"2002-07-09","endDate":null,"createdBy":"JASUR","dateCreated":"2002-07-09","modifiedBy":"CLOHNES","dateModified":"2023-11-16","changeNote":null,"administrativeNotes":"11/16/23 Added alt OID for CCTG ticket number CADSR0003085 cjl; 12/21/22 added AQT for ticket request CADSR0001818 cjl;","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2003322","version":"4","preferredName":"Administration Schedule Term Name","preferredDefinition":"The frequency schedule used for administration of agents.","longName":"MED_SCHED","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Standard","id":"B404581B-9E0E-EC81-E040-BB89AD433FB4","latestVersionIndicator":"Yes","beginDate":"2002-07-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-12-13","modifiedBy":"HARTLEYG","dateModified":"2021-06-17","changeNote":"v4.0 uses a VD version that removes many legacy permissible values, approved by NCI CCR.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2003323","version":"6","preferredName":"Dose Amount Unit of Measure Name","preferredDefinition":"Text name to represent the quantity or dosage of an agent administered to a patient/participant as part of a prior therapy record.","longName":"AGENT_UOM_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"6D887B18-8348-2E8D-E053-F662850AA95D","latestVersionIndicator":"Yes","beginDate":"2018-05-31","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-05-31","modifiedBy":"COOPERM","dateModified":"2018-05-31","changeNote":"Version 6.0 expands max field from 16 to 30 characters maximum as requested for NCI-INC0282787-Theradex UOM 5.31.18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2003324","version":"4","preferredName":"Best Response Assessment Type","preferredDefinition":"The best improvement achieved throughout the entire course of protocol treatment.","longName":"BEST_RESPS_ASSMNT_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"9544757B-656D-35A0-E040-BB89AD434092","latestVersionIndicator":"Yes","beginDate":"2003-11-06","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-11-17","modifiedBy":"SOKKERL","dateModified":"2019-03-07","changeNote":"New version 4.0 uses new version of VD.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2003325","version":"4","preferredName":"Prior Therapy Type Text Code","preferredDefinition":"One or two character representation(s) for type(s) of prior therapy modality (Chemotherapy, Immunotherapy, others) received by a patient/participant.","longName":"PRIOR_RX_TP_TXT_CD","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"1867A381-D079-297A-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-07-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-07-12","modifiedBy":"TANGL","dateModified":"2018-08-01","changeNote":"Value Domain is not correct for this DE.  Replaced by another CCR CDE.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2003339","version":"3","preferredName":"Radiation Therapy Type","preferredDefinition":"Type of radiation therapy being used.","longName":"RT_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"A55B8F01-7D83-6305-E034-080020C9C0E0","latestVersionIndicator":"Yes","beginDate":"2002-07-09","endDate":null,"createdBy":"JASUR","dateCreated":"2002-07-09","modifiedBy":"TSESU","dateModified":"2017-03-07","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2003361","version":"4","preferredName":"Assessment Findings Text","preferredDefinition":"Description of the findings from a procedure.","longName":"PROC_FNG_DESC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"AFAD988F-4967-64FB-E040-BB89AD4333F5","latestVersionIndicator":"Yes","beginDate":"2002-07-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-10-19","modifiedBy":"REEVESD","dateModified":"2011-10-19","changeNote":"New version uses versioned VD with expanded field length from 24 to 100.  Curated for NCI CCR clinical trial.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2003363","version":"4","preferredName":"Treatment Start Date","preferredDefinition":"Begin date of a measure, procedure or agent.","longName":"TX_STT_DT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EBC26768-0A5A-5C79-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-12-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-12-27","modifiedBy":"TYRRELLM","dateModified":"2024-01-17","changeNote":null,"administrativeNotes":"01.17.2024 Added AQT per request ticket CADSR0003292_mmt","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2003364","version":"3","preferredName":"Stop Date","preferredDefinition":"The final or last day of a measure, procedure or agent.","longName":"STOP_DT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"A55B8F01-7DB5-6305-E034-080020C9C0E0","latestVersionIndicator":"Yes","beginDate":"2002-07-09","endDate":null,"createdBy":"JASUR","dateCreated":"2002-07-09","modifiedBy":"SHUJIEH","dateModified":"2016-08-18","changeNote":"CCR CCMG approval of Released status on 1/7/2004.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2003366","version":"3","preferredName":"Total Daily Dose Value","preferredDefinition":"Value to represent the total dose administered of an agent within one day.","longName":"TTL_DAILY_DOSE_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"A55B8F01-7DC3-6305-E034-080020C9C0E0","latestVersionIndicator":"Yes","beginDate":"2002-07-09","endDate":null,"createdBy":"JASUR","dateCreated":"2002-07-09","modifiedBy":"KUMMEROA","dateModified":"2022-09-30","changeNote":null,"administrativeNotes":"2022.9.30 AQT added for ticket request CADSR0001559. ak","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2003387","version":"3","preferredName":"Checklist Number","preferredDefinition":"Unique identifer for each protocol eligibility checklist associated with a protocol; each successive versions or amendments of a study will have a checklist/checklist number associated with it.","longName":"PROT_CHKLST_NUM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"A55B8F01-7DCA-6305-E034-080020C9C0E0","latestVersionIndicator":"Yes","beginDate":"2002-07-09","endDate":null,"createdBy":"JASUR","dateCreated":"2002-07-09","modifiedBy":"VUJANOVA","dateModified":"2019-09-16","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2003388","version":"3","preferredName":"Effective Date","preferredDefinition":"The date of approval of eligibility criteria by NCI.","longName":"EFFCT_DT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"A55B8F01-7DD1-6305-E034-080020C9C0E0","latestVersionIndicator":"Yes","beginDate":"2002-07-09","endDate":null,"createdBy":"JASUR","dateCreated":"2002-07-09","modifiedBy":"REEVESD","dateModified":"2011-06-28","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2003389","version":"3","preferredName":"Waiver Number","preferredDefinition":"The numeric identifier for a sponosor-granted waiver.  Not applicable for NCI sponsored studies.","longName":"WAIVER_NUM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Standard","id":"A55B8F01-7DD8-6305-E034-080020C9C0E0","latestVersionIndicator":"Yes","beginDate":"2002-07-09","endDate":null,"createdBy":"JASUR","dateCreated":"2002-07-09","modifiedBy":"SOKKERL","dateModified":"2019-10-17","changeNote":"Discussed in CCR CCMG on 1/28/2004.  CCR CCMG approval of Released status for non CTEP-sponsored trials.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2003390","version":"3","preferredName":"Eligibility Checklist","preferredDefinition":"Response (Yes, No, or Not Applicable) to each item (question) on a protocol eligibility checklist for patient/participant enrollment.","longName":"ELIG_CHKLST_RESP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"A55B8F01-7DE3-6305-E034-080020C9C0E0","latestVersionIndicator":"Yes","beginDate":"2002-07-09","endDate":null,"createdBy":"JASUR","dateCreated":"2002-07-09","modifiedBy":"SOKKERL","dateModified":"2017-10-02","changeNote":"05/25/2016 wz added NWU CS/CSI.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2003426","version":"3","preferredName":"Adverse Event Onset Date","preferredDefinition":"The date when a symptom or Adverse Event (AE) initially occurred.","longName":"AE_ONSET_DT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"A55B8F01-7EE3-6305-E034-080020C9C0E0","latestVersionIndicator":"Yes","beginDate":"2002-07-09","endDate":null,"createdBy":"JASUR","dateCreated":"2002-07-09","modifiedBy":"MORENOC","dateModified":"2020-04-17","changeNote":"CCR CCMG approval of Released status on 12/17/2003.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2003427","version":"3","preferredName":"Adverse Event Description Text","preferredDefinition":"The qualitative description of an adverse event based on a verbatim report, or to qualify a response of 'other' from a list of adverse events.","longName":"AE_DESC_TXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"A55B8F01-7EEA-6305-E034-080020C9C0E0","latestVersionIndicator":"Yes","beginDate":"2002-07-09","endDate":null,"createdBy":"JASUR","dateCreated":"2002-07-09","modifiedBy":"MMADDINENI","dateModified":"2023-01-25","changeNote":null,"administrativeNotes":"01/25/2023: Added AQT-CADSR0001930-MM","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2003428","version":"3","preferredName":"Common Toxicity Criteria Attribution Code","preferredDefinition":"A scale of values to indicate the causal relation between the treatment modality and the specific adverse event.","longName":"CTC_ATTR_CD","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"A55B8F01-7EF1-6305-E034-080020C9C0E0","latestVersionIndicator":"Yes","beginDate":"2002-07-09","endDate":null,"createdBy":"JASUR","dateCreated":"2002-07-09","modifiedBy":"FORMBUILDER","dateModified":"2012-05-14","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2003429","version":"4","preferredName":"Disease Related Symptom Indicator","preferredDefinition":"The yes/no/unknown question that asks whether a symptom or adverse event is related to disease. [Manually-curated]","longName":"DZ_ATTR_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"517388A9-9F7D-148A-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-07-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-07-07","modifiedBy":"HARTLEYG","dateModified":"2013-04-30","changeNote":"New version of CDE to replace text codes with full text indicators.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2003431","version":"3","preferredName":"Previously Irradiated Indicator","preferredDefinition":"Yes/No/Unknown response to signifity that a lesion or site of disease has previously been irradiated.","longName":"PREV_IRRAD_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"A55B8F01-7F0B-6305-E034-080020C9C0E0","latestVersionIndicator":"Yes","beginDate":"2002-07-09","endDate":null,"createdBy":"JASUR","dateCreated":"2002-07-09","modifiedBy":"KNABLEJ","dateModified":"2018-10-21","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2003432","version":"3","preferredName":"Measurable/Non-Measurable","preferredDefinition":"Indicator of whether a lesion or site of disease is measurable or nonmeasurable.","longName":"MSRBL_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A55B8F01-7F14-6305-E034-080020C9C0E0","latestVersionIndicator":"Yes","beginDate":"2002-07-09","endDate":null,"createdBy":"JASUR","dateCreated":"2002-07-09","modifiedBy":"CHILLIJ","dateModified":"2015-05-06","changeNote":"5/6/15 removed from RECIST CRF CSI and All Mandatory CDE CSI. jc  3/20/15 removed candidate status; CDE 4749031 created for RECISTv1.1 CDE set. jc 8/13/13 added to RECISTv1.1 CRF CSI. jc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2003433","version":"3","preferredName":"Followed For Response Ind","preferredDefinition":"A Yes/No/Unknown indicator that denotes if a subject can be evaluated for response (to protocol treatment).","longName":"FOLLOW_RESP_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"RECIST:Response Evaluation Criteria in Solid Tumors","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"A55B8F01-7F1D-6305-E034-080020C9C0E0","latestVersionIndicator":"Yes","beginDate":"2002-07-09","endDate":null,"createdBy":"JASUR","dateCreated":"2002-07-09","modifiedBy":"FORMBUILDER","dateModified":"2014-03-24","changeNote":"CCR CCMG approved Released status on 11/19/2003.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2003435","version":"3","preferredName":"Measurement Method Procedure Name","preferredDefinition":"Brief description of how a lesion measurement was determined.","longName":"MSRMT_METH","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"A55B8F01-7F2B-6305-E034-080020C9C0E0","latestVersionIndicator":"Yes","beginDate":"2002-07-09","endDate":null,"createdBy":"JASUR","dateCreated":"2002-07-09","modifiedBy":"REEVESD","dateModified":"2011-06-29","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2003436","version":"3","preferredName":"Measurement X in Centimeters","preferredDefinition":"Measurement of a lesion/tumor or location in the \"X\" (first or length) dimension in centimeters; this is the longest measurement or largest value if only one measurement is captured.","longName":"MSRMT_X_CM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"A55B8F01-7F32-6305-E034-080020C9C0E0","latestVersionIndicator":"Yes","beginDate":"2002-07-09","endDate":null,"createdBy":"JASUR","dateCreated":"2002-07-09","modifiedBy":"TAYLORT","dateModified":"2019-05-16","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2003437","version":"3","preferredName":"Lesion Evaluation Number","preferredDefinition":"Sequential number corresponding to an evaluation timepoint.  (O for the baseline evaluation, 1 for the first evaluation, 2 for the second evaluation, etc.)","longName":"LES_EVAL_NUM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"A55B8F01-7F39-6305-E034-080020C9C0E0","latestVersionIndicator":"Yes","beginDate":"2002-07-09","endDate":null,"createdBy":"JASUR","dateCreated":"2002-07-09","modifiedBy":"FORMBUILDER","dateModified":"2012-05-14","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2003438","version":"3","preferredName":"Evaluation Code","preferredDefinition":"Code to follow the response of a specific non-measurable lesion, as specified at the time of each evaluation.","longName":"EVAL_CD","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"A55B8F01-7F40-6305-E034-080020C9C0E0","latestVersionIndicator":"Yes","beginDate":"2002-07-09","endDate":null,"createdBy":"JASUR","dateCreated":"2002-07-09","modifiedBy":"FORMBUILDER","dateModified":"2012-05-14","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2003439","version":"3","preferredName":"Comment Change From Baseline Text","preferredDefinition":"Comment text in reference to a change from baseline measurements.","longName":"CHG_BSL_COMMENT_TXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"A55B8F01-7F47-6305-E034-080020C9C0E0","latestVersionIndicator":"Yes","beginDate":"2002-07-09","endDate":null,"createdBy":"JASUR","dateCreated":"2002-07-09","modifiedBy":"FORMBUILDER","dateModified":"2013-09-26","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2003580","version":"3","preferredName":"Lab Collection Time","preferredDefinition":"The time when  a sample for a lab test was collected.","longName":"LAB_COLL_TM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Standard","id":"A56E8150-8EAC-1CC3-E034-080020C9C0E0","latestVersionIndicator":"Yes","beginDate":"2002-07-10","endDate":null,"createdBy":"JASUR","dateCreated":"2002-07-10","modifiedBy":"HARTLEYG","dateModified":"2021-06-17","changeNote":"Reused existing CDE for Lab CRF. Classified with Standard CRF 4/2009. mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2003581","version":"3","preferredName":"Course Number","preferredDefinition":"Number of the course (cycle) of treatment the patient received.","longName":"CRSE_NUM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"A56E8150-8EB3-1CC3-E034-080020C9C0E0","latestVersionIndicator":"Yes","beginDate":"2002-07-10","endDate":null,"createdBy":"JASUR","dateCreated":"2002-07-10","modifiedBy":"SOKKERL","dateModified":"2019-03-07","changeNote":"CCR CCMG approval of Released status on 1/7/04.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2003583","version":"3","preferredName":"Lot Number","preferredDefinition":"Lot number for the drug supply","longName":"LOT_NUM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"A56E8150-8EC1-1CC3-E034-080020C9C0E0","latestVersionIndicator":"Yes","beginDate":"2002-07-10","endDate":null,"createdBy":"JASUR","dateCreated":"2002-07-10","modifiedBy":"FORMBUILDER","dateModified":"2012-05-14","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2003586","version":"6","preferredName":"Access Route of Administration Text Code","preferredDefinition":"A  text code or name to represent an access route for the administration of agents or substances.","longName":"ACCESS_RTE_TXT_CD","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Standard","id":"2F6EA110-B303-52A4-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-05-01","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-05-01","modifiedBy":"HARTLEYG","dateModified":"2021-06-17","changeNote":"Replaces v5.0 w/extended max field length. Permissible value of 'oral' (po) and alternate question text requested per 3/10/2010 request of G. Diaz.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2003588","version":"3","preferredName":"Course Start Date","preferredDefinition":"The begin date for a course (cycle) of a protocol.","longName":"CRSE_START_DT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"A56E9E7B-DAA8-1DF9-E034-080020C9C0E0","latestVersionIndicator":"Yes","beginDate":"2002-07-10","endDate":null,"createdBy":"JASUR","dateCreated":"2002-07-10","modifiedBy":"SOKKERL","dateModified":"2019-03-08","changeNote":"CCR CCMG approval of Released status on 1/7/2004.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2003589","version":"3","preferredName":"Arm","preferredDefinition":"Protocol-specific arm assignment identified in a formal communication.","longName":"PROT_ARM_ASSIGN","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"A56E9E7B-DAAF-1DF9-E034-080020C9C0E0","latestVersionIndicator":"Yes","beginDate":"2002-07-10","endDate":null,"createdBy":"JASUR","dateCreated":"2002-07-10","modifiedBy":"REEVESD","dateModified":"2011-06-28","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2003593","version":"3","preferredName":"Previous Dose Change Indicator","preferredDefinition":"Indicator of whether the patient dose was changed from the dose given in the prior course (cycle), and if the change was planned or unplanned.","longName":"PREV_DOSE_CHG_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"A56E9E7B-DAD8-1DF9-E034-080020C9C0E0","latestVersionIndicator":"Yes","beginDate":"2002-07-10","endDate":null,"createdBy":"JASUR","dateCreated":"2002-07-10","modifiedBy":"FORMBUILDER","dateModified":"2013-05-22","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2003594","version":"4","preferredName":"Response Assessment Type","preferredDefinition":"The patient's disease state as of the last day of the observation period for the course (cycle).","longName":"RESP_ASSESS_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"9544757B-6432-35A0-E040-BB89AD434092","latestVersionIndicator":"Yes","beginDate":"2002-07-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-11-17","modifiedBy":"TAYLORT","dateModified":"2018-06-29","changeNote":"Uses new version VD.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2003597","version":"3","preferredName":"Response Date","preferredDefinition":"Date of the evaluation used to determine the patient's disease status within a period of protocol time.","longName":"RESP_DT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"A56E9E7B-DB04-1DF9-E034-080020C9C0E0","latestVersionIndicator":"No","beginDate":"2002-07-10","endDate":null,"createdBy":"JASUR","dateCreated":"2002-07-10","modifiedBy":"REEVESD","dateModified":"2011-02-07","changeNote":"CCR CCMG approval of Released status on 12/17/2003.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2003599","version":"4","preferredName":"Toxicity Event Indicator","preferredDefinition":"Yes/No indication of whether toxicity occurred during a specific course (cycle) or phase of protocol activity.","longName":"TOX_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"674F12FE-2BEF-03DA-E053-F662850A9648","latestVersionIndicator":"Yes","beginDate":"2018-03-13","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-13","modifiedBy":"COOPERM","dateModified":"2018-03-13","changeNote":"New version adds OC/Prop concepts to DEC. mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2003601","version":"4","preferredName":"Case Report Form Type","preferredDefinition":"Abbreviated term to identify a data collection instrument (CRF) designed to record all of the clinical study-required information stipulated in the protocol to be reported to the sponsor on each trial subject.","longName":"CRF_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"THERADEX:Theradex Systems Inc","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"BF21935A-CCCF-F93F-E040-BB89AD431368","latestVersionIndicator":"Yes","beginDate":"2012-05-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-05-03","modifiedBy":"REEVESD","dateModified":"2014-03-07","changeNote":"Created to support build of Theradex CRFs in caDSR and in Rave","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2003605","version":"3","preferredName":"Off Study Date","preferredDefinition":"The date when the patient/participant is removed from the protocol, i.e., is not being followed and will not be retreated.","longName":"OFF_STUDY_DT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Standard","id":"A56E9E7B-DB29-1DF9-E034-080020C9C0E0","latestVersionIndicator":"Yes","beginDate":"2002-07-10","endDate":null,"createdBy":"JASUR","dateCreated":"2002-07-10","modifiedBy":"HARTLEYG","dateModified":"2018-10-26","changeNote":"CCR CCMG approval of Released status on 10/22/2003.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2003606","version":"4","preferredName":"Off Study Reason Code","preferredDefinition":"Coded reason the patient/participant is removed from a clinical trial, using an enumerated set of values used in CTMS reporting.","longName":"OFF_STUDY_RSN_CD","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"8E06DFCA-042E-3663-E040-BB89AD4323BD","latestVersionIndicator":"Yes","beginDate":"2010-08-17","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-08-17","modifiedBy":"REEVESD","dateModified":"2012-07-26","changeNote":"Replaces v3.0 with updated PV \"Death\" value meaning","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2003608","version":"3","preferredName":"Best Response Date","preferredDefinition":"Date of the evaluation used to determine the patient's maximum improvement in disease status within a period of protocol time.","longName":"BEST_RESP_DT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"A56E9E7B-DB5F-1DF9-E034-080020C9C0E0","latestVersionIndicator":"Yes","beginDate":"2002-07-10","endDate":null,"createdBy":"JASUR","dateCreated":"2002-07-10","modifiedBy":"COOPERM","dateModified":"2016-03-16","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2003609","version":"3","preferredName":"Relapse Date","preferredDefinition":"The date of the evaluation or procedure used to determine progressive disease after the establishment of a complete response (CR).","longName":"RELAPSE_DT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"A56E9E7B-DB66-1DF9-E034-080020C9C0E0","latestVersionIndicator":"Yes","beginDate":"2002-07-10","endDate":null,"createdBy":"JASUR","dateCreated":"2002-07-10","modifiedBy":"TSESU","dateModified":"2023-08-28","changeNote":"CCR CCMG approval of Released status on 12/17/2003.","administrativeNotes":"2022.9.30 AQT added for ticket request CADSR0001559. ak","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2003640","version":"3","preferredName":"Course Disposition","preferredDefinition":"Status of a course (cycle) of treatment.  A \"completed\" course (cycle) is one which has been conducted in accordance with the protocol with respect to length (two day variance allowed). A course (cycle) is regarded as \"discontinued\" if it was shorter than specified in the protocol.","longName":"CRSE_DISPN","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"A580E2CD-80F3-5718-E034-080020C9C0E0","latestVersionIndicator":"Yes","beginDate":"2002-07-11","endDate":null,"createdBy":"JASUR","dateCreated":"2002-07-11","modifiedBy":"SOKKERL","dateModified":"2019-03-07","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2003707","version":"3","preferredName":"National Cancer Institute Institute Code","preferredDefinition":"A unique alpha-numeric code assigned by NCI to institution where the patient/participant was originally registered on study (institution where the patient signed the informed consent form). The code is assigned to protocol/records to identify the institution(s) participating in NCI-sponsored clinical trials and investigator records to identify address location.","longName":"NCI_INST_CD","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"A5D4755C-9469-5B65-E034-080020C9C0E0","latestVersionIndicator":"Yes","beginDate":"2002-07-15","endDate":null,"createdBy":"JASUR","dateCreated":"2002-07-15","modifiedBy":"FORMBUILDER","dateModified":"2021-09-22","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2003711","version":"3","preferredName":"Cause of Death at Autopsy","preferredDefinition":"Cause of death as confirmed by autopsy.","longName":"ATPSY_DEATH_CAUS","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"A5D4755C-9498-5B65-E034-080020C9C0E0","latestVersionIndicator":"Yes","beginDate":"2002-07-15","endDate":null,"createdBy":"JASUR","dateCreated":"2002-07-15","modifiedBy":"FORMBUILDER","dateModified":"2013-10-28","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2003713","version":"3","preferredName":"Resolved Date","preferredDefinition":"The date when an Adverse Event (AE) is resolved or returns to baseline value, based on standardized criteria (CTCAE).","longName":"RESOLV_DT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"A5D3A856-8C68-5EF2-E034-080020C9C0E0","latestVersionIndicator":"Yes","beginDate":"2002-07-15","endDate":null,"createdBy":"JASUR","dateCreated":"2002-07-15","modifiedBy":"KUMMEROA","dateModified":"2022-07-14","changeNote":"CCR CCMG approval of Released status on 12/17/2003.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2003714","version":"4","preferredName":"Infection Type","preferredDefinition":"A succinct description of the infection (UTI, pneumonia, etc.)","longName":"INFECT_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"B4788368-8D04-4781-E053-4EBD850A5B66","latestVersionIndicator":"Yes","beginDate":"2020-11-19","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-11-19","modifiedBy":"KUMMEROA","dateModified":"2022-03-14","changeNote":"11.19.2020 Versioned to add concept annotation to DEC and VMs for NCI-INC0538950 20C0070 Curation and import_02 request. mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2003715","version":"4","preferredName":"Infectious Agent Name","preferredDefinition":"Name of an infectious agent or microorganism obtained from culture or other testing, using an enumerated set of values.","longName":"INFECT_AGT_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"CEDC2945-2DB9-2C7C-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-12-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2003-12-19","modifiedBy":"WONGW","dateModified":"2013-09-20","changeNote":"CCR CCMG approval of Released status 9/2003.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2003716","version":"4","preferredName":"Infection Treatment Agent Text Name","preferredDefinition":"Text name for therapy or intervention targeting the infectious disease/condition under investigation.","longName":"INFEC_TX_AGT_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"019C7266-B767-0AAA-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-09-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-09-27","modifiedBy":"CHANGP","dateModified":"2017-03-07","changeNote":"Includes expanded max field length.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2003717","version":"3","preferredName":"Adverse Event Infection Outcome","preferredDefinition":"Text description of the outcome of an infecious episode or event.","longName":"INFECT_OUTCOME_TXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"A5D3A856-8C84-5EF2-E034-080020C9C0E0","latestVersionIndicator":"Yes","beginDate":"2002-07-15","endDate":null,"createdBy":"JASUR","dateCreated":"2002-07-15","modifiedBy":"MAESKEB","dateModified":"2011-11-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2003720","version":"3","preferredName":"Page Number","preferredDefinition":"Number of the page of the case report form (CRF) referenced.","longName":"PAGE_NUM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"A60DCE43-3A55-35A6-E034-0003BA0B1A09","latestVersionIndicator":"Yes","beginDate":"2002-07-18","endDate":null,"createdBy":"JASUR","dateCreated":"2002-07-18","modifiedBy":"FORMBUILDER","dateModified":"2021-09-22","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2003721","version":"4","preferredName":"Common Toxicity Criteria Adverse Event Grade","preferredDefinition":"Adverse Event numeric grade (0-5) based on the NCI Common Toxicity Criteria.","longName":"CTC_AE_GD","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"CC812908-4100-47F4-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-11-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2003-11-19","modifiedBy":"REEVESD","dateModified":"2011-03-18","changeNote":"CDE value domain changed from numeric to character, Preferred name revised 11/19/03.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2003745","version":"5","preferredName":"Form Completion Date","preferredDefinition":"The date on which a data capture form (CRF or case report form) was completed.","longName":"FORM_COMPL_DT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Standard","id":"EBC26768-08EB-5C79-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2009-10-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-12-27","modifiedBy":"GDEEN","dateModified":"2023-02-13","changeNote":"10/30/20 jk added Normal Tissue CSI.  10/12/20 jk  added Solid tumor CSI. 7/23/20 jk added BLCA Path CSIs.   Standard Registration Status on completion of caBIG community 30 day balloting process, October 30, 2009.","administrativeNotes":"02.13.23_Set Reg Status to Standard for all CDISC Aligned content_ghd","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2003746","version":"6","preferredName":"Laboratory Finding Test Name","preferredDefinition":"Identifier name given to a test performed on body fluid(s) and tissues; test names are typically comprised of the analyte name, properties (%, Ratio, etc.), the type of body fluid tested, and any special instructions.","longName":"LAB_TEST_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Standard","id":"CBA5B74C-FF4E-94CB-E040-BB89AD435750","latestVersionIndicator":"Yes","beginDate":"2012-10-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-10-09","modifiedBy":"KUMMEROA","dateModified":"2022-07-26","changeNote":"Version 6.0 replaces v5.0 with a versioned VD that increases the max field length from 120 to 200 characters.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2003753","version":"4","preferredName":"Lab Unit of Measure Name","preferredDefinition":"The actual unit of measure for laboratory test results.","longName":"LAB_UOM_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"FAB2D8EC-69A4-68CB-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-06-30","modifiedBy":"MORENOC","dateModified":"2018-10-11","changeNote":"New version includes versioned VD with corrected value meaning/value meaning description.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2003837","version":"3","preferredName":"Result","preferredDefinition":"Text description of a procedure result.","longName":"PROC_RSL_DESC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"A663E2D9-6188-49F6-E034-0003BA0B1A09","latestVersionIndicator":"Yes","beginDate":"2002-07-22","endDate":null,"createdBy":"JASUR","dateCreated":"2002-07-22","modifiedBy":"FORMBUILDER","dateModified":"2012-05-14","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2003852","version":"3.1","preferredName":"Patient Age Value","preferredDefinition":"Age at the time of study enrollment, expressed in number of years completed at the last birthday.","longName":"PT_AGE_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"21953061-6DE1-2CA8-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-11-06","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-11-06","modifiedBy":"KUMMEROA","dateModified":"2022-05-11","changeNote":"v3.1 removes 'CTMS' from short name of CDE.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2003853","version":"4.2","preferredName":"Karnofsky Performance Status Score","preferredDefinition":"Score from the Karnofsky Performance status scale, representing the functional capabilities of a person.","longName":"KARN_PERF_STAT_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F2C45BCA-7920-7026-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-03-23","modifiedBy":"JKNABLE","dateModified":"2023-08-07","changeNote":"New version uses versioned DEC that is sematically complete.  Standard registration status approved by VCDE 5/17/2005. 3/24/2017 added alt question text for CTSP task, wz.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2003855","version":"3","preferredName":"Waiver Indicator","preferredDefinition":"A yes/no/NA indicator to denote if a subject's enrollment/eligibility requirements were waived for a sponsor-approved reason.","longName":"WAIVER_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Standard","id":"A6874AB4-4356-53B4-E034-0003BA0B1A09","latestVersionIndicator":"Yes","beginDate":"2002-07-24","endDate":null,"createdBy":"JASUR","dateCreated":"2002-07-24","modifiedBy":"SOKKERL","dateModified":"2017-03-07","changeNote":"Discussed in CCR CCMG.  CCR CCMG approval of Released status for non CTEP-sponsored trials on 1/28/2004.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2003870","version":"4","preferredName":"Concomitant Agent Concomitant Intervention or Procedure Reason","preferredDefinition":"The reason for administration of a concomitant (nonstudy) agent or measure.   This is not the pharmacologic classification of an agent (antibiotic, analgesic, etc.), but the reason for its administration to the patient. [Manually-curated]","longName":"INDCN_CONCT_AGT_MSR","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Standard","id":"50AA3DC0-2A48-1B29-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-06-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-06-27","modifiedBy":"HARTLEYG","dateModified":"2021-06-17","changeNote":"New version uses VD with extended field length and permissible values.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2003873","version":"4","preferredName":"Procedure Name","preferredDefinition":"Text name assigned to a health care procedure done for diagnostic, surveillance, treatment, palliation, or study-directed purposes.","longName":"PROC_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"24F9C026-FD4B-4457-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-12-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-12-19","modifiedBy":"MMADDINENI","dateModified":"2023-05-15","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2003874","version":"3","preferredName":"Medical History Description","preferredDefinition":"Brief description of major medical and surgical events that occurred during the patient's lifetime.","longName":"MED_HX_DESC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Standard","id":"A68A9776-BC12-581A-E034-0003BA0B1A09","latestVersionIndicator":"Yes","beginDate":"2002-07-24","endDate":null,"createdBy":"JASUR","dateCreated":"2002-07-24","modifiedBy":"HARTLEYG","dateModified":"2021-06-17","changeNote":"CCR CCMG approval of Released status 11/14/2003.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2003876","version":"3.1","preferredName":"Finding Result Indicator","preferredDefinition":"Response represents summary findings for the evaluation of a body system/site as normal (N), abnormal (A), not examined (X), or other enumerated values.","longName":"FNG_RSL_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C4A2ABF7-B9AD-55EA-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-08-21","endDate":"2015-05-29","createdBy":"REEVESD","dateCreated":"2003-08-13","modifiedBy":"COOPERM","dateModified":"2019-09-27","changeNote":"Retired due to change in needs. dmr 5/29/2015 Changed back to released for use in C3D to Rave transition. mc 9.26.19","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2003895","version":"4","preferredName":"Dose Limiting Toxicity Description","preferredDefinition":"Description of dose limiting toxicities for a drug or agent.","longName":"DOSE_LIMT_TOX_DESC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"FA7C3B0E-93EA-DFB1-E040-BB89AD436234","latestVersionIndicator":"Yes","beginDate":"2002-07-26","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-05-28","modifiedBy":"LEEW","dateModified":"2020-01-09","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2003900","version":"3","preferredName":"Corrected Aliquot Counter per Minute Number","preferredDefinition":"Numeric value for counter per minute for the aliquot adjusted to a reference time and corrected for background, crossover.","longName":"COR_ALIQ_CPM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"A6B03275-E387-61A3-E034-0003BA0B1A09","latestVersionIndicator":"Yes","beginDate":"2002-07-26","endDate":null,"createdBy":"JASUR","dateCreated":"2002-07-26","modifiedBy":"MAESKEB","dateModified":"2011-09-13","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2003904","version":"4","preferredName":"Sample ID Number","preferredDefinition":"Set of numbers used to unqiuely identify a sample/specimen.","longName":"SMPL_ID_NUM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"02772734-9B10-6ADF-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-10-06","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-10-06","modifiedBy":"MENARDP","dateModified":"2021-12-15","changeNote":"12/11/14 jc added Exceptional Responder CSI.  New version incorporates longer maximum field length VD.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2003905","version":"3","preferredName":"Tissue Class","preferredDefinition":"Classification of tissue as Normal or Tumor.  ","longName":"TIS_NL_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"A6B03275-E3B2-61A3-E034-0003BA0B1A09","latestVersionIndicator":"Yes","beginDate":"2002-07-26","endDate":null,"createdBy":"JASUR","dateCreated":"2002-07-26","modifiedBy":"REEVESD","dateModified":"2011-07-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2003907","version":"3","preferredName":"Sample Description Text","preferredDefinition":"Text description of a sample or specimen.","longName":"SMPL_DESC_TXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"A6B03275-E3C2-61A3-E034-0003BA0B1A09","latestVersionIndicator":"Yes","beginDate":"2002-07-26","endDate":null,"createdBy":"JASUR","dateCreated":"2002-07-26","modifiedBy":"FINCHAMB","dateModified":"2024-02-06","changeNote":"10/21/20 jk removed MCL CSI reuse.","administrativeNotes":"2/6/24 Added CSI. BF;1/18/23 Added CDS alt name, alt def; removed general CDS CSI, added CDS|Sample CSI; per metadata template. mr\r\n11/1/22 Added CS/CSI for CRDC CDS per CDS metadata template. mr","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2003908","version":"3","preferredName":"Gamma Scan Positive Indicator","preferredDefinition":"The question that asks whether the lesion was seen, or was equivocal in appearance on a gamma scan for taken-up radionuclide.","longName":"GAMMA_SCAN_POS_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"A6B03275-E3CE-61A3-E034-0003BA0B1A09","latestVersionIndicator":"Yes","beginDate":"2002-07-26","endDate":null,"createdBy":"JASUR","dateCreated":"2002-07-26","modifiedBy":"REEVESD","dateModified":"2011-07-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2003968","version":"2","preferredName":"Radiation Therapy Schedule","preferredDefinition":"Set of character terms to capture the frequency or schedule for the administration of an agent or measure.","longName":"RT_SCHED","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"ACC8C207-C6CE-7AD4-E053-4EBD850A939D","latestVersionIndicator":"Yes","beginDate":"2020-08-13","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-08-13","modifiedBy":"COOPERM","dateModified":"2020-08-13","changeNote":"Versioned to replace retired VD. mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2003986","version":"1","preferredName":"Surgery Date","preferredDefinition":"The date of a surgical procedure.","longName":"SURG_DT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Standard","id":"A73C4FEA-1B68-4516-E034-0003BA0B1A09","latestVersionIndicator":"Yes","beginDate":"2002-08-02","endDate":null,"createdBy":"JASUR","dateCreated":"2002-08-02","modifiedBy":"MMADDINENI","dateModified":"2024-01-09","changeNote":"CCR CCMG approval of Released status on 1/7/2004.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2003987","version":"4","preferredName":"Anatomic Site Name","preferredDefinition":"Text name of an anatomic organ site (single) within the body; may be referenced in primary site of disease, surgical intervention, or extent of disease documentation.","longName":"ANAT_SITE_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CC2E19AE-F280-62E8-E040-BB89AD43511D","latestVersionIndicator":"Yes","beginDate":"2005-09-29","endDate":"2012-10-16","createdBy":"REEVESD","dateCreated":"2012-10-16","modifiedBy":"MMADDINENI","dateModified":"2023-08-07","changeNote":"v3.0 replaces v2.0 with a versioned VD that increases the maximum field length from 30 to 50 characters.  v4.0 extends maximum field length from 50 to 120 characters.dr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2003989","version":"4","preferredName":"Eligibility Criteria Text","preferredDefinition":"The complete text of an individual question/criterion on the eligibility checklist of a protocol.","longName":"ELIG_CRIT_TXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"DFF9C09F-98B5-375B-E040-BB89AD4348AC","latestVersionIndicator":"Yes","beginDate":"2013-06-25","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-06-25","modifiedBy":"SOKKERL","dateModified":"2017-10-02","changeNote":"05/25/2016 wz added NWU CS/CSI.v4.0 replaces v3.0 of the CDE with extended maximum length from 200 to 1000 characters.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2003990","version":"3","preferredName":"Eligibility Criteria Indicator","preferredDefinition":"Indicator (Yes/No/Not Applicable) that a patient/participant has met all eligiblity criteria successfully for enrollment in a clinical trial.","longName":"ELIG_CRIT_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"A73E196A-6116-494E-E034-0003BA0B1A09","latestVersionIndicator":"Yes","beginDate":"2002-08-02","endDate":null,"createdBy":"JASUR","dateCreated":"2002-08-02","modifiedBy":"BERGANTW","dateModified":"2020-03-26","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2003991","version":"3","preferredName":"Eligibility Waiver Reason","preferredDefinition":"The reason that a subject is given a sponsor-approved waiver for meeting protocol-defined eligibility requirements.","longName":"ELIG_WAIVER_RSN","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"A73E196A-611D-494E-E034-0003BA0B1A09","latestVersionIndicator":"Yes","beginDate":"2002-08-02","endDate":null,"createdBy":"JASUR","dateCreated":"2002-08-02","modifiedBy":"REEVESD","dateModified":"2011-06-28","changeNote":"Discussed in CCR CCMG 1/28/2004.  CCR CCMG approval of Released status on 1/28/2004 for nonCTEP-sponsored trials.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2004001","version":"1","preferredName":"Residual Disease Extent","preferredDefinition":"The amount of residual disease at the conclusion of a treatment or surgical intervention.","longName":"RESID_DZ_EXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"A7785040-DD33-5E13-E034-0003BA0B1A09","latestVersionIndicator":"Yes","beginDate":"2002-08-05","endDate":null,"createdBy":"JASUR","dateCreated":"2002-08-05","modifiedBy":"MAESKEB","dateModified":"2011-10-13","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2004006","version":"5","preferredName":"Antibody Name","preferredDefinition":"Name of the antibody under review or investigation.","longName":"AB_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7B1D6723-454F-4A6C-E053-F662850A713A","latestVersionIndicator":"Yes","beginDate":"2018-11-20","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-11-20","modifiedBy":"COOPERM","dateModified":"2018-11-20","changeNote":"CCR CCMG approval of Released status 1/7/2004. Versioned VD and moved to CCR to support new CDE version. mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2004007","version":"3","preferredName":"CT Scan Positive Ind","preferredDefinition":"A Yes/No reponse to signify that a lesion or disease was seen on Computer Tomography (CT) scan.","longName":"CT_POS_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"A78D1A47-07FF-2951-E034-0003BA0B1A09","latestVersionIndicator":"Yes","beginDate":"2002-08-06","endDate":null,"createdBy":"JASUR","dateCreated":"2002-08-06","modifiedBy":"REEVESD","dateModified":"2011-07-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2004008","version":"3","preferredName":"Surgical Biopsy Indicator","preferredDefinition":"Indication of whether a lesion was biopsied or not.  ","longName":"SURG_BX_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"A78D1A47-080C-2951-E034-0003BA0B1A09","latestVersionIndicator":"Yes","beginDate":"2002-08-06","endDate":null,"createdBy":"JASUR","dateCreated":"2002-08-06","modifiedBy":"REEVESD","dateModified":"2011-07-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2004011","version":"3","preferredName":"Corrected Radioniclude Counter per Minute","preferredDefinition":"Numeric value to represent a corrected radionuclide dose.","longName":"CORRCTD_CPM_NUCL_NUM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"A78D1A47-0824-2951-E034-0003BA0B1A09","latestVersionIndicator":"Yes","beginDate":"2002-08-06","endDate":null,"createdBy":"JASUR","dateCreated":"2002-08-06","modifiedBy":"MAESKEB","dateModified":"2011-09-13","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2004089","version":"4","preferredName":"CDUS Therapy Number Code","preferredDefinition":"Numeric codes, using MedDRA version 9.0 codes and compliant with the CDUS (Clinical Data Update System), to represent types of therapy.","longName":"CDUS_THERAPY_CD","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"1B8C7EB3-FFA3-0592-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-08-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-08-21","modifiedBy":"FORMBUILDER","dateModified":"2013-05-07","changeNote":"Version 4.0 implements MedDRA v9.0 codes in use by CTEP electronic reporting systems effective July 1, 2006.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2004092","version":"2","preferredName":"Anatomic Organ Site Text","preferredDefinition":"Text name of site(s) within the body or a body organ.","longName":"ANAT_ORG_SITE_TXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"FCF89106-1585-2D93-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-07-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-07-29","modifiedBy":"FORMBUILDER","dateModified":"2012-05-14","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2004095","version":"3","preferredName":"Start Time","preferredDefinition":"The start time for the administration of an intervention, using a 24-hour clock time.","longName":"START_TM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Standard","id":"A7B68E0E-1EC5-38ED-E034-0003BA0B1A09","latestVersionIndicator":"Yes","beginDate":"2002-08-08","endDate":null,"createdBy":"JASUR","dateCreated":"2002-08-08","modifiedBy":"HARTLEYG","dateModified":"2021-06-17","changeNote":"CCR CCMG approval of Released status on 1/7/2004.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2004096","version":"3","preferredName":"Dose Level","preferredDefinition":"Dose Level of an agent or medication, assigned to a protocol patient/participant.","longName":"DOSE_LEVEL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"A7B68E0E-1ECC-38ED-E034-0003BA0B1A09","latestVersionIndicator":"Yes","beginDate":"2002-08-08","endDate":null,"createdBy":"JASUR","dateCreated":"2002-08-08","modifiedBy":"HARTLEYG","dateModified":"2013-04-30","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2004097","version":"3","preferredName":"Agent Actual Dose","preferredDefinition":"The total dose of study drug given to the patient in the time period encompassed by the duration.","longName":"AGT_ACTL_DOSE","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"A7B68E0E-1ED3-38ED-E034-0003BA0B1A09","latestVersionIndicator":"Yes","beginDate":"2002-08-08","endDate":null,"createdBy":"JASUR","dateCreated":"2002-08-08","modifiedBy":"KUMMEROA","dateModified":"2022-08-03","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2004098","version":"6","preferredName":"Actual Dose Administered Unit of Measure Name","preferredDefinition":"Text name to represent units of measure used to describe dosages of a study-dictated agent or measure.","longName":"ACTUAL_DOSE_UOM_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"6D88402D-87EA-31B5-E053-F662850A07A7","latestVersionIndicator":"Yes","beginDate":"2018-05-31","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-05-31","modifiedBy":"COOPERM","dateModified":"2018-05-31","changeNote":"Version 6.0 expands max field from 16 to 30 characters maximum as requested for NCI-INC0282787-Theradex UOM 5.31.18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2004099","version":"5","preferredName":"Time Duration Unit of Measure Code","preferredDefinition":"Text Unit of Measure (UOM) term to express the length of time of an event or activity.","longName":"DUR_UOM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EB9B5BC2-BFDF-09E3-E040-BB89AD4363D5","latestVersionIndicator":"Yes","beginDate":"2013-11-20","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-11-20","modifiedBy":"LISU","dateModified":"2022-03-26","changeNote":"Replaces v4.0 with new version VD in order to correct one PV; Permissible value 'SEC' in v4.0 changed to 'SC' in v5.0 to align with Theradex reporting requirement.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2004100","version":"2","preferredName":"Response Note Text","preferredDefinition":"Free text field to capture details and reason for a response call.","longName":"RESP_NOTE_TXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EBC19B2D-D0D8-603E-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-12-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-12-27","modifiedBy":"REEVESD","dateModified":"2011-06-28","changeNote":"Supports CTMS reporting requirements v. 3.02 and subsequent version.s","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2004101","version":"3","preferredName":"Adverse Event Report Indicator","preferredDefinition":"The question that asks whether an Adverse Event Report was filed with the Institutional Review Board (IRB) and/or the National Cancer Institute (NCI) or sponsor.","longName":"AER_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"A7BA4F51-3E22-45B9-E034-0003BA0B1A09","latestVersionIndicator":"Yes","beginDate":"2002-08-08","endDate":null,"createdBy":"JASUR","dateCreated":"2002-08-08","modifiedBy":"REEVESD","dateModified":"2016-11-14","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2004102","version":"4","preferredName":"Serious Adverse Event  Reason","preferredDefinition":"Reason that an Adverse Event is evaluated to be serious.","longName":"SAE_RSN","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"CC571B25-1DE4-4065-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-11-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2003-11-19","modifiedBy":"MAESKEB","dateModified":"2011-09-09","changeNote":"CDE modified from numeric to character data type, Preferred name revised 11/19/03.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2004103","version":"3","preferredName":"Adverse Event Action","preferredDefinition":"Action taken in response to an adverse event.","longName":"AE_ACTION","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"A7BA4F51-3E43-45B9-E034-0003BA0B1A09","latestVersionIndicator":"Yes","beginDate":"2002-08-08","endDate":null,"createdBy":"JASUR","dateCreated":"2002-08-08","modifiedBy":"HARTLEYG","dateModified":"2013-04-24","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2004104","version":"3","preferredName":"Adverse Event Therapy","preferredDefinition":"Therapy required to treat an adverse event.","longName":"AE_THERAPY","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"A7BA4F51-3E51-45B9-E034-0003BA0B1A09","latestVersionIndicator":"Yes","beginDate":"2002-08-08","endDate":null,"createdBy":"JASUR","dateCreated":"2002-08-08","modifiedBy":"REEVESD","dateModified":"2011-06-28","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2004106","version":"3","preferredName":"Dose Limiting Toxicity Ind","preferredDefinition":"Indication (Y or N) of an Adverse event considered to be a dose-limiting toxicity","longName":"DOSE_LIMT_TOX_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Standard","id":"A7BA4F51-3E5A-45B9-E034-0003BA0B1A09","latestVersionIndicator":"Yes","beginDate":"2002-08-08","endDate":null,"createdBy":"JASUR","dateCreated":"2002-08-08","modifiedBy":"MACASAC","dateModified":"2021-07-29","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2004107","version":"1","preferredName":"Adverse Event Outcome","preferredDefinition":"Final status of the patient related to an adverse event.","longName":"AE_OUTCOME","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"A7B9E7EF-FF81-4759-E034-0003BA0B1A09","latestVersionIndicator":"Yes","beginDate":"2002-08-08","endDate":null,"createdBy":"JASUR","dateCreated":"2002-08-08","modifiedBy":"MAESKEB","dateModified":"2011-11-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2004108","version":"2","preferredName":"Protocol Agent Name","preferredDefinition":"Name of a substance delivered to a patient/participant as part of a clinical trial regimen or plan.","longName":"PROT_AGT_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"2194554E-738B-0E88-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-11-06","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-11-06","modifiedBy":"REEVESD","dateModified":"2014-08-22","changeNote":"v2.0 uses more specific long name to extend use of CDE beyond CTMS trials, and to limit the inclusion of concomitant agents in this element.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2004139","version":"3","preferredName":"Stop Time","preferredDefinition":"The stop time for the administration of an intervention.","longName":"STOP_TM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Standard","id":"A7C96A44-A335-6C78-E034-0003BA0B1A09","latestVersionIndicator":"Yes","beginDate":"2002-08-09","endDate":null,"createdBy":"JASUR","dateCreated":"2002-08-09","modifiedBy":"HARTLEYG","dateModified":"2021-06-17","changeNote":"CCR CCMG approval of Released Status 1/7/2004.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2004140","version":"3","preferredName":"Urine Volume ml","preferredDefinition":"Urine volume collected in milliliters.","longName":"URINE_VOLUME_ML","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"A7C96A44-A33C-6C78-E034-0003BA0B1A09","latestVersionIndicator":"Yes","beginDate":"2002-08-09","endDate":null,"createdBy":"JASUR","dateCreated":"2002-08-09","modifiedBy":"MMADDINENI","dateModified":"2023-08-14","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2004141","version":"3","preferredName":"Parent Drug Assay","preferredDefinition":"The concentration of a Parent Drug Assay.","longName":"PAR_DRUG_ASSAY","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"A7C96A44-A343-6C78-E034-0003BA0B1A09","latestVersionIndicator":"Yes","beginDate":"2002-08-09","endDate":null,"createdBy":"JASUR","dateCreated":"2002-08-09","modifiedBy":"FORMBUILDER","dateModified":"2012-05-14","changeNote":"CCR CCMG approval of Released status on 1/7/2004.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2004142","version":"3","preferredName":"Parent Drug Mean Concentration","preferredDefinition":"The mean concentration of the parent drug, calculated from two or more replicate values.","longName":"PAR_DRUG_MEAN_CONC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"A7C96A44-A34A-6C78-E034-0003BA0B1A09","latestVersionIndicator":"Yes","beginDate":"2002-08-09","endDate":null,"createdBy":"JASUR","dateCreated":"2002-08-09","modifiedBy":"FORMBUILDER","dateModified":"2012-05-14","changeNote":"CCR CCMG approval of Released status 1/7/2004.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2004143","version":"3","preferredName":"Parent Drug Voided Amount","preferredDefinition":"The amount of parent drug in the voided samples.","longName":"P_VOID_AMT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"A7C96A44-A351-6C78-E034-0003BA0B1A09","latestVersionIndicator":"Yes","beginDate":"2002-08-09","endDate":null,"createdBy":"JASUR","dateCreated":"2002-08-09","modifiedBy":"MAESKEB","dateModified":"2011-10-13","changeNote":"CCR CCMG approval of Retired Phased out status on 1/7/2004.  CDE not needed.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2004145","version":"3","preferredName":"Metabolite Mean Concentration","preferredDefinition":"The Metabolite Mean Concentration","longName":"MTBLIT_MEAN_CONC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"A7C96A44-A35F-6C78-E034-0003BA0B1A09","latestVersionIndicator":"Yes","beginDate":"2002-08-09","endDate":null,"createdBy":"JASUR","dateCreated":"2002-08-09","modifiedBy":"FORMBUILDER","dateModified":"2012-05-14","changeNote":"CCR CCMG approval of Released status on 1/7/2004.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2004146","version":"3","preferredName":"Voided Metabolite Amount","preferredDefinition":"The amount of metabolite drug in the voided samples.","longName":"VOID_MTBLIT_AMT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"A7C96A44-A366-6C78-E034-0003BA0B1A09","latestVersionIndicator":"Yes","beginDate":"2002-08-09","endDate":null,"createdBy":"JASUR","dateCreated":"2002-08-09","modifiedBy":"MAESKEB","dateModified":"2011-10-13","changeNote":"CCR CCMG approval of Retired Phased out status on 1/7/2004.  CDE not needed.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2004147","version":"1","preferredName":"Last Contact Date","preferredDefinition":"The date of the last successful contact with the patient, family member, or caregiver.","longName":"LAST_CONTACT_DT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"A7CD3B82-934E-0BA9-E034-0003BA0B1A09","latestVersionIndicator":"Yes","beginDate":"2002-08-09","endDate":null,"createdBy":"JASUR","dateCreated":"2002-08-09","modifiedBy":"DWARZEL","dateModified":"2019-06-21","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2004150","version":"4","preferredName":"Death Primary Cause Descriptive Text","preferredDefinition":"Descriptive text for clarification with the cause of death is 'Other'.","longName":"DEATH_CAUS_TXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"FA7C1A6F-1C35-C2AB-E040-BB89AD436686","latestVersionIndicator":"Yes","beginDate":"2002-08-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-05-28","modifiedBy":"TSESU","dateModified":"2018-07-02","changeNote":"v4.0 replaces v3.0 with an updated Value Domain.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2004151","version":"3","preferredName":"Autopsy Death Cause Text","preferredDefinition":"Descriptive text for clarification when the cause of death at autopsy is 'Other'.","longName":"ATPSY_DEATH_CAUS_TXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"A7CD7B6A-20B4-0C03-E034-0003BA0B1A09","latestVersionIndicator":"Yes","beginDate":"2002-08-09","endDate":null,"createdBy":"JASUR","dateCreated":"2002-08-09","modifiedBy":"GDEEN","dateModified":"2023-01-18","changeNote":null,"administrativeNotes":"01/18/23_Added Alt Name and Classified for CCR/RAVE_ghd","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2004152","version":"3","preferredName":"Death Date","preferredDefinition":"The actual date of a patient's/participant's death.","longName":"DEATH_DT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A7CD7B6A-20BB-0C03-E034-0003BA0B1A09","latestVersionIndicator":"Yes","beginDate":"2002-08-09","endDate":null,"createdBy":"JASUR","dateCreated":"2002-08-09","modifiedBy":"ALAIS","dateModified":"2020-06-05","changeNote":"7/21/17 jk change reg status from Candidate to Application; removed CRF CSI per Round 5 finalization task.  5/28/16 jk added to MCL context CSI. 12/11/14 jc added Exceptional Responder CSI.  12/17/2003 CCR CCMG approval of Released status.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2004154","version":"3","preferredName":"Survival Status, unknown explanation","preferredDefinition":"Explanation of a survival status of 'Unknown'.","longName":"PT_OTHER_STAT_TXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A7CD7B6A-20CE-0C03-E034-0003BA0B1A09","latestVersionIndicator":"Yes","beginDate":"2002-08-09","endDate":null,"createdBy":"JASUR","dateCreated":"2002-08-09","modifiedBy":"KNABLEJ","dateModified":"2017-07-21","changeNote":"7/21/17 jk change reg status from Candidate to Application; removed CRF CSI per Round 5 finalization task.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2004155","version":"3","preferredName":"Death Cause","preferredDefinition":"Code for the reason a patient/participant died related specifically to the disease/condition under investigation","longName":"DEATH_CAUS_CD","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"A7CD7B6A-20D8-0C03-E034-0003BA0B1A09","latestVersionIndicator":"Yes","beginDate":"2002-08-09","endDate":null,"createdBy":"JASUR","dateCreated":"2002-08-09","modifiedBy":"FORMBUILDER","dateModified":"2013-10-28","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2004156","version":"6","preferredName":"Autopsy Sites of Disease Name","preferredDefinition":"Text names of anatomic sites that are involved with the disease/condition under study at the time of death, and confirmed upon autopsy.","longName":"ATPSY_DZ_SITE_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"CC2E19AE-F3AE-62E8-E040-BB89AD43511D","latestVersionIndicator":"Yes","beginDate":"2012-10-16","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-10-16","modifiedBy":"FORMBUILDER","dateModified":"2015-01-06","changeNote":"v5.0 replaced v4.0 archived CDE on 3/1/2012.  v5.0 uses versioned VD that increases the maximum length from 30 to 50 characters.  v6.0 increases maximum field length from 50 to 120 characters.dr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2004160","version":"3","preferredName":"Off Study Other Reason","preferredDefinition":"Text explanation for patient/participant coming off a clinical trial with reason of 'Other'.","longName":"OFF_STUDY_OTH_RSN","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"A806FFAC-9F45-2AF9-E034-0003BA0B1A09","latestVersionIndicator":"Yes","beginDate":"2002-08-12","endDate":null,"createdBy":"JASUR","dateCreated":"2002-08-12","modifiedBy":"CHANGP","dateModified":"2017-02-26","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2004161","version":"3","preferredName":"Progression Date","preferredDefinition":"The date of the evaluation or procedure used to determine the patient's disease status of progressive disease.","longName":"PROGRESSION_DT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"A806FFAC-9F4C-2AF9-E034-0003BA0B1A09","latestVersionIndicator":"Yes","beginDate":"2002-08-12","endDate":null,"createdBy":"JASUR","dateCreated":"2002-08-12","modifiedBy":"SOKKERL","dateModified":"2019-03-07","changeNote":"CCR CCMG approval of Released status on 12/17/2003.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2004162","version":"4","preferredName":"Specimen Sampling Type","preferredDefinition":"Type of specimen/body tissue being sampled, using an enumerated set of values.","longName":"SPEC_SMPLG_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"D5C585A4-18BA-7470-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-03-16","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-03-16","modifiedBy":"CHANGP","dateModified":"2017-01-18","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2004163","version":"3","preferredName":"Event Duration in Hours and Minutes","preferredDefinition":"Duration of an event, such as completion of an interview or a procedure, expressed in hours and minutes.","longName":"EVENT_DUR_HR_MTE","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"A807A83B-0E92-3525-E034-0003BA0B1A09","latestVersionIndicator":"Yes","beginDate":"2002-08-12","endDate":null,"createdBy":"JASUR","dateCreated":"2002-08-12","modifiedBy":"HLAINGY","dateModified":"2017-02-02","changeNote":"CCR CCMG approval of Released status on 1/7/2004.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2004165","version":"5","preferredName":"Parent Drug Mean Concentration Unit of Measure","preferredDefinition":"The unit of measure (UOM) for a parent drug assay's mean concentration.","longName":"PAR_DRUG_MEAN_UOM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"6D88B482-9061-2C06-E053-F662850A2362","latestVersionIndicator":"Yes","beginDate":"2018-05-31","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-05-31","modifiedBy":"COOPERM","dateModified":"2018-05-31","changeNote":"CCR CCMG approval of Released status on 1/7/2004.  Replaces v3.0 due to need to extend maximum field length from 12 to 16 characters. Version 5.0 expands max field from 16 to 30 characters maximum as requested for NCI-INC0282787-Theradex UOM 5.31.18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2004166","version":"3","preferredName":"Metabolite Assay","preferredDefinition":"The Metabolite Assay","longName":"MTBLIT_ASSAY","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"A807A83B-0EA7-3525-E034-0003BA0B1A09","latestVersionIndicator":"Yes","beginDate":"2002-08-12","endDate":null,"createdBy":"JASUR","dateCreated":"2002-08-12","modifiedBy":"FORMBUILDER","dateModified":"2012-05-14","changeNote":"CCR CCMG approval of Released status on 1/7/2004.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2004170","version":"3","preferredName":"Evaluation Date","preferredDefinition":"The date of the evaluation, procedure or visit that yielded data.","longName":"EVAL_DT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Standard","id":"A808AB9C-C24A-398C-E034-0003BA0B1A09","latestVersionIndicator":"Yes","beginDate":"2002-08-12","endDate":null,"createdBy":"JASUR","dateCreated":"2002-08-12","modifiedBy":"TSESU","dateModified":"2022-08-12","changeNote":"CCR CCMG approval of Released status on 12/17/2003.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2004171","version":"2","preferredName":"Autopsy Performed Indicator","preferredDefinition":"Yes, No, or Unknown indication of whether a postmortem examination was performed.","longName":"ATPSY_PERF_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EBC26768-08A9-5C79-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-12-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-12-27","modifiedBy":"GDEEN","dateModified":"2023-01-18","changeNote":"Supports CTMS reporting requirements v.3.02 and subsequent versions.","administrativeNotes":"01/18/23_Added Alt Name and Classified for CCR/RAVE_ghd","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2004172","version":"1","preferredName":"Measurement Y in Centimeters","preferredDefinition":"The measurements of a lesion in Y (2nd or width) dimension in centimeters.","longName":"MSRMT_Y_CM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"A82702B0-B579-1D4F-E034-0003BA0B1A09","latestVersionIndicator":"Yes","beginDate":"2002-08-14","endDate":null,"createdBy":"JASUR","dateCreated":"2002-08-14","modifiedBy":"TAYLORT","dateModified":"2019-05-16","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2004173","version":"1","preferredName":"Measurement Z in Centimeters","preferredDefinition":"The measurements of the lesions in Z (3rd) dimension in centimeters.","longName":"MSRMT_Z_CM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"A825FFFD-2983-1D55-E034-0003BA0B1A09","latestVersionIndicator":"Yes","beginDate":"2002-08-14","endDate":null,"createdBy":"JASUR","dateCreated":"2002-08-14","modifiedBy":"FORMBUILDER","dateModified":"2014-03-24","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2004232","version":"1","preferredName":"Radiation Therapy Site","preferredDefinition":"The anatomic site to which radiation therapy is delivered.","longName":"RT_SITE","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"A7349D89-2FD6-3DCD-E034-0003BA0B1A09","latestVersionIndicator":"Yes","beginDate":"2002-08-02","endDate":null,"createdBy":"JASUR","dateCreated":"2002-08-02","modifiedBy":"FORMBUILDER","dateModified":"2013-05-07","changeNote":"CCR CCMG approval of Released status on 1/28/2004.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2004234","version":"1","preferredName":"Note Date","preferredDefinition":"The date of a note captured as/on a source document.","longName":"NOTE_DT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"A7350F3A-74F8-3DAC-E034-0003BA0B1A09","latestVersionIndicator":"Yes","beginDate":"2002-08-02","endDate":null,"createdBy":"JASUR","dateCreated":"2002-08-02","modifiedBy":"COOPERM","dateModified":"2018-01-24","changeNote":"CCR CCMG approval of Released status on 1/7/2004.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2004252","version":"4","preferredName":"Parent Drug Voided Amount Unit(s) of Measure","preferredDefinition":"Unit of measure for the amount of the parent drug in a void (urination).","longName":"P_VOID_AMT_UOM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"ACC7E43A-1B70-7211-E053-4EBD850A45B2","latestVersionIndicator":"Yes","beginDate":"2020-08-13","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-08-13","modifiedBy":"COOPERM","dateModified":"2021-02-24","changeNote":"Versioned to replace retired VD. mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2004253","version":"4","preferredName":"Metabolite Amt in Void Unit(s) of Measurement","preferredDefinition":"The unit of measure for the total amount of a metabolite in a void (urination).","longName":"VOID_MTBLIT_AMT_UOM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"ACC84097-46F2-20D9-E053-4EBD850A48BA","latestVersionIndicator":"Yes","beginDate":"2020-08-13","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-08-13","modifiedBy":"COOPERM","dateModified":"2020-08-13","changeNote":"Versioned to replace retired VD. mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2004289","version":"1","preferredName":"Systolic Blood Pressure Value","preferredDefinition":"The pressure of the blood against the artery walls during systole (the contraction phase).","longName":"SYST_BP_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Standard","id":"A972A93C-A25A-303D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-08-30","endDate":null,"createdBy":"JASUR","dateCreated":"2002-08-30","modifiedBy":"KUMMEROA","dateModified":"2023-05-25","changeNote":" ","administrativeNotes":"2023.5.25 AQT added per ticket request CADSR0002455. ak","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2004291","version":"1","preferredName":"Diastolic Blood Pressure Value","preferredDefinition":"The pressure of the blood against the artery walls during diastole (the relaxation phase).","longName":"DIAST_BP_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Standard","id":"A97329E8-B6FC-2CAB-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-08-30","endDate":null,"createdBy":"JASUR","dateCreated":"2002-08-30","modifiedBy":"KUMMEROA","dateModified":"2023-05-25","changeNote":" ","administrativeNotes":"2023.5.25 AQT added per ticket request CADSR0002455. ak","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2004309","version":"1","preferredName":"Cardiac Preejection Period Percentage","preferredDefinition":"The interval measurement from the onset of ventricular depolarization to the beginning of mechanical contraction expressed as a percentage.","longName":"CARD_PREEJ_PER_PTG","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"A9CB29CA-66F4-585D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-09-03","endDate":null,"createdBy":"JASUR","dateCreated":"2002-09-03","modifiedBy":"REEVESD","dateModified":"2011-06-28","changeNote":"Redundant with existing CDE.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2004311","version":"3","preferredName":"Heart Left Ventricular Ejection Fraction Echocardiogram Test Percentage Value","preferredDefinition":"The amount of blood ejected from the left ventricle (LV) with each heart beat expressed as a percentage.","longName":"LVEF_PTG","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"33CFAE78-E6B0-7387-E050-BB89AD4315A4","latestVersionIndicator":"Yes","beginDate":"2016-05-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-05-27","modifiedBy":"COOPERM","dateModified":"2019-10-02","changeNote":"Replacing v2.0 CDE by returning 1 decimal place.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2004448","version":"3","preferredName":"Test Name","preferredDefinition":"Finite set of procedures and evaluations (Chest Xray, ECG, etc.) required to be reported to the Clinical Trials Monitoring Service for Phase I/II trials sponsored by CTEP.","longName":"TST_CTMS_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"AA4CA9D9-1D18-3CB2-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-09-10","endDate":null,"createdBy":"JASUR","dateCreated":"2002-09-10","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":"Subsumed by CDE for PROC.  Permissible values are a subset of those attached to PROC.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2006658","version":"1","preferredName":"Toxic Exposure Indicator","preferredDefinition":"A Yes/ No answer to whether an individual has been exposed to a certain type of toxins","longName":"TOXIC_EXP_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B8004BDC-C3F2-30D9-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-03-03","endDate":null,"createdBy":"MEDVEDOH","dateCreated":"2003-03-03","modifiedBy":"GDEEN","dateModified":"2023-10-17","changeNote":"Retired due to lack of use since the time of curation.  No additional use in classifications or CRFs since created.dmr4.7.2015","administrativeNotes":"10.17.23_Transferred ownership to CCR supporting protocol 000302-C (Natural History study)_ghd","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2006910","version":"1","preferredName":"Diagnosis Disease Stage Code","preferredDefinition":"The extent of a disease, especially whether the disease has spread from the original site to other parts of the body, at the time of initial diagnosis.","longName":"DZ_DX_STG","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"BBD54D3E-684D-1108-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-04-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2003-04-21","modifiedBy":"SOKKERL","dateModified":"2018-04-24","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2007875","version":"2","preferredName":"Specimen Laterality","preferredDefinition":"For tumors in paired organs, designates the side on which the specimen was obtained.","longName":"SPEC_LATERALITY","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"786DA1EB-7663-035A-E053-F662850A13A0","latestVersionIndicator":"Yes","beginDate":"2003-08-12","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-10-17","modifiedBy":"KNABLEJ","dateModified":"2022-02-07","changeNote":"Copy created due to inability to designate CTEP context item (workflow status not Released).  CCR CCMG approval of Released status in 12/2003. Versioned to add concepts to DEC. mc 10.17.18","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2008006","version":"3","preferredName":"Anatomic Site Location Descriptor","preferredDefinition":"Detailed spatial description to provide the exact location of an anatomic site or location.","longName":"SITE_LCTN_DESC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"HTMCP:HIV+ Tumor Molecular Characterization Project","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"CDBD6467-D447-6DC5-E040-BB89AD43508C","latestVersionIndicator":"Yes","beginDate":"2012-11-05","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-11-05","modifiedBy":"TSESU","dateModified":"2018-07-16","changeNote":"Used for TCGA Project by request of G. Diaz 4/2010. v3.0 replaces v2.0 with semantically equal precoordinated conceps used in place of postcoordinated concepts in 8 PVs.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2008024","version":"1","preferredName":"Metastatic Site Largest Size","preferredDefinition":"Size of largest measurable site of metastatic disease.","longName":"METC_SITE_LG_SZ","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"C52B426D-CCE8-256F-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-08-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2003-08-18","modifiedBy":"REEVESD","dateModified":"2011-03-18","changeNote":"CCR CCMG approval of Released status on 2/4/2004.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2008041","version":"2","preferredName":"Breast Cancer Invasive Histology Name","preferredDefinition":"Histology of the Invasive component of a breast cancer sample or lesion.","longName":"BRST_CA_INVAS_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E8535B39-C18F-3403-E040-BB89AD43304C","latestVersionIndicator":"Yes","beginDate":"2003-08-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-10-09","modifiedBy":"TAYLORT","dateModified":"2017-08-24","changeNote":"8/24/17 tt CCR specific use NCI Standard 5914586; CDE removed from Microscopic Path CRF per Round 5 finalization task. Changed reg status to \"Application\". Version 2.0 replaces version 1.0 with an updated list of VD permissible values and extended field length.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2008046","version":"2","preferredName":"Breast Carcinoma In Situ Histology","preferredDefinition":"Histology of the In Situ component of a breast cancer sample or lesion.","longName":"BRST_CA_IN_SITU_HIST","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E8535B39-C124-3403-E040-BB89AD43304C","latestVersionIndicator":"Yes","beginDate":"2013-10-09","endDate":"2014-02-25","createdBy":"REEVESD","dateCreated":"2013-10-09","modifiedBy":"COOPERM","dateModified":"2018-11-26","changeNote":"Released latest version. mc 11/26/2018","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2008051","version":"1","preferredName":"Mitotic Count Score","preferredDefinition":"An enumerated score of <7 (1) to >14 (3) mitotic events per 1040x high power field.","longName":"MIT_CT_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"C52E151C-60A4-4167-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-08-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2003-08-18","modifiedBy":"REEVESD","dateModified":"2011-03-18","changeNote":"CCR CCMG approval of Released status on 2/4/2004.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2008056","version":"2","preferredName":"Benign Tissue Change","preferredDefinition":"Benign tissue changes in breast tissue.","longName":"BENIGN_TISS_CHG","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"ACC7D89D-AF26-7422-E053-4EBD850A5E3B","latestVersionIndicator":"Yes","beginDate":"2020-08-13","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-08-13","modifiedBy":"COOPERM","dateModified":"2020-08-13","changeNote":"Versioned and associated with released VD. 8.13.2020 Verified still active in C3D global library. mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2008060","version":"1","preferredName":"Specimen Collection Method Type","preferredDefinition":"Type of method used for specimen acquisition, using an enumerated set of surgical and procedural approaches.  .","longName":"SPEC_COLL_METH_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C52E94E9-A36B-4A80-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-08-18","endDate":"2015-05-29","createdBy":"REEVESD","dateCreated":"2003-08-18","modifiedBy":"COOPERM","dateModified":"2019-09-27","changeNote":"Retired due to change in needs. dmr 5/29/2015 Changed back to released to use in C3D to Rave transition. mc 9.26.19","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2008248","version":"1","preferredName":"Attending Physician Identifier Individuals Name","preferredDefinition":"Name of the Attending Physician for the patient/participant.","longName":"ATTG_MD_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"C6727DA7-A234-53D8-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-09-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2003-09-03","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2008250","version":"1","preferredName":"Pathology Result Date","preferredDefinition":"The date on which pathology results are reviewed.","longName":"PATH_RSL_DT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"C6719204-6FBC-53F9-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-09-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2003-09-03","modifiedBy":"MAESKEB","dateModified":"2011-09-12","changeNote":"CCR CCMG approval of Released status on 1/7/2004.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2008251","version":"1","preferredName":"Specimen Lab Submission Date","preferredDefinition":"Date the specimen is submitted to the lab.","longName":"SPEC_LAB_SUBM_DT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"C6730465-1DBC-53DC-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-09-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2003-09-03","modifiedBy":"CHANGP","dateModified":"2016-10-28","changeNote":"Copied from CTEP DE prior to release; unable to designate DE for CCR.  CCR CCMG approval of Released status on 1/7/2004.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2008265","version":"2","preferredName":"Disease Stage Code","preferredDefinition":"Code to signify the extent of a disease, especially whether the disease has spread from the original site to other parts of the body.","longName":"DZ_STG_CD","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"2193D60D-68EE-20DE-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-15","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-11-06","modifiedBy":"SOKKERL","dateModified":"2023-10-19","changeNote":"Differentiation from CDE expressed as TNM measure.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2008415","version":"1","preferredName":"Change from Baseline Indicator","preferredDefinition":"An alteration or modification from a baseline time point or a set of data,  upon which subsequent measurements or observations are based, answered as Yes, No, Not applicable.","longName":"CHG_BSL_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"C89157E8-D70E-3485-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-09-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2003-09-30","modifiedBy":"REEVESD","dateModified":"2011-07-07","changeNote":"CCR CCMG discussion and approval of Released status on 10/1/2003.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2008419","version":"1","preferredName":"QRSD Interval Time in Milliseconds","preferredDefinition":"The QRSD Interval result from an electrocardiogram, expressed in milliseconds.","longName":"QRSD_INR_MILLSEC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"C8A00B93-7ECE-5440-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-10-01","endDate":null,"createdBy":"REEVESD","dateCreated":"2003-10-01","modifiedBy":"FORMBUILDER","dateModified":"2013-09-26","changeNote":"CCR CCMG approval of Released status 9/5/2003.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2008420","version":"1","preferredName":"QT Interval Time in Milliseconds","preferredDefinition":"The QT Interval result from an electrocardiogram, expressed in milliseconds.","longName":"QT_INR_MILLSEC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"C8A01552-D04D-52E6-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-10-01","endDate":null,"createdBy":"REEVESD","dateCreated":"2003-10-01","modifiedBy":"FORMBUILDER","dateModified":"2013-09-26","changeNote":"CCR CCMG approval of Released status 9/5/2003.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2008421","version":"1","preferredName":"QTC (Corrected) Interval Result","preferredDefinition":"The QTC (Corrected) Interval result from an electrocardiogram, expressed in milliseconds.","longName":"QTC_INR_RSL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"C8A01E97-62B2-543A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-10-01","endDate":null,"createdBy":"REEVESD","dateCreated":"2003-10-01","modifiedBy":"LEEW","dateModified":"2021-12-01","changeNote":"CCR CCMG approval of Released status 9/5/2003.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2008422","version":"1","preferredName":"PR Interval Time in Milliseconds","preferredDefinition":"PR Interval result from an electrocardiogram, expressed in milliseconds.","longName":"PR_INR_MILLSEC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"C8A02B05-6390-5448-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-10-01","endDate":null,"createdBy":"REEVESD","dateCreated":"2003-10-01","modifiedBy":"FORMBUILDER","dateModified":"2013-09-26","changeNote":"CCR CCMG approval of Released status 10/2003.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2008423","version":"2","preferredName":"Electrocardiogram Finding Normal/ Abnormal Indicator","preferredDefinition":"Summary finding of the activity on an electrocardiogram.","longName":"ECG_IMPRESS_FNG","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F3672E11-28F0-3D7C-E040-BB89AD4329CD","latestVersionIndicator":"Yes","beginDate":"2014-02-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-02-27","modifiedBy":"TITARENKOI","dateModified":"2020-05-26","changeNote":"Version 2.0 replaces retired v1.0 with an updated VD that extends the max length from 10 to 30 characters.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2008424","version":"2","preferredName":"Electrocardiography Result Normal/ Abnormal Indicator","preferredDefinition":"The regularity of the electrocardiogram rhythm which helps determine abnormal cardiac rhythm and myocardial damage.","longName":"ECG_RHYTHM_FNG","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F3793667-73A7-EAFC-E040-BB89AD437C80","latestVersionIndicator":"Yes","beginDate":"2014-02-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-02-28","modifiedBy":"REEVESD","dateModified":"2014-02-28","changeNote":"Version 2.0 replaces v1.0 with maximum field length extended from 10 to 30 characters.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2008425","version":"2","preferredName":"P Wave Finding Normal/ Abnormal Indicator","preferredDefinition":"Measurement and interpretation of P wave electrical activity on an electrocardiogram.","longName":"P_WAVE_FNG","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F378A220-FB4C-3113-E040-BB89AD435029","latestVersionIndicator":"Yes","beginDate":"2014-02-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-02-28","modifiedBy":"REEVESD","dateModified":"2014-02-28","changeNote":"Version 2.0 replaces v1.0 with an extended maximum field length from 10 to 30 characters.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2008426","version":"2","preferredName":"QRS Complex Finding Normal/ Abnormal Indicator","preferredDefinition":"Measurement and evaluation of the QRS complex electrical activity on an electrocardiogram.","longName":"QRS _COMPLEX_FNG","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F3793667-727F-EAFC-E040-BB89AD437C80","latestVersionIndicator":"Yes","beginDate":"2014-02-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-02-28","modifiedBy":"REEVESD","dateModified":"2014-02-28","changeNote":"Version 2.0 replaces v1.0 with additional permissible values that requires extension of the maximum field length from 10 to 30 characters.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2008427","version":"2","preferredName":"ST Segment Finding Normal/ Abnormal Indicator","preferredDefinition":"Measurement and evaluation of the ST segment on an electrocardiogram.","longName":"ST_SEG_FNG","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F3793667-7315-EAFC-E040-BB89AD437C80","latestVersionIndicator":"Yes","beginDate":"2014-02-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-02-28","modifiedBy":"REEVESD","dateModified":"2014-02-28","changeNote":"Version 2.0 replaces v1.0 with extended maximum field length from 10 to 30 characters.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2008428","version":"2","preferredName":"Pathology Report Identifier","preferredDefinition":"Unique identification number for the pathology report from which the data was abstracted.","longName":"PATH_REP_ID","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"78610203-3595-345F-E053-F662850AA80D","latestVersionIndicator":"Yes","beginDate":"2003-10-02","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-10-16","modifiedBy":"COLBERTM","dateModified":"2021-11-16","changeNote":"Versioned to use latest version of DEC. mc 10.16.18","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2008432","version":"2","preferredName":"Participant Position Type","preferredDefinition":"The arrangement or orientation of a participant's body at a point in time.","longName":"PART_POS_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"770D09A8-538F-8498-E040-BB89AD433A63","latestVersionIndicator":"Yes","beginDate":"2009-10-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-10-29","modifiedBy":"HARTLEYG","dateModified":"2021-06-17","changeNote":"v2.0 changes name from 'Patient' to 'Participant' with corresponding change in definition and question text.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2008447","version":"2","preferredName":"Alcohol Use Start Age in Years","preferredDefinition":"Age at which behaviors associated with the ingesting of alcoholic beverages, including social drinking, began.  ","longName":"ALC_USE_START_AGE_YR","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"CB64EC4E-DC68-5791-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-11-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2003-11-12","modifiedBy":"KUMMEROA","dateModified":"2023-01-10","changeNote":"V 2.0 uses numeric data type with two decimal places, in compliance with CCR requirements.  ","administrativeNotes":"2023.1.10 AQT and Alt SN added per ticket request CADSR0001837. ak","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2008448","version":"2","preferredName":"Alcohol Use Stop Age in Years","preferredDefinition":"Age at which Behaviors associated with the ingesting of alcoholic beverages, including social drinking, stop, expressed in number of years since birth.","longName":"ALC_USE_STOP_AGE_YR","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"CB64EC4E-DC73-5791-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-11-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2003-11-12","modifiedBy":"HARTLEYG","dateModified":"2018-10-26","changeNote":"V 2.0 uses numeric data type with two decimal places, in compliance with CCR requirements.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2008467","version":"2","preferredName":"First Live Birth Age in Years","preferredDefinition":"Age at the time of first live birth expressed in number of years.","longName":"FIRST_LIVE_BIRTH_AGE","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"CB64EC4E-DC7F-5791-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-11-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2003-11-12","modifiedBy":"HARTLEYG","dateModified":"2016-03-25","changeNote":"V 2.0 uses numeric data type with two decimal places, in compliance with CCR requirements.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2008468","version":"3","preferredName":"Patient Menopause Age In Years","preferredDefinition":"Age at the time of menopause expressed in number of years since birth.","longName":"MENP_AGE_YR","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"287CA895-EBA0-04BD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-02-02","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-02-02","modifiedBy":"ZHANGWE","dateModified":"2020-10-05","changeNote":"v3.0 uses Active and well formed DEC.  2/10/12 - Retired FBPP as part of content cleanup activities per concurrence with Jenny Larkin (NHLBI).","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2178045","version":"1","preferredName":"Age Began Smoking in Years","preferredDefinition":"Age began smoking cigarettes expressed in number of years since birth.","longName":"AGE_BEG_SMK_YR","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"CB64EC4E-DC4C-5791-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-11-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2003-11-12","modifiedBy":"HARTLEYG","dateModified":"2018-10-26","changeNote":"2/10/12  FBPP CS/CSI reference removed; FBPP content retired per Jenny Larkin (NHLBI).  old notes - CCR CDE is numeric data type with two decimal places, in compliance with CCR requirements.  Question taken from the National Health Survey, as requested by DCCP and DCEG.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2178047","version":"1","preferredName":"Stopped Smoking Age in Years","preferredDefinition":"Age at which smoking stopped completely expressed in number of years since birth.","longName":"STOP_SMOK_AGE_YR","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"CB64EC4E-DC53-5791-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-11-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2003-11-12","modifiedBy":"HARTLEYG","dateModified":"2016-08-13","changeNote":"CCR CDE is numeric data type with two decimal places, in compliance with CCR requirements.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2178049","version":"1","preferredName":"Menarche Age in Years","preferredDefinition":"Age at the time of first menstrual period, expressed in number of years since birth.","longName":"MENARCHE_AGE_YR","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"CB64EC4E-DC5A-5791-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-11-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2003-11-12","modifiedBy":"ZHANGWE","dateModified":"2020-06-11","changeNote":"CCR CDE is numeric data type with two decimal places, in compliance with CCR requirements.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2178136","version":"1","preferredName":"Course Stop Date","preferredDefinition":"The date that a course (cycle) as defined by a protocol is completed.","longName":"CRSE_STOP_DT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"CB64EC4E-DCBC-5791-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-11-13","endDate":null,"createdBy":"REEVESD","dateCreated":"2003-11-13","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":"Created to support CCR protocol setup 11/13/03.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2178362","version":"1","preferredName":"Estrogen Receptor Summary Result","preferredDefinition":"The level of estrogen receptor.  Result is expressed as negative, positive, indeterminate, or not done.","longName":"ER_SUMM_RSL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"CC571B25-1D18-4065-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-11-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2003-11-18","modifiedBy":"TAYLORT","dateModified":"2018-02-28","changeNote":"CCR CCMG approval of Released status on 2/4/2004.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2178367","version":"1","preferredName":"Progesterone Receptor Summary Result","preferredDefinition":"Progesterone receptor level.  Result is expressed as negative, positive, indeterminate, or not done.","longName":"PR_SUMM_RSL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"CC571B25-1D2A-4065-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-11-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2003-11-18","modifiedBy":"TAYLORT","dateModified":"2018-02-28","changeNote":"CCR CCMG approval of Released status on 2/4/2004.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2178402","version":"2","preferredName":"Her2 Immunohistochemistry Level Result","preferredDefinition":"The gene that controls cell growth by making the human epidermal growth factor receptor 2, detected by immunohistochemical means and expressed as 0  through 4+.","longName":"HER2_IHC_RSL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"2E18BFE4-8F00-CA26-E050-BB89AD4332A4","latestVersionIndicator":"Yes","beginDate":"2016-03-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-03-15","modifiedBy":"TSESU","dateModified":"2022-07-13","changeNote":"CCR CCMG approval of Released status on 2/4/2004. Used by The Cancer Genome Atlas (TCGA) by request of T. Lichtenberg 5/2010 Versioned to extend VD max length and add PVs for TCGA. mc 3/15/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2178405","version":"1","preferredName":"Her2 ISH Result","preferredDefinition":"Result of Her-2 Testing for fluorescent-tagged amplification, expressed as not amplified, indeterminate, or amplified.","longName":"HER2_ISH_RSL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"CC571B25-1DA6-4065-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-11-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2003-11-18","modifiedBy":"TITARENKOI","dateModified":"2021-02-23","changeNote":"CCR CCMG approval of Released status on 2/4/2004. Used by The Cancer Genome Atlas (TCGA) by request of T. Lichtenberg 5/2010","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2178407","version":"1","preferredName":"Estrogen Receptor Positive Percentage","preferredDefinition":"ER Positive results expressed as a percentage in numbers up to 3 characters with no decimal place.","longName":"ER_POS_PTG","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"CC571B25-1DAE-4065-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-11-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2003-11-18","modifiedBy":"LISU","dateModified":"2022-03-26","changeNote":"CCR CCMG approval of Released status on 2/4/2004.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2178413","version":"1","preferredName":"Progesterone Receptor Positive Percentage","preferredDefinition":"Progesterone receptor level, expressed as % with numbers up to 3 characters with no decimal place.","longName":"PR_POS_PTG","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"CC571B25-1DC0-4065-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-11-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2003-11-18","modifiedBy":"LISU","dateModified":"2022-03-26","changeNote":"CCR CCMG approval of Releasesd status on 2/4/2004. Used by The Cancer Genome Atlas (TCGA) by request of T. Lichtenberg 5/2010","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2178415","version":"1","preferredName":"MIB1 Positive Percentage","preferredDefinition":"Quantity expressed as a percentage in numbers up to 3 characters with no decimal place.","longName":"MIB1_POS_PTG","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"CC571B25-1DC9-4065-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-11-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2003-11-18","modifiedBy":"TSESU","dateModified":"2018-07-16","changeNote":"CCR CCMG approval of Released status on 2/4/2004.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2178467","version":"4","preferredName":"Patient Survival Status","preferredDefinition":"Status of a person's survival and disease at a particular point in time.","longName":"PT_SRVL_STAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"CC812908-4119-47F4-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-11-20","endDate":null,"createdBy":"REEVESD","dateCreated":"2003-11-20","modifiedBy":"SOKKERL","dateModified":"2018-04-24","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2178480","version":"1","preferredName":"Course Day Number","preferredDefinition":"A particular day in a course (cycle) of study-directed activity.","longName":"CRSE_DAY_NUM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"CC812908-4195-47F4-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-11-20","endDate":null,"createdBy":"REEVESD","dateCreated":"2003-11-20","modifiedBy":"COOPERM","dateModified":"2019-10-02","changeNote":"CCR CCMG approval of Released status on 1/7/04.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2178754","version":"1","preferredName":"Adverse Event Course Inclusion Indicator","preferredDefinition":"The inclusion of an AE in a previous course of a protocol, when the adverse event onset date is the same as the new course start date, as represented by a yes/no indicator.","longName":"AE_CRSE_INCL_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CDF85701-6FCD-6221-E034-0003BA12F5E7","latestVersionIndicator":"No","beginDate":"2003-12-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2003-12-08","modifiedBy":"REEVESD","dateModified":"2007-01-27","changeNote":"New version released to meet Value Domain requirements in C3D question, and modify DE definition.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2178754","version":"2","preferredName":"Adverse Events Course Inclusion Indicator","preferredDefinition":"A condition that signifies the inclusion (Y or N) of an AE in the previous course (cycle) of a protocol, based on the adverse event onset date and the course (cycle) start date and time.","longName":"AE_CRSE_INCL_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"D4A6A07C-5589-25A1-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-12-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-03-03","modifiedBy":"REEVESD","dateModified":"2011-06-28","changeNote":"CCR CCMG approval of Released status.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2178801","version":"2","preferredName":"Diagnosis Date","preferredDefinition":"The date of the procedure or evaluation used to determine the diagnosis.","longName":"DX_DT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"D28A1CC4-02D5-27FE-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-10-22","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-02-05","modifiedBy":"MMADDINENI","dateModified":"2024-02-08","changeNote":"1/22/20 jk removed from MCL Biospecimen CSI per MCL SME. 7/17/18 jk revised MCL Core CSI mapping. 12/11/14 jc added Exceptional Responder CSI.","administrativeNotes":"1.09.2024 Added AQT per request ticket CADSR0003248 _mmt\r\n11/29/23 Added 2 alt OIDs for CCTG ticket number CADSR0003123 cjl; 2023.9.6 AQT added per ticket request CADSR0002816. ak","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2178843","version":"1","preferredName":"Ineligibility Reason Text","preferredDefinition":"Reason a subject is ineligible for participation in a clinical trial.","longName":"INELIG_RSN_TXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"CE26673C-62C2-3309-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-12-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2003-12-11","modifiedBy":"SCOTTM","dateModified":"2014-04-02","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2178849","version":"1","preferredName":"Psoriasis Area Severity Index Score (PASI)","preferredDefinition":"A numeric score using the Psoriasis Area Severity Index to assess skin areas for Psoriasis involvement.","longName":"PSOR_AREA_SEV_IX_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"CE26673C-62D9-3309-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-12-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2003-12-11","modifiedBy":"LUY","dateModified":"2013-10-23","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2178851","version":"1","preferredName":"Disease Progression Indicator","preferredDefinition":"Yes/No indication of whether or not progressive disease has occurred.","longName":"DZ_PROG_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"CE9F9974-505C-6348-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-12-16","endDate":null,"createdBy":"REEVESD","dateCreated":"2003-12-16","modifiedBy":"SOKKERL","dateModified":"2018-05-16","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2179998","version":"1","preferredName":"Off Treatment Reason Code","preferredDefinition":"An enumerated list of reasons for a subject to be removed from the treatment or intervention phase of a protocol.","longName":"OFF_TX_RSN_CD","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"CFC6E87F-37CF-6F4D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-01-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-01-08","modifiedBy":"REEVESD","dateModified":"2011-06-30","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2180090","version":"1","preferredName":"Pathology Findings Gross Exam Result ","preferredDefinition":"Results of a pathological review of a specimen or sample of tissue.","longName":"PATH_FNG_GROSS_EXM_RSL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"CFC6E87F-3862-6F4D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-01-13","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-01-13","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2180115","version":"1","preferredName":"Response Assessment Methodology","preferredDefinition":"The technique or mode of analysis used to assess a subject's disease status or progress in reference to protocol-dictated endpoints.","longName":"RESP_ASSESS_METH","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"CFC6E87F-3960-6F4D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-01-14","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-01-14","modifiedBy":"WANGC","dateModified":"2015-07-22","changeNote":"CCR CCMG approval of Released status on 1/7/2004.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2180133","version":"1","preferredName":"Purdue Pegboard Test Criteria","preferredDefinition":"The Purdue Pegboard test measures finger dexterity and hand-eye coordinating by testing an individual's ability to move hands, fingers and arms (gross movement), and control movements of small objects (fingertip dexterity) like pegs.  The test measures the function of the right, left, and/or both hands.  ","longName":"PURD_PEGBD_TST_CRIT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"CFC6E87F-3986-6F4D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-01-16","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-01-16","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":"CCR CCMG approval of Released status on 2/4/2004.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2180139","version":"1","preferredName":"Purdue Pegboard Left Hand Result ","preferredDefinition":"The Purdue Pegboard test result for the left hand.  The numeric result is the number of pegs placed by a subject using the left hand.","longName":"PURD_PEGBD_LT_RSL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"CFC6E87F-3998-6F4D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-01-16","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-01-16","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":"CCR CCMG approval of Released status on 2/4/2004.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2180141","version":"1","preferredName":"Purdue Pegboard Right Hand Result","preferredDefinition":"The Purdue Pegboard test result for the right hand.  The numeric result is the number of pegs placed by a subject using the righthand.","longName":"PURD_PEGBD_RT_RSL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"CFC6E87F-399F-6F4D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-01-16","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-01-16","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":"CCR CCMG approval of Released status on 2/4/2004.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2180147","version":"1","preferredName":"Preference Hand Laterality","preferredDefinition":"Relating to the subject's identification of the preference or dominant hand.  Preference hand can be defined as right, left, or both (ambidexterity).","longName":"PREF_HAND_LAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"CFC6E87F-39BA-6F4D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-01-16","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-01-16","modifiedBy":"MORENOC","dateModified":"2019-02-25","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2180158","version":"1.1","preferredName":"Lansky Performance Status Score","preferredDefinition":"Numeric score representing performance status of a subject under 12 years of age according to the Lansky scale.","longName":"LANSKY_PERF_STAT_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F2C45BCA-79A4-7026-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-03-23","modifiedBy":"HARTLEYG","dateModified":"2021-06-17","changeNote":"New version uses semantically complete new DEC version.  Standard registration status approved by VCDE 5/17/2005.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2180164","version":"1","preferredName":"WEST-Hand Esthesiometer Test Criteria","preferredDefinition":"A set of criteria comprising the WEST-Hand Esthesiometer test.  This is a measure of the degree of tactile sensation of a subject, using weights on digits and recording feeling/nonfeeling of a tactile sensation.  ","longName":"WST_ESTHES_TST_CRIT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"CFC6E87F-3AE5-6F4D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-01-16","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-01-16","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":"CCR CCMG approval of Released status on 2/4/2004.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2180470","version":"1","preferredName":"Health Activity Questionnaire Dressing and Grooming Criteria","preferredDefinition":"Criteria from the Health Activity Questionnaire that relate to a subject's ability to dress and groom onself.","longName":"HAQ_DRES_GRM_CRIT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"D1E79022-C985-4E9F-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-01-26","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-01-27","modifiedBy":"LUY","dateModified":"2013-10-23","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2180481","version":"1","preferredName":"Health Activity Questionnaire Arising Criteria","preferredDefinition":"Health Activity Questionnaire criteria that relate to the subject's ability to arise from bed.","longName":"HAQ_ARISING_CRIT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"D16F2101-FECF-4578-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-01-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-01-27","modifiedBy":"LUY","dateModified":"2013-10-23","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2180484","version":"1","preferredName":"Health Activity Questionnaire Eating Criteria","preferredDefinition":"Health Activity Questionnaire criteria that relate to the subject's ability to eat and feed oneself.","longName":"HAQ_EAT_CRIT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"D16F2101-FED8-4578-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-01-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-01-27","modifiedBy":"LUY","dateModified":"2013-10-23","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2180487","version":"1","preferredName":"Health Activity Questionnaire Walking Criteria","preferredDefinition":"Health Activity Questionnaire criteria that relate to the subject's ability to walk and ambulate.","longName":"HAQ_WALK_CRIT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"D16F2101-FEE1-4578-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-01-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-01-27","modifiedBy":"SBREXT","dateModified":"2016-09-15","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2180489","version":"1","preferredName":"Health Activity Questionnaire Hygiene Criteria","preferredDefinition":"Health Activity Questionnaire criteria that relate to the subject's ability to perform personal hygiene activities.","longName":"HAQ_HYGIENE_CRIT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"D16F2101-FEEA-4578-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-01-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-01-27","modifiedBy":"LUY","dateModified":"2013-10-23","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2180493","version":"1","preferredName":"Health Activity Questionnaire Reach Criteria","preferredDefinition":"Health Activity Questionnaire criteria that relate to the subject's ability to reach and obtain items.","longName":"HAQ_REACH_CRIT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"D16F2101-FEF3-4578-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-01-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-01-27","modifiedBy":"LUY","dateModified":"2013-10-23","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2180495","version":"1","preferredName":"Health Activity Questionnaire Grip Criteria","preferredDefinition":"Health Activity Questionnaire criteria that relate to the subject's ability to grip and turn objects.","longName":"HAQ_GRIP_CRIT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"D16F2101-FEFC-4578-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-01-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-01-27","modifiedBy":"LUY","dateModified":"2013-10-23","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2180498","version":"1","preferredName":"Health Activity Questionnaire Activity Criteria","preferredDefinition":"Health Activity Questionnaire criteria that relate to the subject's ability to perform chores and tasks.","longName":"HAQ_ACT_CRIT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"D16F2101-FF05-4578-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-01-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-01-27","modifiedBy":"LUY","dateModified":"2013-10-23","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2180511","version":"1","preferredName":"Health Activity Questionnaire Aids and Device(s) Names","preferredDefinition":"An enumerated list of aids and devices that a person can use in the performance of daily activities","longName":"HAQ_AID_DEVICE_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"D16F2101-FF0E-4578-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-01-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-01-27","modifiedBy":"LUY","dateModified":"2013-10-23","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2180514","version":"1","preferredName":"Health Activity Questionnaire Help from Another Category","preferredDefinition":"An enumerated list of categories in which an individual needs help from another person. ","longName":"HAQ_HELP_ANOTH_CAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"D16F2101-FF17-4578-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-01-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-01-27","modifiedBy":"LUY","dateModified":"2013-10-23","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2180518","version":"1","preferredName":"Health Activity Questionnaire Health Activity Questionnaire Response Type","preferredDefinition":"A set of enumerated responses for Health Activity Questionnaire items. ","longName":"HAQ_CRIT_RESP_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"D16F2101-FF20-4578-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-01-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-01-27","modifiedBy":"LUY","dateModified":"2013-10-23","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2180563","version":"1","preferredName":"Pharmacokinetics Collection Plan Date","preferredDefinition":"The planned/anticipated date of pharmacokinetic sampling.","longName":"PK_COLL_PLAN_DT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"D16F2101-FF57-4578-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-01-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-01-27","modifiedBy":"GDEEN","dateModified":"2022-12-05","changeNote":"CCR CCMG approval of Released status on 1/7/2004.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2180565","version":"1","preferredName":"Pharmacokinetics Collection Plan Time","preferredDefinition":"The planned time for pharmacokinetic sample collection, using a 24-hour clock (hours and minutes).","longName":"PK_COLL_PLAN_TM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"D16F2101-FF60-4578-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-01-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-01-27","modifiedBy":"KUMMEROA","dateModified":"2023-04-13","changeNote":"CCR CCMG approval of Released status on 1/7/2004.","administrativeNotes":"2023.4.13 AQT added per ticket request CADSR0002302. ak","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2180571","version":"2","preferredName":"Planned Pharmacokinetic Time Interval Text","preferredDefinition":"Text description of the set of time intervals (expressed as a fraction of an hour) for which pharmacokinetic sampling is planned.","longName":"PK_COLL_PLAN_INR_TXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"07D00C2C-372C-1C50-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-01-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-12-14","modifiedBy":"HARTLEYG","dateModified":"2013-04-24","changeNote":"New version implements a text field to capture protocol-specific set of values.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2180907","version":"2","preferredName":"Laboratory Test Normal Range Indicator","preferredDefinition":"Indicator of the result of a laboratory test as compared to the reference range of values for this test.","longName":"LAB_TST_NL_RANGE_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"9BF5C7EE-E756-1E67-E040-BB89AD4359EB","latestVersionIndicator":"Yes","beginDate":"2011-02-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-02-10","modifiedBy":"FOURNIERLA","dateModified":"2015-08-25","changeNote":"Replaces v1.0 with VD that has extended length from 6 to 12","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2180913","version":"1","preferredName":"Test Result Significance Indicator","preferredDefinition":"Indicator placed on a test result, reflecting the decision to report a specific piece of data to a sponsor or monitor.  Response is represented as Y (Yes) or N (No).","longName":"TST_RSL_SIGNIF_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"D28A1CC4-031F-27FE-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-02-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-02-09","modifiedBy":"DASCOMBS","dateModified":"2016-08-04","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2180953","version":"1","preferredName":"Glucksberg Liver Graft Versus Host Disease Stage","preferredDefinition":"Numeric descriptor of stage relating to the Glucksberg criteria for the assessment of acute GVHD in the liver. [Manually-curated]","longName":"GLUCK_LIV_AGVHD_STG","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"D2F0AC9A-5103-3D8A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-02-12","endDate":null,"createdBy":"MAESKEB","dateCreated":"2004-02-12","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2180958","version":"1","preferredName":"Glucksberg Gastrointestinal Graft Versus Host Disease Stage","preferredDefinition":"Numreic value to describe the extent of acute GVHD in the gastrointestinal system, using Glucksberg criteria. [Manually-curated]","longName":"GLUCK_GI_AGVHD_STG","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"D2F0AC9A-5117-3D8A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-02-12","endDate":null,"createdBy":"MAESKEB","dateCreated":"2004-02-12","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2180965","version":"1","preferredName":"Glucksberg Graft Versus Host Disease Assessment Grade","preferredDefinition":"Assessment of a transplant recipient for Graft versus Host Disease, and the assignment of a grade or value to denote the severity of signs and symptoms, using the Glucksberg Diagnostic Criteria for acute GVHD.","longName":"GLUCK_GVHD_ASSESS_GD","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"D2F0AC9A-5145-3D8A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-02-12","endDate":"2015-04-06","createdBy":"REEVESD","dateCreated":"2004-02-12","modifiedBy":"ALEYR","dateModified":"2017-05-11","changeNote":"Data element has not been used in forms or classifications since creation in 2004.  Retired because of lack of community need.  DMR 4.6.2015  2017-05-10: Changed workflow status to \"Released\" as the CDE is needed for use by the CIBMTR.  Removed the end date.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2180969","version":"3","preferredName":"Chronic Graft Versus Host Disease Assessment Anatomic Site Name","preferredDefinition":"Text name(s) of the anatomic sites of the transplant recipient involved with chronic Graft versus Host Disease (GVHD).","longName":"CHR_GVHD_ANAT_SITE","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7BA5FD84-4D66-1BBD-E053-F662850AEDFF","latestVersionIndicator":"Yes","beginDate":"2018-11-27","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-11-27","modifiedBy":"COOPERM","dateModified":"2018-11-27","changeNote":"Version expands max field length. Version uses standard VD.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2181590","version":"2","preferredName":"Laboratory Test NCI Code","preferredDefinition":"Numeric lab source codes assigned by the National Cancer Institute (NCI) Clinical Center Laboratory system as part of the Clinical Data Warehouse (CDW).","longName":"LAB_TST_NCI_CD","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7BA69C3B-F7EC-174A-E053-F662850A1248","latestVersionIndicator":"Yes","beginDate":"2018-11-27","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-11-27","modifiedBy":"COOPERM","dateModified":"2018-11-27","changeNote":"Versioned VD to move to CCR and annotate with rep term. mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2181596","version":"1","preferredName":"Laboratory Data Source Name","preferredDefinition":"Name of the source of a laboratory test result.","longName":"LAB_DATA_SRCE_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"D4A6A07C-5542-25A1-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-03-02","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-03-02","modifiedBy":"GDEEN","dateModified":"2022-11-02","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2181601","version":"1","preferredName":"Prestudy Lab Date","preferredDefinition":"Effective date for the inclusion of lab test results for confirmation of a subject's eligiblity for a clinical trial.","longName":"PRESTUDY_LAB_DT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"D4A6A07C-5556-25A1-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-03-02","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-03-02","modifiedBy":"MAESKEB","dateModified":"2011-09-12","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2181866","version":"1","preferredName":"Contrast Agent  Enhancement Indicator","preferredDefinition":"Indication that an image was enhanced (Y) or not (N) by the use of a contrast agent.","longName":"CNTST_AGT_ENH_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"D5C585A4-1922-7470-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-03-17","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-03-17","modifiedBy":"HARTLEYG","dateModified":"2013-08-12","changeNote":"CCR CCMG approval of Released status on 3/24/2004.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2182072","version":"1","preferredName":"Patient Randomization Date","preferredDefinition":"Date of a process used in therapeutic trials or other research endeavors for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups.","longName":"PT_RNDM_DT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Standard","id":"D64E819C-E48D-2909-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-03-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-03-23","modifiedBy":"TSESU","dateModified":"2023-03-15","changeNote":"Add to the Registration CRF standards based on Round 3 CRF initiative work.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2182204","version":"1","preferredName":"Patient Registration Processing Date","preferredDefinition":"Date of receipt and processing of a completed eligibility checklist for a patient/subject under evaluation for accrual to a clinical trial.","longName":"PT_REG_PROC_DT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"D6DC9422-FB14-0A90-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-03-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-03-30","modifiedBy":"REEVESD","dateModified":"2011-03-18","changeNote":"Replaces use of designated CDE. This definition will allow tracking of the time between signing of informed consent (registration date) and the date of processing of the eligibility checklist.  Approved by CCR on 3/29/2004.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2182451","version":"1","preferredName":"Protocol Long Title Text","preferredDefinition":"Descriptive text used to represent the long title or name of a protocol. [Manually-curated]","longName":"PROT_LONG_TLE_TXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"D703117C-88D8-00CA-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-04-02","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-04-02","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":"CDE supports DICOM Standard PS 3 - 2004.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2182637","version":"1","preferredName":"Antigen Testing Name","preferredDefinition":"Name(s) of the actual antigens used in antigen or skin testing (delayed hypersensitivity testing).","longName":"ATGN_TST_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"D751C8E1-827C-1B6B-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-04-06","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-04-06","modifiedBy":"REEVESD","dateModified":"2011-03-18","changeNote":"CCR CCMG approval of Released status on 4/21/2004.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2182653","version":"1","preferredName":"Antigen Testing Overall Result","preferredDefinition":"Result that represents a summary reading of skin (antigen) testing.","longName":"ATGN_TST_OVRLL_RSL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"D751C8E1-82D5-1B6B-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-04-06","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-04-06","modifiedBy":"REEVESD","dateModified":"2012-05-09","changeNote":"CCR CCMG approval of Released status on 4/21/2004.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2182656","version":"1","preferredName":"Antigen Testing Erythema Results","preferredDefinition":"Result of antigen testing that evaluates and documents the presence of local erythema (redness) at the site of antigen placement.","longName":"ATGN_TST_ERYTH_RSL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"D751C8E1-82E5-1B6B-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-04-06","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-04-06","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":"CCR CCMG approval of Released status on 4/21/2004.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2182658","version":"1","preferredName":"Antigen Testing Induration in Millimeter(s)","preferredDefinition":"Millimeter value for the diameter of induration produced by the placement of antigens.  ","longName":"ATGN_TST_INDURATN_MM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"D751C8E1-82ED-1B6B-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-04-06","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-04-06","modifiedBy":"REEVESD","dateModified":"2011-03-18","changeNote":"CCR CCMG approval of Released status on 4/21/2004.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2182863","version":"2","preferredName":"Blood Component Transfusion Text Name","preferredDefinition":"Name of blood components administered to recipients or donors.","longName":"TRNSF_BLD_COMPN_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Standard","id":"FE52ECB4-C719-617F-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-08-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-08-19","modifiedBy":"TSESU","dateModified":"2017-03-07","changeNote":"Version 2.0 defines values and meanings from version 1.0 with more detail and precision.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2182866","version":"1","preferredName":"Transfuse Blood Component Units","preferredDefinition":"Number of units of blood component transfused into a recipient.","longName":"TRNSF_BLD_COMPN_UNIT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Standard","id":"D751C8E1-848E-1B6B-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-04-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-04-09","modifiedBy":"TSESU","dateModified":"2017-03-07","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2182909","version":"1","preferredName":"Protocol Amendment Date","preferredDefinition":"Date of protocol amendment approval by IRB.  Amendments are versions of the original protocol document, each version with an eligibility checklist, informed consent, and complete revised protocol.","longName":"PROT_AMDT_DT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"D7E44F5E-8440-1C4F-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-04-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-04-12","modifiedBy":"MAESKEB","dateModified":"2019-01-31","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2182950","version":"1","preferredName":"Protocol Closure Date","preferredDefinition":"Date of closure refers to the closing of a study to enrollment.  Patients enrolled on the study at the time of closure will continue their treatment plan.","longName":"PROT_CLOS_DT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"D7E44F5E-853A-1C4F-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-04-13","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-04-13","modifiedBy":"REEVESD","dateModified":"2011-03-18","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2182968","version":"1","preferredName":"Protocol Amendment Identifier","preferredDefinition":"Identifier to uniquely represent an amendment (version) of a protocol.","longName":"PROT_AMDT_ID","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"D7E44F5E-859C-1C4F-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-04-13","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-04-13","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2182974","version":"2","preferredName":"Protocol Monitor Code","preferredDefinition":"Code to uniquely identify the monitor for an NCI protocol/clinical trial. [Manually-curated]","longName":"PROT_MONR_CD","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"3FEF534B-2577-7372-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-11-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-11-27","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2183023","version":"2","preferredName":"Clinical Trial Phase Code","preferredDefinition":"Character code to specify the phase of a clinical trial. [Manually-curated].","longName":"CLIN_TRL_PHASE_CD","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"3FEB8D7C-D1A2-1FB9-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-11-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-11-27","modifiedBy":"ZHANGW","dateModified":"2015-09-16","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2183054","version":"2","preferredName":"Protocol Status Code","preferredDefinition":"Codesto represent the status of a protocol in relation to the ability to enroll participants/patients. [Manually-curated]","longName":"PROT_STAT_CD","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"3FED6ACF-34EF-3855-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-11-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-11-27","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2183079","version":"1","preferredName":"Patient Randomization Indicator","preferredDefinition":"Indicator of Yes or No to specify that a patient/participant has been randomized on a study.","longName":"PT_RNDM_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"D7F790A4-0273-5086-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-04-14","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-04-14","modifiedBy":"NIKITAP","dateModified":"2022-01-07","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2183107","version":"1","preferredName":"Protocol Sponsor Code","preferredDefinition":"Code used to identify the sponsor (IND holder) for a clinical trial.","longName":"PROT_SPNR_CD","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"D7F790A4-0378-5086-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-04-14","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-04-14","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2183195","version":"1","preferredName":"Disease Status Type","preferredDefinition":"Summary status of the amount of disease present at a specified timepoint.","longName":"DZ_STAT_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"D82DA209-13EF-5FF1-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-04-16","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-04-16","modifiedBy":"FORMBUILDER","dateModified":"2013-07-19","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2183233","version":"1","preferredName":"Menstrual Period 12 Months Indicator","preferredDefinition":"Indicator of Yes or No to indicate if a woman has had a menstrual period in the past 12 months.","longName":"MENS_PER_12_MOS_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"D8307BCB-40E1-2325-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-04-16","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-04-16","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2183297","version":"3","preferredName":"Pregnancy History Yes No Three Character Indicator","preferredDefinition":"History of any past pregnancies indicated by Yes or No response.","longName":"PREG_HX_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"D82DA209-1498-5FF1-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-04-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-04-20","modifiedBy":"COOPERM","dateModified":"2011-08-25","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2183299","version":"1","preferredName":"Pregnancy Live Birth Count","preferredDefinition":"Count of the number of successful pregnancies that resulted in the birth of at least one child.","longName":"PREG_LIVEBIRTH_CT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"D82DA209-14A5-5FF1-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-01-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-04-20","modifiedBy":"TITARENI","dateModified":"2021-11-24","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2183304","version":"1","preferredName":"Pregnancy Stillbirth Count","preferredDefinition":"Incidence of stillbirth as part of a woman's pregnancy history.","longName":"PREG_STILLBIRTH_CT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"D82DA209-14BD-5FF1-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-01-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-04-20","modifiedBy":"TITARENI","dateModified":"2021-11-24","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2183312","version":"1","preferredName":"Breast Feeding Indicator","preferredDefinition":"Yes/No response to a question of whether or not a woman has a history of breast feeding an infant.","longName":"BRST_FEED_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"D82DA209-14E3-5FF1-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-04-20","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-04-20","modifiedBy":"RODGERSC","dateModified":"2014-11-07","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2183327","version":"2","preferredName":"Patient Sibling Indicator","preferredDefinition":"Text indicator to represent the occurrence of a cancer diagnosis for any children or siblings of a subject.","longName":"CHLD_SIB_CA_DX_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"06F596AE-C700-4492-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-12-06","modifiedBy":"DWARZEL","dateModified":"2023-03-15","changeNote":"Version 2.0 uses VD that adds permissible values. 2023-03-15 It was noticed that the Effective date was set to 3005 instead of 2005. This was changed to 2005. DW","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2183329","version":"2","preferredName":"Relative Mother Cancer Diagnosis Indicator","preferredDefinition":"Text indicator to represent the occurrence of a cancer diagnosis for mother or any of her relatives.","longName":"MOTH_RELTV_CA_DX_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"06F596AE-C747-4492-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-12-06","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":"Replaces earlier version with an expanded VD.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2183360","version":"2","preferredName":"Laboratory Test Result Numeric Value","preferredDefinition":"Numeric result of the laboratory analysis expressed as a number of 12 digits total, with 5 after the decimal.","longName":"LAB_TST_RSL_NUM_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Standard","id":"775E5CD4-9C94-0703-E040-BB89AD4345B9","latestVersionIndicator":"Yes","beginDate":"2009-11-01","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-11-02","modifiedBy":"KUMMEROA","dateModified":"2023-04-11","changeNote":"Reused existing CDE for Lab CRF. Classified with Standard CRF 4/2009. mc  v2.0 created to update DEC to newest version.","administrativeNotes":"2023.4.11 AQTs added per ticket request CADSR0002291. ak","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2183371","version":"2","preferredName":"Laboratory Test Standard Value","preferredDefinition":"Lab test values as entered by a user irrespective of the unit of measure (UOM) required to perform adverse event grading.","longName":"LAB_TST_RSL_STD_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"775E5CD4-9E25-0703-E040-BB89AD4345B9","latestVersionIndicator":"Yes","beginDate":"2009-11-01","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-11-02","modifiedBy":"COOPERM","dateModified":"2019-10-02","changeNote":"v2.0 released to include updated DEC version.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2183411","version":"1","preferredName":"Transplant Received Date","preferredDefinition":"Date a  transplant infusion (bone marrow, cells) isreceived by the patient.","longName":"TSPL_RECD_DT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"D8F7FB0B-8D41-3453-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-04-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-04-27","modifiedBy":"SETRAKIN","dateModified":"2019-04-22","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2183426","version":"1","preferredName":"SF-36 Questionnaire Total Score","preferredDefinition":"Total numeric score for the SF-36, a 36 question survey for measuring health status and outcomes from the patient's point of view.  Measures 8 health concepts (score 1 - 6), to yield a total score.","longName":"SF36_QUEST_TTL_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"D8F7FB0B-8D6C-3453-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-04-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-04-27","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2183433","version":"1","preferredName":"Fatigue Severity Scale Questionnaire Total Score","preferredDefinition":"Total numeric score for the Fatigue Severity Scale, a psychometric measure of fatigue in a subject with MS or other condition.","longName":"FSS_QUEST_TTL_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"D8F7FB0B-8D7A-3453-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-04-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-04-27","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2183439","version":"1","preferredName":"Beck Depression II Total Score","preferredDefinition":"Total numeric score for Beck Depression Inventory II, a psychometric questionnaire that consists of 21 groups of statements, yielding a total score of 21 to 63 points.","longName":"BECK_DEPRS_II_TTL_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"D8F7FB0B-8D8F-3453-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-04-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-04-27","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2183446","version":"1","preferredName":"Gracely Intensity Scale Score","preferredDefinition":"Numeric score on a Visual Analog Scale of 0 to 20 used by a subject to define the pain intensity experience.","longName":"GRACE_INTS_SCALE_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"D8F7FB0B-8D9D-3453-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-04-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-04-27","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2183450","version":"1","preferredName":"Gracely Unpleasantness Scale Score","preferredDefinition":"Visual Analog Scale of 0 to 20 used by a subject to define the pain unpleasantness experience.","longName":"GRACE_UNPLS_SCALE_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"D8F7FB0B-8DAB-3453-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-04-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-04-27","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2183460","version":"1","preferredName":"FACIT-Sp Physical Well-Being Subcategory Score","preferredDefinition":"Numeric score for the Physical Well-Being subcategory of the FACIT Spiritual Well-being psychometric tool.","longName":"FACITSP_PHYSW_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"D8F7FB0B-8DC5-3453-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-04-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-04-27","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":"Domain score from the FACT-Br (Brain) v. 4, copyright 1987.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2183464","version":"1","preferredName":"FACIT-Sp Social/Family Well-Being Subcategory Score","preferredDefinition":"Numeric score for the Social/Family Well-Being subcategory of the FACIT Spiritual Well-being tool.","longName":"FACITSP_SOCW_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"D8F7FB0B-8DD3-3453-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-04-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-04-27","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":"Domain score from the FACT-Br (Brain) v. 4, copyright 1987.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2183468","version":"1","preferredName":"FACIT-Sp Emotional Well-Being Subcategory Score","preferredDefinition":"Numeric score for the Emotional Well-Being subcategory of the FACIT Spiritual Well-being tool.","longName":"FACITSP_EMOTW_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"D8F7FB0B-8DE1-3453-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-04-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-04-27","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":"Domain score from the FACT-Br (Brain) v. 4, copyright 1987.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2183486","version":"1","preferredName":"FACIT-Sp Additional Concerns Subcategory Score","preferredDefinition":"Numeric score for the Additional Concerns subcategory of the FACIT Spiritual Well-being tool.","longName":"FACITSP_ADDCON_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"D8F7FB0B-8DF4-3453-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-04-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-04-27","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":"Domain score from the FACT-Br (Brain) v. 4, copyright 1987.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2183488","version":"1","preferredName":"FACIT-Sp Functional Well-Being Subcategory Score","preferredDefinition":"Functional Well-Being subcategory of the FACIT Spiritual Well-being tool.","longName":"FACITSP_FUNCW_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"D8F7FB0B-8DFD-3453-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-04-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-04-27","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":"Domain score from the FACT-Br (Brain) v. 4, copyright 1987.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2183492","version":"1","preferredName":"FACIT Spiritual Well-Being Questionnaire Total Score","preferredDefinition":"Numeric total score for the FACIT-Sp Questionnaire to assess subject spiritual well-being through the use of Likert scale questions.","longName":"FACITSP_QUEST_TTL_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"D8F7FB0B-8E0B-3453-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-04-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-04-27","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":"Total score from the FACT-Br (Brain) v. 4, copyright 1987.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2183494","version":"1","preferredName":"Transplant Received Day Number","preferredDefinition":"Number of days lapsed since receipt of transplant (marrow or cells) infusion.  ","longName":"TSPL_RECD_DAY_NUM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"D8F7FB0B-8E14-3453-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-11-20","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-04-28","modifiedBy":"REEVESD","dateModified":"2011-06-28","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2183543","version":"1","preferredName":"Laboratory Data Inclusion Stop Date","preferredDefinition":"Date on which the inclusion of lab test results into a Case Report Form (CRF) stops.","longName":"LAB_INCL_STOP_DT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"D939EDEE-3531-11F4-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-03-02","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-04-29","modifiedBy":"REEVESD","dateModified":"2011-03-18","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2183547","version":"1","preferredName":"Missed Dose Date","preferredDefinition":"Date of a dose of agent/medication ordered for but not taken by a patient/subject.","longName":"MISSED_DOSE_DT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"D939EDEE-353F-11F4-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-04-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-04-29","modifiedBy":"REEVESD","dateModified":"2011-03-18","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2183549","version":"1","preferredName":"Missed Dose Amount","preferredDefinition":"Amount of the dose of agent/medication that was ordered for but not taken by a patient/subject.","longName":"MISSED_DOSE_AMT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"D939EDEE-3548-11F4-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-04-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-04-29","modifiedBy":"REEVESD","dateModified":"2012-02-02","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2183574","version":"4","preferredName":"Histopathologic Differentiation Text Grade","preferredDefinition":"Text grade for the degree of cellular differentiation in a tissue sample.","longName":"HISTPATH_DIFF_TXT_GD","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F6D76EEC-2FB8-57F3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-05-05","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-05-20","modifiedBy":"HARTLEYG","dateModified":"2016-04-05","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2183587","version":"1","preferredName":"Principal Investigator First Name","preferredDefinition":"Full first name of the person responsible for the conduct of a clinical trial. [Manually-curated]","longName":"PI_FIRST_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"D9AFFD26-2294-08E4-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-05-06","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-05-06","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":"4/19/10 released per VCDE request post Silver Review","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2183589","version":"1","preferredName":"Principal Investigator Last Name","preferredDefinition":"Full last name of the person responsible for the conduct of a clinical trial. [Manually-curated]","longName":"PI_LAST_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"D9AFFD26-229F-08E4-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-05-06","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-05-06","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":"4/19/10 released per VCDE request post Silver Review","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2183596","version":"1","preferredName":"Adverse Event Reporter First Name","preferredDefinition":"Full first name of the person reporting an expedited adverse event through submission of a report.","longName":"AE_REPR_FIRST_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"D9AFFD26-22BB-08E4-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-05-06","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-05-06","modifiedBy":"REEVESD","dateModified":"2014-07-16","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2183598","version":"1","preferredName":"Adverse Event Reporter  Last Name","preferredDefinition":"Full last name of the person reporting an expedited adverse event through submission of a report.","longName":"AE_REPR_LAST_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"D9AFFD26-22C3-08E4-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-05-06","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-05-06","modifiedBy":"REEVESD","dateModified":"2014-07-15","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2183600","version":"2","preferredName":"Concomitant Agent Name","preferredDefinition":"Name of a nonstudy agent taken during a course (cycle) of a protocol.","longName":"CONCT_AGT_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"0DDF0D1A-269A-6548-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-01","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-03-01","modifiedBy":"KUMMEROA","dateModified":"2023-10-31","changeNote":"New version uses better DEC. Versioned to add 292 C3D values. mc 11/15/19","administrativeNotes":"2023.10.31 AQT added per ticket request CADSR0003010. ak","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2183617","version":"1","preferredName":"Common Toxicity Criteria Version Number","preferredDefinition":"Version of the Common Toxicity Criteria as referenced by the protocol.","longName":"CTC_VER_NUM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"D9AFFD26-2318-08E4-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-05-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-05-07","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2183619","version":"1","preferredName":"Adverse Event Expected Indicator","preferredDefinition":"Text indicator to represent anticipation that an unfavorable or unintended symptom, sign, or disease including an abnormal laboratory finding) temporally associated with the use of a medical treatment or procedure may occur.","longName":"AE_EXPECT_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Standard","id":"D9AFFD26-2322-08E4-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-05-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-05-07","modifiedBy":"HARTLEYG","dateModified":"2021-06-17","changeNote":"Registration is Standard based on CRF Initiative approval and alignment with BRIDG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2183663","version":"1","preferredName":"Systemic Lupus Activity Measure Total Score","preferredDefinition":"Numeric score as a measure of the activity of a lupus patient using the SLAM (Systemic Lupus Activity Measure).","longName":"SLAM_TTL_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"DA13B9F5-08E3-3EF0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-05-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-05-10","modifiedBy":"PRICEA","dateModified":"2013-10-25","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2183667","version":"1","preferredName":"Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index Total Score","preferredDefinition":"Numeric score on a Psychometric measure of the damage occurring in patients with SLE irregardless of causation.","longName":"SLICCACR_TTL_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"DA13B9F5-08F1-3EF0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-05-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-05-10","modifiedBy":"PRICEA","dateModified":"2013-10-25","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2183675","version":"1","preferredName":"SLEDAI Weighted Score","preferredDefinition":"Weighted numeric scores to be used with responses on the SLEDAI, a psychometric tool measure of symptoms associated with SLE at the time of visit or during the preceding 10 days.","longName":"SLEDAI_WT_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"D9D5A32D-7699-5854-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-05-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-05-11","modifiedBy":"REEVESD","dateModified":"2016-06-13","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2183679","version":"1","preferredName":"SLEDAI Total Score","preferredDefinition":"Psychometric tool measure of symptoms associated with SLE at the time of visit or during the preceding 10 days._Numeric score on a psychometric questionnaire or survey.","longName":"SLEDAI_TTL_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"D9D5A32D-76AB-5854-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-05-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-05-11","modifiedBy":"LUY","dateModified":"2013-10-23","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2183886","version":"1","preferredName":"Hospital Admission Date","preferredDefinition":"Date that a person enters a hospital for admission.","longName":"HOSP_ADM_DT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"DB302B67-DD40-1206-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-05-26","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-05-26","modifiedBy":"LISU","dateModified":"2020-04-30","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2183893","version":"1","preferredName":"Outpatient Visit Date","preferredDefinition":"Occurrence of a visit to an outpatient setting or clinic.","longName":"OUTPT_VST_DT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"DB302B67-DD60-1206-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-05-26","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-05-26","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2184603","version":"1","preferredName":"Image Slice Number","preferredDefinition":"Identifying number to locate a specific slice/cut on an imaging scan.","longName":"IMAGE_SLICE_NUM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"DBE6A285-323D-0C3E-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-06-02","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-06-02","modifiedBy":"REEVESD","dateModified":"2011-03-18","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2184683","version":"1","preferredName":"Height Measurement Feet","preferredDefinition":"Height of an individual expressed as number of feet.","longName":"HT_FT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"DBF85C91-1299-0BCC-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-06-04","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-06-04","modifiedBy":"SOKKERL","dateModified":"2019-10-23","changeNote":"CCR approval of Released status 6/4/2004","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2184685","version":"2","preferredName":"Height in Inches Number","preferredDefinition":"Numeric value to represent the height of a person.","longName":"HT_INCH_NUM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EBC26768-09F0-5C79-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-12-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-12-27","modifiedBy":"SOKKERL","dateModified":"2019-10-23","changeNote":"Supports CTMS v.3.02 and subsequent versions reporting requirements.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2184687","version":"3","preferredName":"Weight in Pounds Number","preferredDefinition":"Numeric value to represent a person's weight in pounds.","longName":"WT_LB_NUM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"96DA72EC-5125-148F-E053-F662850A70B8","latestVersionIndicator":"Yes","beginDate":"2004-12-27","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-11-08","modifiedBy":"COOPERM","dateModified":"2019-11-08","changeNote":"Versioned to use new version of DEC. mc 11/8/19","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2184691","version":"1","preferredName":"Screen Date","preferredDefinition":"Date of an evaluation or assessment of an individual's eligibility to enter a clinical trial.","longName":"SCRN_DT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"DBF85C91-13BD-0BCC-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-06-04","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-06-04","modifiedBy":"KUMMEROA","dateModified":"2021-07-27","changeNote":"5/28/16 jk moved from EDRN to MCL context CSI.  05/25/2016 wz added NWU CS/CSI.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2184773","version":"1","preferredName":"Birth Weight Value","preferredDefinition":"The value for the weight of a person at birth.","longName":"BIRTH_WT_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"DC7213A4-2EEE-20AD-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-06-04","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-06-09","modifiedBy":"SHIDED","dateModified":"2011-05-02","changeNote":"Approval of Released status by CCR 7/15/2004.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2184925","version":"1","preferredName":"Blood Component Transfusion Date","preferredDefinition":"Date of transfusion of blood components such as erythrocytes, leukocytes, platelets, and plasma from a donor to a recipient or back to the donor.","longName":"BLD_COMPN_TRNSF_DT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"DCE5B97D-BF11-3072-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-06-15","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-06-15","modifiedBy":"FORMBUILDER","dateModified":"2015-09-15","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2185504","version":"1","preferredName":"Ovarian Cancer Diagnosis Date","preferredDefinition":"Date a diagnosis of ovarian cancer is established.","longName":"OVAR_CA_DX_DT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"DD7550B5-5361-3CC4-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-06-25","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-06-25","modifiedBy":"CAMPBELB","dateModified":"2011-06-28","changeNote":"Approval of Released status by CCR 7/15/2004.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2185519","version":"1","preferredName":"Household Income Category","preferredDefinition":"Category to designate the total income of a household.","longName":"HSHLD_INCM_CAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"DD7550B5-54A1-3CC4-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-06-25","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-06-25","modifiedBy":"REEVESD","dateModified":"2011-03-18","changeNote":"Approval of Released status by CCR 7/15/2004","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2185521","version":"1","preferredName":"Last Menstrual Period Date","preferredDefinition":"First day of the last menstrual period.","longName":"LMP_DT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"DD7550B5-54DE-3CC4-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-06-25","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-06-25","modifiedBy":"LOWMAND","dateModified":"2017-03-13","changeNote":"Approval of Released status by CCR 7/15/2004.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2185555","version":"1","preferredName":"Menstrual Cycle Day Number","preferredDefinition":"Reference to a specific day within the menstrual cycle, which is typically 28 days in length.","longName":"MENCYC_DAY_NUM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"DD7550B5-57A3-3CC4-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-06-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-06-28","modifiedBy":"REEVESD","dateModified":"2011-03-18","changeNote":"Approval of Released status by CCR 7/15/2004","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2185571","version":"1","preferredName":"Pain Index Score","preferredDefinition":"Numeric score (0 to 10) denoting level of pain at a particular point in time.","longName":"PAIN_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"DD7550B5-5946-3CC4-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-06-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-06-29","modifiedBy":"FORMBUILDER","dateModified":"2014-07-25","changeNote":"Approval of Released status by CCR 7/15/2004.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2185579","version":"1","preferredName":"Definitive Breast Cancer Surgery  Indicator","preferredDefinition":"Yes or No indication of a person having a breast cancer surgical procedure.","longName":"DEF_BRST_CA_SURG_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"DD7550B5-59F0-3CC4-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-06-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-06-29","modifiedBy":"MAESKEB","dateModified":"2013-01-28","changeNote":"Approval of Released status by CCR 7/15/2004","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2185640","version":"1","preferredName":"Alcohol Usage Age 20 Indicator","preferredDefinition":"Indicator of Yes or No to signifty history of alcohol use at the age of 20 years.","longName":"ALC_USE_AGE_20_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"DD7550B5-5DDD-3CC4-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-06-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-06-30","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":"Approval of Released status by CCR 7/15/2004","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2185645","version":"1","preferredName":"Alcohol Consumption Past Year  Indicator","preferredDefinition":"Indicator of Yes or No to to represent a history of alcohol use in the past year.","longName":"ALC_USE_PAST_YR_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"DD7550B5-5E41-3CC4-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-06-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-06-30","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":"Approval of Released status by CCR 7/15/2004","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2185655","version":"1","preferredName":"Smoking Status Change from Baseline Indicator","preferredDefinition":"Response of Yes or No to indicate an alteration in smoking patterns from baseline status.","longName":"SMK_STAT_CHG_BSL_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"DD7550B5-5EE4-3CC4-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-09-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-07-01","modifiedBy":"TITARENKOI","dateModified":"2020-05-27","changeNote":"CCR CCMG discussion and approval of Released status on 10/1/2003.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2186051","version":"2","preferredName":"Patient Contact Text Type","preferredDefinition":"Means through which a patient/participant or family is contacted for follow-up or survival information.","longName":"PT_CNT_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"814F31AB-B7E9-7FEA-E040-BB89AD4336E1","latestVersionIndicator":"Yes","beginDate":"2010-03-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-03-08","modifiedBy":"TITARENKOI","dateModified":"2020-06-02","changeNote":"Replaces v1.0 with VD that has PVs that include 'Participant' along with 'Patient' references.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2186113","version":"1","preferredName":"Lab Test Panel Name","preferredDefinition":"Name given to a logical grouping of lab test values.","longName":"LAB_TST_PANEL_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E0357ECF-0C59-3037-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-07-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-07-27","modifiedBy":"MAESKEB","dateModified":"2011-09-12","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2186115","version":"1","preferredName":"Therapeutic Intent Indicator","preferredDefinition":"Indication of Y (yes) or N (no) to represent the therapeutic intent of an intervention or a procedure (such as surgery).","longName":"TX_INTENT_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E0357ECF-0C98-3037-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-07-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-07-27","modifiedBy":"MAESKEB","dateModified":"2011-10-13","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2186204","version":"2","preferredName":"Disease Diagnosis Term Name","preferredDefinition":"Text name to capture the disease diagnosis of an individual using MedDRA terms.","longName":"DZ_DX_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"MedDRA:Medical Dictionary for Regulatory Affairs","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"02DBEE3F-2481-103A-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-07-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-10-12","modifiedBy":"LUY","dateModified":"2019-06-18","changeNote":"12/11/14 jc added Exceptional Responder CSI. 12/10/14 jc added CDUS Rave Integration CSI.   Version utilizes VD with MedDRA disease terms as identified by CTEP for reporting.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2186214","version":"1","preferredName":"Pulse Oximetry Value","preferredDefinition":"Integer value expressed as a whole number to represent the percentage of oxygen in the blood measured through cutaneous assessment.","longName":"PULS_OXIM_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Standard","id":"E0357ECF-0E1C-3037-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-07-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-07-28","modifiedBy":"HARTLEYG","dateModified":"2021-06-17","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2186397","version":"1","preferredName":"Lesion Measurement Product in Centimeters","preferredDefinition":"Result or product of multiplying dimensions (2 or 3) of a site or specimen expressed in centimeters.","longName":"LES_MSRMT_PROD_CM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E0647F5B-AB0F-4B87-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-08-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-08-03","modifiedBy":"REEVESD","dateModified":"2011-03-18","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2187546","version":"1","preferredName":"Treatment Phase End Date","preferredDefinition":"Date of completion of all courses (cycles) of protocol-directed treatment/intervention, including the normal observation period, and no further treatment courses (cycles) are planned. Definition is in compliance with CTMS reporting requirements v.3.12, October, 2003.","longName":"TX_PHASE_END_DT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E0647F5B-B52B-4B87-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-08-06","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-08-06","modifiedBy":"FORMBUILDER","dateModified":"2012-05-14","changeNote":"Approval of Released status by CCR 8/18/2004","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2187734","version":"1","preferredName":"Laboratory Test Normal Reference Range Text","preferredDefinition":"A set of normal values for the result of a laboratory value. A high and low normal value bracket the range.","longName":"LAB_TST_NL_REFRG_TXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E14DAD17-C6F2-03D4-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-08-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-08-12","modifiedBy":"COOPERM","dateModified":"2019-10-02","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2187768","version":"1","preferredName":"Non Response Treatment Code","preferredDefinition":"Type of therapy/intervention for which conventional response calls (complete response, stable disease, others) are not appropriate, because therapy is given for other reasons (high risk of relapse, palliation).","longName":"NONRESP_TX_CD","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E14DAD17-C832-03D4-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-08-13","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-08-13","modifiedBy":"REEVESD","dateModified":"2011-07-08","changeNote":"Approval of Released status by CCR 8/18/2004, in compliance with CTMS reporting requirements v. 3.12.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2188083","version":"2","preferredName":"Person Marital Status Category","preferredDefinition":"Text term to describe a self-reported demographic parameter indicating a person's current conjugal status.","longName":"PRSN_MARST_CAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Standard","id":"0E0474D9-8B81-0507-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-03-06","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-03-06","modifiedBy":"HARTLEYG","dateModified":"2021-06-17","changeNote":"v2.0 created in conjunction with the caBIG community.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2188136","version":"1","preferredName":"Treatment Since Last Contact Indicator","preferredDefinition":"Indication of Yes or No to signify if a patient has received treatment for the protocol-directed condition since the date of last contact or followup visit.","longName":"TX_SINCE_LASTCNT_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E3081C30-67A0-366D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-09-01","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-09-01","modifiedBy":"TSESU","dateModified":"2018-07-16","changeNote":"CCR approval of Released status on 9/1/2004.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2188434","version":"1","preferredName":"Adverse Event Other Therapy Descriptive Text","preferredDefinition":"Text description of therapy type 'Other' to treat or manage an adverse event.","longName":"AE_OTH_TX_DESC_TXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CTMS:caBIG Clinical Trials Management Systems Workspace","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E4364360-5708-1FD6-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-09-16","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-09-16","modifiedBy":"REEVESD","dateModified":"2011-03-18","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2188441","version":"1","preferredName":"Primary Site of Disease Name","preferredDefinition":"Name of the primary anatomic site of disease using a set of values in compliance with the Adverse Event Expedited Reporting System (AdEERS).","longName":"PRIM_SITE_DZ_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E4364360-57C4-1FD6-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-09-16","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-09-16","modifiedBy":"HARTLEYG","dateModified":"2021-01-25","changeNote":"Supports CTMS v.3.12 reporting requirements, using AdEERS permissible values.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2188473","version":"1","preferredName":"Neurologic Rating Scale Score","preferredDefinition":"Numeric total score from the Neurologic Rating Scale (NRS).","longName":"NEURO_RTG_SCALE_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"Sipes et al, NEUROLOGY 34;1984","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E4364360-5964-1FD6-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-09-17","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-09-17","modifiedBy":"PRICEA","dateModified":"2013-10-23","changeNote":"Supports CCR CRF.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2188621","version":"1","preferredName":"Medication Schedule Descriptive Text","preferredDefinition":"Free text description of a medication schedule.","longName":"MED_SCHED_DESC_TXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E49C180D-84A4-0916-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-09-24","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-09-24","modifiedBy":"REEVESD","dateModified":"2011-04-15","changeNote":"Released status approved by UCI Chao and CCR on 9/24/2004.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2188627","version":"1","preferredName":"Checking Indicator Code","preferredDefinition":"Coded indicator to represent whether or not certain stated circumstances exist or criteria are met.","longName":"CHK_IND_CD","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E49C17FE-4A5A-0918-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-09-24","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-09-24","modifiedBy":"REEVESD","dateModified":"2012-02-03","changeNote":"Released status approval 9/28/2004.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2189871","version":"1.1","preferredName":"Laboratory Assay Method Name","preferredDefinition":"Name of the method of measuring the pharmacologic (PK) effects of a biologically active substance using an intermediate in vivo or in vitro tissue or cell model under controlled conditions.","longName":"LAB_ASSAY_METH_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"DA6B88D4-01F4-A225-E040-BB89AD43361D","latestVersionIndicator":"No","beginDate":"2013-04-15","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-04-15","modifiedBy":"REEVESD","dateModified":"2014-01-28","changeNote":"Subset version of CDE to support CTRP Biomarker Abstraction project.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2190064","version":"1","preferredName":"Follow-Up Status Begin Period Indicator","preferredDefinition":"Indicator of Yes or No to signify start of the follow-up period prescribed in a clinical trial.","longName":"FU_START_BEG_PD_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E5DABA2A-06BA-5AD5-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-10-15","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-10-15","modifiedBy":"MAESKEB","dateModified":"2011-10-13","changeNote":"Created to support CTMS v.3.12 reporting requirements for Off study data.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2193329","version":"2","preferredName":"Diagnosis Present Alpha DVG Date","preferredDefinition":"the presence of a diagnosis or symptoms constituting a diagnosis.","longName":"DX_ALDT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EAC0FC16-1E46-2297-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-10-22","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-12-10","modifiedBy":"REEVESD","dateModified":"2011-03-18","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2194315","version":"1","preferredName":"Target Non-target Lesion Identification Text","preferredDefinition":"Text to represent that a lesion is classified as target or nontarget.","longName":"TGT_NONTGT_IDN_TXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"RECIST:Response Evaluation Criteria in Solid Tumors","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"EACFDBFB-047D-25E6-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-12-17","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-12-17","modifiedBy":"GDEEN","dateModified":"2023-07-10","changeNote":"9/15/17 jk changed \"candidate\" to \"application\"  per 2015 note.  9/1/15 removed \"Candidate\" reg status; CDE 4994199 being used in RECSITv1.1 module instead of this CDE. jk 6/19/14 added \"-\" for nontarget per Rnd 5 comments. jc 8/13/13 added to RECISTv1.1 CRF CSI. jc  Approved by CCR for Release on 12/21/2004","administrativeNotes":"07.10.23_Set RegStatus to Standard for use in NCI Standard CDE collections_ghd","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2195089","version":"1","preferredName":"Cancer Diagnosis Cancer Type ICD9 Text Name","preferredDefinition":"Diagnosis represented as a character short name using ICD-9 cancer types.","longName":"CA_DX_TP_ICD9_TXT_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EBC19B2D-DA75-603E-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-01-05","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-01-05","modifiedBy":"SOKKERL","dateModified":"2018-11-16","changeNote":"8/30/17 jk removed NCI Standards CSI and registration status; CDE removed from Progression CRF module per Round 5 finalization task.  --- Supports Pedigree requirements for CCR Surveillance protocol.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2195184","version":"3","preferredName":"Tumor Contact Anatomic Site Name","preferredDefinition":"Text name of the anatomic site with which a tumor has contact.","longName":"TUM_CNT_ANAT_SITE_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"ACC5B38A-65E1-1C04-E053-4EBD850A01F0","latestVersionIndicator":"Yes","beginDate":"2020-08-13","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-08-13","modifiedBy":"COOPERM","dateModified":"2020-08-13","changeNote":"New version associated with latest version VD.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2195324","version":"1","preferredName":"Positron Emission Tomography Standard Uptake Value Mean Number","preferredDefinition":"Numeric value to represent the mean or average for standardized uptake ratio values during a positron emission tomography scan.","longName":"PET_SUV_MEAN_VAL_NUM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EC63A462-B13B-05FA-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-01-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-01-10","modifiedBy":"HARTLEYG","dateModified":"2017-05-11","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2195326","version":"1","preferredName":"Positron Emission Tomography Standard Uptake Value Maximum Number","preferredDefinition":"Numeric value to represent the largest possible value for a Positron Emission Tomography standardized uptake value ratio.","longName":"PET_SUV_MAX_VAL_NUM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EC63A462-B181-05FA-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-01-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-01-10","modifiedBy":"LISU","dateModified":"2020-05-13","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2195977","version":"2","preferredName":"Lab Test Preference Unit of Measure Name","preferredDefinition":"Preferred unit of measure (UOM) for a laboratory test result, per NCI standards or per protocol specification.","longName":"LAB_TEST_PREF_UOM_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"FA77AA60-E8B1-02A3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-06-30","modifiedBy":"HAMMA","dateModified":"2016-05-17","changeNote":"Supports C3D lab test functionality.  Includes new version VD to correct a value meaning/value meaning description error in the previous VD version.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2196055","version":"1","preferredName":"Lab Test Discrepancy Indicator","preferredDefinition":"Response of 'Y' or 'N' to represent a discrepancy between a lab test name, result type, and the unit of measure used to report the result.","longName":"LAB_TST_DCPY_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EDF6548D-2002-5361-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-01-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-01-21","modifiedBy":"REEVESD","dateModified":"2011-03-18","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2197871","version":"1","preferredName":"Transplant HLA Match Category","preferredDefinition":"Category to signify the precision of HLA matching between the donor and recipient.","longName":"TSPL_HLA_MATCH_CAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EEFD9E97-FBC8-0048-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-01","endDate":"2015-04-06","createdBy":"REEVESD","dateCreated":"2005-02-01","modifiedBy":"MALUMK","dateModified":"2019-03-14","changeNote":"Data element has not been used in forms or classifications since creation in 2005.  Retired because of lack of community need.  DMR 4.6.2015. Moved back to released status by request of CCR 2.26.2016.dmr.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2198276","version":"2","preferredName":"Transplant Conditioning Regimen Text Type","preferredDefinition":"Description of the type of conditioning regimen used to prepare a person for receipt of a transplant.","longName":"TSPL_CONDRGM_TXT_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"AE79ABF0-7EDB-2571-E040-BB89AD430A80","latestVersionIndicator":"Yes","beginDate":"2011-10-04","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-10-04","modifiedBy":"SORTILLD","dateModified":"2018-09-21","changeNote":"Released status approved by CCR on 2/22/2005.  v2.0 extends VD from 15 to 40 characters length.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2198278","version":"1","preferredName":"Transplant Conditioning Regimen Indicator","preferredDefinition":"Indicator of Yes or No to signify that a patient/participant received a conditioning regimen prior to transplantation.","longName":"TSPL_COND_RGM_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EEFD9E97-FE11-0048-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-02","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-02-02","modifiedBy":"KUMMEROA","dateModified":"2020-03-09","changeNote":"Released status approved by CCR on 2/22/2005.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2198284","version":"1","preferredName":"Acute GVHD Organ Text Name","preferredDefinition":"Text name of organ involved with acute Graft vs. Host Disease (GVHD) post transplant.","longName":"ACU_GVHD_ORGAN_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EEFD9E97-FEBA-0048-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-02","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-02-02","modifiedBy":"CHANGP","dateModified":"2016-11-28","changeNote":"Released status approved by CCR on 2/22/2005.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2198925","version":"1","preferredName":"Lesion Appearance Text Type","preferredDefinition":"Text description of the appearance of a superficial lesion.","longName":"LSN_APPEAR_TXT_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EEFD9E98-00B5-0048-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-02","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-02-02","modifiedBy":"SOKKERL","dateModified":"2017-08-03","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2199422","version":"1","preferredName":"Physical Activity Readiness Questionnaire Positive Response Number","preferredDefinition":"Number to represent the total number of positive responses on the Physical Activity Readiness Questionnaire (PAR-Q), a psychometric tool to assess physical activity parameters in adults.","longName":"PARQ_POS_RESP_NUM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EEFD9E98-05B3-0048-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-02-03","modifiedBy":"LUY","dateModified":"2013-10-23","changeNote":"Released status approved by CCR on 2/5/2005.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2199424","version":"1","preferredName":"Physical Activity Readiness Questionnaire Descriptive Text","preferredDefinition":"Comments relating to the administration and completion of the Physical Activity Readiness Questionnaire.","longName":"PARQ_QUEST_DESC_TXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EEFD9E98-05F1-0048-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-02-03","modifiedBy":"LUY","dateModified":"2013-10-23","changeNote":"Released status approved by CCR on 2/5/2005.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2199428","version":"1","preferredName":"Godin Leisure Time Exercise Questionnaire Psychometrics Questionnaire Score","preferredDefinition":"Total numeric score on the Godin Leisure Time Exercise Questionnaire, a psychometric tool that individuals complete as a survey of usual leisure-time exercise habits.","longName":"GODIN_QUEST_NUM_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EEFD9E98-0651-0048-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-02-03","modifiedBy":"LUY","dateModified":"2013-10-23","changeNote":"Released status approved by CCR on 2/5/2005.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2199432","version":"1","preferredName":"Center for Epidemiologic Studies Depression Scale Number Score","preferredDefinition":"Total numeric score on the Center for Epidemiologic Studies Depression Scale (CESD), a short, self-reporting scale intended for the general population.","longName":"CESD_QUEST_NUM_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EEFD9E98-06B0-0048-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-02-03","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":"Released status approved by CCR on 2/5/2005","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2199443","version":"1","preferredName":"Brief Symptom Inventory 18 Questionnaire Psychometrics Questionnaire Number Score","preferredDefinition":"Total numeric score on the Brief Symptom Inventory 18 (BSI 18), a tool used to capture levels of distress in 18 different emotional scenarios.","longName":"BSI18_QUEST_NUM_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EEFD9E98-0830-0048-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-04","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-02-04","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":"Released status approved by CCR on 2/5/2005.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2199495","version":"1","preferredName":"Perceived Stress Scale Questionnaire Number Score","preferredDefinition":"Total numeric score on the Perceived Stress Scale (PSS) questionnaire.","longName":"PSS_QUEST_NUM_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EEFD9E98-0B7A-0048-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-04","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-02-04","modifiedBy":"PANH","dateModified":"2014-11-20","changeNote":"Released status approved by CCR on 2/5/2005","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2199531","version":"2","preferredName":"Bioelectrical Impedance Dual X-ray Absorptometry Body Fat Percent Value","preferredDefinition":"Percentage of total body mass as body fat; determined by dual x-ray absorbtometry or bioelectrial impedance analysis.","longName":"BIA_BDY_FAT_PTG","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7B93021D-7D03-0DF0-E053-F662850A79B6","latestVersionIndicator":"Yes","beginDate":"2018-11-26","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-11-26","modifiedBy":"COOPERM","dateModified":"2018-11-26","changeNote":"Released status approved by CCR on 2/5/2005. Versioned to include latest version VD. mc 11/26/18","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2199545","version":"1","preferredName":"Menstrual Cycle Period Duration Day Number","preferredDefinition":"Number of days duration of a menstrual cycle.","longName":"MENCYC_DURN_DAY_NUM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EEFD9E98-0F50-0048-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-04","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-02-04","modifiedBy":"TITARENKOI","dateModified":"2020-06-30","changeNote":"Released status approved by CCR on 2/5/2005","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2199587","version":"1","preferredName":"Six Minute Walk Run Baseline Pulse Rate Number","preferredDefinition":"Pulse rate as a baseline measure for a six minute walk run test.","longName":"SXMNWRN_BSL_PLS_NUM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EF768D55-3CC8-6E79-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-02-07","modifiedBy":"FORMBUILDER","dateModified":"2013-08-16","changeNote":"CCR approval of Released status on 2/7/2005.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2199589","version":"1","preferredName":"Six Minute Walk Run Recovery Pulse Rate Number","preferredDefinition":"Pulse rate measured at recovery from a six minute walk run test.","longName":"SXMNWRN_RCVY_PLS_NUM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EF768D55-3D06-6E79-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-02-07","modifiedBy":"FORMBUILDER","dateModified":"2013-08-16","changeNote":"CCR approval of Released status on 2/7/2005.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2199594","version":"1","preferredName":"Six Minute Walk Run Baseline Blood Pressure Value","preferredDefinition":"Blood pressure as a baseline measure for a six minute walk run test.","longName":"SXMNWRN_BSL_BP_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EF7759A0-D177-3D49-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-02-07","modifiedBy":"FORMBUILDER","dateModified":"2013-08-16","changeNote":"CCR approval of Released status on 2/7/2005.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2199596","version":"1","preferredName":"Six Minute Walk Run Recovery Blood Pressure Value","preferredDefinition":"Blood pressure as a recovery measure for a six minute walk run test.","longName":"SXMNWRN_RCVY_BP_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EF7759A0-D1B5-3D49-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-02-07","modifiedBy":"FORMBUILDER","dateModified":"2013-08-16","changeNote":"CCR approval of Released status on 2/7/2005.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2199612","version":"1","preferredName":"Six Minute Walk Run Distance in Meter Number","preferredDefinition":"Distance in meters that is covered by an individual taking a six minute walk run test.","longName":"SXMNWRN_DIST_M_NUM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EF768D55-3DD6-6E79-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-02-07","modifiedBy":"FORMBUILDER","dateModified":"2013-08-16","changeNote":"CCR approval of Released status on 2/7/2005.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2199647","version":"1","preferredName":"SF-36 Questionnaire Completion Date","preferredDefinition":"Date of completion of the SF-36, a 36-question survey for measuring health status and outcomes from the patient's point of view.","longName":"SF36_QUEST_COMP_DT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EF9C7808-C6DC-0709-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-04","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-02-08","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":"Released status approved by CCR on 2/5/2005.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2199652","version":"1","preferredName":"Perceived Stress Scale Questionnaire Completion Date","preferredDefinition":"Date of completion of the Perceived Stress Scale (PSS), a predetermined set of questions used to collect clinical data, social status, occupational group, etc.","longName":"PSS_QUEST_COMP_DT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EF9B3DBB-58D6-56B3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-02-08","modifiedBy":"PRICEA","dateModified":"2013-10-28","changeNote":"Released status approved by CCR on 2/5/2005.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2199657","version":"1","preferredName":"Brief Symptom Inventory 18 Questionnaire Completion Date","preferredDefinition":"Date of completion of the Brief Symptom Inventory 18 (BSI 18), a tool used to capture levels of distress in 18 different emotional scenarios.","longName":"BSI18_QUEST_COMP_DT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EF9C7808-C71E-0709-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-02-08","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":"Released status approved by CCR on 2/5/2005.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2199661","version":"1","preferredName":"Center for Epidemiologic Studies Depression Scale Completion Date","preferredDefinition":"Date of completion of the Center for Epidemiologic Studies Depression Scale (CESD), a short, self-reporting scale intended for the general population.","longName":"CESD_SCALE_COMP_DT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EF9C7808-C75D-0709-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-02-08","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":"Released status approved by CCR on 2/5/2005.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2199664","version":"1","preferredName":"Godin Leisure Time Exercise Questionnaire Completion Date","preferredDefinition":"Date of completion of the Godin Leisure Time Exercise Questionnaire, a psychometric tool that individuals complete as a survey of usual leisure-time exercise habits.","longName":"GODIN_LSR_TM_COMP_DT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EF9C7808-C79C-0709-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-02-08","modifiedBy":"ZHANGWE","dateModified":"2013-10-25","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2199667","version":"1","preferredName":"Physical Activity Readiness Questionnaire Completion Date","preferredDefinition":"Date of completion of the Physical Activity Readiness Questionnaire (PAR-Q), a questionnaire to assess physical activity and symptoms in adults.","longName":"PARQ_QUEST_COMP_DT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EF9C7808-C7DA-0709-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-02-08","modifiedBy":"LUY","dateModified":"2013-10-23","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2199908","version":"1","preferredName":"Serious Adverse Event  Indicator","preferredDefinition":"The response indicating whether a serious adverse event occurred.","longName":"AE_SERIOUS_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"Colorectal CDE Disease Committee","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"EFD78FEB-1231-58C1-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-15","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-02-15","modifiedBy":"GDEEN","dateModified":"2023-01-18","changeNote":"Registration is Standard based on CRF Initiative approval and alignment with BRIDG. 6.2.17 Changed definition per NRDS Standards/Mike Montello request.  mc","administrativeNotes":"01/18/23_Added Alt Name and Classified for CCR/RAVE_ghd","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2199956","version":"1","preferredName":"Person Full Address Text","preferredDefinition":"Complete text address of a person, including the street address, city, state, country, and postal code.","longName":"PRSN_FULL_ADDR_TXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EF9DAC66-656D-24E6-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-16","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-02-16","modifiedBy":"MORENOC","dateModified":"2018-05-03","changeNote":"Supports legacy system address information which is not parsed into fields for state, country, etc., but instead is one compound element.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2199971","version":"1","preferredName":"Protocol Treatment Compliance Indicator","preferredDefinition":"Yes or No response to represent the administration of interventions/treatment according to the protocol design.","longName":"PROT_TX_CMPCE_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EFD78FEB-1A58-58C1-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-16","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-02-16","modifiedBy":"DASCOMBS","dateModified":"2016-07-25","changeNote":"Created to support migration of PDMS legacy data to C3D.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2199986","version":"1","preferredName":"Adverse Event Worst Symptom Day Duration","preferredDefinition":"Number of days during which the worst value (apex or nadir) of an adverse event occurred.","longName":"AE_WORST_DUR_DAY_NUM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EFD78FEB-1B21-58C1-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-16","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-02-16","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":"Created to support the migration of PDMS legacy data to C3D.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2200021","version":"1","preferredName":"Hip Circumference Centimeter Number","preferredDefinition":"Number of centimeters in a hip circumference measurement.","longName":"HIP_CIRCUM_CM_NUM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EF9E9878-7B89-4AB8-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-16","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-02-16","modifiedBy":"SOKKERL","dateModified":"2017-09-25","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2200043","version":"2","preferredName":"Chronic Graft Versus Host Disease Biopsy Proven Organ Name","preferredDefinition":"Text name of organs involved with chronic Graft vs. Host Disease (GVHD) post transplant.","longName":"CGVHD_PRVN_ORGAN_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"80D8E1FE-E234-BE25-E040-BB89AD433BA4","latestVersionIndicator":"Yes","beginDate":"2005-02-17","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-03-02","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":"v2.0 replaces v1.0 with expanded VD from 8 to 20 characters.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2200065","version":"1","preferredName":"Graft Versus Host Disease Manifestation Indicator","preferredDefinition":"Indicator of Yes or No to represent the presence of signs, symptoms, and conditions associated with Graft vs. Host Disease (GVHD).","longName":"GVHD_MNFS_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F050ABFC-C298-7084-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-02-18","modifiedBy":"SOKKERL","dateModified":"2017-09-11","changeNote":"CCR approval of Released status on 2/22/2005.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2200090","version":"1","preferredName":"Body Weight Change Text Type","preferredDefinition":"Definition of the type of body weight change an individual has experienced.","longName":"BDY_WT_CHG_TXT_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F050ABFC-C52A-7084-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-02-18","modifiedBy":"SORTILLD","dateModified":"2018-08-29","changeNote":"CCR approval of Released status on 2/22/2005.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2200142","version":"1","preferredName":"Biopsy Finding Descriptive Text","preferredDefinition":"Text to capture the results from the removal and pathologic examination of specimens in the form of small pieces of tissue from the body.","longName":"BX_FNG_DESC_TXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F051425C-ED0D-5B79-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-02-21","modifiedBy":"FORMBUILDER","dateModified":"2013-09-26","changeNote":"CCR approval of Released status on 2/22/2005.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2200156","version":"1","preferredName":"Secondary Malignant Neoplasm At Enrollment Indicator","preferredDefinition":"Indicator of Yes or No to signify the presence of a second malignancy at the time of enrollment into a study.","longName":"SEC_MAL_ENRLL_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F051425C-EE32-5B79-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-02-21","modifiedBy":"RICHARDS","dateModified":"2018-09-26","changeNote":"CCR approval of Released status on 2/22/2005.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2200164","version":"1","preferredName":"Chronic GVHD Composite Assessment Scale Component Text Name","preferredDefinition":"Text names assigned to the components of an assessment that is designed to capture signs and symptoms of chronic Graft vs. Host Disease (GVHD).","longName":"CGVHD_CAS_COMPN_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F051425C-EF5E-5B79-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-02-21","modifiedBy":"PRICEA","dateModified":"2013-10-23","changeNote":"CCR approval of Released status on 2/22/2005.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2200167","version":"1","preferredName":"Chronic GVHD Composite Assessment Scale Score","preferredDefinition":"Score or result for a component of a chronic Graft vs. Host Disease (GVHD) assessment.","longName":"CGVHD_CAS_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F051425C-EFD4-5B79-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-02-21","modifiedBy":"PRICEA","dateModified":"2013-10-23","changeNote":"CCR approval of Released status on 2/22/2005.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2200169","version":"1","preferredName":"Chronic Graft Versus Host Disease Composite Assessment Scale Total Score","preferredDefinition":"Total numeric score on an assessment scale for description of chronic Graft vs. Host Disease (GVHD).","longName":"CGVHD_CAS_TTL_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F051425C-F011-5B79-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-02-21","modifiedBy":"MALUMK","dateModified":"2021-08-12","changeNote":"CCR approval of Released status on 2/22/2005.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2200177","version":"1","preferredName":"Data Not Collected Reason Text","preferredDefinition":"Text reason that data is not collected for an identified portion of a study or project.","longName":"DATA_NOTCOLL_RSN_TXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F051425C-F0D6-5B79-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-02-21","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":"CCR approval of Released status on 2/22/2005.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2200197","version":"1","preferredName":"Nutritional Risk Subscore Number","preferredDefinition":"Subscore of the nutritional risk assessment measure, which combines the scores of the first 4 criteria (Weight, Intake, Symptoms, and Activities/Function) to produce a number used in calculating the total score.","longName":"NUTR_RISK_SUBSC_NUM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F051425C-F38D-5B79-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-02-21","modifiedBy":"PRICEA","dateModified":"2013-10-25","changeNote":"CCR approval of Released status on 2/22/2005","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2200199","version":"1","preferredName":"Nutritional Risk Total Number Score","preferredDefinition":"Total numeric score on a nutritional risk scale (Nutritional Triage Score).","longName":"NUTR_RISK_TTL_NUM_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F051425C-F3CA-5B79-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-02-21","modifiedBy":"PRICEA","dateModified":"2013-10-23","changeNote":"CCR approval of Released status on 2/22/2005","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2200244","version":"1","preferredName":"Autoimmune Manifestation Disease Onset Alpha DVG Date","preferredDefinition":"Date of onset of manifestations or clinical signs and symptoms of an autoimmune condition, described using a date or a text response of Unknown.","longName":"AUTOIM_MNFS_ONSET_DT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F051425C-F7A2-5B79-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-22","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-02-22","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":"CCR approval of Released status on 2/22/2005","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2200255","version":"2","preferredName":"Occupation Return Response Text","preferredDefinition":"Text response to the question of whether or not a person has returned to the activities associated with an occupation.","longName":"OCCUP_RTRN_TXT_RESP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"AACD382E-D444-6F46-E040-BB89AD433CF7","latestVersionIndicator":"Yes","beginDate":"2011-08-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-08-18","modifiedBy":"REEVESD","dateModified":"2011-08-18","changeNote":"Replaces v1.0 with extended field length","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2200260","version":"1","preferredName":"Infection Assessment Text Criteria","preferredDefinition":"Text criteria or questions included in an infection assessment/questionnaire.","longName":"INFECT_ASSESS_CRIT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F051425C-F947-5B79-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-22","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-02-22","modifiedBy":"LUY","dateModified":"2013-10-23","changeNote":"CCR approval of Released status on 2/22/2005","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2200357","version":"1","preferredName":"Off NonTreatment Study Reason Text Type","preferredDefinition":"Text category to represent the reason that a patient/participant ends all activity associated with a clinical trial.","longName":"OFF_NONTX_STUDY_RSN","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F11CE24D-0F9E-49E8-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-02-27","modifiedBy":"MAESKEB","dateModified":"2012-09-26","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2200369","version":"1","preferredName":"Disease Tumor Stage  Number","preferredDefinition":"Numeric value to represent the stage of disease based on the primary tumor (T stage).","longName":"DZ_T_STG_NUM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F11E1A98-D4D2-67E3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-02-28","modifiedBy":"MAESKEB","dateModified":"2012-11-13","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2200371","version":"1","preferredName":"Disease Metastasis Stage Number","preferredDefinition":"Numeric value to represent the stage of disease based on the metastases present (M stage).","longName":"DZ_M_STG_NUM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F11E1A98-D50F-67E3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-02-28","modifiedBy":"MAESKEB","dateModified":"2012-11-13","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2200373","version":"1","preferredName":"Disease Lymph Node Stage Number","preferredDefinition":"Numeric value to represent the stage of disease based on the nodes present (N stage).","longName":"DZ_N_STG_NUM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F11E1A98-D54D-67E3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-02-28","modifiedBy":"MAESKEB","dateModified":"2012-11-13","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2200392","version":"1","preferredName":"Lesion Change from Baseline Percent","preferredDefinition":"Percentage of change in a lesion measurement or assessment from the baseline evaluation.","longName":"LSN_CHG_BSL_PTG","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"RECIST:Response Evaluation Criteria in Solid Tumors","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F11E1A98-D6C8-67E3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-01","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-03-01","modifiedBy":"FORMBUILDER","dateModified":"2015-12-07","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2200531","version":"1","preferredName":"Targeted Lesion Baseline Sum","preferredDefinition":"Sum of longest diameters target lesions or sites of disease at baseline (before receiving any intervention), creating a reference point to which future additional measures will compared.","longName":"TGT_LSN_BSL_SUM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"RECIST:Response Evaluation Criteria in Solid Tumors","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F169098A-E66F-306E-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-01-22","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-03-04","modifiedBy":"MAESKEB","dateModified":"2015-07-15","changeNote":"ISO 11179 Compliance.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2200577","version":"1","preferredName":"Laboratory Test Result Text Type","preferredDefinition":"Text description of the format of the result of a laboratory test.","longName":"LAB_TEST_RSL_TXT_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F16D5628-BD25-64AB-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-04","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-03-04","modifiedBy":"FORMBUILDER","dateModified":"2012-05-14","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2200580","version":"1","preferredName":"Lymph Node Present Indicator","preferredDefinition":"Indicator of Yes or No to signify that a lymph node is present.","longName":"LN_PRES_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F16D5628-BD66-64AB-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-04","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-03-04","modifiedBy":"DAVISJ","dateModified":"2016-03-16","changeNote":"8/20/13 removed reference to RECISTv1.1 CRF CSI. jc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2201838","version":"1","preferredName":"Breast Biopsy Finding Text Name","preferredDefinition":"Text results from the removal and pathologic examination of breast tissue from the body.","longName":"BRST_BX_FNG_TXT_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F2C45BCA-75B7-7026-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-03-23","modifiedBy":"TITARENKOI","dateModified":"2021-02-23","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2201848","version":"1","preferredName":"Biopsy Performed Institution Name","preferredDefinition":"Text name of the institution where a biopsy was performed.","longName":"BX_PERF_INST_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F2C45BCA-7651-7026-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-03-23","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2202134","version":"1","preferredName":"Total Number of Mammogram in Lifetime Count","preferredDefinition":"Total number of mammograms that have been performed in a person's lifetime.","longName":"TTL_NUM_MGM_LFTM_CT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F327273A-05A4-28E4-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-26","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-03-26","modifiedBy":"RODGERSC","dateModified":"2012-11-05","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2202177","version":"1","preferredName":"Vigorous Exercise Past Seven Days Activity Day Per Week Count","preferredDefinition":"Count of the number of days in the past week that vigorous activity such as heavy lifting, aerobics, digging or fast cycling occurred.","longName":"VIG_EXCS_WK_DAY_CT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F323AEE5-528E-6C5E-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-03-27","modifiedBy":"PRICEA","dateModified":"2013-10-28","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2202188","version":"1","preferredName":"Moderate Activity Past Week Days Per Week Count","preferredDefinition":"Count of the number of days that moderate exercise such as carrying light loads, bicycling at a regular pace, or doubles tennis occurred in the past seven days.","longName":"MOD_ACT_DAY_WK_CT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F323AEE5-53CF-6C5E-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-03-27","modifiedBy":"PRICEA","dateModified":"2013-10-28","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2202190","version":"1","preferredName":"Moderate Activity Past Week Time Per Day Category","preferredDefinition":"Category for time spent per day on moderate exercise such as carrying light loads, bicycling at a regular pace, or doubles tennis in the past seven days.","longName":"MOD_ACT_DAY_TM_CAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F323AEE5-5413-6C5E-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-03-27","modifiedBy":"PRICEA","dateModified":"2013-10-28","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2202192","version":"1","preferredName":"Moderate Activity Time Per Day Alpha DVG Number Value","preferredDefinition":"Numeric or 'Unknown' value to represent the amount of time spent on moderate exercise such as carrying light loads, bicycling at a regular pace, or doubles tennis in a day during the past seven days.","longName":"MOD_ACT_TM_DAY_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F323AEE5-5450-6C5E-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-03-27","modifiedBy":"PRICEA","dateModified":"2013-10-28","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2202197","version":"1","preferredName":"Walking Ability Past Seven Days Activity Days Per Week Count","preferredDefinition":"Count of the number of days per week that a person was able to walk over the past seven days.","longName":"WALK_ABIL_DAY_WK_CT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F323AEE5-54B6-6C5E-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-03-27","modifiedBy":"PRICEA","dateModified":"2013-10-28","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2202199","version":"1","preferredName":"Walking Ability Time Per Day Category","preferredDefinition":"Category for time spent per day walk ing over the past seven days, represented as unknown or as time allotments in minutes or hours.","longName":"WALK_ABIL_DAY_TM_CAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F323AEE5-54F4-6C5E-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-03-27","modifiedBy":"PRICEA","dateModified":"2013-10-28","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2202201","version":"1","preferredName":"Walking Ability Time Per Day Alpha DVG Number Value","preferredDefinition":"Numeric or 'Unknown' value to represent the amount of time spent on walking over the past seven days.","longName":"WALK_ABIL_TM_DAY_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F323AEE5-5534-6C5E-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-03-27","modifiedBy":"PRICEA","dateModified":"2013-10-28","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2202206","version":"1","preferredName":"Weekday Sitting Per Day Time Category","preferredDefinition":"Category for time spent per day sitting on a week day during the past seven days, represented as unknown or as time allotments in minutes or hours.","longName":"WKDAY_SIT_DAY_TM_CAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F323AEE5-5599-6C5E-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-03-28","modifiedBy":"PRICEA","dateModified":"2013-10-28","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2202208","version":"1","preferredName":"Weekday Sitting Time Per Day Alpha DVG Number Value","preferredDefinition":"Numeric or 'Unknown' value to represent the amount of time spent sitting on a week day during the past seven days.","longName":"WKDAY_SIT_TM_DAY_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F323AEE5-55D6-6C5E-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-03-28","modifiedBy":"PRICEA","dateModified":"2013-10-28","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2202213","version":"2","preferredName":"Father Relatives Cancer Diagnosis Indicator","preferredDefinition":"Text indicator to signify if there are relatives of the father who have received a diagnosis of cancer.","longName":"FATH_RELTV_CA_DX_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"06F596AE-C7A1-4492-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-12-06","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":"Replaces older version with an expanded values VD.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2202229","version":"1","preferredName":"Nipple Aspiration Breast Laterality Text Name","preferredDefinition":"Text designation of breast on which a nipple aspiration procedure was conducted.","longName":"NIP_ASPTN_LAT_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F323AEE5-5682-6C5E-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-03-28","modifiedBy":"UMLLDR","dateModified":"2016-10-25","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2220102","version":"2","preferredName":"Person Social Security  Number","preferredDefinition":"A person's 9-digit social security number, a unique identifier assigned by the United States Social Security Administration.","longName":"PRSN_SSN","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Standard","id":"0E070B71-97A0-1732-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-03-15","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-03-15","modifiedBy":"AUGERG","dateModified":"2020-01-10","changeNote":"Version 2.0 uses character type value domain.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2220120","version":"1","preferredName":"Protocol Enrollment Sequence Number","preferredDefinition":"Number to represent a participant's position or identifer within a protocol.","longName":"PROT_ENRLL_SEQ_NUM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F42AB25E-79A7-1BC3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-04-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-04-10","modifiedBy":"REEVESD","dateModified":"2011-03-18","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2220461","version":"1","preferredName":"Breast Cancer Invasive Component Text Indicator","preferredDefinition":"Text indication of the presence of an invasive component or cell line in breast cancer, characterized by a tendency to spread, especially into healthy surrounding tissue.","longName":"BRST_CA_INVCOMP_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F50CF4FB-8AD4-6637-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-04-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-04-18","modifiedBy":"TITARENKOI","dateModified":"2020-07-16","changeNote":"Released status approved by CCR on 4/21/2005.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2220543","version":"1","preferredName":"Brief Symptom Inventory 18 Anxiety Domain Number Score","preferredDefinition":"Numeric score from the Anxiety domain of the Brief Symptom Inventory 18 (BSI 18), a tool used to capture levels of distress in 18 different emotional scenarios.","longName":"BSI18_ANX_DOMN_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F51F5EE5-821E-20D0-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-04-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-04-19","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2220545","version":"1","preferredName":"Brief Symptom Inventory 18 Depression Domain Number Score","preferredDefinition":"Numeric score from the Depression domain of the Brief Symptom Inventory 18 (BSI 18), a tool used to capture levels of distress in 18 different emotional scenarios.","longName":"BSI18_DEPR_DOMN_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F51F5EE5-8253-20D0-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-04-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-04-19","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2220547","version":"1","preferredName":"Brief Symptom Inventory 18 Somatization Domain Number Score","preferredDefinition":"Numeric score from the Somatization domain of the Brief Symptom Inventory 18 (BSI 18), a tool used to capture levels of distress in 18 different emotional scenarios.","longName":"BSI18_SOMAT_DOMN_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F51F5EE5-8274-20D0-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-04-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-04-19","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2220549","version":"1","preferredName":"Six Minute Walk Run Test Date","preferredDefinition":"Date of completion of a Six Minute Walk Run test, to evaluate the effect of walking and running on a subject's pulse and blood pressure.","longName":"SXMNWRN_TST_DT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F52012A8-D0A5-399D-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-04-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-04-19","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2220675","version":"1","preferredName":"Progesterone Receptor Level Alpha Number Value","preferredDefinition":"Numeric or text (missing) value to represent the result of a progesterone receptor level assay.","longName":"PR_LVL_ALNUM_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F52012A8-D499-399D-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-04-20","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-04-20","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":"Released status approved by CCR on 4/21/2005.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2221336","version":"1","preferredName":"Maternal Pedigree Assessment Tool Score","preferredDefinition":"Numeric score for the pedigree assessment tool, a record of mother's ancestors, offspring, siblings, and offspring that may be used to determine an individual's risk of developing cancer.","longName":"MAT_PAT_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F54516A5-1EA5-25D2-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-04-25","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-04-25","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":"Released status approved by CCR on 4/27/2005.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2221338","version":"1","preferredName":"Paternal Pedigree Assessment Tool Score","preferredDefinition":"Numeric score for the pedigree assessment tool, a record of father's ancestors, offspring, siblings, and offspring that may be used to determine an indivdual's risk of developing cancer.","longName":"PAT_PAT_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F54516A5-1ED7-25D2-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-04-25","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-04-25","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":"Released status approved by CCR on 4/27/2005.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2221404","version":"1","preferredName":"Five Year Gail Risk Assessment Score","preferredDefinition":"Numeric score that represents a person's risk of developing breast cancer over a five (5) year period, combining information about diagnosis history, menstrual history, birth history, pedigree, and race.","longName":"FIVE_YR_GAIL_RISK_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F54516A5-2130-25D2-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-04-26","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-04-26","modifiedBy":"REEVESD","dateModified":"2013-09-18","changeNote":"Released status approved by CCR on 4/27/2005.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2221406","version":"1","preferredName":"Lifetime Gail Risk Assessment Score","preferredDefinition":"Numeric score that represents a person's risk of developing breast cancer over a lifetime, combining information about diagnosis history, menstrual history, birth history, pedigree, and race.","longName":"LFTM_GAIL_RISK_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F54516A5-2162-25D2-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-04-26","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-04-26","modifiedBy":"REEVESD","dateModified":"2013-09-18","changeNote":"Released status approved by CCR on 4/27/2005.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2221794","version":"1","preferredName":"Ovarian Cancer Histopathology Classification Text Name","preferredDefinition":"Text name for a histopathologic classification of ovarian cancer.","longName":"OVAR_CA_HIST_TXT_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F54516A5-21E6-25D2-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-04-26","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-04-26","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":"Released status approved by CCR on 4/27/2005.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2221854","version":"1","preferredName":"Baseline Breast Cancer Risk Assessment Category Name","preferredDefinition":"Text summary breast cancer risk assessment result for a person, performed as a baseline measure, and using information from the pedigree assessment tool (PAT) and the Gail risk score.","longName":"BSL_BRST_RISK_CAT_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F54516A5-2399-25D2-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-04-26","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-04-26","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":"Released status approved by CCR on 4/27/2005.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2221941","version":"2","preferredName":"Twin Sibling History Text Type","preferredDefinition":"Text name to describe a person's response when asked what type of twin he/she is.","longName":"TWIN_SIBL_HX_TXT_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"82424433-F921-633D-E053-F662850AE9E2","latestVersionIndicator":"Yes","beginDate":"2019-02-19","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-02-19","modifiedBy":"COOPERM","dateModified":"2019-02-19","changeNote":"New version extends max length. mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2222493","version":"1","preferredName":"Agent Dose Count Number","preferredDefinition":"Count number assigned to an individual dose or administration of an agent given to a person.","longName":"AGT_DOSE_CT_NUM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F54516A5-2C7E-25D2-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-04-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-04-28","modifiedBy":"TYRRELLM","dateModified":"2023-10-23","changeNote":null,"administrativeNotes":"10.23.2023 Added AQT on reused CDE per request ticket CADSR0002989_mmt","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2222514","version":"1","preferredName":"Lymph Node Positive IHC Staining Count","preferredDefinition":"Numeric count of the number of lymph nodes that tested positive using an Immunohistochemistry (IHC) staining technique.","longName":"LN_POS_IHC_STN_CT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F54516A5-2DB1-25D2-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-04-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-04-29","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":"Released status approved by CCR on 5/4/2005.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2222520","version":"1","preferredName":"Schubert Oral Mucositis Rating Score","preferredDefinition":"Numeric value to signify the score on the Schubert Oral Mucositis Rating Scale, used to assess inflammation in the mouth.","longName":"SCHB_ORAL_MUCS_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F54516A5-2E28-25D2-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-04-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-04-29","modifiedBy":"REEVESD","dateModified":"2013-09-18","changeNote":"Released status approved by CCR on 5/2/2005.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2226772","version":"1","preferredName":"Other Response Specify Short Text","preferredDefinition":"Short text description to qualify a response of 'Other' to a question, requiring additonal information or a detailed explanation.","longName":"OTX_RESP_SPEC_TXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F600421C-68F5-0246-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-05-09","modifiedBy":"REEVESD","dateModified":"2011-03-18","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2226794","version":"1","preferredName":"Primary Tumors Count","preferredDefinition":"Numeric count of the number of tumors classified as primaries, not sites of metastatic disease.","longName":"PRIM_TUM_CT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F600421C-692E-0246-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-05-09","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2226873","version":"1","preferredName":"Sample Storage Value Number","preferredDefinition":"Number to represent a stored sample's value.","longName":"SMPL_STG_VAL_NUM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F6C1590C-743D-60E6-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-05-10","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2226955","version":"1","preferredName":"Positive Cytology Pathology Indicator","preferredDefinition":"Indicator of Yes or No to signify confirmation of positive cytology or pathology on tissue samples.","longName":"POS_CYT_PATH_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F6C1590C-7551-60E6-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-05-10","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2226966","version":"1","preferredName":"Missed Dose Count","preferredDefinition":"Numeric count to indicate the number of doses of an item that were ordered for but not taken.","longName":"MISS_DOSE_CT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F6C1590C-75AF-60E6-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-05-10","modifiedBy":"KUMMEROA","dateModified":"2022-12-02","changeNote":null,"administrativeNotes":"2022.12.2 AQT added for ticket request CADSR0001748. ak","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2226987","version":"1","preferredName":"Time Duration Minute Number","preferredDefinition":"Length or duration of an event or activity measured in minutes.","longName":"TM_DURN_MIN_NUM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F6C3640F-97FA-601A-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-05-10","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2227029","version":"1","preferredName":"Specimen Collected Amount Number","preferredDefinition":"Number that describes the amount of specimen included in the sample.","longName":"SPEC_COLL_AMT_NUM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F6C3640F-988D-601A-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-05-10","modifiedBy":"KUMMEROA","dateModified":"2023-06-26","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2227065","version":"1","preferredName":"Treatment Regimen Text Type","preferredDefinition":"Short text description of a type of drug regimen or treatment given to a patient.","longName":"TX_REGM_TXT_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F6C3640F-9923-601A-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-05-10","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2227075","version":"1","preferredName":"FACIT-Sp Criteria Text","preferredDefinition":"Text that captures criteria for a FACIT-Spirituality tool question.","longName":"FACITSP_CRIT_TXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F6C1590C-778F-60E6-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-05-10","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2227088","version":"1","preferredName":"FACIT Spiritual Well-Being Questionnaire Number Score","preferredDefinition":"Numeric score on an item in the FACIT-Spirituality questionnaire.","longName":"FACITSP_QUEST_NUM_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F6C1590C-77C1-60E6-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-05-10","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2227343","version":"1","preferredName":"Laboratory Test Positive Negative Result","preferredDefinition":"Result for a lab test, expressed as either positive (+) or negative (-).","longName":"LAB_TEST_POSNEG_RSL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F6C1590C-7827-60E6-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-05-10","modifiedBy":"BEELEST","dateModified":"2015-01-14","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2227358","version":"1","preferredName":"Second-Look Surgical Procedure Text Name","preferredDefinition":"Text name for a surgical procedure used during second-look operation","longName":"SEC_LK_SURG_PROC_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F6C3640F-997B-601A-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-05-10","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2227904","version":"2","preferredName":"Non-Target Lesion Response Text Code","preferredDefinition":"Text code to represent disease response in a non-targeted lesion, using Recist response criteria.","longName":"NTRGET_LES_RESP_CD","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"RECIST:Response Evaluation Criteria in Solid Tumors","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"93AC689E-5DD9-5D7A-E040-BB89AD430948","latestVersionIndicator":"Yes","beginDate":"2010-10-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-10-28","modifiedBy":"HLAINGY","dateModified":"2018-03-05","changeNote":"9/2/13 removed RECISTv1.1 CRF CSI; standard uses CDE 3859382. jc 8/13/13 added to RECISTv1.1 CRF CSI. jc   Replaced v1.0 with a corrected permissible value set","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2227907","version":"1","preferredName":"Target Lesion Response Text Code","preferredDefinition":"Text code to represent disease response in a target lesion, using Recist response criteria.","longName":"TGT_LES_RESP_TXT_CD","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"RECIST:Response Evaluation Criteria in Solid Tumors","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F6D6BDEB-608C-5649-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-05-11","modifiedBy":"SPRINGERL","dateModified":"2021-03-25","changeNote":"9/2/13 removed RECISTv1.1 CRF CSI; standard uses CDE 3859354. jc  8/13/13 added to RECISTv1.1 CRF CSI. jc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2227909","version":"1","preferredName":"Target Lesion Best Response Text Code","preferredDefinition":"Text code to represent best disease response in a target lesion, using Recist response criteria.","longName":"TGT_LES_BEST_RESP_CD","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"RECIST:Response Evaluation Criteria in Solid Tumors","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F6D6BDEB-60CB-5649-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-05-11","modifiedBy":"REEVESD","dateModified":"2016-06-13","changeNote":"10/15/13 removed RECIST CRF CSI; CDE replaced with 3859354. jc 8/13/13 added to RECISTv1.1 CRF CSI. jc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2228478","version":"1","preferredName":"Breast Cancer Noninvasive Component Other Specify Text","preferredDefinition":"Abbreviated or short text field to describe a response of 'Other, Specify' to a question about the non-invasive component of breast cancer.","longName":"BRST_CA_NINV_OTX_TXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F6D76EEC-2B99-57F3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-04-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-05-12","modifiedBy":"REEVESD","dateModified":"2011-03-18","changeNote":"Released status approved by CCR on 5/12/2005.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2228492","version":"1","preferredName":"FACT-G Questionnaire Total Number Score","preferredDefinition":"Total numeric score on the Functional Assessment of Cancer Therapy - General (FACT-G) questionnaire, a tool used to assess subject functionality through the use of Likert scale questions.","longName":"FACTG_QUEST_TTL_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F6ED6E03-4178-1838-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-05-12","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":"Released status approved by CCR on 5/13/2005.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2228496","version":"1","preferredName":"FACT-BMT Additional Concerns Subcategory Number Score","preferredDefinition":"Numeric score for the Additional Concerns subcategory of the Functional Assessment of Cancer Therapy - Bone Marrow Transplant (FACT-BMT) questionnaire.","longName":"FACTBMT_ADDCN_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F6ED6E03-41BE-1838-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-05-12","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":"Released status approved by CCR on 5/13/2005.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2228502","version":"1","preferredName":"FACT-BMT Questionnaire Number Score","preferredDefinition":"Total numeric score on the Functional Assessment of Cancer Therapy - Bone Marrow Transplant (FACT-BMT) questionnaire, a tool used to assess subject functionality after bone marrow transplant through the use of Likert scale questions.","longName":"FACTBMT_QUEST_TTL_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F6ED6E03-420A-1838-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-05-12","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":"Released status approved by CCR on 5/13/2005.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2228545","version":"1","preferredName":"SF-36 Physical Function Subscale Score","preferredDefinition":"Numeric score for the Physical Functioning subscale of the SF-36 Health Survey, a 36-question survey for measuring health status and outcomes from the patient's point of view.","longName":"SF36_PHYSFUNCT_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F6ED6E03-4356-1838-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-13","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-05-13","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":"Released status approved by CCR on 5/13/2005.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2228547","version":"1","preferredName":"SF-36 Role Physical Subscale Score","preferredDefinition":"Numeric score for the Role-Physical subscale of the SF-36 Health Survey, a 36-question survey for measuring health status and outcomes from the patient's point of view.","longName":"SF36_ROLEPHYS_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F6ED6E03-4388-1838-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-13","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-05-13","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":"Released status approved by CCR on 5/13/2005.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2228549","version":"1","preferredName":"SF-36 Bodily Pain Subscale Score","preferredDefinition":"Numeric score for the Bodily Pain subscale of the SF-36 Health Survey, a 36-question survey for measuring health status and outcomes from the patient's point of view.","longName":"SF36_BDYPAIN_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F6ED6E03-43BB-1838-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-13","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-05-13","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":"Released status approved by CCR on 5/13/2005.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2228551","version":"1","preferredName":"SF-36 General Health Subscale Score","preferredDefinition":"Numeric score for the General Health subscale of the SF-36 Health Survey, a 36-question survey for measuring health status and outcomes from the patient's point of view.","longName":"SF36_GENHLTH_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F6ED6E03-43F0-1838-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-13","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-05-13","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":"Released status approved by CCR on 5/13/2005.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2228553","version":"1","preferredName":"SF-36 Vitality Subscale Score","preferredDefinition":"Numeric score for the Vitality subscale of the SF-36 Health Survey, a 36-question survey for measuring health status and outcomes from the patient's point of view.","longName":"SF36_VITALITY_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F6ED6E03-4422-1838-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-13","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-05-13","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":"Released status approved by CCR on 5/13/2005.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2228555","version":"1","preferredName":"SF-36 Social Functioning Subscale  Score","preferredDefinition":"Numeric score for the Social Functioning subscale of the SF-36 Health Survey, a 36-question survey for measuring health status and outcomes from the patient's point of view.","longName":"SF36_SOCFUNCT_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F6ED6E03-4455-1838-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-13","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-05-13","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":"Released status approved by CCR on 5/13/2005.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2228557","version":"1","preferredName":"SF-36 Role Emotional Subscale Score","preferredDefinition":"Numeric score for the Role-Emotional subscale of the SF-36 Health Survey, a 36-question survey for measuring health status and outcomes from the patient's point of view.","longName":"SF36_ROLEEMOT_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F6ED6E03-4488-1838-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-13","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-05-13","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":"Released status approved by CCR on 5/13/2005.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2228559","version":"1","preferredName":"SF-36 Mental Health Subscale Score","preferredDefinition":"Numeric score for the Mental Health subscale of the SF-36 Health Survey, a 36-question survey for measuring health status and outcomes from the patient's point of view.","longName":"SF36_MNTLHLTH_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F6ED6E03-44BB-1838-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-13","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-05-13","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":"Released status approved by CCR on 5/13/2005.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2229830","version":"2","preferredName":"Trail Making Test Complete Text Result","preferredDefinition":"Text name for the interpretation of a Trail Making Test.","longName":"TRAIL_MK_TST_TXT_RSL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"Trail Making Test by US Army, 1944 as part of the  Army Individual Test of General Ability","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"40F7840C-648C-4494-E053-F662850AB73D","latestVersionIndicator":"Yes","beginDate":"2005-05-16","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2016-11-10","modifiedBy":"ZHANGWE","dateModified":"2016-11-10","changeNote":"11/10/2016 created new version for Trail Making Test CDE harmonization, wz.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2231181","version":"1","preferredName":"Physical Activity Intensity Text Category","preferredDefinition":"Category to represent the degree of physical activity associated with a person or an event/regimen.","longName":"PHYS_ACT_INTS_CAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F815B583-779C-63CF-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-05-27","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":"Released status approved by CCR on 6/10/2005.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2231195","version":"1","preferredName":"Steps Per Day Average Number","preferredDefinition":"Average number of steps taken per day by an individual.","longName":"STEP_DAY_AVG_NUM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F815B583-780F-63CF-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-31","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-05-27","modifiedBy":"MORENOC","dateModified":"2016-05-23","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2231211","version":"1","preferredName":"SF-36 Questionnaire Mental Component Summary Score","preferredDefinition":"Numeric Mental Component Summary (MCS) score from the SF-36 Health Survey, a 36-question survey for measuring health status and outcomes from the patient's point of view.","longName":"SF36_MENT_SUMM_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F815B583-7920-63CF-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-05-27","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2231213","version":"1","preferredName":"SF-36 Questionnaire Physical Component Summary Score","preferredDefinition":"Numeric Physical Component Summary (PCS)score on the SF-36 Health Survey, a 36-question survey for measuring health status and outcomes from the patient's point of view.","longName":"SF36_PHYS_SUMM_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F815B583-7951-63CF-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-05-27","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2232986","version":"1","preferredName":"Neurofibromatosis On Study Disease Manifestation Comments Text","preferredDefinition":"Free text to capture signs or symptoms due to neurofibromatosis detected while the patient/participant is on study.","longName":"NF1_ONSTUDY_MNFS_TXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F8927142-645A-5C70-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-11-05","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-06-04","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2233086","version":"1","preferredName":"Modified Physical Activity Assessment Start Date","preferredDefinition":"Start date for an assessment of modified physical assessment, from which a span of time is used to compare an individual's current and previous physical activity level.","longName":"MOD_ACT_START_DT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F90B5E56-BB4D-0F45-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-06-09","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":"Released status approved by CCR on 6/10/2005.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2233088","version":"1","preferredName":"Modified Physical Activity Assessment Stop Date","preferredDefinition":"Stop date for a span of time that is evaluated during an assessment of modified physical activity.","longName":"MOD_ACT_STOP_DT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F90B5E56-BB7F-0F45-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-06-09","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":"Released status approved by CCR on 6/10/2005.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2233097","version":"1","preferredName":"Modified Activity Questionnaire Activity Text Name","preferredDefinition":"Text terms to represent types of physical activity that are assessed as part of the Modified Activity Questionnaire (MAQ).","longName":"MAQ_ACT_TXT_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F920A342-10AF-2A6A-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-06-09","modifiedBy":"LUY","dateModified":"2013-10-23","changeNote":"Released status approved by CCR on 6/10/2005.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2233104","version":"1","preferredName":"Modified Physical Activity Times Per Week Number","preferredDefinition":"Number value to represent the number of times an activity occurred during the timespan of one week.","longName":"MOD_ACT_TM_WK_NUM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F920A342-114E-2A6A-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-06-09","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":"Released status approved by CCR on 6/10/2005.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2233107","version":"1","preferredName":"Modified Physical Activity Minutes Per Time  Number","preferredDefinition":"Number value to represent the number of minutes spent on a specified activity.","longName":"MOD_ACT_MIN_TM_NUM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F90B5E56-BC40-0F45-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-06-09","modifiedBy":"MORENOC","dateModified":"2016-06-14","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2233113","version":"1","preferredName":"Modified Activity Past Four Week Trend Text Category","preferredDefinition":"Text term to describe a person's activity level for the past four weeks as compared to the past 12 months.","longName":"MOD_ACT_PAST_4WK_CAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F90B5E56-BCAC-0F45-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-06-09","modifiedBy":"PRICEA","dateModified":"2013-10-28","changeNote":"Released status approved by CCR on 6/10/2005.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2233125","version":"1","preferredName":"Television Viewing Activity Average Daily Hours Number","preferredDefinition":"Numeric value to represent the average number of hours per day spent watching television.","longName":"TV_VIEW_AVG_HR_NUM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F90B5E56-BD2B-0F45-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-06-10","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":"Released status approved by CCR on 6/10/2005.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2233133","version":"1","preferredName":"Normal Occupation Activity Average Yearly Month Number","preferredDefinition":"Numeric value to signify the average number of months per year spent in a person's normal or routine occupation schedule.","longName":"OCCUP_AVG_YR_MOS_NUM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F92F8E39-66B1-375C-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-06-10","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":"Released status approved by CCR on 6/10/2005.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2233136","version":"1","preferredName":"Modified Physical Activity Difficulty Text Name","preferredDefinition":"Text term to capture activity area in which a person experiences physical difficulty.","longName":"MOD_PHYS_ACT_DIFF_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F92F8E39-6702-375C-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-06-10","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":"Released status approved by CCR on 6/10/2005.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2233157","version":"1","preferredName":"Person Occupation Assessment Start Date","preferredDefinition":"Start date for a time span used to assess a person's occupation or job.","longName":"JOB_ASSESS_START_DT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F9313AE8-B3A9-4260-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-06-10","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":"Released status approved by CCR on 6/10/2005.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2233159","version":"1","preferredName":"Person Occupation Assessment Stop Date","preferredDefinition":"Stop date for a time span used to assess a person's occupation or job.","longName":"JOB_ASSESS_STOP_DT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F9313AE8-B3DB-4260-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-06-10","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":"Released status approved by CCR on 6/10/2005.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2233162","version":"1","preferredName":"Activity Questionnaire Job Number Code","preferredDefinition":"Numeric code to represent a person's job/occupation by category.","longName":"PRSN_MAQ_JOB_NUM_CD","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F9313AE8-B44C-4260-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-06-10","modifiedBy":"LUY","dateModified":"2013-10-23","changeNote":"Released status approved by CCR on 6/10/2005.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2233169","version":"1","preferredName":"Walking Bicycling Activity Minutes Per Day  Number","preferredDefinition":"Number value to represent the number of minutes spent per day walking or bicycling to and from work.","longName":"WALK_BIKE_MINDAY_NUM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F9313AE8-B4B1-4260-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-06-10","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":"Released status approved by CCR on 6/10/2005.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2233171","version":"1","preferredName":"Occupation Average Weekly Day Number","preferredDefinition":"Average number of days per week spent in a person's normal or routine occupation schedule.","longName":"OCCUP_AVG_DAY_WK_NUM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F9313AE8-B4E8-4260-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-06-10","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":"Released status approved by CCR on 6/10/2005.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2233173","version":"1","preferredName":"Occupation Average Daily Hours Number","preferredDefinition":"Average number of hours per day spent in a person's normal or routine occupation schedule.","longName":"OCCUP_AVG_HR_DAY_NUM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F9313AE8-B51A-4260-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-06-10","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":"Released status approved by CCR on 6/10/2005.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2233180","version":"1","preferredName":"Sitting Activity Average Daily Hours Number","preferredDefinition":"Number of hours per day spent sitting.","longName":"SIT_ACT_HR_DAY_NUM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F92F8E39-67EC-375C-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-06-10","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":"Released status approved by CCR on 6/10/2005.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2233197","version":"1","preferredName":"Claus Assessment Percentage Result","preferredDefinition":"Numeric result that reflects the result of a person's breast cancer risk assessment using the Claus Model, evaluating family history, laterality of the disease, incidence of other types of cancer, and BRCA1/2 status.","longName":"CLAUS_ASSESS_PTG_RSL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F9313AE8-B5EC-4260-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-06-10","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":"Released status approved by CCR on 6/10/2005.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2236338","version":"1","preferredName":"FACT-G Questionnaire Not Administered Reason Text Name","preferredDefinition":"Text term to represent the reason that the Functional Assessment to Cancer Therapy (FACT_G)  was not completed by a subject.","longName":"FACTG_NOTADMN_RSN_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F9FA7953-7CA1-043D-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-20","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-06-20","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2236640","version":"1","preferredName":"Vision Assessment Adverse Event Assessment Short Text","preferredDefinition":"Abbreviated text field to capture a determination of the visual capabilities of a person.","longName":"2236588v1.0:2201296v1.0","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F9FA7953-7D93-043D-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-20","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-06-20","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2236775","version":"1","preferredName":"Pain Assessment Short Text","preferredDefinition":"Abbreviated text field to capture the determination of a person's level of pain, with associated symptoms and interventions.","longName":"PAIN_ASSESS_TXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F9FA7953-7DD0-043D-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-20","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-06-20","modifiedBy":"REEVESD","dateModified":"2011-03-18","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2240658","version":"1","preferredName":"Chronic Graft Versus Host Disease Patient Symptom Scale Total Score","preferredDefinition":"Number total score representing the sum of all questions in a chronic Graft vs. Host Disease (GVHD) patient symptom assessment.","longName":"CGVHD_PT_SX_TTL_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"FAB2D8EC-6A60-68CB-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-07-05","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-07-05","modifiedBy":"PRICEA","dateModified":"2013-10-23","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2261746","version":"1","preferredName":"DCIS Diagnosis Cell Percentage","preferredDefinition":"Percentage of DCIS found in a tissue specimen/sample.","longName":"DCIS_CELL_PTG","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"FBB87F7A-634F-1AFC-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-07-12","modifiedBy":"TAYLORT","dateModified":"2019-05-15","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2261749","version":"1","preferredName":"DCIS Disease Extent Number","preferredDefinition":"Numeric value to represent the extent of ducal carcinoma in situ (DCIS) present in breast tissue.","longName":"DCIS_DZ_EXTENT_NUM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"FBB87F7A-6398-1AFC-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-07-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-07-12","modifiedBy":"REEVESD","dateModified":"2011-03-18","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2261888","version":"1","preferredName":"Vision Assessment Indicator","preferredDefinition":"Indication of whether or not an ophthalmologic/vision examination was conducted.","longName":"VSN_ASSESS_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"FBB87D79-992D-0549-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-07-14","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-07-14","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2261891","version":"1","preferredName":"Vision Assessment Assessment Not Done Reason Text","preferredDefinition":"Text explanation of the reason that an ophthalmologic/vision assessment was not completed.","longName":"VSN_ASSESS_ND_TXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"FBB87D79-997A-0549-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-07-14","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-07-14","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2261915","version":"1","preferredName":"Ectopic Pregnancy Count","preferredDefinition":"Number of ectopic pregnancies in a woman's history.","longName":"ECTO_PREG_CT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"FBB87F7A-6732-1AFC-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-07-17","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-07-17","modifiedBy":"TSESU","dateModified":"2018-07-02","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2261932","version":"1","preferredName":"Age At Death Derived in Years Number","preferredDefinition":"Value to represent the age of a person at the time of death, expressed in number of years.","longName":"AGE_DEATH_DERIV_NUM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"FC1FEFCA-4013-3CB3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-07-17","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-07-17","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2261940","version":"1","preferredName":"Caffeinated Beverage Use Text Name","preferredDefinition":"Text terms to identify types of caffeinated beverages consumed/used by a person.","longName":"CAFF_BEV_USE_TXT_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"FC1FEFCA-40E4-3CB3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-07-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-07-18","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2261943","version":"1","preferredName":"Caffeinated Beverage Daily Cup Use Number","preferredDefinition":"Numeric value to represent the number of cups of a caffeinated beverage consumed by a person on an average day.","longName":"CAFF_BEV_DAILY_NUM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"FC1FEFCA-412C-3CB3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-07-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-07-18","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2261945","version":"1","preferredName":"Caffeine Use Other Text","preferredDefinition":"Abbreviated or short text field to describe a participant response of 'other' type of caffeinated beverage consumption.","longName":"CAFF_BEV_USE_OTX_TXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"FC1FEFCA-415D-3CB3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-07-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-07-18","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2261949","version":"1","preferredName":"Physical Exercise Performance Indicator","preferredDefinition":"Indicator of Yes or No to a question to represent physical activity apracticed in recreation, amateur and professional sports, or planned activity to improve physical condition or health.","longName":"PHYS_EXER_PERF_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"FC1FEFCA-41A0-3CB3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-07-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-07-18","modifiedBy":"ZIEGLERK","dateModified":"2013-07-16","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2261951","version":"1","preferredName":"Physical Exercise Performance Activity Average Weekly Hours Number","preferredDefinition":"Numeric value to represent average number of hours per week spent in performance of physical activity as practiced in recreation, amateur and professional sports, or planned activity to improve physical condition or health.","longName":"EXER_AVG_HR_WK_NUM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"FC1FEFCA-41D1-3CB3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-07-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-07-18","modifiedBy":"REEVESD","dateModified":"2011-03-18","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2261959","version":"1","preferredName":"Study Timepoint Course Text Name","preferredDefinition":"Text term to identify a course (cycle) of treatment which is referenced as a study assessment timepoint.","longName":"STDY_TMPT_CRSE_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"FC1FEFCA-4243-3CB3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-07-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-07-18","modifiedBy":"CLOHNES","dateModified":"2022-05-31","changeNote":null,"administrativeNotes":"added alt name OID, CCTG 5/31/22 CJL","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2261967","version":"1","preferredName":"Mammography Average Pixel Density Dots per Inch Number","preferredDefinition":"Average pixel density of breast tissue in a mammographic study, as measured by the average number of pixels per square inch.","longName":"MGM_AVG_PXL_DPI_NUM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"FC1FEFCA-42A4-3CB3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-07-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-07-18","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2261975","version":"1","preferredName":"Breast Fibroglandular Involvement Percentage","preferredDefinition":"Numeric percentage of breast involvement with fibroglandular tissue as a result of evaluation (biopsy, imaging, etc.).","longName":"BRST_FBGLD_PTG","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"FC1FEFCA-4303-3CB3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-07-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-07-18","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2261977","version":"1","preferredName":"Breast Fibroglandular Involvement Laterality Text Name","preferredDefinition":"Text designation of the breast with the highest density of fibroglandular involvement.","longName":"BRST_FBGLD_LAT_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"FC1FEFCA-4333-3CB3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-07-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-07-18","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2261993","version":"1","preferredName":"Mammotome Biopsy Count","preferredDefinition":"Mammotome biopsy removes a small amount or core of breast tissue for examination_the quantity of the specified item.","longName":"MAMMT_BX_CT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FC1FEFCA-4423-3CB3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-07-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-07-18","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2262000","version":"2","preferredName":"Hormone Receptor Assay Indicator","preferredDefinition":"Yes or No indicator to signify that a hormone receptor assay was performed.","longName":"HORM_RCPT_ASSAY_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7B9766FE-A625-04C1-E053-F662850AC1B4","latestVersionIndicator":"Yes","beginDate":"2018-11-27","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-11-27","modifiedBy":"COOPERM","dateModified":"2018-11-27","changeNote":"Restore back to Labs Ind-2 VD, CDE not in CTEP context. - dbw Versioned to use standard indicator VD. mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2262010","version":"1","preferredName":"Prior Treatment Cycle Therapy Course Count","preferredDefinition":"Count of the number of completed courses of a therapy or treatment administered to a patient/participant.","longName":"PRIOR_CRSE_COMP_CT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FC1FEFCA-4453-3CB3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-07-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-07-18","modifiedBy":"ZIEGLERK","dateModified":"2013-10-21","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2262013","version":"1","preferredName":"Prior Therapy Agent Discontinuation Reason Text Name","preferredDefinition":"Text term to represent reason that a therapy agent was discontinued.","longName":"AGT_DISCONT_RSN_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"FC1FEFCA-44AC-3CB3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-07-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-07-18","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2262017","version":"1","preferredName":"Prior Therapy Agent Discontinuation Other Reason Text","preferredDefinition":"Text to capture a response of 'other' as the reason a therapy agent was discontinued.","longName":"AGT_DISCONT_RSN_TXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"FC1FEFCA-44F1-3CB3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-07-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-07-18","modifiedBy":"BROWNTY","dateModified":"2022-03-25","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2262105","version":"1","preferredName":"BRCA1Gene Risk Assessment Score","preferredDefinition":"Numeric result of an evaluation of an individual for the presence of BRCA-1 gene located on human chromosome 17q12-21, using the BRCAPRO computer application. The mutation of these genes is associated with the formation of familial breast and ovarian cancer.","longName":"BRCA1_RISK_ASSESS_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"FC1FEFCA-45A0-3CB3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-07-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-07-19","modifiedBy":"REEVESD","dateModified":"2011-03-18","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2262108","version":"1","preferredName":"Couch Model Risk Assessment Score","preferredDefinition":"Numeric value to represent a probability estimate for detecting a BRCA1 mutation in women with breast cancer who have a family or personal history of breast cancer, ovarian cancer, or both, using the Couch model.","longName":"COUCH_RISK_ASSESS_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"FBB87F7A-67E0-1AFC-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-07-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-07-19","modifiedBy":"REEVESD","dateModified":"2013-09-18","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2262111","version":"1","preferredName":"Years Since Menopause Number","preferredDefinition":"Numeric value to represent the number of years that have elapsed since the onset of a woman's menopause.","longName":"YR_SINCE_MENP_NUM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"FC1FEFCA-45FD-3CB3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-07-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-07-19","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2262114","version":"1","preferredName":"Mammogram Threshold Number","preferredDefinition":"Numeric value to represent the percentage of fibroglandular tissue by the percentage of fatty tissue on a mammogram.","longName":"MGM_THRESH_NUM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"FC1FEFCA-464F-3CB3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-07-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-07-19","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2262121","version":"1","preferredName":"Bone Mineral Density Measurement Site Text Name","preferredDefinition":"Text names for anatomic site measurement  that is collected during a Bone Mineral Density test.","longName":"BMD_MSRMT_SITE_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"FC1FEFCA-469B-3CB3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-07-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-07-19","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2262124","version":"1","preferredName":"Bone Mineral Density Measurement Result Score","preferredDefinition":"Numeric value to represent the score or result of a bone mineral density test.","longName":"BMD_MSRMT_RSL_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"FC1FEFCA-46E1-3CB3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-07-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-07-19","modifiedBy":"LEEW","dateModified":"2019-06-05","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2262133","version":"1","preferredName":"MENQOL Domain Text Name","preferredDefinition":"Text terms to define the four domains of the Menopause-Specific Qualify of Life Questionnaire (MENQOL).","longName":"MENQOL_DOMN_TXT_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"FBB87F7A-6909-1AFC-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-07-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-07-19","modifiedBy":"LUY","dateModified":"2013-10-23","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2262136","version":"1","preferredName":"MENQOL Domain Score","preferredDefinition":"Numeric value to represent the score for a domain assessment using the MENQOL (Menopause-Specific Quality of Life Assessment)..","longName":"MENQOL_DOMN_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"FBB87F7A-6950-1AFC-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-07-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-07-19","modifiedBy":"ZHANGWE","dateModified":"2013-10-23","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2319845","version":"1","preferredName":"Last Known Alive Date","preferredDefinition":"Most recent date on which a person's survival status of 'alive' could be verified.","longName":"LAST_KNWN_ALIVE_DT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"FC6EF0D8-5059-6865-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-07-22","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-07-22","modifiedBy":"COLBERTM","dateModified":"2019-11-13","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2320029","version":"1","preferredName":"Relevant Menstrual History Text","preferredDefinition":"Text to capture the relevant menstrual history of a female.","longName":"RELV_MENS_HX_TXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"FC6EF0D8-50EC-6865-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-07-25","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-07-25","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2320041","version":"1","preferredName":"Vascular Retina Choroid Examination Text","preferredDefinition":"Text field to capture results of an examination of the vascular aspects of the retina and choroid of the eye(s).","longName":"VASC_RETN_CHOR_TXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"FC6EF0D8-5198-6865-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-07-25","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-07-25","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2321160","version":"4","preferredName":"Agent Administration Dose Unit of Measure Name","preferredDefinition":"Text name to represent units of measure used to describe dosages of an agent or measure.","longName":"DOSE_UOM_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"6D888D23-5CD0-3243-E053-F662850A44B7","latestVersionIndicator":"Yes","beginDate":"2018-05-31","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-05-31","modifiedBy":"KUMMEROA","dateModified":"2022-07-14","changeNote":"Version 4.0 expands max field from 16 to 30 characters maximum as requested for NCI-INC0282787-Theradex UOM 5.31.18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2321283","version":"1","preferredName":"Sample Weight In Gram Number","preferredDefinition":"Numeric value to represent the weight of a specimen or tissue sample in number of grams.","longName":"SMPL_WT_GM_NUM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"FCF89106-138E-2D93-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-07-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-07-28","modifiedBy":"COLBERTM","dateModified":"2019-11-13","changeNote":"5/18/16 jk added to MCL context CSI.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2322108","version":"1","preferredName":"Laboratory Test Assay Date","preferredDefinition":"Date of performance of an assay, measurement of the effects of a biologically active substance in tissue(s) using an intermediate in vivo or in vitro tissue or cell model under controlled conditions.","longName":"LAB_TEST_ASSAY_DT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"FD0F852B-0288-7140-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-08-01","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-08-01","modifiedBy":"HARTLEYG","dateModified":"2015-10-15","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2390789","version":"1","preferredName":"Breast Cancer Invasive Component Descriptive Short Text","preferredDefinition":"Abbreviated or shortened text field to capture the breast cancer invasive component that is described as 'other' histology type.","longName":"BRST_CA_INVCOMP_TXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"FE0FD98C-BA96-595D-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-04-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-08-18","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2400278","version":"1","preferredName":"First Degree Relative Diagnosis Breast Carcinoma Number","preferredDefinition":"Numeric value to represent the number of first degree relatives (parent, sibling, and/or child) associated with a diagnosis of breast cancer","longName":"FST_RLTV_BRST_CA_NUM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"FF81124E-0F7F-197D-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-08-31","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-08-31","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":"Released status approved 9/1/2005","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2400280","version":"1","preferredName":"Family History Descriptive Text","preferredDefinition":"Text that provides a description of pertinent family history.","longName":"FAM_HX_DESC_TXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"FF81124E-0FB5-197D-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-08-31","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-08-31","modifiedBy":"BRETTS","dateModified":"2014-02-27","changeNote":"Released status approved 9/1/2005","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2411341","version":"1","preferredName":"Clinical Stage Disease Text Name","preferredDefinition":"Text term to represent the clinical extent of disease in the body in respect to possible surgical intervention","longName":"CLIN_STG_DZ_TXT_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"0149E795-4B4D-054B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-09-22","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-09-22","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2411346","version":"1","preferredName":"Physical Examination Change Descriptive Text","preferredDefinition":"Text to describe an alteration in the results of a systemic evaluation of the body and its functions from one timepoint to another.","longName":"PE_CHG_DESC_TXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"013786F9-7CA7-629F-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-09-22","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-09-22","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2411771","version":"1","preferredName":"Neuropsychology Testing Complete Indicator","preferredDefinition":"Indicator of Yes or No to signify completion of neuropsychological testing, investigating the correlation between experience or behavior and the basic neurophysiological processes. The term neuropsychology stresses the dominant role of the nervous system.","longName":"NEURPSY_TST_CMPL_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"019C7266-AF41-0AAA-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-09-25","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-09-25","modifiedBy":"CARPSE","dateModified":"2014-09-29","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2411773","version":"1","preferredName":"Neuropsychology Testing Complete Date","preferredDefinition":"Date of completion of neuropsychological testing, investigating the correlation between experience or behavior and the basic neurophysiological processes.","longName":"NEURPSY_TST_CMPL_DT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"019C7266-AF73-0AAA-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-09-25","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-09-25","modifiedBy":"CARPSE","dateModified":"2014-10-01","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2411776","version":"1","preferredName":"Central Nervous System Dysfunction Classification Name","preferredDefinition":"Text name representing the judgment of CNS dysfuction classification by the neurobehavioral team at a study timepoint.","longName":"CNS_DYSF_CLASS_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"019C7266-AFC3-0AAA-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-09-25","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-09-25","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2411808","version":"1","preferredName":"Dose Time Elapsed Derived Minute Number","preferredDefinition":"Derived numeric value to represent the number of minutes that have elapsed from the start time of an infusion or agent administration until the time of the collection of a biological sample.","longName":"DOSE_DERIV_MIN_NUM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"019C7266-B66C-0AAA-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-09-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-09-27","modifiedBy":"FORMBUILDER","dateModified":"2012-05-14","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2411867","version":"2","preferredName":"Concomitant Procedure Name","preferredDefinition":"Text name of a measure that is not part of the protocol or treatment program regimen.  Concomitant procedures are performed in response to preexisting conditions/symptoms, or to treat adverse events.","longName":"CONCT_PROC_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"7A151F50-4D6D-26F0-E040-BB89AD437227","latestVersionIndicator":"Yes","beginDate":"2009-12-06","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-12-06","modifiedBy":"SOKKERL","dateModified":"2019-10-22","changeNote":"Replaces v1.0 of this CDE to provide a longer maximum length field.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2414969","version":"1","preferredName":"Research Specimen Collected Tube Type","preferredDefinition":"Types of specimen tube(s) with specimen amounts collected for research purposes.","longName":"RSCH_SPEC_TUBE_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"02772734-9C3E-6ADF-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-10-06","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-10-06","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2415026","version":"1","preferredName":"Specimen Tube Bar Code","preferredDefinition":"Numeric code to identify a single specimen tube, displayed as a barcode.","longName":"SPEC_TUBE_BARCD","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"02772734-9CA2-6ADF-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-10-06","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-10-06","modifiedBy":"HARTLEYG","dateModified":"2015-09-21","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2415047","version":"1","preferredName":"Human Activity Profile Assessment Score","preferredDefinition":"Numeric score on single criterion from the the Human Activity Profile (HAP) test.","longName":"HAP_ASSESS_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"027804FD-E470-104C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-10-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-10-07","modifiedBy":"PRICEA","dateModified":"2013-10-25","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2415051","version":"1","preferredName":"Human Activity Profile Assessment Criterion Name","preferredDefinition":"Text terms to capture primary scoring activity criteria in the Human Activity Profile (HAP) test.","longName":"HAP_ASSESS_CRIT_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"027804FD-E4BD-104C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-10-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-10-07","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2416537","version":"3","preferredName":"Radiation Therapy Field Anatomic Site Name","preferredDefinition":"Text term to identify anatomically-specified areas or fields that are targeted for radiation therapy.","longName":"RT_FIELD_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"720AFF64-6F8D-AF2C-E040-BB89AD435A74","latestVersionIndicator":"Yes","beginDate":"2006-09-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-08-26","modifiedBy":"ALEYR","dateModified":"2019-04-13","changeNote":"v3.0 includes updated VD with increase in maximum field length to meet requirements of NCI CCR program, 8/26/09.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2418908","version":"1","preferredName":"RT Actual Administered Day Count","preferredDefinition":"Numeric value to capture the number of days over which Radiation Therapy was administered to an individual.","longName":"RT_ADMIN_D_CT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"0307659E-EF7A-15EE-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-10-13","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-10-13","modifiedBy":"MAESKEB","dateModified":"2011-09-13","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2419218","version":"1","preferredName":"Radiation Therapy Adverse Event Onset Timeframe Name","preferredDefinition":"Text term to describe the timeframe of the onset of an adverse event in relation to the receipt of radiation treatment.","longName":"RT_AE_ONSET_TMFRM_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"0307659E-F024-15EE-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-10-14","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-10-14","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2422713","version":"1","preferredName":"Biopsy Site Identification Method Type","preferredDefinition":"Text name to represent the type of methodology used to identify and target a site for biopsy.","longName":"BX_SITE_ID_METH_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"03E16831-ACCE-6D9B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-10-25","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-10-25","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2422723","version":"1","preferredName":"Suspicion Malignancy  Likelihood Level","preferredDefinition":"Text term to capture the degree of suspicion that a test result will be malignant.","longName":"SUSP_MALIG_LKHD_LVL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"03DC2736-8608-0515-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-10-25","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-10-25","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2422729","version":"1","preferredName":"Biopsy Target Success Indicator","preferredDefinition":"Indicator of Yes or No to indicate successful targeting of a biopsy based on a scan that was conducted.","longName":"BX_TGT_SUCC_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"03E16831-ACFF-6D9B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-10-25","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-10-25","modifiedBy":"HARTLEYG","dateModified":"2013-04-25","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2422934","version":"1","preferredName":"Biopsy Specimen Destination Use Name","preferredDefinition":"Text term to capture the destination of a biopsy specimen by its intended use.","longName":"BX_SPEC_DEST_USE_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"03E16831-ADC4-6D9B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-10-25","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-10-25","modifiedBy":"SOKKERL","dateModified":"2018-11-06","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2423654","version":"1","preferredName":"Administration Schedule Abbreviated Descriptive Text","preferredDefinition":"Short description of a schedule for medication or intervention administration.","longName":"SCHED_ABB_DESC_TXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"03E16831-B279-6D9B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-10-31","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-10-31","modifiedBy":"FORMBUILDER","dateModified":"2012-05-14","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2427051","version":"1","preferredName":"Clinical Response Assessment Indicator","preferredDefinition":"Indicates the presence of Response assessment outcome variable, based on direct observation and noninvasive examination of a subject.","longName":"CLIN_RESP_ASSESS_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"05116195-E9E5-7341-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-01-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-11-08","modifiedBy":"CLOHNES","dateModified":"2023-11-16","changeNote":null,"administrativeNotes":"11/16/23 Added alt OID for CCTG CADSR0003018 cjl; 11/13/23 Added AQT for CCTG ticket number CADSR0003018 cjl.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2434990","version":"1","preferredName":"Chemotherapy Past Six Week Treatment Indicator","preferredDefinition":"Text indicator to represent the occurrence of any treatment consisting of a chemotherapeutic agent within the past six weeks.","longName":"CHEMO_PAST_6_WK_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"06F49B98-8437-323D-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-05","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-12-05","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2436231","version":"1","preferredName":"Patient Ethnicity Subcategory Text Name","preferredDefinition":"Text terms to represent a patient's self-declared cultural, ancestral or ethnic origination subcategory.","longName":"PRSN_ETHN_SUBCAT_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"06F397CB-4601-08F1-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-12-12","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2436233","version":"1","preferredName":"Tobacco Smoking History Indicator","preferredDefinition":"Text indicator to respresent a person's tobacco smoking, the act of puffing and/or inhaling smoke from a lit tobacco cigarette, cigar, or pipe.","longName":"TOBA_SMOK_HX_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"06F397CB-4634-08F1-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-12-12","modifiedBy":"FORMBUILDER","dateModified":"2021-01-13","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2436238","version":"1","preferredName":"Surgical Menopause History Indicator","preferredDefinition":"Text indicator to represent a history of a person's menopause, the permanent cessation of menses, occurring due to surgery.","longName":"SURG_MENP_HX_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"06F397CB-467D-08F1-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-12-12","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2436245","version":"1","preferredName":"Hormone Replacement Therapy History Indicator","preferredDefinition":"Text indicator to represent a person's history of treatment with estrogens or estrogen/progesterone after menopause or ovariectomy to prevent pathological effects of decreased estrogen production.","longName":"HORM_REPL_TX_HX_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"06F397CB-46C8-08F1-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-12-12","modifiedBy":"DWARZEL","dateModified":"2022-05-23","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2436370","version":"1","preferredName":"NonReplacement Hormone Therapy History Indicator","preferredDefinition":"Text indicator to represent a person's history of treatment with estrogens or estrogen/progesterone for a reason other than replacement for menopause.","longName":"NONREPL_HORM_HX_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"0781A8FE-55B5-0C0C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-12-12","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2436682","version":"1","preferredName":"Hormone Use Duration in Years Number","preferredDefinition":"Duration in years of the period of hormone use by a person.","longName":"HORM_USE_DURN_YR_NUM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"0781A8FE-55EE-0C0C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-12-12","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2436689","version":"1","preferredName":"Birth Control Pill History Indicator","preferredDefinition":"Text indicator to represent a women's use of oral contraceptives/birth control pills.","longName":"BIRTH_CTRL_PILL_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"0781A8FE-563E-0C0C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-12-12","modifiedBy":"REEVESD","dateModified":"2011-03-18","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2436691","version":"1","preferredName":"Birth Control Pill History Duration in Years Number","preferredDefinition":"Duration in years of a women's use of oral contraceptives/birth control pills.","longName":"BIRTH_CTRL_YR_NUM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"0781A8FE-5670-0C0C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-12-12","modifiedBy":"RODGERSC","dateModified":"2015-11-30","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2436696","version":"1","preferredName":"Infertility Treatment Indicator","preferredDefinition":"Text indicator to represent an action or administration of therapeutic agents to produce an effect that is intended to alter a woman's inability to produce children.","longName":"INFTL_TX_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"06F397CB-47A3-08F1-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-12-12","modifiedBy":"FORMBUILDER","dateModified":"2014-09-02","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2436698","version":"1","preferredName":"Infertility Treatment Descriptive Text","preferredDefinition":"Text to describe an action or administration of therapeutic agents to produce an effect intended to alter a woman's inability to produce children.","longName":"INFTL_TX_DESC_TXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"06F397CB-4A74-08F1-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-12-12","modifiedBy":"FORMBUILDER","dateModified":"2014-09-02","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2436860","version":"1","preferredName":"First Degree Relative Cancer Diagnosis Indicator","preferredDefinition":"Text indicator to represent a report or record of a cancer diagnosis in any relative with whom one half of an individual\"s genes is shared (i.e., parent, sibling, offspring).","longName":"FT_DEG_RELTV_CA_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"07D00C2C-354C-1C50-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-13","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-12-13","modifiedBy":"JKNABLE","dateModified":"2023-03-13","changeNote":"Reused for TCGA project via request from J. Gardner. 08/30/10 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2436875","version":"1","preferredName":"Cancer Risk Genetic Testing Indicator","preferredDefinition":"Text indicator to represent a record or history of an individual's analysis of DNA to look for a genetic alteration that may indicate an increased risk for developing cancer.","longName":"CA_RSK_GNTST_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"07D04DD3-7C1E-1CBA-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-13","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-12-13","modifiedBy":"MAESKEB","dateModified":"2012-07-16","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2436882","version":"1","preferredName":"Cancer Risk Genetic Testing Result Text","preferredDefinition":"Text result of an evaluation of an individual's DNA to look for a genetic alteration that may indicate an increased risk for developing cancer.","longName":"CA_RSK_GNTST_RSL_TXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"07CFD8DB-A685-3394-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-13","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-12-13","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2437511","version":"1","preferredName":"Actual Pharmacokinetics Collection Duration Minute Number","preferredDefinition":"Number of minutes associated with a step in the actual sampling schedule for the collection of pharmacokinetic data.","longName":"ACT_PK_COLL_MIN_NUM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"07D00C2C-3794-1C50-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-14","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-12-14","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2437532","version":"1","preferredName":"BRCA1 Gene Mutation Indicator","preferredDefinition":"Text indicator to represent a mutation of the BRCA-1 gene located on human chromosome 17q12-21, which is associated with the formation of familial breast and ovarian cancer.","longName":"BRCA1_GENE_MUTN_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"07D00C2C-380A-1C50-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-14","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-12-14","modifiedBy":"COOPERM","dateModified":"2019-07-18","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2437543","version":"1","preferredName":"BRCA2 Gene Mutation Indicator","preferredDefinition":"Text indicator to represent a mutation of the BRCA2 gene which functions as a tumor suppressor gene; however, its exact function has not been well characterized.","longName":"BRCA2_GENE_MUTN_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"07CFEE0B-B063-3396-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-14","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-12-14","modifiedBy":"COOPERM","dateModified":"2019-07-18","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2442949","version":"1","preferredName":"Hormone Replacement Therapy Indicator","preferredDefinition":"Text indicator to represent a person's history of treatment with estrogens or estrogen/progesterone after menopause or ovariectomy to prevent pathological effects of decreased estrogen production.","longName":"HORM_REPL_TX_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"09108545-EAB2-6C9D-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-12","endDate":null,"createdBy":"MAESKEB","dateCreated":"2006-01-11","modifiedBy":"BONANNIR","dateModified":"2016-09-28","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2442952","version":"1","preferredName":"Female Hormone Replacement Year Category","preferredDefinition":"The category in total years that a female has taken hormone replacements.","longName":"FEM_HORM_REPL_YR_CAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"09108545-EB06-6C9D-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-01-11","endDate":null,"createdBy":"MAESKEB","dateCreated":"2006-01-11","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2448409","version":"1","preferredName":"Protocol Sponsor Serious Adverse Event Notification Indicator","preferredDefinition":"Text indicator of notification of the group sponsoring a clinical trial that a serious adverse event (SAE) has occurred.","longName":"SPNR_SAE_NOTFN_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"0C236CBF-CBCD-2FB2-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-06","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-02-06","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2450913","version":"1","preferredName":"Treatment Delivery Location Name","preferredDefinition":"Text term to designate the organizational unit, such as an institute, where therapeutic agents or treatment is administered.","longName":"TX_DLVY_LCN_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"0C746E5C-12A9-28AF-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-13","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-02-13","modifiedBy":"REEVESD","dateModified":"2011-07-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2451507","version":"1","preferredName":"Neurologic Assessment Finding Name","preferredDefinition":"Text term to represent the result or findings of a neurological assessment.","longName":"NEURO_ASSESS_FNG_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"0C625C4B-2B22-27E6-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-16","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-02-16","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2451717","version":"1","preferredName":"Research Tissue Submission Indicator","preferredDefinition":"Text indicator to represent if there was submission of a research tissue for review and/or analysis.","longName":"RSCH_TISS_SUBM_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"0D052842-714E-4FD3-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-02-21","modifiedBy":"NELSONA","dateModified":"2018-12-13","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2451906","version":"1","preferredName":"Biopsy Performed Indicator","preferredDefinition":"Indicator to represent if a biopsy has been performed.","longName":"BX_PERF_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"0D052842-78ED-4FD3-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-22","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-02-22","modifiedBy":"MMADDINENI","dateModified":"2023-12-18","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2451912","version":"1","preferredName":"Biopsy Sample Tumor Representation Indicator","preferredDefinition":"Text indicator to signify the ability of a biopsy sample or specimen to reflect the tumor of the biopsy subject.","longName":"BX_SMPL_TUM_RPN_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"0D052842-7939-4FD3-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-22","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-02-22","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2452254","version":"1","preferredName":"Minimal Residual Disease Treatment Indicator","preferredDefinition":"Text indicator to represent that treatment was administered in the setting of 'minimal residual disease', when a small amount of a tumor or neoplasm remains after primary, potentially curative therapy.","longName":"MIN_RSDL_DZ_TX_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"0D51E8D8-610B-387C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-22","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-02-22","modifiedBy":"MMADDINENI","dateModified":"2022-12-27","changeNote":null,"administrativeNotes":"12/14/22 added alt, OID CCTG for ticket number CADSR0001800 cjl;","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2452703","version":"1","preferredName":"Dog Sex Type Text Code","preferredDefinition":"Text code to represent the sexual phenotype in a canine/dog.","longName":"DOG_SEX_TP_TXT_CD","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"0D51E8D8-686C-387C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-24","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-02-24","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2452719","version":"1","preferredName":"Nonsteroidal Antiinflammatory Drug Use Indicator","preferredDefinition":"Text indicator to denote past or present use of anti-inflammatory agents (NSAIDs) that are not steroids.","longName":"NSAID_USE_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"0D052842-7ED9-4FD3-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-24","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-02-24","modifiedBy":"MORENOC","dateModified":"2018-04-03","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2452730","version":"1","preferredName":"Veterinary Patient First Name Text","preferredDefinition":"Text value to capture the uniquely identifying name for a veterinary patient by using a word or group of words indicating the patient's  first (personal or given) name.","longName":"VET_PT_FIRST_NM_TXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"0D052842-7F4B-4FD3-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-24","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-02-24","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2452732","version":"1","preferredName":"Veterinary Patient Last Name Text","preferredDefinition":"Text name to uuniquely identify a veterinary patient by using a word or group of words indicating a patient's last (family) name.","longName":"VET_PT_LAST_NM_TXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"0D052842-7F82-4FD3-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-24","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-02-24","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2452737","version":"1","preferredName":"Veterinary Patient Owner Last Name Text","preferredDefinition":"Text value to capture the uniquely identifying name of a veterinary patient's owner's last (family) name. Synonym = Last Name, Surname.","longName":"VET_OWN_LAST_NM_TXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"0D052842-7FCA-4FD3-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-24","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-02-24","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2452741","version":"1","preferredName":"Veterinary Patient Owner First Name Text","preferredDefinition":"Text term to capture the uniquely identifying veterinary patient owner's first (personal or given) name; the name that precedes the surname. Synonym = Given Name.","longName":"VET_OWN_FIRST_NM_TXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"0D052842-8010-4FD3-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-24","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-02-24","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2452762","version":"1","preferredName":"Best Response Veterinary Treatment Type","preferredDefinition":"Text value to denote the best response of a veterinary patient to an intervention or course of treatment.","longName":"BEST_RESP_VET_TX_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"0D052842-8141-4FD3-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-24","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-02-24","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2452775","version":"1","preferredName":"Biopsy Related Adverse Event Occurrence Indicator","preferredDefinition":"Text indicator to signify the occurrence of an adverse event or related event associated with a biopsy procedure.","longName":"BX_REL_AE_OCCUR_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"0D51E8D8-68E4-387C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-24","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-02-24","modifiedBy":"SOKKERL","dateModified":"2019-02-27","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2452783","version":"1","preferredName":"Multiple Specimen Collection Indicator","preferredDefinition":"Text indicator to denote the collection of  more than one specimen from a subject during a single procedure or point in time.","longName":"MULTI_SPEC_COLL_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"0D51E8D8-691C-387C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-24","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-02-24","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2452792","version":"1","preferredName":"Formalin Specimen Fixative Indicator","preferredDefinition":"Indicator to signify the use of a formaldehyde product compound to fix tissues and cells for microscopic study.","longName":"FMLN_SPEC_FIXST_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"0D51E8D8-696B-387C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-24","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-02-24","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2453180","version":"1","preferredName":"Dog Breed Text Name","preferredDefinition":"Text term to designate a homogeneous grouping (breed) for a dog.","longName":"DOG_BREED_TXT_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"0DDD1E7C-BB7B-66D1-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-02-28","modifiedBy":"RODGERSC","dateModified":"2013-05-06","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2453187","version":"1","preferredName":"Institutional Animal Care and Use Committee Consent Form Approval Date","preferredDefinition":"Date of the Institutional Animal Care and Use Committee (IACUC) approval of a trial and informed consent for use with veterinary patients.","longName":"IACUC_APPR_DT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"0DDD1E7C-BBC6-66D1-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-02-28","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2453236","version":"1","preferredName":"Veterinary Patient Performance Status Grade","preferredDefinition":"Numeric value to represent the final result of a determination of  how well a veterinary patient is able to carry out daily activities.","longName":"VET_PT_PERF_STAT_GD","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"0DDD1E7C-BDB5-66D1-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-02-28","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2453334","version":"1","preferredName":"Veterinary Patient Physical Exam Body System Type","preferredDefinition":"Text term to represent the body system(s) assessed during a veterinary patient's physical examination.","longName":"VET_PT_PE_BDY_SYS_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"0DDF0D1A-208A-6548-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-03-01","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-03-01","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2453343","version":"1","preferredName":"Veterinary Patient Performance Assessment Criteria Name","preferredDefinition":"Text term(s) to capture the clinical performance assessment criteria of a veterinary patient.","longName":"VET_ASSESS_CRIT_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"0DDF0D1A-2107-6548-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-03-01","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-03-01","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2453345","version":"1","preferredName":"Dog Owner Performance Assessment Indicator","preferredDefinition":"Indicator of the presence or absence of performance/symptomatology criteria during an owner's ssessment of a domestic dog (Canis familiaris).","longName":"DOG_OWN_ASSESS_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"0DDF0D1A-2139-6548-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-03-01","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-03-01","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2453351","version":"1","preferredName":"Dog Assessment Prior To Schedule Indicator","preferredDefinition":"Text indicator to represent the need for a dog patient to be examined or assessed prior to the next scheduled appointment.","longName":"DOG_ASSESS_SCHED_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"0DDF0D1A-2188-6548-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-03-01","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-03-01","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2453354","version":"2","preferredName":"Specimen Biostorage Condition Category","preferredDefinition":"Text term to represent the temperature conditions under which a biological specimen is stored.","longName":"BIOSTRG_COND_CAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"9881C41C-CC5D-C63B-E040-BB89AD437873","latestVersionIndicator":"Yes","beginDate":"2010-12-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-12-28","modifiedBy":"COOPERM","dateModified":"2011-12-06","changeNote":"Replaces v1.0 with a VD that has extended maximum length of 30 characters.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2453391","version":"1","preferredName":"Veterinary Patient Survival Status","preferredDefinition":"Text term to represent the survival status of a veterinary patient.","longName":"VET_PT_SURV_STAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"0DDF0D1A-2496-6548-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-03-01","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-03-01","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2453403","version":"1","preferredName":"Dog Patient Prior Therapy Type","preferredDefinition":"Text term to represent therapy(ies) that have been administered to dog/canine patients.","longName":"DOG_PT_PRIOR_RX_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"0DDF0D1A-277C-6548-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-03-01","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-03-01","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2453611","version":"1","preferredName":"Veterinary Patient Primary Anatomic Disease Site Name","preferredDefinition":"Text namesof anatomic site of primary disease for veterinary patient assessment.","longName":"VET_PRIM_SITE_DZ_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"0DF2D8DA-7ACF-4D14-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-03-01","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-03-01","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2453625","version":"1","preferredName":"Physical Exam Change Indicator","preferredDefinition":"Text indicator to represent a change in a subject's physical examination since the previous evaluation.","longName":"PC_CHG_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"0E0474D9-844F-0507-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-03-02","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-03-02","modifiedBy":"MAESKEB","dateModified":"2011-09-13","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2453668","version":"1","preferredName":"Veterinary Cooperative Oncology Group CTCAE Term Name","preferredDefinition":"Text term to capture adverse event term description(s) in the Veterinary Cooperative Oncology Group Common Terminology Criteria for Adverse Events (VCOG-CTCAE) following chemotherapy or biological antineoplastic therapy in dogs and cats (v1.0, 2004).","longName":"VCOG_CTCAE_TRM_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"0E0474D9-84B5-0507-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-03-02","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-03-02","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2453716","version":"1","preferredName":"Veterinary Cooperative Oncology Group CTCAE Category","preferredDefinition":"Text term to represent an adverse event term category from the Veterinary Cooperative Oncology Group Common Terminology Criteria for Adverse Events (VCOG-CTCAE) following chemotherapy or biological antineoplastic therapy in dogs and cats (v1.0, 2004).","longName":"VCOG_CTCAE_CAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"0E0474D9-8540-0507-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-03-02","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-03-02","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2453731","version":"1","preferredName":"Veterinary  Patient Diagnosis Disease Term Name","preferredDefinition":"Text term to represent the disease diagnosis of a veterinary patient.","longName":"VET_PT_DX_DZ_TRM_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"0E070B71-8AF5-1732-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-03-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-03-03","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2454528","version":"1","preferredName":"Protocol Arm Assignment Text","preferredDefinition":"Text term to capture protocol arm(s) available as described in a protocol for subject assignment at the time of eligibility completion and enrollment.  Assignment occurs when there is more than one form of intervention or activity available to subjects enrolled in a trial.","longName":"PROT_ARM_ASSIGN_TXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Standard","id":"0E070B71-91FD-1732-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-03-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-03-10","modifiedBy":"COLBERTM","dateModified":"2023-03-24","changeNote":null,"administrativeNotes":"3/24/23 Removed PCDC alt name and CSI. New CDE was developed for PCDC. mr","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2463859","version":"1","preferredName":"Person Numb Emotions Stressful Life Event Response Text Value","preferredDefinition":"Text response on a questionnaire that represents a person's emotionally unresponsive or numb feelings about stressful life events.","longName":"PRSN_NUMB_EVT_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"0F836E72-1AD4-3EB2-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-03-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-03-21","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":"CDE represents question #15 on the Impact of Events Scale; author is Dr. Mardi Horowitz.  Dr. Horowitz granted permission for creation of IES CDEs in March 2006.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2463927","version":"1","preferredName":"Person Reminder Emotions Stressful Life Event Response Text Value","preferredDefinition":"Text response on a questionnaire that represents a person's recount that reminders bring back feelings caused by stressful life events.","longName":"PRSN_REM_EVT_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"0F836E72-1B8E-3EB2-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-03-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-03-21","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":"CDE represents question #14 on the Impact of Events Scale; author is Dr. Mardi Horowitz.  Dr. Horowitz granted permission for creation of IES CDEs in March 2006.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2463936","version":"1","preferredName":"Person Attempt Avoid Thinking Stressful Life Event Response Text Value","preferredDefinition":"Text response on a questionnaire that represents a person's attempt(s) at avoidance of mental activity/thoughts focused on stressful events in life.","longName":"PRSN_ATP_THK_EVT_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"0F836E72-1BDB-3EB2-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-03-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-03-21","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":"CDE represents question #13 on the Impact of Events Scale; author is Dr. Mardi Horowitz.  Dr. Horowitz granted permission for creation of IES CDEs in March 2006.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2463946","version":"1","preferredName":"Person Emotion Avoidance Stressful Life Event Response Text Value","preferredDefinition":"Text response on a questionnaire that represents a person's feelings about avoidance of mental activity/thoughts focused on stressful events in life.","longName":"PRSN_EMOT_EVT_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"0F836E72-1C27-3EB2-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-03-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-03-21","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":"CDE represents question #12 on the Impact of Events Scale; author is Dr. Mardi Horowitz.  Dr. Horowitz granted permission for creation of IES CDEs in March 2006.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2463951","version":"1","preferredName":"Person Other Things Thinking Stressful Life Event Response Text Value","preferredDefinition":"Text response on a questionnaire that represents a person's recount that other things cause thinking about stressful life events.","longName":"PRSN_OTX_THK_EVT_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"0F836E72-1C73-3EB2-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-03-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-03-21","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":"CDE represents question #11 on the Impact of Events Scale; author is Dr. Mardi Horowitz.  Dr. Horowitz granted permission for creation of IES CDEs in March 2006.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2463953","version":"1","preferredName":"Person Mental Picture Stressful Life Event Response Text Value","preferredDefinition":"Text response on a questionnaire that represents a person's verbalization of experiencing mental images about stressful life events.","longName":"PRSN_MTL_PIX_EVT_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"0F836E72-1CA6-3EB2-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-03-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-03-21","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":"CDE represents question #10 on the Impact of Events Scale; author is Dr. Mardi Horowitz.  Dr. Horowitz granted permission for creation of IES CDEs in March 2006.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2463965","version":"1","preferredName":"Person Avoid Speaking Stressful Life Event Response Text Value","preferredDefinition":"Text response on a questionnaire that represents a person's avoidance of talking about stressful life events.","longName":"PRSN_AVD_SPK_EVT_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"0F836E72-1CD8-3EB2-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-03-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-03-21","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":"CDE represents question #9 on the Impact of Events Scale; author is Dr. Mardi Horowitz.  Dr. Horowitz granted permission for creation of IES CDEs in March 2006.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2464013","version":"1","preferredName":"Person Unreal Emotion Stressful Life Event Response Text Value","preferredDefinition":"Text response on a questionnaire that represents a person's unreal feelings about stressful life events.","longName":"PRSN_UNRL_EVT_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"0F836E72-1D0B-3EB2-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-03-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-03-21","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":"CDE represents question #8 on the Impact of Events Scale; author is Dr. Mardi Horowitz.  Dr. Horowitz granted permission for creation of IES CDEs in March 2006.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2464015","version":"1","preferredName":"Person Avoid Reminder Stressful Life Event Response Text Value","preferredDefinition":"Text response on a questionnaire that represents a person's avoidance of reminders about stressful life events.","longName":"PRSN_AVD_REM_EVT_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"0F836E72-1D3E-3EB2-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-03-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-03-21","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":"CDE represents question #7 on the Impact of Events Scale; author is Dr. Mardi Horowitz.  Dr. Horowitz granted permission for creation of IES CDEs in March 2006.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2464017","version":"1","preferredName":"Person Dreams Stressful Life Event Response Text Value","preferredDefinition":"Text response on a questionnaire that represents a person's dreams about stressful life events.","longName":"PRSN_DM_EVT_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"0F836E72-1D71-3EB2-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-03-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-03-21","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":"CDE represents question #6 on the Impact of Events Scale; author is Dr. Mardi Horowitz.  Dr. Horowitz granted permission for creation of IES CDEs in March 2006.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2464021","version":"1","preferredName":"Person Intense Emotions Stressful Life Event Response Text Value","preferredDefinition":"Text response on a questionnaire that represents a person's intense feeling(s) caused by stressful life events.","longName":"PRSN_IN_EMOT_EVT_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"0F836E72-1DBE-3EB2-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-03-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-03-21","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":"CDE represents question #5 on the Impact of Events Scale; author is Dr. Mardi Horowitz.  Dr. Horowitz granted permission for creation of IES CDEs in March 2006.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2464036","version":"1","preferredName":"Person Sleep Disorder Stressful Life Event Response Text Value","preferredDefinition":"Text response on a questionnaire that represents a person's change from the baseline sleeping pattern, due to stressful life events.","longName":"PRSN_SLP_DSD_EVT_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"0F836E72-1E3F-3EB2-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-03-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-03-21","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":"CDE represents question #4 on the Impact of Events Scale; author is Dr. Mardi Horowitz.  Dr. Horowitz granted permission for creation of IES CDEs in March 2006.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2464038","version":"1","preferredName":"Person Removed Memory Stressful Life Event Response Text Value","preferredDefinition":"Text response on a questionnaire that represents a person's attempts at removal of stressful events from memory.","longName":"PRSN_RMVD_MY_EVT_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"0F836E72-1E72-3EB2-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-03-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-03-21","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":"CDE represents question #3 on the Impact of Events Scale; author is Dr. Mardi Horowitz.  Dr. Horowitz granted permission for creation of IES CDEs in March 2006.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2464074","version":"1","preferredName":"Person Avoidance Thinking Stressful Life Event Response Text Value","preferredDefinition":"Text response on a questionnaire that represents a person's avoidance of mental activity/thoughts focused on stressful events in life.","longName":"PRSN_AVD_THK_EVT_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"0F836E72-1EC0-3EB2-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-03-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-03-21","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":"CDE represents question #2 on the Impact of Events Scale; author is Dr. Mardi Horowitz.  Dr. Horowitz granted permission for creation of IES CDEs in March 2006.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2464076","version":"1","preferredName":"Person Accidental Thinking Stressful Life Event Response Text Value","preferredDefinition":"Text response on a questionnaire that represents a person's unintentional or accidental mental activity/thoughts focused on stressful events in life.","longName":"PRSN_ACC_THK_EVT_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"0F836E72-1EF2-3EB2-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-03-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-03-21","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":"CDE represents question #1 on the Impact of Events Scale; author is Dr. Mardi Horowitz.  Dr. Horowitz granted permission for creation of IES CDEs in March 2006.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2468926","version":"1","preferredName":"Patient Disease Body Surface Area Number Category","preferredDefinition":"Numeric value to represent the category that signifies the amount of body surface area involvement by disease.","longName":"PT_DZ_BSA_NUM_CAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"10A1362A-3644-627D-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-04-04","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-04","modifiedBy":"HARTLEYG","dateModified":"2018-03-19","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2474970","version":"1","preferredName":"Melanoma Skin Lesion Pattern Text Type","preferredDefinition":"Text term to represent appearance of skin lesions associated with melanoma.","longName":"MEL_SKN_LSN_PATT_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"115575B9-9443-070F-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-04-13","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-13","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2474972","version":"1","preferredName":"Liver Metastatic Involvement Date","preferredDefinition":"Date of histologic confirmation of the spread of cancer from a tumor composed of atypical neoplastic cells to the liver in the upper abdominal cavity.","longName":"LV_MET_INVLT_DT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"1154A73D-AD1A-1051-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-04-13","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-13","modifiedBy":"REEVESD","dateModified":"2011-03-18","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2475076","version":"1","preferredName":"Organ Tumor Replacement Percent Number","preferredDefinition":"Numeric value representing the percentage of an organ that is replaced by tumor cells.","longName":"ORGAN_RPLMT_PCT_NUM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"11829B33-BCC7-5E99-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-04-15","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-15","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2475080","version":"1","preferredName":"Hepatic Arterial Infusion Completion Time","preferredDefinition":"Clock time of the conclusion of a hepatic arterial infusion/perfusion.","longName":"HAI_COMP_TM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"1182D51F-14A6-64C7-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-04-15","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-15","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2475089","version":"1","preferredName":"Double Balloon Catheter Length Centimeter Number","preferredDefinition":"Linear measurement of a double balloon catheter in centimeters, expressed as a numeric value.","longName":"DBL_BALL_CATH_CM_NUM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"11845214-AE2A-7161-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-04-15","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-15","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2475097","version":"1","preferredName":"Catheter Sampling Location Text Name","preferredDefinition":"Text term for sampling locations associated with a balloon catheter.","longName":"CATH_SMPL_LCTN_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"1183D980-8946-097B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-04-15","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-15","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2475102","version":"3","preferredName":"Adverse Event Study Procedure Attribution Code","preferredDefinition":"Code to indicate the causal relationship between the treatment procedure and the specific adverse event.","longName":"AE_TX_PROC_ATTR_CD","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"237B7ECB-20FC-5D43-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-11-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-11-30","modifiedBy":"SOKKERL","dateModified":"2018-10-05","changeNote":"v2.0 uses codes instead of text terms for values.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2475218","version":"1","preferredName":"Balloon Catheter Associated Procedure Text Name","preferredDefinition":"Text term(s) to represent procedure(s) associated with the use of a balloon venous catheter.","longName":"BALL_CATH_PROC_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"11A359C4-60E6-4FDD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-04-17","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-17","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2475224","version":"1","preferredName":"Patient Movement Protocol Treatment Indicator","preferredDefinition":"Text indicator to signify a protocol subject's progression to the treatment regimen or phase of the trial.","longName":"PT_MVMT_PROT_TX_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"11A2997D-1D8F-5821-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-04-17","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-17","modifiedBy":"KUMMEROA","dateModified":"2023-03-09","changeNote":null,"administrativeNotes":"2023.3.9 AQT added per ticket request CADSR0002119. ak","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2475243","version":"1","preferredName":"Heparin Regimen Treatment Plan Time Interval Text","preferredDefinition":"A text field to capture a time interval in reference to a prescribed heparin dosing plan.","longName":"HEP_TX_TM_INTVL_TXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"11A403C5-8B36-6458-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-04-17","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-17","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2475857","version":"1","preferredName":"Heparin Administered Dose Unit Number","preferredDefinition":"A numeric value to represent a dose of heparin administered, expressed as a number of units.","longName":"HEP_ADMIN_DOSE_NUM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"11B7F245-95FF-4734-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-04-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-18","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2475876","version":"1","preferredName":"Blood Pressure Flow Rate Regimen Time Interval Text","preferredDefinition":"Text term to capture prescribed outline of a monitoring regimen using timepoints relative to blood pressure and flow rate activities.","longName":"BP_FLOW_RGM_ITVL_TXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"11B8BB67-2DDE-6357-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-04-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-18","modifiedBy":"DWARZEL","dateModified":"2012-11-27","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2475888","version":"1","preferredName":"Infusion Flow Rate Number","preferredDefinition":"Numeric value to represent measurement of the continuous movement of an intravenous substance relative to time, expressed as a value in milliliters per minute.","longName":"INF_FLOW_RT_NUM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Standard","id":"11BA28F6-0DE1-7113-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-04-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-18","modifiedBy":"CLOHNES","dateModified":"2022-10-13","changeNote":"9/25/13 removed alt question text and CSI reference for CT Imaging Agent CRF module. jc  7/26/13 added to CT Imaging Agent CRF CSI. jc","administrativeNotes":"10/13/22 added alt name, 2 AQT, classification for CTEP CDISC Harmonization project cjl;","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2475893","version":"1","preferredName":"Mean Arterial Pressure Measurement in Millimeter of Mercury Number","preferredDefinition":"Result of a mean average pressure determination, expressed as a numeric value in millimeters of mercury (mmHg) to the nearest even number.","longName":"MAP_MMHG_NUM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"11BA6DC5-661C-070E-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-04-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-18","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2479040","version":"1","preferredName":"Patient Protocol Repeat Enrollment Indicator","preferredDefinition":"Text indicator to signify a person's repeat enrollment into a protocol's arm or study group.","longName":"PT_PROT_REENRLL_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"122C5E75-088E-12D9-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-04-24","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-24","modifiedBy":"REEVESD","dateModified":"2012-07-16","changeNote":"Curated to support CCR Surgery (Immunotherapy) legacy data migration","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2479403","version":"2","preferredName":"Lesion Thickness Lesion Thickness Millimeter Number","preferredDefinition":"Numeric value to represent the slice thickness of a tumor or lesion, expressed in millimeters.","longName":"LES_THKN_MM_NUM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"1EFEF9DE-F45F-436B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-10-04","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-10-04","modifiedBy":"TSESU","dateModified":"2018-07-02","changeNote":"v2.0 has additional decimal places.  Curated to support CCR Surgery (Immunotherapy) legacy data migration","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2479465","version":"1","preferredName":"HLA Allelotyping Testing Result Text","preferredDefinition":"Text terms to capture the analysis and specification of allelotyping for immune responses and histocompatibility processes.","longName":"HLA_ALLT_RSL_TXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"12480D00-017E-6274-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-04-25","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-25","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":"Curated to support migration from PDMS to C3D in CCR.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2479645","version":"1","preferredName":"Prior Surgical Procedure Extent Text Code","preferredDefinition":"Text codes to represent the extent of prior surgery that was performed.","longName":"PRIOR_SURG_EXT_CD","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"1253D963-0E3B-649C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-04-26","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-26","modifiedBy":"REEVESD","dateModified":"2012-07-16","changeNote":"Curated to support CCR Surgery (Immunotherapy) legacy data migration","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2479650","version":"1","preferredName":"Disease Surgical No Evidence of Disease Indicator","preferredDefinition":"Text indicator to signify that a person's disease status following surgical intervention is 'NED', meaning no evidence of disease, and diagnostic tests fail to detect presence of disease.","longName":"DZ_SURG_NED_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"12552BCE-401F-05CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-04-26","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-26","modifiedBy":"REEVESD","dateModified":"2012-07-16","changeNote":"Curated to support CCR Surgery (Immunotherapy) legacy data migration","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2479656","version":"1","preferredName":"Site Disease Clinically Positive Indicator","preferredDefinition":"Text indicator to indicate that a location or site of disease is clinically positive, based on direct observation or  noninvasive assessment methods. [Manually-curated]","longName":"SITE_DZ_CLIN_POS_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"12548BF5-8ECD-1DAB-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-04-26","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-26","modifiedBy":"REEVESD","dateModified":"2008-01-15","changeNote":"Curated to support migration from PDMS to C3D in CCR.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2479664","version":"1","preferredName":"Surgical Procedure Curative Intent Indicator","preferredDefinition":"Text indicator to signify anticipation that a surgical procedure will result in the cure of a subject. [Manually-curated]","longName":"SURG_CUR_INT_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"1254C158-F69A-2ADD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-04-26","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-26","modifiedBy":"REEVESD","dateModified":"2012-07-16","changeNote":"Curated to support CCR Surgery (Immunotherapy) legacy data migration","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2479703","version":"1","preferredName":"Patient No Therapy Reason Text Code","preferredDefinition":"Text code to offer an explanation for why no treatment was administered to a patient/subject.","longName":"PT_NO_TX_RSN_TXT_CD","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"126E2743-9062-5F61-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-04-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-27","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":"Curated to support migration from PDMS to C3D in CCR.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2480028","version":"1","preferredName":"Patient Disease Body Surface Area Range Text Value","preferredDefinition":"Text entry to represent the range between the highest and lowest percentage of surface area of the body of the patient that is affected by the disease under investigation or study.","longName":"PT_DZ_BSA_RNG_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"12BE714D-0B0A-046E-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-05-01","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-05-01","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2480037","version":"1","preferredName":"Protocol Violation Description Text","preferredDefinition":"Text that provides a statment or an account describing a protocol violation in detail.","longName":"PROT_VIOL_DESC_TXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"12BD8C10-F175-089E-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-05-01","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-05-01","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2480928","version":"1","preferredName":"Laboratory Finding Adverse Event Clinical Significant Text Code Indicator","preferredDefinition":"An abnormal laboratory finding) temporally associated with the use of a medical treatment or procedure that is considered to have clinical relevance to a subject's condition.","longName":"LAB_AE_CLIN_SIGN_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"136D8D99-BA8B-23FD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-05-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-05-10","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":"Curated to support Albert Einstein adoption of C3D.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2481103","version":"1","preferredName":"Patient Other Disposition Descriptive Text","preferredDefinition":"Text description of care continuation decision(s) of 'other type' made for a patient..","longName":"PT_OTX_DISP_DESC_TXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"13733E88-5BCD-3DC6-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-05-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-05-10","modifiedBy":"REEVESD","dateModified":"2012-07-16","changeNote":"Curated to support CCR Surgery (Immunotherapy) legacy data migration","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2481109","version":"1","preferredName":"Followup Assessment Method Text Code","preferredDefinition":"Text code to represent the method used to conduct an assessment of a subject.","longName":"FU_ASSESS_METH_CD","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"13737109-6208-42F2-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-05-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-05-10","modifiedBy":"REEVESD","dateModified":"2012-07-16","changeNote":"Curated to support CCR Surgery (Immunotherapy) legacy data migration","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2481121","version":"1","preferredName":"Primary Tumor Excision Indicator","preferredDefinition":"Text response to signify the removal or excision by surgical means of the primary tumor, and surgical margins are free of gross and microscopic tumor. [Manually-curated]","longName":"PRIM_TUM_EXCS_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"13745BD4-F3B6-5F5C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-05-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-05-10","modifiedBy":"TSESU","dateModified":"2018-07-16","changeNote":"Curated to support CCR Surgery (Immunotherapy) legacy data migration","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2483522","version":"1","preferredName":"Smallpox Vaccination Personal Medical History Indicator","preferredDefinition":"Text indicator to represent a record of a person's innoculation with smallpox, an acute, highly contagious, often fatal infectious disease caused by an orthopoxvirus characterized by a biphasic febrile course and distinctive progressive skin eruptions.","longName":"SMPX_VACC_HX_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"14869732-BD22-57D0-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-05-24","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-05-24","modifiedBy":"REEVESD","dateModified":"2012-07-16","changeNote":"Curated to support CCR Surgery (Immunotherapy) legacy data migration","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2483528","version":"1","preferredName":"Prior Antigen gp100 Personal Medical History Indicator","preferredDefinition":"Text indicator to represent a person's record of an earlier in time history of Melanocyte Lineage-Specific Antigen Glycoprotein 100 (gp100).","longName":"PRIOR_GP100_HX_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"1486C4DD-F28D-5CEF-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-05-24","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-05-24","modifiedBy":"REEVESD","dateModified":"2012-07-16","changeNote":"Curated to support CCR Surgery (Immunotherapy) legacy data migration","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2483533","version":"1","preferredName":"Vitiligo Personal Medical History Indicator","preferredDefinition":"Text indicator to represent a record of a person's history of vitiligo, a disorder consisting of areas of macular depigmentation, commonly on extensor aspects of extremities, on the face or neck, and in skin folds. Age of onset is often in young adulthood and the condition tends to progress gradually with lesions enlarging and extending until a quiescent state is reached.","longName":"VITL_HX_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"1486D6F9-49AB-5DE0-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-05-24","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-05-24","modifiedBy":"REEVESD","dateModified":"2012-07-16","changeNote":"Curated to support CCR Surgery (Immunotherapy) legacy data migration","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2483540","version":"1","preferredName":"Lesion Dermis Type Text Name","preferredDefinition":"Text term to represent the type of dermis involvement in a lesion, an area of abnormal tissue change.","longName":"LESN_DERM_TP_TXT_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"14884EA4-43C8-6DA6-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-05-24","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-05-24","modifiedBy":"REEVESD","dateModified":"2012-07-16","changeNote":"Curated to support CCR Surgery (Immunotherapy) legacy data migration","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2486494","version":"1","preferredName":"Relative Family Cancer History Text Name","preferredDefinition":"Text term to identify a specific level or hierarchy of family relative who has a history of cancer.","longName":"RLTV_FAM_CA_HX_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"160B0F07-9FC8-2391-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-06-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-06-12","modifiedBy":"WONGW","dateModified":"2015-07-24","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2486913","version":"1","preferredName":"Electrocardiography Study Agent Timing Text Name","preferredDefinition":"Text term to describe the relationship in time between the administration of a research study agent and the conduct of an electrocardiogram on a subject.","longName":"ECG_STUDY_AGT_TM_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"16957F20-64CC-551B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-06-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-06-19","modifiedBy":"REBOYJ","dateModified":"2014-01-27","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2493122","version":"1","preferredName":"Electron Microscopy Biopsy Result Text","preferredDefinition":"Text to describe the outcome of electron microscopic review of tissue specimens or fluid from the living body for microscopic examination.","longName":"ELMICRO_BX_RSL_TXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"175BFDD8-D2CE-2F9E-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-06-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-06-29","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2493171","version":"1","preferredName":"Missed Dose Begin Date","preferredDefinition":"The first day on which a quantity or strength of a substance was not administered to an individual.","longName":"MISS_DOSE_START_DT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"17619B2A-4A3B-5273-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-06-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-06-29","modifiedBy":"MAESKEB","dateModified":"2011-09-13","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2493340","version":"1","preferredName":"Missed Dose Stop Date","preferredDefinition":"The last or final day on which a quantity or strength of a substance was not administered to an individual.","longName":"MISS_DOSE_STOP_DT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"1761C72A-6F33-67EA-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-06-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-06-29","modifiedBy":"MAESKEB","dateModified":"2011-09-13","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2493531","version":"1","preferredName":"Patient Missed Dose Reason Name","preferredDefinition":"Text term to represent an explanation of the cause of a patient not receiving a total quantity or strength of a substance (dose).","longName":"PT_MISS_DOSE_RSN_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"17715FBB-5057-1183-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-06-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-06-30","modifiedBy":"LEEW","dateModified":"2019-12-30","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2493548","version":"1","preferredName":"Patient Missed Dose Other Reason Other Text","preferredDefinition":"Text to capture an explanation of the cause of a patient not receiving a total quantity or strength of a substance (dose) that is different than the one(s) previously specified or mentioned.","longName":"PT_MISS_DOSE_OTX_TXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"17717940-1BF9-13F4-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-06-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-06-30","modifiedBy":"LEEW","dateModified":"2019-12-30","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2493642","version":"3","preferredName":"Adverse Event Investigational New Drug Attribution Code","preferredDefinition":"Code to indicate the causal relationship between investigational new drug(s) and a specific adverse event.","longName":"AE_IND_ATTR_CD","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"237B7ECB-2037-5D43-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-11-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-11-30","modifiedBy":"KRYSTKIA","dateModified":"2013-02-14","changeNote":"v2.0 uses codes instead of text terms for values.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2493644","version":"3","preferredName":"Adverse Event Commercial Agent Attribution Code","preferredDefinition":"Code to indicate the causal relationship between commercial agent(s) and a specific adverse event.","longName":"AE_COMM_AGT_ATTR_CD","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"237B7ECB-2006-5D43-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-11-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-11-30","modifiedBy":"MAESKEB","dateModified":"2011-09-12","changeNote":"v2.0 uses codes instead of text terms for values.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2493648","version":"3","preferredName":"Adverse Event Radiation Therapy Attribution Code","preferredDefinition":"Code to indicate the causal relationship between radiation therapy and a specific adverse event.","longName":"AE_RT_ATTR_CD","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"237B7ECB-20CB-5D43-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-11-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-11-30","modifiedBy":"MAESKEB","dateModified":"2011-09-14","changeNote":"v2.0 uses codes instead of text terms for values.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2493651","version":"3","preferredName":"Adverse Event Surgery Attribution Code","preferredDefinition":"Code to indicate the causal relationship between surgery/surgical procedure(s) and a specific adverse event.","longName":"AE_SURG_ATTR_CD","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"237B7ECB-212D-5D43-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-11-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-11-30","modifiedBy":"MAESKEB","dateModified":"2011-09-12","changeNote":"v2.0 uses codes instead of text terms for values.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2493654","version":"3","preferredName":"Adverse Event Procedure Attribution Code","preferredDefinition":"Code to indicate the causal relationship between a procedure and the specific adverse event.  A procedure is any health care procedure done for diagnostic, surveillance, treatment, palliation, or study-directed purposes.","longName":"AE_PROC_ATTR_CD","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"237B7ECB-209A-5D43-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-11-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-11-30","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":"v2.0 uses codes instead of text terms for values.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2493656","version":"3","preferredName":"Adverse Event Other Condition Attribution Code","preferredDefinition":"Code to indicate the causal relationship between a health condition that is different than the one(s) previously specified or mentioned, and a specific adverse event.","longName":"AE_OTX_COND_ATTR_CD","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"237B7ECB-2069-5D43-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-11-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-11-30","modifiedBy":"MAESKEB","dateModified":"2011-09-14","changeNote":"v2.0 uses codes instead of text terms for values.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2493698","version":"1","preferredName":"FDA Adverse Event Expedited Report Submission Yes No Indicator","preferredDefinition":"Text term to represent submission of expedited notification that a subject has experienced an adverse event to the Food and Drug Administration (FDA).","longName":"FDA_EP_AE_SUBM_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"1773D5B0-CEF6-6D75-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-06-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-06-30","modifiedBy":"HARTLEYG","dateModified":"2015-10-20","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2493706","version":"1","preferredName":"Colloidal Gold Electron Microscopy Specimen Evaluation Text","preferredDefinition":"Text field to capture a review of tissue using colloidal gold to provide information about the final structure of that specimen.","longName":"AU_ELMICRO_EVAL_TXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"17762E96-9360-1B61-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-06-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-06-30","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2493712","version":"1","preferredName":"Recombinant Human Tumor Necrosis Factor Electron Microscopy EvaluationText","preferredDefinition":"Text field to capture review of tissue using recombinant human Tumor Necrosis Factor (TNF) to provide information about the final structure of that specimen.","longName":"RH_TNF_ELMICRO_TXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"17759563-7D0E-2644-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-06-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-06-30","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2494320","version":"1","preferredName":"OBA Adverse Event Expedited Report Submission Indicator","preferredDefinition":"Submission of expedited notification that a subject has experienced an adverse event to the Office of Biotechnology Activities (OBA).","longName":"OBA_EP_AE_SUBM_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"17D651FE-F655-5DD1-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-07-05","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-07-05","modifiedBy":"MAESKEB","dateModified":"2011-09-12","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2497510","version":"2","preferredName":"Patient Study Enrollment Disease Anatomic Site Name","preferredDefinition":"Text term(s) for named location(s) of or within the body with study disease involvement at the time a patient/participant in a clinical trial is registered or entered into a clinical trial.","longName":"PT_ENRLL_DZ_ANAT_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"ACC86FBC-2410-450B-E053-4EBD850ADA58","latestVersionIndicator":"Yes","beginDate":"2020-08-13","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-08-13","modifiedBy":"COOPERM","dateModified":"2020-08-13","changeNote":"Versioned to replace retired VD. mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2497512","version":"2","preferredName":"Patient Diagnosis Disease Anatomic Site Name","preferredDefinition":"Text term(s) for named location(s) of or within the body with study disease involvement at the time a patient/participant in a clinical trial is diagnosed.","longName":"PT_DX_DZ_ANAT_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"ACC85A43-4E69-226B-E053-4EBD850AD310","latestVersionIndicator":"Yes","beginDate":"2020-08-13","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-08-13","modifiedBy":"COOPERM","dateModified":"2020-08-13","changeNote":"Reviewed and approved by CCR 7/20/2006. Versioned to use latest version of VD. mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2516088","version":"1","preferredName":"Activated Clotting Time Laboratory Procedure Finding Time Seconds Integer","preferredDefinition":"Numeric value with no fractional part to capture the result for a lab test of Activated Clotting Time (ACT), a measure of the anticoagulation affects of heparin.","longName":"ACT_LAB_FNG_SEC_INTG","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"1BC36D98-9D12-6395-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-08-24","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-08-24","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2520626","version":"1","preferredName":"Psychometrics Testing Time Result Time in Seconds Integer","preferredDefinition":"Numeric value to represent time required to complate an assessment of a psychological variable.","longName":"PSYCM_TM_SEC_INTG","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"1E0B5D1E-B353-62C8-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-09-22","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-09-22","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2520635","version":"1","preferredName":"Wechsler Intelligence Scale for Children IV SubTest Name","preferredDefinition":"Text terms to describe subtest components that together comprise the Weschler Intelligence Scale for Children Fourth Edition (WISC-IV).","longName":"WISCIV_SUBTEST_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"1E0B9A6E-B374-179B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-09-22","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-09-22","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":"Curated to support creation of neuropsychometric tool scoring formats within C3D for the CCR Neuropsychology Division.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2520644","version":"1","preferredName":"Wechsler Intelligence Scale for Children IV Raw Score","preferredDefinition":"Number of items correctly answered, that has not been transformed, on the Wechsler Intelligence Scale for Children Fourth Edition (WISC-IV).  Raw scores range from a maximum score of 0 to 136 depending on the area being assessed.","longName":"WISCIV_TEST_RAW_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"1E0BD1D4-D40A-1F7C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-09-22","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-09-22","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":"Curated to support creation of neuropsychometric tool scoring formats within C3D for the CCR Neuropsychology Division.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2520650","version":"1","preferredName":"Wechsler Intelligence Scale for Children IV Scaled Score","preferredDefinition":"A subtest standard score as a result of assessment with the Wechsler Intelligence Scale for Children Fourth Edition (WISC-IV); a scaled score usually has a mean of 10, a range of 1 to 19,  and a standard deviation of 3.","longName":"WISCIV_TEST_SCL_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"1E0BEC85-30A5-2465-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-09-22","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-09-22","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":"Curated to support creation of neuropsychometric tool scoring formats within C3D for the CCR Neuropsychology Division.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2520657","version":"1","preferredName":"Wechsler Intelligence Scale for Children IV Scale Name","preferredDefinition":"Text terms to identify scales to measure intellectual functioning within the Wechsler Intelligence Scale for Children Fourth Edition (WISC-IV).","longName":"WISCIV_SCL_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"1E0BFC5B-99FC-26B9-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-09-22","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-09-22","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":"Curated to support creation of neuropsychometric tool scoring formats within C3D for the CCR Neuropsychology Division.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2520667","version":"1","preferredName":"Wechsler Intelligence Scale for Children IV Composite Score","preferredDefinition":"Numeric value to represent combination of scores from two or more scales of the Wechsler Intelligence Scale for Children Fourth Edition (WISC-IV); composite score range is 40 to 160.","longName":"WISCIV_TEST_COMP_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"1E0D1F80-FB7D-2BDB-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-09-22","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-09-22","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":"Curated to support creation of neuropsychometric tool scoring formats within C3D for the CCR Neuropsychology Division.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2520676","version":"1","preferredName":"Wechsler Intelligence Scale for Children IV Percentile Rank Value","preferredDefinition":"Derived score that determines an individual's position relative to the standardization sample when testing with the Wechsler Intelligence Scale for Children Fourth Edition (WISC-IV).","longName":"WISCIV_PCT_RANK_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"1E0D4502-50C4-3181-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-09-22","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-09-22","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":"Curated to support creation of neuropsychometric tool scoring formats within C3D for the CCR Neuropsychology Division.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2524777","version":"1","preferredName":"Acute Myelogenous Leukemia Response Criteria","preferredDefinition":"Text description of acute myelogenous leukemia status as a result of the effects from treatment or intervention.","longName":"AML_RESP_CRIT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"1ED995FB-EE1D-27B3-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-10-02","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-10-02","modifiedBy":"SOKKERL","dateModified":"2018-04-09","changeNote":"Approved by CCR for Released status on 10.3.2006.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2526981","version":"1","preferredName":"Wide Range Achievement Test 3 Domain Name","preferredDefinition":"Text terms by which test sections of the Wide Range Achievement Test Revision 3 (WRAT3) are known; WRAT3 is a standardized, individually-administered test of word recognition, spelling, and mathematics.","longName":"WRAT3_DOM_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"1F890C1D-A671-51DF-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-10-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-10-11","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":"Curated to support creation of neuropsychometric tool scoring formats within C3D for the CCR Neuropsychology Division.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2526985","version":"1","preferredName":"Wide Range Achievement Test 3 Raw Score","preferredDefinition":"Number of items correctly answered, that has not been transformed, on the Wide Range Achievement Test Revision 3 (WRAT3).  Raw scores range from 0 to 57 (Blue and Tan versions), with a total range of 0 to 99 for the combined version of the test.","longName":"WRAT3_RAW_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"1F8927E4-91B5-5704-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-10-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-10-11","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":"Curated to support creation of neuropsychometric tool scoring formats within C3D for the CCR Neuropsychology Division.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2526990","version":"1","preferredName":"Wide Range Achievement Test 3 Standardized Score","preferredDefinition":"Raw score on the Wide Range Achievement Test Revision 3 (WRAT3) that has been transformed to have a designated mean and standard deviation, to express how far an examinee's score lies from the mean of the distribution in terms of the standard deviation.  Raw scores range from <45 to >155.","longName":"WRAT3_STD_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"1F895AFB-7B11-5F22-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-10-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-10-11","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":"Curated to support creation of neuropsychometric tool scoring formats within C3D for the CCR Neuropsychology Division.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2526994","version":"1","preferredName":"Wide Range Achievement Test 3 Percentile Value","preferredDefinition":"Numeric designation of an individual's position relative to the standardization sample when tested with the Wide Range Achievement Test Revision 3 (WRAT3).","longName":"WRAT3_PCT_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"1F897965-0791-6389-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-10-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-10-11","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":"Curated to support creation of neuropsychometric tool scoring formats within C3D for the CCR Neuropsychology Division.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2533192","version":"1","preferredName":"California Verbal Learning Test Children's Version Recall Measure Name","preferredDefinition":"Text terms for measures of recall and contrast scores within the California Verbal Learning Test Children's Version (CVLT-C). CVLT-C provides a short, individually administered assessment  of the strategies and processes involved in learning and recall of  verbal material. Assessment is made in the context of an everyday event.  It measures both recall and recognition of words over a number of trials  and has been found to be sensitive to memory deficits resulting from a  variety of neurological conditions. It is designed for ages 5 through  16.","longName":"CVLTC_RECALL_MEAS_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"21072EA3-0349-331B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-10-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-10-30","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2533198","version":"1","preferredName":"California Verbal Learning Test Children's Version Learning Characteristic Name","preferredDefinition":"Text terms for learning characteristics within the California Verbal Learning Test Children's Version (CVLT-C). CVLT-C provides a short, individually administered assessment of the strategies and processes involved in learning and recall of  verbal material;  assessment is made in the context of an everyday event,  measuring both recall and recognition of words over a number of trials  and has been found to be sensitive to memory deficits resulting from a  variety of neurological conditions. It is designed for ages 5 through  16.","longName":"CVLTC_LEARN_CHAR_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"2106EAF1-9B53-4766-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-10-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-10-30","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2533203","version":"1","preferredName":"California Verbal Learning Test, Children's Version Recognition Measurement Name","preferredDefinition":"Text terms for recognition measures within the California Verbal Learning Test Children's Version (CVLT-C). CVLT-C provides a short, individually administered assessment of the strategies and processes involved in learning and recall of  verbal material;  assessment is made in the context of an everyday event,  measuring both recall and recognition of words over a number of trials  and has been found to be sensitive to memory deficits resulting from a  variety of neurological conditions. It is designed for ages 5 through  16.","longName":"CVLTC_RECOG_MEAS_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"21084720-A940-5075-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-10-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-10-30","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2533256","version":"1","preferredName":"California Verbal Learning Test, Children's Version Recall Error Name","preferredDefinition":"Text terms for recall errors made during testing with the California Verbal Learning Test Children's Version (CVLT-C). CVLT-C provides a short, individually administered assessment of the strategies and processes involved in learning and recall of  verbal material;  assessment is made in the context of an everyday event,  measuring both recall and recognition of words over a number of trials  and has been found to be sensitive to memory deficits resulting from a  variety of neurological conditions. It is designed for ages 5 through  16.","longName":"CVLTC_RECALL_ERR_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"2107A05D-D42A-5A4B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-10-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-10-30","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2536958","version":"1","preferredName":"Response Assessment Certification Initials Name","preferredDefinition":"Initials of the person, usually the Principal Investigator (PI), attesting to the validity of a patient's response assessment, or the Data Manager's initials attesting to the validity of a patient's Date of Death.","longName":"RESP_CERT_INIT_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"2157DF9B-66EC-34D4-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-11-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-11-03","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":"Created to support migration of Immunotherapy elements to C3D.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2536962","version":"1","preferredName":"Response Assessment Certification Date","preferredDefinition":"Date of documented validation of a patient's response assessment or date of death.","longName":"RESP_ASSESS_CERT_DT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"215903B6-752C-3841-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-11-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-11-03","modifiedBy":"REEVESD","dateModified":"2012-07-16","changeNote":"Curated to support CCR Surgery (Immunotherapy) legacy data migration","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2536973","version":"1","preferredName":"Central  Registration Notification Off Study Information Indicator","preferredDefinition":"Text indication of the notification of the Central Registration Office with a patient's off study and/or death information.","longName":"REG_NTFC_OFF_STD_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"2158B1C5-C679-4F46-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-11-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-11-03","modifiedBy":"REEVESD","dateModified":"2012-07-16","changeNote":"Curated to support CCR Surgery (Immunotherapy) legacy data migration","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2536978","version":"1","preferredName":"Patient Protocol Assignment Number","preferredDefinition":"Identifier for the protocol on which the patient is next registered.","longName":"PT_PROT_ASSIGN_NUM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"2158E29B-F77C-5482-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-11-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-11-03","modifiedBy":"REEVESD","dateModified":"2012-07-16","changeNote":"Curated to support CCR Surgery (Immunotherapy) legacy data migration","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2536998","version":"1","preferredName":"Finding Radiology Series Number","preferredDefinition":"Unique identifier for an imaging series on which there is a finding/result.","longName":"FNG_RAD_SER_NUM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"215E427C-95B0-72C5-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-11-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-11-03","modifiedBy":"REEVESD","dateModified":"2011-03-18","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2541438","version":"1","preferredName":"Medical Staff Fellow Full Name Text","preferredDefinition":"Text name for a medical professional  who provides care to a patient in a health care setting.","longName":"MED_FLLW_FULL_NM_TXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"222210C9-3F27-2B23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-11-13","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-11-13","modifiedBy":"ZHANGWE","dateModified":"2021-04-22","changeNote":"Curated to support CCR Surgery (Immunotherapy) legacy data migration","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2541714","version":"2","preferredName":"Medical Device Complication Type","preferredDefinition":"Category to reference any disease or disorder that occurs during the course of (or because of) the use of a physical item in medical treatment or diagnosis.","longName":"MED_DVC_CMPLC_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"9F9FF0B0-EB54-F4D8-E040-BB89AD431C09","latestVersionIndicator":"Yes","beginDate":"2011-03-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-03-29","modifiedBy":"REEVESD","dateModified":"2011-03-29","changeNote":"Curated for NCI CCR clinical trial.  Replaces v1.0 with extended length from 20 to 40 characters.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2541736","version":"1","preferredName":"Medical Device Vessel Embolization Name","preferredDefinition":"Text terms to identify blood vessels embolized as treatment to block the flow of blood to a tumor.","longName":"MED_DEV_VSL_EMBLZ_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"2223A935-3DBD-1CC2-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-11-13","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-11-13","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2541752","version":"1","preferredName":"Veterinary Medicine Institution Name","preferredDefinition":"Text term to identify a site where healthcare services are provided for non-human animals.","longName":"VET_MED_INST_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"22252996-F82B-31B8-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-11-13","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-11-13","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2541767","version":"1","preferredName":"Perfusion Pump Start Time","preferredDefinition":"Point in time when a hepatic pump used to deliver a precise amount of drug at a specific rate begins the administration.","longName":"PERF_PUMP_STRT_TM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"2224EEF3-9CEB-5034-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-11-13","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-11-13","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2541769","version":"1","preferredName":"Perfusion Pump Stop Time","preferredDefinition":"The point in time when a hepatic pump used to deliver a precise amount of drug at a specific rate ends or completes the administration of agent.","longName":"PERF_PUMP_STOP_TM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"2224EEF3-9CFD-5034-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-11-13","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-11-13","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2547790","version":"2","preferredName":"Concomitant Measure Medication Adverse Event Attribution Code","preferredDefinition":"Code to indicate the causal relationship between a concomitant measure or medication, and the specific adverse event.","longName":"AE_CONCT_MSR_ATTR_CD","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"237AA6C2-668B-60AF-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-11-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-11-30","modifiedBy":"HARTLEYG","dateModified":"2017-03-23","changeNote":"v2.0 uses codes instead of text terms for values.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2547801","version":"3","preferredName":"Medical Device Adverse Event Attribution Code","preferredDefinition":"Code to indicate the causal relationship between a medical device and the specific adverse event.","longName":"AE_MED_DVC_ATTR_CD","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"25B00A36-A041-0F0A-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-11-29","endDate":"2006-11-29","createdBy":"REEVESD","dateCreated":"2006-12-28","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2549633","version":"1","preferredName":"Breast Tumor T4 Stage Finding Status","preferredDefinition":"Text terms to designate evidence of T4 disease.","longName":"BRSTCA_T4_FNG_STAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"23D1DD9F-51D7-3BCB-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-12-04","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-12-04","modifiedBy":"REEVESD","dateModified":"2011-03-18","changeNote":"Curated to support I-SPY CRF curation in C3D.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2555229","version":"1","preferredName":"FACT-Br Questionnaire Physical Well-Being Score","preferredDefinition":"Numeric value for the Physical Well-Being scale of the FACT-Brain questionnaire, a 50-item instrument that assesses general physical,  social, emotional and functional well-being, as well as brain  tumor-specific concerns.","longName":"FACTB_PHYSW_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"24E3BF36-04A3-5E3E-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-12-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-12-18","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":"Created for Duke study in Rave and C3D.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2555233","version":"1","preferredName":"FACT-Br Questionnaire Social Family Well-Being Score","preferredDefinition":"Numeric value for the Social/Family Well-Being scale of the FACT-Brain questionnaire, a 50-item instrument that assesses general physical,  social, emotional and functional well-being, as well as brain  tumor-specific concerns.","longName":"FACTB_SOCFAM_WB_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"24E3C626-0293-603B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-12-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-12-18","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":"Created for Duke study in Rave and C3D.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2555235","version":"1","preferredName":"FACT-Br Questionnaire Emotional Well-Being Score","preferredDefinition":"Numeric value for the Emotional Well-Being scale of the FACT-Brain questionnaire, a 50-item instrument that assesses general physical,  social, emotional and functional well-being, as well as brain  tumor-specific concerns.","longName":"FACTB_EMOT_WB_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"24E3D811-E567-6240-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-12-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-12-18","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":"Created for Duke study in Rave and C3D.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2555238","version":"1","preferredName":"FACT-Br Questionnaire Functional Well-Being Score","preferredDefinition":"Numeric value for the Functional Well-Being scale of the FACT-Brain questionnaire, a 50-item instrument that assesses general physical,  social, emotional and functional well-being, as well as brain  tumor-specific concerns.","longName":"2555197v1.0:2555217v1.0","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"24E3D811-E579-6240-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-12-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-12-18","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":"Created for Duke study in Rave and C3D.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2555240","version":"1","preferredName":"FACT-Br Questionnaire Additional Concerns Score","preferredDefinition":"Numeric value for the Additional Concerns scale of the FACT-Brain questionnaire, a 50-item instrument that assesses general physical,  social, emotional and functional well-being, as well as brain  tumor-specific concerns.","longName":"FACTB_ADD_CONC_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"24E3D811-E58B-6240-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-12-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-12-18","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":"Curated to support Duke University clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2555244","version":"1","preferredName":"FACT-Br Questionnaire Outcome Index Score","preferredDefinition":"Numeric computed Trial Outcome Index (TOI) for the FACT-Brain questionnaire, a 50-item instrument that assesses general physical,  social, emotional and functional well-being, as well as brain  tumor-specific concerns.","longName":"FACTB_QUEST_TOI_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"24E3F2B2-FC73-6933-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-12-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-12-18","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":"Created for Duke study in Rave and C3D.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2555246","version":"1","preferredName":"FACT-Br Questionnaire Total Score","preferredDefinition":"Composite result for the FACT-Brain questionnaire, a 50-item instrument that assesses general physical,  social, emotional and functional well-being, as well as brain  tumor-specific concerns.","longName":"FACTB_QUEST_TTL_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"24E3F2B2-FC85-6933-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-12-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-12-18","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":"Created for Duke study in Rave and C3D.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2556909","version":"1","preferredName":"Disease Attribution Event Attribution Code","preferredDefinition":"Code to indicate the causal relationship between the disease under investigation and a specific adverse event.","longName":"AE_DZ_ATTR_CD","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"24FA4C72-A4BB-291A-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-11-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-12-19","modifiedBy":"MAESKEB","dateModified":"2011-09-12","changeNote":"v2.0 uses codes instead of text terms for values.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2584114","version":"1","preferredName":"Primary Other Site of Disease Name","preferredDefinition":"A text description of an 'other' originating or primary anatomic site of the disease/condition under investigation or review.","longName":"PRIM_OTX_DZ_SITE_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"25E949F0-E1D2-0301-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-12-31","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-12-31","modifiedBy":"TSESU","dateModified":"2018-07-02","changeNote":"updated for ISO compliance","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2585176","version":"1","preferredName":"Chronic Graft Versus Host Disease Assessment Score","preferredDefinition":"Numeric value measuring the transplant recipient for signs and symptoms of chronic Graft versus Host Disease (GVHD).","longName":"CGVHD_ASSESS_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"26810A93-30E2-4E53-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-01-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-01-07","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":"Curated to support NIH cGVHD Scoring Sheet addition to C3D by CCR.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2585182","version":"2","preferredName":"Chronic GVHD Assessment Anatomic Site Name","preferredDefinition":"Text name of organs assessed to be involved with chronic Graft vs. Host Disease (GVHD) post transplant.","longName":"CGVHD_ASSESS_SITE_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"DC1E9B8C-A7C0-678D-E040-BB89AD4360FB","latestVersionIndicator":"Yes","beginDate":"2013-05-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-05-07","modifiedBy":"REEVESD","dateModified":"2013-05-07","changeNote":"Curated to support NIH cGVHD Scoring Sheet addition to C3D by CCR. v2.0 replaces v1.0 to increase maximum field length from 17 to 50 characters","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2585198","version":"1","preferredName":"Chronic Graft Versus Host Disease Skin Characteristic Name","preferredDefinition":"Text terms describing symptoms of chronic Graft vs. Host Disease (GVHD) that involve the skin.","longName":"CGVHD_SKIN_CHAR_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"2680A93F-FE2E-72D0-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-01-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-01-08","modifiedBy":"MAESKEB","dateModified":"2022-03-31","changeNote":"Curated to support NIH cGVHD Scoring Sheet addition to C3D by CCR.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2585206","version":"1","preferredName":"Chronic Graft Versus Host Disease Eye Mean Tearing Result Category","preferredDefinition":"As part of a chronic Graft vs. Host Disease (GVHD) assessment, outcome of a mean tear test expressed in millimeter (mm) categories","longName":"CGVHD_EYE_TEAR_CAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"2680EC3C-C668-0B97-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-01-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-01-08","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":"Curated to support NIH cGVHD Scoring Sheet addition to C3D by CCR.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2585220","version":"1","preferredName":"Chronic Graft Versus Host Disease Other Characteristic Type","preferredDefinition":"Text term(s) to identify indicators, clinical manifestations, and/or complications related to cGVHD (chronic Graft vs. Host Disease) not otherwise identified.","longName":"CGVHD_OXT_CHAR_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"2687E852-2C20-02EC-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-01-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-01-08","modifiedBy":"MALUMK","dateModified":"2021-08-12","changeNote":"Curated to support NIH cGVHD Scoring Sheet addition to C3D by CCR.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2585224","version":"1","preferredName":"Chronic Graft Versus Host Disease Other Characteristic Text","preferredDefinition":"Text to describe indicators, clinical manifestations, or complications related to cGVHD (chronic Graft vs. Host Disease) that are not otherwise identified.","longName":"CGVHD_OTX_CHAR_TXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"2687FD5B-89B1-09D5-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-01-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-01-08","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":"Curated to support NIH cGVHD Scoring Sheet addition to C3D by CCR.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2593424","version":"1","preferredName":"FACT-O Physical Well-Being Score","preferredDefinition":"Numeric value for the Physical Well-Being scale of the FACT-Ovarian questionnaire, an instrument that assesses general physical,  social, emotional and functional well-being, as well as ovarian tumor-specific concerns.","longName":"FACTO_PHYSW_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"28B8F91E-E104-4412-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-02-05","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-02-05","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2593426","version":"1","preferredName":"FACT-O Social Family Well-Being Score","preferredDefinition":"Numeric value for the Social/Family Well-Being scale of the FACT-Ovarian questionnaire, an instrument that assesses general physical,  social, emotional and functional well-being, as well as ovarian tumor-specific concerns.","longName":"FACTO_SOCFAM_WB_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"28BA025E-C06F-45A5-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-02-05","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-02-05","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2593428","version":"1","preferredName":"FACT-O Emotional Well-Being Score","preferredDefinition":"Numeric value for the Emotional Well-Being scale of the FACT-Ovarian questionnaire, an instrument that assesses general physical,  social, emotional and functional well-being, as well as ovarian tumor-specific concerns.","longName":"FACTO_EMOT_WB_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"28BA0BD0-D9DE-47B5-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-02-05","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-02-05","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2593430","version":"1","preferredName":"FACT-O Functional Well-Being Score","preferredDefinition":"Numeric value for the Functional Well-Being scale of the FACT-Ovarian questionnaire, an instrument that assesses general physical,  social, emotional and functional well-being, as well as brain  tumor-specific concerns.","longName":"FACTO_FUNCWB_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"28BA0BD0-D9F0-47B5-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-02-05","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-02-05","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2593432","version":"1","preferredName":"FACT-O Additional Concerns Score","preferredDefinition":"Numeric value for the Additional Concerns scale of the FACT-Ovarian questionnaire, an instrument that assesses general physical,  social, emotional and functional well-being, as well as brain  tumor-specific concerns.","longName":"FACTO_ADD_CONC_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"28BA1D8B-4391-4AC7-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-02-05","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-02-05","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2593434","version":"1","preferredName":"FACT-O Questionnaire Total Score","preferredDefinition":"Composite result for the FACT-Ovarian questionnaire, an instrument that assesses general physical,  social, emotional and functional well-being, as well as ovarian tumor-specific concerns.","longName":"FACTO_QUEST_TTL_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"28BA26C5-B93E-4C20-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-02-05","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-02-05","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2603096","version":"1","preferredName":"Person Tissue Sample Post Protocol Destruction Status","preferredDefinition":"Text indicator of whether tissues samples that were collected per protocol and stored for future use were destroyed at the completion of the protocol.[Manually-curated]","longName":"SMPL_POST_DSTR_STAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"2A52957C-F7BF-442F-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-02-25","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-02-25","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2614959","version":"1","preferredName":"Dog Respiration Pattern Text","preferredDefinition":"Text description of a dog's respiratiory pattern.","longName":"DOG_RESP_PATT_TXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2C49CCBE-2576-6408-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-03-22","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-03-22","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2615195","version":"2","preferredName":"Electrocardiogram Finding Arrhythmia Type","preferredDefinition":"Text term to represent the results of a graphic tracing (electrocardiogram) that documents an abnormal rate of muscle contractions in the heart.","longName":"ECG_FNG_ARRHY_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"18CF5291-581A-29D7-E050-BB89AD434AB0","latestVersionIndicator":"Yes","beginDate":"2015-06-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-06-18","modifiedBy":"GARRIDOJ","dateModified":"2017-10-24","changeNote":"v2.0 uses new version of the VD in order to correct misspellings in the permissible values (Mobitz) and value meanings.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2635206","version":"1","preferredName":"Adverse Event Investigational Device Exemption Attribution Code","preferredDefinition":"Code to indicate the causal relationship between an Investigational Device Exemption (IDE) and a specific adverse event. [Manually-curated]","longName":"AE_IDE_ATTR_CD","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"2F6AF322-E81D-592D-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-05-01","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-05-01","modifiedBy":"MAESKEB","dateModified":"2011-09-12","changeNote":"Approved by CCR for release 5.1.2007.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2635211","version":"1","preferredName":"Adverse Event Research Attribution Code","preferredDefinition":"Code to indicate an adverse event's relationship to the subject's participation in the study, including study-related therapy and procedures. [Manually-curated]","longName":"AE_RSCH_ATTR_CD","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"2F6C3800-9799-5F40-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-05-01","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-05-01","modifiedBy":"MAESKEB","dateModified":"2011-09-12","changeNote":"Approved by CCR for release 5.1.2007.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2656638","version":"1","preferredName":"Medical Device Type","preferredDefinition":"A particular classification of instrument, apparatus, implement, machine, contrivance, implant, in vitro reagent, or other similar or related article, or any supplement to them, intended for use in the diagnosis of disease or other conditions, or in the cure, mitigation, treatment, or prevention of disease, in man or other animals. [Manually-curated]","longName":"MEDDEV_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"334120EE-CC0B-6154-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-06-19","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2659867","version":"1","preferredName":"Breast Assessment Complete Indicator","preferredDefinition":"Text term to signify whether or not a breast exam was done. [Manually-curated]","longName":"BRST_ASSESS_COMP_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"33BC6554-9F90-34A3-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-25","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-06-25","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2659874","version":"1","preferredName":"PTEN Gene Mutation Present Indicator","preferredDefinition":"Text term to signify a mutation of the PTEN (Phosphatase and Tensin homolog) gene located on human chromosone 10q23.3, which is associated with the formation of multiple advanced cancers. [Manually-curated]","longName":"PTEN_MUT_PRES_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"33BB99D9-DCA7-3C7E-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-25","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-06-25","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2659876","version":"1","preferredName":"P53 Gene Level Indicator","preferredDefinition":"Text term to signify the mutation of the p53 Gene (Protein 53) located on human chromosone 17p13.1, which is associated with the formation of familial breast and ovarian cancer. [Manually-curated]","longName":"P53_GENE_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"33BBC165-1F35-440E-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-25","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-06-25","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2660011","version":"2","preferredName":"Breast Carcinoma Mutation Probability Model","preferredDefinition":"Text term for a model that evaluates the mutation probability of breast cancer.","longName":"BRST_CA_PROB_MDL_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"A28C426D-5846-E1D9-E040-BB89AD435D39","latestVersionIndicator":"Yes","beginDate":"2007-06-25","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-05-05","modifiedBy":"MAESKEB","dateModified":"2012-07-16","changeNote":"Repalces v1.0 with extended maximum field length from 20 to 50 characters.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2669132","version":"1","preferredName":"Breast Carcinoma Mutation Family Probability Percentage","preferredDefinition":"Numeric chance or probability that members of a family will develop a breast cancer gene mutation. [Manually-curated]","longName":"BRST_CA_FAM_PROB_PCT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"367F0095-3784-5609-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-07-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-07-30","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2671194","version":"1","preferredName":"Breast Carcinoma Mutation Individual Probability Percentage","preferredDefinition":"Numeric chance or probability that a patient/subject will develop a breast cancer gene mutation. [Manually-curated]","longName":"BRST_CA_MUT_IND_PCT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"372AF926-A899-038C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-08-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-08-08","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2671199","version":"1","preferredName":"Breast Carcinoma Mutation Individual Highest Prior Probability Percentage","preferredDefinition":"The highest probability of a patient or subject in a family to develop a breast cancer gene mutation. [Manually-curated]","longName":"BRST_CA_MUT_HP_PCT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"372C32D6-599E-0C0F-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-08-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-08-08","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2671204","version":"1","preferredName":"Individual Family Tumor Suppressor Gene Testing Indicator","preferredDefinition":"Text term to signify the presence or absence of a suppressor gene that normally inhibits the growth of tumors. [Manually-curated]","longName":"PRSN_FAM_GNTST_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"372C6E29-BE1B-1364-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-08-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-08-08","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2680034","version":"1","preferredName":"Physician Global Status Disease Severity Score","preferredDefinition":"Measure of the physician's overall impression of disease status using the Severity-Weighted Assessment Tool (SWAT) scoring tool. [Manually-curated]","longName":"MD_GLOB_ASSESS_DZ_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"39CF6523-09B8-0DCB-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-09-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-09-10","modifiedBy":"REEVESD","dateModified":"2013-09-18","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2680061","version":"1","preferredName":"Patient Skin Disease Impact Quality of Life Score","preferredDefinition":"Score of the effect of skin disease on a patient's quality of life  Results are reported as a composite (average) score. [Manually-curated]","longName":"PT_SKIN_IMP_QOL_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"39D12DEA-F335-6A27-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-09-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-09-10","modifiedBy":"ZHANGWE","dateModified":"2013-10-23","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2680067","version":"1","preferredName":"Person Pruritus Intensity Area in Centimeter Number","preferredDefinition":"Numeric score on a Visual Analog Scale used by a subject to rate a pruritis intensity experience. [Manually-curated]","longName":"PERS_PRUR_INT_CM_NUM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"39D1789C-A9C2-023D-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-09-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-09-10","modifiedBy":"PRICEA","dateModified":"2013-10-25","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2680075","version":"1","preferredName":"RET Oncogene Mutation Status Codon Identifier","preferredDefinition":"Identifier to represent a germline mutation of the RET (REarranged during Transfection) proto-oncogene, which codes for a receptor tyrosine kinase, to cause multiple endocrine neoplasia type 2A (MEN 2A) and 2B (MEN 2B) and familial medullary thyroid carcinoma (FMTC). MEN 2 mutations have been shown to result in RET oncogenic activation. [Manually-curated]","longName":"RET_ONCOG_CODON_ID","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"39D4F6B7-6527-6F59-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-09-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-09-11","modifiedBy":"BEELEST","dateModified":"2012-08-30","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2694934","version":"1","preferredName":"Disease Metastasis TNM Metastasis Category","preferredDefinition":"Classification using the AJCC system to represent metastases (M) that have spread from the organ in which it first appeared to another organ. [Manually-curated]","longName":"DZ_MET_TNM_M_CAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"3E8384FA-DD1B-5876-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-11-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-11-09","modifiedBy":"ZHANGW","dateModified":"2011-12-02","changeNote":"Curated to support CCR protocols.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2695108","version":"1","preferredName":"Participating Patient Ancillary Study Consent Date","preferredDefinition":"Date a patient participating in a companion protocol signs the informed consent for that ancillary trial.","longName":"PART_PT_ANCILL_IC_DT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"3EC488A3-C1F2-07B5-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-11-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-11-12","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":"Curated to support CCR protocols.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2695111","version":"1","preferredName":"Vision Assessment Date","preferredDefinition":"Date of the completion of an ophthalmologic examination to assess vision. [Manually-curated]","longName":"VISN_ASSESS_DT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"3EC61846-68D1-2356-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-11-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-11-12","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":"Curated to support CCR protocols.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2695116","version":"1","preferredName":"Audiometric Test Assessment Indicator","preferredDefinition":"Text indicator of whether or not a complete hearing or audiometry test was conducted. [Manually-curated]","longName":"AUD_TEST_ASSESS_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"3EC64444-F8F4-305E-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-11-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-11-12","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":"Curated to support CCR protocols.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2695118","version":"1","preferredName":"Vision Ophthalmologic Assessment Indicator","preferredDefinition":"Text indicator of whether or not a complete vision or ophthalmologic examination was conducted. [Manually-curated]","longName":"VSN_OPHTH_ASSESS_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"3EC6676E-0332-3617-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-11-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-11-12","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":"Curated to support CCR protocols.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2695120","version":"1","preferredName":"Audiometric Test Assessment Date","preferredDefinition":"Date of the completion of a complete hearing or audiometric test. [Manually-curated]","longName":"AUD_TST_ASSESS_DT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"3EC5809C-0BF4-3D4F-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-11-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-11-12","modifiedBy":"PROSVIROVAB","dateModified":"2019-01-17","changeNote":"Curated to support CCR protocols.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2718474","version":"1","preferredName":"Measurable Indicator Indicator","preferredDefinition":"Text term to signify whether or not a site or lesion can be measured. [Manually-curated]","longName":"MSRBL_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"42D85E26-923C-6292-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-07-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-01-03","modifiedBy":"CORRALC","dateModified":"2014-12-19","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2721344","version":"1","preferredName":"Common Toxicity Criteria Derived Adverse Event Code","preferredDefinition":"Character code to represent a calculated or derived adverse event term and comprised of three parts: Common Terminology Criteria Adverse Event (CTCAE) category, then the CTCAE supraordinate term, and finally the select term for each adverse event. [Manually-curated]","longName":"DERIV_CTC_AE_CD","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"43CD0482-4F5C-3BE1-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-01-15","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-01-15","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":"Curated to support CCR Surgery Branch (Immunotherapy) legacy data migration","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2721353","version":"1","preferredName":"Adverse Event Attribution Code","preferredDefinition":"Text code to signify the causal relationship between the treatment modality and the specific adverse event. [Manually-curated]","longName":"AE_ATTRIB_CD","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"43CC96D7-9F12-5098-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-01-15","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-01-15","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":"Curated to support CCR Surgery Branch (Immunotherapy) legacy data migration","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2721362","version":"1","preferredName":"Serious Adverse Event Code","preferredDefinition":"Text code to signfiy the reason an adverse event is clasified as serious. [Manually-curated]","longName":"SAE_CD","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"43CCF9DF-327B-5FC6-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-01-15","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-01-15","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":"Curated to support CCR Surgery Branch (Immunotherapy) legacy data migration","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2721370","version":"1","preferredName":"Adverse Event Action Code","preferredDefinition":"Text code to signify the action taken in response to an unwanted effect caused by a drug or therapy. [Manually-curated]","longName":"AE_ACTION_CD","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"43CE1F1E-4C3C-648F-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-01-15","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-01-15","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":"Curated to support CCR Surgery Branch (Immunotherapy) legacy data migration","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2721379","version":"1","preferredName":"Adverse Event Outcome Code","preferredDefinition":"Text code to represent the final result or outcome of an adverse event. [Manually-curated]","longName":"AE_OUTCOME_CD","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"43CE6952-466F-7090-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-01-15","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-01-15","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":"Curated to support CCR Surgery Branch (Immunotherapy) legacy data migration","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2721410","version":"2","preferredName":"Surgical Procedure National Cancer Institute Occurrence Yes No Character Indicator","preferredDefinition":"Text indicator to signify whether or not a surgical procedure occurred at the National Cancer Institute (NCI). [Manually-curated]","longName":"SURG_NCI_OCC_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"4D0A258F-4ECB-16D2-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-05-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-12","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":"Curated to support CCR Surgery (Immunotherapy) legacy data migration","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2721413","version":"1","preferredName":"Anatomic Site Assessment Text","preferredDefinition":"Text description of named anatomic site(s) in the body. [Manually-curated]","longName":"ANAT_SITE_TXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"43CEE5AF-89C3-33DB-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-01-15","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-01-15","modifiedBy":"CLOHNES","dateModified":"2023-01-24","changeNote":"Curated to support CCR Immunotherapy legacy data migration","administrativeNotes":"1/24/23 added AQT for ticket number CADSR0001948 for CCTG cjl.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2721417","version":"1","preferredName":"Pathology Cytology Sampling Positive Negative Code","preferredDefinition":"Text code to denote confirmation of positive cytology or pathology results. [Manually-curated]","longName":"PATH_CYT_SMPLG_CD","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"43D045B6-CB56-42DE-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-01-15","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-01-15","modifiedBy":"REEVESD","dateModified":"2011-03-18","changeNote":"Curated to support CCR immunotherapy legacy data migration","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2721430","version":"1","preferredName":"Radiation Therapy Administered Code","preferredDefinition":"Text code to identify the type of radiotherapy administered to a patient. [Manually-curated]","longName":"RT_ADMIN_CD","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"43D64DD5-5F38-57F2-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-01-16","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-01-16","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":"Curated to support CCR immunotherapy legacy data migration","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2721441","version":"1","preferredName":"Radiation Therapy Total Dose Text","preferredDefinition":"The total dose of radiation therapy administered to an individual expressed as a dosage amount.","longName":"RT_TTL_DOSE_TXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"43D5E974-7709-7018-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-01-16","endDate":"2008-02-18","createdBy":"REEVESD","dateCreated":"2008-01-16","modifiedBy":"SOKKERL","dateModified":"2019-12-13","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2721569","version":"1","preferredName":"Prior Therapy Administered Code","preferredDefinition":"Text term to signify the modality or type of prior therapy administered to an individual. [Manually-curated]","longName":"PRIOR_RX_ADMIN_CD","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"43D89F32-A4DD-6C28-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-01-16","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-01-16","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":"Curated to support CCR immunotherapy legacy data migration","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2721616","version":"2","preferredName":"Informed Consent Signature Prior Treatment Indicator","preferredDefinition":"Text indicator to denote if the proper consent for participation in a clinical study was signed before the initiation of study treatment. [Manually-curated]","longName":"IC_SIG_PRIOR_TX_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"5172E953-E50F-6E0E-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-07-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-07-07","modifiedBy":"COLBERTM","dateModified":"2020-02-11","changeNote":"Curated to support CCR Surgery (Immunotherapy) legacy data migration; new version uses text indicators, not codes of Y and N.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2721620","version":"1","preferredName":"Patient Person Gender Code","preferredDefinition":"Text code to specify the classfication of the gender role of a person. [Manually-curated]","longName":"PRSN_GENDER_CD","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"43D9B6C1-E4E9-26F5-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-01-16","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-01-16","modifiedBy":"FORMBUILDER","dateModified":"2012-05-14","changeNote":"Curated to support CCR Surgery (Immunotherapy) legacy data migration","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2721654","version":"1","preferredName":"Body Weight Kilogram Value","preferredDefinition":"Numeric value to represent the body weight of a person in kilograms (kg) at a specific point in time. [Manually-curated]","longName":"BDY_WT_KG_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"43DB6208-9FA0-43F9-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-01-16","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-01-16","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":"Curated to support CCR Surgery (Immunotherapy) legacy data migration","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2721661","version":"1","preferredName":"Person Height Measurement Centimeter Value","preferredDefinition":"Numeric value computed to represent the vertical distance from the base to the top of an individual as expressed in centimeters (cm). [Manually-curated]","longName":"PRSN_HT_MSRMT_CM_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"43DAA820-E9AA-4FE6-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-01-16","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-01-16","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":"Curated to support CCR Surgery (Immunotherapy) legacy data migration","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2728598","version":"1","preferredName":"Patient Treatment Study Course Identifier","preferredDefinition":"Unique course identifier created from a representation of a treatment assignment combined with a sequential number from within that protocol or treatment, and referred to as a case identifier. [Manually-curated]","longName":"PT_TX_STDY_CRSE_ID","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"45DE7437-C452-70C7-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-02-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-02-11","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":"Curated to support CCR immunotherapy legacy data migration","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2728607","version":"1","preferredName":"Lymph Node Total Removed Count","preferredDefinition":"Numeric value or notation to represent the number of lymph nodes a patient has had removed. [Manually-curated]","longName":"LN_TTL_REM_CT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"45E26C3E-147B-0CA6-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-02-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-02-11","modifiedBy":"LEONARDM","dateModified":"2013-10-09","changeNote":"Curated to support CCR immunotherapy legacy data migration","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2728630","version":"1","preferredName":"Metastatic Disease Anatomic Site Count","preferredDefinition":"Numeric value or notation to represent the number of metastatic disease sites assigned to a patient. [Manually-curated]","longName":"MET_DZ_STE_TTL_CT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"45E1B44D-F905-15C5-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-02-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-02-11","modifiedBy":"WONGW","dateModified":"2013-01-25","changeNote":"Curated to support CCR Surgery (Immunotherapy) legacy data migration","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2732184","version":"1","preferredName":"Protocol Course Number Count","preferredDefinition":"Numeric value assigned to identify a period of protocol activity; a course is comprised of multiple cycles of protocol-dictated activities. [Manually-curated]","longName":"PROT_COURS_NUM_CT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Standard","id":"47348885-9C0E-404A-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-02-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-02-28","modifiedBy":"HARTLEYG","dateModified":"2021-06-17","changeNote":"Curated to support CCR Surgery Branch (Immunotherapy) legacy data migration","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2732192","version":"1","preferredName":"Computer Program Created Record Update Date","preferredDefinition":"Most recent date on which an entry created by a computer program is updated.","longName":"COMP_RECD_UPDT_DT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"4738E706-4952-3F77-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-02-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-02-28","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":"Curated to support CCR Surgery Branch (Immunotherapy) legacy data migration","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2732194","version":"1","preferredName":"Computer Program Created Record Generation Date","preferredDefinition":"Date on which an entry or record generated by a computer program is created [Manually-curated]","longName":"COMP_RECD_GEN_DT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"4738F4F9-21E7-413B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-02-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-02-28","modifiedBy":"MAESKEB","dateModified":"2016-02-08","changeNote":"Curated to support CCR Surgery Branch (Immunotherapy) legacy data migration","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2732889","version":"1","preferredName":"Person Cutaneous T-Cell Non-Hodgkin Lymphoma Skin Therapy Difficulty Anxiety Psychometrics Assessment Score","preferredDefinition":"Response on a psychometric measure documenting how often a human being experiences anxiety over the inconvenience of treatment for CTCL (Cutaneous T-Cell Lymphoma) in the skin. [Manually-curated]","longName":"CTCL_SKN_TX_ANX_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"4788E259-DC17-5AB4-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-03-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-03-03","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":"Curated to support CCR PI request to add CTCL-specific items to Skindex measure for CTCL involvement in skin","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2732891","version":"1","preferredName":"Person Cutaneous T-Cell Non-Hodgkin Lymphoma Skin Painful Lesion Psychometrics Assessment Score","preferredDefinition":"Response on a psychometric measure documenting how often a human being experiences painful lesions or tumors due to CTCL (Cutaneous T-Cell lymphoma) in the skin. [Manually-curated]","longName":"CTCL_SKN_PN_LES_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"4788FA31-208D-5F9F-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-03-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-03-03","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":"Curated to support CCR PI request to add CTCL-specific items to Skindex measure for CTCL involvement in skin","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2732893","version":"1","preferredName":"Person Cutaneous T-Cell Non-Hodgkin Lymphoma Skin Fatigue Fatigue Stress and Coping Psychometrics Assessment Score","preferredDefinition":"Response on a psychometric measure documenting how often a human being experiences fatigue in coping or dealing with CTCL (Cutaneous T-Cell Lymphoma) in the skin. [Manually-curated]","longName":"CTCL_SKN_FAT_COP_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"478A083E-44E8-62FA-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-03-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-03-03","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":"Curated to support CCR PI request to add CTCL-specific items to Skindex measure for CTCL involvement in skin","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2732895","version":"1","preferredName":"Person Cutaneous T-Cell Non-Hodgkin Lymphoma Skin Red Pink Appearance Anxiety Psychometrics Assessment Score","preferredDefinition":"Response on a psychometric measure documenting how often a human being is bothered by red or pink skin appearance due to CTCL (Cutaneous T-Cell Lymphoma) in the skin. [Manually-curated]","longName":"CTCL_SKN_APPEAR_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"478988E7-DC28-1EAA-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-03-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-03-03","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":"Curated to support CCR PI request to add CTCL-specific items to Skindex measure for CTCL involvement in skin","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2732897","version":"1","preferredName":"Person Cutaneous T-Cell Non-Hodgkin Lymphoma Skin Walking Difficulty Psychometrics Assessment Score","preferredDefinition":"Response on a psychometric measure documenting how often a person experiences difficulty walking due to CTCL (Cutaneous T-Cell Lymphoma) in the skin. [Manually-curated]","longName":"CTCL_SKN_WK_DIFF_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"47899A4A-12AC-2E37-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-03-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-03-03","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":"Curated to support CCR PI request to add CTCL-specific items to Skindex measure for CTCL involvement in skin","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2732899","version":"1","preferredName":"Person Cutaneous T-Cell Non-Hodgkin Lymphoma Skin Hand Activity Difficulty Psychometrics Assessment Score","preferredDefinition":"Response on a psychometric measure documenting how often a human being has difficulty performing activities requiring the use of hands due to CTCL (Cutaneous T-Cell Lymphoma) in the skin. [Manually-curated]","longName":"CTCL_SKN_HD_DIFF_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"4789CCFB-5295-3D54-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-03-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-03-03","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":"Curated to support CCR PI request to add CTCL-specific items to Skindex measure for CTCL involvement in skin","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2732901","version":"1","preferredName":"Person Cutaneous T-Cell Non-Hodgkin Lymphoma Skin Dryness Psychometrics Assessment Score","preferredDefinition":"Response on a psychometric measure documenting how often a human being experiences dry or flaky skin due to CTCL (Cutaneous T-Cell Lymphoma) involvement. [Manually-curated]","longName":"CTCL_SKN_DRY_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"4789DDFD-57C0-40A0-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-03-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-03-03","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":"Curated to support CCR PI request to add CTCL-specific items to Skindex measure for CTCL involvement in skin","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2732903","version":"1","preferredName":"Person Cutaneous T-Cell Non-Hodgkin Lymphoma Skin Painful Hand Foot Crack Psychometrics Assessment Score","preferredDefinition":"Response on a psychometric measure documenting how often a human being experiences painful cracks on the hands or feet due to CTCL (Cutaneous T-Cell Lymphoma) in the skin. [Manually-curated]","longName":"CTCL_SKN_PN_CRACK_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"4789F4F9-A4B3-447F-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-03-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-03-03","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":"Curated to support CCR PI request to add CTCL-specific items to Skindex measure for CTCL involvement in skin","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2732905","version":"1","preferredName":"Person Cutaneous T-Cell Non-Hodgkin Lymphoma Skin Bed Time Single Perception Psychometrics Assessment Score","preferredDefinition":"Response on a psychometric measure documenting how often a human being feels alone in the world because of CTCL (Cutaneous T-Cell Lymphoma) in the skin. [Manually-curated]","longName":"CTCL_SKN_ALONE_FL_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"478B0BBB-755A-4B20-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-03-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-03-03","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":"Curated to support CCR PI request to add CTCL-specific items to Skindex measure for CTCL involvement in skin","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2732907","version":"1","preferredName":"Person Cutaneous T-Cell Non-Hodgkin Lymphoma Skin Bed Time Psychometrics Assessment Score","preferredDefinition":"Response on a psychometric measure documenting how often a human spends time in bed due to CTCL (Cutaneous T-Cell Lymphoma) in the skin. [Manually-curated]","longName":"CTCL_SKN_BED_TM_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"478B1904-FE87-4D09-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-03-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-03-03","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":"Curated to support CCR PI request to add CTCL-specific items to Skindex measure for CTCL involvement in skin","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2732909","version":"1","preferredName":"Person Cutaneous T-Cell Non-Hodgkin Lymphoma Skin Chills Perception Psychometrics Assessment Score","preferredDefinition":"Response on a psychometric measure documenting how often a human being experiences chills because of CTCL (Cutaneous T-Cell Lymphoma) in the skin. [Manually-curated]","longName":"CTCL_SKN_CHILL_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"478B273C-5939-5017-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-03-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-03-03","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":"Curated to support CCR PI request to add CTCL-specific items to Skindex measure for CTCL involvement in skin","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2732911","version":"1","preferredName":"Person Cutaneous T-Cell Non-Hodgkin Lymphoma Skin Home Clean Difficulty Psychometrics Assessment Score","preferredDefinition":"Response on a psychometric measure documenting how often a human being experiences fatigue in coping or dealing with CTCL (Cutaneous T-Cell Lymphoma) in the skin. [Manually-curated]","longName":"CTCL_SKN_CL_DIFF_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"478B3613-6EE3-533E-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-03-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-03-03","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":"Curated to support CCR PI request to add CTCL-specific items to Skindex measure for CTCL involvement in skin","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2732913","version":"1","preferredName":"Person Cutaneous T-Cell Non-Hodgkin Lymphoma Skin Future Anxiety Psychometrics Assessment Score","preferredDefinition":"Response on a psychometric measure documenting how often a human being worries about the uncertainty of the future due to CTCL (Cutaneous T-Cell Lymphoma) involvement in the skin. [Manually-curated]","longName":"CTCL_SKN_FT_ANX_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"478B474C-78EE-5656-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-03-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-03-03","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":"Curated to support CCR PI request to add CTCL-specific items to Skindex measure for CTCL involvement in skin","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2732915","version":"1","preferredName":"Person Cutaneous T-Cell Non-Hodgkin Lymphoma Skin Exudate Psychometrics Assessment Score","preferredDefinition":"Response on a psychometric measure documenting how often a human being experiences oozing of the skin due to CTCL (Cutaneous T-Cell Lymphoma) in the skin. [Manually-curated]","longName":"CTCL_SKN_EXUD_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"478B561C-6729-597A-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-03-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-03-03","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":"Curated to support CCR PI request to add CTCL-specific items to Skindex measure for CTCL involvement in skin","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2732917","version":"1","preferredName":"Person Cutaneous T-Cell Non-Hodgkin Lymphoma Skin Anxiety Information Psychometrics Assessment Score","preferredDefinition":"Response on a psychometric measure documenting how often a human being is bothered by the misunderstanding of others about their CTCL (Cutaneous T-Cell Lymphoma) in the skin. [Manually-curated]","longName":"CTCL_SKN_MISTG_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"478B65BD-ADEA-5C04-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-03-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-03-03","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":"Curated to support CCR PI request to add CTCL-specific items to Skindex measure for CTCL involvement in skin","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2732919","version":"1","preferredName":"Person Cutaneous T-Cell Non-Hodgkin Lymphoma Skin Problem Stress and Coping Psychometrics Assessment Score","preferredDefinition":"Response on a psychometric measure documenting how often a human being experiences difficulty coping with CTCL (Cutaneous T-Cell Lymphoma) in the skin. [Manually-curated]","longName":"CTCL_SKN_COP_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"478B73B5-EB71-5F23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-03-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-03-03","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":"Curated to support CCR PI request to add CTCL-specific items to Skindex measure for CTCL involvement in skin","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2733091","version":"1","preferredName":"Prior Therapy Administered Modality Type","preferredDefinition":"Name of therapy modality(ies) received by a subject prior to enrollment into a clinical trial. [Manually-curated]","longName":"PRIOR_TX_MOD_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"479D73E4-436D-007E-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-03-04","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-03-04","modifiedBy":"TITARENKOI","dateModified":"2021-05-04","changeNote":"Curated to support CCR Surgery (Immunotherapy) legacy data migration","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2735776","version":"2","preferredName":"Primary Site of Disease Anatomic Site Name","preferredDefinition":"Text term for originating or primary anatomic site of the disease/condition under investigation or review.","longName":"PRIM_DZ_ANAT_SITE_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"CD366040-9CA3-3F65-E040-BB89AD4326C6","latestVersionIndicator":"Yes","beginDate":"2012-10-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-10-29","modifiedBy":"COOPERM","dateModified":"2020-07-09","changeNote":"12/11/14 jc added Exceptional Responder CSI.  v2.0 replaced v1.0 with versioned VD that increases max field length.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2735778","version":"3","preferredName":"Adverse Event Complicating Infection Anatomic Site Name","preferredDefinition":"Text term to identify the primary anatomic site of an infection.","longName":"AE_INFEC_ANAT_STE_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"CC2DD3C2-6105-290A-E040-BB89AD43263E","latestVersionIndicator":"Yes","beginDate":"2012-10-16","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-10-16","modifiedBy":"REEVESD","dateModified":"2012-10-16","changeNote":"v2.0 uses versioned VD 1.2 which increases maximum length from 30 to 50 characters. v3.0 extends maximum field length from 50 to 120 characters.dr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2735780","version":"1","preferredName":"Adverse Event Complicating Infection Anatomic Location Descriptive Text","preferredDefinition":"Free text description of the anatomic location of an infectious event. [Manually-curated]","longName":"INFEC_ANAT_STE_TXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"48CA55BE-3074-245F-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-03-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-03-19","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":"Added to infectious episode C3D templated based on recommendations of CCR CCMG February 2008.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2736357","version":"1","preferredName":"Clinical Trial Protocol Suffix Identifier","preferredDefinition":"One-character term to identify protocol subgroups (may include protocol amendments) and patient reenrollments to a trial. [Manually-curated]","longName":"PROT_SUFF_ID","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"48DA7C15-5BC6-654F-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-03-20","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-03-20","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":"Curated to support CCR Surgery (Immunotherapy) legacy data migration","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2736361","version":"1","preferredName":"Patient Disease Code","preferredDefinition":"Character term to identify a patient's disease at the time of diagnosis. [Manually-curated]","longName":"PT_DZ_CD","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"48DD0467-E73F-51E8-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-03-20","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-03-20","modifiedBy":"ZHWENDY","dateModified":"2022-09-13","changeNote":"Curated to support CCR Surgery (Immunotherapy) legacy data migration","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2736365","version":"1","preferredName":"Medical Staff Fellow Name","preferredDefinition":"Name to identify a professional medical person who provide care to patients in a healthcare setting, organized facility, institution or agency. [Manually-curated]","longName":"MED_STFF_FLLW_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"48DD3710-4842-598A-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-03-20","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-03-20","modifiedBy":"MMADDINENI","dateModified":"2024-01-08","changeNote":"Curated to support CCR Surgery (Immunotherapy) legacy data migration","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2736372","version":"1","preferredName":"Patient Enrollment Occurrence Count","preferredDefinition":"Numeric value to designate the number of times a patient/subject has been registered into a single clinical trial. [Manually-curated].","longName":"PT_ENROLL_OCCR_CT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"48DC85F4-089F-6430-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-03-20","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-03-20","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":"Curated to support CCR Surgery (Immunotherapy) legacy data migration","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2736857","version":"1","preferredName":"Protocol Agent Identifier","preferredDefinition":"Three-character code to identify a protocol agent used in a clinical trial. [Manually-curated]","longName":"PROT_AGT_ID","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"4942FAD1-30AF-5B20-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-03-25","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-03-25","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":"Curated to support CCR Surgery (Immunotherapy) legacy data migration","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2737046","version":"1","preferredName":"Protocol Agent Course Dose Count","preferredDefinition":"Numeric value to identify the total number of doses of protocol agent delivered to a patient over a course of protocol treatment; a course is a period of protocol-prescribed activity composed of numerous cycles of treatment. [Manually-curated]","longName":"PROT_AGT_CRS_DOSE_CT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"4956C2A7-5732-3DE0-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-03-26","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-03-26","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":"Curated to support CCR Surgery (Immunotherapy) legacy data migration","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2737057","version":"1","preferredName":"Protocol Agent Course Rate Or Total Dose Value","preferredDefinition":"Numeric value for the total dose or rate of administration of a protocol agent over a course of protocol therapy. [Manually-curated]","longName":"PROT_CRS_RT_DOSE_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"49579BAF-83A1-6D30-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-03-26","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-03-26","modifiedBy":"REEVESD","dateModified":"2011-03-18","changeNote":"Curated to support CCR Surgery (Immunotherapy) legacy data migration","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2737162","version":"2","preferredName":"Concomitant Agent Concomitant Procedure Name","preferredDefinition":"Text name of agent or procedure that is not part of the protocol regimen, and is generally used for treatment of preexisting conditions or symptoms, and for adverse events.","longName":"CONCT_AGT_PROC_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"3D706EE9-660E-43CE-E053-F662850AF5C9","latestVersionIndicator":"Yes","beginDate":"2016-09-26","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-09-26","modifiedBy":"REEVESD","dateModified":"2016-09-26","changeNote":"v2.0 replaces CDE v1.0 with VD that has been extended from 24 to 100 characters based on community request.9.26.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2737302","version":"1","preferredName":"Weight Clinical Trial Timepoint Code","preferredDefinition":"Code to identify a clinical trial timepoint that adds context to a person's weight. {Manually-curated]","longName":"WT_CLIN_TRL_TMPT_CD","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"496C9C3F-4D7F-0060-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-03-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-03-27","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":"Curated to support CCR Surgery (Immunotherapy) legacy data migration","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2737320","version":"1","preferredName":"Pulmonary Function Test Result Value","preferredDefinition":"Numeric value resulting from a test performed to assess how well lungs inhale and exhale air and how efficiently they transfer oxygen into the blood. [Manually-curated]","longName":"PFT_RSL_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"496E0B5D-96F6-1538-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-03-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-03-27","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":"Curated to support CCR Surgery (Immunotherapy) legacy data migration","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2737336","version":"1","preferredName":"Pulmonary Function Test Name","preferredDefinition":"Text name of a pulmonary function test. {Manually-curated]","longName":"PFT_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"496D9E89-EA9C-5DD4-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-03-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-03-27","modifiedBy":"TSESU","dateModified":"2017-12-25","changeNote":"Curated to support CCR Surgery (Immunotherapy) legacy data migration","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2738409","version":"1","preferredName":"Disease Extent Status Code","preferredDefinition":"Character code to signify the change or state of disease at a specific point in time. [Manually-curated]","longName":"DZ_EXT_STAT_CD","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"49BCA2C9-5985-280C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-03-31","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-03-31","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":"Curated to support CCR Surgery (Immunotherapy) legacy data migration","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2738426","version":"1","preferredName":"Measurement Not Entered Reason Disease Status Code","preferredDefinition":"Character code to identify the reason a disease measurement was not recorded. [Manually-entered]","longName":"MSRMT_NOT_ENT_RSN_CD","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"49BE2955-7ACE-4C26-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-03-31","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-03-31","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":"Curated to support CCR Surgery (Immunotherapy) legacy data migration","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2738436","version":"1","preferredName":"Protocol Immune Radiolabeled Antibody Therapy Administered Indicator","preferredDefinition":"Text indicator for a dose of agent containing a radioactive isotope being administered to a patient. [Manually-curated]","longName":"PROT_RADABTX_ADM_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"49BE6051-C85E-5868-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-03-31","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-03-31","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":"Curated to support CCR Surgery (Immunotherapy) legacy data migration","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2738508","version":"2","preferredName":"Response Assessment Code","preferredDefinition":"Code to identify a patient's response to protocol intervention.","longName":"RESP_ASSESS_CD","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"D4813252-CCDC-71BE-E040-BB89AD4341ED","latestVersionIndicator":"Yes","beginDate":"2013-01-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-01-30","modifiedBy":"CHANGP","dateModified":"2016-10-28","changeNote":"Curated to support CCR Surgery (Immunotherapy) legacy data migration. v2.0 replaces v1.0 with extended field length.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2740379","version":"2","preferredName":"Patient Self-Report Skin Fatigue Five Point Likert Scale Score","preferredDefinition":"Self-reported response to a Skindex-29 question asking if the subject's skin condition makes the person tired. [Manually-curated]","longName":"PT_SR_SKN_FAT_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"Skindex-29 Copyright 1996, M.-M. Chren, MD","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"4CAEBAA5-F6BF-5F2A-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-05-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-07","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":"Curated to support CCR need to include Skindex-29 in C3D.  Replaces v1.0 CDE with corrected VD.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2740381","version":"2","preferredName":"Patient Self-Report Skin Sex Behavior Interference Five Point Likert Scale Score","preferredDefinition":"Self-reported response to a Skindex-29 question asking if the subject's skin condition interferes with the person's sex life. [Manually-curated]","longName":"PT_SR_SKN_SXLF_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"Skindex-29 Copyright 1996, M.-M. Chren, MD","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"4CAEBAA5-F67E-5F2A-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-05-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-07","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":"Curated to support CCR need to include Skindex-29 in C3D.  Replaces v1.0 CDE with corrected VD.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2740383","version":"2","preferredName":"Patient Self-Report Skin Emotional Frustration Five Point Likert Scale Score","preferredDefinition":"Self-reported response to a Skindex-29 question asking if the subject is annoyed by the person's skin condition. [Manually-curated]","longName":"PT_SR_SKN_ANNOY_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"Skindex-29 Copyright 1996, M.-M. Chren, MD","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"4CAEBAA5-F63D-5F2A-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-05-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-07","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":"Curated to support CCR need to include Skindex-29 in CCR.  Replaces v1.0 CDE with corrected VD.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2740385","version":"2","preferredName":"Patient Self-Report Skin Hemorrhage Five Point Likert Scale Score","preferredDefinition":"Self-reported response to a Skindex-29 question asking if the subject's skin condition bleeds. [Manually-curated]","longName":"PT_SR_SKN_BLD_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"Skindex-29 Copyright 1996, M.-M. Chren, MD","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"4CAEBAA5-F5FC-5F2A-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-05-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-07","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":"Curated to support CCR need to include Skindex-29 in C3D.  Replaces v1.0 CDE with a corrected VD.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2740575","version":"2","preferredName":"Patient Self-Report Skin Humiliation Five Point Likert Scale Score","preferredDefinition":"Self-reported response to a Skindex-29 question asking if the subject's skin condition causes humiliation. [Manually-curated]","longName":"PT_SR_SKN_HUMIL_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"Skindex-29 Copyright 1996, M.-M. Chren, MD","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"4CAF7078-FFBB-539D-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-04-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-07","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":"Curated to support CCR need to include Skindex-29 in C3D.  Replaces v1.0 CDE with corrected VD.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2740579","version":"2","preferredName":"Patient Self-Report Skin Need Human Proximity Effect Five Point Likert Scale Score","preferredDefinition":"Self-reported response to a Skindex-29 question asking if the skin condition affects the subject's desire to be with people. [Manually-curated]","longName":"PT_SR_SKN_ND_PROX_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"Skindex-29 Copyright 1996, M.-M. Chren, MD","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"4CAF5E4E-F061-4F62-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-05-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-07","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":"Curated to support CCR need to include Skindex-29 in C3D.  Replaces v1.0 CDE with corrected VD.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2740582","version":"2","preferredName":"Patient Self-Report Skin Sensitivity Five Point Likert Scale Score","preferredDefinition":"Self-reported response to a Skindex-29 question asking if a subject's skin is sensitive. [Manually-curated]","longName":"PT_SR_SKN_SENS_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"Skindex-29 Copyright 1996, M.-M. Chren, MD","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"4CAF4CB8-4DC8-4C07-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-05-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-07","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":"Curated to support CCR need to include Skindex-29 in C3D.  Replaces v1.0 CDE with corrected VD.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2740585","version":"2","preferredName":"Patient Self-Report Skin Frustration Five Point Likert Scale Score","preferredDefinition":"Self-reported response to a Skindex-29 question asking if a subject is frustrated by a skin condition. [Manually-curated]","longName":"PT_SR_SKN_FRUST_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"Skindex-29 Copyright 1996, M.-M. Chren, MD","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"4CAF3AA6-ACF6-490B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-05-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-07","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":"Curated to support CCR need to include Skindex-29 in C3D.  Replaces v1.0 CDE with corrected VD.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2740587","version":"2","preferredName":"Patient Self-Report Skin People Love Problem Five Point Likert Scale Score","preferredDefinition":"Self-reported response to a Skindex-29 question asking if a skin condition is a problem for the people loved by a subject. [Manually-curated]","longName":"PT_SR_SKN_LOV_PRB_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"Skindex-29 Copyright 1996, M.-M. Chren, MD","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"4CAF28AD-EB04-4641-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-05-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-07","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":"Curated to support CCR need to include Skindex-29 in C3D.  Replaces v1.0 with corrected VD.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2740589","version":"2","preferredName":"Patient Self-Report Skin Embarassment Five Point Likert Scale Score","preferredDefinition":"Self-reported response to a Skindex-29 question asking if a subject is embarassed by a skin condition. [Manually-curated]","longName":"PT_SR_SKN_EMBARMT_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"Skindex-29 Copyright 1996, M.-M. Chren, MD","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"4CAF10CF-150D-3F55-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-04-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-07","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":"Curated to support CCR need to include Skindex-29 in C3D.  Replaces v1.0 CDE with corrected VD.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2740592","version":"2","preferredName":"Patient Self-Report Skin Effect Other Human Interaction Five Point Likert Scale Score","preferredDefinition":"Self-reported response to a Skindex-29 question asking if a skin condition affects a subject's interactions with others. [Manually-curated]","longName":"PT_SR_SKN_OTX_INT_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"Skindex-29 Copyright 1996, M.-M. Chren, MD","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"4CA52C7F-82CB-6F7A-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-05-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-07","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":"Curated to support CCR need to include Skindex-29 in C3D.  Replaces v1.0 with corrected VD.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2740595","version":"2","preferredName":"Patient Self-Report Skin Irritation Five Point Likert Scale Score","preferredDefinition":"Self-reported response to a Skindex-29 question asking if a subject's skin is iritated. [Manually-curated]","longName":"PT_SR_SKN_IRR_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"Skindex-29 Copyright 1996, M.-M. Chren, MD","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"4CA52C7F-8282-6F7A-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-05-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-07","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":"Curated to support CCR need to include Skindex-29 in C3D.  v2.0 corrects VD.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2740600","version":"2","preferredName":"Patient Self-Report Skin Display Affection Difficulty Five Point Likert Scale Score","preferredDefinition":"Self-reported response to a Skindex-29 question asking if a subject's skin condition makes showing affection difficult. [Manually-curated]","longName":"PT_SR_SKN_DSP_AFF_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"Skindex-29 Copyright 1996, M.-M. Chren, MD","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"4CA3D3E0-E953-5CA3-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-05-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-07","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":"Curated to support CCR need to include Skindex-29 in C3D.  v2.0 corrects VD.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2740608","version":"2","preferredName":"Patient Self-Report Skin Water Irritation Five Point Likert Scale Score","preferredDefinition":"Self-reported response to a Skindex-29 question asking if water (bathing, washing hands) bothers a subject's skin condition. [Manually-curated]","longName":"PT_SR_SKN_H2O_IRR_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"Skindex-29 Copyright 1996, M.-M. Chren, MD","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4C9CEB5B-CFBA-5AFA-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-05-06","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-07","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":"Curated to support CCR need to include Skindex-29 in C3D.  Replaces v1.0 with corrected VD.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2740611","version":"2","preferredName":"Patient Self-Report Skin Anger Five Point Likert Scale Score","preferredDefinition":"Self-reported response to a Skindex-29 question asking about a subject's anger about a skin condition. [Manually-curated]","longName":"PT_SR_SKN_ANG_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"Skindex-29 Copyright 1996, M.-M. Chren, MD","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"4BFABB66-1C72-309B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-04-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-04-28","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":"New version uses updated VD with text permissible values.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2740616","version":"2","preferredName":"Patient Self-Report Skin Etiology Performance Activity Self Pattern Five Point Likert Scale Score","preferredDefinition":"Self-reported response to a Skindex-29 question asking about a subject's tendency to do things alone because of a skin condition. [Manually-curated]","longName":"PT_SR_SKN_ETI_ALN_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"Skindex-29 Copyright 1996, M.-M. Chren, MD","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"4C9CEB5B-CF54-5AFA-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-05-06","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-07","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":"Curated to support CCR need to include Skindex-29 in C3D.  v2.0 uses corrected VD.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2740624","version":"2","preferredName":"Patient Self-Report Skin Worse Condition Anxiety Five Point Likert Scale Score","preferredDefinition":"Self-reported response to a Skindex-29 question asking about a subject's worry that their skin condition may get worse. [Manually-curated]","longName":"PT_SR_SKN_WS_ANX_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"Skindex-29 Copyright 1996, M.-M. Chren, MD","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"4C9CAE94-43E8-4D61-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-05-06","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-07","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":"Curated to support CCR need to include Skindex-29 in C3D.  Replaces v1.0 with corrected VD.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2740627","version":"2","preferredName":"Patient Self-Report Skin Shame Five Point Likert Scale Score","preferredDefinition":"Self-reported response to a Skindex-29 question asking about a subject being ashamed about a skin condition. [Manually-curated]","longName":"PT_SR_SKN_SHM_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"Skindex-29 Copyright 1996, M.-M. Chren, MD","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"4C9CA3AF-AC0B-4B8D-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-05-05","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-07","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":"Curated to support CCR need to include Skindex-29 in C3D.  v2.0 includes corrected VD.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2740631","version":"2","preferredName":"Patient Self-Report Skin Effect Person Emotion Attachment Proximity Five Point Likert Scale Score","preferredDefinition":"Self-reported response to a Skindex-29 question asking about the affect of a skin condition on how close a subject can be with loved one.. [Manually-curated]","longName":"PT_SR_SKN_PROX_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"Skindex-29 Copyright 1996, M.-M. Chren, MD","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"4C9D492A-85C0-38AC-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-05-06","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-07","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":"Curated to support CCR need to include Skindex-29 in C3D.  Replaces v1.0 CDE with corrected VD.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2740636","version":"2","preferredName":"Patient Self-Report Skin Pruritus Five Point Likert Scale Score","preferredDefinition":"Self-reported response to a Skindex-29 question asking about the affect of a skin condition on how close a subject can be with loved one.. [Manually-curated]","longName":"PT_SR_SKN_PRUR_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"Skindex-29 Copyright 1996, M.-M. Chren, MD","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"4C9D1FBD-90AC-30D5-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-05-06","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-07","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":"Curated to support CCR need to include Skindex-29 in C3D.  v2.0 uses corrected VD.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2740642","version":"2","preferredName":"Patient Self-Report Skin Scar Anxiety Five Point Likert Scale Score","preferredDefinition":"Self-reported response to a Skindex-29 question asking about a subject's worry about getting scars from a skin condition. [Manually-curated]","longName":"PT_SR_SKN_SCR_ANX_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"Skindex-29 Copyright 1996, M.-M. Chren, MD","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"4C9D0D8A-22EF-2BAA-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-05-06","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-07","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":"Curated to support CCR need to include Skindex-29 in C3D.  v2.0 corrects VD.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2740652","version":"2","preferredName":"Patient Self-Report Skin Etiology Remaining Home Pattern Five Point Likert Scale Score","preferredDefinition":"Self-reported response to a Skindex-29 question asking about a subject's tendency to stay at home because of a skin condition. [Manually-curated]","longName":"PT_SR_SKN_ETI_HOM_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"Skindex-29 Copyright 1996, M.-M. Chren, MD","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"4C9C47B6-074B-0995-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-04-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-06","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":"Curated to support CCR need to include Skindex-29 in C3D.  v2.0 corrects VD.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2740654","version":"2","preferredName":"Patient Self-Report Skin Burning Sensation Five Point Likert Scale Score","preferredDefinition":"Self-reported response to a Skindex-29 question asking about a subject's skin condition burning or stinging. [Manually-curated]","longName":"PT_SR_SKN_BRN_SEN_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"Skindex-29 Copyright 1996, M.-M. Chren, MD","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"4C9AF055-102C-6D7B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-04-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-06","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":"Curated to support CCR need to include Skindex-29 in C3D.  Version 2.0 corrects VD.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2740691","version":"2","preferredName":"Patient Self-Report Skin Etiology Depression Five Point Likert Scale Score","preferredDefinition":"Self-reported response to a Skindex-29 question asking about a skin condition making a subject feel depressed. [Manually-curated]","longName":"PT_SR_SKN_ETI_DEP_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"Skindex-29 Copyright 1996, M.-M. Chren, MD","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"4C9AF055-0FE5-6D7B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-04-14","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-06","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":"Curated to support CCR need to include Skindex-29 in C3D.  Version 2.0 corrects VD.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2740695","version":"2","preferredName":"Patient Self-Report Skin Effect Social Life Five Point Likert Scale Score","preferredDefinition":"Self-reported response to a Skindex-29 question asking about a skin condition affecting a subject's social life. [Manually-curated]","longName":"PT_SR_SKN_SOC_LIF_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"Skindex-29 Copyright 1996, M.-M. Chren, MD","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"4C9AF055-0F9E-6D7B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-04-14","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-06","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":"Curated to support CCR need to add Skindex-29 to C3D.  v2.0 corrects VD.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2740699","version":"2","preferredName":"Patient Self-Report Skin  Employment Hobby Difficulty Five Point Likert Scale Score","preferredDefinition":"Self-reported response to a Skindex-29 question asking about a skin condition making it hard for a subject to work or do hobbies. [Manually-curated]","longName":"PT_SR_SKN_WK_JOB_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"Skindex-29 Copyright 1996, M.-M. Chren, MD","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"4BFABB66-1C40-309B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-04-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-04-28","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":"New version uses corrected VD with text permissible values","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2740716","version":"2","preferredName":"Patient Self-Report Skin Serious Condition Anxiety Five Point Likert Scale Score","preferredDefinition":"Self-reported response to a Skindex-29 question asking about a subject's worry that a skin condition may be serious. [Manually-curated]","longName":"PT_SR_SKN_SER_CON_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"Skindex-29 Copyright 1996, M.-M. Chren, MD","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"4C9AD65F-8979-6A40-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-04-14","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-06","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":"Curated to support CCR need to add Skindex-29 to C3D.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2740742","version":"2","preferredName":"Patient Self-Report Skin Effect Sleep Five Point Likert Scale Score","preferredDefinition":"Self-reported response to a Skindex-29 question asking about the effect of a skin condition on how well a subject sleeps. [Manually-curated]","longName":"PT_SR_SKN_EFF_SLP_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"Skindex-29 Copyright 1996, M.-M. Chren, MD","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"4C9AD65F-893A-6A40-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-04-14","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-06","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":"Curated to support CCR need to add Skindex-29 to C3D.  v2.0 corrects VD.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2740744","version":"2","preferredName":"Patient Self-Report Skin Pain Five Point Likert Scale Score","preferredDefinition":"Self-reported response to a Skindex-29 question asking a subject about skin hurting. [Manually-curated]","longName":"PT_SR_SKN_PN_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"Skindex-29 Copyright 1996, M.-M. Chren, MD","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"4C9A8F4D-19DB-59BC-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-04-14","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-06","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":"Curated to support CCR add the Skindex-29 questionnaire to C3D.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2748297","version":"1","preferredName":"Patient Self-Report Anxiety Medication Procedure Side Effect Five Point Likert Scale Score","preferredDefinition":"Self-reported response to a Skindex-29 question asking if a subject worries about side effects of skin medications and treatments. [Manually-curated]","longName":"PT_SR_MED_TX_EFF_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"Skindex-29 Copyright 1996, M.-M. Chren, MD","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"4CA51BE4-9E3B-6CBA-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-05-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-07","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":"Curated to support CCR need to add Skindex-29 to C3D.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2761377","version":"1","preferredName":"Acute Graft Versus Host Disease Diagnosis Date","preferredDefinition":"Date of the onset of a syndrome of immologically mediated tissue damage occurring following allogeneic transplant usually affecting the skin, liver, and gi tract.  Onset is usually within one hundred days of transplantation or immunologic manipulation. [Manually-curated]","longName":"AGVHD_DX_DT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"50DC544D-B370-48C7-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-06-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-06-30","modifiedBy":"CHANGP","dateModified":"2016-10-08","changeNote":"Curated to support CCR Acute GVHD trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2763028","version":"1","preferredName":"Dose Limiting Toxicity Indicator","preferredDefinition":"Text term to indicate if a toxicity type has occurred that makes it impossible to escalate the dosage of a therapy agent/measure.","longName":"DOSE_LIM_TOX_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"5173C787-BB88-1E40-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-07-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-07-07","modifiedBy":"RODGERSC","dateModified":"2018-04-04","changeNote":"Curated to support Surgery Branch (Immunotherapy) migration to C3D","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2763030","version":"1","preferredName":"Adverse Event Report Filed Indicator","preferredDefinition":"Text term to indicate the filing of an adverse event report. [Manually-curated]","longName":"AER_FILED_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"5173EA15-3F9B-2401-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-07-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-07-07","modifiedBy":"HARTLEYG","dateModified":"2013-03-29","changeNote":"Curated to support Surgery Branch (Immunotherapy) migration to C3D","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2767073","version":"1","preferredName":"Pulse Rate Measurement Value","preferredDefinition":"Numeric value to represent the measurement of the heart rate, which is the number of contractions (heart beats) expressed in \"beats per minute\" (bpm). [Manually-curated]","longName":"PULSE_RATE_MSRMT_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Standard","id":"524C136C-F565-47E5-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-07-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-07-18","modifiedBy":"KUMMEROA","dateModified":"2023-05-25","changeNote":"Replaces CDE 2004287 which was retired because of a VD with 3 decimals.","administrativeNotes":"2023.5.25 ASQT added per ticket request CADSR0002455. ak","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2767077","version":"1","preferredName":"Temperature Celsius Scale Value","preferredDefinition":"Numeric value to signify the degree of hotness or coldness of a body or environment using the Celsius (Centigrade) scale. [Manually-curated]","longName":"TEMP_CELS_SCL_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"524BC1E5-57C9-673A-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-07-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-07-18","modifiedBy":"TITARENKOI","dateModified":"2020-06-25","changeNote":"Replaces CDE 2004286 which has a VD with 3 decimal places.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2767083","version":"1","preferredName":"Temperature Degrees Fahrenheit Scale Value","preferredDefinition":"Numeric value to signify the body temperature expressed in Fahrenheit degrees. [Manually-curated]","longName":"TEMP_FAHREN_SCL_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"524D0D7F-5115-73B8-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-07-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-07-18","modifiedBy":"SOKKERL","dateModified":"2019-10-23","changeNote":"Replaces CDE 2180846 which has a VD with 3 decimals.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2767152","version":"1","preferredName":"Left Ventricular Ejection Time Measurement Millisecond Number","preferredDefinition":"Numeric value to represent the time of ejection of blood from the left ventricle beginning with the opening of the aortic value and ending with aortic value closure, expressed as a number of milliseconds. [Manually-curated]","longName":"LVET_MSRMT_MS_NUM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"524D852D-920B-4701-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-07-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-07-18","modifiedBy":"REEVESD","dateModified":"2011-06-28","changeNote":"Replaces CDE 2004310, which has a VD with 3 decimal places.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2787191","version":"1","preferredName":"Laboratory Procedure Immunohistochemistry Result Percentage Value","preferredDefinition":"Numeric value (percent) to indicate the strength of an immunohistochemistry (IHC) staining result. [Manually-curated]","longName":"LAB_PROC_IHC_PTG_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"578F7DB6-BF62-3A4A-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-09-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-09-23","modifiedBy":"REEVESD","dateModified":"2016-09-06","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2787279","version":"1","preferredName":"Person Skin Evaluation Occurrence Indicator","preferredDefinition":"Text term to signify whether a skin evaluation has been done for an individual. A skin evaluation is done to assess cafe-au-lait spots, dermal characteristics, and subcutaneous neurofibromas. [Manually-curated]","longName":"SKN_EVAL_OCC_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"579219F1-A019-3801-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-09-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-09-23","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":"Curated to suport CCR adoption of C3D","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2787287","version":"1","preferredName":"Person Skin Evaluation Occurrence Date","preferredDefinition":"Date of an evaluation of an individual's skin for dermal characteristics and neurofibromas. [Manually-curated]","longName":"SKN_EVAL_OCC_DT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"57926717-1F1B-45F9-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-09-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-09-23","modifiedBy":"TSESU","dateModified":"2019-08-21","changeNote":"Curated to suport CCR adoption of C3D","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2787292","version":"1","preferredName":"Person Rehabilitation Evaluation Occurrence Indicator","preferredDefinition":"Text term to signify whether or not a comprehensive rehabilitation evaluation for musculoskeletal and functional status, with stereo photogrammetry to evaluate for dysmorphia deformity, was done. [Manually-curated]","longName":"REHAB_EVAL_OCC_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"57918EC8-0840-4D4F-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-09-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-09-23","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":"Curated to suport CCR adoption of C3D","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2787297","version":"1","preferredName":"Person Rehabilitation Evaluation Occurrence Date","preferredDefinition":"Date of an individual's rehabilitation evaluation for muculoskeletal and functional status, and stereo programmetry for dysmorphia deformity. [Manually-curated]","longName":"REHAB_EVAL_OCC_DT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5791F6B0-0B76-605A-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-09-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-09-23","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":"Curated to suport CCR adoption of C3D","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2787302","version":"1","preferredName":"Person Endocrine Evaluation Occurrence Indicator","preferredDefinition":"Text term to signify whether or not an endocrine evaluation, including endocrine lab studies and hormonal studies, was performed. [Manually-curated]","longName":"ENDCR_EVAL_OCC_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"579338DF-B4A7-6C50-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-09-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-09-23","modifiedBy":"SPRINGERL","dateModified":"2021-03-17","changeNote":"Curated to suport CCR adoption of C3D","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2787304","version":"1","preferredName":"Person Endocrine Evaluation Occurrence Date","preferredDefinition":"Date an individual's endocrine consult or evaluation was done, including endocrine lab studies and hormonal studies. [Manually-curated]","longName":"ENDCR_EVAL_OCC_DT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5792B026-817D-0E3A-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-09-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-09-23","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":"Curated to suport CCR adoption of C3D","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2787322","version":"1","preferredName":"Person Endocrine Evaluation Test Name","preferredDefinition":"Text term to identify an evaluation or procedure used to evaluate an individual's endocrine function. [Manually-curated]","longName":"ENDCR_EVAL_TEST_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"57940350-8F9A-20EF-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-09-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-09-23","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":"Curated to suport CCR adoption of C3D","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2787327","version":"1","preferredName":"Person Speech Evaluation Occurrence Indicator","preferredDefinition":"Text term to signify whether or not a speech evaluation including an assessment of motor functions, preschool language testing, clinical evaluation of language fundamentals, expressive vocabulary test, Peabody picture vocabulary test, Goldman Fristoe tests of articulation, Fischer Logerman tests of articulation and Tests of Pragmatic Language was performed. [Manually-curated]","longName":"SPCH_EVAL_OCC_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"57942821-625B-27E0-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-09-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-09-23","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":"Curated to suport CCR adoption of C3D","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2787329","version":"1","preferredName":"Person Speech Evaluation Occurrence Date","preferredDefinition":"Date on which a speech evaluation was performed for an individual. [Manually-curated]","longName":"SPCH_EVAL_OCC_DT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"57943D8E-2DFD-2C90-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-09-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-09-23","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":"Curated to suport CCR adoption of C3D","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2793535","version":"1","preferredName":"Lab Test Referenced Unit of Measure Name","preferredDefinition":"Assigned value for standard of measurement for a lab test result that is identified through the use of referenced source(s) from the originating site; a referenced unit of measure is not received with the subject data, but is assigned. [Manually-curated]","longName":"LAB_REFD_UOM_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"58D07CC0-66BC-4205-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-10-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-10-09","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2793621","version":"1","preferredName":"Laboratory Test Reference Normal Range Text","preferredDefinition":"Text to capture value(s) for normal range for a lab test result that is assigned through the use of referenced source(s) from the originating site; a referenced normal value(s) range is not received with the subject data, but is assigned. [Manually-curated]","longName":"LAB_REF_NL_RANGE_TXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"58D35D73-61F2-4F95-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-10-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-10-09","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2795701","version":"1","preferredName":"Child Head Circumference Centimeter Number","preferredDefinition":"Value in centimeters to represent the distance around a child's head at a point above the ears and midway between the eyebrows and the hairline to the occipital prominence at the back of the head. [Manually-curated]","longName":"CHILD_HD_CIRC_CM_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"5A429CAA-9A63-424D-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-10-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-10-27","modifiedBy":"REEVESD","dateModified":"2015-05-19","changeNote":"Curated to support CCR Pediatric trial.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2795703","version":"1","preferredName":"Person Mid-Upper Arm Circumference Centimeter Number","preferredDefinition":"Value in centimeters to represent the measurement of the mid-upper right arm circumference at the mid-point between the tip of the shoulder and the tip of the elbow. [Manually-curated]","longName":"PERS_MUAC_CM_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5A42ACFC-1E60-4542-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-10-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-10-27","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":"Curated to support CCR Pediatric trial.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2795705","version":"1","preferredName":"Person Knee Height Centimeter Number","preferredDefinition":"Value in centimeters to represent the vertical measurement or distance from the heel to the anterior surface of the thigh over the femoral condyles, when both the knee and ankle were bent to 90 degree angles. [Manually-curated]","longName":"PERS_KNEE_HT_CM_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5A42BC6B-8716-4929-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-10-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-10-27","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":"Curated to support CCR Pediatric trial.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2795707","version":"1","preferredName":"Person Arm Span Centimeter Number","preferredDefinition":"Value in centimeters to represent of the distance between a extended right and left middle fingers, measured across the back; sometimes used as an estimate of stature (length or height). [Manually-curated]","longName":"PERS_ARM_SPAN_CM_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5A42D03E-A7C9-4C67-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-10-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-10-27","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":"Curated to support CCR Pediatric trial.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2795712","version":"1","preferredName":"Person Upper Arm Length Centimeter Number","preferredDefinition":"Value in centimeters to represent the distance from the superior lateral surface of the acromion to the inferior surface of the elbow with the arm flexed at 90 degrees. [Manually-curated]","longName":"PERS_UP_ARM_CM_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5A42F3AA-1161-54DB-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-10-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-10-27","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":"Curated to support CCR Pediatric trial.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2795717","version":"1","preferredName":"Person Tibia Length Centimeter Number","preferredDefinition":"Value in centimeters to represent the linear measurement or length of the tibia, the bone located between the femur and the tarsus, being part of the lower leg. [Manually-curated]","longName":"PERS_TIBIA_CM_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5A42F3AA-11B7-54DB-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-10-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-10-27","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":"Curated to support CCR Pediatric trial.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2795808","version":"1","preferredName":"Person Inadequate Energy Occurrence FACT-G Questionnaire Scale Score","preferredDefinition":"Numeric score from the scale used by FACT-G Quality of Life questionnaire to assess a person's lack of energy. [Manually-curated]","longName":"PERS_ENER_FACTG_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5A561442-324C-0578-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-10-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-10-28","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":"Curated with permission from Dr. David Cella for use by CCR to capture FACT-G (v4.0) data in C3D.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2795813","version":"1","preferredName":"Person Nausea Occurrence FACT-G Questionnaire Scale Score","preferredDefinition":"Numeric score from the scale used by FACT-G Quality of Life questionnaire to assess a person's feeling of nausea. [Manually-curated]","longName":"PERS_NAUS_FACTG_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5A565F8E-CAED-1570-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-10-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-10-28","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":"Curated with permission from Dr. David Cella for use by CCR to capture FACT-G (v4.0) data in C3D.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2795825","version":"1","preferredName":"Person Family Need Physical Condition FACT-G Questionnaire Scale Score","preferredDefinition":"Numeric score from the scale used by FACT-G Quality of Life questionnaire to assess a person's trouble meeting family needs during to physical condition. [Manually-curated]","longName":"PERS_NEED_FACTG_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5A559A56-44A2-21E3-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-10-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-10-28","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":"Curated with permission from Dr. David Cella for use by CCR to capture FACT-G (v4.0) data in C3D.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2796033","version":"1","preferredName":"Person Pain Occurrence FACT-G Questionnaire Scale Score","preferredDefinition":"Numeric score from the scale used by FACT-G Quality of Life questionnaire to assess a person's feeling of pain. [Manually-curated]","longName":"PERS_PAIN_FACTG_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5A7AC21B-0C97-7517-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-10-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-10-30","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":"Curated with permission from Dr. David Cella for use by CCR to capture FACT-G (v4.0) data in C3D.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2796039","version":"1","preferredName":"Person Difficulty With Therapeutic Procedure Side Effect FACT-G Questionnaire Scale Score","preferredDefinition":"Numeric score from the scale used by FACT-G Quality of Life questionnaire to assess a person's feelings of being bothered by treatment side effects. [Manually-curated]","longName":"PERS_TX_EFF_FACTG_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5A7AF608-4DFD-0A53-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-10-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-10-30","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":"Curated with permission from Dr. David Cella for use by CCR to capture FACT-G (v4.0) data in C3D.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2796044","version":"1","preferredName":"Person Malaise Occurrence FACT-G Questionnaire Scale Score","preferredDefinition":"Numeric score from the scale used by FACT-G Quality of Life questionnaire to assess a person's feeling of malaise or 'ill' feeling. [Manually-curated]","longName":"PERS_MAL_FACTG_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5A7C1F38-4B79-1340-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-10-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-10-30","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":"Possible CDEs for Hepatitis B Position Statement","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2796054","version":"1","preferredName":"Person Required Bed Rest Occurrence FACT-G Questionnaire Scale Score","preferredDefinition":"Numeric score from the scale used by FACT-G Quality of Life questionnaire to assess a person's feeling of being forced to spend time in bed. [Manually-curated]","longName":"PERS_BEDRST_FACTG_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5A7C4F41-07DD-1C75-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-10-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-10-30","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":"Curated with permission from Dr. David Cella for use by CCR to capture FACT-G (v4.0) data in C3D.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2796637","version":"1","preferredName":"Person Friend Relationship FACT-G Questionnaire Scale Score","preferredDefinition":"Numeric score from the scale used by FACT-G Quality of Life questionnaire to assess a person's feeling closeness to friends. [Manually-curated]","longName":"PERS_FRND_FACTG_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5A8F56E6-72DE-501D-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-10-31","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-10-31","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":"Curated with permission from Dr. David Cella for use by CCR to capture FACT-G (v4.0) data in C3D.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2796643","version":"1","preferredName":"Person Family Emotion Support FACT-G Questionnaire Scale Score","preferredDefinition":"Numeric score from the scale used by FACT-G Quality of Life questionnaire to assess a person's feeling of receiving emotional support from family. [Manually-curated]","longName":"PERS_FAM_FACTG_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5A917BD5-EB8C-3B18-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-10-31","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-10-31","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":"Curated with permission from Dr. David Cella for use by CCR to capture FACT-G (v4.0) data in C3D.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2796647","version":"1","preferredName":"Person Friend Emotion Support FACT-G Questionnaire Scale Score","preferredDefinition":"Numeric score from the scale used by FACT-G Quality of Life questionnaire to assess a person's feeling of receiving emotional support from friends. [Manually-curated]","longName":"PERS_FRD_FACTG_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5A90B9B9-8B91-4505-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-10-31","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-10-31","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":"Curated with permission from Dr. David Cella for use by CCR to capture FACT-G (v4.0) data in C3D.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2796654","version":"1","preferredName":"Person Condition Family Accepted FACT-G Questionnaire Scale Score","preferredDefinition":"Numeric score from the scale used by FACT-G Quality of Life questionnaire to assess a person's feeling that family has accepted the individual's illness. [Manually-curated]","longName":"PERS_FAM_AC_FACTG_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5A925035-0DBB-604D-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-10-31","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-10-31","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":"Curated with permission from Dr. David Cella for use by CCR to capture FACT-G (v4.0) data in C3D.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2796665","version":"1","preferredName":"Person Satisfaction Condition Family Communication FACT-G Questionnaire Scale Score","preferredDefinition":"Numeric score from the scale used by FACT-G Quality of Life questionnaire to assess a person's feeling of satisfaction with family communication about the individual's illness. [Manually-curated]","longName":"PERS_COMM_FACTG_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5A91C323-980A-00EF-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-10-31","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-10-31","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":"Curated with permission from Dr. David Cella for use by CCR to capture FACT-G (v4.0) data in C3D.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2796670","version":"1","preferredName":"Person Main Support Relationship FACT-G Questionnaire Scale Score","preferredDefinition":"Numeric score from the scale used by FACT-G Quality of Life questionnaire to assess a person's feeling of closeness to the individual's partner (or main support). [Manually-curated]","longName":"PERS_SUPP_FACTG_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5A91E368-3A66-05F8-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-10-31","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-10-31","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":"Curated with permission from Dr. David Cella for use by CCR to capture FACT-G (v4.0) data in C3D.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2796681","version":"1","preferredName":"Person Sex Behavior Satisfaction FACT-G Questionnaire Scale Score","preferredDefinition":"Numeric score from the scale used by FACT-G Quality of Life questionnaire to assess a person's feeling of satisfaction with the individual's sex life. [Manually-curated]","longName":"PERS_SX_BH_FACTG_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5A9331EE-9E16-1505-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-10-31","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-10-31","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":"Curated with permission from Dr. David Cella for use by CCR to capture FACT-G (v4.0) data in C3D.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2797461","version":"1","preferredName":"Person Sadness Occurrence FACT-G Questionnaire Scale Score","preferredDefinition":"Numeric score from the scale used by FACT-G Quality of Life questionnaire to assess a person's feeling of sadness. [Manually-curated]","longName":"PERS_SAD_FACTG_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"5AE4146B-3013-1FAC-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-11-04","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-11-04","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":"Curated with permission of author, Dr. David Cella, to use as part of the FACT-G tool in a CCR protocol","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2797465","version":"1","preferredName":"Person Satisfaction Illness Coping FACT-G Questionnaire Scale Score","preferredDefinition":"Numeric score from the scale used by FACT-G Quality of Life questionnaire to assess a person's feeling of satisfaction associated with coping with illness. [Manually-curated]","longName":"PERS_SAT_FACTG_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"5AE443F5-57AC-667E-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-11-04","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-11-04","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":"Curated with permission of author, Dr. David Cella, to use as part of the FACT-G tool in a CCR protocol","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2797550","version":"1","preferredName":"Person Hopelessness Disease Activity FACT-G Questionnaire Scale Score","preferredDefinition":"Numeric score from the scale used by FACT-G Quality of Life questionnaire to assess a person's feeling of losing hope in the fight against an illness. [Manually-curated]","longName":"PERS_HOPELN_FACTG_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"5AEF7FE8-A189-4311-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-11-05","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-11-05","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":"Curated with permission of author, Dr. David Cella, to use as part of the FACT-G tool in a CCR protocol","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2797555","version":"1","preferredName":"Person Nervous Occurrence FACT-G Questionnaire Scale Score","preferredDefinition":"Numeric score from the scale used by FACT-G Quality of Life questionnaire to assess a person's feeling of nervousness. [Manually-curated]","longName":"PERS_NERV_FACTG_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"5AEE9EAA-B895-496F-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-11-05","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-11-05","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":"Curated with permission of author, Dr. David Cella, to use as part of the FACT-G tool in a CCR protocol","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2797559","version":"1","preferredName":"Person Anxiety Death FACT-G Questionnaire Scale Score","preferredDefinition":"Numeric score from the scale used by FACT-G Quality of Life questionnaire to assess a person's worry about dying. [Manually-curated]","longName":"PERS_DTH_FACTG_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"5AEEDC47-903B-5607-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-11-05","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-11-05","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":"Curated with permission of author, Dr. David Cella, to use as part of the FACT-G tool in a CCR protocol","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2797564","version":"1","preferredName":"Person Anxiety Worse Condition FACT-G Questionnaire Scale Score","preferredDefinition":"Numeric score from the scale used by FACT-G Quality of Life questionnaire to assess a person's worry that the individual's condition will get worse. [Manually-curated]","longName":"PERS_WOR_FACTG_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"5AEEFF42-5807-5CC1-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-11-05","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-11-05","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":"Curated with permission of author, Dr. David Cella, to use as part of the FACT-G tool in a CCR protocol","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2797712","version":"1","preferredName":"Person Ability Work FACT-G Questionnaire Scale Score","preferredDefinition":"Numeric score from the scale used by FACT-G Quality of Life questionnaire to assess a person's ability to work, including work at home. [Manually-curated]","longName":"PERS_WK_FACTG_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5AF70CD0-B6D0-517D-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-11-05","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-11-05","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":"Curated with permission of the author, Dr. David Cella, to be used to create the FACT-G tool for a CCR trial.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2797720","version":"1","preferredName":"Person Work Satisfaction FACT-G Questionnaire Scale Score","preferredDefinition":"Numeric score from the scale used by FACT-G Quality of Life questionnaire to assess a person's feeling that work (including work at home) is fulfilling. [Manually-curated]","longName":"PERS_SAT_WK_FACTG_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5AF77F3F-D035-6469-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-11-05","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-11-05","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":"Curated with permission of the author, Dr. David Cella, to be used to create the FACT-G tool for a CCR trial.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2797882","version":"1","preferredName":"Person Ability Life Appreciation FACT-G Questionnaire Scale Score","preferredDefinition":"Numeric score from the scale used by FACT-G Quality of Life questionnaire to assess a person's ability to enjoy life. [Manually-curated]","longName":"PERS_APP_LF_FACTG_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5B077770-FB35-300C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-11-06","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-11-06","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":"Curated with permission of the author, Dr. David Cella, to be used to create the FACT-G tool for a CCR trial.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2797887","version":"1","preferredName":"Person Condition Accepted FACT-G Questionnaire Scale Score","preferredDefinition":"Numeric score from the scale used by FACT-G Quality of Life questionnaire to assess a person's acceptance of the individual's illness. [Manually-curated]","longName":"PERS_ACCD_FACTG_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5B06A507-F41E-3992-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-11-06","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-11-06","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":"Curated with permission of the author, Dr. David Cella, to be used to create the FACT-G tool for a CCR trial.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2797893","version":"1","preferredName":"Person Positive Sleep Activity FACT-G Questionnaire Scale Score","preferredDefinition":"Numeric score from the scale used by FACT-G Quality of Life questionnaire to assess a person is sleeping well. [Manually-curated]","longName":"PERS_SLP_FACTG_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5B06E3A7-2E42-43F7-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-11-06","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-11-06","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":"Curated with permission of the author, Dr. David Cella, to be used to create the FACT-G tool for a CCR trial.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2797902","version":"1","preferredName":"Person Enjoyment of Life Activity FACT-G Questionnaire Scale Score","preferredDefinition":"Numeric score from the scale used by FACT-G Quality of Life questionnaire to assess a person's enjoyment of the things ususally done for fun. [Manually-curated]","longName":"PERS_ENJ_FACTG_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5B0815BD-E400-4EED-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-11-06","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-11-06","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":"Curated with permission of the author, Dr. David Cella, to be used to create the FACT-G tool for a CCR trial.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2797913","version":"1","preferredName":"Person Current Satisfaction Quality of Life FACT-G Questionnaire Scale Score","preferredDefinition":"Numeric score from the scale used by FACT-G Quality of Life questionnaire to assess a person's current level of satisfaction with quality of life. [Manually-curated]","longName":"PERS_QOL_FACTG_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5B083F50-C1B2-56BC-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-11-06","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-11-06","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":"Curated with permission of the author, Dr. David Cella, to be used to create the FACT-G tool for a CCR trial.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2806413","version":"1","preferredName":"Pediatric Quality of Life Assessment Total Score","preferredDefinition":"Numeric value for the total score on the Pediatric Quality of Life Inventory (PedsQL) for healthy children and adolescents, computed from four scales, and 23 total items. [Manually-curated]","longName":"PEDSQL_TTL_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5CF30AD2-3379-5F6A-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-11-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-11-30","modifiedBy":"TSESU","dateModified":"2017-08-29","changeNote":"Curated for ETIB CCR trial.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2806422","version":"2","preferredName":"Lung Function Outcome Score","preferredDefinition":"Numeric value representing an individual's Total Lung Function Score (LFS), computed by the extent of FEV1 and DLCO compromise.","longName":"LUNG_FUNCT_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"720AFF64-7084-AF2C-E040-BB89AD435A74","latestVersionIndicator":"Yes","beginDate":"2009-08-26","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-08-26","modifiedBy":"PANH","dateModified":"2015-08-01","changeNote":"CDE v2.0 created based on NCI CCR additional information that required increased field length and change in upper and lower boundaries of VD.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2807549","version":"1","preferredName":"Activity Scale Child Performance Assessment Score","preferredDefinition":"Numeric score for the Performance version of the Activity Scale for Kids, a generic self-report measure to describe and evaluate changes in the level of daily life in children 5-15 years of age. [Manually-curated]","longName":"ASK_PERF_ASSESS_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"5D0BC5C1-1322-6A6B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-12-02","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-12-02","modifiedBy":"REEVESD","dateModified":"2015-03-07","changeNote":"Curated for CCR ETIB trial in C3D.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2807551","version":"1","preferredName":"Activity Scale Child Capability Assessment Score","preferredDefinition":"Numeric score for the Capability version of the Activity Scale for Kids, a generic self-report measure to describe and evaluate changes in the level of daily life in children 5-15 years of age. [Manually-curated]","longName":"ASK_CAP_ASSESS_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"5D0BF570-7BCD-72AC-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-12-02","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-12-02","modifiedBy":"REEVESD","dateModified":"2015-03-07","changeNote":"Curated for CCR ETIB trial in C3D.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2807559","version":"3","preferredName":"Person Integer::6 Minute Walking Distance International Foot Value","preferredDefinition":"Numeric value for the number of feet walked by an individual in 6 minutes.","longName":"PERS_6_MIN_DIST_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8D2DCC6D-2235-9273-E040-BB89AD432A8F","latestVersionIndicator":"Yes","beginDate":"2010-08-06","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-08-06","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":"Curated for CCR ETIB trial in C3D.  Replaces v2.0 with two decimal places.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2807564","version":"2","preferredName":"Person Integer::2 Minute Walking Distance International Foot Value","preferredDefinition":"Numeric value for the number of feet walked by an individual in 2 minutes.","longName":"PERS_2_MIN_DIST_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8D64A02E-C8C0-A740-E040-BB89AD434412","latestVersionIndicator":"Yes","beginDate":"2008-12-02","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-08-09","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":"Curated for CCR ETIB trial in C3D. v2.0 replaces v1.0 with VD that has two decimals.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2807572","version":"2","preferredName":"Person Dominant Hand Grip Pressure Pound per Square Inch Value","preferredDefinition":"Numeric value to represent the grip strength in the dominant hand for an individual measured as number of pounds per square inch (psi).","longName":"DOM_HD_GRP_PSI_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8D2B9E37-8915-431F-E040-BB89AD435B56","latestVersionIndicator":"Yes","beginDate":"2010-08-06","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-08-06","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":"Curated for CCR ETIB trial in C3D. v2.0 replaces v1.0 with two decimals in VD","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2821360","version":"1","preferredName":"Composite Color Assessment Index Skin Lesion Severity Ratio Category","preferredDefinition":"Response using three consecutive Minolta colorimeter measurements at each site of skin disease, with readings from index lesions and adjacent clinically uninvolved skin compared to determine disease response. [Manually-curated]","longName":"COL_INDX_SKN_RTO_CAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"5FBD8385-730D-AB11-E040-BB89AD435F76","latestVersionIndicator":"Yes","beginDate":"2009-01-05","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-01-05","modifiedBy":"REEVESD","dateModified":"2015-05-19","changeNote":"Curated to support protocol 07C0013 in CCR","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2827625","version":"1","preferredName":"Person Transplantation Sequence Count","preferredDefinition":"Numeric value to represent the sequence of an individual's transplantation procedure.","longName":"PERS_TXPLT_SEQ_CT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"60FCB3E3-1D3A-6C38-E040-BB89AD431D10","latestVersionIndicator":"Yes","beginDate":"2009-01-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-01-21","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":"Curated to support Transplantation protocol in CCR 2/2009.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2827627","version":"1","preferredName":"Prior BMSCT Administered Transplant Count","preferredDefinition":"The number of transplant procedures the participant has received prior to enrollment on a trial.","longName":"PRIOR_BMSCT_TXPLT_CT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"60FCB3E3-1DC7-6C38-E040-BB89AD431D10","latestVersionIndicator":"Yes","beginDate":"2009-01-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-01-21","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":"Curated to support Transplantation protocol in CCR 2/2009.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2829693","version":"2","preferredName":"HLA Typing Mismatch Gene Location Name","preferredDefinition":"Name of antigen to indicate the location of HLA mismatch.","longName":"HLA_MSMCH_ANTG_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"DA94592A-7037-53A1-E040-BB89AD43015B","latestVersionIndicator":"Yes","beginDate":"2009-01-26","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-04-17","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"v2.0 replaces v1.0 of this CDE with an extended VD field from 2 to 6 characters.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2829701","version":"1","preferredName":"Current Transplantation Disease Status","preferredDefinition":"Text term to represent the current status of the participant's underlying disease.","longName":"CURR_TXPLT_DZ_STAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"61694C36-3609-DC55-E040-BB89AD43020E","latestVersionIndicator":"Yes","beginDate":"2009-01-26","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-01-26","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":"Curated to support Transplantation protocol in CCR 2/2009.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2829785","version":"1","preferredName":"Disease Or Secondary Neoplasm Chronic Graft Versus Host Disease Diagnosis Indicator","preferredDefinition":"Text term to signfiy whether a participant had underlying disease or a second malignancy present at the time of chronic Graft versus Host Disease (cGVHD) diagnosis.","longName":"SEC_MALIG_CGVHD_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"616FA566-B7B7-2870-E040-BB89AD434025","latestVersionIndicator":"Yes","beginDate":"2009-01-26","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-01-26","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":"Curated to support Transplantation protocol in CCR 2/2009.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2829792","version":"1","preferredName":"Person Transplantation Risk Category","preferredDefinition":"Group designation for a participant to represent the amount of risk associated with a transplantation procedure.","longName":"PERS_TXPLT_RISK_CAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"616FA566-B86C-2870-E040-BB89AD434025","latestVersionIndicator":"Yes","beginDate":"2009-01-26","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-01-26","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":"Curated to support Transplantation protocol in CCR 2/2009.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2829798","version":"1","preferredName":"Person Derivation Age At Transplantation Value","preferredDefinition":"Computed value for a person's age at the time of a transplant, based on date of birth and date of the transplantation procedure.","longName":"DER_AGE_TXPLT_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"617023FE-C044-EADF-E040-BB89AD432D2C","latestVersionIndicator":"Yes","beginDate":"2009-01-26","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-01-26","modifiedBy":"KUMMEROA","dateModified":"2022-09-29","changeNote":"Curated to support Transplantation protocol in CCR 2/2009.","administrativeNotes":"2022.9.29 AQT added for ticket request CADSR0001559.ak","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2831388","version":"1","preferredName":"Lung Function Outcome Category","preferredDefinition":"Classification of lung function based on the score of the FEV1 and DLCO assessment.","longName":"LUNG_FUNCT_OUTC_CAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6207FA57-2D28-ABF8-E040-BB89AD435A4E","latestVersionIndicator":"Yes","beginDate":"2009-02-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-02-03","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":"Curated to support Tranplantion protocol from CCR.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2848669","version":"1","preferredName":"Short Form Brief Pain Inventory Complete Indicator","preferredDefinition":"Text term to signify whether the Brief Pain Inventory short form, consisting of nine questions, has been completed.","longName":"SHORT_BPI_COM_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"653C12C5-D771-36C9-E040-BB89AD437BC5","latestVersionIndicator":"Yes","beginDate":"2009-03-16","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-03-16","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":"Curated for CCR protocol 3/2009.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2848671","version":"1","preferredName":"Long Form Brief Pain Inventory Complete Indicator","preferredDefinition":"Text term to signify whether the Brief Pain Inventory long form, consisting of 32 questions, has been completed.","longName":"LONG_BPI_COM_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"653C12C5-D79C-36C9-E040-BB89AD437BC5","latestVersionIndicator":"Yes","beginDate":"2009-03-16","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-03-16","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":"Curated for CCR protocol 3/2009.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2848676","version":"1","preferredName":"Dermatology Life Quality Index Complete Indicator","preferredDefinition":"Text term to signify that the Dermatology Life Quality Index tool, with 10 items, was completed.","longName":"DERM_LIFQUALIDX_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"653C70E1-78A8-0355-E040-BB89AD432F5B","latestVersionIndicator":"Yes","beginDate":"2009-03-16","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-03-16","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":"Curated for CCR protocol 3/2009.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2848689","version":"1","preferredName":"Pain Assessment Visual Analog Scale Score","preferredDefinition":"Text term that an individual chooses to self-describe a feeling of pain.","longName":"PAIN_ASSESS_VAS_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"653C70E1-79ED-0355-E040-BB89AD432F5B","latestVersionIndicator":"Yes","beginDate":"2009-03-16","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-03-16","modifiedBy":"PRICEA","dateModified":"2013-10-23","changeNote":"Curated for CCR protocol 3/2009.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2848726","version":"1","preferredName":"Patient Global Change Impression Measurement Category","preferredDefinition":"Classificiation of the response of an individual to a question of how their status has changed since the start of the clinical trial/study.","longName":"PT_GLOB_CHG_IMP_CAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"653E57B7-CC87-A979-E040-BB89AD436FB1","latestVersionIndicator":"Yes","beginDate":"2009-03-16","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-03-16","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":"Curated for CCR protocol 3/2009.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2848839","version":"1","preferredName":"Protocol Ice Application Timepoint Category","preferredDefinition":"Text term to signify if an event(s) has/have occurred prior to or after the application of ice to an individual.","longName":"PROT_ICEAPP_TMPT_CAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"653F7EDE-A1F6-268E-E040-BB89AD4345A6","latestVersionIndicator":"Yes","beginDate":"2009-03-16","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-03-16","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":"Curated for CCR protocol 3/2009.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2854865","version":"1","preferredName":"Acute Graft Versus Host Disease Late Occurrence Indicator","preferredDefinition":"Text term to signify whether an individual has features of late acute Graft vs. Host Disease (GVHD), such as vomiting, diarrhea, erythematous skin.","longName":"AGVHD_LT_OCURS_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"65C9E4D1-CBE0-C2BB-E040-BB89AD430C4B","latestVersionIndicator":"Yes","beginDate":"2009-03-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-03-23","modifiedBy":"REEVESD","dateModified":"2015-03-07","changeNote":"Curated to support CCR Transplant study 08C0097.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2854873","version":"1","preferredName":"Chronic Graft Versus Host Disease Diagnosis Severity Type","preferredDefinition":"Text term to describe the intensity or severity of chronic Graft vs. Host Disease (GVHD) organ involvement at the time of diagnosis.","longName":"CGVHD_DX_SVRTY_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"65C9E4D1-CC5C-C2BB-E040-BB89AD430C4B","latestVersionIndicator":"Yes","beginDate":"2009-03-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-03-23","modifiedBy":"MAESKEB","dateModified":"2022-03-31","changeNote":"Curated to support CCR Transplant study 08C0097.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2854875","version":"1","preferredName":"Chronic Graft Versus Host Disease Skin Involvement Body Surface Area Value","preferredDefinition":"Numeric value to represent the percentage (%) of skin involvement in a chronic Graft vs. Host Disease (GVHD) assessment of an individual.","longName":"CGVHD_SK_INV_BSA_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"65C9E4D1-CC7B-C2BB-E040-BB89AD430C4B","latestVersionIndicator":"Yes","beginDate":"2009-03-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-03-23","modifiedBy":"REEVESD","dateModified":"2015-05-19","changeNote":"Curated to support CCR Transplant study 08C0097.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2854883","version":"1","preferredName":"Chronic Graft Versus Host Disease Skin Ulcer Assessment Anatomic Site Specify","preferredDefinition":"Text description of the anatomic location of chronic Graft vs. Host Disease (GVHD) skin ulcer(s).","longName":"CGVHD_ULC_SITE_TXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"65CB0AFD-887B-979B-E040-BB89AD432753","latestVersionIndicator":"Yes","beginDate":"2009-03-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-03-23","modifiedBy":"REEVESD","dateModified":"2015-05-19","changeNote":"Curated to support CCR Transplant study 08C0097.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2854921","version":"1","preferredName":"Chronic Graft Versus Host Disease Skin Ulcer Size Longest Measurement Value","preferredDefinition":"Numeric value to represent the dimension of the largest ulceration lesion in an individual with chronic Graft vs. Host Disease (GVHD) as measured in centimeters.","longName":"CGVHD_ULC_LG_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"65CB5B31-DECD-774D-E040-BB89AD433143","latestVersionIndicator":"Yes","beginDate":"2009-03-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-03-23","modifiedBy":"REEVESD","dateModified":"2015-05-19","changeNote":"Curated to support CCR Transplant study 08C0097.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2854938","version":"1","preferredName":"Chronic Graft Versus Host Disease Eye Wetting Assessment Outcome","preferredDefinition":"Value to represent the number of millimeters of wetting per eye of an individual with chronic Graft vs. Host Disease (GVHD), or the alternative result of an eye wetting assessment.","longName":"CGVHD_EYE_WET_OUTC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"65CB5B31-DF99-774D-E040-BB89AD433143","latestVersionIndicator":"Yes","beginDate":"2009-03-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-03-23","modifiedBy":"REEVESD","dateModified":"2015-05-19","changeNote":"Curated to support CCR Transplant study 08C0097.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2855026","version":"1","preferredName":"Chronic Graft Versus Host Disease Oral Cavity Mucosa Change Category","preferredDefinition":"Text category to signify the intensity of changes in erythema, lichenoid or mucoceles in the oral cavity mucosa for an individual with chronic Graft vs. Host Disease (GVHD).","longName":"CGVHD_MUC_CHG_CAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"65CCDBF3-40F5-57E0-E040-BB89AD432F3B","latestVersionIndicator":"Yes","beginDate":"2009-03-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-03-23","modifiedBy":"REEVESD","dateModified":"2015-05-19","changeNote":"Curated to support CCR Transplant study 08C0097.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2855033","version":"1","preferredName":"Chronic Graft Versus Host Disease Oral Cavity Mucosa Ulcer Change Category","preferredDefinition":"Text classification of changes in oral mucosa lesions measured in an individual with chronic Graft vs. Host Disease (GVHD).","longName":"CGVHD_ULC_CHG_CAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"65CCDBF3-41B6-57E0-E040-BB89AD432F3B","latestVersionIndicator":"Yes","beginDate":"2009-03-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-03-23","modifiedBy":"REEVESD","dateModified":"2015-05-19","changeNote":"Curated to support CCR Transplant study 08C0097.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2855037","version":"1","preferredName":"Chronic Graft Versus Host Disease Oral Cavity Change Total Score","preferredDefinition":"Numeric value to represent the total score assigned for all mucosal changes in an individual with chronic Graft vs. Host Disease (GVHD).","longName":"CGVHD_MUC_CHG_TTL_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"65CD6107-C322-D642-E040-BB89AD430A37","latestVersionIndicator":"Yes","beginDate":"2009-03-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-03-23","modifiedBy":"REEVESD","dateModified":"2015-05-19","changeNote":"Curated to support CCR Transplant study 08C0097.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2855056","version":"1","preferredName":"Chronic Graft Versus Host Disease Severity Score","preferredDefinition":"Numeric value that represents the global rating or score for the intensity or severity of an individual's chronic Graft vs. Host Disease (GVHD).","longName":"CGVHD_SVRTY_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"65CCDBF3-43B0-57E0-E040-BB89AD432F3B","latestVersionIndicator":"Yes","beginDate":"2009-03-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-03-23","modifiedBy":"SBR","dateModified":"2016-11-20","changeNote":"Curated to support CCR Transplant study 08C0097.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2855066","version":"1","preferredName":"Chronic Graft Versus Host Disease Severity Global Rating Score","preferredDefinition":"Numeric value to represent the health care provider's global score for severity of an individual's chronic Graft vs. Host Disease (GVHD) using a 0 to 10 point scale.","longName":"CGVHD_SCRTY_GLOB_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"65CE19B1-0DE6-3B64-E040-BB89AD437B15","latestVersionIndicator":"Yes","beginDate":"2009-03-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-03-23","modifiedBy":"REEVESD","dateModified":"2015-05-19","changeNote":"Curated to support CCR Transplant study 08C0097.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2855082","version":"1","preferredName":"Past Month Chronic Graft Versus Host Disease Severity Global Rating Score","preferredDefinition":"Health Care Provider global rating score to describe the status of an individual with chronic Graft vs. Host Disease (GVHD) as compared to the previous month.","longName":"MON_CGVHD_GLOB_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"65CE19B1-0F6F-3B64-E040-BB89AD437B15","latestVersionIndicator":"Yes","beginDate":"2009-03-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-03-23","modifiedBy":"PRICEA","dateModified":"2013-10-28","changeNote":"Curated to support CCR Transplant study 08C0097.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2855122","version":"1","preferredName":"Patient Self-Report Chronic Graft Versus Host Disease Severity Symptom Score","preferredDefinition":"Numeric value to represent the result of a patient-reported assessment of the severity of chronic Graft vs. Host Disease (GVHD) symptoms that includes but is not limited to skin itching, mouth dryness, mouth pain, mouth sensitivity, skin and/or joint tightening and genital discomfort when measured on a ten (10) point scale (with '0' as none to '10' being as bad as the individual can imagine).","longName":"SLFREP_CGVHD_GLOB_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"65D971B9-7573-F4A9-E040-BB89AD435996","latestVersionIndicator":"Yes","beginDate":"2009-03-24","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-03-24","modifiedBy":"SBR","dateModified":"2016-09-21","changeNote":"Curated to support CCR Transplant study 08C0097.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2855127","version":"1","preferredName":"Chronic Graft Versus Host Disease Patient Self-Report Main Eye Problem Text","preferredDefinition":"Text to describe the self-described main complaint of an individual with chronic Graft vs. Host Disease (GVHD) in regard to eyes.","longName":"CGVHD_SLFREP_EYE_TXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"65D971B9-75B9-F4A9-E040-BB89AD435996","latestVersionIndicator":"Yes","beginDate":"2009-03-24","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-03-24","modifiedBy":"REEVESD","dateModified":"2015-05-19","changeNote":"Curated to support CCR Transplant study 08C0097.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2855142","version":"1","preferredName":"Chronic Graft Versus Host Disease Patient Self-Report Main Eye Problem Score","preferredDefinition":"Numeric value to represent self-reported severity of eye symptoms for an individual with chronic Graft vs. Host Disease (GVHD) using a ten (10) point scale (with '0' being not at all severe to '10' being most severe).","longName":"CGVHD_SLFREP_EYE_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"65D971B9-75D8-F4A9-E040-BB89AD435996","latestVersionIndicator":"Yes","beginDate":"2009-03-24","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-03-24","modifiedBy":"REEVESD","dateModified":"2015-05-19","changeNote":"Curated to support CCR Transplant study 08C0097.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2855147","version":"1","preferredName":"Chronic Graft Versus Host Disease Vulva Vagina Symptom Indicator","preferredDefinition":"Text term to signify any self-reported vulvovaginal symptoms such as burning, pain, or discomfort in the vagina, labia or vulva, or any discomfort or pain during sexual intercourse, in an individual with chronic Graft vs. Host Disease (GVHD).","longName":"CGVHD_VULVAG_SX_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"65D971B9-761D-F4A9-E040-BB89AD435996","latestVersionIndicator":"Yes","beginDate":"2009-03-24","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-03-24","modifiedBy":"REEVESD","dateModified":"2015-05-19","changeNote":"Curated to support CCR Transplant study 08C0097.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2855165","version":"1","preferredName":"Chronic Graft Versus Host Disease Patient Self-Report Severity  Score","preferredDefinition":"Numeric value that represents the global rating or score for the self-reported intensity or severity of an individual's chronic Graft vs. Host Disease (GVHD).","longName":"CGVHD_SLFRP_SVRTY_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"65DA3867-66B3-4479-E040-BB89AD4367E8","latestVersionIndicator":"Yes","beginDate":"2009-03-24","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-03-24","modifiedBy":"REEVESD","dateModified":"2015-05-19","changeNote":"Curated to support CCR Transplant study 08C0097.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2855167","version":"1","preferredName":"Chronic Graft Versus Host Disease Patient Self-Report Severity Global Rating Score","preferredDefinition":"Numeric value to represent the self-reported global score for severity of an individual's chronic Graft vs. Host Disease (GVHD) using a 0 to 10 point scale.","longName":"CGVHD_SLFRP_GLOB_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"65DA3867-66D2-4479-E040-BB89AD4367E8","latestVersionIndicator":"Yes","beginDate":"2009-03-24","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-03-24","modifiedBy":"REEVESD","dateModified":"2015-05-19","changeNote":"Curated to support CCR Transplant study 08C0097.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2855173","version":"1","preferredName":"Past Month Patient Self-Report Chronic Graft Versus Host Disease Severity Global Rating Score","preferredDefinition":"Self-reported global rating score to describe the status of an individual with chronic Graft vs. Host Disease (GVHD) as compared to the previous month.","longName":"MON_SLFRP_CGVHD_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"65DA3867-6734-4479-E040-BB89AD4367E8","latestVersionIndicator":"Yes","beginDate":"2009-03-24","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-03-24","modifiedBy":"PRICEA","dateModified":"2013-10-25","changeNote":"Curated to support CCR Transplant study 08C0097.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2861124","version":"1","preferredName":"Patient Assessment Current Pain Score","preferredDefinition":"Numeric value to represent an individual's self-reported level of pain or discomfort at a specific point in time.","longName":"PT_CURR_PN_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"67951008-7A64-3A66-E040-BB89AD433990","latestVersionIndicator":"Yes","beginDate":"2009-04-15","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-04-15","modifiedBy":"PRICEA","dateModified":"2013-10-25","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2876795","version":"1","preferredName":"Acute Graft Versus Host Disease Resolution Prior Chronic Graft Versus Host Disease Onset Indicator","preferredDefinition":"Text term to signify whether acute graft versus host disease (aGVHD) resolved prior to the onset of chronic graft versus host disease (cGVHD).","longName":"AGVHD_RES_CGVHD_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"69F73041-E1D8-F2E5-E040-BB89AD431A19","latestVersionIndicator":"Yes","beginDate":"2009-05-15","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-05-15","modifiedBy":"REEVESD","dateModified":"2015-03-07","changeNote":"Curated to support CCR ETIB study.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2876820","version":"1","preferredName":"Pulmonary Or Systemic Viral Infection Integer::90 Day Post Bone Marrow Transplant Indicator","preferredDefinition":"Text term to signify the presence of pulmonary infection or systemic viral infection in the first 90 days post bone marrow transplantation (BMT).","longName":"PULM_INF_90D_BMT_INF","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"69F73041-E33B-F2E5-E040-BB89AD431A19","latestVersionIndicator":"Yes","beginDate":"2009-05-15","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-05-15","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":"Curated to support CCR ETIB study.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2876822","version":"1","preferredName":"Pulmonary Or Systemic Viral Infection Integer::90 Day Post Bone Marrow Transplant Text","preferredDefinition":"Text to describe virus(es) identified in pulmonary infections or systemic infections diagnosed 90 days post bone marrow transplantation.","longName":"PULM_INF_90D_BMT_TXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"69F73041-E35A-F2E5-E040-BB89AD431A19","latestVersionIndicator":"Yes","beginDate":"2009-05-15","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-05-15","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":"Curated to support CCR ETIB study.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2876891","version":"1","preferredName":"Active Or Recurrent Cytomegalovirus Integer::90 Day Post Bone Marrow Transplant Indicator","preferredDefinition":"Text term to signify whether any cytomegalovirus (CMV) disease or evidence of reactivation occurred 90 days post bone marrow transplantation.","longName":"CMV_INF_90D_BMT_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"69F85638-E4A5-0F05-E040-BB89AD432E33","latestVersionIndicator":"Yes","beginDate":"2009-05-15","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-05-15","modifiedBy":"REEVESD","dateModified":"2015-03-07","changeNote":"Curated to support CCR ETIB study.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2880382","version":"1","preferredName":"Acute Graft Versus Host Disease Biopsy Proven Indicator","preferredDefinition":"Text term to signify biopsy-based verification of a diagnosis of acute Graft vs. Host Disease (GVHD).","longName":"AGVHD_BX_PROV_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"6A68620E-7CE8-4CDA-E040-BB89AD4307CD","latestVersionIndicator":"Yes","beginDate":"2009-05-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-05-21","modifiedBy":"KUMMEROA","dateModified":"2022-07-25","changeNote":"Curated to support CCR ETIB protocol.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2898464","version":"1","preferredName":"Third National Health and Nutrition Examination Survey Computated Value Text","preferredDefinition":"A computed value intended for use as a reference to interpret the results of pulmonary function tests/spirometry testing; the NHANES III value is a reference that is compared to the results of a subject's testing in order to derive percentage of expected values for pulmonary function testing.","longName":"NHANESIII_VAL_TXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6B9F4103-AA44-7F7B-E040-BB89AD4306D5","latestVersionIndicator":"Yes","beginDate":"2009-06-05","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-06-05","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":"Curated to support CCR use of C3D.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2901644","version":"1","preferredName":"Lab Procedure Preference Unit of Measure Name","preferredDefinition":"Preferred unit of measure (UOM) for a laboratory test result, per NCI standards or per protocol specification.","longName":"LAB_PROC_PREF_UOM_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6C691C28-59FB-198E-E040-BB89AD43066E","latestVersionIndicator":"Yes","beginDate":"2009-06-15","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-06-15","modifiedBy":"HAMMA","dateModified":"2016-05-17","changeNote":"Supports C3D lab test functionality.  Includes new version VD to correct a value meaning/value meaning description error in the previous VD version.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2922102","version":"2","preferredName":"Acquired Immunodeficiency Syndrome Systemic Illness Stage","preferredDefinition":"Value to represent the extent of the deficiency of cellular immunity caused by the human immunodeficiency virus (HIV) as characterized by the occurrence of systemic illness and changes in overall health.","longName":"AIDS_SYS_ILL_STG","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"BCB5619C-8F29-3686-E040-BB89AD43356C","latestVersionIndicator":"Yes","beginDate":"2009-07-24","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-04-02","modifiedBy":"REEVESD","dateModified":"2015-03-07","changeNote":"Curated for CCR Intramural trial. v2.0 replaces v1.0 with a Value domain and value set that have been reworked","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2922104","version":"1","preferredName":"Acquired Immunodeficiency Syndrome Immune Stage","preferredDefinition":"Numeric value to represent the extent of the deficiency of cellular immunity caused by the human immunodeficiency virus (HIV) as characterized by change in CD4 count.","longName":"AIDS_IMM_STG","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"6F74F66D-0B47-6833-E040-BB89AD43171E","latestVersionIndicator":"Yes","beginDate":"2009-07-24","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-07-24","modifiedBy":"SOKKERL","dateModified":"2017-05-26","changeNote":"Curated for CCR Intramural trial.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2922106","version":"1","preferredName":"Acquired Immunodeficiency Syndrome Tumor Stage","preferredDefinition":"Value to represent the extent of the deficiency of cellular immunity caused by the human immunodeficiency virus (HIV) as characterized by the occurrence and anatomic location of sites of disease.","longName":"AIDS_TUM_STG","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"6F74B07E-A640-9C19-E040-BB89AD4373EA","latestVersionIndicator":"Yes","beginDate":"2009-07-24","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-07-24","modifiedBy":"SOKKERL","dateModified":"2017-05-26","changeNote":"Curated for CCR Intramural trial.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2932889","version":"1","preferredName":"Past Month Incomplete Empty Bladder Occurrence AUA Symptom Assessment Score","preferredDefinition":"Numeric value to signify how often over the past month a person had a sensation of not emptying the bladder completely before urination was finished.","longName":"P_MON_INC_BLAD_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"AUA:American Urological Association","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7156CAE9-35AD-266E-E040-BB89AD437B5C","latestVersionIndicator":"Yes","beginDate":"2009-08-17","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-08-17","modifiedBy":"PRICEA","dateModified":"2013-10-25","changeNote":"Curated for NCI CCR trial. The AUA Symptom Score is a measure of the American Urological Association.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2932891","version":"1","preferredName":"Past Month Urinary Frequency Occurrence AUA Symptom Assessment Score","preferredDefinition":"Numeric value to signify how often over the past month a person had to urinate again less than 2 hours after he/she finished urinating.","longName":"P_MON_UR_FREQ_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"AUA:American Urological Association","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7156CAE9-35CD-266E-E040-BB89AD437B5C","latestVersionIndicator":"Yes","beginDate":"2009-08-17","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-08-17","modifiedBy":"PRICEA","dateModified":"2013-10-25","changeNote":"Curated for NCI CCR trial. The AUA Symptom Score is a measure of the American Urological Association.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2932893","version":"1","preferredName":"Past Month Intermittent Urination Occurrence AUA Symptom Assessment Score","preferredDefinition":"Numeric value to signify how often over the past month a person found he/he had to stop and start again several times during urination.","longName":"P_MON_INT_UR_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"AUA:American Urological Association","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7156CAE9-35ED-266E-E040-BB89AD437B5C","latestVersionIndicator":"Yes","beginDate":"2009-08-17","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-08-17","modifiedBy":"PRICEA","dateModified":"2013-10-25","changeNote":"Curated for NCI CCR trial. The AUA Symptom Score is a measure of the American Urological Association.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2932895","version":"1","preferredName":"Past Month Urinary Urgency Occurrence AUA Symptom Assessment Score","preferredDefinition":"Numeric value to signify how often over the past month a person has found it difficult to postpone urination due to urinary urgency.","longName":"P_MON_UR_URG_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"AUA:American Urological Association","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7156CAE9-360D-266E-E040-BB89AD437B5C","latestVersionIndicator":"Yes","beginDate":"2009-08-17","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-08-17","modifiedBy":"PRICEA","dateModified":"2013-10-25","changeNote":"Curated for NCI CCR trial. The AUA Symptom Score is a measure of the American Urological Association.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2932897","version":"1","preferredName":"Past Month Weak Urination Occurrence AUA Symptom Assessment Score","preferredDefinition":"Numeric value to signify how often over the past month a person has noticed a weak urination stream.","longName":"P_MON_WK_UR_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"AUA:American Urological Association","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7156CAE9-362D-266E-E040-BB89AD437B5C","latestVersionIndicator":"Yes","beginDate":"2009-08-17","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-08-17","modifiedBy":"PRICEA","dateModified":"2013-10-25","changeNote":"Curated for NCI CCR trial. The AUA Symptom Score is a measure of the American Urological Association.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2932899","version":"1","preferredName":"Past Month Push Urination Occurrence AUA Symptom Assessment Score","preferredDefinition":"Numeric value to signify how often over the past month a person had to push or strain to begin urination.","longName":"P_MON_PSH_UR_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"AUA:American Urological Association","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7156CAE9-364D-266E-E040-BB89AD437B5C","latestVersionIndicator":"Yes","beginDate":"2009-08-17","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-08-17","modifiedBy":"PRICEA","dateModified":"2013-10-25","changeNote":"Curated for NCI CCR trial. The AUA Symptom Score is a measure of the American Urological Association.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2932908","version":"1","preferredName":"Past Month Nocturia Frequency Score","preferredDefinition":"Numeric value to represent how often over the past month did a person get up to urinate from bedtime until the time he/she got up in the morning.","longName":"P_MON_NOCT_FREQ_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"AUA:American Urological Association","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7156CAE9-3752-266E-E040-BB89AD437B5C","latestVersionIndicator":"Yes","beginDate":"2009-08-17","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-08-17","modifiedBy":"PRICEA","dateModified":"2013-10-25","changeNote":"Curated for NCI CCR trial. The AUA Symptom Score is a measure of the American Urological Association.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2935344","version":"1","preferredName":"Urinary System American Urological Association Symptom Assessment Total Score","preferredDefinition":"Numeric value for the compiled score of self-reported urinary system performance, function, quality, or ability as measured by the American Urological Association (AUA).","longName":"UR_SYS_AUA_SX_TTL_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"AUA:American Urological Association","workflowStatus":"RELEASED","registrationStatus":"Application","id":"71E7AA84-1655-26D8-E040-BB89AD43122A","latestVersionIndicator":"Yes","beginDate":"2009-08-24","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-08-24","modifiedBy":"PRICEA","dateModified":"2013-10-25","changeNote":"Curated for NCI CCR trial. The AUA Symptom Score is a measure of the American Urological Association.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2935359","version":"1","preferredName":"Quality of Life Urinary Symptom Score","preferredDefinition":"Text term to represent the subjective measurement of an individual's sense of well-being and ability to enjoy life in the presence of urinary symptoms.","longName":"QOL_UR_SX_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"AUA:American Urological Association","workflowStatus":"RELEASED","registrationStatus":"Application","id":"71E7905D-5264-F565-E040-BB89AD431A85","latestVersionIndicator":"Yes","beginDate":"2009-08-24","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-08-24","modifiedBy":"PRICEA","dateModified":"2013-10-25","changeNote":"Curated for NCI CCR trial. The AUA Symptom Score is a measure of the American Urological Association.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2935482","version":"1","preferredName":"Sex Behavior Quality of Life Erection Confidence Past Integer::6 Month Assessment Score","preferredDefinition":"Numeric entry that describes a man's confidence that he can achieve and maintain an erection.","longName":"SEX_QOL_ER_CO_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"71F38B8F-10FE-E0A6-E040-BB89AD431E31","latestVersionIndicator":"Yes","beginDate":"2009-08-25","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-08-25","modifiedBy":"PRICEA","dateModified":"2013-10-25","changeNote":"Curated for NCI CCR trial.  The SHIM is a tool to assess ED (Erectile Dysfunction) in males, and is based on a past six months assessment.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2935502","version":"1","preferredName":"Sex Behavior Quality of Life Erection Sufficient Penetration Past Integer::6 Month Assessment Score","preferredDefinition":"Numeric entry that describes a man's assessment of how often his erections were sufficient for penetration.","longName":"SEX_QOL_ER_PEN_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"71F38B8F-1245-E0A6-E040-BB89AD431E31","latestVersionIndicator":"Yes","beginDate":"2009-08-25","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-08-25","modifiedBy":"PRICEA","dateModified":"2013-10-25","changeNote":"Curated for NCI CCR trial.  The SHIM is a tool to assess ED (Erectile Dysfunction) in males, and is based on a past six months assessment.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2935509","version":"1","preferredName":"Sex Behavior Quality of Life Erection Maintenance Past Integer::6 Month Assessment Score","preferredDefinition":"Numeric entry to describe a man's assessment of how often he is able to maintain an erection after penetration of his partner.","longName":"SEX_QOL_ER_MAN_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"71F38B8F-130C-E0A6-E040-BB89AD431E31","latestVersionIndicator":"Yes","beginDate":"2009-08-25","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-08-25","modifiedBy":"PRICEA","dateModified":"2013-10-25","changeNote":"Curated for NCI CCR trial.  The SHIM is a tool to assess ED (Erectile Dysfunction) in males, and is based on a past six months assessment.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2935517","version":"1","preferredName":"Sex Behavior Quality of Life Erection Maintenance Difficulty Past Integer::6 Month Assessment Score","preferredDefinition":"Numeric entry that describes a man's assessment of how often it was to maintain an erection to completion of intercourse.","longName":"SEX_QOL_MAN_DIF_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"71F38B8F-1410-E0A6-E040-BB89AD431E31","latestVersionIndicator":"Yes","beginDate":"2009-08-25","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-08-25","modifiedBy":"PRICEA","dateModified":"2013-10-25","changeNote":"Curated for NCI CCR trial.  The SHIM is a tool to assess ED (Erectile Dysfunction) in males, and is based on a past six months assessment.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2935523","version":"1","preferredName":"Sex Behavior Quality of Life Sexual Intercourse Satisfaction Past Integer::6 Month Assessment Score","preferredDefinition":"Numeric entry that describes a man's assessment of how often attempted sexual intercourse was satisfatory..","longName":"SEX_QOL_ER_SAT_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"71F38B8F-1485-E0A6-E040-BB89AD431E31","latestVersionIndicator":"Yes","beginDate":"2009-08-25","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-08-25","modifiedBy":"PRICEA","dateModified":"2013-10-25","changeNote":"Curated for NCI CCR trial.  The SHIM is a tool to assess ED (Erectile Dysfunction) in males, and is based on a past six months assessment.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2936023","version":"1","preferredName":"Sex Behavior Health Assessment  Total Score","preferredDefinition":"Numeric value to represent the composite score from responding to a number of questions to assess a man's sexual health.","longName":"SEX_HLTH_ASS_TTL_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"71FC0BB1-ACB7-D22B-E040-BB89AD431B32","latestVersionIndicator":"Yes","beginDate":"2009-08-25","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-08-25","modifiedBy":"PRICEA","dateModified":"2013-10-25","changeNote":"Curated for NCI CCR trial. The SHIM is a tool to assess ED (Erectile Dysfunction) in males, and is based on a past six months assessment.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2939172","version":"1","preferredName":"Peritoneal Carcinomatosis Stage","preferredDefinition":"Categorization of the extent of peritoneal carcinomatosis in the abdomen, using the Gilly Classification to describe the size and location of sites of disease.","longName":"GILLY_PER_CARC_STG","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"Gilly Classification: Gilly Classification published by Gilly et al., 1994, for the characterization of Peritoneal Carcinomatosis","workflowStatus":"RELEASED","registrationStatus":"Application","id":"731362BE-1E2A-6B34-E040-BB89AD4367DE","latestVersionIndicator":"Yes","beginDate":"2009-09-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-09-08","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":"Created to support NCI CCR trial.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2940057","version":"1","preferredName":"Protocol Agent Manufacturer Adverse Event Reporting Submission Indicator","preferredDefinition":"Text term to represent submission of expedited notification that a subject has experienced an adverse event to the manufacturer/producer of the therapeutic agent (drug, intervention therapy) used in a clinical trial protocol.","longName":"PROT_AGT_MANU_AE_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"738A90B5-E8F1-3725-E040-BB89AD433887","latestVersionIndicator":"Yes","beginDate":"2009-09-14","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-09-14","modifiedBy":"MAESKEB","dateModified":"2013-04-12","changeNote":"Curated to support NCI CCR protocol.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2960697","version":"1","preferredName":"Graft Versus Host Disease Treatment With Immunosuppressive Therapy Indicator","preferredDefinition":"Text term to signify whether Graft vs. Host Disease (GVHD) was treated with agents or therapy to suppress the immune response.","longName":"GVHD_TX_IMSUPTX_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7878D36F-0089-FBCB-E040-BB89AD433354","latestVersionIndicator":"Yes","beginDate":"2009-11-16","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-11-16","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":"Curated to support CCR Transplantation study.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2960701","version":"1","preferredName":"Malignant Neoplasm At Chronic Graft Versus Host Disease Diagnosis Indicator","preferredDefinition":"Text term to signify whether a malignant disease was present at the time of chronic Graft vs. Host Disease (GVHD) was diagnosed.","longName":"NEO_CGVHD_DX_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"78791C5E-7926-6DCD-E040-BB89AD431121","latestVersionIndicator":"Yes","beginDate":"2009-11-16","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-11-16","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":"Curated to support CCR Transplantation study.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2960705","version":"1","preferredName":"Secondary Malignant Neoplasm At Chronic Graft Versus Host Disease Diagnosis Indicator","preferredDefinition":"Text term to signify whether a malignancy derived as a result of a primary condition was present at the time of chronic Graft vs. Host Disease (GVHD) diagnosis.","longName":"SEC_MLG_CGVHD_DX_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"78791C5E-7958-6DCD-E040-BB89AD431121","latestVersionIndicator":"Yes","beginDate":"2009-11-16","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-11-16","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":"Curated to support CCR Transplantation study.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2960710","version":"1","preferredName":"HLA Antigens Crossmatch IncompatibilityType","preferredDefinition":"Text subdivision to signify the type of human leukocyte antigen (HLA) matching Incompatibility was detected during HLA typing..","longName":"HLA_CRSMCH_INCOMP_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"78791C5E-79E9-6DCD-E040-BB89AD431121","latestVersionIndicator":"Yes","beginDate":"2009-11-16","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-11-16","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":"Curated to support CCR Transplantation study.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2960714","version":"1","preferredName":"Infection Integer::90 Day Post Bone Marrow Transplantation Indicator","preferredDefinition":"Text term to signify whether an infection occurred within 90 days after a bone marrow transplantion occurred.","longName":"INF_90D_POST_BMT_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7879C44D-D06C-625A-E040-BB89AD43465D","latestVersionIndicator":"Yes","beginDate":"2009-11-16","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-11-16","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":"Curated to support CCR Transplantation study.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2960733","version":"1","preferredName":"Engraftment Syndrome Symptom Present Indicator","preferredDefinition":"Text term to signify the presence of symptoms of marrow engraftment such as fever, rash, or pulmonary deterioration became evident after a bone marrow transplantation.","longName":"HYPAC_ENGRF_SX_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7879F572-2F25-1F89-E040-BB89AD431E42","latestVersionIndicator":"Yes","beginDate":"2009-11-16","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-11-16","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":"Curated to support CCR Transplantation study.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2960739","version":"1","preferredName":"Bone Marrow Transplantation Within Integer::90 Day Occurrence Indicator","preferredDefinition":"Text term to signify whether a disease relapse occurred within 90 days following a bone marrow transplantation procedure.","longName":"BMT_WN_90D_REL_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"7879F572-2F7B-1F89-E040-BB89AD431E42","latestVersionIndicator":"Yes","beginDate":"2009-11-16","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-11-16","modifiedBy":"REEVESD","dateModified":"2015-05-19","changeNote":"Curated to support CCR Transplantation study.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2963411","version":"1","preferredName":"PSA Doubling Time Month Duration Number","preferredDefinition":"Number to represent the calculation result of the time in months required for a PSA (Prostate Specific Antigen) value to double in value.","longName":"PSA_DOUB_TM_MON_NUM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"79218C3C-F1B9-D5D5-E040-BB89AD431330","latestVersionIndicator":"Yes","beginDate":"2009-11-24","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-11-24","modifiedBy":"KENNISHM","dateModified":"2021-06-03","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2963477","version":"1","preferredName":"PSA Increase Slope Monthly Rate","preferredDefinition":"Numeric value to represent the rate of rise in the PSA (Prostate Specific Antigen) level per month expressed as ng/mL.","longName":"PSA_INC_SLOPE_MON_RT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7922C244-4A8D-DA02-E040-BB89AD436C14","latestVersionIndicator":"Yes","beginDate":"2009-11-24","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-11-24","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2963486","version":"1","preferredName":"PSA Velocity Increase Monthly Rate","preferredDefinition":"Number to represent the calculated result of the monthly rate of increase in PSA (Prostate Specific Antigen) levels in succeeding PSA tests, expressed as ng/mL per month.","longName":"PSA_VEL_INC_MON_RT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7922C244-4B41-DA02-E040-BB89AD436C14","latestVersionIndicator":"Yes","beginDate":"2009-11-24","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-11-24","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2965037","version":"1","preferredName":"Person Post Intervention Biological Response Occurrence Indicator","preferredDefinition":"Text description of the type of biological response achieved by a person after an intervention.","longName":"P_INTV_BIO_RESP_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7A237FAD-4E64-6C96-E040-BB89AD43191C","latestVersionIndicator":"Yes","beginDate":"2009-12-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-12-07","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":"Curated to support CCR trial in C3D","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2970715","version":"1","preferredName":"Person Comorbidity Condition Name","preferredDefinition":"Text term to identify a coexistent disease or condition in a person.","longName":"PER_COMORB_COND_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"7B037CB7-500D-491D-E040-BB89AD43668D","latestVersionIndicator":"Yes","beginDate":"2009-12-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-12-18","modifiedBy":"COOPERM","dateModified":"2018-03-26","changeNote":"Possible CDEs for Hepatitis B Position Statement","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2972043","version":"1","preferredName":"Manual Ability Measure-36 Assessment Complete Indicator","preferredDefinition":"Text term to signify a completed assessment using the Manual Ability Measure-36 Assessment (MAM-36), a rating scale of 36 everyday tasks that measures self-reported manual ability.","longName":"MAM36_COMP_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7BC43C75-C2FA-2830-E040-BB89AD434841","latestVersionIndicator":"Yes","beginDate":"2009-12-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-12-28","modifiedBy":"PRICEA","dateModified":"2013-10-28","changeNote":"Curated for NCI CCR Protocol in C3D.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2972045","version":"1","preferredName":"Manual Ability Measure-36 Assessment Complete Date","preferredDefinition":"Calendar date of a completed assessment using the Manual Ability Measure-36 (MAM-36), a rating scale of 36 everyday tasks that measures self-reported manual ability.","longName":"MAM36_COMP_DT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7BC43C75-C319-2830-E040-BB89AD434841","latestVersionIndicator":"Yes","beginDate":"2009-12-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-12-28","modifiedBy":"PRICEA","dateModified":"2013-10-28","changeNote":"Curated for NCI CCR Protocol in C3D.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2972047","version":"1","preferredName":"Manual Ability Measure-36 Assessment Result Measure Score","preferredDefinition":"Numeric value for a score on the Manual Ability Measure-36 (MAM-36), a rating scale of 36 everyday tasks that measures self-reported manual ability.","longName":"MAM36_MSR_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7BC43C75-C338-2830-E040-BB89AD434841","latestVersionIndicator":"Yes","beginDate":"2009-12-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-12-28","modifiedBy":"PRICEA","dateModified":"2013-10-23","changeNote":"Curated for NCI CCR Protocol in C3D.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2972049","version":"1","preferredName":"Manual Ability Measure-36 Assessment Result Total Score","preferredDefinition":"Numeric value to represent the total score for the Manual Ability Measure-36 Assessment (MAM-36), a rating scale of 36 everyday tasks that measures self-reported manual ability.","longName":"MAM36_TTL_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7BC43C75-C357-2830-E040-BB89AD434841","latestVersionIndicator":"Yes","beginDate":"2009-12-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-12-28","modifiedBy":"PRICEA","dateModified":"2013-10-23","changeNote":"Curated for NCI CCR Protocol in C3D.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2972051","version":"1","preferredName":"Jebsen-Taylor Hand Function Test Assessment Complete Indicator","preferredDefinition":"Text term to signify the status of a Jebsen-Taylor Hand Function Test Assessment, a seven part test that evaluates a broad range of hand functions used in daily activities using common items such as cans, paper clips, and pencils.","longName":"JBTAY_HD_COMP_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7BC43C75-C376-2830-E040-BB89AD434841","latestVersionIndicator":"Yes","beginDate":"2009-12-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-12-28","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":"Curated for NCI CCR Protocol in C3D.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2972053","version":"1","preferredName":"Jebsen-Taylor Hand Function Test Assessment Complete Date","preferredDefinition":"Calendar date of the completion of the Jebsen-Taylor Hand Function Text Assessment, a seven part test that evaluates a broad range of hand functions used in daily activities using common items such as cans, paper clips, and pencils.","longName":"JBTAY_HD_COMP_DT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7BC43C75-C395-2830-E040-BB89AD434841","latestVersionIndicator":"Yes","beginDate":"2009-12-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-12-28","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":"Curated for NCI CCR Protocol in C3D.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2972055","version":"1","preferredName":"Jebsen-Taylor Hand Function Test NonDominant Hand Score","preferredDefinition":"Numeric value to represent the nondominant hand score on the Jebsen-Taylor Hand Function Test, a seven part test that evaluates a broad range of hand functions used in daily activities using common items such as cans, paper clips, and pencils.","longName":"JBTAY_HD_NDOM_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7BC43C75-C3B4-2830-E040-BB89AD434841","latestVersionIndicator":"Yes","beginDate":"2009-12-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-12-28","modifiedBy":"REEVESD","dateModified":"2013-09-18","changeNote":"Curated for NCI CCR Protocol in C3D.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2974006","version":"1","preferredName":"Jebsen-Taylor Hand Function Test Assessment Result Dominant Hand Score","preferredDefinition":"Numeric value to represent the dominant hand score on the Jebsen-Taylor Hand Function Test, a seven part test that evaluates a broad range of hand functions used in daily activities using common items such as cans, paper clips, and pencils.","longName":"JBTAY_HD_DOM_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7BCD2B56-1008-3667-E040-BB89AD436539","latestVersionIndicator":"Yes","beginDate":"2009-12-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-12-28","modifiedBy":"REEVESD","dateModified":"2013-09-18","changeNote":"Curated for NCI CCR Protocol in C3D.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2974017","version":"1","preferredName":"Grooved Pegboard Test Assessment Complete Indicator","preferredDefinition":"Text term to signify a completed assessment using the Grooved Pegboard test, a manipulative dexterity test using a pegboard device with five rows of five holes.  It features 25 key-style pegs with holes in various positions in space, and is especially good for testing lateralized brain damage.","longName":"GRV_PGB_COMP_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"Grooved Pegboard Test, Lezak, 1995","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7BCD2B56-10F6-3667-E040-BB89AD436539","latestVersionIndicator":"Yes","beginDate":"2009-12-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-12-28","modifiedBy":"REEVESD","dateModified":"2012-05-09","changeNote":"Curated for NCI CCR Protocol in C3D.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2974031","version":"1","preferredName":"Grooved Pegboard Test Assessment Complete Date","preferredDefinition":"Calendar date of a completed assessment using the Grooved Pegboard test, a manipulative dexterity test using a pegboard device with five rows of five holes.  It features 25 key-style pegs with holes in various positions in space, and is especially good for testing lateralized brain damage.","longName":"GRV_PGB_COMP_DT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"Grooved Pegboard Test, Lezak, 1995","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7BCD7E77-EFAF-37E6-E040-BB89AD4306C5","latestVersionIndicator":"Yes","beginDate":"2009-12-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-12-28","modifiedBy":"REEVESD","dateModified":"2012-05-09","changeNote":"Curated for NCI CCR Protocol in C3D.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2974231","version":"1","preferredName":"Grooved Pegboard Test Assessment Right Hand Result Time Value","preferredDefinition":"Time measured in seconds for the completion of a task that is part of the Grooved Pegboard Test using the right hand.","longName":"GRV_PGB_RHD_TM_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"Grooved Pegboard Test, Lezak, 1995","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7BD1E891-8D5A-8DA1-E040-BB89AD4354E9","latestVersionIndicator":"Yes","beginDate":"2009-12-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-12-28","modifiedBy":"REEVESD","dateModified":"2012-05-09","changeNote":"Curated for NCI CCR Protocol in C3D.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2974233","version":"1","preferredName":"Grooved Pegboard Test Assessment Left Hand Result Time Value","preferredDefinition":"Time measured in seconds for the completion of a task that is part of the Grooved Pegboard Test using the left hand.","longName":"GRV_PGB_LHD_TM_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"Grooved Pegboard Test, Lezak, 1995","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7BD1E891-8D79-8DA1-E040-BB89AD4354E9","latestVersionIndicator":"Yes","beginDate":"2009-12-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-12-28","modifiedBy":"REEVESD","dateModified":"2012-05-09","changeNote":"Curated for NCI CCR Protocol in C3D.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2974235","version":"1","preferredName":"Grooved Pegboard Test Assessment Right Hand Result Time Sum Value","preferredDefinition":"Total sum of time measured in seconds for the completion of tasks that are part of the Grooved Pegboard Test using the right hand.","longName":"GRV_PGB_RHD_SUM_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"Grooved Pegboard Test, Lezak, 1995","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7BD1E891-8DA6-8DA1-E040-BB89AD4354E9","latestVersionIndicator":"Yes","beginDate":"2009-12-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-12-28","modifiedBy":"REEVESD","dateModified":"2012-05-09","changeNote":"Curated for NCI CCR Protocol in C3D.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2974237","version":"1","preferredName":"Grooved Pegboard Test Assessment Left Hand Result Time Sum Value","preferredDefinition":"Total sum of time measured in seconds for the completion of tasks that are part of the Grooved Pegboard Test using the left hand.","longName":"GRV_PGB_LHD_SUM_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"Grooved Pegboard Test, Lezak, 1995","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7BD1E891-8DCB-8DA1-E040-BB89AD4354E9","latestVersionIndicator":"Yes","beginDate":"2009-12-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-12-28","modifiedBy":"REEVESD","dateModified":"2012-05-09","changeNote":"Curated for NCI CCR Protocol in C3D.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2974240","version":"1","preferredName":"Disabilities of the Arm Shoulder and Hand Outcome Measure Assessment Complete Indicator","preferredDefinition":"Text term to signify a completed assessment using the Disabilities of the Arm Shoulder and Hand Outcome Measure (DASH), a 30-item, self-reported questionnaire designed to measure physical and social function along with symptom impact associated with musculosketetal disorders of the upper limb.","longName":"DASH_COMP_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7BD1E891-8DEA-8DA1-E040-BB89AD4354E9","latestVersionIndicator":"Yes","beginDate":"2009-12-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-12-28","modifiedBy":"LUY","dateModified":"2013-10-23","changeNote":"Curated for NCI CCR Protocol in C3D.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2974242","version":"1","preferredName":"Assessment of Motor and Process Skills Assessment Complete Indicator","preferredDefinition":"Text term to signify a completed assessment using the Assessment of Motor and Process Skills Assessment (AMPS), an observational assessment that is used to measure the quality of a person's activities of daily living (ADL); the quality of the person's ADL performance is assessed by rating the effort, efficiency, safety, and independence of 16 ADL motor and 20 ADL process skill items.","longName":"AMPS_COMP_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"7BD1E891-8E09-8DA1-E040-BB89AD4354E9","latestVersionIndicator":"Yes","beginDate":"2009-12-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-12-28","modifiedBy":"REEVESD","dateModified":"2015-05-19","changeNote":"Curated for NCI CCR Protocol in C3D.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2974244","version":"1","preferredName":"Disabilities of the Arm Shoulder and Hand Outcome Measure Assessment Complete Date","preferredDefinition":"Calendar date for a completed assessment using the Disabilities of the Arm Shoulder and Hand Outcome Measure (DASH), a 30-item, self-reported questionnaire designed to measure physical and social function along with symptom impact associated with musculosketetal disorders of the upper limb.","longName":"DASH_COMP_DT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7BD1E891-8E2B-8DA1-E040-BB89AD4354E9","latestVersionIndicator":"Yes","beginDate":"2009-12-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-12-28","modifiedBy":"LUY","dateModified":"2013-10-23","changeNote":"Curated for NCI CCR Protocol in C3D.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2974246","version":"1","preferredName":"Assessment of Motor and Process Skills Assessment Complete Date","preferredDefinition":"Calendar date of a completed assessment using the Assessment of Motor and Process Skills Assessment (AMPS), an observational assessment that is used to measure the quality of a person's activities of daily living (ADL); the quality of the person's ADL performance is assessed by rating the effort, efficiency, safety, and independence of 16 ADL motor and 20 ADL process skill items.","longName":"AMPS_COMP_DT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"7BD1E891-8E4A-8DA1-E040-BB89AD4354E9","latestVersionIndicator":"Yes","beginDate":"2009-12-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-12-28","modifiedBy":"REEVESD","dateModified":"2015-05-19","changeNote":"Curated for NCI CCR Protocol in C3D.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2974373","version":"1","preferredName":"Disabilities of the Arm Shoulder and Hand Outcome Measure Disability Symptom Total Score","preferredDefinition":"Numeric value representing the total score of the Disability/Symptom portion of the Disabilities of the Arm, Shoulder and Hand Outcome measure, a 30-item, self-reported questionnaire designed to measure physical and social function along with symptom impact associated with musculosketetal disorders of the upper limb.","longName":"DASH_DIS_SX_TTL_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7BD81A05-848F-EEB3-E040-BB89AD433F44","latestVersionIndicator":"Yes","beginDate":"2009-12-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-12-29","modifiedBy":"LUY","dateModified":"2013-10-23","changeNote":"Curated for NCI CCR Protocol in C3D.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2974375","version":"1","preferredName":"Disabilities of the Arm Shoulder and Hand Outcome Measure Work Module Total Score","preferredDefinition":"Numeric value representing the total score of the Work Module portion of the Disabilities of the Arm, Shoulder and Hand Outcome measure, a 30-item, self-reported questionnaire designed to measure physical and social function along with symptom impact associated with musculosketetal disorders of the upper limb.","longName":"DASH_WK_MOD_TTL_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7BD81A05-84AE-EEB3-E040-BB89AD433F44","latestVersionIndicator":"Yes","beginDate":"2009-12-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-12-29","modifiedBy":"LUY","dateModified":"2013-10-23","changeNote":"Curated for NCI CCR Protocol in C3D.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2974377","version":"1","preferredName":"Disabilities of the Arm Shoulder and Hand Outcome Measure Sports Performing Arts Module Total Score","preferredDefinition":"Numeric value representing the total score of the Sports/Performing Arts portion of the Disabilities of the Arm, Shoulder and Hand Outcome measure, a 30-item, self-reported questionnaire designed to measure physical and social function along with symptom impact associated with musculosketetal disorders of the upper limb.","longName":"DASH_SPT_PFAR_TTL_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7BD81A05-84CD-EEB3-E040-BB89AD433F44","latestVersionIndicator":"Yes","beginDate":"2009-12-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-12-29","modifiedBy":"LUY","dateModified":"2013-10-24","changeNote":"Curated for NCI CCR Protocol in C3D.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2974379","version":"1","preferredName":"Assessment of Motor and Process Skills ADL Motor Skills Total Score","preferredDefinition":"Numeric value representing the total score of the Activities of Daily Living (ADL) motor skills portion of the Assessment of Motor and Process Skills (AMPS), an observational assessment that is used to measure the quality of a person's activities of daily living (ADL); the quality of the person's ADL performance is assessed by rating the effort, efficiency, safety, and independence of 16 ADL motor and 20 ADL process skill items.","longName":"AMPS_MOT_SKL_TTL_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"7BD81A05-84EC-EEB3-E040-BB89AD433F44","latestVersionIndicator":"Yes","beginDate":"2009-12-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-12-29","modifiedBy":"REEVESD","dateModified":"2015-05-19","changeNote":"Curated for NCI CCR Protocol in C3D.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2974381","version":"1","preferredName":"Assessment of Motor and Process Skills Process Total Score","preferredDefinition":"Numeric value representing the total score of the Activities of Daily Living (ADL) process skills portion of the Assessment of Motor and Process Skills (AMPS), an observational assessment that is used to measure the quality of a person's activities of daily living (ADL); the quality of the person's ADL performance is assessed by rating the effort, efficiency, safety, and independence of 16 ADL motor and 20 ADL process skill items.","longName":"AMPS_PROC_SKL_TTL_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"7BD8A964-EDD2-8A21-E040-BB89AD436C37","latestVersionIndicator":"Yes","beginDate":"2009-12-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-12-29","modifiedBy":"REEVESD","dateModified":"2015-05-19","changeNote":"Curated for NCI CCR Protocol in C3D.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2974477","version":"1","preferredName":"PTEN Gene Mutation Location Text","preferredDefinition":"Text description of the chromosonal location of the PTEN gene, which plays a role in signal transduction and apoptosis, and is involved in the regulation of cell cycle progression.","longName":"PTEN_GENE_LCTN_TXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7BDA0716-63E8-8752-E040-BB89AD432DA2","latestVersionIndicator":"Yes","beginDate":"2009-12-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-12-29","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":"Curated for NCI CCR Protocol in C3D.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2974480","version":"1","preferredName":"PTEN Gene Mutation Type","preferredDefinition":"Text description of a subdivision or type of PTEN gene mutation.","longName":"PTEN_GENE_MUT_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7BD8A964-F219-8A21-E040-BB89AD436C37","latestVersionIndicator":"Yes","beginDate":"2009-12-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-12-29","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":"Curated for NCI CCR Protocol in C3D.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2974485","version":"1","preferredName":"Cowden Syndrome Diagnostic Criterion Name","preferredDefinition":"Text term representing a diagnostic criterion of Cowden Syndrome, a hereditary disease characterized by multiple ectodermal, mesodermal, and endodermal nevoid and neoplastic anomalies, papules of the face and oral mucosa, and other changes occur in the skin, in the thyroid, the breast, the gastrointestinal system, and the nervous system.","longName":"CWD_SYN_DX_CRIT_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"7BD8A964-F23D-8A21-E040-BB89AD436C37","latestVersionIndicator":"Yes","beginDate":"2009-12-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-12-29","modifiedBy":"REEVESD","dateModified":"2015-05-19","changeNote":"Curated for NCI CCR Protocol in C3D.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2974490","version":"1","preferredName":"Cowden Syndrome Diagnosis Criteria Indicator","preferredDefinition":"Text term to signify whether the diagnostic criteria required to establish a diagnosis of Cowden Syndrome have been met.","longName":"CWD_SYN_DX_CRIT_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"7BD8A964-F25C-8A21-E040-BB89AD436C37","latestVersionIndicator":"Yes","beginDate":"2009-12-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-12-29","modifiedBy":"REEVESD","dateModified":"2015-05-19","changeNote":"Curated for NCI CCR Protocol in C3D.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2983793","version":"2","preferredName":"Brain Neoplasm Specified Anatomic Site Name","preferredDefinition":"Text term to identify the specified/detailed anatomic location of a malignant neoplasm that arises from or metastasize to structures within the cranium.","longName":"BRAIN_CA_SPEC_STE_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"9AB98E0F-43F5-C937-E040-BB89AD430F7D","latestVersionIndicator":"Yes","beginDate":"2011-01-25","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-01-25","modifiedBy":"REEVESD","dateModified":"2015-05-19","changeNote":"Curated to support NCI CCR trial; replaces v1.0 with extended length VD","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3005293","version":"1","preferredName":"Graft Versus Host Disease Diagnosis Type","preferredDefinition":"Type of Graft vs. Host Disease (GVHD) assessed at the time of participant enrollment on a study.","longName":"GVHD_DX_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7EAAAB23-82AC-3381-E040-BB89AD435A9F","latestVersionIndicator":"Yes","beginDate":"2010-02-02","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-02-02","modifiedBy":"GDEEN","dateModified":"2023-04-17","changeNote":"Curated to support CCR Transplantation trial.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3005318","version":"1","preferredName":"Late Acute Graft Versus Host Disease Clinical Trial Enrollment Subtype Type","preferredDefinition":"A subtype of the late acute Graft vs Host Disease (GVHD) determined at the time of participant enrollment on a study.","longName":"LT_AC_GVHD_ENRL_SBTP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7EAB8C7C-CDF4-328C-E040-BB89AD433B37","latestVersionIndicator":"Yes","beginDate":"2010-02-02","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-02-02","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":"Curated to support CCR Transplantation trial.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3005331","version":"1","preferredName":"Skin Graft Versus Host Disease Secondary Sign Name","preferredDefinition":"Objective ancillary data related to the signs and symptoms of skin Graft vs Host Disease (GVHD).  This is part of the Chronic GVHD Composite Assessment Scale evaluation tool, but does not contribute to that score.","longName":"SKN_GVHD_ANC_SGN_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7EAB8C7C-CF2F-328C-E040-BB89AD433B37","latestVersionIndicator":"Yes","beginDate":"2010-02-02","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-02-02","modifiedBy":"PRICEA","dateModified":"2013-10-23","changeNote":"Curated to support CCR Transplantation trial.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3005338","version":"1","preferredName":"Skin Graft Versus Host Disease Pain Assessment Score","preferredDefinition":"Numeric value that is a subject assessment of pain due to skin disease caused by Graft versus Host Disease (GVHD). This is part of the chronic GVHD Composite Assessment Scale evaluation tool, but does not contribute to that score.","longName":"SKN_GVHD_PN_ASSM_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7EAB8C7C-CF9D-328C-E040-BB89AD433B37","latestVersionIndicator":"Yes","beginDate":"2010-02-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-02-03","modifiedBy":"PRICEA","dateModified":"2013-10-23","changeNote":"Curated to support CCR Transplantation trial.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3005344","version":"1","preferredName":"Skin Graft Versus Host Disease Pruritus Assessment Score","preferredDefinition":"Numeric value that is a subject assessment of level of discomfort from pruritus (itching) due to skin disease caused by Graft versus Host Disease (GVHD). This is part of the chronic GVHD Composite Assessment Scale evaluation tool, but does not contribute to that score.","longName":"SKN_GVHD_PRU_ASSM_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7EAB8C7C-CFFF-328C-E040-BB89AD433B37","latestVersionIndicator":"Yes","beginDate":"2010-02-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-02-03","modifiedBy":"PRICEA","dateModified":"2013-10-23","changeNote":"Curated to support CCR Transplantation trial.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3005352","version":"1","preferredName":"Skin Graft Versus Host Disease Patient Self-Report Clinical Severity Score","preferredDefinition":"Numeric value to represent a patient's reported subjective assessment of the degree of disease activity on the skin caused by Graft versus Host Disease (GVHD).  This is part of the Chronic GVHD Composite Assessment Scale evaluation tool, but does not contribute to that score.","longName":"SKN_GVHD_SFRP_SEV_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7EAB8C7C-D06B-328C-E040-BB89AD433B37","latestVersionIndicator":"Yes","beginDate":"2010-02-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-02-03","modifiedBy":"PRICEA","dateModified":"2013-10-23","changeNote":"Curated to support CCR Transplantation trial.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3005373","version":"1","preferredName":"Skin Graft Versus Host Disease Clinician Report Clinical Severity Score","preferredDefinition":"Numeric value to represent a clinician reported subjective assessment of the patient's degree of disease activity on the skin caused by Graft versus Host Disease (GVHD).  This is part of the Chronic GVHD Composite Assessment Scale evaluation tool, but does not contribute to that score.","longName":"SKN_GVHD_CLRP_SEV_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7EAB8C7C-D08A-328C-E040-BB89AD433B37","latestVersionIndicator":"Yes","beginDate":"2010-02-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-02-03","modifiedBy":"PRICEA","dateModified":"2013-10-23","changeNote":"Curated to support CCR Transplantation trial.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3005387","version":"1","preferredName":"Skin Erythema Graft Versus Host Disease Body Surface Area Value","preferredDefinition":"Value to represent the total body surface area (BSA) of erythematous changes related to cutaneous Graft versus Host Disease (GVHD). This is part of the Chronic GVHD Composite Assessment Scale evaluation tool.","longName":"SKN_ERY_BSA_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7EAB8C7C-D151-328C-E040-BB89AD433B37","latestVersionIndicator":"Yes","beginDate":"2010-02-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-02-03","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":"Curated to support CCR Transplantation trial.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3005389","version":"1","preferredName":"Skin Graft Versus Host Disease Dermal Sclerosis Body Surface Area Value","preferredDefinition":"Value to represent the total body surface area (BSA) of dermal sclerosis related to cutaneous Graft versus Host Disease (GVHD). This is part of the Chronic GVHD Composite Assessment Scale evaluation tool.","longName":"SKN_DERM_SCL_BSA_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7EAB8C7C-D170-328C-E040-BB89AD433B37","latestVersionIndicator":"Yes","beginDate":"2010-02-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-02-03","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":"Curated to support CCR Transplantation trial.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3005391","version":"1","preferredName":"Skin Graft Versus Host Disease Deep Sclerosis Body Surface Area Value","preferredDefinition":"Value to represent the total body surface area (BSA) of subcutaneous sclerosis related to cutaneous Graft versus Host Disease (GVHD) in adults. This is part of the Chronic GVHD Composite Assessment Scale evaluation tool.","longName":"DP_DERM_SCL_BSA_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7EAB8C7C-D18F-328C-E040-BB89AD433B37","latestVersionIndicator":"Yes","beginDate":"2010-02-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-02-03","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":"Curated to support CCR Transplantation trial.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3005404","version":"2","preferredName":"Schirmer Test Wetting Without Anesthesia Millimeter Value","preferredDefinition":"Value representing result of Schirmer\"s tear test of the eye without anesthesia, determining whether or not the eye produces enough tears to keep it moist.","longName":"SCHM_WO_ANES_MM_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8D2DCC6D-21DD-9273-E040-BB89AD432A8F","latestVersionIndicator":"Yes","beginDate":"2010-08-06","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-08-06","modifiedBy":"TAYLORT","dateModified":"2018-02-09","changeNote":"Curated to support CCR Transplantation trial.  v2.0 replaces v1.0 with a VD with two decimals","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3005406","version":"2","preferredName":"Schirmer Test Wetting With Anesthesia Procedure Result Millimeter Value","preferredDefinition":"Value representing result of Schirmer\"s tear test of the eye with anesthesia, determining whether or not the eye produces enough tears to keep it moist.","longName":"SCHM_W_ANES_MM_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8D2DCC6D-21A5-9273-E040-BB89AD432A8F","latestVersionIndicator":"Yes","beginDate":"2010-08-06","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-08-06","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":"Curated to support CCR Transplantation trial. v2.0 replaces v1.0 with a VD with two decimals.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3005411","version":"2","preferredName":"Average Both Eye Schirmer Test Wetting With Anesthesia Procedure Result Millimeter Value","preferredDefinition":"Result of calculation of the average tear measurement produced by both eyes using anesthesia.","longName":"AVG_SCHM_W_ANES_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"8D2DCC6D-216F-9273-E040-BB89AD432A8F","latestVersionIndicator":"Yes","beginDate":"2010-08-06","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-08-06","modifiedBy":"REEVESD","dateModified":"2015-05-19","changeNote":"Curated to support CCR Transplantation trial.  v2.0 replaces v1.0 with a VD with two decimals.??.,mnbvcxzzxcvbnm,./][poiuytrewq","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3005415","version":"2","preferredName":"Average Both Eye Schirmer Test Wetting Without Anesthesia Procedure Result Millimeter Value","preferredDefinition":"Result of calculation of the average tear measurement produced by both eyes without the use of anesthesia.","longName":"AVG_SCHM_WO_ANES_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"8D2DCC6D-2139-9273-E040-BB89AD432A8F","latestVersionIndicator":"Yes","beginDate":"2010-08-06","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-08-06","modifiedBy":"REEVESD","dateModified":"2015-05-19","changeNote":"Curated to support CCR Transplantation trial. v2.0 replaces v1.0 with a VD with two decimals.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3005420","version":"2","preferredName":"Active Range of Motion Testing Predicted Result","preferredDefinition":"Numeric value to represent the percent of predicted range of motion result.","longName":"AROM_PRED_RSL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"80772D30-1746-2E02-E040-BB89AD4372C5","latestVersionIndicator":"Yes","beginDate":"2010-02-25","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-02-25","modifiedBy":"COOPERM","dateModified":"2018-11-20","changeNote":"Curated to support CCR Transplantation trial. v2.0 replaces v1.0 with additiona of 2 decimal places to VD.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3005425","version":"2","preferredName":"Person Dominant Hand Hold Predicted Pressure Pound per Square Inch Value","preferredDefinition":"Numeric value to represent the percent of predicted grip strength in the dominant hand.","longName":"DOM_HAND_PRD_PRS_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8D2BC4F2-EC2B-BF29-E040-BB89AD430E06","latestVersionIndicator":"Yes","beginDate":"2010-02-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-08-06","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":"Curated to support CCR Transplantation trial. v2.0 replaces v1.0 with a VD that has two decimal places","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3005447","version":"1","preferredName":"Graft Versus Host Disease Vulva Vaginal Symptoms Assessment Code","preferredDefinition":"Numeric code for vaginal or vulvar symptoms noted as part of the chronic Graft versus Host Disease (GVHD) Composite Assessment Scale evaluation tool, specifically the vaginal/vulvar component.","longName":"CGVHD_VUL_VAG_SX_CD","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7EAB8C7C-D584-328C-E040-BB89AD433B37","latestVersionIndicator":"Yes","beginDate":"2010-02-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-02-03","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":"Curated to support CCR Transplantation trial.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3005455","version":"1","preferredName":"Gender Adjusted Chronic Graft Versus Host Disease Symptom Score","preferredDefinition":"A gender-adjusted score for the chronic Graft versus Host Disease (GVHD) patient symptom assessment, calculated as the total score for the assessment divided by the number of evaluated components. [Note: for females, total score is divided by 8; for males, total score is divided by 7.]","longName":"AGE_ADJ_CGVHD_SX_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7EAB8C7C-D604-328C-E040-BB89AD433B37","latestVersionIndicator":"Yes","beginDate":"2010-02-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-02-03","modifiedBy":"REEVESD","dateModified":"2013-09-18","changeNote":"Curated to support CCR Transplantation trial.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3005481","version":"1","preferredName":"Current Chronic Graft Versus Host Disease Immunosuppressive Therapy Intensity Category","preferredDefinition":"Categorization to capture the intensity of current immunosuppression therapy given for the treatment of chronic Graft versus Host Disease (GVHD).","longName":"CGVHD_IMM_INT_CAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7EAFA041-4698-70AD-E040-BB89AD436D7B","latestVersionIndicator":"Yes","beginDate":"2010-02-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-02-03","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":"Curated to support CCR Transplantation trial.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3005501","version":"1","preferredName":"Therapeutic Effect Chronic Graft Versus Host Disease Treatment Type","preferredDefinition":"The therapeutic intent for treatment of chronic Graft versus Host Disease (GVHD) at the time of clinic visit.","longName":"CGVHD_TX_THER_INT_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7EAFA041-47BD-70AD-E040-BB89AD436D7B","latestVersionIndicator":"Yes","beginDate":"2010-02-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-02-03","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":"Curated to support CCR Transplantation trial.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3005555","version":"1","preferredName":"Clinician Interpretation Chronic Graft Versus Host Disease Status","preferredDefinition":"Text term to describe a clinician's impression of chronic Graft versus Host Disease (GVHD) activity.","longName":"CLIN_INT_CGVHD_STAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"7EB48A62-4E49-BD36-E040-BB89AD437094","latestVersionIndicator":"Yes","beginDate":"2010-02-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-02-03","modifiedBy":"REEVESD","dateModified":"2015-05-19","changeNote":"Curated to support CCR Transplantation trial.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3005560","version":"1","preferredName":"Idiopathic Pneumonia Syndrome Present Indicator","preferredDefinition":"Text term to signify the presence of Idiopathic Pneumonia Syndrome (IPS) after bone marrow transplantation; this is a distinct post transplant entity that involves clinical respiratory deterioration and radiographic findings in the absence of infectious pathogens.","longName":"IPS_PRES_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7EB48A62-4E9E-BD36-E040-BB89AD437094","latestVersionIndicator":"Yes","beginDate":"2010-02-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-02-03","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":"Curated to support CCR Transplantation trial.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3009159","version":"1","preferredName":"Biospecimen Collection Procedure Name","preferredDefinition":"Name of of the test or procedure used for biospecimen acquisition,","longName":"SPEC_COLL_PROC_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"7F5466BB-D99C-956A-E040-BB89AD43035C","latestVersionIndicator":"Yes","beginDate":"2010-02-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-02-11","modifiedBy":"SOKKERL","dateModified":"2019-05-09","changeNote":"Curated to support Johns Hopkins in C3D","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3017456","version":"1","preferredName":"Range of Motion Test Name Assessment Description Text","preferredDefinition":"Text to describd the anatomic location that is targeted for Range of Motion (ROM) testing.","longName":"ROM_TEST_NM_DESC_TXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"80778A5A-56BD-FEE2-E040-BB89AD436073","latestVersionIndicator":"Yes","beginDate":"2010-02-25","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-02-25","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":"Curated to support Duke University adoption of C3D for ThermoDox trial.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3018736","version":"1","preferredName":"Cowden Syndrome Other Diagnostic Criterion Text","preferredDefinition":"Text to describe a diagnostic criterion of Cowden Syndrome, a hereditary disease characterized by multiple ectodermal, mesodermal, and endodermal nevoid and neoplastic anomalies, papules of the face and oral mucosa, and other changes occur in the skin, in the thyroid, the breast, the gastrointestinal system, and the nervous system.","longName":"CWD_SYN_OTH_CRIT_TXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"80D8E1FE-E126-BE25-E040-BB89AD433BA4","latestVersionIndicator":"Yes","beginDate":"2010-03-02","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-03-02","modifiedBy":"REEVESD","dateModified":"2015-05-19","changeNote":"Curated to support CCR clinical trial.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3018787","version":"1","preferredName":"Adverse Event Verbatim CTCAE Version 4.0 Migration Text","preferredDefinition":"Text to capture verbatim or clinical description of an adverse event that was created using version 2.0 or 3.0 of the Common Terminology Criteria for Adverse Events (CTCAE) but migrated to version 4.0 of the CTCAE as part of regulatory and reporting requirements.","longName":"AE_VE_CTCAE4_MIG_TXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"80EA5F7C-1CB6-EB25-E040-BB89AD434A68","latestVersionIndicator":"Yes","beginDate":"2010-03-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-03-03","modifiedBy":"REEVESD","dateModified":"2015-05-19","changeNote":"Curated to support CTCAE data in CCR trials","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3019295","version":"1","preferredName":"Person Pincer Grip Measurement Indicator","preferredDefinition":"Text term to signify that an evaluation of grip strength using a pincer to gather measurement(s) was conducted.","longName":"PIN_CRP_MSRMT_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"80FE80CE-9658-ABB3-E040-BB89AD436E6B","latestVersionIndicator":"Yes","beginDate":"2010-03-04","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-03-04","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":"Curated to support CCR clinical trial build in C3D.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3019419","version":"2","preferredName":"Person Pincer Grip 1 To 1 Left Hand Measurement Pressure Pound Value","preferredDefinition":"Numeric value to represent the Pincer grip strength generated in a prehension pattern of the tip of the left thumb opposing the index finger of the same hand, measured in pounds.","longName":"PIN_GRP_1TO1_LF_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"87FEDB8E-74E2-3DBB-E040-BB89AD43383A","latestVersionIndicator":"Yes","beginDate":"2010-03-04","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-06-01","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":"Curated to support CCR clinical trial build in C3D. Replaces v1.0 with extended VD.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3019422","version":"2","preferredName":"Person Pincer Grip 1 To 1 Right Hand Measurement Pressure Pound Value","preferredDefinition":"Numeric value to represent the Pincer grip strength generated in a prehension pattern of the tip of the right thumb opposing the index finger of the same hand, measured in pounds.","longName":"PIN_GRP_1TO1_RT_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"87FEDB8E-7513-3DBB-E040-BB89AD43383A","latestVersionIndicator":"Yes","beginDate":"2010-03-04","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-06-01","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":"Curated to support CCR clinical trial build in C3D.  v2.0 Replaces v1.0 with extended Value Domain.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3019424","version":"2","preferredName":"Person Pincer Grip 3Jaw Device Left Hand Measurement Pressure Pound Value","preferredDefinition":"Numeric value to represent the Pincer grip strength generated in a prehension pattern in which the pad of the thumb on the left hand opposes the middle finger of the same hand, measured in pounds.","longName":"PIN_GRP_3JAW_LF_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"87FEDB8E-7544-3DBB-E040-BB89AD43383A","latestVersionIndicator":"Yes","beginDate":"2010-03-04","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-06-01","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":"Curated to support CCR clinical trial build in C3D. v2.0 replaces v1.0 with extended length Value Domain.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3019432","version":"2","preferredName":"Person Pincer Grip 3Jaw Device Right Hand Measurement Pressure Pound Value","preferredDefinition":"Numeric value to represent the Pincer grip strength generated in a prehension pattern in which the pad of the thumb on the right hand opposes the middle finger of the same hand, measured in pounds.","longName":"PIN_GRP_3JAW_RT_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"87FEDB8E-7575-3DBB-E040-BB89AD43383A","latestVersionIndicator":"Yes","beginDate":"2010-03-04","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-06-01","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":"Curated to support CCR clinical trial build in C3D. v2.0 replaces v1.0 with extended length Value Domain.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3019436","version":"2","preferredName":"Person Pincer Grip Lateral Left Hand Measurement Pressure Pound Value","preferredDefinition":"Numeric value to represent the Pincer grip strength generated when the pad of the thumb of the left hand opposes the lateral side of the index finger of the same hand, as measued in pounds.","longName":"PIN_GRP_LAT_LF_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"87FEDB8E-75A6-3DBB-E040-BB89AD43383A","latestVersionIndicator":"Yes","beginDate":"2010-03-04","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-06-01","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":"Curated to support CCR clinical trial build in C3D. v2.0 replaces v1.0 with extended length Value Domain.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3019439","version":"2","preferredName":"Person Pincer Grip Lateral Right Hand Measurement Pressure Pound Value","preferredDefinition":"Numeric value to represent the Pincer grip strength generated when the pad of the thumb of the right hand opposes the lateral side of the index finger of the same hand, as measued in pounds.","longName":"PIN_GRP_LAT_RT_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"87FEDB8E-75D7-3DBB-E040-BB89AD43383A","latestVersionIndicator":"Yes","beginDate":"2010-03-04","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-06-01","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":"Curated to support CCR clinical trial build in C3D. v2.0 replaces v1.0 with extended length Value Domain.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3019445","version":"1","preferredName":"Institutional Biosafety Committee Expedited Report Submission Indicator","preferredDefinition":"Text term to signify whether an expedited report was submitted to an institutional-level board mandated by federal law for oversight of recombinant DNA research and work involving biohazardous agents taking place at that institution (IBC).","longName":"IBC_EXP_REP_SUBM_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"810093FF-BF0B-08CB-E040-BB89AD430A71","latestVersionIndicator":"Yes","beginDate":"2010-03-04","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-03-04","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":"Curated to support CCR clinical trial build in C3D.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3019671","version":"1","preferredName":"Off-Treatment Therapy Administered Type","preferredDefinition":"information related to off-treatment therapy being administered._the type of therapy administered to a patient.","longName":"OFF_TX_ADM_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81016392-2EAF-3C4F-E040-BB89AD431FC4","latestVersionIndicator":"Yes","beginDate":"2010-03-04","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-03-04","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":"Curated to support CCR trial built in C3D","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3021564","version":"1","preferredName":"Post Clinical Study Protocol Received Therapy Start Date","preferredDefinition":"Calendar date for the start of therapy an individual may receive after going off the treatment phase of a protocol/clinical trial.","longName":"POST_PROT_TX_ST_DT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"818DED3A-4902-17D3-E040-BB89AD4304FC","latestVersionIndicator":"Yes","beginDate":"2010-03-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-03-11","modifiedBy":"REEVESD","dateModified":"2012-01-12","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3021566","version":"1","preferredName":"Post Clinical Study Protocol Received Therapy Stop Date","preferredDefinition":"Calendar date for the end or completion of therapy an individual may receive after going off the treatment phase of a protocol/clinical trial.","longName":"POST_PROT_TX_STP_DT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"818DED3A-4921-17D3-E040-BB89AD4304FC","latestVersionIndicator":"Yes","beginDate":"2010-03-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-03-11","modifiedBy":"REEVESD","dateModified":"2012-01-12","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3021572","version":"1","preferredName":"Post Clinical Trial Treatment Type","preferredDefinition":"Text classification of the type of treatment administered to an individual after going off the treatment portion of a clinical trial.","longName":"POST_PROT_TX_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"818DED3A-49D7-17D3-E040-BB89AD4304FC","latestVersionIndicator":"Yes","beginDate":"2010-03-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-03-11","modifiedBy":"TSESU","dateModified":"2017-03-08","changeNote":"Added to support NCI CRF standards for the Prior/Post therapy module","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3027959","version":"1","preferredName":"Gastric Carcinoma Lauren Histologic Category","preferredDefinition":"Text term to represent a Lauren Classification histologic categorization of gastric carcinoma.","longName":"GAST_LAUR_HIST_CAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"82128AAE-6657-DBAB-E040-BB89AD436C1D","latestVersionIndicator":"Yes","beginDate":"2010-03-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-03-18","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":"Curated to support NCI CCR trial.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3027964","version":"1","preferredName":"Cancer Patient Peritoneal Lavage Internal Bleeding Detection Outcome Category","preferredDefinition":"Text indicator of whether internal bleeding was detected during a peritoneal lavage procedure performed on a cancer patient.","longName":"PER_LVG_INT_BLD_CAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"8212C367-4612-76C9-E040-BB89AD435F6E","latestVersionIndicator":"Yes","beginDate":"2010-03-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-03-18","modifiedBy":"REEVESD","dateModified":"2011-07-07","changeNote":"Curated to support NCI CCR trial.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3028357","version":"1","preferredName":"Microcalcification Carcinoma Surgical Procedure Involvement Indicator","preferredDefinition":"Text indicator to signify the presence of microcalcification(s) at the time of surgery for a cancer patient.","longName":"MCCAL_INVL_SURG_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"82196F52-E57D-4A27-E040-BB89AD433BD8","latestVersionIndicator":"Yes","beginDate":"2010-03-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-03-18","modifiedBy":"GEINOZS","dateModified":"2016-09-27","changeNote":"Curated to support NCI CCR trial.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3028360","version":"1","preferredName":"Vascular Invasion Carcinoma Surgical Procedure Involvement Indicator","preferredDefinition":"Text indicator to signify the presence of vascular invasion at the time of surgery for a cancer patient.","longName":"VAS_INVL_SURG_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"82196F52-E5C7-4A27-E040-BB89AD433BD8","latestVersionIndicator":"Yes","beginDate":"2010-03-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-03-18","modifiedBy":"REEVESD","dateModified":"2011-07-07","changeNote":"Curated to support NCI CCR trial.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3028363","version":"1","preferredName":"Lymphatic Invasion Carcinoma Surgical Procedure Involvement Indicator","preferredDefinition":"Text indicator to signify the presence of lymphatic invasion at the time of surgery for a cancer patient.","longName":"LYM_INVL_SURG_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"8219B149-A86F-706D-E040-BB89AD435D6E","latestVersionIndicator":"Yes","beginDate":"2010-03-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-03-18","modifiedBy":"REEVESD","dateModified":"2011-06-30","changeNote":"Curated to support NCI CCR trial.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3028365","version":"1","preferredName":"Necrosis Carcinoma Surgical Procedure Involvement Indicator","preferredDefinition":"Text indicator to signify the presence of necrosis at the time of surgery for a cancer patient.","longName":"NEC_INVL_SURG_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"8219B149-A88E-706D-E040-BB89AD435D6E","latestVersionIndicator":"Yes","beginDate":"2010-03-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-03-18","modifiedBy":"REEVESD","dateModified":"2011-06-30","changeNote":"Curated to support NCI CCR trial.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3029235","version":"1","preferredName":"Natural History Surgical Or Protocol Procedure Name","preferredDefinition":"Text name of a surgical or operative procedure used in a Natural History protocol.","longName":"NH_SURG_PROC_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"828E2366-CF89-ADF1-E040-BB89AD4329CB","latestVersionIndicator":"Yes","beginDate":"2010-03-24","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-03-24","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":"Curated to support NCI CCR Surgery Branch Natural History trial.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3029295","version":"1","preferredName":"Anatomic Site Resection Lobe Or Segment Code","preferredDefinition":"Numeric value to identify a lobe or segment of an organ resected, such as the liver, lung, breast, or brain.","longName":"ANAT_RES_LB_REG_CD","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"828DA416-3928-01D2-E040-BB89AD435C52","latestVersionIndicator":"Yes","beginDate":"2010-03-24","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-03-24","modifiedBy":"REEVESD","dateModified":"2015-05-19","changeNote":"Curated to support NCI CCR Surgery Branch Natural History trial.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3049856","version":"1","preferredName":"Mitotic Index Nuclear Antigen Tumor Present Text","preferredDefinition":"Text description of the mitotic index, the ratio between the number of cells in mitosis and the total number of cells, using against the nuclear antigen Ki-67 or MIB.","longName":"MITIND_NUC_ANT_TXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"838D91A3-8DAB-848A-E040-BB89AD433CBD","latestVersionIndicator":"Yes","beginDate":"2010-04-06","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-04-06","modifiedBy":"REEVESD","dateModified":"2014-05-21","changeNote":"Curated for CCR Brain tumor trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3049860","version":"1","preferredName":"Concurrent Radiation Therapy Treatment Type","preferredDefinition":"Text term to identify the modality or type of treatment delivered concurrently with radiation therapy.","longName":"CON_RT_TX_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"838D91A3-8E1B-848A-E040-BB89AD433CBD","latestVersionIndicator":"Yes","beginDate":"2010-04-06","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-04-06","modifiedBy":"REEVESD","dateModified":"2015-05-19","changeNote":"Curated for CCR Brain tumor trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3049869","version":"1","preferredName":"Oligodendroglial Tumor Gene Subtype Text","preferredDefinition":"Text description of oligodendroglial tumor gene classes or subtypes.","longName":"OLIG_GENE_SUBTP_TXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"838D91A3-8E99-848A-E040-BB89AD433CBD","latestVersionIndicator":"Yes","beginDate":"2010-04-06","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-04-06","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":"Curated for CCR Brain tumor trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3049874","version":"1","preferredName":"Glioblastoma Gene Subtype Text","preferredDefinition":"Text description of glioblastoma gene classes or subtypes.","longName":"GLIO_GENE_SUBTP_TXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"838D91A3-8ED7-848A-E040-BB89AD433CBD","latestVersionIndicator":"Yes","beginDate":"2010-04-06","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-04-06","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":"Curated for CCR Brain tumor trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3049886","version":"1","preferredName":"Brain Neoplasm Medical Complication Type","preferredDefinition":"Text term for symptom or disorder that can occur in association with a brain tumor.","longName":"BR_TUM_MED_COMP_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"838D91A3-9022-848A-E040-BB89AD433CBD","latestVersionIndicator":"Yes","beginDate":"2010-04-06","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-04-06","modifiedBy":"REEVESD","dateModified":"2015-05-19","changeNote":"Curated for CCR Brain tumor trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3049902","version":"1","preferredName":"Positron Emission Tomography Blood Pool Standardized Uptake Mean Value","preferredDefinition":"Numeric value to represent the mean or average for blood pool mean standardized uptake value (SUV) during a positron emission tomography (PET) scan.","longName":"PET_SUV_BLD_PL_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8392AF30-D8A3-7398-E040-BB89AD43648E","latestVersionIndicator":"Yes","beginDate":"2010-04-06","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-04-06","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":"Curated to support NCI CCR trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3079268","version":"1","preferredName":"Gliomatosis Cerebri Post Brain Neoplasm Surgery Occurrence Indicator","preferredDefinition":"Text term to indicate the presence of Gliomatosis cerebri following brain tumor surgery.","longName":"GLIOCER_POST_SUR_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8562D0F6-4A44-2509-E040-BB89AD436132","latestVersionIndicator":"Yes","beginDate":"2010-04-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-04-29","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":"Curated to support NCI CCR trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3079286","version":"1","preferredName":"Biomarker Test Result Interpretation Type","preferredDefinition":"Text term to interpret the result of a biomarker test.","longName":"BIOM_RSL_INT_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"85649081-7E18-6772-E040-BB89AD434A0F","latestVersionIndicator":"Yes","beginDate":"2010-04-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-04-29","modifiedBy":"REEVESD","dateModified":"2015-05-19","changeNote":"Curated to support NCI CCR trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3082312","version":"1","preferredName":"Person Primary Care Evaluation of Mental Disorders Patient Health Questionnaire Complete Indicator","preferredDefinition":"Text indicator to signify that the PRIME-MD PHQ-9, a self-administered diagnostic instrument developed for use in Primary Care settings to screen for common mental disorders, including alcohol abuse and dependence, was completed by an individual.","longName":"PRIMEPHQ9_COMP_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"85E0A353-19F2-65F6-E040-BB89AD436D25","latestVersionIndicator":"Yes","beginDate":"2010-05-05","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-05-05","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":"Curated to support NCI CCR brain tumor natural history trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3082314","version":"1","preferredName":"Person Generalized Anxiety Disorder Questionnaire Complete Indicator","preferredDefinition":"Text indicator to signify that the Generalized Anxiety Disorder Questionnaire (GAD-7), a self-administered diagnostic instrument developed to screen for generalized anxiety disorder, was completed by an individual.","longName":"PER_GAD7_COMP_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"85E0A353-1A1E-65F6-E040-BB89AD436D25","latestVersionIndicator":"Yes","beginDate":"2010-05-05","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-05-05","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":"Curated to support NCI CCR brain tumor natural history trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3082323","version":"1","preferredName":"Person Primary Care Evaluation of Mental Disorders Patient Health Questionnaire Total Score Psychometric Questionnaire Two Digit Score","preferredDefinition":"Numeric value for the total score on the PRIME-MD PHQ-9, a self-administered diagnostic instrument developed for use in Primary Care settings to screen for common mental disorders, including alcohol abuse and dependence.","longName":"PRIMEMDPHQ9_TTL_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"85E0A353-1AAD-65F6-E040-BB89AD436D25","latestVersionIndicator":"Yes","beginDate":"2010-05-05","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-05-05","modifiedBy":"PWEST","dateModified":"2014-02-11","changeNote":"Curated to support NCI CCR brain tumor natural history trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3082325","version":"1","preferredName":"Person Generalized Anxiety Disorder Questionnaire Total Two Digit Score","preferredDefinition":"Numeric value for the total score on the GAD-7, a self-administered diagnostic instrument developed to screen for generalized anxiety disorder.","longName":"PER_GAD7_TTL_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"85E0A353-1AD9-65F6-E040-BB89AD436D25","latestVersionIndicator":"Yes","beginDate":"2010-05-05","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-05-05","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":"Curated to support NCI CCR brain tumor natural history trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3115540","version":"1","preferredName":"Eye Examination Assessment Results Text","preferredDefinition":"Text description of the result of an ophthalmologic exam of a person.","longName":"EYE_EXAM_RSL_TXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8A2C696C-6421-7F69-E040-BB89AD433512","latestVersionIndicator":"Yes","beginDate":"2010-06-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-06-29","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":"Curated for CCR Trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3117409","version":"1","preferredName":"Electrocardiogram Normal Abnormal Code","preferredDefinition":"Coded summary finding based on an electrocardiogram.","longName":"ECG_IMPRESS_CD","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8AA7C4D5-D5D7-431B-E040-BB89AD4313D5","latestVersionIndicator":"Yes","beginDate":"2010-07-05","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-05","modifiedBy":"FORMBUILDER","dateModified":"2013-09-26","changeNote":"Curated for CCR trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3117411","version":"1","preferredName":"Site type Normal/ Abnormal indicator Code","preferredDefinition":"Code to signify the type of anatomic site where specimen/ sample has been collected.","longName":"SITE_TP_CD","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8AA7C4D5-D603-431B-E040-BB89AD4313D5","latestVersionIndicator":"Yes","beginDate":"2010-07-05","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-05","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":"Curated for CCR trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3117413","version":"1","preferredName":"Electrocardiography Result Normal Abnormal Code","preferredDefinition":"Code to signify the regularity of the electrocardiogram rhythm which helps determine abnormal cardiac rhythm and myocardial damage.","longName":"ECG_RHYTHM_FNG_CD","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8AA7C4D5-D632-431B-E040-BB89AD4313D5","latestVersionIndicator":"Yes","beginDate":"2010-07-05","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-05","modifiedBy":"FORMBUILDER","dateModified":"2013-09-26","changeNote":"Curated for CCR trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3117415","version":"1","preferredName":"P Wave Finding Normal Abnormal Code","preferredDefinition":"Code to represent the measurement and interpretation of P wave electrical activity on an electrocardiogram.","longName":"P_WAVE_FNG_CD","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8AA7F9C2-9BD4-D506-E040-BB89AD436156","latestVersionIndicator":"Yes","beginDate":"2010-07-05","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-05","modifiedBy":"FORMBUILDER","dateModified":"2013-09-26","changeNote":"Curated for CCR trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3117444","version":"1","preferredName":"QRS Complex Finding Normal Abnormal Code","preferredDefinition":"Code to represent the measurement and evaluation of the QRS complex electrical activity on an electrocardiogram.","longName":"QRS _CMPLX_FNG_CD","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8AA7C4D5-D65E-431B-E040-BB89AD4313D5","latestVersionIndicator":"Yes","beginDate":"2010-07-05","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-05","modifiedBy":"FORMBUILDER","dateModified":"2013-09-26","changeNote":"Curated for CCR Trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3117682","version":"1","preferredName":"ST Segment Finding Normal Abnormal Code","preferredDefinition":"Code to represent the measurement and evaluation of the ST segment on an electrocardiogram.","longName":"ST_SEG_FNG_CD","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8AA7C4D5-D68A-431B-E040-BB89AD4313D5","latestVersionIndicator":"Yes","beginDate":"2010-07-05","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-05","modifiedBy":"FORMBUILDER","dateModified":"2013-09-26","changeNote":"Curated for CCR Trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3126060","version":"1","preferredName":"Lesion Evaluable Disease Status Indicator","preferredDefinition":"Text term to signify whether a lesion is evaluable for response based on a protocol/study\"s definition of \"evaluable\".","longName":"LES_EVAL_STAT_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8CEBA149-F5FF-91E0-E040-BB89AD4325CC","latestVersionIndicator":"Yes","beginDate":"2010-08-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-08-03","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":"Curated for CCR NOB study","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3126066","version":"1","preferredName":"Lesion Measurable Disease Status Indicator","preferredDefinition":"Text term to signify whether a lesion can be accurately measured, as a basis to judge response to treatment, as based on a protocol/study\"s definition of \"evaluable\".","longName":"LES_MEAS_STAT_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8CEBA149-F688-91E0-E040-BB89AD4325CC","latestVersionIndicator":"Yes","beginDate":"2010-08-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-08-03","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":"Curated for CCR NOB study","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3126077","version":"1","preferredName":"Post Treatment Study Follow-up Agent Name","preferredDefinition":"Text name for an agent taken by an individual during the post-therapy or followup portion of the patient's treatment plan.","longName":"POST_TX_FU_AGT_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8CEC9CF9-F4CF-77C5-E040-BB89AD437145","latestVersionIndicator":"Yes","beginDate":"2010-08-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-08-03","modifiedBy":"REEVESD","dateModified":"2011-07-28","changeNote":"Curated for CCR studies","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3135074","version":"1","preferredName":"KRAS Gene Mutation Detection Result","preferredDefinition":"Text term to signify the ability to detect a mutation on the KRAS non wild-type gene.","longName":"KRAS_MUT_DET_RSL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8FB1B450-2D72-E4A8-E040-BB89AD430741","latestVersionIndicator":"Yes","beginDate":"2010-09-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-09-07","modifiedBy":"REEVESD","dateModified":"2013-06-04","changeNote":"Curated for the Center for Cancer Research","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3137643","version":"1","preferredName":"Positron Positron Emission Tomography Use Reason","preferredDefinition":"Text term to explain the reason that a Positron Emission Tomography (PET) scan was done for a patient.","longName":"PET_USE_RSN","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"902E0CEA-CBEF-FD71-E040-BB89AD437F44","latestVersionIndicator":"Yes","beginDate":"2010-09-13","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-09-13","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":"Curated to support Center for Cancer Research POB study","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3150982","version":"1","preferredName":"Time Duration Number Value","preferredDefinition":"Value that is paired with a unit of measure (hours, weeks, days) to express the length of time that an activity or event lasted.","longName":"TM_DURN_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"926FA384-2048-103F-E040-BB89AD436206","latestVersionIndicator":"Yes","beginDate":"2010-10-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-10-12","modifiedBy":"FORMBUILDER","dateModified":"2012-05-14","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3158684","version":"2","preferredName":"Primary Neoplasm Secondary Anatomic Site Name","preferredDefinition":"Locations within the body of secondary spread of a primary neoplasm.","longName":"PRIM_NEOP_SEC_ST_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"ACC8ACC2-10CD-6D55-E053-4EBD850AEDA8","latestVersionIndicator":"Yes","beginDate":"2020-08-13","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-08-13","modifiedBy":"COOPERM","dateModified":"2020-08-13","changeNote":"Curated for NCI CCR clinical trial. Versioned to use latest version VD. mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3163341","version":"1","preferredName":"Specimen Collected Indicator","preferredDefinition":"Text term to signify whether a biospecimen was collected from an individual.","longName":"SPEC_COLL_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"965E05D8-FEE0-83A6-E040-BB89AD4371F2","latestVersionIndicator":"Yes","beginDate":"2010-12-01","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-12-01","modifiedBy":"MMADDINENI","dateModified":"2024-01-09","changeNote":"Curated to support NCI CCR trials.","administrativeNotes":"03/02/2023- Added AQTs-CADSR0002102-MM","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3165502","version":"1","preferredName":"Tumor Assessed Percentage Amount","preferredDefinition":"The percentage of tumor assessed by a procedure specified within a clinical trial or research.","longName":"TUM_ASSESS_PTG","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"96ED5614-B6C1-8F45-E040-BB89AD43534A","latestVersionIndicator":"Yes","beginDate":"2010-12-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-12-08","modifiedBy":"COOPERM","dateModified":"2017-02-02","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3187291","version":"1","preferredName":"Radiation Therapy Oncology Group Late Effects  Adverse Event Name","preferredDefinition":"Text name for a late morbidity event, using criteria from the Radiation Therapy Oncology Group (RTOG) to score/grade adverse events from radiation therapy.","longName":"RTOG_LT_EFF_AE_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"RTOG CRF:Radiation Therapy Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"9AC6E59A-978A-5F20-E040-BB89AD436844","latestVersionIndicator":"Yes","beginDate":"2011-01-26","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-01-26","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeNote":"Curated for CCR clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3187293","version":"1","preferredName":"Radiation Therapy Oncology Group Acute Effect Adverse Event Name","preferredDefinition":"Text name for an acute morbidity event, using criteria from the Radiation Therapy Oncology Group (RTOG) to score/grade adverse events from radiation therapy.","longName":"RTOG_AC_EFF_AE_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"RTOG CRF:Radiation Therapy Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"9AC6E59A-97DC-5F20-E040-BB89AD436844","latestVersionIndicator":"Yes","beginDate":"2011-01-26","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-01-26","modifiedBy":"REEVESD","dateModified":"2016-07-12","changeNote":"Curated for CCR clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3191829","version":"1","preferredName":"Person 2 Minute Walking Rate Predicted Percentage Value","preferredDefinition":"Numeric percentage value to represent a two minute walk distance in feet, divided by two to yield velocity in feet/minute, and then further divided by normative data on walk velocity to yield the value predicted for a person's age range.","longName":"PER_2MN_PRED_PCT_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9C3F4ED9-C1FA-E314-E040-BB89AD4341B8","latestVersionIndicator":"Yes","beginDate":"2011-02-14","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-02-14","modifiedBy":"REEVESD","dateModified":"2011-02-14","changeNote":"Curated for cGVHD trial in CCR","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3191830","version":"1","preferredName":"Person 6 Minute Walking Rate Predicted Percentage","preferredDefinition":"Numeric percentage value to represent a six minute walk distance in feet, divided by two to yield velocity in feet/minute, and then further divided by normative data on walk velocity to yield the value predicted for a person's age range.","longName":"PER_6MN_PRED_PCT_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9C3F4ED9-C226-E314-E040-BB89AD4341B8","latestVersionIndicator":"Yes","beginDate":"2011-02-14","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-02-14","modifiedBy":"REEVESD","dateModified":"2011-02-14","changeNote":"Curated for cGVHD trial in CCR","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3192094","version":"1","preferredName":"Adverse Event Occurrence Indicator","preferredDefinition":"Text indicator of resolved, new or ongoing adverse event activity during a course of therapy.","longName":"AE_OCC_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"9C56580C-A641-A992-E040-BB89AD43107F","latestVersionIndicator":"Yes","beginDate":"2011-02-15","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-02-15","modifiedBy":"REEVESD","dateModified":"2015-05-19","changeNote":"Curated for CCR trials","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3192531","version":"1","preferredName":"Specimen Laboratory Arrival Time","preferredDefinition":"Clock time for the arrival of a biospecimen in a laboratory for processing/testing.","longName":"SPEC_LAB_ARR_TM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9C80BBD3-4B34-2558-E040-BB89AD435ABF","latestVersionIndicator":"Yes","beginDate":"2011-02-17","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-02-17","modifiedBy":"REEVESD","dateModified":"2011-02-22","changeNote":"Curated for CCR trials","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3193829","version":"1","preferredName":"Harvest Procedure Operating Room Entry Time","preferredDefinition":"Clock time at which an individual's body enters the Operating Room (OR) for a tissue harvest procedure.","longName":"HARV_OR_ENT_TM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9D5BDC68-2751-9538-E040-BB89AD433F7F","latestVersionIndicator":"Yes","beginDate":"2011-02-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-02-28","modifiedBy":"REEVESD","dateModified":"2011-03-04","changeNote":"Curated for CCR clinical trial.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3197297","version":"1","preferredName":"Last Contact Time","preferredDefinition":"Clock time of the last successful contact with the patient, family member, or caregiver.","longName":"LAST_CONTACT_TM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9D94CD67-C133-90DF-E040-BB89AD434F30","latestVersionIndicator":"Yes","beginDate":"2011-03-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-03-03","modifiedBy":"REEVESD","dateModified":"2011-03-04","changeNote":"Curated for NCI CCR trials","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3201558","version":"1","preferredName":"Actual Pharmacokinetics Collection Minute Number","preferredDefinition":"Actual sampling schedule time in minutes for the collection of pharmacokinetic data.","longName":"ACT_PK_COLL_MN_NUM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"9E24E347-9DA9-3835-E040-BB89AD4379CD","latestVersionIndicator":"Yes","beginDate":"2011-03-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-03-10","modifiedBy":"REEVESD","dateModified":"2015-03-07","changeNote":"Created for NCI CCR trials","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3209055","version":"1","preferredName":"Unexpected Adverse Event Occurrence Coded Indicator","preferredDefinition":"Text code to signify the occurrence of an adverse event associated with a medical product or procedure that has not been previously observed, whether or not the event was anticipated because of the pharmacologic properties of the study agent or the nature of the medical procedure.","longName":"UNEXP_AE_OCC_CD_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F2CBAC3-48D5-2CE6-E040-BB89AD436195","latestVersionIndicator":"Yes","beginDate":"2011-03-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-03-23","modifiedBy":"HARTLEYG","dateModified":"2013-06-06","changeNote":"Curated for NCI CCR clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3228020","version":"1","preferredName":"Specimen Sampled Type","preferredDefinition":"Text descriptor of body fluid or tissue being sampled.","longName":"SPEC_SMPL_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A0FAC75D-4312-3746-E040-BB89AD43057E","latestVersionIndicator":"Yes","beginDate":"2011-04-15","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-04-15","modifiedBy":"COLBERTM","dateModified":"2019-11-13","changeNote":"5/18/16 jk added to MCL context CSI.    Curated to support NCI CCR trials","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3234083","version":"1","preferredName":"Collection Research Biospecimen Name","preferredDefinition":"Text identification of a biospecimen collected for an individual participating in a research setting.","longName":"COLL_RES_BIOSP_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"A28CB361-DDC2-E660-E040-BB89AD434FBA","latestVersionIndicator":"Yes","beginDate":"2011-05-05","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-05-05","modifiedBy":"REEVESD","dateModified":"2015-05-19","changeNote":"Curated for NCI CCR clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3234550","version":"1","preferredName":"Diagnostic Catheter Type","preferredDefinition":"Name of a catheter used for diagnostic testing/purposes in an individual.","longName":"DIAG_CATH_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A303ADD5-33E5-A055-E040-BB89AD436BE3","latestVersionIndicator":"Yes","beginDate":"2011-05-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-05-11","modifiedBy":"REEVESD","dateModified":"2011-05-12","changeNote":"Curated for NCI CCR clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3234557","version":"1","preferredName":"Implantable Access Port Type","preferredDefinition":"Name of an implantable access port used agent administration or blood sampling in an individual.","longName":"PORT_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A303EEF3-035A-E6DE-E040-BB89AD432283","latestVersionIndicator":"Yes","beginDate":"2011-05-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-05-11","modifiedBy":"REEVESD","dateModified":"2011-05-12","changeNote":"Curated for NCI CCR clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3234563","version":"1","preferredName":"Infusion Catheter Type","preferredDefinition":"Name of a catheter used agent or fluid administration in an individual.","longName":"INF_CATH_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A303EEF3-03F5-E6DE-E040-BB89AD432283","latestVersionIndicator":"Yes","beginDate":"2011-05-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-05-11","modifiedBy":"REEVESD","dateModified":"2011-05-12","changeNote":"Curated for NCI CCR clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3234571","version":"1","preferredName":"Infusion Catheter Tip Placement Anatomic Site","preferredDefinition":"Name of the anatomic site (vessel) in which an infusion catheter tip is placed.","longName":"INF_CATH_PLCM_STE","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A3046782-6AEE-E8E8-E040-BB89AD433610","latestVersionIndicator":"Yes","beginDate":"2011-05-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-05-11","modifiedBy":"REEVESD","dateModified":"2011-05-12","changeNote":"Curated for NCI CCR clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3234575","version":"1","preferredName":"Person Catheter Replacement Indicator","preferredDefinition":"Text term to signify whether a person's catheter was removed and another implanted.","longName":"PERS_CATH_REPL_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A303EEF3-051C-E6DE-E040-BB89AD432283","latestVersionIndicator":"Yes","beginDate":"2011-05-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-05-11","modifiedBy":"REEVESD","dateModified":"2011-05-12","changeNote":"Curated for NCI CCR clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3234576","version":"1","preferredName":"Person Catheter Replacement Date","preferredDefinition":"Calendar date for when a person's catheter was removed and another implanted.","longName":"PERS_CATH_REPL_DT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A303EEF3-061A-E6DE-E040-BB89AD432283","latestVersionIndicator":"Yes","beginDate":"2011-05-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-05-11","modifiedBy":"REEVESD","dateModified":"2011-05-12","changeNote":"Curated for NCI CCR clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3234620","version":"1","preferredName":"Person Portacath Replacement Indicator","preferredDefinition":"Text term to signify whether a person's implanted access port was removed and another implanted.","longName":"PERS_PORT_REPL_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A31354FC-CB58-2A7A-E040-BB89AD4312B1","latestVersionIndicator":"Yes","beginDate":"2011-05-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-05-12","modifiedBy":"REEVESD","dateModified":"2011-05-12","changeNote":"Curated for NCI CCR clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3234621","version":"1","preferredName":"Person Port Replacement Date","preferredDefinition":"Calendar date for when a person's implanted access port was removed and another implanted.","longName":"PERS_PORT_REPL_DT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A31354FC-CB84-2A7A-E040-BB89AD4312B1","latestVersionIndicator":"Yes","beginDate":"2011-05-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-05-12","modifiedBy":"REEVESD","dateModified":"2011-05-12","changeNote":"Curated for NCI CCR clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3237315","version":"1","preferredName":"Radioisotope Scheduled Dose Administration Indicator","preferredDefinition":"Text term to signify whether the scheduled dose of a radiotracer/radioisotope was administered to a patient.","longName":"RAD_SCH_DOSE_ADM_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A3F64E1C-32B2-4144-E040-BB89AD432DD4","latestVersionIndicator":"Yes","beginDate":"2011-05-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-05-23","modifiedBy":"REEVESD","dateModified":"2011-05-23","changeNote":"Curated for NCI CCR clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3240882","version":"2","preferredName":"Acute Graft Versus Host Disease Flare Last Medical Examination Indicator","preferredDefinition":"Text term to signify whether a patient experienced a sudden flare or worsening of symptoms associated with acute Graft vs. Host Disease (AGVHD) since last examination.","longName":"AGVHD_FLARE_EXM_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7B108C00-707D-32F2-E053-F662850AA634","latestVersionIndicator":"Yes","beginDate":"2018-11-20","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-11-20","modifiedBy":"COOPERM","dateModified":"2018-11-20","changeNote":"Curated for NCI CCR clinical trial. Versioned to replace VD with indicator standard VD. 11.20.18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3240891","version":"1","preferredName":"Acute Graft Versus Host Disease Flare Last Medical Examination CTMS Date","preferredDefinition":"Date of the onset of a flare or worsening of symptoms associated with acute Graft vs. Host Disease (AGVHD) that occurred since the last examination.","longName":"AGVHD_FLARE_EXAM_DT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"A4304A99-CC25-642B-E040-BB89AD4359E0","latestVersionIndicator":"Yes","beginDate":"2011-05-26","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-05-26","modifiedBy":"REEVESD","dateModified":"2015-03-07","changeNote":"Curated for NCI CCR clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3240929","version":"2","preferredName":"Person Cytogenetic Remission Bone Marrow Occurrence Indicator","preferredDefinition":"Text term to signify whether a person achieved a positive disease response based on cytogenetic analysis of a bone marrow sample.","longName":"PER_CYT_REM_BM_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"ACC870DE-25AC-48CA-E053-4EBD850AFE2D","latestVersionIndicator":"Yes","beginDate":"2020-08-13","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-08-13","modifiedBy":"COOPERM","dateModified":"2020-08-13","changeNote":"Versioned to replace retired VD. mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3240955","version":"1","preferredName":"Acute Graft Versus Host Disease Diagnosis Type","preferredDefinition":"Text term to further classify a diagnosis of acute Graft vs. Host Disease (AGVHD).","longName":"AGVHD_DX_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"A43302C5-0D9E-1B6B-E040-BB89AD437D83","latestVersionIndicator":"Yes","beginDate":"2011-05-26","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-05-26","modifiedBy":"REEVESD","dateModified":"2015-03-07","changeNote":"Curated for NCI CCR clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3242917","version":"1","preferredName":"Transplantation Infection Source","preferredDefinition":"The grafting of tissues from one individual to another or place to place within a single individual._A disorder resulting from the presence and activity of a microbial, viral, or parasitic agent. It can be transmitted by direct or indirect contact. -- 2003_Source; where something is available._A disorder resulting from the presence and activity of a microbial, viral, or parasitic agent. It can be transmitted by direct or indirect contact. -- 2003_Source; where something is available.","longName":"TXPLT_INF_SRCE","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A52FED45-79AE-572C-E040-BB89AD436917","latestVersionIndicator":"Yes","beginDate":"2011-06-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-06-08","modifiedBy":"REEVESD","dateModified":"2011-06-14","changeNote":"Curated for NCI CCR Transplantation clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3244952","version":"1","preferredName":"Malignant Neoplasm Transplantation Timepoint Response Category","preferredDefinition":"Text term designating the disease response of an individual at the time of transplantation.","longName":"TUM_TXPLT_RESP_CAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A5C68EF1-9A76-F144-E040-BB89AD436767","latestVersionIndicator":"Yes","beginDate":"2011-06-15","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-06-15","modifiedBy":"REEVESD","dateModified":"2016-09-01","changeNote":"Curated for NCI CCR transplantation protocol","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3245943","version":"1","preferredName":"First Erythrocyte Count 8 For 30 Day Without Blood Transfusion Date","preferredDefinition":"First date of 30 days in which the hemoglobin of a patient reaches a value of 8 grams per deciliter without the use of transfusion(s).","longName":"FIR_RBC8_30D_NOTX_DT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A638B7C9-BF93-5BA6-E040-BB89AD4340B3","latestVersionIndicator":"Yes","beginDate":"2011-06-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-06-21","modifiedBy":"REEVESD","dateModified":"2011-06-21","changeNote":"Curated for NCI CCR Transplantation protocol","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3253413","version":"1","preferredName":"Kaposi Sarcoma Response Code","preferredDefinition":"Code to signify the response of a patient with Kaposi's Sarcoma (KS) to treatment.","longName":"KS_RESP_CD","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A80C21D3-E882-4D9C-E040-BB89AD435885","latestVersionIndicator":"Yes","beginDate":"2011-07-14","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-07-14","modifiedBy":"REEVESD","dateModified":"2011-07-14","changeNote":"Curated for NCI CCR clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3263237","version":"1","preferredName":"Person Disability Indicator","preferredDefinition":"Text indicator to signify whether an individual states he/she is on disability at the time of questioning.","longName":"PER_DISBL_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AAC6859E-93B1-C262-E040-BB89AD431431","latestVersionIndicator":"Yes","beginDate":"2011-08-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-08-18","modifiedBy":"ZHWENDY","dateModified":"2023-08-16","changeNote":"Curated to support NCI CCR ETIB trial","administrativeNotes":"2023.08.16: Added AQT per  cadsr0002759.wz","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3263238","version":"1","preferredName":"Person Search Employment Opportunities Indicator","preferredDefinition":"Text term to signify whether an individual is seeking full-time or part-time employment at the time of questioning.","longName":"PER_EMPL_SRCH_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AAC6859E-93D0-C262-E040-BB89AD431431","latestVersionIndicator":"Yes","beginDate":"2011-08-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-08-18","modifiedBy":"REEVESD","dateModified":"2011-08-18","changeNote":"Curated to support NCI CCR ETIB trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3263239","version":"1","preferredName":"Person Retirement Indicator","preferredDefinition":"Text indicator to signify whether an individual identifies retirement status at the time of questioning.","longName":"PER_RETMT_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AAC6859E-93EF-C262-E040-BB89AD431431","latestVersionIndicator":"Yes","beginDate":"2011-08-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-08-18","modifiedBy":"REEVESD","dateModified":"2011-08-18","changeNote":"Curated to support NCI CCR ETIB trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3263240","version":"1","preferredName":"Infection Prior One Year Present Indicator","preferredDefinition":"Text indicator to signify whether an individual identifies a history of having an infection within the year prior to questioning.","longName":"INF_PRIOR_YR_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AAC6859E-940E-C262-E040-BB89AD431431","latestVersionIndicator":"Yes","beginDate":"2011-08-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-08-18","modifiedBy":"REEVESD","dateModified":"2011-08-18","changeNote":"Curated to support NCI CCR ETIB trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3263241","version":"1","preferredName":"Intravenous Treatment Or Hospitalization Infection Prior One Year Present Indicator","preferredDefinition":"Text indicator to signify whether an individual has a history of intravenous treatment(s) or hospitalization to treat an infection during the year prior to questioning.","longName":"IV_HOSP_INF_YR_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AAC6859E-942D-C262-E040-BB89AD431431","latestVersionIndicator":"Yes","beginDate":"2011-08-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-08-18","modifiedBy":"FORMBUILDER","dateModified":"2014-07-29","changeNote":"Curated to support NCI CCR ETIB trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3265499","version":"3","preferredName":"AIDS-Related Kaposi Sarcoma Tumor Extent Stage","preferredDefinition":"Term to describe the disease stage for an individual with AIDS-related Kaposi's sarcoma, using the AIDS Clinical Trials group staging classification to evaluate extent of tumor present.","longName":"AIDSKS_TUM_EXT_STG","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"ACTG TIS Classification:AIDS Clinical Trials Group staging classification for AIDS-associated Kaposi's sarcoma","workflowStatus":"RELEASED","registrationStatus":"Application","id":"51E41299-0F46-1812-E053-F662850A9C67","latestVersionIndicator":"Yes","beginDate":"2017-06-13","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-06-13","modifiedBy":"COOPERM","dateModified":"2017-06-13","changeNote":"Curated for NCI CCR trial; v2.0 replaces v1.0 with reworked Value domain and permissible value set 6.13.17 v3.0 includes precoordinated concept annotation for VMs plus 1 additional PV. mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3265500","version":"2","preferredName":"AIDS-Related Kaposi Sarcoma Immunosuppression Extent Stage","preferredDefinition":"Term to describe the disease stage for an individual with AIDS-related Kaposi's sarcoma, using the AIDS Clinical Trials group staging classification to evaluate the degree of immunosuppression present.","longName":"AIDSKS_IMMUN_EXT_STG","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"ACTG TIS Classification:AIDS Clinical Trials Group staging classification for AIDS-associated Kaposi's sarcoma","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"BCB5619C-8EB1-3686-E040-BB89AD43356C","latestVersionIndicator":"Yes","beginDate":"2011-08-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-04-02","modifiedBy":"REEVESD","dateModified":"2015-05-19","changeNote":"Curated for NCI CCR trial; v2.0 replaces v1.0 with reworked Value domain and permissible value set","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3265501","version":"1","preferredName":"AIDS-Related Kaposi Sarcoma Systemic Illness Stage","preferredDefinition":"Term to describe the disease stage for an individual with AIDS-related Kaposi's sarcoma, using the AIDS Clinical Trials group staging classification to evaluate the degree of Immunosuppression present based on CD4 cell count.","longName":"AIDSKS_SYS_ILL_STG","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"ACTG TIS Classification:AIDS Clinical Trials Group staging classification for AIDS-associated Kaposi's sarcoma","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"ABBDB1FF-1548-6351-E040-BB89AD4318BE","latestVersionIndicator":"Yes","beginDate":"2011-08-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-08-30","modifiedBy":"REEVESD","dateModified":"2015-05-19","changeNote":"Curated for NCI CCR trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3265623","version":"1","preferredName":"Leukemic Leptomeningeal Central Nervous System Disease Diagnosis Occurrence Indicator","preferredDefinition":"Text term to signify whether leptomeningeal disease was present in the central nervous system (CNS) at the time an individual was diagnosed with leukemia.","longName":"LPTM_CNS_DX_OCC_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"ABD14CC7-4B5F-8EC1-E040-BB89AD43561F","latestVersionIndicator":"Yes","beginDate":"2011-08-31","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-08-31","modifiedBy":"REEVESD","dateModified":"2011-08-31","changeNote":"Curated to support NCI CCR clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3265624","version":"1","preferredName":"Leukemic Extramedullary Central Nervous System Disease Diagnosis Occurrence Indicator","preferredDefinition":"Text term to signify whether leptomeningeal disease was present in the central nervous system (CNS) at the time an individual was diagnosed with leukemia.","longName":"EXTRM_CNS_DX_OCC_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"ABD14CC7-4B7E-8EC1-E040-BB89AD43561F","latestVersionIndicator":"Yes","beginDate":"2011-08-31","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-08-31","modifiedBy":"BROWNTY","dateModified":"2022-04-21","changeNote":"Curated to support NCI CCR clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3297239","version":"1","preferredName":"Person Brief Ataxia Rating Scale Total Score","preferredDefinition":"Numeric value representing the score on the Brief Ataxia Rating Scale (BARS).","longName":"PER_BARS_TTL_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AFCE9A84-25E8-58F6-E040-BB89AD430157","latestVersionIndicator":"Yes","beginDate":"2011-10-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-10-21","modifiedBy":"LUY","dateModified":"2013-10-22","changeNote":"Curated for NCI CCR ETIB clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3298542","version":"1","preferredName":"Patient Eligibility Confirmation Code Indicator","preferredDefinition":"Code that signifies whether an individual has met eligibility requirements for protocol enrollment.","longName":"PT_ELIG_CD_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B04AC04D-C241-0627-E040-BB89AD432C31","latestVersionIndicator":"Yes","beginDate":"2011-10-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-10-27","modifiedBy":"SOKKERL","dateModified":"2019-10-17","changeNote":"Curated to support NCI CCR 2011 protocol template","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3298921","version":"1","preferredName":"Graft Versus Host Disease Preventive Intervention Therapy Type","preferredDefinition":"Text name of  the agent administered to an individual as part of Graft vs Host Disease (GVHD) prophylaxis.","longName":"GVHD_PREV_INT_TX_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B0C75B1F-DF67-A8AF-E040-BB89AD436668","latestVersionIndicator":"Yes","beginDate":"2011-11-02","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-11-02","modifiedBy":"ZHWENDY","dateModified":"2022-07-20","changeNote":"Curated to support NCI CCR Transplantation trial","administrativeNotes":"7/20/2022: fixed the box symbol in AQT.wz","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3298927","version":"1","preferredName":"Graft Versus Host Disease Other Preventive Intervention Administration Text","preferredDefinition":"Name of a prophylactic agent administered to an individual with Graft vs Host Disease (GVHD) which is different from the one(s) previously specified.","longName":"GVHD_OTX_PREV_TX_TXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B0C75B1F-DFE1-A8AF-E040-BB89AD436668","latestVersionIndicator":"Yes","beginDate":"2011-11-02","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-11-02","modifiedBy":"REEVESD","dateModified":"2011-11-02","changeNote":"Curated to support NCI CCR Transplantation trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3340437","version":"1","preferredName":"Person Human Immunodeficiency Virus Physical Well-being Assessment Result FAHI SubScale Score","preferredDefinition":"Numeric value to represent the score of an individual assessed with the Physical Well-Being subscale of the Functional Assessment of HIV Infection (FAHI) questionnaire.","longName":"PER_PHYS_WB_FAHI_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B53A6DF2-4C65-7FC1-E040-BB89AD437C9B","latestVersionIndicator":"Yes","beginDate":"2011-12-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-12-29","modifiedBy":"COOPERM","dateModified":"2015-09-24","changeNote":"Functional Assessment of HIV Infection (revised; Peterman, Cella, Mo, & McCain, 1997) subdomain and total scores collected.  Curated to support NCI CCR HIV trial.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3340438","version":"1","preferredName":"Person Human Immunodeficiency Virus Emotional Well-being Assessment Result FAHI SubScale Score","preferredDefinition":"Numeric value to represent the score of an individual assessed with the Emotional Well-Being subscale of the Functional Assessment of HIV Infection (FAHI) questionnaire.","longName":"PER_EMOT_WB_FAHI_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B53A6DF2-4C84-7FC1-E040-BB89AD437C9B","latestVersionIndicator":"Yes","beginDate":"2011-12-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-12-29","modifiedBy":"COOPERM","dateModified":"2015-09-24","changeNote":"Functional Assessment of HIV Infection (revised; Peterman, Cella, Mo, & McCain, 1997) subdomain and total scores collected.  Curated to support NCI CCR HIV trial.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3340439","version":"1","preferredName":"Person Human Immunodeficiency Virus Kaposi Sarcoma Assessment Result FAHI SubScale Score","preferredDefinition":"Numeric value to represent the score of an individual assessed with the Living with Kaposi Sarcoma (KS) subscale of the Functional Assessment of HIV Infection (FAHI) questionnaire.","longName":"PER_KS_WB_FAHI_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B53A6DF2-4CA3-7FC1-E040-BB89AD437C9B","latestVersionIndicator":"Yes","beginDate":"2011-12-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-12-29","modifiedBy":"COOPERM","dateModified":"2015-09-24","changeNote":"Functional Assessment of HIV Infection (revised; Peterman, Cella, Mo, & McCain, 1997) subdomain and total scores collected.  Curated to support NCI CCR HIV trial.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3340440","version":"1","preferredName":"Person Human Immunodeficiency Virus Functional Well-being Result FAHI SubScale Score","preferredDefinition":"Numeric value to represent the score of an individual assessed with the Functional and Global Well-being subscale of the Functional Assessment of HIV Infection (FAHI) questionnaire.","longName":"PER_FUNC_WB_FAHI_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B53A6DF2-4CC2-7FC1-E040-BB89AD437C9B","latestVersionIndicator":"Yes","beginDate":"2011-12-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-12-29","modifiedBy":"COOPERM","dateModified":"2015-09-24","changeNote":"Functional Assessment of HIV Infection (revised; Peterman, Cella, Mo, & McCain, 1997) subdomain and total scores collected.  Curated to support NCI CCR HIV trial.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3340441","version":"1","preferredName":"Person Human Immunodeficiency Virus Social Well-being Result FAHI SubScale Score","preferredDefinition":"Numeric value to represent the score of an individual assessed with the Social Well-being subscale of the Functional Assessment of HIV Infection (FAHI) questionnaire.","longName":"PER_SOC_WB_FAHI_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B53A6DF2-4CE1-7FC1-E040-BB89AD437C9B","latestVersionIndicator":"Yes","beginDate":"2011-12-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-12-29","modifiedBy":"COOPERM","dateModified":"2015-09-24","changeNote":"Functional Assessment of HIV Infection (revised; Peterman, Cella, Mo, & McCain, 1997) subdomain and total scores collected.  Curated to support NCI CCR HIV trial.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3340442","version":"1","preferredName":"Person Human Immunodeficiency Virus Cognitive Function Result FAHI SubScale Score","preferredDefinition":"Numeric value to represent the score of an individual assessed with the Cognitive Functioning subscale of the Functional Assessment of HIV Infection (FAHI) questionnaire.","longName":"PER_COGN_WB_FAHI_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B53A6DF2-4D00-7FC1-E040-BB89AD437C9B","latestVersionIndicator":"Yes","beginDate":"2011-12-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-12-29","modifiedBy":"COOPERM","dateModified":"2015-09-24","changeNote":"Functional Assessment of HIV Infection (revised; Peterman, Cella, Mo, & McCain, 1997) subdomain and total scores collected.  Curated to support NCI CCR HIV trial.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3340443","version":"1","preferredName":"Person Human Immunodeficiency Virus Additional Concern Result FAHI SubScale Score","preferredDefinition":"Numeric value to represent the score of an individual assessed with the Additional Concerns subscale of the Functional Assessment of HIV Infection (FAHI) questionnaire.","longName":"PER_ADD_CONC_FAHI_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B53A6DF2-4D1F-7FC1-E040-BB89AD437C9B","latestVersionIndicator":"Yes","beginDate":"2011-12-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-12-29","modifiedBy":"PRICEA","dateModified":"2013-10-23","changeNote":"Functional Assessment of HIV Infection (revised; Peterman, Cella, Mo, & McCain, 1997) subdomain and total scores collected.  Curated to support NCI CCR HIV trial.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3340444","version":"1","preferredName":"Person Human Immunodeficiency Virus FAHI Total Score","preferredDefinition":"Numeric value to represent the total score of an individual assessed with the Functional Assessment of HIV Infection (FAHI) questionnaire.","longName":"PER_FAHI_TTL_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B53A6DF2-4D3E-7FC1-E040-BB89AD437C9B","latestVersionIndicator":"Yes","beginDate":"2011-12-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-12-29","modifiedBy":"COOPERM","dateModified":"2015-09-24","changeNote":"Functional Assessment of HIV Infection (revised; Peterman, Cella, Mo, & McCain, 1997) subdomain and total scores collected.  Curated to support NCI CCR HIV trial.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3370608","version":"1","preferredName":"Data Entry Certification Occurrence Date","preferredDefinition":"Calendar date on which a collection of entered data is reviewed, assessed and validated.","longName":"DATA_ENT_CERT_DT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B84DB87E-EBA3-21D4-E040-BB89AD436BB9","latestVersionIndicator":"Yes","beginDate":"2012-02-06","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-02-06","modifiedBy":"REEVESD","dateModified":"2012-02-06","changeNote":"Curated to support NCI CCR clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3370609","version":"1","preferredName":"Data Entry Certification Occurrence Initials Name","preferredDefinition":"Initials (First, Middle, Last) of the individual who reviewed, assessed and validated a collection of entered data.","longName":"DATA_ENT_CERT_INIT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B84DB87E-EBC2-21D4-E040-BB89AD436BB9","latestVersionIndicator":"Yes","beginDate":"2012-02-06","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-02-06","modifiedBy":"REEVESD","dateModified":"2012-02-06","changeNote":"Curated to support NCI CCR clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3371630","version":"1","preferredName":"Patient Death Location Code","preferredDefinition":"Code to capture the location of a patient's death.","longName":"PT_DTH_LCTN_CD","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B861EE80-1002-FCEF-E040-BB89AD4377D6","latestVersionIndicator":"Yes","beginDate":"2012-02-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-02-07","modifiedBy":"REEVESD","dateModified":"2012-02-07","changeNote":"Curated for NCI CCR clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3373419","version":"1","preferredName":"Oral Chronic Graft Versus Host Disease Prior Therapy Administration Indicator","preferredDefinition":"Text term to signify whether prior therapy for oral chronic graft vs. host disease (cGVHD) was administered.","longName":"ORAL_CGVHD_TX_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B877A62F-3ED5-FE49-E040-BB89AD43499A","latestVersionIndicator":"Yes","beginDate":"2012-02-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-02-08","modifiedBy":"REEVESD","dateModified":"2012-02-08","changeNote":"Curated for NCI CCR clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3377357","version":"1","preferredName":"Prior Therapy Administered Agent Name","preferredDefinition":"Text name for a therapeutic agent administered to treat the condition/disease under investigation before the start date of a clinical trial or research study.","longName":"PRIOR_TX_AGT_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B8DE5037-ADF4-9462-E040-BB89AD432B92","latestVersionIndicator":"Yes","beginDate":"2012-02-13","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-02-13","modifiedBy":"ROUILLAS","dateModified":"2015-09-18","changeNote":"Curated to provide an enumerated set of values for prior therapy","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3408549","version":"1","preferredName":"Patient Oral Pain Assessment Visual Analog Scale Value","preferredDefinition":"Numeric value to represent a patient's self-identified oral pain intensity on a 10 point Visual Analog Scale (VAS), in which '0' is no pain and '10' is the worst pain.","longName":"ORAL_PN_VAS_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BAAA3DC4-6016-572D-E040-BB89AD430E2A","latestVersionIndicator":"Yes","beginDate":"2012-03-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-03-07","modifiedBy":"PRICEA","dateModified":"2013-10-23","changeNote":"Curated for NCI CCR ETIB clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3408554","version":"1","preferredName":"Patient Oral Sensitivity Assessment Visual Analog Scale Value","preferredDefinition":"Numeric value to represent a patient's self-identified oral sensitivity intensity on a 10 point Visual Analog Scale (VAS), in which '0' is no sensitivity and '10' is the worst sensitivity.","longName":"ORAL_SENS_VAS_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BAAA3DC4-608A-572D-E040-BB89AD430E2A","latestVersionIndicator":"Yes","beginDate":"2012-03-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-03-07","modifiedBy":"PRICEA","dateModified":"2013-10-23","changeNote":"Curated for NCI CCR ETIB clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3408559","version":"1","preferredName":"Patient Oral Dryness Assessment Visual Analog Scale Value","preferredDefinition":"Numeric value to represent a patient's self-identified oral dryness intensity on a 10 point Visual Analog Scale (VAS), in which '0' is no dryness and '10' is the worst dryness.","longName":"ORAL_DRY_VAS_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BAAA3DC4-60FF-572D-E040-BB89AD430E2A","latestVersionIndicator":"Yes","beginDate":"2012-03-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-03-07","modifiedBy":"PRICEA","dateModified":"2013-10-23","changeNote":"Curated for NCI CCR ETIB clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3408916","version":"1","preferredName":"Oral Cavity 2 Week Prior Assessment Scale Result","preferredDefinition":"Text term to describe a patient's perception of changes in their oral cavity condition compare to two weeks ago.","longName":"OR_2WK_PR_ASSESS_RSL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BAABB968-E2E8-33AD-E040-BB89AD4339C0","latestVersionIndicator":"Yes","beginDate":"2012-03-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-03-07","modifiedBy":"REEVESD","dateModified":"2012-03-07","changeNote":"Curated for NCI CCR ETIB clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3411454","version":"1","preferredName":"Patient Data Statistical Analysis Inclusion Indicator","preferredDefinition":"Text term to signify whether a patient's data is to be included in statistical analysis procedures.","longName":"PT_DATA_ANLY_INC_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BAADC058-F145-6672-E040-BB89AD436AB1","latestVersionIndicator":"Yes","beginDate":"2012-03-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-03-07","modifiedBy":"REEVESD","dateModified":"2012-03-07","changeNote":"Curated to support NCI CCR NOB clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3422240","version":"1","preferredName":"Person Affective Oral Pain At Rest Type","preferredDefinition":"Text term that identifies an aspect of affective pain at rest as described by a person with oral pain.","longName":"AFF_ORL_PN_RST_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"POM:Pain-O-Meter","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"BC3C8C88-9C85-6712-E040-BB89AD437A00","latestVersionIndicator":"Yes","beginDate":"2012-03-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-03-27","modifiedBy":"REEVESD","dateModified":"2012-03-28","changeNote":"CDEs support the Pain-O-Meter (POM) measure of pain.  Permissible values should not be extended or changed.  CDEs curated for NCI CCR clinical trial.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3422951","version":"1","preferredName":"Person Affective Oral Pain Swallowing Type","preferredDefinition":"Text term that identifies an aspect of sensory pain that occurs during swallowing as described by a person with oral pain.","longName":"AFF_ORL_PN_SWL_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"POM:Pain-O-Meter","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"BC3EF5E0-5746-5A57-E040-BB89AD431322","latestVersionIndicator":"Yes","beginDate":"2012-03-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-03-27","modifiedBy":"REEVESD","dateModified":"2012-03-28","changeNote":"CDEs support the Pain-O-Meter (POM) measure of pain.  Permissible values should not be extended or changed.  CDEs curated for NCI CCR clinical trial.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3422958","version":"1","preferredName":"Person Sensory Oral Pain At Rest Type","preferredDefinition":"Text term that identifies an aspect of sensory pain at rest as described by a person with oral pain.","longName":"SEN_ORL_PN_RST_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"POM:Pain-O-Meter","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"BC3EF5E0-5765-5A57-E040-BB89AD431322","latestVersionIndicator":"Yes","beginDate":"2012-03-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-03-27","modifiedBy":"REEVESD","dateModified":"2012-03-28","changeNote":"CDEs support the Pain-O-Meter (POM) measure of pain.  Permissible values should not be extended or changed.  CDEs curated for NCI CCR clinical trial.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3422959","version":"1","preferredName":"Person Sensory Oral Pain Swallowing Type","preferredDefinition":"Text term that identifies an aspect of sensory pain that occurs during swallowing as described by a person with oral pain.","longName":"SEN_ORL_PN_SWL_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"POM:Pain-O-Meter","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"BC3F35EE-7E2E-1DC6-E040-BB89AD435A81","latestVersionIndicator":"Yes","beginDate":"2012-03-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-03-27","modifiedBy":"REEVESD","dateModified":"2012-03-28","changeNote":"CDEs support the Pain-O-Meter (POM) measure of pain.  Permissible values should not be extended or changed.  CDEs curated for NCI CCR clinical trial.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3422978","version":"1","preferredName":"Person Oral Pain At Rest Duration Category","preferredDefinition":"Text term that best describes the duration pattern at rest for a person with oral pain.","longName":"PER_ORL_PN_RST_DUR_","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"POM:Pain-O-Meter","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"BC3FA497-ECB2-F133-E040-BB89AD435473","latestVersionIndicator":"Yes","beginDate":"2012-03-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-03-27","modifiedBy":"REEVESD","dateModified":"2012-03-28","changeNote":"CDEs support the Pain-O-Meter (POM) measure of pain.  Permissible values should not be extended or changed.  CDEs curated for NCI CCR clinical trial.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3422979","version":"1","preferredName":"Person Oral Pain Swallowing Duration Category","preferredDefinition":"Text term that best describes the duration pattern at rest for a person with oral pain.","longName":"PER_ORL_PN_SWL_DUR_","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"POM:Pain-O-Meter","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"BC3FA497-ECD1-F133-E040-BB89AD435473","latestVersionIndicator":"Yes","beginDate":"2012-03-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-03-27","modifiedBy":"REEVESD","dateModified":"2012-03-28","changeNote":"CDEs support the Pain-O-Meter (POM) measure of pain.  Permissible values should not be extended or changed.  CDEs curated for NCI CCR clinical trial.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3422980","version":"1","preferredName":"Person Sensory Oral Pain Weighted Value","preferredDefinition":"Numeric value to represent the weighted score for sensory oral pain using word descriptors from the Painometer (POM).","longName":"PER_SEN_OR_PN_WT_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"POM:Pain-O-Meter","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"BC3FB4F4-D43F-B30B-E040-BB89AD431875","latestVersionIndicator":"Yes","beginDate":"2012-03-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-03-27","modifiedBy":"PRICEA","dateModified":"2013-10-25","changeNote":"CDEs support the Pain-O-Meter (POM) measure of pain.  Permissible values should not be extended or changed.  CDEs curated for NCI CCR clinical trial.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3422982","version":"1","preferredName":"Person Affective Oral Pain Weighted Value","preferredDefinition":"Numeric value to represent the weighted score for affective oral pain using word descriptors from the Painometer (POM).","longName":"PER_AFF_OR_PN_WT_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"POM:Pain-O-Meter","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"BC3FB4F4-D4F3-B30B-E040-BB89AD431875","latestVersionIndicator":"Yes","beginDate":"2012-03-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-03-27","modifiedBy":"PRICEA","dateModified":"2013-10-25","changeNote":"CDEs support the Pain-O-Meter (POM) measure of pain.  Permissible values should not be extended or changed.  CDEs curated for NCI CCR clinical trial.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3422983","version":"1","preferredName":"Person Sensory Oral Total Pain Score","preferredDefinition":"Numeric value to represent the sum of all intensity values for sensory oral pain.","longName":"PER_SEN_ORL_TL_PN_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"POM:Pain-O-Meter","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"BC3FA497-ECF0-F133-E040-BB89AD435473","latestVersionIndicator":"Yes","beginDate":"2012-03-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-03-27","modifiedBy":"REEVESD","dateModified":"2013-09-18","changeNote":"CDEs support the Pain-O-Meter (POM) measure of pain.  Permissible values should not be extended or changed.  CDEs curated for NCI CCR clinical trial.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3422984","version":"1","preferredName":"Person Affective Oral Total Pain Score","preferredDefinition":"Numeric value to represent the sum of all intensity values for affective oral pain.","longName":"PER_AFF_ORL_PN_TL_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"POM:Pain-O-Meter","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"BC3FA497-ED0F-F133-E040-BB89AD435473","latestVersionIndicator":"Yes","beginDate":"2012-03-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-03-27","modifiedBy":"PRICEA","dateModified":"2013-10-25","changeNote":"CDEs support the Pain-O-Meter (POM) measure of pain.  Permissible values should not be extended or changed.  CDEs curated for NCI CCR clinical trial.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3422985","version":"1","preferredName":"Person Oral Pain Intensity Total Score","preferredDefinition":"Numeric value to represent the sum of both sensory and affective oral pain scores using the Painometer (POM) measure.","longName":"PER_ORL_PN_TTL_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"POM:Pain-O-Meter","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"BC3FA497-ED31-F133-E040-BB89AD435473","latestVersionIndicator":"Yes","beginDate":"2012-03-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-03-27","modifiedBy":"PRICEA","dateModified":"2013-10-25","changeNote":"CDEs support the Pain-O-Meter (POM) measure of pain.  Permissible values should not be extended or changed.  CDEs curated for NCI CCR clinical trial.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3431294","version":"1","preferredName":"Lesion Diameter Measurement","preferredDefinition":"Measurement of a lesion/tumor or location in the \"X\" (first or length) dimension in millimeters; this is the longest measurement or largest value if only one measurement is captured.","longName":"MSRMT_X_MM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BCDEF3E0-01D2-67A7-E040-BB89AD437539","latestVersionIndicator":"Yes","beginDate":"2012-04-04","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-04-04","modifiedBy":"HARTLEYG","dateModified":"2019-04-29","changeNote":"Curated to support Duke University Sarcoma trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3436491","version":"1","preferredName":"Acute Graft Versus Host Disease Maximum Severity Index Grade","preferredDefinition":"Grade to signify the overall intensity of liver, gastrointestinal, and skin signs and symptoms in a person with acute Graft versus Host Disease (GVHD).","longName":"AGVHD_MAX_SEV_IDX_GD","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"IBMTR:International Bone Marrow Transplant Registry","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"BD6BD69E-DF3C-248F-E040-BB89AD4321A9","latestVersionIndicator":"Yes","beginDate":"2012-04-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-04-11","modifiedBy":"REEVESD","dateModified":"2015-03-07","changeNote":"Curated to support NCI CCR trial.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3461036","version":"1","preferredName":"Evaluation Day Of The Week Name","preferredDefinition":"Any of the seven named, 24-hour divisions of a calendar week during which an evaluation is performed.","longName":"EVAL_DAY_WK_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"C00E0D44-CD78-40A6-E040-BB89AD4373E8","latestVersionIndicator":"Yes","beginDate":"2012-05-15","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-05-15","modifiedBy":"REEVESD","dateModified":"2015-05-19","changeNote":"Curated for NCI CCR protocol","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3462265","version":"1","preferredName":"Chronic Graft Versus Host Disease Immunosuppression Stratification Category","preferredDefinition":"Stratification classification to signify the intensity of immunosuppression in an individual with chronic Graft Versus Host Disease (GVHD).","longName":"CGVHD_IMM_STRAT_CAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"C0B0DBF3-FFE8-CE57-E040-BB89AD430C3E","latestVersionIndicator":"Yes","beginDate":"2012-05-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-05-23","modifiedBy":"REEVESD","dateModified":"2015-05-19","changeNote":"Created for NCI CCR clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3553260","version":"1","preferredName":"Response Assessment Myeloma Status Category","preferredDefinition":"Text term to define the result of myeloma after therapeutic intervention/treatment.","longName":"RESP_ASSESS_MYL_CAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C6BFBB7F-48CB-518F-E040-BB89AD431BA0","latestVersionIndicator":"Yes","beginDate":"2012-08-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-08-08","modifiedBy":"REEVESD","dateModified":"2012-08-13","changeNote":"Curated to support NCI CCR clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3595650","version":"1","preferredName":"Chronic Graft Versus Host Disease NIH Consensus Response Criteria Type","preferredDefinition":"Result of assessment of chronic Graft versus Host Disease (cGVHD) post treatment using the NIH Consensus Response criteria.","longName":"CGVHD_NIH_CON_RES_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"CA6AC159-5AC9-B7AA-E040-BB89AD430D21","latestVersionIndicator":"Yes","beginDate":"2012-09-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-09-23","modifiedBy":"REEVESD","dateModified":"2015-05-19","changeNote":"Curated to support NCI CCR Transplanation trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3595924","version":"1","preferredName":"Minimal Residual Disease Status","preferredDefinition":"Text term to signify the presence of a remainder of a tumor or a site of disease after therapy.","longName":"MRD_STAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CA82209A-0473-186C-E040-BB89AD431DA3","latestVersionIndicator":"Yes","beginDate":"2012-09-25","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-09-25","modifiedBy":"WINCHC","dateModified":"2022-04-26","changeNote":"Curated to support NCI CCR trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3597277","version":"1","preferredName":"Timepoint Post Transplantation Name","preferredDefinition":"Text term to identify a study timepoint at which transplantation engraftment status is assessed.","longName":"TMPT_POST_TXPLT_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CA987FDD-7827-D3D1-E040-BB89AD43197E","latestVersionIndicator":"Yes","beginDate":"2012-09-26","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-09-26","modifiedBy":"REEVESD","dateModified":"2012-09-26","changeNote":"Curated to support NCI CCR transplantation trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3597284","version":"1","preferredName":"Prior Bone Marrow Stem Cell Transplantation Comorbidity Index Weighted Score","preferredDefinition":"Numeric score applied when assessing comorbidity(ies) associated with hematopoietic cell transplantion (HCT).","longName":"HCT_CI_WT_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CA98DD63-6927-EAF0-E040-BB89AD4350E8","latestVersionIndicator":"Yes","beginDate":"2012-09-26","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-09-26","modifiedBy":"REEVESD","dateModified":"2012-09-26","changeNote":"Curated to support NCI CCR transplantation trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3597293","version":"1","preferredName":"Hematopoietic Cell Transplant Relapse Risk Category","preferredDefinition":"Classification to signify the likelihood of recurrence of malignancy following hematopoietic cell transplantation, based on one or more of the following parameters: marrow morphology, flow cytometry, cytogenetic studies, including fluorescence in situ hybridization, electrophoresis, immunofixation assays, and polymerase chain reaction-based assays for disease  markers, or imaging results.","longName":"HCT_REL_RSK_CAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CA98DD63-6A0B-EAF0-E040-BB89AD4350E8","latestVersionIndicator":"Yes","beginDate":"2012-09-26","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-09-26","modifiedBy":"REEVESD","dateModified":"2012-09-26","changeNote":"Curated to support NCI CCR transplant trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3679494","version":"1","preferredName":"Skin Quality of Life Reduced Work Activity Assessment Three Point Scale","preferredDefinition":"Numeric response to a question that asks much an individual's skin has been a problem when working or studying.","longName":"SKN_RED_WK_3PT_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D4D79299-6806-F8F4-E040-BB89AD430F75","latestVersionIndicator":"Yes","beginDate":"2013-02-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-02-03","modifiedBy":"REEVESD","dateModified":"2014-10-03","changeNote":"Created to support NCI CCR clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3679498","version":"1","preferredName":"Skin Quality of Life Reduced Work Activity Relevance Indicator","preferredDefinition":"Text answer to a question that asks if an individual's skin prevented him/her from working or studying.","longName":"SKN_RED_WK_RELV_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D4D79299-6888-F8F4-E040-BB89AD430F75","latestVersionIndicator":"Yes","beginDate":"2013-02-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-02-03","modifiedBy":"REEVESD","dateModified":"2014-10-03","changeNote":"Created to support NCI CCR clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3690258","version":"1","preferredName":"Agent Therapeutic Level Category","preferredDefinition":"Text definition of a dose of agent in reference to its therapeutic level when associated with an individual on a study.","longName":"AGT_THER_LVL_CAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"D6935A5D-9DA4-4A15-E040-BB89AD435626","latestVersionIndicator":"Yes","beginDate":"2013-02-25","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-02-25","modifiedBy":"REEVESD","dateModified":"2015-05-19","changeNote":"Curated to support NCI CCR clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3704171","version":"1","preferredName":"Pain Medication Side Effect Descriptive Text","preferredDefinition":"Text to describe the side effects attributed to the use of pain medication.","longName":"PN_MED_SD_EFF_TXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"D8D9ECE5-899B-655F-E040-BB89AD430A9E","latestVersionIndicator":"Yes","beginDate":"2013-03-26","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-03-26","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3704291","version":"1","preferredName":"Pain Medication Side Effect Yes No Indicator","preferredDefinition":"Text term to signify whether a person is having side effects associated with pain medication.","longName":"PN_MED_SDEFF_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"D8E33570-E5EB-5710-E040-BB89AD434C21","latestVersionIndicator":"Yes","beginDate":"2013-03-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-03-27","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3704292","version":"1","preferredName":"Excessive Pain Medication Use Concern Yes No Uncertain Indicator","preferredDefinition":"Text term to signify whether a person has concern that he/she is using too much pain medication.","longName":"EX_PN_MED_CONC_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"D8E33570-E60A-5710-E040-BB89AD434C21","latestVersionIndicator":"Yes","beginDate":"2013-03-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-03-27","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3704293","version":"1","preferredName":"Excessive Pain Medication Use Concern Reason Text","preferredDefinition":"Text to describe the reason for an individual's concern that he/she is using too much pain medication","longName":"EX_PN_MED_RSN_TXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"D8E33570-E629-5710-E040-BB89AD434C21","latestVersionIndicator":"Yes","beginDate":"2013-03-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-03-27","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3704294","version":"1","preferredName":"Increased Pain Medication Need Yes No Uncertain Indicator","preferredDefinition":"Text term to signify whether a person feels the need for a stronger type of pain medication.","longName":"INC_PN_MED_NEED_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"D8E33570-E648-5710-E040-BB89AD434C21","latestVersionIndicator":"Yes","beginDate":"2013-03-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-03-27","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3704295","version":"1","preferredName":"Diagnosis Pain Occurrence Yes No Uncertain Indicator","preferredDefinition":"Text term to signify whether pain was a symptom at the time of first diagnosis.","longName":"DX_PN_OCC_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"D8E33570-E66A-5710-E040-BB89AD434C21","latestVersionIndicator":"Yes","beginDate":"2013-03-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-03-27","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3704296","version":"1","preferredName":"Pain Medication Daily Use Daily Yes No Indicator","preferredDefinition":"Text term to signify whether an individual feels that pain requires medication each day.","longName":"PN_MED_DLY_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"D8E37271-F6E1-74D2-E040-BB89AD437AC4","latestVersionIndicator":"Yes","beginDate":"2013-03-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-03-27","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3704297","version":"1","preferredName":"Person First Awareness Diagnosis Month Count","preferredDefinition":"Numeric entry to represent the number of months that have elapsed since a person first learned of his/her diagnosis.","longName":"FRST_DX_MTH_CT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"D8E37271-F700-74D2-E040-BB89AD437AC4","latestVersionIndicator":"Yes","beginDate":"2013-03-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-03-27","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3704298","version":"1","preferredName":"Pain Therapeutic Procedure Effect Relationship Yes No Indicator","preferredDefinition":"Text term to signify whether a person feels that their pain is due to the effect(s) of treatment.","longName":"PN_TX_RLTN_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"D8E37271-F71F-74D2-E040-BB89AD437AC4","latestVersionIndicator":"Yes","beginDate":"2013-03-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-03-27","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3704299","version":"1","preferredName":"Pain Primary Diagnosis Relationship Yes No Indicator","preferredDefinition":"Text term to signify whether a person feels that their pain is due to the primary disease.","longName":"PN_PRIM_DX_RLTN_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"D8E37271-F73E-74D2-E040-BB89AD437AC4","latestVersionIndicator":"Yes","beginDate":"2013-03-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-03-27","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3704300","version":"1","preferredName":"Unrelated Medical Condition Yes No Indicator","preferredDefinition":"Text term to signify whether a person feels that their pain is due an unrelated medical condition.","longName":"PN_MED_COND_RLTN_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"D8E37271-F75D-74D2-E040-BB89AD437AC4","latestVersionIndicator":"Yes","beginDate":"2013-03-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-03-27","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3704301","version":"1","preferredName":"Unrelated Medical Condition Description Text","preferredDefinition":"Text to describe a medical condition unrelated to an individual's primary disease/diagnosis.","longName":"UNRL_MED_COND_TXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"D8E37271-F784-74D2-E040-BB89AD437AC4","latestVersionIndicator":"Yes","beginDate":"2013-03-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-03-27","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3729260","version":"1","preferredName":"Question Display Sequence Number","preferredDefinition":"Numeric value to denote the order or serial arrangement of the components of a question or data items.","longName":"QUEST_DISPL_SEQ_NUM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"DB07000B-6C77-5636-E040-BB89AD437DCE","latestVersionIndicator":"Yes","beginDate":"2013-04-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-04-23","modifiedBy":"FORMBUILDER","dateModified":"2013-10-28","changeNote":"Created to replace CDE 2181607 (VD of that CDE retired by owner).","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3743618","version":"1","preferredName":"Past Month Surgical Procedure Occurrence Yes No Indicator","preferredDefinition":"Text term to signify whether an individual had a surgical procedure in the past month.","longName":"P_MON_SURG_PROC_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"DC039070-1E95-3906-E040-BB89AD432539","latestVersionIndicator":"Yes","beginDate":"2013-05-05","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-05-05","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3743633","version":"1","preferredName":"Past Month Surgical Procedure Description Text","preferredDefinition":"Text to describe the surgical procedure(s) that a person had over the previous month.","longName":"P_MON_SURG_PROC_TXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"DC05ECF6-D441-60BE-E040-BB89AD4365CD","latestVersionIndicator":"Yes","beginDate":"2013-05-06","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-05-06","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3743639","version":"1","preferredName":"Reduced Pain Therapeutic Procedure Method Text","preferredDefinition":"Text to describe treatments and approaches that make a person's pain feel better.","longName":"RED_PAIN_METHD_TXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"DC05ECF6-D4A3-60BE-E040-BB89AD4365CD","latestVersionIndicator":"Yes","beginDate":"2013-05-06","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-05-06","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3743643","version":"1","preferredName":"Increased Pain Cause Text","preferredDefinition":"Text to describe the activities or causes for a person's increased pain.","longName":"INC_PAIN_CAUS_TXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"DC05ECF6-D4F1-60BE-E040-BB89AD4365CD","latestVersionIndicator":"Yes","beginDate":"2013-05-06","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-05-06","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3743731","version":"1","preferredName":"Post Medication Return Pain Efficacy Duration","preferredDefinition":"Text term to describe the length of time a medication is effective until pain returns.","longName":"P_MED_PAIN_EFF_DURN","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"DC0F0A26-5F79-7164-E040-BB89AD431E12","latestVersionIndicator":"Yes","beginDate":"2013-05-06","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-05-06","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3743751","version":"1","preferredName":"Person Pain Description Type","preferredDefinition":"Text term to identify the adjective(s) that describe a person's pain.","longName":"PERS_PAIN_DESC_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"DC101110-D392-5A30-E040-BB89AD432527","latestVersionIndicator":"Yes","beginDate":"2013-05-06","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-05-06","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3743849","version":"1","preferredName":"Pain Medication Daily Frequency","preferredDefinition":"Text term to describe how often a person takes a dose of pain medication during in one day.","longName":"PAIN_MED_DLY_FREQ","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"DC1045D7-8926-8047-E040-BB89AD4357A0","latestVersionIndicator":"Yes","beginDate":"2013-05-06","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-05-06","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3743971","version":"1","preferredName":"Increased Pain Medication Use Need Yes No Uncertain Indicator","preferredDefinition":"Text term to signify whether a person has the need to take more pain medication than prescribed.","longName":"INC_PAIN_MED_ND_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"DC10ACBE-A04C-3AF1-E040-BB89AD4327FD","latestVersionIndicator":"Yes","beginDate":"2013-05-06","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-05-06","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3744033","version":"1","preferredName":"Person Pain Relief Method Type","preferredDefinition":"Text term to describe the type of method or treatment a person uses for pain relief.","longName":"PER_PAIN_RLF_METH_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"DC10F885-E7A9-E748-E040-BB89AD4355D2","latestVersionIndicator":"Yes","beginDate":"2013-05-06","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-05-06","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3744153","version":"1","preferredName":"Person Pain Relief Other Method Descriptive Text","preferredDefinition":"Text to describe a method used by a person to relieve pain that is different from the options offered.","longName":"PER_PAIN_RLF_OTH_TXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"DC10F885-E7E9-E748-E040-BB89AD4355D2","latestVersionIndicator":"Yes","beginDate":"2013-05-06","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-05-06","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3744281","version":"1","preferredName":"Medications not Prescribed Taken for Pain Descriptive Text","preferredDefinition":"Text to describe medications not prescribed by a person's physician that are taken for pain.","longName":"MED_NONPRES_PAIN_TXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"DC10F885-E837-E748-E040-BB89AD4355D2","latestVersionIndicator":"Yes","beginDate":"2013-05-06","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-05-06","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3747962","version":"1","preferredName":"Chronic Graft Versus Host Disease Diagnostic Criteria Name","preferredDefinition":"Term to describe clinical manifestation(s) used to diagnose chronic Graft versus Host Disease (cGVHD).","longName":"CGVHD_DIAG_CRIT_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"DC2BA403-3035-66AD-E040-BB89AD4350F2","latestVersionIndicator":"Yes","beginDate":"2013-05-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-05-07","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3748008","version":"1","preferredName":"Chronic Graft Versus Host Disease Distinct Diagnostic Feature Name","preferredDefinition":"Tem to describe a distinctive diagnostic characteristic of chronic Graft versus Host Disease (cGVHD).","longName":"CGVHD_DIST_FEAT_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"DC2BA403-3319-66AD-E040-BB89AD4350F2","latestVersionIndicator":"Yes","beginDate":"2013-05-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-05-07","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3755631","version":"1","preferredName":"Chronic Graft Versus Host Disease Other Diagnostic Feature Name","preferredDefinition":"Text term to identify a diagnostic characteristic of chronic Graft versus Host Disease (cGVHD) that is different than a set of options.","longName":"CGVHD_OTX_DIAG_FT_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"DC411577-9AE8-49BE-E040-BB89AD434EFB","latestVersionIndicator":"Yes","beginDate":"2013-05-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-05-08","modifiedBy":"MAESKEB","dateModified":"2022-03-31","changeNote":"Curated to support NCI CCR clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3755637","version":"1","preferredName":"Chronic Graft Versus Host Disease Common Feature Name","preferredDefinition":"Term to describe a commonly occurring characteristic or clinical manifestation of chronic Graft versus Host Disease (cGVHD).","longName":"CGVHD_COM_FT_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"DC41D01B-C794-6455-E040-BB89AD430E87","latestVersionIndicator":"Yes","beginDate":"2013-05-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-05-08","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3829134","version":"1","preferredName":"Shoulder Passive Range of Motion Symptom Severity Testing Result 7 Point Likert Scale","preferredDefinition":"Numeric rating of the severity of a patient's shoulder symptoms evaluated through Passive Range of Motion (PROM) exercises.","longName":"SHL_PROM_7PT_LIK_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E2ACBF35-07A1-1869-E040-BB89AD435E2A","latestVersionIndicator":"Yes","beginDate":"2013-07-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-07-29","modifiedBy":"MALUMK","dateModified":"2021-08-12","changeNote":"Curated to support NCI Center for Cancer Research trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3829135","version":"1","preferredName":"Elbow Passive Range of Motion Symptom Severity Testing Result 7 Point Likert Scale","preferredDefinition":"Numeric rating of the severity of a patient's elbow symptoms evaluated through Passive Range of Motion (PROM) exercises.","longName":"ELB_PROM_7PT_LIK_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E2ACBF35-07C0-1869-E040-BB89AD435E2A","latestVersionIndicator":"Yes","beginDate":"2013-07-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-07-29","modifiedBy":"MALUMK","dateModified":"2021-08-12","changeNote":"Curated to support NCI Center for Cancer Research trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3829136","version":"1","preferredName":"Wrist Finger Passive Range of Motion Symptom Severity Testing Result 7 Point Likert Scale","preferredDefinition":"Numeric rating of the severity of a patient's wrist and fingers symptoms evaluated through Passive Range of Motion (PROM) exercises.","longName":"WRS_PROM_7PT_LIK_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E2AD1F16-20D1-0F77-E040-BB89AD433B5D","latestVersionIndicator":"Yes","beginDate":"2013-07-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-07-29","modifiedBy":"MALUMK","dateModified":"2021-08-12","changeNote":"Curated to support NCI Center for Cancer Research trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3829153","version":"1","preferredName":"Foot Dorsiflexion Passive Range of Motion Symptom Severity Testing Result 4 Point Likert Scale","preferredDefinition":"Numeric rating of the severity of a patient's foot dorsiflexion symptoms evaluated through Passive Range of Motion (PROM) exercises.","longName":"FT_PROM_4PT_LIK_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E2B67D9C-B18F-7B70-E040-BB89AD4337B4","latestVersionIndicator":"Yes","beginDate":"2013-07-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-07-30","modifiedBy":"MALUMK","dateModified":"2021-08-12","changeNote":"Curated to support NCI Center for Cancer Research trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3856226","version":"1","preferredName":"Chronic Lymphocytic Leukemia Nodule Present Absent Not Done Code","preferredDefinition":"Code to signify whether nodules of chronic lymphocytic leukemia (CLL) are present in the CLL cells.","longName":"CLL_NDL_PRES_CD","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E413D877-F8AE-BE26-E040-BB89AD43456A","latestVersionIndicator":"Yes","beginDate":"2013-08-16","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-08-16","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR Surgery branch protocol","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3856551","version":"1","preferredName":"Chronic Lymphocytic Leukemia Cells Normal Cellularity Code","preferredDefinition":"Code to signify whether chronic lymphocytic leukemia (CLL) cells are normocellular for a person's age.","longName":"CLL_NL_CELL_CD","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E4159D7C-7216-91AC-E040-BB89AD431876","latestVersionIndicator":"Yes","beginDate":"2013-08-16","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-08-16","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR Surgery branch protocol","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3856552","version":"1","preferredName":"Lymphoma Cell Morphology Code","preferredDefinition":"Code to signify the morphology of lymphoma cells.","longName":"LYM_CLL_MORPH_CD","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E4159D7C-7235-91AC-E040-BB89AD431876","latestVersionIndicator":"Yes","beginDate":"2013-08-16","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-08-16","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR Surgery branch protocol","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3856573","version":"1","preferredName":"Lymphoma Cell Immunohistochemical Test Result Code","preferredDefinition":"Code to represent the result of immunohistochemical testing of lymphoma cells.","longName":"LYM_IHC_TST_CD","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E41610C4-4B94-97B9-E040-BB89AD435CC6","latestVersionIndicator":"Yes","beginDate":"2013-08-16","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-08-16","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR Surgery branch protocol","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3872811","version":"1","preferredName":"Chronic Lymphocytic Leukemia Symptom Present Absent Not Done Code","preferredDefinition":"Code to represent whether disease related symptoms are present during the examination of a patient.","longName":"CLL_SC_PRES_CLL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E580D969-2275-6E19-E040-BB89AD432266","latestVersionIndicator":"Yes","beginDate":"2013-09-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-09-03","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR Surgery branch protocol","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3872815","version":"1","preferredName":"Liver Disease Status Normal Abnormal Not Done Indicator Code","preferredDefinition":"Code to represent the status of a patient's liver.","longName":"LV_STAT_CD","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E580D969-22BD-6E19-E040-BB89AD432266","latestVersionIndicator":"Yes","beginDate":"2013-09-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-09-03","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR Surgery branch protocol","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3872816","version":"1","preferredName":"Palpable Liver Present Code","preferredDefinition":"Code to signify whether an enlarged liver is palpable during a patient's examination.","longName":"PALP_LV_PRES_CD","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E580D969-22DC-6E19-E040-BB89AD432266","latestVersionIndicator":"Yes","beginDate":"2013-09-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-09-03","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR Surgery branch protocol","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3872817","version":"1","preferredName":"Liver PET Test Result Code","preferredDefinition":"Code to represent the outcome of a liver Positron Emission Tomography (PET) scan.","longName":"LV_PET_RES_CD","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E580D969-22FB-6E19-E040-BB89AD432266","latestVersionIndicator":"Yes","beginDate":"2013-09-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-09-03","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR Surgery branch protocol","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3874596","version":"1","preferredName":"Spleen Involved Indicator Code","preferredDefinition":"Code to signify the status of a patient's spleen.","longName":"SPL_INVLMT_CD","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E5938D85-2A2A-1480-E040-BB89AD430B87","latestVersionIndicator":"Yes","beginDate":"2013-09-04","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-09-04","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR Surgery branch protocol","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3874613","version":"1","preferredName":"Splenomegaly Palpation Code","preferredDefinition":"Code to signify whether an enlarged spleen is palpable during a patient's examination.","longName":"SPLMGLY_PALP_CD","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E5938D85-2A49-1480-E040-BB89AD430B87","latestVersionIndicator":"Yes","beginDate":"2013-09-04","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-09-04","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR Surgery branch protocol","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3874642","version":"1","preferredName":"Spleen Positron Emission Tomography Test Result Code","preferredDefinition":"Code to represent the results of a spleen positron emission test (PET) scan.","longName":"SPL_PET_RSL_CD","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E593EBEB-CE1A-21AA-E040-BB89AD433633","latestVersionIndicator":"Yes","beginDate":"2013-09-04","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-09-04","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR Surgery branch protocol","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3874723","version":"1","preferredName":"Modified Immune Response Criteria Type","preferredDefinition":"Term to represent the response of an individual to treatment using modified standard immune-related response criteria.","longName":"TUM_MOD_IMM_RESP_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E594A46A-F9A0-FEC5-E040-BB89AD43226D","latestVersionIndicator":"Yes","beginDate":"2013-09-04","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-09-04","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3876443","version":"1","preferredName":"PSA Failure Risk Factor Classification Category","preferredDefinition":"Classification to describe the relative risk of PSA failure in an individual, based on the D'Amico risk classification system which is a standard in prostate cancer treatment.","longName":"PSA_FAIL_RSK_FCT_CAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E5A92FD2-A835-DE91-E040-BB89AD432606","latestVersionIndicator":"Yes","beginDate":"2013-09-05","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-09-05","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3902240","version":"1","preferredName":"Head Plaque Body Surface Involvement Percentage","preferredDefinition":"Numeric value to represent the percentage of plaque involvement on the surface of the head.","longName":"HD_PLQ_BS_PCT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E69916AA-32A0-43C2-E040-BB89AD434E87","latestVersionIndicator":"Yes","beginDate":"2013-09-17","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-09-17","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3902242","version":"1","preferredName":"Arm Plaque Body Surface Involvement Percentage","preferredDefinition":"Numeric value to represent the percentage of plaque involvement on the surface of the arms.","longName":"ARM_PLQ_BS_PCT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E69916AA-32BF-43C2-E040-BB89AD434E87","latestVersionIndicator":"Yes","beginDate":"2013-09-17","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-09-17","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3902244","version":"1","preferredName":"Trunk Plaque Body Surface Involvement Percentage","preferredDefinition":"Numeric value to represent the percentage of plaque involvement on the surface of an individual's trunk.","longName":"TRUNK_PLQ_BS_PCT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E69916AA-331D-43C2-E040-BB89AD434E87","latestVersionIndicator":"Yes","beginDate":"2013-09-17","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-09-17","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3902248","version":"1","preferredName":"Legs Plaque Body Surface Involvement Percentage","preferredDefinition":"Numeric value to represent the percentage of plaque involvement on the surface of an individual's legs.","longName":"LEG_PLQ_BS_PCT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E69916AA-3360-43C2-E040-BB89AD434E87","latestVersionIndicator":"Yes","beginDate":"2013-09-17","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-09-17","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3902278","version":"1","preferredName":"Head Plaque Body Surface Involvement Subtotal Percentage","preferredDefinition":"Percentage value to describe the percent of an individual's head affected by plaque multiplied by a modifier to yield a calculated percent of affected area on the head.","longName":"HD_PLQ_SUBTTL_PCT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E69A5734-A779-389C-E040-BB89AD435356","latestVersionIndicator":"Yes","beginDate":"2013-09-17","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-09-17","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3902279","version":"1","preferredName":"Arms Plaque Body Surface Involvement Subtotal Percentage","preferredDefinition":"Percentage value to describe the percent of an individual's arms affected by plaque multiplied by a modifier to yield a calculated percent of affected area on the arms.","longName":"ARM_PLQ_SUBTTL_PCT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E69A5734-A798-389C-E040-BB89AD435356","latestVersionIndicator":"Yes","beginDate":"2013-09-17","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-09-17","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3902280","version":"1","preferredName":"Legs Plaque Body Surface Involvement Subtotal Percentage","preferredDefinition":"Percentage value to describe the percent of an individual's legs affected by plaque multiplied by a modifier to yield a calculated percent of affected area on the legs.","longName":"LEG_PLQ_SUBTTL_PCT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E69A5734-A7BF-389C-E040-BB89AD435356","latestVersionIndicator":"Yes","beginDate":"2013-09-17","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-09-17","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3902281","version":"1","preferredName":"Trunk Plaque Body Surface Involvement Subtotal Percentage","preferredDefinition":"Percentage value to describe the percent of an individual's trunk affected by plaque multiplied by a modifier to yield a calculated percent of affected area on the trunk.","longName":"TRK_PLQ_SUBTTL_PCT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E69A5734-A7F4-389C-E040-BB89AD435356","latestVersionIndicator":"Yes","beginDate":"2013-09-17","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-09-17","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3902282","version":"1","preferredName":"Total Body Surface Plaque Involvement Sum Percentage","preferredDefinition":"Percentage value to describe the percent of an individual's total body affected by plaque as a sum of individual body sites (head, trunk, arms, legs).","longName":"TLBDY_PLQ_SUBTTL_PCT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E69A5734-A813-389C-E040-BB89AD435356","latestVersionIndicator":"Yes","beginDate":"2013-09-17","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-09-17","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3902597","version":"1","preferredName":"Physician Global Assessment Plaque Score","preferredDefinition":"Numeric value representing the physician's assessment of the patient's burden of plaque disease.","longName":"PGA_PLAQUE_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E6AE5C5A-FED5-1075-E040-BB89AD43364D","latestVersionIndicator":"Yes","beginDate":"2013-09-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-09-18","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3902611","version":"1","preferredName":"Physician Global Assessment Pustule Score","preferredDefinition":"Numeric value representing the physician's assessment of the patient's burden of pustular disease.","longName":"PGA_PUSTULE_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E6AE5C5A-FEF4-1075-E040-BB89AD43364D","latestVersionIndicator":"Yes","beginDate":"2013-09-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-09-18","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3902612","version":"1","preferredName":"Overall Physician Global Assessment Score","preferredDefinition":"Numeric value representing the physician's overall assessment of the patient's burden of skin disease.","longName":"OVERALL_PGA_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E6AE5C5A-FF13-1075-E040-BB89AD43364D","latestVersionIndicator":"Yes","beginDate":"2013-09-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-09-18","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3903187","version":"1","preferredName":"Linear Analogue Self-Assessment Past Week Average Severity Pain Score Likert Scale","preferredDefinition":"A person's stated perception of the average severity of their pain during the past week, using a Likert scale value captured as a numeric value.","longName":"VAS_PN_WK_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E6C13409-F5F5-574A-E040-BB89AD4367E6","latestVersionIndicator":"Yes","beginDate":"2013-09-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-09-19","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3903192","version":"1","preferredName":"Linear Analogue Self-Assessment Past Week Average Arthritis Effect Score Likert Scale","preferredDefinition":"A person's stated perception of the average effect of arthritis during the past week, using a Likert scale value captured as a numeric value.","longName":"VAS_ARTH_WK_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E6C13409-F643-574A-E040-BB89AD4367E6","latestVersionIndicator":"Yes","beginDate":"2013-09-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-09-19","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3906454","version":"1","preferredName":"Head Plaque Erythema Pustular Scale","preferredDefinition":"Numeric value to represent the erythema/redness associated with plaque occurring on the head.","longName":"HD_PLQ_ERY_PUS_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E71ABBC2-AF09-1159-E040-BB89AD43635D","latestVersionIndicator":"Yes","beginDate":"2013-09-24","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-09-24","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR Pustular dermatoses trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3906455","version":"1","preferredName":"Arms Plaque Erythema Pustular Scale","preferredDefinition":"Numeric value to represent the erythema/redness associated with plaque occurring on the arms.","longName":"ARM_PLQ_ERY_PUS_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E71ABBC2-AF28-1159-E040-BB89AD43635D","latestVersionIndicator":"Yes","beginDate":"2013-09-24","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-09-24","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR Pustular dermatoses trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3906456","version":"1","preferredName":"Trunk Plaque Erythema Pustular Scale","preferredDefinition":"Numeric value to represent the erythema/redness associated with plaque occurring on the trunk.","longName":"TRK_PLQ_ERY_PUS_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E71ABBC2-AF47-1159-E040-BB89AD43635D","latestVersionIndicator":"Yes","beginDate":"2013-09-24","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-09-24","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR Pustular dermatoses trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3906457","version":"1","preferredName":"Legs Plaque Erythema Pustular Scale","preferredDefinition":"Numeric value to represent the erythema/redness associated with plaque occurring on the legs.","longName":"LEG_PLQ_ERY_PUS_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E71ABBC2-AF66-1159-E040-BB89AD43635D","latestVersionIndicator":"Yes","beginDate":"2013-09-24","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-09-24","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR Pustular dermatoses trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3906458","version":"1","preferredName":"Head Plaque Induration Pustular Scale","preferredDefinition":"Numeric value to represent the induration/thickness associated with plaque occurring on the head.","longName":"HD_PLQ_IDN_PUS_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E71ABBC2-AF85-1159-E040-BB89AD43635D","latestVersionIndicator":"Yes","beginDate":"2013-09-24","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-09-24","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR Pustular dermatoses trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3906459","version":"1","preferredName":"Arms Plaque Induration Pustular Scale","preferredDefinition":"Numeric value to represent the induration/thickness associated with plaque occurring on the arms.","longName":"ARM_PLQ_IDN_PUS_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E71ABBC2-AFA4-1159-E040-BB89AD43635D","latestVersionIndicator":"Yes","beginDate":"2013-09-24","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-09-24","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR Pustular dermatoses trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3906460","version":"1","preferredName":"Trunk Plaque Induration Pustular Scale","preferredDefinition":"Numeric value to represent the induration/thickness associated with plaque occurring on the trunk.","longName":"TRK_PLQ_IDN_PUS_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E71ABBC2-AFC3-1159-E040-BB89AD43635D","latestVersionIndicator":"Yes","beginDate":"2013-09-24","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-09-24","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR Pustular dermatoses trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3906461","version":"1","preferredName":"Legs Plaque Induration Pustular Scale","preferredDefinition":"Numeric value to represent the induration/thickness associated with plaque occurring on the legs.","longName":"LEG_PLQ_IDN_PUS_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E71ABBC2-AFE2-1159-E040-BB89AD43635D","latestVersionIndicator":"Yes","beginDate":"2013-09-24","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-09-24","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR Pustular dermatoses trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3906462","version":"1","preferredName":"Head Plaque Desquamation Pustular Scale","preferredDefinition":"Numeric value to represent the desquamation/scaling associated with plaque occurring on the head.","longName":"HD_PLQ_DSQ_PUS_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E71ABBC2-B001-1159-E040-BB89AD43635D","latestVersionIndicator":"Yes","beginDate":"2013-09-24","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-09-24","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR Pustular dermatoses trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3906463","version":"1","preferredName":"Arms Plaque Desquamation Pustular Scale","preferredDefinition":"Numeric value to represent the desquamation/scaling associated with plaque occurring on the arms.","longName":"ARM_PLQ_DSQ_PUS_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E71ABBC2-B020-1159-E040-BB89AD43635D","latestVersionIndicator":"Yes","beginDate":"2013-09-24","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-09-24","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR Pustular dermatoses trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3906464","version":"1","preferredName":"Trunk Plaque Desquamation Pustular Scale","preferredDefinition":"Numeric value to represent the desquamation/scaling associated with plaque occurring on the trunk.","longName":"TRK_PLQ_DSQ_PUS_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E71ABBC2-B0D6-1159-E040-BB89AD43635D","latestVersionIndicator":"Yes","beginDate":"2013-09-24","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-09-24","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR Pustular dermatoses trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3906465","version":"1","preferredName":"Legs Plaque Desquamation Pustular Scale","preferredDefinition":"Numeric value to represent the desquamation/scaling associated with plaque occurring on the legs.","longName":"LEG_PLQ_DSQ_PUS_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E71ABBC2-B102-1159-E040-BB89AD43635D","latestVersionIndicator":"Yes","beginDate":"2013-09-24","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-09-24","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR Pustular dermatoses trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3906466","version":"1","preferredName":"Head Plaque Pustular Scale","preferredDefinition":"Numeric value to represent the pustules associated with plaque occurring on the head.","longName":"HD_PLQ_PUS_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E71ABBC2-B12E-1159-E040-BB89AD43635D","latestVersionIndicator":"Yes","beginDate":"2013-09-24","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-09-24","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR Pustular dermatoses trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3906467","version":"1","preferredName":"Arms Plaque Pustular Scale","preferredDefinition":"Numeric value to represent the pustules associated with plaque occurring on the arms.","longName":"ARM_PLQ_PUS_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E71ABBC2-B15A-1159-E040-BB89AD43635D","latestVersionIndicator":"Yes","beginDate":"2013-09-24","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-09-24","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR Pustular dermatoses trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3906468","version":"1","preferredName":"Trunk Plaque Pustular Scale","preferredDefinition":"Numeric value to represent the pustules associated with plaque occurring on the trunk.","longName":"TRK_PLQ_PUS_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E71ABBC2-B186-1159-E040-BB89AD43635D","latestVersionIndicator":"Yes","beginDate":"2013-09-24","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-09-24","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR Pustular dermatoses trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3906469","version":"1","preferredName":"Legs Plaque Pustular Scale","preferredDefinition":"Numeric value to represent the pustules associated with plaque occurring on the legs.","longName":"LEG_PLQ_PUS_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E71ABBC2-B1B2-1159-E040-BB89AD43635D","latestVersionIndicator":"Yes","beginDate":"2013-09-24","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-09-24","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR Pustular dermatoses trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3906470","version":"1","preferredName":"Head Plaque Sum Characteristics Value","preferredDefinition":"Calculated sum of erythema/redness, induration/thickness, desquamation/scaling and pustules characteristics associated with plaque occurring on the head.","longName":"HD_PLQ_SUM_CH_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E71ABBC2-B1ED-1159-E040-BB89AD43635D","latestVersionIndicator":"Yes","beginDate":"2013-09-24","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-09-24","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR Pustular dermatoses trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3906471","version":"1","preferredName":"Arms Plaque Sum Characteristics Value","preferredDefinition":"Calculated sum of erythema/redness, induration/thickness, desquamation/scaling and pustules characteristics associated with plaque occurring on the arms.","longName":"ARM_PLQ_SUM_CH_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E71ABBC2-B20C-1159-E040-BB89AD43635D","latestVersionIndicator":"Yes","beginDate":"2013-09-24","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-09-24","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR Pustular dermatoses trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3906472","version":"1","preferredName":"Trunk Plaque Sum Characteristics Value","preferredDefinition":"Calculated sum of erythema/redness, induration/thickness, desquamation/scaling and pustules characteristics associated with plaque occurring on the trunk.","longName":"TRK_PLQ_SUM_CH_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E71ABBC2-B22B-1159-E040-BB89AD43635D","latestVersionIndicator":"Yes","beginDate":"2013-09-24","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-09-24","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR Pustular dermatoses trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3906473","version":"1","preferredName":"Legs Plaque Sum Characteristics Value","preferredDefinition":"Calculated sum of erythema/redness, induration/thickness, desquamation/scaling and pustules characteristics associated with plaque occurring on the legs.","longName":"LEG_PLQ_SUM_CH_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E71ABBC2-B24A-1159-E040-BB89AD43635D","latestVersionIndicator":"Yes","beginDate":"2013-09-24","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-09-24","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR Pustular dermatoses trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3906474","version":"1","preferredName":"Head Plaque Weight Score","preferredDefinition":"Numeric value representing the sum of plaque characteristics occurring on the head multiplied by a modifier value of 0.1 to yield a weighted plaque score.","longName":"HD_PLQ_WT_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E71ABBC2-B2A5-1159-E040-BB89AD43635D","latestVersionIndicator":"Yes","beginDate":"2013-09-24","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-09-24","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR Pustular dermatoses trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3906475","version":"1","preferredName":"Arms Plaque Weight Score","preferredDefinition":"Numeric value representing the sum of plaque characteristics occurring on the arms multiplied by a modifier value of 0.2 to yield a weighted plaque score.","longName":"ARM_PLQ_WT_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E71ABBC2-B2C4-1159-E040-BB89AD43635D","latestVersionIndicator":"Yes","beginDate":"2013-09-24","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-09-24","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR Pustular dermatoses trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3906476","version":"1","preferredName":"Trunk Plaque Weight Score","preferredDefinition":"Numeric value representing the sum of plaque characteristics occurring on the trunk multiplied by a modifier value of 0.3 to yield a weighted plaque score.","longName":"TRK_PLQ_WT_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E71ABBC2-B2E3-1159-E040-BB89AD43635D","latestVersionIndicator":"Yes","beginDate":"2013-09-24","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-09-24","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR Pustular dermatoses trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3906477","version":"1","preferredName":"Legs Plaque Weight Score","preferredDefinition":"Numeric value representing the sum of plaque characteristics occurring on the legs multiplied by a modifier value of 0.4 to yield a weighted plaque score.","longName":"LEG_PLQ_WT_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E71ABBC2-B302-1159-E040-BB89AD43635D","latestVersionIndicator":"Yes","beginDate":"2013-09-24","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-09-24","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR Pustular dermatoses trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3906478","version":"1","preferredName":"Head Plaque Body Surface Area Scale","preferredDefinition":"Numeric code to represent the extent of body surface area on the head with plaque involvement.","longName":"HD_PLQ_BSA_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E71ABBC2-B35D-1159-E040-BB89AD43635D","latestVersionIndicator":"Yes","beginDate":"2013-09-24","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-09-24","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR Pustular dermatoses trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3906479","version":"1","preferredName":"Arms Plaque Body Surface Area Scale","preferredDefinition":"Numeric code to represent the extent of body surface area on the arms with plaque involvement.","longName":"ARM_PLQ_BSA_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E71ABBC2-B37C-1159-E040-BB89AD43635D","latestVersionIndicator":"Yes","beginDate":"2013-09-24","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-09-24","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR Pustular dermatoses trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3906480","version":"1","preferredName":"Trunk Plaque Body Surface Area Scale","preferredDefinition":"Numeric code to represent the extent of body surface area on the trunk with plaque involvement.","longName":"TRK_PLQ_BSA_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E71ABBC2-B39B-1159-E040-BB89AD43635D","latestVersionIndicator":"Yes","beginDate":"2013-09-24","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-09-24","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR Pustular dermatoses trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3906481","version":"1","preferredName":"Legs Plaque Body Surface Area Scale","preferredDefinition":"Numeric code to represent the extent of body surface area on the legs with plaque involvement.","longName":"LEG_PLQ_BSA_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E71ABBC2-B3BA-1159-E040-BB89AD43635D","latestVersionIndicator":"Yes","beginDate":"2013-09-24","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-09-24","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR Pustular dermatoses trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3906482","version":"1","preferredName":"Head Plaque Body Surface Area Importance Weight Product Value","preferredDefinition":"Calculated value representing the weighted plaque score multiplied by the area score for plaque occurring on the head.","longName":"HD_PLQ_BSA_PROD_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E71ABBC2-B415-1159-E040-BB89AD43635D","latestVersionIndicator":"Yes","beginDate":"2013-09-24","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-09-24","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR Pustular dermatoses trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3906483","version":"1","preferredName":"Arms Plaque Body Surface Area Importance Weight Product Value","preferredDefinition":"Calculated value representing the weighted plaque score multiplied by the area score for plaque occurring on the arms.","longName":"ARM_PLQ_BSA_PROD_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E71ABBC2-B434-1159-E040-BB89AD43635D","latestVersionIndicator":"Yes","beginDate":"2013-09-24","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-09-24","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR Pustular dermatoses trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3906484","version":"1","preferredName":"Trunk Plaque Body Surface Area Importance Weight Product Value","preferredDefinition":"Calculated value representing the weighted plaque score multiplied by the area score for plaque occurring on the trunk.","longName":"TRK_PLQ_BSA_PROD_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E71ABBC2-B453-1159-E040-BB89AD43635D","latestVersionIndicator":"Yes","beginDate":"2013-09-24","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-09-24","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR Pustular dermatoses trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3906485","version":"1","preferredName":"Legs Plaque Body Surface Area Importance Weight Product Value","preferredDefinition":"Calculated value representing the weighted plaque score multiplied by the area score for plaque occurring on the legs.","longName":"LEG_PLQ_BSA_PROD_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E71ABBC2-B472-1159-E040-BB89AD43635D","latestVersionIndicator":"Yes","beginDate":"2013-09-24","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-09-24","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR Pustular dermatoses trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3906491","version":"1","preferredName":"Pustular PASI Total Score","preferredDefinition":"Calculated total value for the Pustular PASI score based on head, arms, legs and trunk measures of involvement and plaque characteristics.","longName":"PUS_PASI_TTL_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E720C748-4164-ECB1-E040-BB89AD4317D5","latestVersionIndicator":"Yes","beginDate":"2013-09-24","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-09-24","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR Pustular dermatoses trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3906494","version":"1","preferredName":"Biopsy Pustular Dermatosis Involvement Status","preferredDefinition":"Text term to signify whether a biopsy result was affected by pustular dermatosis.","longName":"BX_PUS_DERM_INV_STAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E7214A2A-7DC0-7759-E040-BB89AD43044A","latestVersionIndicator":"Yes","beginDate":"2013-09-24","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-09-24","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR Pustular dermatoses trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3906495","version":"1","preferredName":"Biopsy Pustular Dermatosis Reason Code","preferredDefinition":"Code to signify the reason that a biopsy for pustular dermatosis was performed.","longName":"BX_PUS_DERM_RSN_CD","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E7214A2A-7DEC-7759-E040-BB89AD43044A","latestVersionIndicator":"Yes","beginDate":"2013-09-24","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-09-24","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR Pustular dermatoses trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3910849","version":"1","preferredName":"Chronic Lymphocytic Leukemia Nodule Present Absent Not Done Category","preferredDefinition":"Category to signify whether nodules of chronic lymphocytic leukemia (CLL) are present in the CLL cells.","longName":"CLL_NDL_PRES_CAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E79E0F34-AA7B-3A71-E040-BB89AD437638","latestVersionIndicator":"Yes","beginDate":"2013-09-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-09-30","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR Surgery branch protocol","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3910850","version":"1","preferredName":"Chronic Lymphocytic Leukemia Symptom Present Absent Not Done Category","preferredDefinition":"Term to signify whether Chronic Lymphocytic Leukemia (CLL) related symptoms are present during the examination of a patient.","longName":"CLL_SC_PRES_CAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E79E0F34-AA9B-3A71-E040-BB89AD437638","latestVersionIndicator":"Yes","beginDate":"2013-09-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-09-30","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR Surgery branch protocol","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3911830","version":"1","preferredName":"Liver Disease Status Normal Abnormal Not Done Category","preferredDefinition":"Text term to represent the status of a patient's liver.","longName":"LV_STAT_CAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E79F6606-A5C3-B815-E040-BB89AD431DE7","latestVersionIndicator":"Yes","beginDate":"2013-09-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-09-30","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR Surgery branch protocol","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3911832","version":"1","preferredName":"Palpable Liver Present Category","preferredDefinition":"Code to signify whether an enlarged liver is palpable during a patient's examination.","longName":"PALP_LV_PRES_CAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E79F6606-A628-B815-E040-BB89AD431DE7","latestVersionIndicator":"Yes","beginDate":"2013-09-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-09-30","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR Surgery branch protocol","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3911833","version":"1","preferredName":"Splenomegaly Palpation Category","preferredDefinition":"Text term to signify whether an enlarged spleen is palpable during a patient's examination.","longName":"SPLMGLY_PALP_CAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E79F6606-A648-B815-E040-BB89AD431DE7","latestVersionIndicator":"Yes","beginDate":"2013-09-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-09-30","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR Surgery branch protocol","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3911840","version":"1","preferredName":"Spleen Involved Indicator Category","preferredDefinition":"Text term to signify the status of a patient's spleen.","longName":"SPL_INVLMT_CAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E79FC127-EA38-3F7F-E040-BB89AD430F6F","latestVersionIndicator":"Yes","beginDate":"2013-09-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-09-30","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR Surgery branch protocol","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3911851","version":"1","preferredName":"Liver PET Test Result Category","preferredDefinition":"Text term to represent the outcome of a liver Positron Emission Tomography (PET) scan.","longName":"LV_PET_RES_CAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E79FC127-EA9E-3F7F-E040-BB89AD430F6F","latestVersionIndicator":"Yes","beginDate":"2013-09-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-09-30","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR Surgery branch protocol","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3911852","version":"1","preferredName":"Spleen Positron Emission Tomography Test Result Category","preferredDefinition":"Text term to represent the results of a spleen positron emission test (PET) scan.","longName":"SPL_PET_RSL_CAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E79FC127-EAD7-3F7F-E040-BB89AD430F6F","latestVersionIndicator":"Yes","beginDate":"2013-09-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-09-30","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR Surgery branch protocol","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3911863","version":"1","preferredName":"Chronic Lymphocytic Leukemia Cells Normal Cellularity Yes No Or Not Done Not Applicable Indicator","preferredDefinition":"Text term to signify whether chronic lymphocytic leukemia (CLL) cells are normocellular for a person's age.","longName":"CLL_NL_CELL_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E79FC127-EB63-3F7F-E040-BB89AD430F6F","latestVersionIndicator":"Yes","beginDate":"2013-09-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-09-30","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR Surgery branch protocol","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3911865","version":"1","preferredName":"Lymphoma Cell Morphology Category","preferredDefinition":"Text term to signify the morphology of lymphoma cells.","longName":"LYM_CLL_MORPH_CAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E79FC127-EB91-3F7F-E040-BB89AD430F6F","latestVersionIndicator":"Yes","beginDate":"2013-09-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-09-30","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR Surgery branch protocol","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3911866","version":"1","preferredName":"Lymphoma Cell Immunohistochemical Test Result Category","preferredDefinition":"Text term to represent the result of immunohistochemical testing of lymphoma cells.","longName":"LYM_IHC_TST_CAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E79FC127-EBB1-3F7F-E040-BB89AD430F6F","latestVersionIndicator":"Yes","beginDate":"2013-09-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-09-30","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR Surgery branch protocol","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3913849","version":"1","preferredName":"Connective Tissue Disorder Personal Medical History Text","preferredDefinition":"Text to describe a patient's account of their history of experiencing a connective tissue disease (ex. lupus, rheumatoid arthritis, dermatomyositis/polymyositis).","longName":"CNTV_TS_DS_MEDHX_TXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E7D66DB8-62A0-D8BA-E040-BB89AD436B36","latestVersionIndicator":"Yes","beginDate":"2013-10-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-10-03","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3923811","version":"1","preferredName":"Right Palmar Region Plaque Erythema Pustular Scale","preferredDefinition":"Numeric value to represent the erythema/redness associated with plaque occurring in the palm of the right hand.","longName":"RPLM_PLQ_ERY_PUS_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E9045079-A234-88FE-E040-BB89AD4361F9","latestVersionIndicator":"Yes","beginDate":"2013-10-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-10-18","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI Center for Cancer Research (CCR) clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3923812","version":"1","preferredName":"Left Palmar Region Plaque Erythema Pustular Scale","preferredDefinition":"Numeric value to represent the erythema/redness associated with plaque occurring in the palm of the left hand.","longName":"LPLM_PLQ_ERY_PUS_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E9045079-A254-88FE-E040-BB89AD4361F9","latestVersionIndicator":"Yes","beginDate":"2013-10-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-10-18","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI Center for Cancer Research (CCR) clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3923813","version":"1","preferredName":"Right Plantar Region Plaque Erythema Pustular Scale","preferredDefinition":"Numeric value to represent the erythema/redness associated with plaque occurring on the sole of the right foot.","longName":"RPTR_PLQ_ERY_PUS_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E9045079-A277-88FE-E040-BB89AD4361F9","latestVersionIndicator":"Yes","beginDate":"2013-10-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-10-18","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI Center for Cancer Research (CCR) clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3923814","version":"1","preferredName":"Left Plantar Region Plaque Erythema Pustular Scale","preferredDefinition":"Numeric value to represent the erythema/redness associated with plaque occurring on the sole of the left foot.","longName":"LPTR_PLQ_ERY_PUS_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E9060C31-1B6A-B5AB-E040-BB89AD432A8B","latestVersionIndicator":"Yes","beginDate":"2013-10-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-10-18","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI Center for Cancer Research (CCR) clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3923831","version":"1","preferredName":"Right Palmar Region Plaque Desquamation Pustular Scale","preferredDefinition":"Numeric value to represent the desquamation/scaling associated with plaque occurring in the right palm.","longName":"RPLM_PLQ_DSQ_PUS_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E9060C31-1B8F-B5AB-E040-BB89AD432A8B","latestVersionIndicator":"Yes","beginDate":"2013-10-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-10-18","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI Center for Cancer Research (CCR) clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3923832","version":"1","preferredName":"Left Palmar Region Plaque Desquamation Pustular Scale","preferredDefinition":"Numeric value to represent the desquamation/scaling associated with plaque occurring in the left palm.","longName":"LPLM_PLQ_DSQ_PUS_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E9060C31-1BAF-B5AB-E040-BB89AD432A8B","latestVersionIndicator":"Yes","beginDate":"2013-10-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-10-18","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI Center for Cancer Research (CCR) clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3923833","version":"1","preferredName":"Right Plantar Region Plaque Desquamation Pustular Scale","preferredDefinition":"Numeric value to represent the desquamation/scaling associated with plaque occurring on the sole of the right foot.","longName":"RPTR_PLQ_DSQ_PUS_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E9060C31-1BCF-B5AB-E040-BB89AD432A8B","latestVersionIndicator":"Yes","beginDate":"2013-10-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-10-18","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI Center for Cancer Research (CCR) clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3923834","version":"1","preferredName":"Left Plantar Region Plaque Desquamation Pustular Scale","preferredDefinition":"Numeric value to represent the desquamation/scaling associated with plaque occurring on the sole of the left foot.","longName":"LPTR_PLQ_DSQ_PUS_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E9060C31-1BF2-B5AB-E040-BB89AD432A8B","latestVersionIndicator":"Yes","beginDate":"2013-10-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-10-18","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI Center for Cancer Research (CCR) clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3923951","version":"1","preferredName":"Right Palmar Region Plaque Pustular Scale","preferredDefinition":"Numeric value to represent the pustules associated with plaque occurring in the palm of the right hand.","longName":"RPLM_PLQ_PUS_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E907184B-6704-D39A-E040-BB89AD431AF5","latestVersionIndicator":"Yes","beginDate":"2013-10-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-10-18","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI Center for Cancer Research (CCR) clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3923952","version":"1","preferredName":"Left Palmar Region Plaque Pustular Scale","preferredDefinition":"Numeric value to represent the pustules associated with plaque occurring in the palm of the left hand.","longName":"LPLM_PLQ_PUS_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E907184B-6728-D39A-E040-BB89AD431AF5","latestVersionIndicator":"Yes","beginDate":"2013-10-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-10-18","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI Center for Cancer Research (CCR) clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3923953","version":"1","preferredName":"Right Plantar Region Plaque Pustular Scale","preferredDefinition":"Numeric value to represent the pustules associated with plaque occurring on the sole of the right foot.","longName":"RPTR_PLQ_PUS_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E907184B-676C-D39A-E040-BB89AD431AF5","latestVersionIndicator":"Yes","beginDate":"2013-10-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-10-18","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI Center for Cancer Research (CCR) clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3923954","version":"1","preferredName":"Left Plantar Region Plaque Pustular Scale","preferredDefinition":"Numeric value to represent the pustules associated with plaque occurring on the sole of the left foot.","longName":"LPTR_PLQ_PUS_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E907184B-678C-D39A-E040-BB89AD431AF5","latestVersionIndicator":"Yes","beginDate":"2013-10-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-10-18","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI Center for Cancer Research (CCR) clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3923955","version":"1","preferredName":"Right Palmar Region Plaque Sum Characteristics Value","preferredDefinition":"Calculated sum of erythema/redness, induration/thickness, desquamation/scaling and pustules characteristics associated with plaque occurring in the palm of the right hand.","longName":"RPLM_PLQ_SUM_CH_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E907184B-67AC-D39A-E040-BB89AD431AF5","latestVersionIndicator":"Yes","beginDate":"2013-10-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-10-18","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI Center for Cancer Research (CCR) clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3923971","version":"1","preferredName":"Left Palmar Region Plaque Sum Characteristics Value","preferredDefinition":"Calculated sum of erythema/redness, induration/thickness, desquamation/scaling and pustules characteristics associated with plaque occurring in the palm of the left hand.","longName":"LPLM_PLQ_SUM_CH_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E907184B-67F4-D39A-E040-BB89AD431AF5","latestVersionIndicator":"Yes","beginDate":"2013-10-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-10-18","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI Center for Cancer Research (CCR) clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3923972","version":"1","preferredName":"Right Plantar Region Plaque Sum Characteristics Value","preferredDefinition":"Calculated sum of erythema/redness, induration/thickness, desquamation/scaling and pustules characteristics associated with plaque occurring on the sole of the right foot.","longName":"RPTR_PLQ_SUM_CH_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E907184B-6818-D39A-E040-BB89AD431AF5","latestVersionIndicator":"Yes","beginDate":"2013-10-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-10-18","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI Center for Cancer Research (CCR) clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3923975","version":"1","preferredName":"Left Plantar Region Plaque Sum Characteristics Value","preferredDefinition":"Calculated sum of erythema/redness, induration/thickness, desquamation/scaling and pustules characteristics associated with plaque occurring on the sole of the left foot.","longName":"LPTR_PLQ_SUM_CH_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E9082262-0DB6-7A16-E040-BB89AD436DFF","latestVersionIndicator":"Yes","beginDate":"2013-10-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-10-18","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI Center for Cancer Research (CCR) clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3923976","version":"1","preferredName":"Right Palmar Region Plaque Weight Score","preferredDefinition":"Numeric value representing the sum of plaque characteristics occurring in the palm of the right hand multiplied by a modifier value of 0.1 to yield a weighted plaque score.","longName":"RPLM_PLQ_WT_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E9082262-0DFC-7A16-E040-BB89AD436DFF","latestVersionIndicator":"Yes","beginDate":"2013-10-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-10-18","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI Center for Cancer Research (CCR) clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3923977","version":"1","preferredName":"Left Palmar Region Plaque Weight Score","preferredDefinition":"Numeric value representing the sum of plaque characteristics occurring in the palm of the left hand multiplied by a modifier value of 0.1 to yield a weighted plaque score.","longName":"LPLM_PLQ_WT_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E90832FE-6856-76E9-E040-BB89AD433923","latestVersionIndicator":"Yes","beginDate":"2013-10-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-10-18","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI Center for Cancer Research (CCR) clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3923979","version":"1","preferredName":"Right Plantar Region Plaque Weight Score","preferredDefinition":"Numeric value representing the sum of plaque characteristics occurring on the sole of the right foot multiplied by a modifier value of 0.1 to yield a weighted plaque score.","longName":"RTR_PLQ_WT_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E90832FE-68A9-76E9-E040-BB89AD433923","latestVersionIndicator":"Yes","beginDate":"2013-10-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-10-18","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI Center for Cancer Research (CCR) clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3923980","version":"1","preferredName":"Left Plantar Region Plaque Weight Score","preferredDefinition":"Numeric value representing the sum of plaque characteristics occurring on the sole of the left foot multiplied by a modifier value of 0.1 to yield a weighted plaque score.","longName":"LPTR_PLQ_WT_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E9082262-0E42-7A16-E040-BB89AD436DFF","latestVersionIndicator":"Yes","beginDate":"2013-10-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-10-18","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI Center for Cancer Research (CCR) clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3923981","version":"1","preferredName":"Right Palmar Region Plaque Body Surface Involvement Percentage","preferredDefinition":"Numeric value to represent the percentage of plaque involvement in the palm of the right hand.","longName":"RPLM_PLQ_BS_PCT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E90832FE-68F0-76E9-E040-BB89AD433923","latestVersionIndicator":"Yes","beginDate":"2013-10-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-10-18","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI Center for Cancer Research (CCR) clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3923997","version":"1","preferredName":"Left Palmar Region Plaque Body Surface Involvement Percentage","preferredDefinition":"Numeric value to represent the percentage of plaque involvement in the palm of the left hand.","longName":"LPLM_PLQ_BS_PCT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E90832FE-6910-76E9-E040-BB89AD433923","latestVersionIndicator":"Yes","beginDate":"2013-10-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-10-18","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI Center for Cancer Research (CCR) clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3924011","version":"1","preferredName":"Right Plantar Region Plaque Body Surface Involvement Percentage","preferredDefinition":"Numeric value to represent the percentage of plaque involvement on the sole of the right foot.","longName":"RPTR_PLQ_BS_PCT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E90832FE-6937-76E9-E040-BB89AD433923","latestVersionIndicator":"Yes","beginDate":"2013-10-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-10-18","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI Center for Cancer Research (CCR) clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3924013","version":"1","preferredName":"Left Plantar Region Plaque Body Surface Involvement Percentage","preferredDefinition":"Numeric value to represent the percentage of plaque involvement on the sole of the left foot.","longName":"LPTR_PLQ_BS_PCT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E90832FE-6957-76E9-E040-BB89AD433923","latestVersionIndicator":"Yes","beginDate":"2013-10-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-10-18","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI Center for Cancer Research (CCR) clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3924014","version":"1","preferredName":"Right Palmar Region Plaque Body Surface Area Scale","preferredDefinition":"Numeric code to represent the extent of body surface area in the palm of the right hand with plaque involvement.","longName":"RPLM_PLQ_BSA_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E9082262-0EBB-7A16-E040-BB89AD436DFF","latestVersionIndicator":"Yes","beginDate":"2013-10-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-10-18","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI Center for Cancer Research (CCR) clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3924015","version":"1","preferredName":"Left Palmar Region Plaque Body Surface Area Scale","preferredDefinition":"Numeric code to represent the extent of body surface area in the palm of the left hand with plaque involvement.","longName":"LPLM_PLQ_BSA_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E9082262-0EE9-7A16-E040-BB89AD436DFF","latestVersionIndicator":"Yes","beginDate":"2013-10-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-10-18","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI Center for Cancer Research (CCR) clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3924016","version":"1","preferredName":"Right Plantar Region Plaque Body Surface Area Scale","preferredDefinition":"Numeric code to represent the extent of body surface area on the sole of the right foot with plaque involvement.","longName":"RPTR_PLQ_BSA_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E9082262-0F34-7A16-E040-BB89AD436DFF","latestVersionIndicator":"Yes","beginDate":"2013-10-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-10-18","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI Center for Cancer Research (CCR) clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3924017","version":"1","preferredName":"Left Plantar Region Plaque Body Surface Area Scale","preferredDefinition":"Numeric code to represent the extent of body surface area on the sole of the left foot with plaque involvement.","longName":"LPTR_PLQ_BSA_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E9082262-0F54-7A16-E040-BB89AD436DFF","latestVersionIndicator":"Yes","beginDate":"2013-10-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-10-18","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI Center for Cancer Research (CCR) clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3924019","version":"1","preferredName":"Right Palmar Region Plaque Body Surface Area Importance Weight Product Value","preferredDefinition":"Calculated value representing the weighted plaque score multiplied by the area score for plaque occurring in the palm of the right hand.","longName":"RPLM_PLQ_BSA_PRO_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E9082262-0F99-7A16-E040-BB89AD436DFF","latestVersionIndicator":"Yes","beginDate":"2013-10-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-10-18","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI Center for Cancer Research (CCR) clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3924032","version":"1","preferredName":"Left Palmar Region Plaque Body Surface Area Importance Weight Product Value","preferredDefinition":"Calculated value representing the weighted plaque score multiplied by the area score for plaque occurring in the palm of the left hand..","longName":"LPLM_PLQ_BSA_PRO_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E9089289-EBB0-2B16-E040-BB89AD43095B","latestVersionIndicator":"Yes","beginDate":"2013-10-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-10-18","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI Center for Cancer Research (CCR) clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3924051","version":"1","preferredName":"Right Plantar Region Plaque Body Surface Area Importance Weight Product Value","preferredDefinition":"Calculated value representing the weighted plaque score multiplied by the area score for plaque occurring on the sole of the right foot.","longName":"RPTR_PLQ_BSA_PRO_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E908B442-3790-D312-E040-BB89AD430452","latestVersionIndicator":"Yes","beginDate":"2013-10-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-10-18","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI Center for Cancer Research (CCR) clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3924052","version":"1","preferredName":"Left Plantar Region Plaque Body Surface Area Importance Weight Product Value","preferredDefinition":"Calculated value representing the weighted plaque score multiplied by the area score for plaque occurring on the sole of the left foot..","longName":"LPTR_PLQ_BSA_PRO_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E908B442-3851-D312-E040-BB89AD430452","latestVersionIndicator":"Yes","beginDate":"2013-10-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-10-18","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI Center for Cancer Research (CCR) clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3924053","version":"1","preferredName":"PalmoPlantar PASI Total Score","preferredDefinition":"Calculated total value for the PalmoPlantar PASI (PPPASI) score based on right palm, left palm, right sole and left sole measures of involvement and plaque characteristics.","longName":"PLM_PTR_PASI_TTL_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E908B442-3871-D312-E040-BB89AD430452","latestVersionIndicator":"Yes","beginDate":"2013-09-24","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-10-18","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI Center for Cancer Research (CCR) clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3946631","version":"1","preferredName":"Disease or Disorder New Disease Progression Diagnosis Name","preferredDefinition":"Text term for the diagnosis of new spread or progression of disease.","longName":"DZ_NEW_PD_DIAG_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EA87B0E5-6735-6876-E040-BB89AD437204","latestVersionIndicator":"Yes","beginDate":"2013-11-06","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-11-06","modifiedBy":"REEVESD","dateModified":"2013-11-06","changeNote":"Curated to support NCI CCR clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3948980","version":"1","preferredName":"Patient Sustained Engraftment Occurrence Date","preferredDefinition":"Calendar date of recovery of bone marrow function with neutrophil recovery associated with more than 95% T-cell and myeloid cell chimerism at day 100 post transplantation.","longName":"PT_SUS_ENG_DT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EAA9943F-BD35-5771-E040-BB89AD4330FA","latestVersionIndicator":"Yes","beginDate":"2013-11-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-11-08","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Created to support NCI Center for Cancer Research (CCR) transplantation trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3948981","version":"1","preferredName":"Patient Primary Graft Failure Date","preferredDefinition":"Calendar date of a patient's inability to achieve a sustained donor engraftment defined as neutrophil recovery associated with more than 95% T-cell and myeloid cell donor chimerism at day 100.","longName":"PT_PRM_GFT_FAIL_DT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EAA9943F-BD54-5771-E040-BB89AD4330FA","latestVersionIndicator":"Yes","beginDate":"2013-11-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-11-08","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Created to support NCI Center for Cancer Research (CCR) transplantation trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3948982","version":"1","preferredName":"Patient Secondary Graft Failure Date","preferredDefinition":"Calendar date of documented sustained donor engraftment followed by 1) severe neutropenia (ANC < 500/mm3) and bone marrow biopsy with cellularity of less than 25%, or 2) absence of donor cells in the marrow or blood demonstrated by a chimerism assay without subsequent improvement either spontaneously or after growth factor treatment.","longName":"PT_SEC_GFT_FAIL_DT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EAA9943F-BD73-5771-E040-BB89AD4330FA","latestVersionIndicator":"Yes","beginDate":"2013-11-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-11-08","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Created to support NCI Center for Cancer Research (CCR) transplantation trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3962911","version":"1","preferredName":"Physician Diagnosed Elevated Blood Pressure Daily Medication Personal Medical History Yes No Not Applicable Indicator","preferredDefinition":"Text term to signify whether a physician has diagnosed an individual with high blood pressure that needs daily medication.","longName":"MD_BP_MED_HX_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EC06F6AA-3E6D-77C4-E040-BB89AD434457","latestVersionIndicator":"Yes","beginDate":"2013-11-25","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-11-25","modifiedBy":"REEVESD","dateModified":"2014-03-07","changeNote":"Curated to support NCI CCR clinical trial for Anakinra in pustular dermatoses.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3962912","version":"1","preferredName":"Physician Diagnosed Elevated Cholesterol Daily Medication Personal Medical History Yes No Not Applicable Indicator","preferredDefinition":"Text term to signify whether a physician has diagnosed an individual with high cholesterol that needs daily medication.","longName":"MD_CHOL_MED_HX_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EC06F6AA-3E9B-77C4-E040-BB89AD434457","latestVersionIndicator":"Yes","beginDate":"2013-11-25","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-11-25","modifiedBy":"REEVESD","dateModified":"2014-03-07","changeNote":"Curated to support NCI CCR clinical trial for Anakinra in pustular dermatoses.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3962913","version":"1","preferredName":"Physician Diagnosed Myocardial infarction Coronary Artery Disease Personal Medical History Yes No Not Applicable Indicator","preferredDefinition":"Text term to signify whether a physician has diagnosed an individual with a heart attack (myocardial infarction) or coronary artery disease.","longName":"MD_MI_CAD_MED_HX_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EC06F6AA-3EC9-77C4-E040-BB89AD434457","latestVersionIndicator":"Yes","beginDate":"2013-11-25","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-11-25","modifiedBy":"REEVESD","dateModified":"2014-03-07","changeNote":"Curated to support NCI CCR clinical trial for Anakinra in pustular dermatoses.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3962914","version":"1","preferredName":"Congestive Heart Failure History Yes No Not Applicable Indicator","preferredDefinition":"Text term to signify whether a physician has diagnosed an individual with heart failure.","longName":"CHF_MED_HX_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EC06F6AA-3EF7-77C4-E040-BB89AD434457","latestVersionIndicator":"Yes","beginDate":"2013-11-25","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-11-25","modifiedBy":"REEVESD","dateModified":"2014-03-07","changeNote":"Curated to support NCI CCR clinical trial for Anakinra in pustular dermatoses.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3962915","version":"1","preferredName":"Physician Diagnosed Peripheral Vascular Disorder Surgical Procedure Personal Medical History Yes No Not Applicable Indicator","preferredDefinition":"Text term to signify whether a physician has diagnosed an individual as needing an operative procedure due to peripheral vascular disease.","longName":"SURG_PVD_MED_HX_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EC06F6AA-3F25-77C4-E040-BB89AD434457","latestVersionIndicator":"Yes","beginDate":"2013-11-25","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-11-25","modifiedBy":"REEVESD","dateModified":"2014-03-07","changeNote":"Curated to support NCI CCR clinical trial for Anakinra in pustular dermatoses.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3962916","version":"1","preferredName":"Physician Diagnosis Stroke Cerebrovascular Accident Transient Ischemic Attack Blood Clot Cardiovascular Disorder Personal Medical History Yes No Not Applicable Indicator","preferredDefinition":"Text term to signify whether a physician has diagnosed an individual as having a stroke, cerebrovascular accident, blood clot or bleeding on the brain, or transient ischemic attack (TIA).","longName":"CVA_TIA_MED_HX_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EC06F6AA-3F53-77C4-E040-BB89AD434457","latestVersionIndicator":"Yes","beginDate":"2013-11-25","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-11-25","modifiedBy":"OBROPTAJ","dateModified":"2014-09-04","changeNote":"Curated to support NCI CCR clinical trial for Anakinra in pustular dermatoses.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4024767","version":"1","preferredName":"MD Anderson Symptom Inventory - Core Past 24 Hour Severity Total Score","preferredDefinition":"The mean of all responses by an individual to the Severity domain of the MD Anderson Symptom Inventory.","longName":"MDASI_CORE_24_TTL_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EDEA3275-DE60-1839-E040-BB89AD430288","latestVersionIndicator":"Yes","beginDate":"2013-12-19","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-12-19","modifiedBy":"TSESU","dateModified":"2018-10-09","changeNote":"Created for CCR per request by D.Reeves. mc 12/19/13","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4024768","version":"1","preferredName":"MD Anderson Symptom Inventory - Core Past 24 Hour Interference Total Score","preferredDefinition":"The mean of all responses by an individual to the Interference domain of the MD Anderson Symptom Inventory","longName":"MDASI_CORE_24_INT_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EDEA3275-DE80-1839-E040-BB89AD430288","latestVersionIndicator":"Yes","beginDate":"2013-12-19","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-12-19","modifiedBy":"TSESU","dateModified":"2018-10-09","changeNote":"Created for CCR per request by D.Reeves. mc 12/19/13","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4024778","version":"1","preferredName":"Symptom Assessment Questionnaire Total Score","preferredDefinition":"The mean of all responses by an individual to the symptom assessment tool.","longName":"SX_ASSMT_TTL_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EDE9F5C2-EB34-A461-E040-BB89AD43353E","latestVersionIndicator":"Yes","beginDate":"2013-12-19","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-12-19","modifiedBy":"REEVESD","dateModified":"2013-12-20","changeNote":"Created for CCR per request by D.Reeves. mc 12/19/13","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4024779","version":"1","preferredName":"Symptom Assessment Questionnaire Other Symptom Report Indicator","preferredDefinition":"Indicator that signifies whether or not the individual has other symptoms not previously reported.","longName":"SX_ASSMT_OTX_SX_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EDEA3275-DEA6-1839-E040-BB89AD430288","latestVersionIndicator":"Yes","beginDate":"2013-12-19","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-12-19","modifiedBy":"REEVESD","dateModified":"2013-12-20","changeNote":"Created for CCR per request by D.Reeves. mc 12/19/13","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4024783","version":"1","preferredName":"Symptom Assessment Questionnaire Other Symptom Report Descriptive Text","preferredDefinition":"Text field to capture the name of another symptom not previously reported.","longName":"SX_ASSMT_OTX_TXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EDEA3275-DEEC-1839-E040-BB89AD430288","latestVersionIndicator":"Yes","beginDate":"2013-12-19","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-12-19","modifiedBy":"REEVESD","dateModified":"2013-12-20","changeNote":"Created for CCR per request by D.Reeves. mc 12/19/13","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4024784","version":"1","preferredName":"Symptom Inventory Past 24 Hours Severity Other Symptom at its Worst Score 11 Point Likert Scale","preferredDefinition":"An individual's stated perception of the severity of another symptom, not previously reported, at its worst in the last 24 hours, using an eleven-point Likert scale.","longName":"SX_INV_24_SEV_WST_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EDEA3275-DF0C-1839-E040-BB89AD430288","latestVersionIndicator":"Yes","beginDate":"2013-12-19","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-12-19","modifiedBy":"REEVESD","dateModified":"2013-12-20","changeNote":"Created for CCR per request by D.Reeves. mc 12/19/13","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4030781","version":"1","preferredName":"No Cardiovascular Disorder Personal Medical History Yes No Not Applicable Indicator","preferredDefinition":"Text term to signify whether a patient has No History of cardiovascular disease.","longName":"NO_CV_MED_HX_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EEC38743-DDEB-BBAF-E040-BB89AD432F3F","latestVersionIndicator":"Yes","beginDate":"2013-12-01","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-12-30","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR clinical trial for Anakinra in pustular dermatoses.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4030784","version":"1","preferredName":"Physician Diagnosed Chronic Obstructive Pulmonary Disease Daily Medication Personal Medical History Yes No Not Applicable Indicator","preferredDefinition":"Text term to signify whether a physician has diagnosed COPD (Emphysema of Chronic bronchitis) requiring daily treatment or treatment for flare ups in a patient.","longName":"COPD_TX_MED_HX_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EEC37A50-1F0F-1F20-E040-BB89AD4338BE","latestVersionIndicator":"Yes","beginDate":"2013-12-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-12-30","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR clinical trial for Anakinra in pustular dermatoses.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4030791","version":"1","preferredName":"Physician Diagnosed Asthma Daily Medication Personal Medical History Yes No Not Applicable Indicator","preferredDefinition":"Text term to signify whether a physician has diagnosed asthma requiring daily treatment or treatment for flare ups in a patient.","longName":"ASTHMA_TX_MED_HX_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EEC37A50-1F3C-1F20-E040-BB89AD4338BE","latestVersionIndicator":"Yes","beginDate":"2013-12-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-12-30","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR clinical trial for Anakinra in pustular dermatoses.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4030793","version":"1","preferredName":"Lung Disease Other Personal Medical History Assessment Specify","preferredDefinition":"Text to capture physician diagnosed other lung disease within a patient.","longName":"LUNG_DZ_MED_HX_SPEC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EEC37A50-1F82-1F20-E040-BB89AD4338BE","latestVersionIndicator":"Yes","beginDate":"2013-12-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-12-30","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support Anakinra in pustular dermatoses trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4030795","version":"1","preferredName":"No Lung Disease Personal Medical History Yes No Not Applicable Indicator","preferredDefinition":"Text term to signify whether a patient has No History of lung disease.","longName":"NO_LUNG_MED_HX_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EEC37A50-1FAF-1F20-E040-BB89AD4338BE","latestVersionIndicator":"Yes","beginDate":"2013-12-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-12-30","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR clinical trial for Anakinra in pustular dermatoses.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4030799","version":"1","preferredName":"Physician Diagnosed HIV Infection Personal Medical History Yes No Not Applicable Indicator","preferredDefinition":"Text term to signify whether a physician has diagnosed HIV infection in a patient.","longName":"HIV_INF_MED_HX_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EEC37A50-1FDC-1F20-E040-BB89AD4338BE","latestVersionIndicator":"Yes","beginDate":"2013-12-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-12-30","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR clinical trial for Anakinra in pustular dermatoses.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4034163","version":"1","preferredName":"Physician Diagnosed Acquired Immunodeficiency Syndrome Personal Medical History Yes No Not Applicable Indicator","preferredDefinition":"Text term to signify whether a physician has diagnosed AIDS by a CD4 count of less than or equal to 200 and a history of opportunistic infection in a patient.","longName":"AIDS_MED_HX_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EEC37A50-2009-1F20-E040-BB89AD4338BE","latestVersionIndicator":"Yes","beginDate":"2013-12-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-12-30","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR clinical trial for Anakinra in pustular dermatoses.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4035054","version":"1","preferredName":"Physician Diagnosed Hepatitis B Positive Finding Personal Medical History Yes No Not Applicable Indicator","preferredDefinition":"Text term to signify whether a physician has diagnosed Hepatitis B in a patient.","longName":"HEP_B_MED_HX_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EEC42E32-F980-227F-E040-BB89AD430D67","latestVersionIndicator":"Yes","beginDate":"2013-12-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-12-30","modifiedBy":"WINCHC","dateModified":"2022-04-14","changeNote":"Curated to support NCI CCR clinical trial for Anakinra in pustular dermatoses.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4035056","version":"1","preferredName":"Physician Diagnosed Hepatitis C Positive Finding Personal Medical History Yes No Not Applicable Indicator","preferredDefinition":"Text term to signify whether a physician has diagnosed Hepatitis C in a patient.","longName":"HEP_C_MED_HX_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EEC42E32-F9AD-227F-E040-BB89AD430D67","latestVersionIndicator":"Yes","beginDate":"2013-12-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-12-30","modifiedBy":"TSESU","dateModified":"2023-03-21","changeNote":"Curated to support NCI CCR clinical trial for Anakinra in pustular dermatoses.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4035071","version":"1","preferredName":"Physician Diagnosed Tuberculosis Therapy and Hospitalization Personal Medical History Yes No Not Applicable Indicator","preferredDefinition":"Text term to signify whether a physician has diagnosed tuberculosis infection with symptoms requiring treatment and/or hospitalization in a patient.","longName":"TB_TX_MED_HX_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EEC478DC-2811-1F7E-E040-BB89AD4340DD","latestVersionIndicator":"Yes","beginDate":"2013-12-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-12-30","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR clinical trial for Anakinra in pustular dermatoses.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4035073","version":"1","preferredName":"Tuberculosis Exposure Personal Medical History Yes No Not Applicable Indicator","preferredDefinition":"Text term to signify whether a physician has diagnosed tuberculosis exposure with no symptoms or hospitalization requirement in a patient.","longName":"TB_EXPS_MED_HX_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EEC478DC-283E-1F7E-E040-BB89AD4340DD","latestVersionIndicator":"Yes","beginDate":"2013-12-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-12-30","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR clinical trial for Anakinra in pustular dermatoses.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4035074","version":"1","preferredName":"Physician Diagnosed Infection Attribution Hospitalization Personal Medical History Yes No Not Applicable Indicator","preferredDefinition":"Text term to signify whether a physician has diagnosed any infection requiring hospitalization in a patient.","longName":"INF_HOSP_MED_HX_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EEC478DC-286B-1F7E-E040-BB89AD4340DD","latestVersionIndicator":"Yes","beginDate":"2013-12-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-12-30","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR clinical trial for Anakinra in pustular dermatoses.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4035075","version":"1","preferredName":"Physician Diagnosed Infection Attribution Hospitalization Within 12 Months Personal Medical History Yes No Not Applicable Indicator","preferredDefinition":"Text term to signify whether a physician has diagnosed any infection in a patient that required hospitalization within the last 12 months.","longName":"INF_12MOS_MED_HX_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EEC478DC-2898-1F7E-E040-BB89AD4340DD","latestVersionIndicator":"Yes","beginDate":"2013-12-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-12-30","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR clinical trial for Anakinra in pustular dermatoses.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4035076","version":"1","preferredName":"Physician Diagnosed Infection Attribution Oral Antibiotic Therapy Within 12 Months Personal Medical History Yes No Not Applicable Indicator","preferredDefinition":"Text term to signify whether a physician has diagnosed any infection in a patient that required oral antibiotics within the last 12 months.","longName":"INF_12M_ORAL_HX_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EEC478DC-28C5-1F7E-E040-BB89AD4340DD","latestVersionIndicator":"Yes","beginDate":"2013-12-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-12-30","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR clinical trial for Anakinra in pustular dermatoses.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4035077","version":"1","preferredName":"Physician Diagnosed Greater Than or Equal To 2 Infections Attribution Oral Antibiotic Therapy Within 12 Months Personal Medical History Yes No Not Applicable Indicator","preferredDefinition":"Text term to signify whether a physician has diagnosed two or more infections in a patient that required oral antibiotics within the last 12 months.","longName":"INF2_12M_ORAL_HX_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EEC478DC-28F5-1F7E-E040-BB89AD4340DD","latestVersionIndicator":"Yes","beginDate":"2013-12-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-12-30","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR clinical trial for Anakinra in pustular dermatoses.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4035078","version":"1","preferredName":"Infection Other Personal Medical History Descriptive Text","preferredDefinition":"Text to describe any infection diagnosed by a physician within a patient that is different than the one(s) previously specified or mentioned.","longName":"INF_OTX_TXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EEC478DC-2922-1F7E-E040-BB89AD4340DD","latestVersionIndicator":"Yes","beginDate":"2013-12-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-12-30","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR clinical trial for Anakinra in pustular dermatoses.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4035079","version":"1","preferredName":"No Infection Personal Medical History Yes No Not Applicable Indicator","preferredDefinition":"Text term to signify whether a patient has No History of an infection.","longName":"NO_INF_MED_HX_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EEC478DC-294F-1F7E-E040-BB89AD4340DD","latestVersionIndicator":"Yes","beginDate":"2013-12-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-12-30","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR clinical trial for Anakinra in pustular dermatoses.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4035080","version":"1","preferredName":"Physician Diagnosed Gastric or Peptic Ulcer Gastrointestinal Disease Personal Medical History Yes No Not Applicable Indicator","preferredDefinition":"Text term to signify whether a physician has diagnosed a stomach ulcer or peptic ulcer disease in a patient.","longName":"ULC_MED_HX_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EEC478DC-297C-1F7E-E040-BB89AD4340DD","latestVersionIndicator":"Yes","beginDate":"2013-12-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-12-30","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR clinical trial for Anakinra in pustular dermatoses.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4035081","version":"1","preferredName":"Physician Diagnosed Mild Liver Disease Personal Medical History Yes No Not Applicable Indicator","preferredDefinition":"Text term to signify whether a physician has diagnosed mild liver disease in a patient.","longName":"MLD_LV_DZ_MED_HX_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EEC478DC-29A9-1F7E-E040-BB89AD4340DD","latestVersionIndicator":"Yes","beginDate":"2013-12-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-12-30","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR clinical trial for Anakinra in pustular dermatoses.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4035082","version":"1","preferredName":"Physician Diagnosed Moderate to Severe Liver Disease Personal Medical History Yes No Not Applicable Indicator","preferredDefinition":"Text term to signify whether a physician has diagnosed moderate to severe liver disease in a patient.","longName":"MOD_LV_DZ_MED_HX_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EEC478DC-29D6-1F7E-E040-BB89AD4340DD","latestVersionIndicator":"Yes","beginDate":"2013-12-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-12-30","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR clinical trial for Anakinra in pustular dermatoses.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4035084","version":"1","preferredName":"Physician Diagnosed Chronic Renal Disorder Personal Medical History Yes No Not Applicable Indicator","preferredDefinition":"Text term to signify whether a physician has diagnosed chronic kidney disease in a patient.","longName":"CHR_RENAL_MED_HX_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EEC4D55A-92E2-DF0E-E040-BB89AD434F0E","latestVersionIndicator":"Yes","beginDate":"2013-12-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-12-30","modifiedBy":"ABATEL","dateModified":"2021-05-28","changeNote":"Curated to support NCI CCR clinical trial for Anakinra in pustular dermatoses.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4035085","version":"1","preferredName":"Physician Diagnosed Chronic Renal Disorder Requires Dialysis Kidney Replacement Therapy Medical History Yes No Not Applicable Indicator","preferredDefinition":"Text term to signify whether a physician has diagnosed chronic kidney disease requiring dialysis or preparation for kidney replacement therapy in a patient.","longName":"REN_DIAL_MED_HX_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EEC4D55A-930F-DF0E-E040-BB89AD434F0E","latestVersionIndicator":"Yes","beginDate":"2013-12-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-12-30","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR clinical trial for Anakinra in pustular dermatoses.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4035086","version":"1","preferredName":"Physician Diagnosed Inflammatory Bowel Disease Personal Medical History Yes No Not Applicable Indicator","preferredDefinition":"Text term to signify whether a physician has diagnosed inflammatory bowel disease (e.g. ulcerative colitis, Crohn's disease) in a patient.","longName":"INF_BWL_MED_HX_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EEC4D55A-933F-DF0E-E040-BB89AD434F0E","latestVersionIndicator":"Yes","beginDate":"2013-12-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-12-30","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR clinical trial for Anakinra in pustular dermatoses.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4035087","version":"1","preferredName":"Gastrointestinal Tract or Kidney Disease Other Personal Medical History Descriptive Text","preferredDefinition":"Text to describe any gastrointestinal tract or kidney disease diagnosed by a physician within a patient that is different than the one(s) previously specified or mentioned.","longName":"GI_RENAL_OTX_TXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EEC4D55A-936C-DF0E-E040-BB89AD434F0E","latestVersionIndicator":"Yes","beginDate":"2013-12-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-12-30","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR clinical trial for Anakinra in pustular dermatoses.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4035088","version":"1","preferredName":"No Gastrointestinal Tract or Kidney Disease or Disorder Personal Medical History Yes No Not Applicable Indicator","preferredDefinition":"Text term to signify whether a patient has No History of gastrointestinal tract or kidney disease.","longName":"NO_GI_REN_HX_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EEC4D55A-9399-DF0E-E040-BB89AD434F0E","latestVersionIndicator":"Yes","beginDate":"2013-12-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-12-30","modifiedBy":"CHANGP","dateModified":"2017-02-27","changeNote":"Curated to support NCI CCR clinical trial for Anakinra in pustular dermatoses.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4035091","version":"1","preferredName":"Physician Diagnosed Diabetes Mellitus Requiring Medication Personal Medical History Yes No Not Applicable Indicator","preferredDefinition":"Text term to signify whether a physician has diagnosed diabetes requiring medication by mouth or insulin injection in a patient.","longName":"DM_MDS_MED_HX_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EEC4D55A-93C6-DF0E-E040-BB89AD434F0E","latestVersionIndicator":"Yes","beginDate":"2013-12-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-12-30","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR clinical trial for Anakinra in pustular dermatoses.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4035092","version":"1","preferredName":"Physician Diagnosed Diabetes Mellitus Complication Personal Medical History Yes No Not Applicable Indicator","preferredDefinition":"Text term to signify whether a physician has diagnosed diabetes requiring medication with complication (e.g. eye problems, neuropathy, kidney disease) in a patient.","longName":"DM_COMPL_MED_HX_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EEC4D55A-93F3-DF0E-E040-BB89AD434F0E","latestVersionIndicator":"Yes","beginDate":"2013-12-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-12-30","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR clinical trial for Anakinra in pustular dermatoses.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4035093","version":"1","preferredName":"Endocrine Disorder or Disease Other Personal Medical History Descriptive Text","preferredDefinition":"Text to describe any endocrine disease diagnosed by a physician within a patient that is different than the one(s) previously specified or mentioned.","longName":"ENDCR_DZ_OTX_TXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EEC4D55A-9420-DF0E-E040-BB89AD434F0E","latestVersionIndicator":"Yes","beginDate":"2013-12-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-12-30","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR clinical trial for Anakinra in pustular dermatoses.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4035094","version":"1","preferredName":"No Endocrine Disease Personal Medical History Yes No Not Applicable Indicator","preferredDefinition":"Text term to signify whether a patient has No History of endocrine disease.","longName":"NO_ENDCR_DZ_HX_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EEC4D55A-944D-DF0E-E040-BB89AD434F0E","latestVersionIndicator":"Yes","beginDate":"2013-12-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-12-30","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR clinical trial for Anakinra in pustular dermatoses.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4035095","version":"1","preferredName":"Physician Diagnosed Osteoarthritis Personal Medical History Yes No Not Applicable Indicator","preferredDefinition":"Text term to signify whether a physician has diagnosed osteoarthritis in a patient.","longName":"OSTEOARTH_MED_HX_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EEC559A0-9E44-B5DE-E040-BB89AD430232","latestVersionIndicator":"Yes","beginDate":"2013-12-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-12-30","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR clinical trial for Anakinra in pustular dermatoses.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4035096","version":"1","preferredName":"Physician Diagnosed Gout Personal Medical History Yes No Not Applicable Indicator","preferredDefinition":"Text term to signify whether a physician has diagnosed gout in a patient.","longName":"GOUT_MED_HX_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EEC559A0-9E71-B5DE-E040-BB89AD430232","latestVersionIndicator":"Yes","beginDate":"2013-12-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-12-30","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR clinical trial for Anakinra in pustular dermatoses.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4035097","version":"1","preferredName":"Rheumatologist Diagnosed Psoriatic Arthritis Personal Medical History Yes No Not Applicable Indicator","preferredDefinition":"Text term to signify whether a Rheumatologist has diagnosed psoriatic arthritis in a patient.","longName":"RHEU_PART_MED_HX_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EEC559A0-9EA2-B5DE-E040-BB89AD430232","latestVersionIndicator":"Yes","beginDate":"2013-12-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-12-30","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR clinical trial for Anakinra in pustular dermatoses.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4035098","version":"1","preferredName":"Physician Diagnosed Psoriatic Arthritis Personal Medical History Yes No Not Applicable Indicator","preferredDefinition":"Text term to signify whether a physician has diagnosed psoriatic arthritis in a patient.","longName":"PHYS_PART_MED_HX_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EEC559A0-9ECF-B5DE-E040-BB89AD430232","latestVersionIndicator":"Yes","beginDate":"2013-12-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-12-30","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR clinical trial for Anakinra in pustular dermatoses.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4035271","version":"1","preferredName":"Musculoskeletal Disease Other Personal Medical History Descriptive Text","preferredDefinition":"Text to describe any musculoskeletal disease diagnosed by a physician within a patient that is different than the one(s) previously specified or mentioned.","longName":"MUSCL_DZ_OTX_TXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EEC70387-4B0D-485C-E040-BB89AD433B0B","latestVersionIndicator":"Yes","beginDate":"2013-12-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-12-30","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR clinical trial for Anakinra in pustular dermatoses.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4035272","version":"1","preferredName":"No Musculoskeletal Disease Personal Medical History Yes No Not Applicable Indicator","preferredDefinition":"Text term to signify whether a patient has No History of musculoskeletal disease.","longName":"NO_MUSCUL_DZ_HX_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EEC70387-4B2E-485C-E040-BB89AD433B0B","latestVersionIndicator":"Yes","beginDate":"2013-12-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-12-30","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR clinical trial for Anakinra in pustular dermatoses.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4035273","version":"1","preferredName":"Physician Diagnosed Depression Medication Counseling Required Personal Medical History Yes No Not Applicable Indicator","preferredDefinition":"Text term to signify whether a physician has diagnosed depression requiring counseling and/or prescription medication in a patient.","longName":"DEP_CSL_MED_HX_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EEC70387-4B4F-485C-E040-BB89AD433B0B","latestVersionIndicator":"Yes","beginDate":"2013-12-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-12-30","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR clinical trial for Anakinra in pustular dermatoses.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4035274","version":"1","preferredName":"Physician Diagnosed Anxiety Medication Counseling Required Personal Medical History Yes No Not Applicable Indicator","preferredDefinition":"Text term to signify whether a physician has diagnosed anxiety requiring counseling and/or prescription medication in a patient.","longName":"ANXTY_CSL_MED_HX_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EEC70387-4B70-485C-E040-BB89AD433B0B","latestVersionIndicator":"Yes","beginDate":"2013-12-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-12-30","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR clinical trial for Anakinra in pustular dermatoses.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4035275","version":"1","preferredName":"Psychiatric Disorder Other Personal Medical History Descriptive Text","preferredDefinition":"Text to describe any psychiatric disease diagnosed by a physician within a patient that is different than the one(s) previously specified or mentioned.","longName":"PSYCH_DZ_OTX_TXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EEC70387-4B91-485C-E040-BB89AD433B0B","latestVersionIndicator":"Yes","beginDate":"2013-12-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-12-30","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR clinical trial for Anakinra in pustular dermatoses.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4035276","version":"1","preferredName":"No Psychiatric Disorder Personal Medical History Yes No Not Applicable Indicator","preferredDefinition":"Text term to signify whether a patient has No History of psychiatric disease.","longName":"NO_PSYCH_DZ_HX_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EEC70387-4BB2-485C-E040-BB89AD433B0B","latestVersionIndicator":"Yes","beginDate":"2013-12-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-12-30","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR clinical trial for Anakinra in pustular dermatoses.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4035277","version":"1","preferredName":"Physician Diagnosed Multiple Sclerosis Personal Medical History Yes No Not Applicable Indicator","preferredDefinition":"Text term to signify whether a physician has diagnosed multiple sclerosis in a patient.","longName":"MS_MED_HX_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EEC70387-4BD3-485C-E040-BB89AD433B0B","latestVersionIndicator":"Yes","beginDate":"2013-12-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-12-30","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR clinical trial for Anakinra in pustular dermatoses.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4035278","version":"1","preferredName":"Physician Diagnosed Optic Neuritis Personal Medical History Yes No Not Applicable Indicator","preferredDefinition":"Text term to signify whether a physician has diagnosed optic neuritis in a patient.","longName":"OPT_NEUR_MED_HX_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EEC70387-4BF4-485C-E040-BB89AD433B0B","latestVersionIndicator":"Yes","beginDate":"2013-12-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-12-30","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR clinical trial for Anakinra in pustular dermatoses.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4035279","version":"1","preferredName":"Physician Diagnosed Parkinson's Disease Personal Medical History Yes No Not Applicable Indicator","preferredDefinition":"Text term to signify whether a physician has diagnosed Parkinson's disease in a patient.","longName":"PARK_DZ_MED_HX_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EEC70387-4C15-485C-E040-BB89AD433B0B","latestVersionIndicator":"Yes","beginDate":"2013-12-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-12-30","modifiedBy":"PANH","dateModified":"2018-10-02","changeNote":"Curated to support NCI CCR clinical trial for Anakinra in pustular dermatoses.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4035280","version":"1","preferredName":"Physician Diagnosed Dementia or Alzheimer's Disease Personal Medical History Yes No Not Applicable Indicator","preferredDefinition":"Text term to signify whether a physician has diagnosed dementia or Alzheimer's disease in a patient.","longName":"DEM_ALZHM_MED_HX_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EEC7373E-27E3-C83A-E040-BB89AD437B5A","latestVersionIndicator":"Yes","beginDate":"2013-12-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-12-30","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR clinical trial for Anakinra in pustular dermatoses.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4035281","version":"1","preferredName":"Physician Diagnosed Paralysis Disease Personal Medical History Yes No Not Applicable Indicator","preferredDefinition":"Text term to signify whether a physician has diagnosed paralysis in a patient.","longName":"PARLYSIS_MED_HX_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EEC7373E-2804-C83A-E040-BB89AD437B5A","latestVersionIndicator":"Yes","beginDate":"2013-12-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-12-30","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR clinical trial for Anakinra in pustular dermatoses.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4035282","version":"1","preferredName":"Neurological Disease Other Personal Medical History Descriptive Text","preferredDefinition":"Text to describe any neurologic disease diagnosed by a physician within a patient that is different than the one(s) previously specified or mentioned.","longName":"NEUR_DZ_OTX_TXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EEC7373E-2825-C83A-E040-BB89AD437B5A","latestVersionIndicator":"Yes","beginDate":"2013-12-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-12-30","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR clinical trial for Anakinra in pustular dermatoses.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4035283","version":"1","preferredName":"No Neurologic Disease Personal Medical History Yes No Not Applicable Indicator","preferredDefinition":"Text term to signify whether a patient has No History of neurologic disease.","longName":"NO_NEUR_DZ_HX_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EEC7373E-2846-C83A-E040-BB89AD437B5A","latestVersionIndicator":"Yes","beginDate":"2013-12-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-12-30","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR clinical trial for Anakinra in pustular dermatoses.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4035284","version":"1","preferredName":"Physician Diagnosed Internal Carcinoma Personal Medical History Yes No Not Applicable Indicator","preferredDefinition":"Text term to signify whether a physician has diagnosed any internal cancer (e.g. colon, lung, breast, prostate, leukemia, lymphoma) in a patient.","longName":"INTRN_CA_MED_HX_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EEC7373E-2867-C83A-E040-BB89AD437B5A","latestVersionIndicator":"Yes","beginDate":"2013-12-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-12-30","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR clinical trial for Anakinra in pustular dermatoses.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4035285","version":"1","preferredName":"Physician Diagnosed Metastatic Solid Tumor Personal Medical History Yes No Not Applicable Indicator","preferredDefinition":"Text term to signify whether a physician has diagnosed any metastatic solid cancer in a patient.","longName":"MET_TUM_MED_HX_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EEC70387-4C36-485C-E040-BB89AD433B0B","latestVersionIndicator":"Yes","beginDate":"2013-12-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-12-30","modifiedBy":"MORENOC","dateModified":"2017-01-25","changeNote":"Curated to support NCI CCR clinical trial for Anakinra in pustular dermatoses.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4035286","version":"1","preferredName":"Physician Diagnosed Melanoma Personal Medical History Yes No Not Applicable Indicator","preferredDefinition":"Text term to signify whether a physician has diagnosed melanoma in a patient.","longName":"MELANOMA_MED_HX_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EEC70387-4C57-485C-E040-BB89AD433B0B","latestVersionIndicator":"Yes","beginDate":"2013-12-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-12-30","modifiedBy":"KRYSTKIA","dateModified":"2016-09-20","changeNote":"Curated to support NCI CCR clinical trial for Anakinra in pustular dermatoses.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4035287","version":"1","preferredName":"Physician Diagnosed Basal Cell or Squamous Cell Skin Carcinoma Personal Medical History Yes No Not Applicable Indicator","preferredDefinition":"Text term to signify whether a physician has diagnosed non-melanoma skin cancer (Basal Cell or Squamous Cell Carcinoma) in a patient.","longName":"BAS_SQUAM_MED_HX_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EEC7373E-2895-C83A-E040-BB89AD437B5A","latestVersionIndicator":"Yes","beginDate":"2013-12-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-12-30","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR clinical trial for Anakinra in pustular dermatoses.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4035288","version":"1","preferredName":"No Cancer Personal Medical History Yes No Not Applicable Indicator","preferredDefinition":"Text term to signify whether a patient has No History of cancer.","longName":"NO_CANCER_DZ_HX_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EEC7373E-28B6-C83A-E040-BB89AD437B5A","latestVersionIndicator":"Yes","beginDate":"2013-12-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-12-30","modifiedBy":"TAYLORT","dateModified":"2022-01-11","changeNote":"Curated to support NCI CCR clinical trial for Anakinra in pustular dermatoses.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4035289","version":"1","preferredName":"Physician Diagnosed Connective Tissue Disease Personal Medical History Yes No Not Applicable Indicator","preferredDefinition":"Text term to signify whether a physician has diagnosed any connective tissue disease (e.g. lupus, rheumatoid arthritis, dermatomyositis/polymyositis) in a patient.","longName":"CONN_TISS_MED_HX_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EEC70387-4C78-485C-E040-BB89AD433B0B","latestVersionIndicator":"Yes","beginDate":"2013-12-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-12-30","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR clinical trial for Anakinra in pustular dermatoses.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4035290","version":"1","preferredName":"Connective Tissue Disease Daily Medication Usage Yes No Indicator","preferredDefinition":"Text term to signify whether a patient takes daily medication for connective tissue disease.","longName":"CONN_TISS_DL_MED_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EEC70387-4C99-485C-E040-BB89AD433B0B","latestVersionIndicator":"Yes","beginDate":"2013-12-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-12-30","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR clinical trial for Anakinra in pustular dermatoses.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4035291","version":"1","preferredName":"Autoimmune Disease Other Personal Medical History Descriptive Text","preferredDefinition":"Text to describe any autoimmune disease diagnosed by a physician within a patient that is different than the one(s) previously specified or mentioned.","longName":"AUTOIMM_DZ_OTX_TXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EEC70387-4CBA-485C-E040-BB89AD433B0B","latestVersionIndicator":"Yes","beginDate":"2013-12-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-12-30","modifiedBy":"SOKKERL","dateModified":"2019-06-13","changeNote":"Curated to support NCI CCR clinical trial for Anakinra in pustular dermatoses.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4035292","version":"1","preferredName":"No Autoimmune Disease Personal Medical History Yes No Not Applicable Indicator","preferredDefinition":"Text term to signify whether a patient has No History of autoimmune disease.","longName":"NO_AUTOIMM_DZ_HX_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EEC70387-4CDB-485C-E040-BB89AD433B0B","latestVersionIndicator":"Yes","beginDate":"2013-12-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-12-30","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR clinical trial for Anakinra in pustular dermatoses.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4095761","version":"1","preferredName":"Current Oral Cavity Symptom Name","preferredDefinition":"Term to identify a current oral cavity symptom experienced by a person.","longName":"CURR_ORL_CAV_SX_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EFF5F6BA-D96D-897E-E040-BB89AD435748","latestVersionIndicator":"Yes","beginDate":"2014-01-14","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-01-14","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4214028","version":"1","preferredName":"Dental Bleeding on Probing Positive Negative Not Done Unknown Category","preferredDefinition":"Text term to signify whether bleeding on probing (BOP) when a periodontal probe is used during an oral examination.","longName":"D_PP_BOP_PE_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F46B2891-02ED-1A27-E040-BB89AD431E41","latestVersionIndicator":"Yes","beginDate":"2014-03-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-03-12","modifiedBy":"REEVESD","dateModified":"2014-03-12","changeNote":"Curated to support NCI CCR clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4214057","version":"1","preferredName":"Dental Oral Cavity Clinical Abnormality Detection Yes No Clinical Abnormality Indicator","preferredDefinition":"Text indicator to signify whether clinical abnormalities are detected in the mouth on probing during an oral examination.","longName":"ORL_CAV_CLIN_ABN_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F46BE48B-3F9A-866B-E040-BB89AD433E1C","latestVersionIndicator":"Yes","beginDate":"2014-03-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-03-12","modifiedBy":"REEVESD","dateModified":"2014-03-12","changeNote":"Curated to support NCI CCR clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4214090","version":"1","preferredName":"Dental Periodontal Probing Result Code","preferredDefinition":"Numeric code from the Periodontal Screening and Recording (PSR) screening index for periodontal disease representing the results of an oral cavity examination.","longName":"DENT_PSR_RSL_CD","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F46BE48B-3FB9-866B-E040-BB89AD433E1C","latestVersionIndicator":"Yes","beginDate":"2014-03-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-03-12","modifiedBy":"REEVESD","dateModified":"2014-03-12","changeNote":"Curated to support NCI CCR clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4260497","version":"1","preferredName":"Stage IV Lung Cancer Diagnosis Age Value","preferredDefinition":"The number of years since birth when the presence of Stage IV lung cancer was observed or occurred.  Stage IV includes: (Any T, Any N, M1a); (Any T, Any N, M1b).","longName":"4260346v1.0:3270323v1.0","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5FF4F0C-6219-DEA8-E040-BB89AD4301CA","latestVersionIndicator":"Yes","beginDate":"2014-04-01","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2014-04-01","modifiedBy":"CHILLIJ","dateModified":"2014-04-02","changeNote":"4/2/14 jc changed from DDE to CDE; VD changed to 3270323 to match CDE 3284879. CDE released per Lilly Jiang.  4/1/14 jc created for C3D Nebraska study (Mary Jackson).","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4275302","version":"1","preferredName":"Electrocardiographic Finding QTcB Assessment Result Time in Millisecond Number","preferredDefinition":"A formula-based value which takes into account the physiologic shortening of the QT interval which occurs as the heart rate increases, permitting comparison of the QT interval across a range of rates. It is mathematically defined as: QTcB = QT/SqRootRR(seconds) and theoretically corrects the QT interval to that which would be observed at a heart rate of 1 cycle per second.","longName":"QTCB_RSL_TM_MSEC_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F756B3C4-3148-E910-E040-BB89AD4348AC","latestVersionIndicator":"Yes","beginDate":"2014-04-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-04-18","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4275306","version":"1","preferredName":"Electrocardiographic Finding QTcF Assessment Result Time in Millisecond Number","preferredDefinition":"A formula-based value which takes into account the physiologic shortening of the QT interval which occurs as the heart rate increases, permitting comparison of the QT interval across a range of rates. It is mathematically defined as: QTcF = QT/CubeRootRR(seconds) and theoretically corrects the QT interval to that which would be observed at a heart rate of 1 cycle per second","longName":"QTCF_RSL_TM_MSEC_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F756B3C4-3168-E910-E040-BB89AD4348AC","latestVersionIndicator":"Yes","beginDate":"2014-04-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-04-18","modifiedBy":"GDEEN","dateModified":"2023-02-24","changeNote":"Curated to support NCI CCR clinical trial","administrativeNotes":"1/20/2023: Added AQT per cadsr0002069.wz","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4348091","version":"1","preferredName":"Body Joints Swelling Effusion Assessment Count","preferredDefinition":"Numeric value to represent the number of evaluated body joints that have swelling or effusion(s) present.","longName":"JNT_SWL_EFF_CT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"FB01A233-3AFD-83D2-E040-BB89AD435889","latestVersionIndicator":"Yes","beginDate":"2014-06-04","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-06-04","modifiedBy":"REEVESD","dateModified":"2014-06-11","changeNote":"Curated to support NCI Center for Cancer Research clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4348092","version":"1","preferredName":"Joint Range of Motion Decreased Tender Painful Assessment Count","preferredDefinition":"Numeric value to represent the number of body joints evaluated to have limited and either tender or painful range of motion.","longName":"ROM_DEC_TEN_PN_JT_CT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"FB01A233-3B29-83D2-E040-BB89AD435889","latestVersionIndicator":"Yes","beginDate":"2014-06-04","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-06-04","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI Center for Cancer Research clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4348256","version":"1","preferredName":"Joint Range of Motion Decreased Occurrence Count","preferredDefinition":"Numeric value to represent the number of body joints evaluated to have marked limited range of motion.","longName":"DEC_JT_ROM_CT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"FB049E38-9577-D183-E040-BB89AD4332C6","latestVersionIndicator":"Yes","beginDate":"2014-06-04","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-06-04","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI Center for Cancer Research clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4348257","version":"1","preferredName":"Active Joint Total Occurrence Count","preferredDefinition":"Numeric value to represent the total number of body joints evaluated to be active. (Total of number of joints with swelling or effusion + number of joints with limited range of motion and either tenderness or painful range of motion without swelling or effusion.)","longName":"ACT_JT_ROM_CT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"FB049E38-95A4-D183-E040-BB89AD4332C6","latestVersionIndicator":"Yes","beginDate":"2014-06-04","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-06-04","modifiedBy":"REEVESD","dateModified":"2015-03-07","changeNote":"Curated to support NCI Center for Cancer Research clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4363065","version":"1","preferredName":"Frenchay Activities Index Assessment Percentage Value","preferredDefinition":"Percentage value for an interviewer administered questionnaire which asks a subject to rate the frequency with which they participate in various instrumental, leisure/work and outdoor activities.","longName":"FRENCHAY_INDX_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"FC494BC5-4DC6-D28A-E040-BB89AD433F0A","latestVersionIndicator":"Yes","beginDate":"2014-06-20","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-06-20","modifiedBy":"REEVESD","dateModified":"2014-09-23","changeNote":"Created to support NCI Center for Cancer Research clinical trial.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4363066","version":"1","preferredName":"Activity Card Sort Assessment Percentage Value","preferredDefinition":"Percentage value for the Activity Card edition 2 occupational therapy administered instrument for assessment participation in occupational performance of instrumental, social-cultural and leisure activities.","longName":"ACTIVITY_CD_SORT_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"FC49A46C-5C39-AAE6-E040-BB89AD4348F3","latestVersionIndicator":"Yes","beginDate":"2014-06-20","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-06-20","modifiedBy":"REEVESD","dateModified":"2014-09-23","changeNote":"Created to support NCI Center for Cancer Research clinical trial.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4363067","version":"2","preferredName":"Barthel Index Score Assessment Total Score","preferredDefinition":"Numeric value for an interviewer administered questionnaire consisting of ten items that measure a person's daily functioning specifically in activities of daily living and mobility.","longName":"BARTHEL_INDX_TTL_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7B92CDFF-54B7-57CE-E053-F662850AE0A7","latestVersionIndicator":"Yes","beginDate":"2018-11-26","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-11-26","modifiedBy":"COOPERM","dateModified":"2018-11-26","changeNote":"Created to support NCI Center for Cancer Research clinical trial. Versioned VD for NCIP to change range 2/5/2017. Versioned CDE to use latest version VD. mc 11/26/18","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4383231","version":"1","preferredName":"PI-RADS T2 Peripheral Zone Assessed Score","preferredDefinition":"Score to represent a structured reporting scheme for multiparametric prostate cancer imaging including T2 weighted images, a dynamic contrast-enhanced study (DCE), diffusion weighted imaging (DWI), and possibly spectroscopy (MRS).","longName":"PIRADS_T2_PZ_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"FDCAF842-735F-C996-E040-BB89AD43203C","latestVersionIndicator":"Yes","beginDate":"2014-07-09","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2014-07-09","modifiedBy":"REEVESD","dateModified":"2014-07-22","changeNote":"Curated to support NCI intramural program CCR clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4383232","version":"1","preferredName":"PI-RADS T2 Transitional Zone Assessed Score","preferredDefinition":"Score to represent a structured reporting scheme for multiparametric prostate cancer imaging including T2 weighted images, a dynamic contrast-enhanced study (DCE), diffusion weighted imaging (DWI), and possibly spectroscopy (MRS) using the time it takes for the net nuclear spin in the plane that is perpendicular to the magnetic field of a spectrometer to decay to zero.","longName":"PIRADS_T2_TZ_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"FDCAF842-738C-C996-E040-BB89AD43203C","latestVersionIndicator":"Yes","beginDate":"2014-07-09","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2014-07-09","modifiedBy":"REEVESD","dateModified":"2014-07-22","changeNote":"Curated to support NCI intramural program CCR clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4383251","version":"1","preferredName":"PI-RADS Diffusion Weighted Imaging Assessed Score","preferredDefinition":"Score to represent a structured reporting scheme for multiparametric prostate cancer imaging and diagnosis. Prostate images are obtained using multiple MRI techniques including T2 weighted images, a dynamic contrast-enhanced study (DCE), diffusion weighted imaging (DWI), and possibly spectroscopy (MRS) with a diffusion MRI technique in which diffusion-sensitizing gradients are applied to the imaging sequence.","longName":"PIRADS_DWI_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"FDCAF842-73BC-C996-E040-BB89AD43203C","latestVersionIndicator":"Yes","beginDate":"2014-07-09","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2014-07-09","modifiedBy":"REEVESD","dateModified":"2014-07-22","changeNote":"Curated to support NCI intramural program CCR clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4383252","version":"1","preferredName":"PI-RADS DCE-MRI Assessed Score","preferredDefinition":"Score to represent a structured reporting scheme for multiparametric prostate cancer imaging using multiple MRI techniques including T2 weighted images, a dynamic contrast-enhanced study (DCE), diffusion weighted imaging (DWI), and possibly spectroscopy (MRS) with a modification of contrast-enhanced MRI that allows observation of functional properties in addition to structural properties.","longName":"PIRADS_DCE_MRI_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"FDCAF842-73E9-C996-E040-BB89AD43203C","latestVersionIndicator":"Yes","beginDate":"2014-07-09","endDate":"2015-08-04","createdBy":"CHILLIJ","dateCreated":"2014-07-09","modifiedBy":"MMADDINENI","dateModified":"2024-01-15","changeNote":"8/4/15 unretired per owner request; this CDE is needed for PI-RADSv1 questions. 8/4/2015 retired and superceded by CDE 4928130 curated for PI-RADSv2 response set./tt_Curated to support NCI intramural program CCR clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4383254","version":"1","preferredName":"PI-RADS Spectroscopy Citrate Peak And Choline Peak Assessed Score","preferredDefinition":"Score to represent a structured reporting scheme for multiparametric prostate cancer imaging using multiple MRI techniques including T2 weighted images, a dynamic contrast-enhanced study (DCE), diffusion weighted imaging (DWI), and possibly spectroscopy (MRS) using citrate peak and choline peak concentrations.","longName":"PIRADS_MRS_PEAKS_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"FDCAF842-7435-C996-E040-BB89AD43203C","latestVersionIndicator":"Yes","beginDate":"2014-07-09","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2014-07-09","modifiedBy":"REEVESD","dateModified":"2014-07-22","changeNote":"Curated to support NCI intramural program CCR clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4383271","version":"1","preferredName":"PI-RADS Overall Classification Score","preferredDefinition":"Score to represent a generalization for a structured reporting scheme for multiparametric prostate cancer imaging using multiple MRI techniques including T2 weighted images, a dynamic contrast-enhanced study (DCE), diffusion weighted imaging (DWI), and possibly spectroscopy (MRS).","longName":"PIRADS_OVRALL_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"FDCB8337-E7AF-FCE5-E040-BB89AD4337D3","latestVersionIndicator":"Yes","beginDate":"2014-07-09","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2014-07-09","modifiedBy":"REEVESD","dateModified":"2014-07-22","changeNote":"Curated to support NCI intramural program CCR clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4383272","version":"1","preferredName":"MRI T2 Change Category","preferredDefinition":"Group or classification to represent imaging results that use radiofrequency waves and a strong magnetic field rather than x-rays to provide amazingly clear and detailed pictures of internal organs and tissues.","longName":"MRI_T2_CHG_CAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"FDCBBB8B-4AA1-CBA1-E040-BB89AD4359FA","latestVersionIndicator":"Yes","beginDate":"2014-07-09","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2014-07-09","modifiedBy":"REEVESD","dateModified":"2014-07-22","changeNote":"Curated to support NCI intramural program CCR clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4383273","version":"1","preferredName":"DCE MRI Change Category","preferredDefinition":"Grouping or classification to represent a modification of contrast-enhanced MRI that allows observation of functional properties in addition to structural properties.","longName":"DCE_MRI_CHG_CAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"FDCBBB8B-4ACE-CBA1-E040-BB89AD4359FA","latestVersionIndicator":"Yes","beginDate":"2014-07-09","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2014-07-09","modifiedBy":"REEVESD","dateModified":"2014-07-22","changeNote":"Curated to support NCI intramural program CCR clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4387751","version":"1","preferredName":"DWI MRI Apparent Diffusion Coefficient (ADC) Change Category","preferredDefinition":"Group or classification to represent a measurement of the magnitude of diffusion of water molecules within tissue using a strong magnetic field rather than x-rays.","longName":"DWI_MRI_ADC_CHG_CAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"FE7C38EB-3B61-23C2-E040-BB89AD437421","latestVersionIndicator":"Yes","beginDate":"2014-07-18","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2014-07-18","modifiedBy":"REEVESD","dateModified":"2014-07-22","changeNote":"Curated to support NCI intramural program CCR clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4392182","version":"1","preferredName":"DWI MRI High B-Value Change Category","preferredDefinition":"Group or classification to represent a measurement of the magnitude of diffusion of water molecules within tissue using radiofrequency waves and a strong magnetic field rather than x-rays to provide amazingly clear and detailed pictures of internal organs and tissues.","longName":"DWI_MRI_BVAL_CHG_CAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"FE7C902F-D437-4346-E040-BB89AD4363BF","latestVersionIndicator":"Yes","beginDate":"2014-07-18","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2014-07-18","modifiedBy":"REEVESD","dateModified":"2014-07-22","changeNote":"Curated to support NCI intramural program CCR clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4394076","version":"1","preferredName":"Ocular Surface Disease Index Assessment Score","preferredDefinition":"Numeric value as a result of an ocular evaluation with the Ocular Surface Disease Index (OSDI), a 12 item questionnaire designed to provide a rapid assessment of the symptoms of ocular irritation consistent with dry eye disease and their impact on vision-related functioning, higher scores representing greater disability.","longName":"OSDI_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"FEA2925E-DDD3-D8B6-E040-BB89AD434B8C","latestVersionIndicator":"Yes","beginDate":"2014-07-20","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-20","modifiedBy":"REEVESD","dateModified":"2014-07-21","changeNote":"Curated to support NCI CCR clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4440886","version":"1","preferredName":"Plasmacytoma Detected Yes No Unknown Indicator","preferredDefinition":"Text term to signify the presence of Plasmacytoma in a patient at the time of assessment.","longName":"PLASMACYT_DETD_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"FFFF8F45-7F03-74F2-E040-BB89AD43431A","latestVersionIndicator":"Yes","beginDate":"2014-08-06","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-08-06","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR trial.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4507186","version":"1","preferredName":"Bronchiolitis Obliterans Disease Referring Institution Present Yes No Unknown Indicator","preferredDefinition":"Text term to signify whether a diagnosis of Bronchiolitis Obliterans (BO) was made by a patient's referring institution.","longName":"BO_REF_INST_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"048A302A-A35A-C126-E050-BB89AD431E48","latestVersionIndicator":"Yes","beginDate":"2014-10-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-10-03","modifiedBy":"REEVESD","dateModified":"2014-10-06","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4507197","version":"1","preferredName":"Bronchiolitis Obliterans Disease Pulmonary Function Test Diagnostic Technique Yes No Unknown Indicator","preferredDefinition":"Text term to signify whether a diagnosis of Bronchiolitis Obliterans (BO) was made based on pulmonary function tests (PFTs).","longName":"BO_DX_PFT_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"048A302A-A379-C126-E050-BB89AD431E48","latestVersionIndicator":"Yes","beginDate":"2014-10-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-10-03","modifiedBy":"REEVESD","dateModified":"2014-10-06","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4507201","version":"1","preferredName":"Bronchiolitis Obliterans Disease Computed Tomography Diagnostic Technique Yes No Unknown Indicator","preferredDefinition":"Text term to signify whether a diagnosis of Bronchiolitis Obliterans (BO) was made based on Computed Tomography (CT).","longName":"BO_DX_CT_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"048A302A-A3BD-C126-E050-BB89AD431E48","latestVersionIndicator":"Yes","beginDate":"2014-10-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-10-03","modifiedBy":"REEVESD","dateModified":"2014-10-06","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4508078","version":"1","preferredName":"Bronchiolitis Obliterans Disease External Institution Diagnosis Yes No Unknown Indicator","preferredDefinition":"Text term to signify whether a diagnosis of Bronchiolitis Obliterans (BO) is biopsy-proven from an external institution.","longName":"BO_DX_EXT_DX_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"048A17B1-A821-1C70-E050-BB89AD432173","latestVersionIndicator":"Yes","beginDate":"2014-10-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-10-03","modifiedBy":"REEVESD","dateModified":"2014-10-06","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4508080","version":"1","preferredName":"Bronchiolitis Obliterans Disease National Institutes of Health Biopsy Proven Diagnosis Yes No Unknown Indicator","preferredDefinition":"Text term to signify whether a diagnosis of Bronchiolitis Obliterans (BO) is based on a biopsy taken at the National Institutes of Health (NIH).","longName":"BO_DX_NIH_DX_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"048A17B1-A843-1C70-E050-BB89AD432173","latestVersionIndicator":"Yes","beginDate":"2014-10-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-10-03","modifiedBy":"REEVESD","dateModified":"2014-10-06","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4508081","version":"1","preferredName":"Bronchiolitis Obliterans Disease Therapy Administered Yes No Unknown Indicator","preferredDefinition":"Text term to signify whether a patient has received Bronchiolitis Obliterans (BO) specific therapy.","longName":"BO_DX_TX_ADM_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"048A17B1-A867-1C70-E050-BB89AD432173","latestVersionIndicator":"Yes","beginDate":"2014-10-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-10-03","modifiedBy":"REEVESD","dateModified":"2014-10-06","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4508082","version":"1","preferredName":"Bronchiolitis Obliterans Disease Patient Reported Benefit Yes No Unknown Indicator","preferredDefinition":"Text term to signify whether a patient has reported benefits after receiving Bronchiolitis Obliterans (BO) specific therapy.","longName":"BO_DX_TX PR_BENF_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"048A17B1-A886-1C70-E050-BB89AD432173","latestVersionIndicator":"Yes","beginDate":"2014-10-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-10-03","modifiedBy":"REEVESD","dateModified":"2014-10-06","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4508083","version":"1","preferredName":"Bronchiolitis Obliterans Disease Forced Expiratory Volume in 1 Second Benefit Yes No Unknown Indicator","preferredDefinition":"Text term to signify whether a patient has reported FEV1 benefit (>15%) after receiving Bronchiolitis Obliterans (BO) specific therapy.","longName":"BO_DX_FEV1_BENF_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"048A17B1-A8A5-1C70-E050-BB89AD432173","latestVersionIndicator":"Yes","beginDate":"2014-10-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-10-03","modifiedBy":"REEVESD","dateModified":"2014-10-06","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4508084","version":"1","preferredName":"Bronchiolitis Obliterans Disease Activity Restriction Yes No Indicator","preferredDefinition":"Text term to signify whether a patient with Bronchiolitis Obliterans (BO) has any limitations to activity.","longName":"BO_DX_ACT_RESTR_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"048A17B1-A8C4-1C70-E050-BB89AD432173","latestVersionIndicator":"Yes","beginDate":"2014-10-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-10-03","modifiedBy":"REEVESD","dateModified":"2014-10-06","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4508118","version":"1","preferredName":"Bronchiolitis Obliterans National Institutes of Health Diagnostic Category","preferredDefinition":"Grouping to describe how a diagnosis of Bronchiolitis Obliterans (BO) was made at the National Institutes of Health (NIH).","longName":"BO_NIH_DX_CAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"048A17B1-A9BB-1C70-E050-BB89AD432173","latestVersionIndicator":"Yes","beginDate":"2014-10-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-10-03","modifiedBy":"REEVESD","dateModified":"2014-10-06","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4541231","version":"1","preferredName":"Physical Examination Joint Finding Normal Abnormal Not Assessed Outcome","preferredDefinition":"The result from a measure for obtaining the outcome of a joint physical exam/assessment in research efforts investigating arthritis/spondyloarthritis.","longName":"PE_JNT_FNDG_OUTCM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"05A50929-A9F5-97BC-E050-BB89AD437F97","latestVersionIndicator":"Yes","beginDate":"2014-10-17","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-10-17","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI Center for Cancer Research clinical trial.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4559960","version":"1","preferredName":"Second Primary Neoplasm Diagnosis Descriptive Text","preferredDefinition":"Text that captures the diagnosis and a description of a patient's second malignancy.","longName":"SEC_MALGN_DESC_TXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"067E9584-FAEE-850D-E050-BB89AD4304A6","latestVersionIndicator":"Yes","beginDate":"2014-10-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-10-28","modifiedBy":"CLOHNES","dateModified":"2023-12-12","changeNote":"Curated to support NCI Center for Cancer Research Immunotherapy Division trial","administrativeNotes":"12/12/23 Added alt OID for CCTG ticket number CADSR0003182 cjl.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4614617","version":"1","preferredName":"Neuroendocrine Carcinoma Histopathologic Classification Grade","preferredDefinition":"Text term to describe the degree of cellular differentiation in a neuroendocrine tissue sample.","longName":"NEUR_HISTPATH_GD","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"08ED0A2A-98B1-C182-E050-BB89AD436A0C","latestVersionIndicator":"Yes","beginDate":"2014-11-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-11-28","modifiedBy":"HARTLEYG","dateModified":"2019-11-27","changeNote":"Curated to support NCI Center for Cancer Research (CCR) clinical trial. 12.1.2014.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4616014","version":"1","preferredName":"Neuropsychological Symptom Present Name","preferredDefinition":"Name to identify the presence of a neuropsychological symptom.","longName":"NEURPSY_SX_PRES_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"0927FE3B-D423-3FFB-E050-BB89AD4363D7","latestVersionIndicator":"Yes","beginDate":"2014-12-01","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-12-01","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI Center for Cancer Research (CCR) clinical trial. 12.1.2014.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4616015","version":"1","preferredName":"Neuropsychological Symptom Present Yes No Indicator","preferredDefinition":"Text term to signify the presence or absence of a neuropsychological symptom(s).","longName":"NEURPSY_SX_PRES_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"0927FE3B-D442-3FFB-E050-BB89AD4363D7","latestVersionIndicator":"Yes","beginDate":"2014-12-01","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-12-01","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI Center for Cancer Research (CCR) clinical trial. 12.1.2014.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4616016","version":"1","preferredName":"Neuropsychological Symptom Severity Category","preferredDefinition":"Text term to represent the severity of a neuropsychological symptom.","longName":"NEUROPSY_SX_SEV_CAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"0927FE3B-D461-3FFB-E050-BB89AD4363D7","latestVersionIndicator":"Yes","beginDate":"2014-12-01","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-12-01","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI Center for Cancer Research (CCR) clinical trial. 12.1.2014.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4616017","version":"1","preferredName":"Neuropsychological Symptom Duration","preferredDefinition":"Text term to describe the duration of a neuropsychological symptom.","longName":"NEUROPSY_SX_DURN","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"0927FE3B-D480-3FFB-E050-BB89AD4363D7","latestVersionIndicator":"Yes","beginDate":"2014-12-01","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-12-01","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI Center for Cancer Research (CCR) clinical trial. 12.1.2014.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4631952","version":"1","preferredName":"Laboratory Test Result Code","preferredDefinition":"Numbered category to represent the result of a laboratory test.","longName":"2200571v1.0:4631951v1.0","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"FDA:FDA MedWatch Form 3500","workflowStatus":"RELEASED","registrationStatus":"Application","id":"09F09C7A-C504-95BB-E050-BB89AD430594","latestVersionIndicator":"Yes","beginDate":"2014-12-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-12-11","modifiedBy":"COOPERM","dateModified":"2017-12-19","changeNote":"Curated to support FDA MedWatch form 3500.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4675414","version":"1","preferredName":"Transplantation Clinical Remission Occurrence Yes No Indicator","preferredDefinition":"Text term to signify whether a patient has achieved a response of less than 5% blast count in the bone marrow following transplantation.","longName":"TXPLT_CL_REMIS_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0D4C71F9-2495-DDD6-E050-BB89AD432965","latestVersionIndicator":"Yes","beginDate":"2015-01-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-01-23","modifiedBy":"REEVESD","dateModified":"2017-02-11","changeNote":"Curated to support NCI CCR ETIB clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4744251","version":"1","preferredName":"Person Replication Competent Retrovirus Present Yes No Indicator","preferredDefinition":"Text indicator to signify whether a patient has been diagnosed with Replication Competent Retrovirus (RCR).","longName":"REP_COMP_RETROVR_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"112BE233-05D2-77CD-E050-BB89AD43035C","latestVersionIndicator":"Yes","beginDate":"2015-03-13","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-03-13","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR clinical trial for Gene Therapy. 3.15.2013 dmr.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4744252","version":"1","preferredName":"Person Replication Competent Lentivirus Present Yes No Indicator","preferredDefinition":"Text indicator to signify whether a patient has been diagnosed with Replication Competent Lentivirus (RCL).","longName":"REP_COMP_LENTIVR_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"112BE233-0601-77CD-E050-BB89AD43035C","latestVersionIndicator":"Yes","beginDate":"2015-03-13","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-03-13","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR clinical trial for Gene Therapy. 3.15.2013 dmr.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4744253","version":"1","preferredName":"Local Health Care Provider Letter Sent Yes No Indicator","preferredDefinition":"Text term to signify whether a letter was sent to a patient's local physician.","longName":"LOC_HCP_LET_SENT_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"112BF17A-A67A-F09C-E050-BB89AD43679E","latestVersionIndicator":"Yes","beginDate":"2015-03-13","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-03-13","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR clinical trial for Gene Therapy. 3.15.2013 dmr.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4744314","version":"1","preferredName":"Local Health Care Provider Letter Received Yes No Indicator","preferredDefinition":"Text indicator to signify whether a clinical team at NIH has received a response sent to a patient's local physician.","longName":"LCL_PROV_LET_REC_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"112C4B22-4BD6-CA36-E050-BB89AD431DCE","latestVersionIndicator":"Yes","beginDate":"2015-03-13","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-03-13","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR clinical trial for Gene Therapy. 3.15.2013 dmr.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4747479","version":"1","preferredName":"Patient Long-Term Follow-up Status","preferredDefinition":"Definition of a patient's longterm follow-up and specimen collection agreement made with specified healthcare provider(s).","longName":"PT_LONGTM_FLUP_STAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1196068C-3BA1-CDA3-E050-BB89AD437B7A","latestVersionIndicator":"Yes","beginDate":"2015-03-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-03-18","modifiedBy":"REEVESD","dateModified":"2017-02-11","changeNote":"Curated to support NCI CCR clinical trial.3.2015.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4753721","version":"1","preferredName":"Past Year Patient Health Problem Occurrence Yes No Indicator","preferredDefinition":"Text term to signify whether a patient has experienced health problems in the past calendar year.","longName":"P_YR_HLTH_OCC_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Application","id":"120DF07A-5E87-E759-E050-BB89AD4327D5","latestVersionIndicator":"Yes","beginDate":"2015-03-24","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-03-24","modifiedBy":"REEVESD","dateModified":"2017-02-11","changeNote":"Curated to support NCI CCR clinical trial.3.2015.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4753774","version":"1","preferredName":"Past Year Patient Health Problem Information Comments Text","preferredDefinition":"Text to describe a patient's health problems over the past calendar year.","longName":"P_YR_HLTH_COMMT_TXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Application","id":"120DF07A-5EF7-E759-E050-BB89AD4327D5","latestVersionIndicator":"Yes","beginDate":"2015-03-24","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-03-24","modifiedBy":"REEVESD","dateModified":"2017-02-11","changeNote":"Curated to support NCI CCR clinical trial.3.2015.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4757290","version":"1","preferredName":"Past Year Patient Hospitalization Occurrence Yes No Indicator","preferredDefinition":"Text term to signify whether a patient was hospitalized in the past calendar year.","longName":"P_YR_HOSPITLZATN_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Application","id":"121E482B-B345-D5B7-E050-BB89AD433F79","latestVersionIndicator":"Yes","beginDate":"2015-03-25","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-03-25","modifiedBy":"REEVESD","dateModified":"2017-02-11","changeNote":"Curated to support NCI CCR clinical trial.3.2015.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4757311","version":"1","preferredName":"Past Year Health Care Provider Patient Visit Occurrence Yes No Indicator","preferredDefinition":"Text term to signify whether a patient visited any healthcare provider in the past calendar year.","longName":"P_YR_HLTH_VISIT_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Application","id":"121E482B-B364-D5B7-E050-BB89AD433F79","latestVersionIndicator":"Yes","beginDate":"2015-03-25","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-03-25","modifiedBy":"REEVESD","dateModified":"2017-02-11","changeNote":"Curated to support NCI CCR clinical trial.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4757312","version":"1","preferredName":"Past Year Health New Medication Start Yes No Indicator","preferredDefinition":"Text term to signify whether a patient started any new medications in the past calendar year.","longName":"P_YR_NEW_MEDCTN_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Application","id":"121E482B-B383-D5B7-E050-BB89AD433F79","latestVersionIndicator":"Yes","beginDate":"2015-03-25","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-03-25","modifiedBy":"REEVESD","dateModified":"2017-02-11","changeNote":"Curated to support NCI CCR clinical trial.3.2015.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4757319","version":"1","preferredName":"Past Year Patient New Disease or Disorder Occurrence Yes No Indicator","preferredDefinition":"Text term to signify whether a patient developed any new conditions or illness in the past calendar year.","longName":"P_YR_NEW_ILLCOND_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Application","id":"121E482B-B3BB-D5B7-E050-BB89AD433F79","latestVersionIndicator":"Yes","beginDate":"2015-03-25","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-03-25","modifiedBy":"REEVESD","dateModified":"2017-02-11","changeNote":"Curated to support NCI CCR clinical trial.3.2015.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4757320","version":"1","preferredName":"Past Year Patient Hospitalization Information Comments Text","preferredDefinition":"Text to describe a patient's hospitalization(s) over the past calendar year.","longName":"P_YR_HOSP_COMMT_TXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Application","id":"121E482B-B3DA-D5B7-E050-BB89AD433F79","latestVersionIndicator":"Yes","beginDate":"2015-03-25","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-03-25","modifiedBy":"REEVESD","dateModified":"2017-02-11","changeNote":"Curated to support NCI CCR clinical trial.3.2015.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4757321","version":"1","preferredName":"Past Year Health Care Provider Patient Visit Information Comments Text","preferredDefinition":"Text to describe a patient's visit with any healthcare provider(s) over the past calendar year.","longName":"P_YR_VISIT_COMMT_TXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Application","id":"121E482B-B3F9-D5B7-E050-BB89AD433F79","latestVersionIndicator":"Yes","beginDate":"2015-03-25","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-03-25","modifiedBy":"REEVESD","dateModified":"2017-02-11","changeNote":"Curated to support NCI CCR clinical trial.3.2015.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4757322","version":"1","preferredName":"Past Year Health New Medication Start Information Comments Text","preferredDefinition":"Text to describe any new medications the patient has started over the past calendar year.","longName":"P_YR_MEDCT_COMMT_TXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Application","id":"121E482B-B418-D5B7-E050-BB89AD433F79","latestVersionIndicator":"Yes","beginDate":"2015-03-25","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-03-25","modifiedBy":"REEVESD","dateModified":"2017-02-11","changeNote":"Curated to support NCI CCR clinical trial.3.2015.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4757323","version":"1","preferredName":"Past Year Patient New Disease or Disorder Information Comments Text","preferredDefinition":"Text to describe any new conditions or illnesses the patient has developed over the past calendar year.","longName":"P_YR_NEWIL_COMMT_TXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Application","id":"121E482B-B437-D5B7-E050-BB89AD433F79","latestVersionIndicator":"Yes","beginDate":"2015-03-25","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-03-25","modifiedBy":"REEVESD","dateModified":"2017-02-11","changeNote":"Curated to support NCI CCR clinical trial.3.2015.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4763595","version":"1","preferredName":"Research Biospecimen Blood Collection Yes No Unknown Indicator","preferredDefinition":"Text indicator to signify whether research samples are collected.","longName":"BLD_COL_RCR_TEST_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"124DE556-DF78-693D-E050-BB89AD435E50","latestVersionIndicator":"Yes","beginDate":"2015-03-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-03-27","modifiedBy":"REEVESD","dateModified":"2015-03-30","changeNote":"Curated to support NCI CCR clinical trial.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4769615","version":"1","preferredName":"Genetically Modified Autologous Lymphocyte Infusion Occurrence Date","preferredDefinition":"The calendar date of an infusion of genetically modified autologous lymphocytes into a patient.","longName":"GEN_MOD_ALYMP_INF_DT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Application","id":"12BC9CEA-C793-836C-E050-BB89AD437B68","latestVersionIndicator":"Yes","beginDate":"2015-04-02","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-04-02","modifiedBy":"REEVESD","dateModified":"2017-02-11","changeNote":"Curated to support NCI CCR protocol.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4786667","version":"1","preferredName":"Research Specimen Collection Type","preferredDefinition":"Text name for a biospecimen from a patient with the intent of testing for research or clinical trial-associated purpose(s).","longName":"RSCH_SPEC_COLL_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"134D312E-5463-5AEF-E050-BB89AD43431E","latestVersionIndicator":"Yes","beginDate":"2015-04-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-04-09","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR revised Storage CRF creation in C3D. 4.9.2015.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4786749","version":"1","preferredName":"Research Biospecimen Collection Schedule Interval","preferredDefinition":"Time point during or at which a research specimen was collected.","longName":"RSCH_COLL_SCHED_ITVL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"134DA5AA-5CAE-C591-E050-BB89AD433AB9","latestVersionIndicator":"Yes","beginDate":"2015-04-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-04-09","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support NCI CCR Storage CRF creation.4.9.2015.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4841814","version":"1","preferredName":"Interleukin-2 Not Given Reason","preferredDefinition":"Brief explanation for not administering a dose of Interleukin-2 (IL-2).","longName":"IL2_NOTGIV_RSN","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"1726FB99-7CEF-6662-E050-BB89AD43074F","latestVersionIndicator":"Yes","beginDate":"2015-05-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-05-28","modifiedBy":"REEVESD","dateModified":"2015-05-28","changeNote":"Curated to support NCI CCR clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4864237","version":"1","preferredName":"Disease Response Choi Criteria Category","preferredDefinition":"Patient categorization based on a composite set of criteria developed by Choi et al. using imaging techniques in the evaluation of gastrointestinal stromal tumors response to imatinib mesylate treatment.","longName":"RESP_CHOI_CRIT_CAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1853980C-0DE0-D362-E050-BB89AD43458F","latestVersionIndicator":"Yes","beginDate":"2015-06-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-06-12","modifiedBy":"REEVESD","dateModified":"2015-06-12","changeNote":"Curated to support NCI CCR clinical trial for locally advanced unresectable Chordoma.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4884011","version":"1","preferredName":"Cell Harvest Event Name","preferredDefinition":"Text to describe an event or procedure associated with cell harvest activity.","longName":"CELL_HARV_EVT_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"19208FEE-2399-DD7C-E050-BB89AD433624","latestVersionIndicator":"Yes","beginDate":"2015-06-22","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-06-22","modifiedBy":"REEVESD","dateModified":"2015-06-25","changeNote":"Curated to support NCI CCR Cell Harvest CRF from Immunotherapy Section.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4884074","version":"1","preferredName":"Cell Harvest Event Date","preferredDefinition":"Date of the event or procedure associated with cell harvest activity.","longName":"CELL_HARV_EVNT_DT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"19204F40-6747-5F07-E050-BB89AD43479B","latestVersionIndicator":"Yes","beginDate":"2015-06-22","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-06-22","modifiedBy":"REEVESD","dateModified":"2015-06-25","changeNote":"Curated to support NCI CCR Cell Harvest CRF from Immunotherapy Section.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4884075","version":"1","preferredName":"Cell Harvest Procedure On Hold Reason","preferredDefinition":"Term to explain the cause of a delay or hold on cell harvest activity.","longName":"CELL_HARV_HLD_RSN","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"19204F40-6769-5F07-E050-BB89AD43479B","latestVersionIndicator":"Yes","beginDate":"2015-06-22","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-06-22","modifiedBy":"REEVESD","dateModified":"2015-06-25","changeNote":"Curated to support NCI CCR Cell Harvest CRF from Immunotherapy Section.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4884080","version":"1","preferredName":"Tumor Infiltrating Lymphocyte Harvest Procedure Access Site","preferredDefinition":"Anatomic site from which a Tumor Infiltrating Lymphocyte or TIL Harvest is initiated.","longName":"TIL_HARV_ACC_STE","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"19204F40-67AF-5F07-E050-BB89AD43479B","latestVersionIndicator":"Yes","beginDate":"2015-06-22","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-06-22","modifiedBy":"REEVESD","dateModified":"2015-06-25","changeNote":"Curated to support NCI CCR Cell Harvest CRF from Immunotherapy Section.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4884086","version":"1","preferredName":"Tumor Infiltrating Lymphocyte Harvest Access Procedure Type","preferredDefinition":"Extent of surgical procedure used to secure Tumor Infiltrating Lymphocyte or TIL harvest access.","longName":"TIL_HARV_PROC_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"19204F40-6810-5F07-E050-BB89AD43479B","latestVersionIndicator":"Yes","beginDate":"2015-06-22","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-06-22","modifiedBy":"REEVESD","dateModified":"2015-06-25","changeNote":"Curated to support NCI CCR Cell Harvest CRF from Immunotherapy Section.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4884092","version":"1","preferredName":"Peripheral Blood Lymphocyte Harvest Access Type","preferredDefinition":"Access device used to initiate Peripheral Blood Lymphocyte or PBL harvest activity.","longName":"PBL_HARV_ACC_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"19204F40-684B-5F07-E050-BB89AD43479B","latestVersionIndicator":"Yes","beginDate":"2015-06-22","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-06-22","modifiedBy":"REEVESD","dateModified":"2015-06-25","changeNote":"Curated to support NCI CCR Cell Harvest CRF from Immunotherapy Section.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4884093","version":"1","preferredName":"Cell Harvest Procedure Collection Amount Liter Value","preferredDefinition":"Numeric quantity in liters of cell harvest collected.","longName":"CELL_HARV_COLL_L_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"19204F40-686A-5F07-E050-BB89AD43479B","latestVersionIndicator":"Yes","beginDate":"2015-06-22","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-06-22","modifiedBy":"REEVESD","dateModified":"2015-06-25","changeNote":"Curated to support NCI CCR Cell Harvest CRF from Immunotherapy Section.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4884111","version":"1","preferredName":"Cell Harvest Procedure Attempt Count","preferredDefinition":"Number of times a cell harvest procedure is attempted on a patient.","longName":"CELL_HARV_ATTPT_CT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"192140EF-7B83-AFF1-E050-BB89AD433649","latestVersionIndicator":"Yes","beginDate":"2015-06-22","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-06-22","modifiedBy":"REEVESD","dateModified":"2015-06-25","changeNote":"Curated to support NCI CCR Cell Harvest CRF from Immunotherapy Section.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4884112","version":"1","preferredName":"Cell Harvest Procedure Unsuccessful Reason","preferredDefinition":"Explanation of the reason a cell harvest procedure in a patient was unsuccessful.","longName":"CELL_HARV_UNSUC_RSN","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"192140EF-7BA2-AFF1-E050-BB89AD433649","latestVersionIndicator":"Yes","beginDate":"2015-06-22","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-06-22","modifiedBy":"REEVESD","dateModified":"2015-06-25","changeNote":"Curated to support NCI CCR Cell Harvest CRF from Immunotherapy Section.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4884711","version":"1","preferredName":"Cell Harvest Treatment Type","preferredDefinition":"Treatment designation associated with a cell harvest treatment study.","longName":"CELL_HARV_TX_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"192C68CC-F139-B0DB-E050-BB89AD437DB5","latestVersionIndicator":"Yes","beginDate":"2015-06-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-06-23","modifiedBy":"REEVESD","dateModified":"2015-06-25","changeNote":"Curated to support NCI CCR Cell Harvest CRF from Immunotherapy Section.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4884731","version":"1","preferredName":"Cell Harvest Procedure Treatment Not Done Reason","preferredDefinition":"Explanation for a patient enrolled in cell harvest treatment study not receiving treatment.","longName":"CELL_HARV_TX_NDN_RSN","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"192C68CC-F158-B0DB-E050-BB89AD437DB5","latestVersionIndicator":"Yes","beginDate":"2015-06-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-06-23","modifiedBy":"REEVESD","dateModified":"2015-06-25","changeNote":"Curated to support NCI CCR Cell Harvest CRF from Immunotherapy Section.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4928130","version":"1","preferredName":"PI-RADS DCE-MRI PZ TZ Scale","preferredDefinition":"A negative/positive response using the PI-RADSv2 reference standard of scoring the Peripheral Zone (PZ) or Transition Zone (TZ) for DCE MRI.","longName":"PI-RADS_DCE_MRI_PZ_TZ_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1C7D36EC-7C72-BD03-E050-BB89AD43098D","latestVersionIndicator":"Yes","beginDate":"2015-08-04","endDate":null,"createdBy":"TAYLORT","dateCreated":"2015-08-04","modifiedBy":"CHILLIJ","dateModified":"2015-08-04","changeNote":"8/4/2015 curated for PI-RADSv2 response set; supercedes CDE 4383252/tt.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5021897","version":"1","preferredName":"Lesion Change From Baseline Percentage Value","preferredDefinition":"Numeric value to represent lesion or site of disease percentage change from a baseline measurement","longName":"CHG_BSL_PCT_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"20482D95-6CF3-2FF7-E050-BB89AD4366E5","latestVersionIndicator":"Yes","beginDate":"2015-09-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-09-21","modifiedBy":"REEVESD","dateModified":"2015-09-22","changeNote":"Curated to support NCI CCR trial.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5021908","version":"1","preferredName":"Lesion Change From Best Overall Response Percentage Value","preferredDefinition":"Numeric value to represent lesion or site of disease percentage change from a measurement taken during the best response to treatment.","longName":"CHG_BR_PCT_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"20483F3D-C119-74E8-E050-BB89AD43449A","latestVersionIndicator":"Yes","beginDate":"2015-09-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-09-21","modifiedBy":"REEVESD","dateModified":"2015-09-22","changeNote":"Curated to support NCI CCR trial.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5024903","version":"1","preferredName":"Disease Registering Status","preferredDefinition":"Term to identify the status of disease at the timepoint of patient registration into a clinical trial.","longName":"DZ_REGISTRATN_STAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"209716FA-F4ED-C0C4-E050-BB89AD4346BF","latestVersionIndicator":"Yes","beginDate":"2015-09-25","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-09-25","modifiedBy":"REEVESD","dateModified":"2015-10-07","changeNote":"Curated for MDACC Brain Tumor trial now being conducted by NCI CCR Dr. Gilbert PI. dmr.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5025953","version":"1","preferredName":"Diagnosis Method Type","preferredDefinition":"Name of the technique or modality used to document the initial diagnosis of a patient.","longName":"DX_METH_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"20D1A3BA-8A7D-1039-E050-BB89AD434448","latestVersionIndicator":"Yes","beginDate":"2015-09-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-09-28","modifiedBy":"REEVESD","dateModified":"2015-10-07","changeNote":"Curated for MDACC Brain Tumor trial now being conducted by NCI CCR Dr. Gilbert PI. dmr.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5025957","version":"1","preferredName":"Patient Spine Disease Involvement Yes No Unknown Indicator","preferredDefinition":"Text term to signify whether a patient's disease status includes involvement of the spine.","longName":"PT_SPIN_DZ_INVLT_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"20D216F6-0CAA-68A9-E050-BB89AD433988","latestVersionIndicator":"Yes","beginDate":"2015-09-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-09-28","modifiedBy":"REEVESD","dateModified":"2015-10-07","changeNote":"Curated for MDACC Brain Tumor trial now being conducted by NCI CCR Dr. Gilbert PI. dmr.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5025962","version":"1","preferredName":"Patient Electroencephalography Occurrence Date","preferredDefinition":"Calendar date of electroencephalography for a patient.","longName":"PT_EEG_DT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"20D216F6-0D1E-68A9-E050-BB89AD433988","latestVersionIndicator":"Yes","beginDate":"2015-09-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-09-28","modifiedBy":"REEVESD","dateModified":"2015-10-07","changeNote":"Curated for MDACC Brain Tumor trial now being conducted by NCI CCR Dr. Gilbert PI. dmr.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5025963","version":"1","preferredName":"Patient Electroencephalography Occurrence Time","preferredDefinition":"Clock time of electroencephalography for a patient.","longName":"PT_EEG_TM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"20D216F6-0D4F-68A9-E050-BB89AD433988","latestVersionIndicator":"Yes","beginDate":"2015-09-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-09-28","modifiedBy":"REEVESD","dateModified":"2015-10-07","changeNote":"Curated for MDACC Brain Tumor trial now being conducted by NCI CCR Dr. Gilbert PI. dmr.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5026404","version":"1","preferredName":"Before Seizure ActivityType","preferredDefinition":"Delineation of a patient behavior that occurred before the appearance of seizure activity.","longName":"PRE_SZ_ACT_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"20D52C8D-BFA7-51C7-E050-BB89AD43701D","latestVersionIndicator":"Yes","beginDate":"2015-09-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-09-28","modifiedBy":"REEVESD","dateModified":"2015-10-07","changeNote":"Curated for MDACC Brain Tumor trial now being conducted by NCI CCR Dr. Gilbert PI. dmr.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5026408","version":"1","preferredName":"Patient Seizure Description Category","preferredDefinition":"Descriptive classification to describe signs and/or symptoms that occurred during a seizure.","longName":"PT_SZ_DESC_CAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"20D52C8D-BFC6-51C7-E050-BB89AD43701D","latestVersionIndicator":"Yes","beginDate":"2015-09-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-09-28","modifiedBy":"REEVESD","dateModified":"2015-10-07","changeNote":"Curated for MDACC Brain Tumor trial now being conducted by NCI CCR Dr. Gilbert PI. dmr.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5026409","version":"1","preferredName":"Post Seizure Activity Type","preferredDefinition":"Identification of care-related activity that occurred at the time or following a patient seizure.","longName":"POST_SZ_ACT_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"20D52C8D-BFE5-51C7-E050-BB89AD43701D","latestVersionIndicator":"Yes","beginDate":"2015-09-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-09-28","modifiedBy":"REEVESD","dateModified":"2015-10-07","changeNote":"Curated for MDACC Brain Tumor trial now being conducted by NCI CCR Dr. Gilbert PI. dmr.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5026551","version":"1","preferredName":"Simple Partial Seizure Sign Symptom Category","preferredDefinition":"Delineation of signs and/or symptoms experienced by a patient having a simple partial seizure.","longName":"SIMP_PRL_SZ_SIGN_CAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"20E2CCF0-ED85-0D47-E050-BB89AD434682","latestVersionIndicator":"Yes","beginDate":"2015-09-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-09-29","modifiedBy":"REEVESD","dateModified":"2015-10-07","changeNote":"Curated for MDACC Brain Tumor trial now being conducted by NCI CCR Dr. Gilbert PI. dmr.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5026556","version":"1","preferredName":"Complex Partial Seizure Sign Symptom Category","preferredDefinition":"Term to identify signs and/or symptoms associated with a patient's complex partial seizures.","longName":"COMP_PTL_SZ_SX_CAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"20E2CCF0-EE0A-0D47-E050-BB89AD434682","latestVersionIndicator":"Yes","beginDate":"2015-09-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-09-29","modifiedBy":"REEVESD","dateModified":"2015-10-07","changeNote":"Curated for MDACC Brain Tumor trial now being conducted by NCI CCR Dr. Gilbert PI. dmr.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5026577","version":"1","preferredName":"Partial Seizure Secondary General Seizure Category","preferredDefinition":"Term to delineate sign(s) and symptom(s) experienced by a patient with a partial seizure with secondary generalized seizure activity.","longName":"PTL_SZ_GEN_SZ_CAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"20E2CCF0-EF0B-0D47-E050-BB89AD434682","latestVersionIndicator":"Yes","beginDate":"2015-09-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-09-29","modifiedBy":"REEVESD","dateModified":"2015-10-07","changeNote":"Curated for MDACC Brain Tumor trial now being conducted by NCI CCR Dr. Gilbert PI. dmr.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5026759","version":"1","preferredName":"Patient Diagnosis Seizure Type","preferredDefinition":"Term to define the extent of seizure activity in an individual.","longName":"PT_DX_SZ_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"20E6AF9C-1B1D-D190-E050-BB89AD435F8D","latestVersionIndicator":"Yes","beginDate":"2015-09-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-09-29","modifiedBy":"REEVESD","dateModified":"2015-10-07","changeNote":"Curated for MDACC Brain Tumor trial now being conducted by NCI CCR Dr. Gilbert PI. dmr.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5027871","version":"1","preferredName":"Patient Electroencephalography Occurrence Yes No Indicator","preferredDefinition":"Text term to signify whether a patient had an electroencephalography study of the brain completed.","longName":"PT_EEG_DONE_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"21615860-83B3-180B-E050-BB89AD436E7B","latestVersionIndicator":"Yes","beginDate":"2015-10-05","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-10-05","modifiedBy":"REEVESD","dateModified":"2015-10-07","changeNote":"Curated for MDACC Brain Tumor trial now being conducted by NCI CCR Dr. Gilbert PI. dmr.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5027872","version":"1","preferredName":"Seizure Sign Symptom Yes No Indicator","preferredDefinition":"Text term to signify whether a sign or symptom related to seizure activity occurred within a patient.","longName":"SEIZ_ACT_SS_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"21615860-83DF-180B-E050-BB89AD436E7B","latestVersionIndicator":"Yes","beginDate":"2015-10-05","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-10-05","modifiedBy":"REEVESD","dateModified":"2015-10-07","changeNote":"Curated for MDACC Brain Tumor trial now being conducted by NCI CCR Dr. Gilbert PI. dmr.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5028272","version":"1","preferredName":"Radiation Therapy Relapse Date","preferredDefinition":"Calendar date of return of disease following radiation therapy with a period of improvement or complete remission.","longName":"RT_RELAPSE_DT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"2189EF50-FE02-CB37-E050-BB89AD437EA1","latestVersionIndicator":"Yes","beginDate":"2015-10-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-10-07","modifiedBy":"REEVESD","dateModified":"2015-10-07","changeNote":"Curated for MDACC Brain Tumor trial now being conducted by NCI CCR Dr. Gilbert PI. dmr.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5028276","version":"1","preferredName":"Systemic Therapy Relapse Date","preferredDefinition":"Calendar date of return of disease following systemic therapy with a period of improvement or complete remission.","longName":"SYS_TX_RELAPSE_DT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"2189EF50-FE45-CB37-E050-BB89AD437EA1","latestVersionIndicator":"Yes","beginDate":"2015-10-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-10-07","modifiedBy":"REEVESD","dateModified":"2015-10-07","changeNote":"Curated for MDACC Brain Tumor trial now being conducted by NCI CCR Dr. Gilbert PI. dmr.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5028278","version":"1","preferredName":"Surgical Procedure Relapse Date","preferredDefinition":"Calendar date of return of disease following surgery with a period of improvement or complete remission.","longName":"SURG_TX_RELAPSE_DT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"2189EF50-FE91-CB37-E050-BB89AD437EA1","latestVersionIndicator":"Yes","beginDate":"2015-10-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-10-07","modifiedBy":"REEVESD","dateModified":"2015-10-07","changeNote":"Curated for MDACC Brain Tumor trial now being conducted by NCI CCR Dr. Gilbert PI. dmr.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5028281","version":"1","preferredName":"Surgical Treatment Reason","preferredDefinition":"Text term to explain the surgical setting or reason surgery was used for a patient.","longName":"SURG_TX_RSN","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"218A5C43-2D31-89FB-E050-BB89AD432852","latestVersionIndicator":"Yes","beginDate":"2015-10-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-10-07","modifiedBy":"REEVESD","dateModified":"2015-10-07","changeNote":"Curated for MDACC Brain Tumor trial now being conducted by NCI CCR Dr. Gilbert PI. dmr.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5028283","version":"1","preferredName":"Postoperative Chemotherapy Treatment Begin Date","preferredDefinition":"Calendar date on which a chemotherapy agent or regimen was started on a postoperative patient.","longName":"POSTOP_CHEMO_BEG_DT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"218A5C43-2D95-89FB-E050-BB89AD432852","latestVersionIndicator":"Yes","beginDate":"2015-10-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-10-07","modifiedBy":"REEVESD","dateModified":"2015-10-07","changeNote":"Curated for MDACC Brain Tumor trial now being conducted by NCI CCR Dr. Gilbert PI. dmr.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5028284","version":"1","preferredName":"Postoperative Radiographic Assessment Date","preferredDefinition":"Calendar date on which a radiographic assessment was done on a postoperative patient.","longName":"POSTOP_RAD_ASSMT_DT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"2189EF50-FEB0-CB37-E050-BB89AD437EA1","latestVersionIndicator":"Yes","beginDate":"2015-10-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-10-07","modifiedBy":"REEVESD","dateModified":"2015-10-07","changeNote":"Curated for MDACC Brain Tumor trial now being conducted by NCI CCR Dr. Gilbert PI. dmr.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5028297","version":"1","preferredName":"Radiation Therapy Field Type","preferredDefinition":"Term to identify the type of field used in the delivery of radiation therapy to a patient.","longName":"RT_FLD_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"218AF363-FBBF-B7F2-E050-BB89AD435258","latestVersionIndicator":"Yes","beginDate":"2015-10-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-10-07","modifiedBy":"REEVESD","dateModified":"2015-10-07","changeNote":"Curated for MDACC Brain Tumor trial now being conducted by NCI CCR Dr. Gilbert PI. dmr.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5028311","version":"1","preferredName":"Radiotherapy Field Type Indicator","preferredDefinition":"Text term to signify whether a specified radiotherapy field delivery modality was used during the delivery of radiation therapy.","longName":"RT_FLD_TP_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"2189EF51-003B-CB37-E050-BB89AD437EA1","latestVersionIndicator":"Yes","beginDate":"2015-10-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-10-07","modifiedBy":"REEVESD","dateModified":"2015-10-07","changeNote":"Curated for MDACC Brain Tumor trial now being conducted by NCI CCR Dr. Gilbert PI. dmr.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5028312","version":"1","preferredName":"Maximum Daily Corticosteroid Dose Administered Value","preferredDefinition":"Numeric value for the largest daily corticosteroid dose taken by a patient at the time of an assessment.","longName":"MAX_DLY_STD_DOSE_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"2189EF51-005B-CB37-E050-BB89AD437EA1","latestVersionIndicator":"Yes","beginDate":"2015-10-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-10-07","modifiedBy":"SPRINGERL","dateModified":"2021-03-19","changeNote":"Curated for MDACC Brain Tumor trial now being conducted by NCI CCR Dr. Gilbert PI. dmr.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5028331","version":"1","preferredName":"Longest Measurable Lesions Sum Diameters Value","preferredDefinition":"Numeric value to indicate the sum of the longest diameters of all measurable lesions captured in centimeters (cm).","longName":"LONG_DIAM_MES_CM_SUM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"218BB7BB-B099-9B0B-E050-BB89AD432CE3","latestVersionIndicator":"Yes","beginDate":"2015-10-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-10-07","modifiedBy":"SHEIKHM","dateModified":"2021-10-27","changeNote":"Curated for MDACC Brain Tumor trial now being conducted by NCI CCR Dr. Gilbert PI. dmr.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5028354","version":"1","preferredName":"Disease Evaluation Verification Category","preferredDefinition":"Term used primarily by a physician to confirm or indicate whether revision in a patient's disease evaluation assessment is needed.","longName":"DZ_EVAL_VERIF_CAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"218BDA20-718C-2494-E050-BB89AD43234D","latestVersionIndicator":"Yes","beginDate":"2015-10-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-10-07","modifiedBy":"REEVESD","dateModified":"2015-10-07","changeNote":"Curated for MDACC Brain Tumor trial now being conducted by NCI CCR Dr. Gilbert PI. dmr.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5028355","version":"1","preferredName":"Disease Evaluation Verification Date","preferredDefinition":"Calendar date on which a physician confirms or indicates whether revision in a patient's disease evaluation assessment is needed.","longName":"DZ_EVAL_VERIF_DT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"218BDA20-71BD-2494-E050-BB89AD43234D","latestVersionIndicator":"Yes","beginDate":"2015-10-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-10-07","modifiedBy":"REEVESD","dateModified":"2015-10-07","changeNote":"Curated for MDACC Brain Tumor trial now being conducted by NCI CCR Dr. Gilbert PI. dmr.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5028358","version":"1","preferredName":"Radiation Therapy Reason","preferredDefinition":"Term to explain the reason for the use of radiotherapy in a patient.","longName":"RT_RSN","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"218BDA20-71DC-2494-E050-BB89AD43234D","latestVersionIndicator":"Yes","beginDate":"2015-10-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-10-07","modifiedBy":"REEVESD","dateModified":"2015-10-07","changeNote":"Curated for MDACC Brain Tumor trial now being conducted by NCI CCR Dr. Gilbert PI. dmr.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5028371","version":"1","preferredName":"Cerebrospinal Fluid Cytology Performed Finding Result","preferredDefinition":"Summary result of a cerebrospinal fluid (CSF) cytological laboratory finding.","longName":"2865263v1.0:2676304v1.0","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"218D2856-3DF0-16B4-E050-BB89AD436A50","latestVersionIndicator":"Yes","beginDate":"2015-10-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-10-07","modifiedBy":"GALITG","dateModified":"2022-01-27","changeNote":"Curated for MDACC Brain Tumor trial now being conducted by NCI CCR Dr. Gilbert PI. dmr.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5028415","version":"1","preferredName":"Thymus Gland Disease Assessment Timepoint Total Volume","preferredDefinition":"Numeric value for the volume in cubic centimeters (cm3) of the thymus gland at the time of a disease assessment.","longName":"THYM_VOL_ASSMT_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"218F743C-4ECD-CE3A-E050-BB89AD436416","latestVersionIndicator":"Yes","beginDate":"2015-10-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-10-07","modifiedBy":"REEVESD","dateModified":"2015-10-09","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5028426","version":"1","preferredName":"Thymus Gland Size McCune Category","preferredDefinition":"Classification of the size of the thymus gland at disease assessment using the McCune evaluation of  thymus size using TI scale to assess thymic enlargement in thoracic CTs.","longName":"MCCUNE_THYM_SIZE_CAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"Hakim, F.T. et al. (2005); McCune J.M et al. (1998)","workflowStatus":"RELEASED","registrationStatus":"Application","id":"218F98B0-424C-29A3-E050-BB89AD437754","latestVersionIndicator":"Yes","beginDate":"2015-10-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-10-07","modifiedBy":"DWARZEL","dateModified":"2022-05-23","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5028436","version":"1","preferredName":"Thymus Disease Assessment Fat Measurement Grade","preferredDefinition":"Numeric value representing the fat content of the thymus gland at disease assessment using a grading classification based on CT characteristics of the thymus in adults as described by Simanovsky N, et al. (2012)","longName":"THYM_FAT_MSRMT_GD","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"Simanovsky N, et al. (2012)","workflowStatus":"RELEASED","registrationStatus":"Application","id":"21904B5E-D302-1A41-E050-BB89AD43383C","latestVersionIndicator":"Yes","beginDate":"2015-10-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-10-07","modifiedBy":"REEVESD","dateModified":"2015-10-08","changeNote":"Based on work published by Simanovsky N, et al. (published 2012) and used by NCI CCR in clinical trial. dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5028611","version":"1","preferredName":"Sum Lesion Diameter Products Value","preferredDefinition":"Total sum of products (transverse diameter multiplied by perpendicular diameter) for all measurable lesions described in square centimeters (cm2).","longName":"SUM_MEA_LES_PROD_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"21A60649-4195-0039-E050-BB89AD4324C3","latestVersionIndicator":"Yes","beginDate":"2015-10-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-10-09","modifiedBy":"REEVESD","dateModified":"2015-10-19","changeNote":"Curated to support NCI CCR Brain Tumor trial.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5034212","version":"1","preferredName":"Specimen Submission Other Reason","preferredDefinition":"Explanation for submission of a specimen that is different from a list of options.","longName":"SPEC_SUBM_OTX_RSN","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"22135FED-7852-9BF8-E050-BB89AD436BBF","latestVersionIndicator":"Yes","beginDate":"2015-10-14","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-10-14","modifiedBy":"REEVESD","dateModified":"2015-10-19","changeNote":"Curated to support NCI CCR Brain Tumor trial.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5034234","version":"1","preferredName":"Sample Collection Expected Date","preferredDefinition":"The planned or anticipated date when a sample (specimen) will be collected.","longName":"SMPL_COLL_EXPECT_DT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"221491E5-13AC-C09B-E050-BB89AD4302B5","latestVersionIndicator":"Yes","beginDate":"2015-10-14","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-10-14","modifiedBy":"REEVESD","dateModified":"2015-10-19","changeNote":"Curated to support NCI CCR Brain Tumor trial.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5034236","version":"1","preferredName":"Sample Collection Expected Time","preferredDefinition":"The planned or anticipated time when a sample (specimen) will be collected.","longName":"SPEC_COLL_EXPECT_TM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"2214A181-DD69-EF9F-E050-BB89AD4326C3","latestVersionIndicator":"Yes","beginDate":"2015-10-14","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-10-14","modifiedBy":"REEVESD","dateModified":"2015-10-19","changeNote":"Curated to support NCI CCR Brain Tumor trial.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5034244","version":"1","preferredName":"Concomitant Medication Current Cycle Change Event Indicator","preferredDefinition":"Term to signify whether there has been a change in a patient's concomitant therapy during the current cycle.","longName":"CONCOM_CYC_CHG_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"2214A181-DDD4-EF9F-E050-BB89AD4326C3","latestVersionIndicator":"Yes","beginDate":"2015-10-14","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-10-14","modifiedBy":"REEVESD","dateModified":"2015-10-19","changeNote":"Curated to support NCI CCR Brain Tumor trial.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5034396","version":"1","preferredName":"Agent Dose Modification Reason","preferredDefinition":"Explanation of the cause for a study drug dose modification.","longName":"AGENT_DOSE_MOD_RSN","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"2215F775-F03A-C55D-E050-BB89AD434B20","latestVersionIndicator":"Yes","beginDate":"2015-10-14","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-10-14","modifiedBy":"LEEW","dateModified":"2019-11-19","changeNote":"Curated to support NCI CCR Brain Tumor trial.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5034432","version":"1","preferredName":"Disease Progression Post Treatment Date","preferredDefinition":"Calendar date post-treatment of the return of a disease after a period of remission.","longName":"DZ_PROG_POST_TX_DT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"22175BA5-56E8-8825-E050-BB89AD433FE9","latestVersionIndicator":"Yes","beginDate":"2015-10-14","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-10-14","modifiedBy":"REEVESD","dateModified":"2015-10-19","changeNote":"Curated to support NCI CCR Brain Tumor trial.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5034450","version":"1","preferredName":"Protocol Treatment Telephone Confirmed Compliance Yes No Not Applicable Indicator","preferredDefinition":"Text term to signify whether the participant is compliant with protocol intervention(s) per telephone conversation.","longName":"PROT_COMP_CONF_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"22175BA5-58A4-8825-E050-BB89AD433FE9","latestVersionIndicator":"Yes","beginDate":"2015-10-14","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-10-14","modifiedBy":"REEVESD","dateModified":"2016-05-13","changeNote":"Curated to support NCI CCR Brain Tumor trial.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5034451","version":"1","preferredName":"MD Anderson Symptom Inventory Assessment Indicator","preferredDefinition":"Text term to signify whether an MD Anderson Symptom Inventory (MDASI) self-administered questionnaire was given to a patient.","longName":"MDASI_ASSMT_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"2217B6A3-ED2C-2CB4-E050-BB89AD431BD3","latestVersionIndicator":"Yes","beginDate":"2015-10-14","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-10-14","modifiedBy":"REEVESD","dateModified":"2015-10-19","changeNote":"Curated to support NCI CCR Brain Tumor trial.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5034456","version":"1","preferredName":"Seizure Activity Per Education Sheet Occurrence Yes No Unknown Not Applicable Indicator","preferredDefinition":"Text term to signify whether a patient has experienced seizure activity as described in the Education Sheet.","longName":"SEIZ_EDUC_SHEET_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"22175BA5-58F8-8825-E050-BB89AD433FE9","latestVersionIndicator":"Yes","beginDate":"2015-10-14","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-10-14","modifiedBy":"REEVESD","dateModified":"2016-02-26","changeNote":"Curated to support NCI CCR Brain Tumor trial.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5034491","version":"1","preferredName":"Seizure Activity Per Education Document Date","preferredDefinition":"Calendar date of patient seizure activity as described in the Education Sheet.","longName":"SEIZ_ACT_EDUC_DT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"221FD21A-CC93-A7EF-E050-BB89AD432169","latestVersionIndicator":"Yes","beginDate":"2015-10-15","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-10-15","modifiedBy":"REEVESD","dateModified":"2015-10-19","changeNote":"Curated to support NCI CCR Brain Tumor trial.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5034492","version":"1","preferredName":"Seizure Activity Per Education Document Time","preferredDefinition":"Clock time of patient seizure activity as described in the Education Sheet.","longName":"SEIZ_ACT_EDUC_TM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"221FD21A-CCB2-A7EF-E050-BB89AD432169","latestVersionIndicator":"Yes","beginDate":"2015-10-15","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-10-15","modifiedBy":"REEVESD","dateModified":"2015-10-19","changeNote":"Curated to support NCI CCR Brain Tumor trial.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5034517","version":"1","preferredName":"Plexiform Neurofibroma Classification Category","preferredDefinition":"Classification to represent the nodularity component of plexiform neurofibroma.","longName":"PLEX_NEUFB_CLASS_CAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"2223A597-451A-AE1F-E050-BB89AD433168","latestVersionIndicator":"Yes","beginDate":"2015-10-15","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-10-15","modifiedBy":"REEVESD","dateModified":"2015-10-15","changeNote":"Curated to support NF1 study in NCI CCR.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5035626","version":"1","preferredName":"Biospecimen Collection Unit of Measure","preferredDefinition":"Term to describe the unit of measurement applied to a biospecimen collection.","longName":"SPEC_QUAN_UOM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"223B305D-E1DC-6C83-E050-BB89AD433DFD","latestVersionIndicator":"Yes","beginDate":"2015-10-16","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-10-16","modifiedBy":"TANGL","dateModified":"2018-07-30","changeNote":"Curated to support NCI CCR Brain Tumor trial.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5035694","version":"1","preferredName":"Specimen Submission Reason","preferredDefinition":"Explanation for the submission of a biospecimen from a patient.","longName":"SPEC_SUBMSN_RSN","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"223D3E09-824C-57B7-E050-BB89AD434334","latestVersionIndicator":"Yes","beginDate":"2015-10-16","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-10-16","modifiedBy":"REEVESD","dateModified":"2015-10-19","changeNote":"Curated to support NCI CCR Brain Tumor trial.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5035778","version":"1","preferredName":"New Cancer Therapy Type","preferredDefinition":"Term to describe the number of agents included in therapy regimen.","longName":"NEW_ANTICA_TX_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"223EE1E8-2840-61CF-E050-BB89AD436EF1","latestVersionIndicator":"Yes","beginDate":"2015-10-16","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-10-16","modifiedBy":"REEVESD","dateModified":"2017-02-11","changeNote":"Curated to support NCI CCR Brain Tumor trial.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5035814","version":"1","preferredName":"New Cancer Therapy Not Reported Administration Indicator","preferredDefinition":"Text term to signify whether a patient has started a new anticancer therapy that has not been reported.","longName":"NEW_CATX_NOREP_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"223F5AD0-E473-E74D-E050-BB89AD4338D3","latestVersionIndicator":"Yes","beginDate":"2015-10-16","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-10-16","modifiedBy":"REEVESD","dateModified":"2015-10-19","changeNote":"Curated to support NCI CCR Brain Tumor trial.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5035831","version":"1","preferredName":"New Cancer Therapy Not Reported Begin Date","preferredDefinition":"Calendar date on which new anticancer therapy is initiated.","longName":"NEW_ANTICA_TX_BEG_DT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"226F274B-3F54-2147-E050-BB89AD435368","latestVersionIndicator":"Yes","beginDate":"2015-10-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-10-19","modifiedBy":"REEVESD","dateModified":"2015-10-19","changeNote":"Curated to support NCI CCR Brain Tumor trial.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5035838","version":"1","preferredName":"Patient Contact Outcome","preferredDefinition":"Result of an effort to contact a patient.","longName":"PT_CONT_OUTCM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"226F274B-3FFC-2147-E050-BB89AD435368","latestVersionIndicator":"Yes","beginDate":"2015-10-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-10-19","modifiedBy":"REEVESD","dateModified":"2015-11-13","changeNote":"Curated to support NCI CCR Brain Tumor trial.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5042377","version":"1","preferredName":"Medical History Myocardial Infarction Previous Year Before Trial Registration Yes No Unknown Indicator","preferredDefinition":"Text term to signify whether a patient has a history of myocardial infarction (MI) one year prior to clinical trial registration.","longName":"HX_MI_YR_PRI_REG_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"23A7E9C9-AC4C-C143-E050-BB89AD43576C","latestVersionIndicator":"Yes","beginDate":"2015-11-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-11-03","modifiedBy":"REEVESD","dateModified":"2015-11-13","changeNote":"Curated to support NCI CCR study of brain cancer BTTC11, a study being run also at MD Anderson, so the lists of values and semantics are created exactly to support that trial. 11.13.2015. dmr.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5042378","version":"1","preferredName":"Myocardial Infarction Most Recent Occurrence Date","preferredDefinition":"Calendar data of the most recently occurring myocardial infarction (MI) in a patient.","longName":"MI_REC_OCC_DT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Application","id":"23A7E9C9-AC6B-C143-E050-BB89AD43576C","latestVersionIndicator":"Yes","beginDate":"2015-11-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-11-03","modifiedBy":"COOPERM","dateModified":"2017-10-20","changeNote":"Curated to support NCI CCR study of brain cancer BTTC11, a study being run also at MD Anderson, so the lists of values and semantics are created exactly to support that trial. 11.13.2015. dmr.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5042382","version":"1","preferredName":"Cardiac Dysrhythmia Occurrence Yes No Unknown Indicator","preferredDefinition":"Text term to signify whether a patient experienced any cardiac dysrhythmia(s).","longName":"CARD_DYSRTH_OCC_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Application","id":"23A7E9C9-ACAE-C143-E050-BB89AD43576C","latestVersionIndicator":"Yes","beginDate":"2015-11-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-11-03","modifiedBy":"COOPERM","dateModified":"2017-10-20","changeNote":"Curated to support NCI CCR study of brain cancer BTTC11, a study being run also at MD Anderson, so the lists of values and semantics are created exactly to support that trial. 11.13.2015. dmr.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5042383","version":"1","preferredName":"Cardiac Dysrhythmia Condition Status","preferredDefinition":"Text term to describe if a cardiac dysthymia is being managed and under control.","longName":"CARD_DYSRTH_CON_STAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Application","id":"23A7E9C9-ACCE-C143-E050-BB89AD43576C","latestVersionIndicator":"Yes","beginDate":"2015-11-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-11-03","modifiedBy":"COOPERM","dateModified":"2017-10-20","changeNote":"Curated to support NCI CCR study of brain cancer BTTC11, a study being run also at MD Anderson, so the lists of values and semantics are created exactly to support that trial. 11.13.2015. dmr.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5042385","version":"1","preferredName":"Patient Other Cardiac Condition Occurrence Yes No Unknown Indicator","preferredDefinition":"Text term to signify whether a patient has experienced any cardiac disease history that is different from conditions already identified.","longName":"PT_OTX_CARD_COND_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Application","id":"23A8BC15-0A3B-8031-E050-BB89AD4341AA","latestVersionIndicator":"Yes","beginDate":"2015-11-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-11-03","modifiedBy":"COOPERM","dateModified":"2017-10-20","changeNote":"Curated to support NCI CCR study of brain cancer BTTC11, a study being run also at MD Anderson, so the lists of values and semantics are created exactly to support that trial. 11.13.2015. dmr.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5042386","version":"1","preferredName":"Patient Other Cardiac Condition Occurrence Other Specify","preferredDefinition":"Text description of a cardiac condition that is different from those already identified.","longName":"PT_OTX_CARD_CON_SPEC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Application","id":"23A7E9C9-AD2A-C143-E050-BB89AD43576C","latestVersionIndicator":"Yes","beginDate":"2015-11-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-11-03","modifiedBy":"COOPERM","dateModified":"2017-10-20","changeNote":"Curated to support NCI CCR study of brain cancer BTTC11, a study being run also at MD Anderson, so the lists of values and semantics are created exactly to support that trial. 11.13.2015. dmr.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5042430","version":"1","preferredName":"Radiation Therapy Organ Brain Anatomic Site","preferredDefinition":"Named location with the central nervous system that received radiation therapy (RT).","longName":"RT_ORG_BRN_ANAT_STE","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Application","id":"23A7E9C9-AE66-C143-E050-BB89AD43576C","latestVersionIndicator":"Yes","beginDate":"2015-11-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-11-03","modifiedBy":"COOPERM","dateModified":"2017-10-20","changeNote":"Curated to support NCI CCR study of brain cancer BTTC11, a study being run also at MD Anderson, so the lists of values and semantics are created exactly to support that trial. 11.13.2015. dmr.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5042455","version":"1","preferredName":"Surgical Procedure Organ Brain Tumor Anatomic Site","preferredDefinition":"Named location with the central nervous system that was the site of a surgical procedure.","longName":"SUR_ORG_BRN_ANAT_STE","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Application","id":"23A7E9C9-AE85-C143-E050-BB89AD43576C","latestVersionIndicator":"Yes","beginDate":"2015-11-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-11-03","modifiedBy":"COOPERM","dateModified":"2017-10-20","changeNote":"Curated to support NCI CCR study of brain cancer BTTC11, a study being run also at MD Anderson, so the lists of values and semantics are created exactly to support that trial. 11.13.2015. dmr.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5042458","version":"1","preferredName":"Disease Lesion Organ Brain Anatomic Site","preferredDefinition":"Named location with the central nervous system that is the site of a disease lesion.","longName":"LES_ORG_BRN_ANAT_STE","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Application","id":"23A7E9C9-AECB-C143-E050-BB89AD43576C","latestVersionIndicator":"Yes","beginDate":"2015-11-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-11-03","modifiedBy":"COOPERM","dateModified":"2017-10-20","changeNote":"Curated to support NCI CCR study of brain cancer BTTC11, a study being run also at MD Anderson, so the lists of values and semantics are created exactly to support that trial. 11.13.2015. dmr.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5042911","version":"1","preferredName":"Radiation Therapy CNS Anatomic Site","preferredDefinition":"Named location in the body that received radiation therapy.","longName":"RT_CNS_ANAT_SITE","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"23D150D0-36C7-E0EE-E050-BB89AD434349","latestVersionIndicator":"Yes","beginDate":"2015-11-05","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-11-05","modifiedBy":"REEVESD","dateModified":"2015-11-13","changeNote":"Curated to support NCI CCR study of brain cancer BTTC11, a study being run also at MD Anderson, so the lists of values and semantics are created exactly to support that trial. 11.13.2015. dmr.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5042912","version":"1","preferredName":"Surgical Procedure CNS Anatomic Site","preferredDefinition":"Named location in the body for a surgical procedure.","longName":"SURG_CNS_ANAT_SITE","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"23D150D0-36E6-E0EE-E050-BB89AD434349","latestVersionIndicator":"Yes","beginDate":"2015-11-05","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-11-05","modifiedBy":"REEVESD","dateModified":"2015-11-13","changeNote":"Curated to support NCI CCR study of brain cancer BTTC11, a study being run also at MD Anderson, so the lists of values and semantics are created exactly to support that trial. 11.13.2015. dmr.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5042913","version":"1","preferredName":"Lesion CNS Anatomic Site","preferredDefinition":"Named location in the body of a disease lesion.","longName":"LES_CNS_ANAT_SITE","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"23D150D0-371E-E0EE-E050-BB89AD434349","latestVersionIndicator":"Yes","beginDate":"2015-11-05","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-11-05","modifiedBy":"REEVESD","dateModified":"2015-11-13","changeNote":"Curated to support NCI CCR study of brain cancer BTTC11, a study being run also at MD Anderson, so the lists of values and semantics are created exactly to support that trial. 11.13.2015. dmr.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5043327","version":"1","preferredName":"Radiation Therapy Specified Anatomic Site Name","preferredDefinition":"Named and more specified location in the body that received radiation therapy.","longName":"RT_SPEC_SITE_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"2420E0AF-ACF8-A62A-E050-BB89AD4364A4","latestVersionIndicator":"Yes","beginDate":"2015-11-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-11-09","modifiedBy":"REEVESD","dateModified":"2015-11-13","changeNote":"Curated to support NCI CCR study of brain cancer BTTC11, a study being run also at MD Anderson, so the lists of values and semantics are created exactly to support that trial. 11.13.2015. dmr.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5043328","version":"1","preferredName":"Surgical Procedure Specified Anatomic Site Name","preferredDefinition":"Named and more specified location in the body that was the site of a surgical procedure.","longName":"SURG_SPEC_SITE_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"2420E0AF-AD1E-A62A-E050-BB89AD4364A4","latestVersionIndicator":"Yes","beginDate":"2015-11-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-11-09","modifiedBy":"REEVESD","dateModified":"2015-11-13","changeNote":"Curated to support NCI CCR study of brain cancer BTTC11, a study being run also at MD Anderson, so the lists of values and semantics are created exactly to support that trial. 11.13.2015. dmr.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5043329","version":"1","preferredName":"Lesion Anatomic Specified Anatomic Site Name","preferredDefinition":"Named and more specified location in the body for the site of a lesion.","longName":"LESION_SPEC_SITE_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"2421620A-CAE4-40B8-E050-BB89AD430957","latestVersionIndicator":"Yes","beginDate":"2015-11-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-11-09","modifiedBy":"REEVESD","dateModified":"2015-11-13","changeNote":"Curated to support NCI CCR study of brain cancer BTTC11, a study being run also at MD Anderson, so the lists of values and semantics are created exactly to support that trial. 11.13.2015. dmr.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5043361","version":"1","preferredName":"Anatomic Site Side Detail Type","preferredDefinition":"Specification relating to the side or laterality of an anatomic location.","longName":"ANAT_STE_SDE_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"24217E2F-16D1-718B-E050-BB89AD4318A8","latestVersionIndicator":"Yes","beginDate":"2015-11-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-11-09","modifiedBy":"REEVESD","dateModified":"2015-11-13","changeNote":"Curated to support NCI CCR study of brain cancer BTTC11, a study being run also at MD Anderson, so the lists of values and semantics are created exactly to support that trial. 11.13.2015. dmr.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5043463","version":"1","preferredName":"Brain Surgical Resection Type","preferredDefinition":"Name of a surgical procedure used to resection or remove a portion of a brain lesion.","longName":"BR_SURG_RES_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Application","id":"24217E2F-1875-718B-E050-BB89AD4318A8","latestVersionIndicator":"Yes","beginDate":"2015-11-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-11-09","modifiedBy":"COOPERM","dateModified":"2017-10-20","changeNote":"Curated to support NCI CCR study of brain cancer BTTC11, a study being run also at MD Anderson, so the lists of values and semantics are created exactly to support that trial. 11.13.2015. dmr.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5044633","version":"1","preferredName":"Disease Recurrent Disease Cancer Progression Diagnosis Yes No Unknown Not Applicable Indicator","preferredDefinition":"Text term to signify whether there was a first relapse or progression of disease.","longName":"RECR_DZ_PROG_DX_IND4","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"246D22D7-76D6-4488-E050-BB89AD436EAB","latestVersionIndicator":"Yes","beginDate":"2015-11-13","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-11-13","modifiedBy":"TITARENKOI","dateModified":"2021-05-04","changeNote":"Curated to support NCI CCR study of brain cancer BTTC11, a study being run also at MD Anderson, so the lists of values and semantics are created exactly to support that trial. 11.13.2015. dmr.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5053662","version":"1","preferredName":"Prior Systemic Treatment Regimen Count","preferredDefinition":"The number counting the total systemic regimens of therapy the patient received prior to enrolling the current protocol, where multiple drugs or a staged therapy count as a single regimen.","longName":"PRIOR_SYSTMC_RGM_CT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"254D1312-042D-78D3-E050-BB89AD431A13","latestVersionIndicator":"Yes","beginDate":"2015-11-24","endDate":null,"createdBy":"MAESKEB","dateCreated":"2015-11-24","modifiedBy":"MAESKEB","dateModified":"2015-11-25","changeNote":"Created for C3D. bsm","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5094920","version":"1","preferredName":"Primary Immunodeficiency Post Allogeneic Bone Marrow Transplantation Disease or Survival End Point Type","preferredDefinition":"Disease or survival endpoint applied to a patient with primary immunodeficiency condition treated with allogeneic bone marrow transplantation (BMT).","longName":"IMMN_POSTALL_END_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"27F820F3-DAA1-1A5B-E050-BB89AD43527C","latestVersionIndicator":"Yes","beginDate":"2015-12-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-12-28","modifiedBy":"REEVESD","dateModified":"2015-12-28","changeNote":"Curated to support NCI CCR primary immunodeficiency clinical trial. 12/28/2015.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5095202","version":"1","preferredName":"Vision Assessment Anatomic Site","preferredDefinition":"Named locations of or within the eye typically included in an ophthalmologic examination.","longName":"VSN_ASSESS_ANAT_STE","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"280CB7B5-C7F9-43D4-E050-BB89AD4365A7","latestVersionIndicator":"Yes","beginDate":"2015-12-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-12-29","modifiedBy":"REEVESD","dateModified":"2015-12-29","changeNote":"Created to support NCI CCR clinical trials per request of Elizabeth Ness.12.29.2015.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5096115","version":"1","preferredName":"Pediatric Oncologist Consultation Post Last Visit Occurrence Yes No Unknown Indicator","preferredDefinition":"Text term to signify whether a patient/patient's parents visited a pediatric oncologist since the last clinical trials team visit.","longName":"PED_ONC_VST_OCC_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"2888530D-6A4F-05C3-E050-BB89AD433480","latestVersionIndicator":"Yes","beginDate":"2016-01-04","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-01-04","modifiedBy":"COOPERM","dateModified":"2017-08-18","changeNote":"Created to support NCI CCR clinical trial.1.4.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5096813","version":"1","preferredName":"Adverse Event Post Last Visit Occurrence Yes No Unknown Indicator","preferredDefinition":"Text term to signify whether a patient experienced an adverse event since the last clinical trials team visit.","longName":"AE_VST_OCC_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"28A32349-85BB-18DF-E050-BB89AD433D79","latestVersionIndicator":"Yes","beginDate":"2016-01-05","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-01-05","modifiedBy":"REEVESD","dateModified":"2016-01-06","changeNote":"Created to support NCI CCR clinical trial.1.4.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5100811","version":"1","preferredName":"Quality of Life Complete Assessment Yes No Unknown Indicator","preferredDefinition":"Text term to signify whether a quality of life (QOL) evaluation was completed or done for a person.","longName":"QOL_ASSMT_IND3","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"293A03DD-C8D4-6879-E050-BB89AD432172","latestVersionIndicator":"Yes","beginDate":"2016-01-13","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-01-13","modifiedBy":"GARRIDOJ","dateModified":"2016-11-17","changeNote":"Created to support NCI CCR clinical trial. 1.13.2016 dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5100812","version":"2","preferredName":"Quality of Life Absent Assessment Reason Text","preferredDefinition":"Text to describe the reason a quality of life (QOL) assessment for a person is absent or was not done.","longName":"QOL_ABSNT_RSN_TXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"BC16BCA8-F934-27A3-E053-4EBD850ABE37","latestVersionIndicator":"Yes","beginDate":"2021-02-24","endDate":null,"createdBy":"COOPERM","dateCreated":"2021-02-24","modifiedBy":"CLOHNES","dateModified":"2022-11-01","changeNote":"Versioned for new VD version. mc 2.24.21 mc Created for use in NCI CCR clinical trial. 1.13.2016. dmr","administrativeNotes":"11/01/22 Added AQT and alt OID cjl;","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5117017","version":"1","preferredName":"Memorial Symptom Assessment Scale Past Week Other Symptom Indicator","preferredDefinition":"Person's stated observation of whether or not they were experiencing other symptoms, within the past week, using a yes or no response.","longName":"MSAS_OTHER_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2ABA1309-AD27-A036-E050-BB89AD435993","latestVersionIndicator":"Yes","beginDate":"2016-02-01","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-02-01","modifiedBy":"HARTLEYG","dateModified":"2017-05-15","changeNote":"Curated for CCR_MSAS_SF_02.01.16_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5117024","version":"1","preferredName":"Memorial Symptom Assessment Scale Past Week How Much Distress Other Symptom Score 5 Point Scale","preferredDefinition":"Person's stated observation in the past week how much distress they had from having other symptoms, using a five-point Likert scale.","longName":"MSAS_D_OTHER_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2ABA1309-AD47-A036-E050-BB89AD435993","latestVersionIndicator":"Yes","beginDate":"2016-02-01","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-02-01","modifiedBy":"HARTLEYG","dateModified":"2017-05-15","changeNote":"Curated for CCR_MSAS_SF_02.01.16_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5117025","version":"1","preferredName":"Memorial Symptom Assessment Scale Past Week Symptom Other Specify","preferredDefinition":"The text response describing other symptoms that have not been previously listed.","longName":"MSAS_OTHER_SPECIFY","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2ABA1309-AD67-A036-E050-BB89AD435993","latestVersionIndicator":"Yes","beginDate":"2016-02-01","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-02-01","modifiedBy":"HARTLEYG","dateModified":"2017-05-15","changeNote":"Curated for CCR_MSAS_SF_02.01.16_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5143352","version":"1","preferredName":"Primary Immunodeficiency Prior Therapy Type","preferredDefinition":"Name to represent an therapy modality or approach used to treat a patient with Primary immunodeficiencies (PIs) at a point in time before an evaluation or treatment time point.","longName":"PRIM_IMMUD_PR_TX_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"2CB2C7B9-1ADC-1DFE-E050-BB89AD433C1E","latestVersionIndicator":"Yes","beginDate":"2016-02-26","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-02-26","modifiedBy":"REEVESD","dateModified":"2016-04-05","changeNote":"Curated to support NCI CCR primary immunodeficiency trial.4.5.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5156168","version":"1","preferredName":"Correlative Study Results Availability Date","preferredDefinition":"Calendar date on which the results from a correlative study designed to translate basic science findings into clinically use tools were available.","longName":"CORR_STDY_RSL_AVL_DT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"2E18BFE4-8EA8-CA26-E050-BB89AD4332A4","latestVersionIndicator":"Yes","beginDate":"2016-03-15","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-03-15","modifiedBy":"REEVESD","dateModified":"2016-07-08","changeNote":"Curated to support NCI CCR clinical trial.7.8.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5189591","version":"1","preferredName":"Human Activity Profile 1 Getting In and Out of Chairs or Bed Without Assistance 3 Point Scale","preferredDefinition":"Persons' stated observation of their ability to get in and out of chairs or bed (without assistance), using a three point Likert scale.","longName":"HAP_Q1_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"HAP:Human Activity Profile. Daughton, DM and Fix, James, J Rehabil Res Dev. 41(4): 621-630, 1980.","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2EA41F07-FA03-ED3A-E050-BB89AD431A56","latestVersionIndicator":"Yes","beginDate":"2016-03-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-03-22","modifiedBy":"COOPERM","dateModified":"2016-03-24","changeNote":"Created for CCR request by P.Asangong for GVHD study. mc 3/22/2016","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5189592","version":"1","preferredName":"Human Activity Profile 2 Listening to the Radio 3 Point Scale","preferredDefinition":"Persons' stated observation of their ability to listen to the radio, using a three point Likert scale.","longName":"HAP_Q2_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"HAP:Human Activity Profile. Daughton, DM and Fix, James, J Rehabil Res Dev. 41(4): 621-630, 1980.","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2EA41F07-FA2A-ED3A-E050-BB89AD431A56","latestVersionIndicator":"Yes","beginDate":"2016-03-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-03-22","modifiedBy":"COOPERM","dateModified":"2016-03-24","changeNote":"Created for CCR request by P.Asangong for GVHD study. mc 3/22/2016","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5189593","version":"1","preferredName":"Human Activity Profile 3 Reading Books, Magazines or Newspapers 3 Point Scale","preferredDefinition":"Persons' stated observation of their ability to read books, magazines, or newspapers, using a three point Likert scale.","longName":"HAP_Q3_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"HAP:Human Activity Profile. Daughton, DM and Fix, James, J Rehabil Res Dev. 41(4): 621-630, 1980.","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2EA41F07-FA51-ED3A-E050-BB89AD431A56","latestVersionIndicator":"Yes","beginDate":"2016-03-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-03-22","modifiedBy":"COOPERM","dateModified":"2016-03-24","changeNote":"Created for CCR request by P.Asangong for GVHD study. mc 3/22/2016","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5189594","version":"1","preferredName":"Human Activity Profile 4 Writing Letters or Notes 3 Point Scale","preferredDefinition":"Persons' stated observation of their ability to write (letters, notes), using a three point Likert scale.","longName":"HAP_Q4_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"HAP:Human Activity Profile. Daughton, DM and Fix, James, J Rehabil Res Dev. 41(4): 621-630, 1980.","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2EA41F07-FA78-ED3A-E050-BB89AD431A56","latestVersionIndicator":"Yes","beginDate":"2016-03-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-03-22","modifiedBy":"COOPERM","dateModified":"2016-03-24","changeNote":"Created for CCR request by P.Asangong for GVHD study. mc 3/22/2016","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5189595","version":"1","preferredName":"Human Activity Profile 5 Working at a Desk or Table 3 Point Scale","preferredDefinition":"Persons' stated observation of their ability to work at a desk or table, using a three point Likert scale.","longName":"HAP_Q5_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"HAP:Human Activity Profile. Daughton, DM and Fix, James, J Rehabil Res Dev. 41(4): 621-630, 1980.","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2EA41F07-FA9F-ED3A-E050-BB89AD431A56","latestVersionIndicator":"Yes","beginDate":"2016-03-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-03-22","modifiedBy":"COOPERM","dateModified":"2016-03-24","changeNote":"Created for CCR request by P.Asangong for GVHD study. mc 3/22/2016","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5189596","version":"1","preferredName":"Human Activity Profile 6 Standing for More Than 1 Minute 3 Point Scale","preferredDefinition":"Persons' stated observation of their ability to stand (for more than 1 minute), using a three point Likert scale.","longName":"HAP_Q6_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"HAP:Human Activity Profile. Daughton, DM and Fix, James, J Rehabil Res Dev. 41(4): 621-630, 1980.","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2EA41F07-FAC6-ED3A-E050-BB89AD431A56","latestVersionIndicator":"Yes","beginDate":"2016-03-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-03-22","modifiedBy":"COOPERM","dateModified":"2016-03-24","changeNote":"Created for CCR request by P.Asangong for GVHD study. mc 3/22/2016","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5189597","version":"1","preferredName":"Human Activity Profile 7 Standing for More Than 5 Minutes 3 Point Scale","preferredDefinition":"Persons' stated observation of their ability to stand (more than 5 minutes), using a three point Likert scale.","longName":"HAP_Q7_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"HAP:Human Activity Profile. Daughton, DM and Fix, James, J Rehabil Res Dev. 41(4): 621-630, 1980.","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2EA44CCD-70E4-835B-E050-BB89AD432FC0","latestVersionIndicator":"Yes","beginDate":"2016-03-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-03-22","modifiedBy":"COOPERM","dateModified":"2016-03-24","changeNote":"Created for CCR request by P.Asangong for GVHD study. mc 3/22/2016","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5189598","version":"1","preferredName":"Human Activity Profile 8 Dressing or Undressing Without Assistance 3 Point Scale","preferredDefinition":"Persons' stated observation of their ability to dress or undress (without assistance), using a three point Likert scale.","longName":"HAP_Q8_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"HAP:Human Activity Profile. Daughton, DM and Fix, James, J Rehabil Res Dev. 41(4): 621-630, 1980.","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2EA41F07-FAED-ED3A-E050-BB89AD431A56","latestVersionIndicator":"Yes","beginDate":"2016-03-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-03-22","modifiedBy":"COOPERM","dateModified":"2016-03-24","changeNote":"Created for CCR request by P.Asangong for GVHD study. mc 3/22/2016","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5189599","version":"1","preferredName":"Human Activity Profile 9 Getting Clothes from Drawers or Closets 3 Point Scale","preferredDefinition":"Persons' stated observation of their ability to get clothes from drawers or closets, using a three point Likert scale.","longName":"HAP_Q9_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"HAP:Human Activity Profile. Daughton, DM and Fix, James, J Rehabil Res Dev. 41(4): 621-630, 1980.","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2EA41F07-FB14-ED3A-E050-BB89AD431A56","latestVersionIndicator":"Yes","beginDate":"2016-03-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-03-22","modifiedBy":"COOPERM","dateModified":"2016-03-24","changeNote":"Created for CCR request by P.Asangong for GVHD study. mc 3/22/2016","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5189600","version":"1","preferredName":"Human Activity Profile 10 Getting In or Out of a Car Without Assistance 3 Point Scale","preferredDefinition":"Persons' stated observation of their ability to get in or out of a car without assistance, using a three point Likert scale.","longName":"HAP_Q10_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"HAP:Human Activity Profile. Daughton, DM and Fix, James, J Rehabil Res Dev. 41(4): 621-630, 1980.","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2EA41F07-FB3B-ED3A-E050-BB89AD431A56","latestVersionIndicator":"Yes","beginDate":"2016-03-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-03-22","modifiedBy":"COOPERM","dateModified":"2016-03-24","changeNote":"Created for CCR request by P.Asangong for GVHD study. mc 3/22/2016","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5189611","version":"1","preferredName":"Human Activity Profile 11 Dining at a Restaurant 3 Point Scale","preferredDefinition":"Persons' stated observation of their ability to dine at a restaurant, using a three point Likert scale.","longName":"HAP_Q11_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"HAP:Human Activity Profile. Daughton, DM and Fix, James, J Rehabil Res Dev. 41(4): 621-630, 1980.","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2EA41F07-FB62-ED3A-E050-BB89AD431A56","latestVersionIndicator":"Yes","beginDate":"2016-03-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-03-22","modifiedBy":"COOPERM","dateModified":"2016-03-24","changeNote":"Created for CCR request by P.Asangong for GVHD study. mc 3/22/2016","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5189612","version":"1","preferredName":"Human Activity Profile 12 Playing Cards or Table Games 3 Point Scale","preferredDefinition":"Persons' stated observation of their ability to play cards or table games, using a three point Likert scale.","longName":"HAP_Q12_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"HAP:Human Activity Profile. Daughton, DM and Fix, James, J Rehabil Res Dev. 41(4): 621-630, 1980.","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2EA41F07-FB89-ED3A-E050-BB89AD431A56","latestVersionIndicator":"Yes","beginDate":"2016-03-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-03-22","modifiedBy":"COOPERM","dateModified":"2016-03-24","changeNote":"Created for CCR request by P.Asangong for GVHD study. mc 3/22/2016","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5189613","version":"1","preferredName":"Human Activity Profile 13 Bathing Without Assistance 3 Point Scale","preferredDefinition":"Persons' stated observation of their ability to take a bath (no assistance needed), using a three point Likert scale.","longName":"HAP_Q13_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"HAP:Human Activity Profile. Daughton, DM and Fix, James, J Rehabil Res Dev. 41(4): 621-630, 1980.","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2EA41F07-FBB0-ED3A-E050-BB89AD431A56","latestVersionIndicator":"Yes","beginDate":"2016-03-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-03-22","modifiedBy":"COOPERM","dateModified":"2016-03-24","changeNote":"Created for CCR request by P.Asangong for GVHD study. mc 3/22/2016","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5189614","version":"1","preferredName":"Human Activity Profile 14 Putting on Shoes Stockings or Socks Without Rest or a Break 3 Point Scale","preferredDefinition":"Persons' stated observation of their ability to put on shoes, stockings, or socks (no rest or break needed), using a three point Likert scale.","longName":"HAP_Q14_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"HAP:Human Activity Profile. Daughton, DM and Fix, James, J Rehabil Res Dev. 41(4): 621-630, 1980.","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2EA41F07-FBD7-ED3A-E050-BB89AD431A56","latestVersionIndicator":"Yes","beginDate":"2016-03-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-03-22","modifiedBy":"COOPERM","dateModified":"2016-03-24","changeNote":"Created for CCR request by P.Asangong for GVHD study. mc 3/22/2016","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5189615","version":"1","preferredName":"Human Activity Profile 15 Attending a Movie Play Church Event or Sports Activity 3 Point Scale","preferredDefinition":"Persons' stated observation of their ability to attend a movie, play, church event or sports activity, using a three point Likert scale.","longName":"HAP_Q15_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"HAP:Human Activity Profile. Daughton, DM and Fix, James, J Rehabil Res Dev. 41(4): 621-630, 1980.","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2EA41F07-FBFE-ED3A-E050-BB89AD431A56","latestVersionIndicator":"Yes","beginDate":"2016-03-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-03-22","modifiedBy":"COOPERM","dateModified":"2016-03-24","changeNote":"Created for CCR request by P.Asangong for GVHD study. mc 3/22/2016","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5189616","version":"1","preferredName":"Human Activity Profile 16 Walking 30 Yards 3 Point Scale","preferredDefinition":"Persons' stated observation of their ability to walk 30 yards (27 meters), using a three point Likert scale.","longName":"HAP_Q16_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"HAP:Human Activity Profile. Daughton, DM and Fix, James, J Rehabil Res Dev. 41(4): 621-630, 1980.","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2EA41F07-FC25-ED3A-E050-BB89AD431A56","latestVersionIndicator":"Yes","beginDate":"2016-03-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-03-22","modifiedBy":"COOPERM","dateModified":"2016-03-24","changeNote":"Created for CCR request by P.Asangong for GVHD study. mc 3/22/2016","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5189617","version":"1","preferredName":"Human Activity Profile 17 Walking 30 Yards Nonstop 3 Point Scale","preferredDefinition":"Persons' stated observation of their ability to walk 30 yards (nonstop), using a three point Likert scale.","longName":"HAP_Q17_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"HAP:Human Activity Profile. Daughton, DM and Fix, James, J Rehabil Res Dev. 41(4): 621-630, 1980.","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2EA41F07-FC4C-ED3A-E050-BB89AD431A56","latestVersionIndicator":"Yes","beginDate":"2016-03-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-03-22","modifiedBy":"COOPERM","dateModified":"2016-03-24","changeNote":"Created for CCR request by P.Asangong for GVHD study. mc 3/22/2016","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5189618","version":"1","preferredName":"Human Activity Profile 18 Dressing or Undressing Without Rest or a Break 3 Point Scale","preferredDefinition":"Persons' stated observation of their ability to dress or undress (no rest break needed), using a three point Likert scale.","longName":"HAP_Q18_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"HAP:Human Activity Profile. Daughton, DM and Fix, James, J Rehabil Res Dev. 41(4): 621-630, 1980.","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2EA41F07-FC73-ED3A-E050-BB89AD431A56","latestVersionIndicator":"Yes","beginDate":"2016-03-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-03-22","modifiedBy":"COOPERM","dateModified":"2016-03-24","changeNote":"Created for CCR request by P.Asangong for GVHD study. mc 3/22/2016","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5189619","version":"1","preferredName":"Human Activity Profile 19 Using Public Transport or Driving a Car 99 Miles or Less 3 Point Scale","preferredDefinition":"Persons' stated observation of their ability to use public transport or drive a car (99 miles or less), using a three point Likert scale.","longName":"HAP_Q19_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"HAP:Human Activity Profile. Daughton, DM and Fix, James, J Rehabil Res Dev. 41(4): 621-630, 1980.","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2EA41F07-FC9A-ED3A-E050-BB89AD431A56","latestVersionIndicator":"Yes","beginDate":"2016-03-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-03-22","modifiedBy":"COOPERM","dateModified":"2016-03-24","changeNote":"Created for CCR request by P.Asangong for GVHD study. mc 3/22/2016","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5189620","version":"1","preferredName":"Human Activity Profile 20 Using Public Transport or Driving a Car 100 Miles or More 3 Point Scale","preferredDefinition":"Persons' stated observation of their ability to use public transport or drive a car (100 miles or more), using a three point Likert scale.","longName":"HAP_Q20_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"HAP:Human Activity Profile. Daughton, DM and Fix, James, J Rehabil Res Dev. 41(4): 621-630, 1980.","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2EA41F07-FCC1-ED3A-E050-BB89AD431A56","latestVersionIndicator":"Yes","beginDate":"2016-03-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-03-22","modifiedBy":"COOPERM","dateModified":"2016-03-24","changeNote":"Created for CCR request by P.Asangong for GVHD study. mc 3/22/2016","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5189621","version":"1","preferredName":"Human Activity Profile 21 Cooking Your Own Meals 3 Point Scale","preferredDefinition":"Persons' stated observation of their ability to cook their own meals, using a three point Likert scale.","longName":"HAP_Q21_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"HAP:Human Activity Profile. Daughton, DM and Fix, James, J Rehabil Res Dev. 41(4): 621-630, 1980.","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2EA41F07-FCE8-ED3A-E050-BB89AD431A56","latestVersionIndicator":"Yes","beginDate":"2016-03-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-03-22","modifiedBy":"COOPERM","dateModified":"2016-03-24","changeNote":"Created for CCR request by P.Asangong for GVHD study. mc 3/22/2016","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5189622","version":"1","preferredName":"Human Activity Profile 22 Washing or Drying Dishes 3 Point Scale","preferredDefinition":"Persons' stated observation of their ability to wash or dry dishes, using a three point Likert scale.","longName":"HAP_Q22_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"HAP:Human Activity Profile. Daughton, DM and Fix, James, J Rehabil Res Dev. 41(4): 621-630, 1980.","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2EA41F07-FD0F-ED3A-E050-BB89AD431A56","latestVersionIndicator":"Yes","beginDate":"2016-03-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-03-22","modifiedBy":"COOPERM","dateModified":"2016-03-24","changeNote":"Created for CCR request by P.Asangong for GVHD study. mc 3/22/2016","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5189623","version":"1","preferredName":"Human Activity Profile 23 Putting Groceries on Shelves 3 Point Scale","preferredDefinition":"Persons' stated observation of their ability to put groceries on shelves, using a three point Likert scale.","longName":"HAP_Q23_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"HAP:Human Activity Profile. Daughton, DM and Fix, James, J Rehabil Res Dev. 41(4): 621-630, 1980.","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2EA41F07-FD36-ED3A-E050-BB89AD431A56","latestVersionIndicator":"Yes","beginDate":"2016-03-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-03-22","modifiedBy":"COOPERM","dateModified":"2016-03-24","changeNote":"Created for CCR request by P.Asangong for GVHD study. mc 3/22/2016","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5189624","version":"1","preferredName":"Human Activity Profile 24 Ironing or Folding Clothes 3 Point Scale","preferredDefinition":"Persons' stated observation of their ability to iron or fold clothes, using a three point Likert scale.","longName":"HAP_Q24_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"HAP:Human Activity Profile. Daughton, DM and Fix, James, J Rehabil Res Dev. 41(4): 621-630, 1980.","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2EA41F07-FD5D-ED3A-E050-BB89AD431A56","latestVersionIndicator":"Yes","beginDate":"2016-03-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-03-22","modifiedBy":"COOPERM","dateModified":"2016-03-24","changeNote":"Created for CCR request by P.Asangong for GVHD study. mc 3/22/2016","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5189625","version":"1","preferredName":"Human Activity Profile 25 Dusting or Polishing Furniture or a Polishing Car 3 Point Scale","preferredDefinition":"Persons' stated observation of their ability to dust or polish furniture or polish a car, using a three point Likert scale.","longName":"HAP_Q25_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"HAP:Human Activity Profile. Daughton, DM and Fix, James, J Rehabil Res Dev. 41(4): 621-630, 1980.","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2EA4C412-86F5-FF36-E050-BB89AD430568","latestVersionIndicator":"Yes","beginDate":"2016-03-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-03-22","modifiedBy":"COOPERM","dateModified":"2016-03-24","changeNote":"Created for CCR request by P.Asangong for GVHD study. mc 3/22/2016","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5189631","version":"1","preferredName":"Human Activity Profile 26 Showering 3 Point Scale","preferredDefinition":"Persons' stated observation of their ability to shower, using a three point Likert scale.","longName":"HAP_Q26_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"HAP:Human Activity Profile. Daughton, DM and Fix, James, J Rehabil Res Dev. 41(4): 621-630, 1980.","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2EA4C412-871C-FF36-E050-BB89AD430568","latestVersionIndicator":"Yes","beginDate":"2016-03-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-03-22","modifiedBy":"COOPERM","dateModified":"2016-03-24","changeNote":"Created for CCR request by P.Asangong for GVHD study. mc 3/22/2016","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5189632","version":"1","preferredName":"Human Activity Profile 27 Climbing 6 Steps 3 Point Scale","preferredDefinition":"Persons' stated observation of their ability to climb 6 steps, using a three point Likert scale.","longName":"HAP_Q27_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"HAP:Human Activity Profile. Daughton, DM and Fix, James, J Rehabil Res Dev. 41(4): 621-630, 1980.","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2EA4C412-8743-FF36-E050-BB89AD430568","latestVersionIndicator":"Yes","beginDate":"2016-03-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-03-22","modifiedBy":"COOPERM","dateModified":"2016-03-24","changeNote":"Created for CCR request by P.Asangong for GVHD study. mc 3/22/2016","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5189633","version":"1","preferredName":"Human Activity Profile 28 Climbing 6 Steps Nonstop 3 Point Scale","preferredDefinition":"Persons' stated observation of their ability to climb 6 steps nonstop, using a three point Likert scale.","longName":"HAP_Q28_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"HAP:Human Activity Profile. Daughton, DM and Fix, James, J Rehabil Res Dev. 41(4): 621-630, 1980.","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2EA41F07-FD84-ED3A-E050-BB89AD431A56","latestVersionIndicator":"Yes","beginDate":"2016-03-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-03-22","modifiedBy":"COOPERM","dateModified":"2016-03-24","changeNote":"Created for CCR request by P.Asangong for GVHD study. mc 3/22/2016","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5189634","version":"1","preferredName":"Human Activity Profile 29 Climbing 9 Steps 3 Point Scale","preferredDefinition":"Persons' stated observation of their ability to climb 9 steps, using a three point Likert scale.","longName":"HAP_Q29_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"HAP:Human Activity Profile. Daughton, DM and Fix, James, J Rehabil Res Dev. 41(4): 621-630, 1980.","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2EA41F07-FDAB-ED3A-E050-BB89AD431A56","latestVersionIndicator":"Yes","beginDate":"2016-03-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-03-22","modifiedBy":"COOPERM","dateModified":"2016-03-24","changeNote":"Created for CCR request by P.Asangong for GVHD study. mc 3/22/2016","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5189635","version":"1","preferredName":"Human Activity Profile 30 Climbing 12 Steps 3 Point Scale","preferredDefinition":"Persons' stated observation of their ability to climb 12 steps, using a three point Likert scale.","longName":"HAP_Q30_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"HAP:Human Activity Profile. Daughton, DM and Fix, James, J Rehabil Res Dev. 41(4): 621-630, 1980.","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2EA41F07-FDD2-ED3A-E050-BB89AD431A56","latestVersionIndicator":"Yes","beginDate":"2016-03-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-03-22","modifiedBy":"COOPERM","dateModified":"2016-03-24","changeNote":"Created for CCR request by P.Asangong for GVHD study. mc 3/22/2016","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5189636","version":"1","preferredName":"Human Activity Profile 31 Walking One Half Block on Level Ground 3 Point Scale","preferredDefinition":"Persons' stated observation of their ability to walk one half block on level ground, using a three point Likert scale.","longName":"HAP_Q31_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"HAP:Human Activity Profile. Daughton, DM and Fix, James, J Rehabil Res Dev. 41(4): 621-630, 1980.","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2EA41F07-FDF9-ED3A-E050-BB89AD431A56","latestVersionIndicator":"Yes","beginDate":"2016-03-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-03-22","modifiedBy":"COOPERM","dateModified":"2016-03-24","changeNote":"Created for CCR request by P.Asangong for GVHD study. mc 3/22/2016","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5189651","version":"1","preferredName":"Human Activity Profile 32 Walking One Half Block on Level Ground Nonstop 3 Point Scale","preferredDefinition":"Persons' stated observation of their ability to walk one half block on level ground nonstop, using a three point Likert scale.","longName":"HAP_Q32_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"HAP:Human Activity Profile. Daughton, DM and Fix, James, J Rehabil Res Dev. 41(4): 621-630, 1980.","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2EA54EC5-0171-254C-E050-BB89AD431352","latestVersionIndicator":"Yes","beginDate":"2016-03-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-03-22","modifiedBy":"COOPERM","dateModified":"2016-03-24","changeNote":"Created for CCR request by P.Asangong for GVHD study. mc 3/22/2016","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5189652","version":"1","preferredName":"Human Activity Profile 33 Ability to Make a Bed Not Changing Sheets 3 Point Scale","preferredDefinition":"Persons' stated observation of their ability to make a bed (not changing sheets), using a three point Likert scale.","longName":"HAP_Q33_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"HAP:Human Activity Profile. Daughton, DM and Fix, James, J Rehabil Res Dev. 41(4): 621-630, 1980.","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2EA54EC5-0198-254C-E050-BB89AD431352","latestVersionIndicator":"Yes","beginDate":"2016-03-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-03-22","modifiedBy":"COOPERM","dateModified":"2016-03-24","changeNote":"Created for CCR request by P.Asangong for GVHD study. mc 3/22/2016","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5189653","version":"1","preferredName":"Human Activity Profile 34 Cleaning Windows 3 Point Scale","preferredDefinition":"Persons' stated observation of their ability to clean windows, using a three point Likert scale.","longName":"HAP_Q34_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"HAP:Human Activity Profile. Daughton, DM and Fix, James, J Rehabil Res Dev. 41(4): 621-630, 1980.","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2EA54EC5-01BF-254C-E050-BB89AD431352","latestVersionIndicator":"Yes","beginDate":"2016-03-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-03-22","modifiedBy":"COOPERM","dateModified":"2016-03-24","changeNote":"Created for CCR request by P.Asangong for GVHD study. mc 3/22/2016","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5189654","version":"1","preferredName":"Human Activity Profile 35 Kneeling or Squatting to Do Light Work 3 Point Scale","preferredDefinition":"Persons' stated observation of their ability to kneel or squat to do light work, using a three point Likert scale.","longName":"HAP_Q35_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"HAP:Human Activity Profile. Daughton, DM and Fix, James, J Rehabil Res Dev. 41(4): 621-630, 1980.","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2EA54EC5-01E6-254C-E050-BB89AD431352","latestVersionIndicator":"Yes","beginDate":"2016-03-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-03-22","modifiedBy":"COOPERM","dateModified":"2016-03-24","changeNote":"Created for CCR request by P.Asangong for GVHD study. mc 3/22/2016","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5189671","version":"1","preferredName":"Human Activity Profile 36 Carrying a Light Load of Groceries 3 Point Scale","preferredDefinition":"Persons' stated observation of their ability to carry a light load of groceries, using a three point Likert scale.","longName":"HAP_Q36_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"HAP:Human Activity Profile. Daughton, DM and Fix, James, J Rehabil Res Dev. 41(4): 621-630, 1980.","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2EA58DEF-E031-946E-E050-BB89AD43300B","latestVersionIndicator":"Yes","beginDate":"2016-03-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-03-22","modifiedBy":"COOPERM","dateModified":"2016-03-24","changeNote":"Created for CCR request by P.Asangong for GVHD study. mc 3/22/2016","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5189672","version":"1","preferredName":"Human Activity Profile 37 Climbing 9 Steps Nonstop 3 Point Scale","preferredDefinition":"Persons' stated observation of their ability to climb 9 steps nonstop, using a three point Likert scale.","longName":"HAP_Q37_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"HAP:Human Activity Profile. Daughton, DM and Fix, James, J Rehabil Res Dev. 41(4): 621-630, 1980.","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2EA58DEF-E058-946E-E050-BB89AD43300B","latestVersionIndicator":"Yes","beginDate":"2016-03-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-03-22","modifiedBy":"COOPERM","dateModified":"2016-03-24","changeNote":"Created for CCR request by P.Asangong for GVHD study. mc 3/22/2016","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5189673","version":"1","preferredName":"Human Activity Profile 38 Climbing 12 Steps Nonstop 3 Point Scale","preferredDefinition":"Persons' stated observation of their ability to climb 12 steps nonstop, using a three point Likert scale.","longName":"HAP_Q38_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"HAP:Human Activity Profile. Daughton, DM and Fix, James, J Rehabil Res Dev. 41(4): 621-630, 1980.","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2EA58DEF-E080-946E-E050-BB89AD43300B","latestVersionIndicator":"Yes","beginDate":"2016-03-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-03-22","modifiedBy":"COOPERM","dateModified":"2016-03-24","changeNote":"Created for CCR request by P.Asangong for GVHD study. mc 3/22/2016","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5189674","version":"1","preferredName":"Human Activity Profile 39 Walking One Half Block Uphill 3 Point Scale","preferredDefinition":"Persons' stated observation of their ability to walk 1/2 block uphill, using a three point Likert scale.","longName":"HAP_Q39_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"HAP:Human Activity Profile. Daughton, DM and Fix, James, J Rehabil Res Dev. 41(4): 621-630, 1980.","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2EA58DEF-E0A7-946E-E050-BB89AD43300B","latestVersionIndicator":"Yes","beginDate":"2016-03-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-03-22","modifiedBy":"COOPERM","dateModified":"2016-03-24","changeNote":"Created for CCR request by P.Asangong for GVHD study. mc 3/22/2016","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5189675","version":"1","preferredName":"Human Activity Profile 40 Walking One Half Block Uphill Nonstop 3 Point Scale","preferredDefinition":"Persons' stated observation of their ability to walk 1/2 block uphill nonstop, using a three point Likert scale.","longName":"HAP_Q40_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"HAP:Human Activity Profile. Daughton, DM and Fix, James, J Rehabil Res Dev. 41(4): 621-630, 1980.","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2EA58DEF-E0D1-946E-E050-BB89AD43300B","latestVersionIndicator":"Yes","beginDate":"2016-03-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-03-22","modifiedBy":"COOPERM","dateModified":"2016-03-24","changeNote":"Created for CCR request by P.Asangong for GVHD study. mc 3/22/2016","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5189676","version":"1","preferredName":"Human Activity Profile 41 Shopping by Yourself 3 Point Scale","preferredDefinition":"Persons' stated observation of their ability to shop by themselves, using a three point Likert scale.","longName":"HAP_Q41_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"HAP:Human Activity Profile. Daughton, DM and Fix, James, J Rehabil Res Dev. 41(4): 621-630, 1980.","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2EA58DEF-E0F8-946E-E050-BB89AD43300B","latestVersionIndicator":"Yes","beginDate":"2016-03-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-03-22","modifiedBy":"COOPERM","dateModified":"2016-03-24","changeNote":"Created for CCR request by P.Asangong for GVHD study. mc 3/22/2016","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5189677","version":"1","preferredName":"Human Activity Profile 42 Washing Clothes by Yourself 3 Point Scale","preferredDefinition":"Persons' stated observation of their ability to wash clothes by themselves, using a three point Likert scale.","longName":"HAP_Q42_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"HAP:Human Activity Profile. Daughton, DM and Fix, James, J Rehabil Res Dev. 41(4): 621-630, 1980.","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2EA58DEF-E122-946E-E050-BB89AD43300B","latestVersionIndicator":"Yes","beginDate":"2016-03-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-03-22","modifiedBy":"COOPERM","dateModified":"2016-03-24","changeNote":"Created for CCR request by P.Asangong for GVHD study. mc 3/22/2016","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5189691","version":"1","preferredName":"Human Activity Profile 43 Walking 1 Block on Level Ground 3 Point Scale","preferredDefinition":"Persons' stated observation of their ability to walk 1 block on level ground, using a three point Likert scale.","longName":"HAP_Q43_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"HAP:Human Activity Profile. Daughton, DM and Fix, James, J Rehabil Res Dev. 41(4): 621-630, 1980.","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2EA5C742-3B2D-1C28-E050-BB89AD431E84","latestVersionIndicator":"Yes","beginDate":"2016-03-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-03-22","modifiedBy":"COOPERM","dateModified":"2016-03-24","changeNote":"Created for CCR request by P.Asangong for GVHD study. mc 3/22/2016","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5189692","version":"1","preferredName":"Human Activity Profile 44 Walking 2 Blocks on Level Ground 3 Point Scale","preferredDefinition":"Persons' stated observation of their ability to walk 2 block on level ground, using a three point Likert scale.","longName":"HAP_Q44_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"HAP:Human Activity Profile. Daughton, DM and Fix, James, J Rehabil Res Dev. 41(4): 621-630, 1980.","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2EA58DEF-E149-946E-E050-BB89AD43300B","latestVersionIndicator":"Yes","beginDate":"2016-03-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-03-22","modifiedBy":"COOPERM","dateModified":"2016-03-24","changeNote":"Created for CCR request by P.Asangong for GVHD study. mc 3/22/2016","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5189693","version":"1","preferredName":"Human Activity Profile 45 Walking 1 Block on Level Ground Nonstop 3 Point Scale","preferredDefinition":"Persons' stated observation of their ability to walk 1 block on level ground (nonstop), using a three point Likert scale.","longName":"HAP_Q45_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"HAP:Human Activity Profile. Daughton, DM and Fix, James, J Rehabil Res Dev. 41(4): 621-630, 1980.","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2EA58DEF-E170-946E-E050-BB89AD43300B","latestVersionIndicator":"Yes","beginDate":"2016-03-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-03-22","modifiedBy":"COOPERM","dateModified":"2016-03-24","changeNote":"Created for CCR request by P.Asangong for GVHD study. mc 3/22/2016","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5189694","version":"1","preferredName":"Human Activity Profile 46 Walking 2 Blocks on Level Ground Nonstop 3 Point Scale","preferredDefinition":"Persons' stated observation of their ability to walk 2 blocks on level ground (nonstop), using a three point Likert scale.","longName":"HAP_Q46_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"HAP:Human Activity Profile. Daughton, DM and Fix, James, J Rehabil Res Dev. 41(4): 621-630, 1980.","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2EA5C742-3B54-1C28-E050-BB89AD431E84","latestVersionIndicator":"Yes","beginDate":"2016-03-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-03-22","modifiedBy":"COOPERM","dateModified":"2016-03-24","changeNote":"Created for CCR request by P.Asangong for GVHD study. mc 3/22/2016","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5189697","version":"1","preferredName":"Human Activity Profile 47 Scrubbing Doors Walls or Cars 3 Point Scale","preferredDefinition":"Persons' stated observation of their ability to scrub (doors, walls, or cars), using a three point Likert scale.","longName":"HAP_Q47_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"HAP:Human Activity Profile. Daughton, DM and Fix, James, J Rehabil Res Dev. 41(4): 621-630, 1980.","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2EA58DEF-E197-946E-E050-BB89AD43300B","latestVersionIndicator":"Yes","beginDate":"2016-03-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-03-22","modifiedBy":"COOPERM","dateModified":"2016-03-24","changeNote":"Created for CCR request by P.Asangong for GVHD study. mc 3/22/2016","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5189698","version":"1","preferredName":"Human Activity Profile 48 Making a Bed and Changing Sheets 3 Point Scale","preferredDefinition":"Persons' stated observation of their ability to make a bed (change sheets), using a three point Likert scale.","longName":"HAP_Q48_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"HAP:Human Activity Profile. Daughton, DM and Fix, James, J Rehabil Res Dev. 41(4): 621-630, 1980.","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2EA58DEF-E1BE-946E-E050-BB89AD43300B","latestVersionIndicator":"Yes","beginDate":"2016-03-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-03-22","modifiedBy":"COOPERM","dateModified":"2016-03-24","changeNote":"Created for CCR request by P.Asangong for GVHD study. mc 3/22/2016","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5189703","version":"1","preferredName":"Human Activity Profile 49 Sweeping 3 Point Scale","preferredDefinition":"Persons' stated observation of their ability to sweep, using a three point Likert scale.","longName":"HAP_Q49_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"HAP:Human Activity Profile. Daughton, DM and Fix, James, J Rehabil Res Dev. 41(4): 621-630, 1980.","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2EA5C742-3BBB-1C28-E050-BB89AD431E84","latestVersionIndicator":"Yes","beginDate":"2016-03-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-03-22","modifiedBy":"COOPERM","dateModified":"2016-03-24","changeNote":"Created for CCR request by P.Asangong for GVHD study. mc 3/22/2016","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5189704","version":"1","preferredName":"Human Activity Profile 50 Sweeping 5 Minutes Nonstop 3 Point Scale","preferredDefinition":"Persons' stated observation of their ability to sweep (5 minutes nonstop), using a three point Likert scale.","longName":"HAP_Q50_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"HAP:Human Activity Profile. Daughton, DM and Fix, James, J Rehabil Res Dev. 41(4): 621-630, 1980.","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2EA58DEF-E246-946E-E050-BB89AD43300B","latestVersionIndicator":"Yes","beginDate":"2016-03-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-03-22","modifiedBy":"COOPERM","dateModified":"2016-03-24","changeNote":"Created for CCR request by P.Asangong for GVHD study. mc 3/22/2016","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5189705","version":"1","preferredName":"Human Activity Profile 51 Carrying a Large Suitcase or Bowling 1 Game 3 Point Scale","preferredDefinition":"Persons' stated observation of their ability to carry a large suitcase or bowl (1 game), using a three point Likert scale.","longName":"HAP_Q51_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"HAP:Human Activity Profile. Daughton, DM and Fix, James, J Rehabil Res Dev. 41(4): 621-630, 1980.","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2EA58DEF-E26D-946E-E050-BB89AD43300B","latestVersionIndicator":"Yes","beginDate":"2016-03-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-03-22","modifiedBy":"COOPERM","dateModified":"2016-03-24","changeNote":"Created for CCR request by P.Asangong for GVHD study. mc 3/22/2016","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5189706","version":"1","preferredName":"Human Activity Profile 52 Vacuuming Carpets 3 Point Scale","preferredDefinition":"Persons' stated observation of their ability to vacuum carpets, using a three point Likert scale.","longName":"HAP_Q52_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"HAP:Human Activity Profile. Daughton, DM and Fix, James, J Rehabil Res Dev. 41(4): 621-630, 1980.","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2EA58DEF-E294-946E-E050-BB89AD43300B","latestVersionIndicator":"Yes","beginDate":"2016-03-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-03-22","modifiedBy":"COOPERM","dateModified":"2016-03-24","changeNote":"Created for CCR request by P.Asangong for GVHD study. mc 3/22/2016","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5189774","version":"1","preferredName":"Human Activity Profile 53 Vacuuming Carpets 5 Minutes Nonstop 3 Point Scale","preferredDefinition":"Persons' stated observation of their ability to vacuum carpets (5 minutes nonstop), using a three point Likert scale.","longName":"HAP_Q53_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"HAP:Human Activity Profile. Daughton, DM and Fix, James, J Rehabil Res Dev. 41(4): 621-630, 1980.","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2EA77499-AB73-8F11-E050-BB89AD433367","latestVersionIndicator":"Yes","beginDate":"2016-03-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-03-22","modifiedBy":"COOPERM","dateModified":"2016-03-24","changeNote":"Created for CCR request by P.Asangong for GVHD study. mc 3/22/2016","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5189775","version":"1","preferredName":"Human Activity Profile 54 House Painting 3 Point Scale","preferredDefinition":"Persons' stated observation of their ability to paint (interior or exterior), using a three point Likert scale.","longName":"HAP_Q54_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"HAP:Human Activity Profile. Daughton, DM and Fix, James, J Rehabil Res Dev. 41(4): 621-630, 1980.","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2EA7AF59-01F0-4BB2-E050-BB89AD4379DC","latestVersionIndicator":"Yes","beginDate":"2016-03-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-03-22","modifiedBy":"COOPERM","dateModified":"2016-03-24","changeNote":"Created for CCR request by P.Asangong for GVHD study. mc 3/22/2016","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5189776","version":"1","preferredName":"Human Activity Profile 55 Walking 6 Blocks on Level Ground 3 Point Scale","preferredDefinition":"Persons' stated observation of their ability to walk 6 blocks on level ground, using a three point Likert scale.","longName":"HAP_Q55_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"HAP:Human Activity Profile. Daughton, DM and Fix, James, J Rehabil Res Dev. 41(4): 621-630, 1980.","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2EA7AF59-0217-4BB2-E050-BB89AD4379DC","latestVersionIndicator":"Yes","beginDate":"2016-03-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-03-22","modifiedBy":"COOPERM","dateModified":"2016-03-24","changeNote":"Created for CCR request by P.Asangong for GVHD study. mc 3/22/2016","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5189778","version":"1","preferredName":"Human Activity Profile 56 Walking 6 Blocks on Level Ground Nonstop 3 Point Scale","preferredDefinition":"Persons' stated observation of their ability to walk 6 blocks on level ground (nonstop), using a three point Likert scale.","longName":"HAP_Q56_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"HAP:Human Activity Profile. Daughton, DM and Fix, James, J Rehabil Res Dev. 41(4): 621-630, 1980.","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2EA7AF59-027D-4BB2-E050-BB89AD4379DC","latestVersionIndicator":"Yes","beginDate":"2016-03-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-03-22","modifiedBy":"COOPERM","dateModified":"2016-03-24","changeNote":"Created for CCR request by P.Asangong for GVHD study. mc 3/22/2016","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5189792","version":"1","preferredName":"Human Activity Profile 57 Carrying Out the Garbage 3 Point Scale","preferredDefinition":"Persons' stated observation of their ability to carry out the garbage, using a three point Likert scale.","longName":"HAP_Q57_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"HAP:Human Activity Profile. Daughton, DM and Fix, James, J Rehabil Res Dev. 41(4): 621-630, 1980.","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2EA77499-AB9E-8F11-E050-BB89AD433367","latestVersionIndicator":"Yes","beginDate":"2016-03-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-03-22","modifiedBy":"COOPERM","dateModified":"2016-03-24","changeNote":"Created for CCR request by P.Asangong for GVHD study. mc 3/22/2016","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5189793","version":"1","preferredName":"Human Activity Profile 58 Carrying a Heavy Load of Groceries 3 Point Scale","preferredDefinition":"Persons' stated observation of their ability to carry a heavy load of groceries, using a three point Likert scale.","longName":"HAP_Q58_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"HAP:Human Activity Profile. Daughton, DM and Fix, James, J Rehabil Res Dev. 41(4): 621-630, 1980.","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2EA77499-ABC5-8F11-E050-BB89AD433367","latestVersionIndicator":"Yes","beginDate":"2016-03-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-03-22","modifiedBy":"COOPERM","dateModified":"2016-03-24","changeNote":"Created for CCR request by P.Asangong for GVHD study. mc 3/22/2016","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5189794","version":"1","preferredName":"Human Activity Profile 59 Climbing 24 Steps 3 Point Scale","preferredDefinition":"Persons' stated observation of their ability to climb 24 steps, using a three point Likert scale.","longName":"HAP_Q59_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"HAP:Human Activity Profile. Daughton, DM and Fix, James, J Rehabil Res Dev. 41(4): 621-630, 1980.","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2EA77499-ABEC-8F11-E050-BB89AD433367","latestVersionIndicator":"Yes","beginDate":"2016-03-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-03-22","modifiedBy":"COOPERM","dateModified":"2016-03-24","changeNote":"Created for CCR request by P.Asangong for GVHD study. mc 3/22/2016","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5189795","version":"1","preferredName":"Human Activity Profile 60 Climbing 36 Steps 3 Point Scale","preferredDefinition":"Persons' stated observation of their ability to climb 36 steps, using a three point Likert scale.","longName":"HAP_Q60_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"HAP:Human Activity Profile. Daughton, DM and Fix, James, J Rehabil Res Dev. 41(4): 621-630, 1980.","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2EA77499-AC13-8F11-E050-BB89AD433367","latestVersionIndicator":"Yes","beginDate":"2016-03-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-03-22","modifiedBy":"COOPERM","dateModified":"2016-03-24","changeNote":"Created for CCR request by P.Asangong for GVHD study. mc 3/22/2016","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5189796","version":"1","preferredName":"Human Activity Profile 61 Climbing 24 Steps Nonstop 3 Point Scale","preferredDefinition":"Persons' stated observation of their ability to climb 24 steps (nonstop), using a three point Likert scale.","longName":"HAP_Q61_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"HAP:Human Activity Profile. Daughton, DM and Fix, James, J Rehabil Res Dev. 41(4): 621-630, 1980.","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2EA77499-AC3A-8F11-E050-BB89AD433367","latestVersionIndicator":"Yes","beginDate":"2016-03-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-03-22","modifiedBy":"COOPERM","dateModified":"2016-03-24","changeNote":"Created for CCR request by P.Asangong for GVHD study. mc 3/22/2016","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5189797","version":"1","preferredName":"Human Activity Profile 62 Climbing 36 Steps Nonstop 3 Point Scale","preferredDefinition":"Persons' stated observation of their ability to climb 36 steps (nonstop), using a three point Likert scale.","longName":"HAP_Q62_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"HAP:Human Activity Profile. Daughton, DM and Fix, James, J Rehabil Res Dev. 41(4): 621-630, 1980.","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2EA77499-AC61-8F11-E050-BB89AD433367","latestVersionIndicator":"Yes","beginDate":"2016-03-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-03-22","modifiedBy":"COOPERM","dateModified":"2016-03-24","changeNote":"Created for CCR request by P.Asangong for GVHD study. mc 3/22/2016","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5189798","version":"1","preferredName":"Human Activity Profile 63 Walking 1 Mile 3 Point Scale","preferredDefinition":"Persons' stated observation of their ability to walk 1 mile, using a three point Likert scale.","longName":"HAP_Q63_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"HAP:Human Activity Profile. Daughton, DM and Fix, James, J Rehabil Res Dev. 41(4): 621-630, 1980.","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2EA77499-AC88-8F11-E050-BB89AD433367","latestVersionIndicator":"Yes","beginDate":"2016-03-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-03-22","modifiedBy":"COOPERM","dateModified":"2016-03-24","changeNote":"Created for CCR request by P.Asangong for GVHD study. mc 3/22/2016","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5189799","version":"1","preferredName":"Human Activity Profile 64 Walking 1 Mile Nonstop 3 Point Scale","preferredDefinition":"Persons' stated observation of their ability to walk 1 mile (nonstop), using a three point Likert scale.","longName":"HAP_Q64_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"HAP:Human Activity Profile. Daughton, DM and Fix, James, J Rehabil Res Dev. 41(4): 621-630, 1980.","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2EA77499-ACAF-8F11-E050-BB89AD433367","latestVersionIndicator":"Yes","beginDate":"2016-03-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-03-22","modifiedBy":"COOPERM","dateModified":"2016-03-24","changeNote":"Created for CCR request by P.Asangong for GVHD study. mc 3/22/2016","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5189800","version":"1","preferredName":"Human Activity Profile 65 Running 110 Yards or Playing Softball or Baseball 3 Point Scale","preferredDefinition":"Persons' stated observation of their ability to run 110 yards (100 meters) or play softball/baseball, using a three point Likert scale.","longName":"HAP_Q65_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"HAP:Human Activity Profile. Daughton, DM and Fix, James, J Rehabil Res Dev. 41(4): 621-630, 1980.","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2EA80074-9FA0-E8D9-E050-BB89AD437871","latestVersionIndicator":"Yes","beginDate":"2016-03-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-03-22","modifiedBy":"COOPERM","dateModified":"2016-03-24","changeNote":"Created for CCR request by P.Asangong for GVHD study. mc 3/22/2016","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5189811","version":"1","preferredName":"Human Activity Profile 66 Social Dancing 3 Point Scale","preferredDefinition":"Persons' stated observation of their ability to dance (social), using a three point Likert scale.","longName":"HAP_Q66_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"HAP:Human Activity Profile. Daughton, DM and Fix, James, J Rehabil Res Dev. 41(4): 621-630, 1980.","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2EA90933-781C-5399-E050-BB89AD432C9F","latestVersionIndicator":"Yes","beginDate":"2016-03-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-03-22","modifiedBy":"COOPERM","dateModified":"2016-03-24","changeNote":"Created for CCR request by P.Asangong for GVHD study. mc 3/22/2016","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5189812","version":"1","preferredName":"Human Activity Profile 67 Doing Calisthenics or Aerobic Dancing 5 Minutes Nonstop 3 Point Scale","preferredDefinition":"Persons' stated observation of their ability to do calisthenics or aerobic dancing (5 minutes nonstop), using a three point Likert scale.","longName":"HAP_Q67_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"HAP:Human Activity Profile. Daughton, DM and Fix, James, J Rehabil Res Dev. 41(4): 621-630, 1980.","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2EA90933-7843-5399-E050-BB89AD432C9F","latestVersionIndicator":"Yes","beginDate":"2016-03-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-03-22","modifiedBy":"COOPERM","dateModified":"2016-03-24","changeNote":"Created for CCR request by P.Asangong for GVHD study. mc 3/22/2016","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5189813","version":"1","preferredName":"Human Activity Profile 68 Mowing The Lawn with a Power Mower 3 Point Scale","preferredDefinition":"Persons' stated observation of their ability to mow the lawn (power mower, not a riding mower), using a three point Likert scale.","longName":"HAP_Q68_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"HAP:Human Activity Profile. Daughton, DM and Fix, James, J Rehabil Res Dev. 41(4): 621-630, 1980.","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2EA90933-786A-5399-E050-BB89AD432C9F","latestVersionIndicator":"Yes","beginDate":"2016-03-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-03-22","modifiedBy":"COOPERM","dateModified":"2016-03-24","changeNote":"Created for CCR request by P.Asangong for GVHD study. mc 3/22/2016","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5189814","version":"1","preferredName":"Human Activity Profile 69 Walking 2 Miles 3 Point Scale","preferredDefinition":"Persons' stated observation of their ability to walk 2 miles, using a three point Likert scale.","longName":"HAP_Q69_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"HAP:Human Activity Profile. Daughton, DM and Fix, James, J Rehabil Res Dev. 41(4): 621-630, 1980.","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2EA90933-7897-5399-E050-BB89AD432C9F","latestVersionIndicator":"Yes","beginDate":"2016-03-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-03-22","modifiedBy":"COOPERM","dateModified":"2016-03-24","changeNote":"Created for CCR request by P.Asangong for GVHD study. mc 3/22/2016","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5189815","version":"1","preferredName":"Human Activity Profile 70 Walking 2 Miles Nonstop 3 Point Scale","preferredDefinition":"Persons' stated observation of their ability to walk 2 miles (nonstop), using a three point Likert scale.","longName":"HAP_Q70_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"HAP:Human Activity Profile. Daughton, DM and Fix, James, J Rehabil Res Dev. 41(4): 621-630, 1980.","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2EA90933-78BE-5399-E050-BB89AD432C9F","latestVersionIndicator":"Yes","beginDate":"2016-03-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-03-22","modifiedBy":"COOPERM","dateModified":"2016-03-24","changeNote":"Created for CCR request by P.Asangong for GVHD study. mc 3/22/2016","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5189816","version":"1","preferredName":"Human Activity Profile 71 Climbing 50 Steps or Two and One Half Floors 3 Point Scale","preferredDefinition":"Persons' stated observation of their ability to climb 50 steps (2 1/2 floors), using a three point Likert scale.","longName":"HAP_Q71_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"HAP:Human Activity Profile. Daughton, DM and Fix, James, J Rehabil Res Dev. 41(4): 621-630, 1980.","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2EA90933-78E5-5399-E050-BB89AD432C9F","latestVersionIndicator":"Yes","beginDate":"2016-03-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-03-22","modifiedBy":"COOPERM","dateModified":"2016-03-24","changeNote":"Created for CCR request by P.Asangong for GVHD study. mc 3/22/2016","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5189817","version":"1","preferredName":"Human Activity Profile 72 Shoveling Digging or Spading 3 Point Scale","preferredDefinition":"Persons' stated observation of their ability to shovel, dig, or spade, using a three point Likert scale.","longName":"HAP_Q72_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"HAP:Human Activity Profile. Daughton, DM and Fix, James, J Rehabil Res Dev. 41(4): 621-630, 1980.","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2EA90933-790C-5399-E050-BB89AD432C9F","latestVersionIndicator":"Yes","beginDate":"2016-03-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-03-22","modifiedBy":"COOPERM","dateModified":"2016-03-24","changeNote":"Created for CCR request by P.Asangong for GVHD study. mc 3/22/2016","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5189818","version":"1","preferredName":"Human Activity Profile 73 Shoveling Digging or Spading 5 Minutes Nonstop 3 Point Scale","preferredDefinition":"Persons' stated observation of their ability to shovel, dig, or spade (5 minutes nonstop), using a three point Likert scale.","longName":"HAP_Q73_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"HAP:Human Activity Profile. Daughton, DM and Fix, James, J Rehabil Res Dev. 41(4): 621-630, 1980.","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2EA90933-7933-5399-E050-BB89AD432C9F","latestVersionIndicator":"Yes","beginDate":"2016-03-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-03-22","modifiedBy":"COOPERM","dateModified":"2016-03-24","changeNote":"Created for CCR request by P.Asangong for GVHD study. mc 3/22/2016","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5189819","version":"1","preferredName":"Human Activity Profile 74 Climbing 50 Steps Nonstop 3 Point Scale","preferredDefinition":"Persons' stated observation of their ability to climb 50 steps (nonstop), using a three point Likert scale.","longName":"HAP_Q74_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"HAP:Human Activity Profile. Daughton, DM and Fix, James, J Rehabil Res Dev. 41(4): 621-630, 1980.","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2EA90933-795A-5399-E050-BB89AD432C9F","latestVersionIndicator":"Yes","beginDate":"2016-03-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-03-22","modifiedBy":"COOPERM","dateModified":"2016-03-24","changeNote":"Created for CCR request by P.Asangong for GVHD study. mc 3/22/2016","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5189820","version":"1","preferredName":"Human Activity Profile 75 Walking 3 Miles or Golfing 18 Holes Without a Riding Cart 3 Point Scale","preferredDefinition":"Persons' stated observation of their ability to walk 3 miles or golf 18 holes without a riding cart, using a three point Likert scale.","longName":"HAP_Q75_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"HAP:Human Activity Profile. Daughton, DM and Fix, James, J Rehabil Res Dev. 41(4): 621-630, 1980.","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2EA90933-7981-5399-E050-BB89AD432C9F","latestVersionIndicator":"Yes","beginDate":"2016-03-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-03-22","modifiedBy":"COOPERM","dateModified":"2016-03-24","changeNote":"Created for CCR request by P.Asangong for GVHD study. mc 3/22/2016","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5189821","version":"1","preferredName":"Human Activity Profile 76 Walking 3 Miles Nonstop 3 Point Scale","preferredDefinition":"Persons' stated observation of their ability to walk 3 miles (nonstop), using a three point Likert scale.","longName":"HAP_Q76_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"HAP:Human Activity Profile. Daughton, DM and Fix, James, J Rehabil Res Dev. 41(4): 621-630, 1980.","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2EA90933-79A8-5399-E050-BB89AD432C9F","latestVersionIndicator":"Yes","beginDate":"2016-03-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-03-22","modifiedBy":"COOPERM","dateModified":"2016-03-24","changeNote":"Created for CCR request by P.Asangong for GVHD study. mc 3/22/2016","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5189822","version":"1","preferredName":"Human Activity Profile 77 Swimming 25 Yards 3 Point Scale","preferredDefinition":"Persons' stated observation of their ability to swim 25 yards, using a three point Likert scale.","longName":"HAP_Q77_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"HAP:Human Activity Profile. Daughton, DM and Fix, James, J Rehabil Res Dev. 41(4): 621-630, 1980.","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2EA90933-79CF-5399-E050-BB89AD432C9F","latestVersionIndicator":"Yes","beginDate":"2016-03-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-03-22","modifiedBy":"COOPERM","dateModified":"2016-03-24","changeNote":"Created for CCR request by P.Asangong for GVHD study. mc 3/22/2016","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5189823","version":"1","preferredName":"Human Activity Profile 78 Swimming 25 Yards Nonstop 3 Point Scale 3 Point Scale","preferredDefinition":"Persons' stated observation of their ability to swim 25 yards (nonstop), using a three point Likert scale.","longName":"HAP_Q78_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"HAP:Human Activity Profile. Daughton, DM and Fix, James, J Rehabil Res Dev. 41(4): 621-630, 1980.","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2EA90933-79F6-5399-E050-BB89AD432C9F","latestVersionIndicator":"Yes","beginDate":"2016-03-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-03-22","modifiedBy":"COOPERM","dateModified":"2016-03-24","changeNote":"Created for CCR request by P.Asangong for GVHD study. mc 3/22/2016","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5189824","version":"1","preferredName":"Human Activity Profile 79 Bicycling 1 Mile 3 Point Scale","preferredDefinition":"Persons' stated observation of their ability to bicycle 1 mile, using a three point Likert scale.","longName":"HAP_Q79_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"HAP:Human Activity Profile. Daughton, DM and Fix, James, J Rehabil Res Dev. 41(4): 621-630, 1980.","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2EA90933-7A1D-5399-E050-BB89AD432C9F","latestVersionIndicator":"Yes","beginDate":"2016-03-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-03-22","modifiedBy":"COOPERM","dateModified":"2016-03-24","changeNote":"Created for CCR request by P.Asangong for GVHD study. mc 3/22/2016","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5189825","version":"1","preferredName":"Human Activity Profile 80 Bicycling 2 Miles 3 Point Scale","preferredDefinition":"Persons' stated observation of their ability to bicycle 2 miles, using a three point Likert scale.","longName":"HAP_Q80_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"HAP:Human Activity Profile. Daughton, DM and Fix, James, J Rehabil Res Dev. 41(4): 621-630, 1980.","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2EA90933-7A44-5399-E050-BB89AD432C9F","latestVersionIndicator":"Yes","beginDate":"2016-03-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-03-22","modifiedBy":"COOPERM","dateModified":"2016-03-24","changeNote":"Created for CCR request by P.Asangong for GVHD study. mc 3/22/2016","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5189826","version":"1","preferredName":"Human Activity Profile 81 Bicycling 1 Mile Nonstop 3 Point Scale","preferredDefinition":"Persons' stated observation of their ability to bicycle 1 mile (nonstop), using a three point Likert scale.","longName":"HAP_Q81_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"HAP:Human Activity Profile. Daughton, DM and Fix, James, J Rehabil Res Dev. 41(4): 621-630, 1980.","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2EA90933-7A6B-5399-E050-BB89AD432C9F","latestVersionIndicator":"Yes","beginDate":"2016-03-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-03-22","modifiedBy":"COOPERM","dateModified":"2016-03-24","changeNote":"Created for CCR request by P.Asangong for GVHD study. mc 3/22/2016","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5189827","version":"1","preferredName":"Human Activity Profile 82 Bicycling 2 Miles Nonstop 3 Point Scale","preferredDefinition":"Persons' stated observation of their ability to bicycle 2 miles (nonstop), using a three point Likert scale.","longName":"HAP_Q82_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"HAP:Human Activity Profile. Daughton, DM and Fix, James, J Rehabil Res Dev. 41(4): 621-630, 1980.","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2EA90933-7A92-5399-E050-BB89AD432C9F","latestVersionIndicator":"Yes","beginDate":"2016-03-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-03-22","modifiedBy":"COOPERM","dateModified":"2016-03-24","changeNote":"Created for CCR request by P.Asangong for GVHD study. mc 3/22/2016","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5189828","version":"1","preferredName":"Human Activity Profile 83 Running or Jogging One Quarter Mile 3 Point Scale","preferredDefinition":"Persons' stated observation of their ability to run or jog 1/2 mile, using a three point Likert scale.","longName":"HAP_Q83_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"HAP:Human Activity Profile. Daughton, DM and Fix, James, J Rehabil Res Dev. 41(4): 621-630, 1980.","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2EA90933-7AB9-5399-E050-BB89AD432C9F","latestVersionIndicator":"Yes","beginDate":"2016-03-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-03-22","modifiedBy":"COOPERM","dateModified":"2016-03-24","changeNote":"Created for CCR request by P.Asangong for GVHD study. mc 3/22/2016","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5189829","version":"1","preferredName":"Human Activity Profile 84 Running or Jogging One Half Mile 3 Point Scale","preferredDefinition":"Persons' stated observation of their ability to run or jog 1/2 mile, using a three point Likert scale.","longName":"HAP_Q84_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"HAP:Human Activity Profile. Daughton, DM and Fix, James, J Rehabil Res Dev. 41(4): 621-630, 1980.","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2EA90933-7AE0-5399-E050-BB89AD432C9F","latestVersionIndicator":"Yes","beginDate":"2016-03-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-03-22","modifiedBy":"COOPERM","dateModified":"2016-03-24","changeNote":"Created for CCR request by P.Asangong for GVHD study. mc 3/22/2016","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5189830","version":"1","preferredName":"Human Activity Profile 85 Playing Tennis or Racquetball 3 Point Scale","preferredDefinition":"Persons' stated observation of their ability to play tennis or racquetball, using a three point Likert scale.","longName":"HAP_Q85_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"HAP:Human Activity Profile. Daughton, DM and Fix, James, J Rehabil Res Dev. 41(4): 621-630, 1980.","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2EA90933-7B07-5399-E050-BB89AD432C9F","latestVersionIndicator":"Yes","beginDate":"2016-03-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-03-22","modifiedBy":"COOPERM","dateModified":"2016-03-24","changeNote":"Created for CCR request by P.Asangong for GVHD study. mc 3/22/2016","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5189831","version":"1","preferredName":"Human Activity Profile 86 Playing a Basketball or Soccer Game 3 Point Scale","preferredDefinition":"Persons' stated observation of their ability to play basketball/soccer (game play), using a three point Likert scale.","longName":"HAP_Q86_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"HAP:Human Activity Profile. Daughton, DM and Fix, James, J Rehabil Res Dev. 41(4): 621-630, 1980.","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2EA90933-7B2F-5399-E050-BB89AD432C9F","latestVersionIndicator":"Yes","beginDate":"2016-03-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-03-22","modifiedBy":"COOPERM","dateModified":"2016-03-24","changeNote":"Created for CCR request by P.Asangong for GVHD study. mc 3/22/2016","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5189832","version":"1","preferredName":"Human Activity Profile 87 Running or Jogging One Quarter Mile Nonstop 3 Point Scale","preferredDefinition":"Persons' stated observation of their ability to run or jog 1/4 mile (nonstop), using a three point Likert scale.","longName":"HAP_Q87_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"HAP:Human Activity Profile. Daughton, DM and Fix, James, J Rehabil Res Dev. 41(4): 621-630, 1980.","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2EA90933-7B56-5399-E050-BB89AD432C9F","latestVersionIndicator":"Yes","beginDate":"2016-03-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-03-22","modifiedBy":"COOPERM","dateModified":"2016-03-24","changeNote":"Created for CCR request by P.Asangong for GVHD study. mc 3/22/2016","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5189833","version":"1","preferredName":"Human Activity Profile 88 Running or Jogging One Half Mile Nonstop 3 Point Scale","preferredDefinition":"Persons' stated observation of their ability to run or jog 1/2 mile (nonstop), using a three point Likert scale.","longName":"HAP_Q88_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"HAP:Human Activity Profile. Daughton, DM and Fix, James, J Rehabil Res Dev. 41(4): 621-630, 1980.","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2EA90933-7B7D-5399-E050-BB89AD432C9F","latestVersionIndicator":"Yes","beginDate":"2016-03-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-03-22","modifiedBy":"COOPERM","dateModified":"2016-03-24","changeNote":"Created for CCR request by P.Asangong for GVHD study. mc 3/22/2016","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5189834","version":"1","preferredName":"Human Activity Profile 89 Running or Jogging 1 Mile 3 Point Scale","preferredDefinition":"Persons' stated observation of their ability to run or jog 1 mile, using a three point Likert scale.","longName":"HAP_Q89_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"HAP:Human Activity Profile. Daughton, DM and Fix, James, J Rehabil Res Dev. 41(4): 621-630, 1980.","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2EA90933-7BA4-5399-E050-BB89AD432C9F","latestVersionIndicator":"Yes","beginDate":"2016-03-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-03-22","modifiedBy":"COOPERM","dateModified":"2016-03-24","changeNote":"Created for CCR request by P.Asangong for GVHD study. mc 3/22/2016","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5189835","version":"1","preferredName":"Human Activity Profile 90 Running or Jogging 2 Miles 3 Point Scale","preferredDefinition":"Persons' stated observation of their ability to run or jog 2 miles, using a three point Likert scale.","longName":"HAP_Q90_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"HAP:Human Activity Profile. Daughton, DM and Fix, James, J Rehabil Res Dev. 41(4): 621-630, 1980.","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2EA90933-7BCB-5399-E050-BB89AD432C9F","latestVersionIndicator":"Yes","beginDate":"2016-03-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-03-22","modifiedBy":"COOPERM","dateModified":"2016-03-24","changeNote":"Created for CCR request by P.Asangong for GVHD study. mc 3/22/2016","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5189836","version":"1","preferredName":"Human Activity Profile 91 Running or Jogging 3 Miles 3 Point Scale","preferredDefinition":"Persons' stated observation of their ability to run or jog 3 miles, using a three point Likert scale.","longName":"HAP_Q91_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"HAP:Human Activity Profile. Daughton, DM and Fix, James, J Rehabil Res Dev. 41(4): 621-630, 1980.","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2EA90933-7BF2-5399-E050-BB89AD432C9F","latestVersionIndicator":"Yes","beginDate":"2016-03-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-03-22","modifiedBy":"COOPERM","dateModified":"2016-03-24","changeNote":"Created for CCR request by P.Asangong for GVHD study. mc 3/22/2016","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5189837","version":"1","preferredName":"Human Activity Profile 92 Running or Jogging 1 Mile in 12 Minutes or Less 3 Point Scale","preferredDefinition":"Persons' stated observation of their ability to run or jog 1 mile in 12 minutes or less, using a three point Likert scale.","longName":"HAP_Q92_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"HAP:Human Activity Profile. Daughton, DM and Fix, James, J Rehabil Res Dev. 41(4): 621-630, 1980.","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2EA90933-7C22-5399-E050-BB89AD432C9F","latestVersionIndicator":"Yes","beginDate":"2016-03-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-03-22","modifiedBy":"COOPERM","dateModified":"2016-03-24","changeNote":"Created for CCR request by P.Asangong for GVHD study. mc 3/22/2016","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5189838","version":"1","preferredName":"Human Activity Profile 93 Running or Jogging 2 Miles in 20 Minutes or Less 3 Point Scale","preferredDefinition":"Persons' stated observation of their ability to run or jog 2 miles in 20 minutes or less, using a three point Likert scale.","longName":"HAP_Q93_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"HAP:Human Activity Profile. Daughton, DM and Fix, James, J Rehabil Res Dev. 41(4): 621-630, 1980.","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2EA90933-7C49-5399-E050-BB89AD432C9F","latestVersionIndicator":"Yes","beginDate":"2016-03-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-03-22","modifiedBy":"COOPERM","dateModified":"2016-03-24","changeNote":"Created for CCR request by P.Asangong for GVHD study. mc 3/22/2016","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5189839","version":"1","preferredName":"Human Activity Profile 94 Running or Jogging 3 Miles in 30 Minutes or Less 3 Point Scale","preferredDefinition":"Persons' stated observation of their ability to run or jog 3 miles in 30 minutes or less, using a three point Likert scale.","longName":"HAP_Q94_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"HAP:Human Activity Profile. Daughton, DM and Fix, James, J Rehabil Res Dev. 41(4): 621-630, 1980.","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2EA985FE-20DC-0CED-E050-BB89AD434773","latestVersionIndicator":"Yes","beginDate":"2016-03-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-03-22","modifiedBy":"COOPERM","dateModified":"2016-03-24","changeNote":"Created for CCR request by P.Asangong for GVHD study. mc 3/22/2016","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5192777","version":"1","preferredName":"Hematopoietic Stem Cell Graft-versus-Host Unidirectional Mismatch HLA Match Category","preferredDefinition":"Classification representing the degree of haplotype match/mismatch when a recipient of a hematopoietic stem cell transplantation is not fully matched with their donor for HLA-A, HLA-B, HLA-C, and HLA-DRB1 and the heterozygous recipient is receiving a graft from a homozygous donor.","longName":"HST_HZ_HOMZ_MTCH_CAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"2ECCCCF9-17BF-96EB-E050-BB89AD431345","latestVersionIndicator":"Yes","beginDate":"2016-03-24","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-03-24","modifiedBy":"REEVESD","dateModified":"2016-04-05","changeNote":"Curated to support NCI CCR Primary Immunodeficiency trial. 4.5.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5192778","version":"1","preferredName":"Hematopoietic Stem Cell Host-versus-Graft Unidirectional Mismatch Identification Transplant HLA Match Category","preferredDefinition":"Classification representing the degree of haplotype match/mismatch when a recipient of a hematopoietic stem cell transplantation is not fully matched with their donor for HLA-A, HLA-B, HLA-C, and HLA-DRB1 and the homozygous recipient is receiving a graft from a heterozygous donor.","longName":"HST_HOMZ_HZ_MTCH_CAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"2ECCCCF9-17ED-96EB-E050-BB89AD431345","latestVersionIndicator":"Yes","beginDate":"2016-03-24","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-03-24","modifiedBy":"REEVESD","dateModified":"2016-04-05","changeNote":"Curated to support NCI CCR Primary Immunodeficiency trial. 4.5.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5215075","version":"1","preferredName":"Lymphocyte Count Recovery Post Transplant Date","preferredDefinition":"Calendar date of lymphocyte count recovery post transplantation and as defined in a clinical trial protocol.","longName":"LYM_CT_POST_TXPLT_DT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"2FEA0C5F-18A3-F37D-E050-BB89AD43280F","latestVersionIndicator":"Yes","beginDate":"2016-04-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-04-07","modifiedBy":"REEVESD","dateModified":"2016-04-07","changeNote":"Curated to support NCI CCR clinical trial.4.7.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5228612","version":"1","preferredName":"Acute Graft Versus Host Disease Anorexia Present Yes No Unk ND NA Indicator","preferredDefinition":"Text term to signify whether a loss of appetite occurred related to the occurrence of acute graft versus host disease.","longName":"ACUTE_GVHD_ANORX_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Application","id":"30ED1A9C-12BA-F7E1-E050-BB89AD4307A9","latestVersionIndicator":"Yes","beginDate":"2016-04-20","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-04-20","modifiedBy":"REEVESD","dateModified":"2016-04-21","changeNote":"Curated to support NCI CCR GVHD protocols.4.20.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5228993","version":"1","preferredName":"Acute Graft Versus Host Disease Bullous Dermatitis at Evaluation Present Yes No Indicator","preferredDefinition":"Text term to signify whether bullous dermatitis was/is present during the assessment of a patient with acute Graft vs Host Disease (GVHD).","longName":"AGVHD_BULL_PRES_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Application","id":"30F0A638-03A0-3FA2-E050-BB89AD432F28","latestVersionIndicator":"Yes","beginDate":"2016-04-20","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-04-20","modifiedBy":"REEVESD","dateModified":"2016-04-21","changeNote":"Curated to support NCI CCR GVHD protocols.4.20.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5229000","version":"1","preferredName":"Acute Graft Versus Host Disease Ileus Present Yes No Indicator","preferredDefinition":"Text term to signify whether ileus formation was detected during the assessment of a patient with acute Graft vs Host Disease (GVHD).","longName":"AGVHD_ILEUS_PRES_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Application","id":"30EFF8EE-1CEC-4F6C-E050-BB89AD432AE5","latestVersionIndicator":"Yes","beginDate":"2016-04-20","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-04-20","modifiedBy":"REEVESD","dateModified":"2016-04-21","changeNote":"Curated to support NCI CCR GVHD protocols.4.20.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5230731","version":"1","preferredName":"Chronic Graft Versus Host Disease Patient Self-Report Last 7 Days Skin Itching at its Worst Score 11 Point Scale","preferredDefinition":"A person's stated observation of the severity of skin itching at it's worst in the last 7 days, using an eleven-point scale.","longName":"CGVHD_SLFRP_ITCH_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"3114DD91-BA28-7224-E050-BB89AD431656","latestVersionIndicator":"Yes","beginDate":"2016-04-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-04-22","modifiedBy":"REEVESD","dateModified":"2016-04-25","changeNote":"Curated to support NCI CCR GVHD study.4.25.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5230732","version":"1","preferredName":"Chronic Graft Versus Host Disease Patient Self-Report Last 7 Days Skin and/or Joint Tightening at its Worst Score 11 Point Scale","preferredDefinition":"A person's stated observation of the severity of skin and/or joint tightening at it's worst in the last 7 days, using an 11 point scale.","longName":"CGVHD_SLFRP_TGHT_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"3114DD91-BA48-7224-E050-BB89AD431656","latestVersionIndicator":"Yes","beginDate":"2016-04-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-04-22","modifiedBy":"REEVESD","dateModified":"2016-04-25","changeNote":"Curated to support NCI CCR GVHD study.4.25.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5230733","version":"1","preferredName":"Chronic Graft Versus Host Disease Patient Self-Report Last 7 Days Mouth Sensitivity at its Worst Score 11 Point Scale","preferredDefinition":"A person's stated observation of the severity of mouth sensitivity at it's worst in the last 7 days, using an 11 point scale.","longName":"CGVHD_SLFRP_SENS_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"31162795-E451-F180-E050-BB89AD435C23","latestVersionIndicator":"Yes","beginDate":"2016-04-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-04-22","modifiedBy":"REEVESD","dateModified":"2016-04-25","changeNote":"Curated to support NCI CCR GVHD study.4.25.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5230734","version":"1","preferredName":"Chronic Graft Versus Host Disease Patient Self-Report Last 7 Days Genital Discomfort at its Worst Score 11 Point Scale","preferredDefinition":"A person's stated observation of the severity of genital discomfort at it's worst in the last 7 days, using an 11 point scale.","longName":"CGVHD_SLFRP_GENT_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"31162795-E471-F180-E050-BB89AD435C23","latestVersionIndicator":"Yes","beginDate":"2016-04-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-04-22","modifiedBy":"REEVESD","dateModified":"2016-04-25","changeNote":"Curated to support NCI CCR GVHD study.4.25.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5230754","version":"1","preferredName":"Chronic Graft Versus Host Disease Patient Self-Report Main Eye Problem Score 11 Point Severity Scale","preferredDefinition":"A person's stated observation rating chronic Graft versus Host Disease (cGvHD) eye symptom severity, using an 11 point scale.","longName":"CGVHD_SLFRP_EYE_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"3114DD91-BA6E-7224-E050-BB89AD431656","latestVersionIndicator":"Yes","beginDate":"2016-04-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-04-22","modifiedBy":"REEVESD","dateModified":"2016-04-25","changeNote":"Curated to support NCI CCR GVHD study.4.25.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5230755","version":"1","preferredName":"Chronic Graft Versus Host Disease Patient Self-Report Global Rating Symptom Severity Score 11 Point Scale","preferredDefinition":"A person's stated observation rating their chronic Graft vs. Host Disease (cGvHD) symptom severity, using an 11 point scale.","longName":"CGVHD_SLFRP_SSVR_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"3114DD91-BA8E-7224-E050-BB89AD431656","latestVersionIndicator":"Yes","beginDate":"2016-04-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-04-22","modifiedBy":"REEVESD","dateModified":"2016-04-25","changeNote":"Curated to support NCI CCR GVHD study.4.25.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5234425","version":"1","preferredName":"Chronic Graft Versus Host Disease Clinician Assessment Skin Response Category","preferredDefinition":"Text term that represents the chronic graft versus host disease response for skin based on clinician assessment.","longName":"CGVHD_CLIN_SKIN_CAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"3156DE18-4BD1-C131-E050-BB89AD433856","latestVersionIndicator":"Yes","beginDate":"2016-04-25","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-04-25","modifiedBy":"REEVESD","dateModified":"2016-05-02","changeNote":"Created for CCR study 16C0094 as requested by P.Asangong. mc 4/25/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5234426","version":"1","preferredName":"Chronic Graft Versus Host Disease Clinician Assessment Eye Response Category","preferredDefinition":"Text term that represents the chronic graft versus host disease response for eyes based on clinician assessment.","longName":"CGVHD_CLIN_EYE_CAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"3156DE18-4BF1-C131-E050-BB89AD433856","latestVersionIndicator":"Yes","beginDate":"2016-04-25","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-04-25","modifiedBy":"REEVESD","dateModified":"2016-05-02","changeNote":"Created for CCR study 16C0094 as requested by P.Asangong. mc 4/25/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5234427","version":"1","preferredName":"Chronic Graft Versus Host Disease Clinician Assessment Mouth Response Category","preferredDefinition":"Text term that represents the chronic graft versus host disease response for mouth based on clinician assessment.","longName":"CGVHD_CLIN_ORAL_CAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"3156DE18-4C11-C131-E050-BB89AD433856","latestVersionIndicator":"Yes","beginDate":"2016-04-25","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-04-25","modifiedBy":"REEVESD","dateModified":"2016-05-02","changeNote":"Created for CCR study 16C0094 as requested by P.Asangong. mc 4/25/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5234428","version":"1","preferredName":"Chronic Graft Versus Host Disease Clinician Assessment Esophagus Response Category","preferredDefinition":"Text term that represents the chronic graft versus host disease response for esophagus based on clinician assessment.","longName":"CGVHD_CLIN_ESPH_CAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"3156DE18-4C34-C131-E050-BB89AD433856","latestVersionIndicator":"Yes","beginDate":"2016-04-25","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-04-25","modifiedBy":"REEVESD","dateModified":"2016-05-02","changeNote":"Created for CCR study 16C0094 as requested by P.Asangong. mc 4/25/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5234429","version":"1","preferredName":"Chronic Graft Versus Host Disease Clinician Assessment Upper GI Response Category","preferredDefinition":"Text term that represents the chronic graft versus host disease response for upper gastrointestinal tract based on clinician assessment.","longName":"CGVHD_CLIN_UPGI_CAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"3156DE18-4C55-C131-E050-BB89AD433856","latestVersionIndicator":"Yes","beginDate":"2016-04-25","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-04-25","modifiedBy":"REEVESD","dateModified":"2016-05-02","changeNote":"Created for CCR study 16C0094 as requested by P.Asangong. mc 4/25/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5234430","version":"1","preferredName":"Chronic Graft Versus Host Disease Clinician Assessment Lower GI Response Category","preferredDefinition":"Text term that represents the chronic graft versus host disease response for lower gastrointestinal tract based on clinician assessment.","longName":"CGVHD_CLIN_LOWGI_CAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"31571635-3620-AE77-E050-BB89AD433717","latestVersionIndicator":"Yes","beginDate":"2016-04-25","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-04-25","modifiedBy":"REEVESD","dateModified":"2016-05-02","changeNote":"Created for CCR study 16C0094 as requested by P.Asangong. mc 4/25/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5234431","version":"1","preferredName":"Chronic Graft Versus Host Disease Clinician Assessment Liver Response Category","preferredDefinition":"Text term that represents the chronic graft versus host disease response for liver based on clinician assessment.","longName":"CGVHD_CLIN_LIVER_CAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"31571635-3640-AE77-E050-BB89AD433717","latestVersionIndicator":"Yes","beginDate":"2016-04-25","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-04-25","modifiedBy":"REEVESD","dateModified":"2016-05-02","changeNote":"Created for CCR study 16C0094 as requested by P.Asangong. mc 4/25/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5234432","version":"1","preferredName":"Chronic Graft Versus Host Disease Clinician Assessment Lung Response Category","preferredDefinition":"Text term that represents the chronic graft versus host disease response for lung based on clinician assessment.","longName":"CGVHD_CLIN_LUNG_CAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"31571635-3660-AE77-E050-BB89AD433717","latestVersionIndicator":"Yes","beginDate":"2016-04-25","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-04-25","modifiedBy":"REEVESD","dateModified":"2016-05-02","changeNote":"Created for CCR study 16C0094 as requested by P.Asangong. mc 4/25/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5234433","version":"1","preferredName":"Chronic Graft Versus Host Disease Clinician Assessment Joints and Fascia Response Category","preferredDefinition":"Text term that represents the chronic graft versus host disease response for joints and fascia based on clinician assessment.","longName":"CGVHD_CLIN_JOINT_CAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"31571635-3680-AE77-E050-BB89AD433717","latestVersionIndicator":"Yes","beginDate":"2016-04-25","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-04-25","modifiedBy":"REEVESD","dateModified":"2016-05-02","changeNote":"Created for CCR study 16C0094 as requested by P.Asangong. mc 4/25/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5234434","version":"1","preferredName":"Chronic Graft Versus Host Disease Clinician Assessment Global Response Category","preferredDefinition":"Text term that represents the chronic graft versus host disease global response based on clinician assessment.","longName":"CGVHD_CLIN_GLOBL_CAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"31575AAE-B8C7-0F77-E050-BB89AD4319E0","latestVersionIndicator":"Yes","beginDate":"2016-04-25","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-04-25","modifiedBy":"REEVESD","dateModified":"2016-05-02","changeNote":"Created for CCR study 16C0094 as requested by P.Asangong. mc 4/25/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5250596","version":"1","preferredName":"Medication Treatment Procedure Graft Versus Host Disease Administered Name","preferredDefinition":"An action or administration of agent(s) to produce an effect in a patient with graft versus host disease (GVHD).","longName":"TX_GVHD_ADM_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"3204A00A-056D-927E-E050-BB89AD43374A","latestVersionIndicator":"Yes","beginDate":"2016-05-04","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-05-04","modifiedBy":"MAESKEB","dateModified":"2022-04-04","changeNote":"Curated to support NCI Center for Cancer Research (CCR) GVHD trials.5.4.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5292940","version":"1","preferredName":"Combs Prognostic Index Score","preferredDefinition":"Numeric score to predict the outcome of reirradiation for recurrent glioma which includes elements of histology, age of the individual and the time between initial radiation therapy and reirradiation.","longName":"COMBS_PROG_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"Combs Prognostic Index:Stephanie E. Combs, et.al., 2013","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"354442CE-D8B7-6A41-E050-BB89AD4328BB","latestVersionIndicator":"Yes","beginDate":"2016-06-14","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-06-14","modifiedBy":"REEVESD","dateModified":"2016-06-21","changeNote":"Created for CCR as requested by D.Reeves. mc 6/14/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5338931","version":"1","preferredName":"Pulmonary Function Test Reference Data Value","preferredDefinition":"A value that provides a context to evaluate the results of pulmonary function testing in an individual in comparison to the distribution of like measurements in a reference population.","longName":"PFT_REF_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"37213CC5-46A8-B6D7-E050-BB89AD435DE4","latestVersionIndicator":"Yes","beginDate":"2016-07-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-07-08","modifiedBy":"TSESU","dateModified":"2017-12-25","changeNote":"Curated to support NCI CCR clinical trial.7.8.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5338991","version":"1","preferredName":"Bronchodilator Usage Yes No Unknown Indicator","preferredDefinition":"Text term to signify whether a person has used or is using a bronchodilator.","longName":"BRONCHODIL_USE_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"37213CC5-4704-B6D7-E050-BB89AD435DE4","latestVersionIndicator":"Yes","beginDate":"2016-07-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-07-08","modifiedBy":"REEVESD","dateModified":"2016-07-11","changeNote":"Curated to support NCI CCR clinical trial in C3D.7.8.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5340947","version":"1","preferredName":"Donor Cell Infusion Administration Type","preferredDefinition":"Text term to identify the category of donor cellular infusion (DCI) administered to an individual usually in the setting of a hematopoietic stem cell transplant (HSCT).","longName":"DCI_ADM_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"375D4B08-68DF-010D-E050-BB89AD4312C9","latestVersionIndicator":"Yes","beginDate":"2016-07-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-07-11","modifiedBy":"REEVESD","dateModified":"2017-02-11","changeNote":"Curated to support NCI CCR transplant study.7.11.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5340961","version":"1","preferredName":"Donor Cell Infusion Other Specify Text","preferredDefinition":"Text to describe the category of donor cellular infusion (DCI) administered to an individual usually in the setting of a hematopoietic stem cell transplant (HSCT) that is different from the options presented.","longName":"DCI_OTX_SPEC_TXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"375E14BC-EF50-5EF3-E050-BB89AD43701C","latestVersionIndicator":"Yes","beginDate":"2016-07-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-07-11","modifiedBy":"REEVESD","dateModified":"2016-07-11","changeNote":"Curated to support NCI CCR transplant study.7.11.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5342242","version":"1","preferredName":"COXEN Score Sensitivity Scale","preferredDefinition":"An ordered reference standard used to measure drug sensitivity predictions for bladder tumors based on the COXEN algorithm.","longName":"COXEN_SENS_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"37669BA3-0475-5F5B-E050-BB89AD430A77","latestVersionIndicator":"Yes","beginDate":"2016-07-11","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-07-11","modifiedBy":"REEVESD","dateModified":"2016-07-13","changeNote":"Created for COXEN study in C3D. mc 7/11/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5342243","version":"1","preferredName":"Sensitive Anticancer Agent Name","preferredDefinition":"Name of the FDA-approved anticancer agent to which an NCI-60 cell line is predicted to be sensitive.","longName":"SENS_ANTI_CA_DRUG_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"37669BA3-0486-5F5B-E050-BB89AD430A77","latestVersionIndicator":"Yes","beginDate":"2016-07-11","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-07-11","modifiedBy":"REEVESD","dateModified":"2016-07-13","changeNote":"Created for COXEN study in C3D. mc 7/11/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5342244","version":"1","preferredName":"Sensitive Anticancer Agent Chosen Treatment Name","preferredDefinition":"Name of the sensitive anticancer agent that was chosen for treatment using the COXEN algorithm.","longName":"COXEN_DRUG_NAME","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"37669BA3-04B6-5F5B-E050-BB89AD430A77","latestVersionIndicator":"Yes","beginDate":"2016-07-11","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-07-11","modifiedBy":"REEVESD","dateModified":"2016-07-13","changeNote":"Created for COXEN study in C3D. mc 7/11/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5342256","version":"1","preferredName":"Sensitive Anticancer Agent Chosen Treatment Number","preferredDefinition":"Number associated with a sensitive anticancer agent chosen for treatment.","longName":"COXEN_DRUG_NUMBER","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"376724BF-8939-5113-E050-BB89AD436B03","latestVersionIndicator":"Yes","beginDate":"2016-07-11","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-07-11","modifiedBy":"REEVESD","dateModified":"2016-07-13","changeNote":"Created for COXEN study in C3D. mc 7/11/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5351357","version":"1","preferredName":"Mesothelin Positive Cells Percentage Value","preferredDefinition":"Numeric value for the percentage of Mesothelin-positive cells in a biospecimen or sample.","longName":"MESOTH_POS_PCT_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"37EE4F89-B61C-C106-E050-BB89AD43274E","latestVersionIndicator":"Yes","beginDate":"2016-07-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-07-18","modifiedBy":"REEVESD","dateModified":"2016-07-19","changeNote":"Curated to support NCI CCR clinical trial.7.19.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5351358","version":"1","preferredName":"Mesothelin Membrane Intensity Scale","preferredDefinition":"Score for the strength of a population of Mesothelin-positive cells in a biospecimen or sample.","longName":"MESOTH_MEM_INTSY_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"37EE8E93-F703-FFE6-E050-BB89AD436FC6","latestVersionIndicator":"Yes","beginDate":"2016-07-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-07-18","modifiedBy":"REEVESD","dateModified":"2016-07-19","changeNote":"Curated to support NCI CCR clinical trial.7.19.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5355415","version":"1","preferredName":"Bayer Classification of Visual Acuity Changes Grade","preferredDefinition":"Result of assessment for vision changes using a grading system for best corrected visual acuity following treatment with anetumab ravtansine (BAY 94-9343).","longName":"BAYER_VIS_ACUITY_GD","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"38398293-0656-1D19-E050-BB89AD432BE0","latestVersionIndicator":"Yes","beginDate":"2016-07-22","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-07-22","modifiedBy":"REEVESD","dateModified":"2016-07-25","changeNote":"Curated to support NCI CCR clinical trial.7.25.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5355416","version":"1","preferredName":"Bayer Classification for Corneal Epitheliopathy Grade","preferredDefinition":"Result of assessment for corneal changes using a grading system for changes in corneal morphology following treatment with anetumab ravtansine (BAY 94-9343).","longName":"BAYER_CORN_EPITH_GD","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"38398293-0675-1D19-E050-BB89AD432BE0","latestVersionIndicator":"Yes","beginDate":"2016-07-22","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-07-22","modifiedBy":"REEVESD","dateModified":"2016-07-25","changeNote":"Curated to support NCI CCR clinical trial.7.25.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5366591","version":"1","preferredName":"Neurofibromatosis Type 1 Trial Enrollment Status","preferredDefinition":"Disease status term to capture the screening assessment of the progression status of Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) within the time frame specified in a protocol.","longName":"NEUROFIB1_ENRLL_STAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"38B558D6-DCD4-A562-E050-BB89AD434744","latestVersionIndicator":"Yes","beginDate":"2016-07-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-07-28","modifiedBy":"REEVESD","dateModified":"2016-07-28","changeNote":"Curated to support NCI CCR clinical trial.7.28.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5400994","version":"1","preferredName":"Derkay Staging Recurrent Papillomatosis Staging Score","preferredDefinition":"Numeric value that represents the staging score for an anatomic site assessed for recurrent papillomatosis using the Derkay staging measure.","longName":"DERKAY_PAP_SITE_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"39D208B1-4604-EBF6-E050-BB89AD4358B1","latestVersionIndicator":"Yes","beginDate":"2016-08-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-08-11","modifiedBy":"REEVESD","dateModified":"2016-08-14","changeNote":"Curated to support NCI CCR clinical trial.8.11.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5401011","version":"1","preferredName":"Derkay Recurrent Papillomatosis Assessment Total Score","preferredDefinition":"Numeric value representing the sum of scores from all anatomic sites assessed for recurrent papillomatosis using the Derkay staging measure.","longName":"DERKAY_PAP_TL_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"39D208B1-4661-EBF6-E050-BB89AD4358B1","latestVersionIndicator":"Yes","beginDate":"2016-08-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-08-11","modifiedBy":"REEVESD","dateModified":"2016-10-18","changeNote":"Curated to support NCI CCR clinical trial.8.11.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5401013","version":"1","preferredName":"Derkay Recurrent Papillomatosis Result Laryngeal Anatomic Site","preferredDefinition":"Named laryngeal anatomic site examined for recurrent papillomatosis.","longName":"DERKAY_LARYNG_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"39D2364D-0861-71B6-E050-BB89AD4304DD","latestVersionIndicator":"Yes","beginDate":"2016-08-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-08-11","modifiedBy":"REEVESD","dateModified":"2016-10-18","changeNote":"Curated to support NCI CCR clinical trial.8.11.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5401014","version":"1","preferredName":"Derkay Recurrent Papillomatosis Result Trachea Anatomic Site","preferredDefinition":"Named tracheal anatomic site examined for recurrent papillomatosis.","longName":"DERKAY_TRACH_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"39D2364D-0880-71B6-E050-BB89AD4304DD","latestVersionIndicator":"Yes","beginDate":"2016-08-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-08-11","modifiedBy":"REEVESD","dateModified":"2016-10-18","changeNote":"Curated to support NCI CCR clinical trial.8.11.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5401018","version":"1","preferredName":"Derkay Recurrent Papillomatosis Result Other Anatomic Site","preferredDefinition":"Named other anatomic site examined for recurrent papillomatosis.","longName":"DERKAY_OTX_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"39D2364D-089F-71B6-E050-BB89AD4304DD","latestVersionIndicator":"Yes","beginDate":"2016-08-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-08-11","modifiedBy":"REEVESD","dateModified":"2016-10-18","changeNote":"Curated to support NCI CCR clinical trial.8.11.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5434491","version":"1","preferredName":"6 Minute Walk Functional Test Exercise Duration Minute One Decimal Count","preferredDefinition":"Number to describe the amount of time in minutes required for an individual to complete the Six Minute Walk Test.","longName":"SIX_MWT_DURN_MIN_CT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"3B383EC8-84E5-FA0D-E050-BB89AD433723","latestVersionIndicator":"Yes","beginDate":"2016-08-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-08-29","modifiedBy":"REEVESD","dateModified":"2016-08-30","changeNote":"Curated to support NCI CCR clinical trial.8.29.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5441215","version":"1","preferredName":"Diagnosis Malignancy Prior Transplantation Yes No Indicator","preferredDefinition":"Text term to signify whether a malignancy was diagnosed prior to a bone marrow transplantation procedure.","longName":"MALIG_PR_BMT_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"3B7423CD-9832-E6CF-E050-BB89AD4325DF","latestVersionIndicator":"Yes","beginDate":"2016-09-01","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-09-01","modifiedBy":"REEVESD","dateModified":"2016-10-21","changeNote":"Curated to support NCI CCR Primary Immunosuppression CFR Template.10.21.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5441297","version":"1","preferredName":"Malignant Neoplasm Post Transplantation Disease Response Category","preferredDefinition":"Text term designating the disease response of an individual after a transplantation procedure has been done.","longName":"TUM_BMT_PST_RESP_CAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"3B74A913-FCE6-0169-E050-BB89AD43790E","latestVersionIndicator":"Yes","beginDate":"2016-09-01","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-09-01","modifiedBy":"REEVESD","dateModified":"2016-10-21","changeNote":"Curated to support NCI CCR Primary Immunodeficiency CRF Template.10.21.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5441350","version":"1","preferredName":"Additional Malignancy Therapy Post Transplantation Yes No Indicator","preferredDefinition":"Text term to signify whether additional malignancy-directed therapy was administered after bone marrow transplantation.","longName":"ADD_ML_PST_TXPLT_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"3B74A913-FD93-0169-E050-BB89AD43790E","latestVersionIndicator":"Yes","beginDate":"2016-09-01","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-09-01","modifiedBy":"REEVESD","dateModified":"2016-10-21","changeNote":"Curated to support NCI CCR Primary Immunosuppression CFR Template.10.21.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5448051","version":"1","preferredName":"New Malignant Neoplasm Post Transplantation Yes No Indicator","preferredDefinition":"Text term to signify whether a patient develops a new malignancy after a bone marrow transplantation.","longName":"NEW_MALIG_PBMT_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"3BDAD84A-89A2-6E08-E050-BB89AD4324C1","latestVersionIndicator":"Yes","beginDate":"2016-09-06","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-09-06","modifiedBy":"REEVESD","dateModified":"2016-10-21","changeNote":"Curated to support NCI CCR Primary Immunosuppression CFR Template.10.21.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5448055","version":"1","preferredName":"New  Lymphoproliferative Disorder Post Transplantation Yes No Indicator","preferredDefinition":"Text term to signify whether a patient develops a new lymphoproliferative disease after a bone marrow transplantation.","longName":"NEW_LMPH_PST_BMT_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"3BDAD84A-89EA-6E08-E050-BB89AD4324C1","latestVersionIndicator":"Yes","beginDate":"2016-09-06","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-09-06","modifiedBy":"REEVESD","dateModified":"2016-10-21","changeNote":"Curated to support NCI CCR Primary Immunosuppression CFR Template.10.21.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5448154","version":"1","preferredName":"Diagnosis Lymphoproliferative Disorder Prior Transplantation Yes No Indicator","preferredDefinition":"Text term to signify whether lymphoproliferative disease was diagnosed prior to a bone marrow transplantation procedure.","longName":"LMPH_DISR_PR_BMT_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"3BDCF7FA-0E64-58C8-E050-BB89AD430FAF","latestVersionIndicator":"Yes","beginDate":"2016-09-06","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-09-06","modifiedBy":"REEVESD","dateModified":"2016-10-21","changeNote":"Curated to support NCI CCR Primary Immunosuppression CFR Template.10.21.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5448233","version":"1","preferredName":"Diagnosis Opportunistic Infection Issues Prior Transplantation Yes No Indicator","preferredDefinition":"Text term to signify whether opportunistic infectious issues were diagnosed prior to a bone marrow transplantation procedure.","longName":"OPP_INFCT_PR_BMT_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"3BDDB23C-ACCB-F30A-E050-BB89AD4360A0","latestVersionIndicator":"Yes","beginDate":"2016-09-06","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-09-06","modifiedBy":"REEVESD","dateModified":"2016-10-21","changeNote":"Curated to support NCI CCR Primary Immunosuppression CFR Template.10.21.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5448313","version":"1","preferredName":"Diagnosis  Protracted Recurrent Infectious Issues Prior Transplantation Yes No Indicator","preferredDefinition":"Text term to signify whether protracted recurrent infectious issues were diagnosed prior to a bone marrow transplantation procedure.","longName":"PRO_INFCT_PR_BMT_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"3BDDDA37-288D-F255-E050-BB89AD435203","latestVersionIndicator":"Yes","beginDate":"2016-09-06","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-09-06","modifiedBy":"REEVESD","dateModified":"2016-10-21","changeNote":"Curated to support NCI CCR Primary Immunosuppression CFR Template.10.21.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5448394","version":"1","preferredName":"Diagnosis Autoimmune Issues Prior Transplantation Yes No Indicator","preferredDefinition":"Text term to signify whether autoimmune issues were diagnosed prior to a bone marrow transplantation procedure.","longName":"AUTOIM_IS_PR_BMT_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"3BDDDA37-28D6-F255-E050-BB89AD435203","latestVersionIndicator":"Yes","beginDate":"2016-09-06","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-09-06","modifiedBy":"REEVESD","dateModified":"2016-10-21","changeNote":"Curated to support NCI CCR Primary Immunosuppression CFR Template.10.21.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5448398","version":"1","preferredName":"Diagnosis Hypogammaglobulinemia Prior Transplantation Yes No Indicator","preferredDefinition":"Text term to signify whether hypogammaglobulinemia was diagnosed prior to a bone marrow transplantation procedure.","longName":"HYPOGAMM_PR_BMT_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"3BDE4CC1-482E-B2B8-E050-BB89AD4347C7","latestVersionIndicator":"Yes","beginDate":"2016-09-06","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-09-06","modifiedBy":"REEVESD","dateModified":"2016-10-21","changeNote":"Curated to support NCI CCR Primary Immunosuppression CFR Template.10.21.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5448402","version":"1","preferredName":"Diagnosis Immune Dysregulation Prior Transplantation Yes No Indicator","preferredDefinition":"Text term to signify whether immune dysregulation was diagnosed prior to a bone marrow transplantation procedure.","longName":"IMM_DYSRG_PR_BMT_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"3BDE6057-305D-95D6-E050-BB89AD436B11","latestVersionIndicator":"Yes","beginDate":"2016-09-06","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-09-06","modifiedBy":"REEVESD","dateModified":"2016-10-21","changeNote":"Curated to support NCI CCR Primary Immunosuppression CFR Template.10.21.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5448414","version":"1","preferredName":"Diagnosis Chronic Elevated Virus Level Prior Transplantation Yes No Indicator","preferredDefinition":"Text term to signify whether chronic elevation of viral level(s) was diagnosed prior to a bone marrow transplantation procedure.","longName":"ELEV_VIRS_PR_BMT_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"3BDE6057-30A4-95D6-E050-BB89AD436B11","latestVersionIndicator":"Yes","beginDate":"2016-09-06","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-09-06","modifiedBy":"REEVESD","dateModified":"2016-10-21","changeNote":"Curated to support NCI CCR Primary Immunosuppression CFR Template.10.21.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5448434","version":"1","preferredName":"Additional  Lymphoproliferative Disorder Therapy Post Transplantation Occurrence Yes No Indicator","preferredDefinition":"Text term to signify whether additional lymphoproliferative disorder-directed therapy was administered after bone marrow transplantation.","longName":"ADD_LM_PST_TXPLT_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"3BEA02E1-A803-75FA-E050-BB89AD430DC2","latestVersionIndicator":"Yes","beginDate":"2016-09-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-09-07","modifiedBy":"REEVESD","dateModified":"2016-10-21","changeNote":"Curated to support NCI CCR Primary Immunosuppression CFR Template.10.21.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5448475","version":"1","preferredName":"Diagnosis Active Opportunistic Infection Transplantation Yes No Indicator","preferredDefinition":"Text term to signify whether an active opportunistic infection was present at the time of a bone marrow transplant.","longName":"ACTV_OI_TXPLT_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"3BEB103D-1D9B-D279-E050-BB89AD4357B4","latestVersionIndicator":"Yes","beginDate":"2016-09-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-09-07","modifiedBy":"REEVESD","dateModified":"2016-10-21","changeNote":"Curated to support NCI CCR Primary Immunosuppression CFR Template.10.21.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5448479","version":"1","preferredName":"Active Recurrent Infection Transplantation Yes No Indicator","preferredDefinition":"Text term to signify whether active recurrent infection was present at the time of a bone marrow transplant.","longName":"ACTV_INFEC_TXPLT_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"3BEB103D-1DE0-D279-E050-BB89AD4357B4","latestVersionIndicator":"Yes","beginDate":"2016-09-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-09-07","modifiedBy":"REEVESD","dateModified":"2016-10-21","changeNote":"Curated to support NCI CCR Primary Immunosuppression CFR Template.10.21.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5448491","version":"1","preferredName":"Active Immune Dysregulation Transplantation Yes No Indicator","preferredDefinition":"Text term to signify whether active immune dysregulation was present at the time of a bone marrow transplant.","longName":"ACT_IMMDYS_TXPLT_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"3BEB103D-1E25-D279-E050-BB89AD4357B4","latestVersionIndicator":"Yes","beginDate":"2016-09-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-09-07","modifiedBy":"REEVESD","dateModified":"2016-10-21","changeNote":"Curated to support NCI CCR Primary Immunosuppression CFR Template.10.21.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5525869","version":"1","preferredName":"Overall Disease Response Transplantation Plus Therapy Category","preferredDefinition":"Disease response in an individual who has completed bone marrow transplantation with additional therapy.","longName":"OVL_RESP_TPLT_TX_CAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"3F276591-3511-4C3F-E053-F662850A6B6A","latestVersionIndicator":"Yes","beginDate":"2016-10-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-10-18","modifiedBy":"REEVESD","dateModified":"2016-10-21","changeNote":"Curated to support NCI CCR Primary Immunosuppression CFR Template.10.21.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5525882","version":"1","preferredName":"Lymphoproliferative Disease PreBMT Response Category","preferredDefinition":"Identification of the status of lymphoproliferative disease prior to bone marrow transplantation.","longName":"LYMPH_DZ_PBMT_RE_CAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"3F2780C2-F8CE-5C18-E053-F662850AFFA1","latestVersionIndicator":"Yes","beginDate":"2016-10-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-10-18","modifiedBy":"REEVESD","dateModified":"2016-10-21","changeNote":"Curated to support NCI CCR Primary Immunosuppression CFR Template.10.21.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5526315","version":"1","preferredName":"Lymphoproliferative Disease PostBMT Response Category","preferredDefinition":"Identification of the status of lymphoproliferative disease post bone marrow transplantation.","longName":"LYMPH_DZ_POST_DZ_CAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"3F2780C2-F8FA-5C18-E053-F662850AFFA1","latestVersionIndicator":"Yes","beginDate":"2016-10-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-10-18","modifiedBy":"REEVESD","dateModified":"2016-10-21","changeNote":"Curated to support NCI CCR Primary Immunosuppression CFR Template.10.21.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5526386","version":"1","preferredName":"Opportunistic Infection PostBMT Response Category","preferredDefinition":"Identification of the status of opportunistic infection (OI) post bone marrow transplantation.","longName":"OI_POST_BMT_RESP_CAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"3F28429B-3C9D-4C54-E053-F662850AB49F","latestVersionIndicator":"Yes","beginDate":"2016-10-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-10-18","modifiedBy":"REEVESD","dateModified":"2016-10-21","changeNote":"Curated to support NCI CCR Primary Immunosuppression CFR Template.10.21.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5526391","version":"1","preferredName":"Extensive Recurrent Infection Timepoint PostBMT Response Category","preferredDefinition":"Identification of the status of protracted, extensive infection post bone marrow transplantation.","longName":"INF_POST_BMT_RES_CAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"3F28429B-3CBC-4C54-E053-F662850AB49F","latestVersionIndicator":"Yes","beginDate":"2016-10-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-10-18","modifiedBy":"REEVESD","dateModified":"2016-10-21","changeNote":"Curated to support NCI CCR Primary Immunosuppression CFR Template.10.21.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5526429","version":"1","preferredName":"Diagnosis Autoimmune Disease Prior Transplantation Occurrence Yes No Indicator","preferredDefinition":"Text term to signify whether autoimmune issues were diagnosed prior to a bone marrow transplantation procedure.","longName":"AUTOIMM_PREBMT_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"3F28A7CE-F9C4-1DD8-E053-F662850A8D9A","latestVersionIndicator":"Yes","beginDate":"2016-10-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-10-18","modifiedBy":"REEVESD","dateModified":"2016-10-21","changeNote":"Curated to support NCI CCR Primary Immunosuppression CFR Template.10.21.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5526460","version":"1","preferredName":"Diagnosis Autoimmune Disease Prior Transplantation Description Comments Text","preferredDefinition":"Text to describe an autoimmune disease issue at the time of bone marrow transplantation.","longName":"AUTOIM_DZ_PREBMT_TXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"3F28BA8F-F08E-2A50-E053-F662850AF762","latestVersionIndicator":"Yes","beginDate":"2016-10-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-10-18","modifiedBy":"REEVESD","dateModified":"2016-10-21","changeNote":"Curated to support NCI CCR Primary Immunosuppression CFR Template.10.21.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5526485","version":"1","preferredName":"Autoimmune Disease PostBMT Response Category","preferredDefinition":"Identification of the status of active autoimmune issues post bone marrow transplantation.","longName":"AUT_POST_BMT_RES_CAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"3F28BA8F-F0D2-2A50-E053-F662850AF762","latestVersionIndicator":"Yes","beginDate":"2016-10-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-10-18","modifiedBy":"REEVESD","dateModified":"2016-10-21","changeNote":"Curated to support NCI CCR Primary Immunosuppression CFR Template.10.21.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5527443","version":"1","preferredName":"Immunoglobulin Type","preferredDefinition":"Defining name to identify a category of immunoglobulin.","longName":"IMMUNOGLOB_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"3F37C10C-BE56-2168-E053-F662850AC503","latestVersionIndicator":"Yes","beginDate":"2016-10-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-10-19","modifiedBy":"REEVESD","dateModified":"2016-10-21","changeNote":"Curated to support NCI CCR Primary Immunosuppression CFR Template.10.21.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5527448","version":"1","preferredName":"Chronic Immunoglobulin Replacement Therapy Timepoint Transplantation Yes No Indicator","preferredDefinition":"Text term to signify whether an individual was on chronic immunoglobulin replacement therapy at the time of bone marrow transplantation.","longName":"CH_IMMUN_REP_BMT_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"3F37C10C-BEB4-2168-E053-F662850AC503","latestVersionIndicator":"Yes","beginDate":"2016-10-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-10-19","modifiedBy":"REEVESD","dateModified":"2016-10-21","changeNote":"Curated to support NCI CCR Primary Immunosuppression CFR Template.10.21.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5527455","version":"1","preferredName":"Hypogammaglobulinemia PostBMT Response Category","preferredDefinition":"Identification of the status of hypogammaglobulinemia post bone marrow transplantation.","longName":"HYPOGAM_PBMT_RES_CAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"3F382605-A59F-622D-E053-F662850A1293","latestVersionIndicator":"Yes","beginDate":"2016-10-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-10-19","modifiedBy":"REEVESD","dateModified":"2016-10-21","changeNote":"Curated to support NCI CCR Primary Immunosuppression CFR Template.10.21.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5527459","version":"1","preferredName":"Diagnosis Hypergammaglobulinemia Prior Transplantation Yes No Indicator","preferredDefinition":"Text term to signify whether hypergammaglobulinema was diagnosed prior to a bone marrow transplantation procedure.","longName":"HYPERGAM_PR_BMT_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"3F37C10C-BFC8-2168-E053-F662850AC503","latestVersionIndicator":"Yes","beginDate":"2016-10-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-10-19","modifiedBy":"REEVESD","dateModified":"2016-10-21","changeNote":"Curated to support NCI CCR Primary Immunosuppression CFR Template.10.21.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5527597","version":"1","preferredName":"Immune Dysregulation Type","preferredDefinition":"Text name to identify a category of immune dysregulation.","longName":"IMMUN_DYSREG_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"3F39CB70-5EA9-4F53-E053-F662850AA7DB","latestVersionIndicator":"Yes","beginDate":"2016-10-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-10-19","modifiedBy":"REEVESD","dateModified":"2016-10-21","changeNote":"Curated to support NCI CCR Primary Immunosuppression CFR Template.10.21.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5527614","version":"1","preferredName":"Immune Dysregulation PostBMT Response Category","preferredDefinition":"Identification of the status of immune dysregulation post bone marrow transplantation.","longName":"IMM_DYSREG_BMT_CAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"3F39EDF0-A649-21FB-E053-F662850A3ACA","latestVersionIndicator":"Yes","beginDate":"2016-10-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-10-19","modifiedBy":"REEVESD","dateModified":"2016-10-21","changeNote":"Curated to support NCI CCR Primary Immunosuppression CFR Template.10.21.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5527629","version":"1","preferredName":"Viral Infection Timepoint Transplantation Yes No Indicator","preferredDefinition":"Text term to signify whether viral issues were present at the time of a bone marrow transplant.","longName":"VIRAL_ISS_TXPLT_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"3F39E7E3-B921-22E0-E053-F662850ABE1B","latestVersionIndicator":"Yes","beginDate":"2016-10-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-10-19","modifiedBy":"REEVESD","dateModified":"2016-10-21","changeNote":"Curated to support NCI CCR Primary Immunosuppression CFR Template.10.21.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5527641","version":"1","preferredName":"Viral Therapy Timepoint Transplantation Yes No Indicator","preferredDefinition":"Text term to signify whether therapy for viral issues was being administered at the time of bone marrow transplantation.","longName":"VIR_TX_BMT_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"3F39EDF0-A68F-21FB-E053-F662850A3ACA","latestVersionIndicator":"Yes","beginDate":"2016-10-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-10-19","modifiedBy":"REEVESD","dateModified":"2016-10-21","changeNote":"Curated to support NCI CCR Primary Immunosuppression CFR Template.10.21.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5527877","version":"1","preferredName":"Viral Source Category","preferredDefinition":"Text identification of the origin biologic material associated with a viral infection.","longName":"VIRAL_SRCE_CAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"3F4C6595-C856-7E5D-E053-F662850A57F1","latestVersionIndicator":"Yes","beginDate":"2016-10-20","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-10-20","modifiedBy":"REEVESD","dateModified":"2016-10-21","changeNote":"Curated to support NCI CCR Primary Immunosuppression CFR Template.10.21.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5527894","version":"1","preferredName":"Virus Name","preferredDefinition":"Text term to identify a virus associated with a condition or disease.","longName":"VIRUS_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"3F4C6595-C94F-7E5D-E053-F662850A57F1","latestVersionIndicator":"Yes","beginDate":"2016-10-20","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-10-20","modifiedBy":"GDEEN","dateModified":"2023-04-17","changeNote":"Curated to support NCI CCR Primary Immunodeficiency CRF Template.10.21.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5528088","version":"1","preferredName":"Chronic Elevated Virus Timepoint PostBMT Response Category","preferredDefinition":"Identification of the status of chronic elevation of virus post bone marrow transplantation.","longName":"VIRUS_PBMT_RESP_CAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"3F4EA436-3161-604E-E053-F662850A8158","latestVersionIndicator":"Yes","beginDate":"2016-10-20","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-10-20","modifiedBy":"REEVESD","dateModified":"2016-10-21","changeNote":"Curated to support NCI CCR Primary Immunosuppression CFR Template.10.21.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5542583","version":"1","preferredName":"Iliac Crest Bone Marrow Aspirate Touch Prep Result","preferredDefinition":"Text description of the result of a iliac crest biopsy and aspirate that have received touch preparation.","longName":"BM_ASP_TCHPREP_RSL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"3FB2A090-EDD1-3135-E053-F662850AE5EA","latestVersionIndicator":"Yes","beginDate":"2016-10-25","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-10-25","modifiedBy":"REEVESD","dateModified":"2016-10-25","changeNote":"Curated to use in NCI CCR Biomarker eCRF.10.25.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5542590","version":"1","preferredName":"Bone Marrow Biopsy Myeloid Precursor Involvement Specimen Percentage Value","preferredDefinition":"Numeric value to represent the percentage of erythroid precursors in a bone marrow specimen.","longName":"BM_BX_MYL_PRC_PC_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"3FB2BB1E-6DEB-5DC1-E053-F662850AE1A0","latestVersionIndicator":"Yes","beginDate":"2016-10-25","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-10-25","modifiedBy":"REEVESD","dateModified":"2016-10-25","changeNote":"Curated to use in NCI CCR Biomarker eCRF.10.25.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5542591","version":"1","preferredName":"Bone Marrow Biopsy Erythroid Precursor Involvement Specimen Percentage Value","preferredDefinition":"Numeric value to represent the percentage of erythroid precursors in a bone marrow specimen.","longName":"BM_BX_ERY_PRC_PC_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"3FB2BB1E-6DFB-5DC1-E053-F662850AE1A0","latestVersionIndicator":"Yes","beginDate":"2016-10-25","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-10-25","modifiedBy":"REEVESD","dateModified":"2016-10-25","changeNote":"Curated to use in NCI CCR Biomarker eCRF.10.25.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5557037","version":"1","preferredName":"Bone Marrow CD25 Count Flow Cytometry Result Value","preferredDefinition":"Numeric result of the evaluation of a bone marrow specimen for CD25 cells using flow cytometry.","longName":"BM_CD25_FC_AB_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"4029A5BE-ADB7-38C8-E053-F662850A5C53","latestVersionIndicator":"Yes","beginDate":"2016-10-31","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-10-31","modifiedBy":"REEVESD","dateModified":"2016-11-01","changeNote":"Curated to support creation of NCI CCR Bone Marrow CRF in C3D.11.1.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5557038","version":"1","preferredName":"Bone Marrow CD25 Count Flow Cytometry Result Percentage Value","preferredDefinition":"Percentage result of the evaluation of a bone marrow specimen for CD25 cells using flow cytometry.","longName":"BM_CD25_FC_PC_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"4029AD63-E577-5D23-E053-F662850AC19D","latestVersionIndicator":"Yes","beginDate":"2016-10-31","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-10-31","modifiedBy":"REEVESD","dateModified":"2016-11-01","changeNote":"Curated to support creation of NCI CCR Bone Marrow CRF in C3D.11.1.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5557039","version":"1","preferredName":"Bone Marrow CD19 Count Flow Cytometry Result Value","preferredDefinition":"Numeric result of the evaluation of a bone marrow specimen for CD19 cells using flow cytometry.","longName":"BM_CD19_FC_AB_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"4029AD63-E58A-5D23-E053-F662850AC19D","latestVersionIndicator":"Yes","beginDate":"2016-10-31","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-10-31","modifiedBy":"REEVESD","dateModified":"2016-11-01","changeNote":"Curated to support creation of NCI CCR Bone Marrow CRF in C3D.11.1.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5557040","version":"1","preferredName":"Bone Marrow CD19 Count Flow Cytometry Result Percentage Value","preferredDefinition":"Percentage result of the evaluation of a bone marrow specimen for CD19 cells using flow cytometry.","longName":"BM_CD19_FC_PC_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"4029A5BE-ADC7-38C8-E053-F662850A5C53","latestVersionIndicator":"Yes","beginDate":"2016-10-31","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-10-31","modifiedBy":"ARCHERJ","dateModified":"2021-03-01","changeNote":"Curated to support creation of NCI CCR Bone Marrow CRF in C3D.11.1.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5557093","version":"1","preferredName":"Bone Marrow CD22 Count Flow Cytometry Result Value","preferredDefinition":"Numeric result of the evaluation of a bone marrow specimen for CD22 cells using flow cytometry.","longName":"BM_CD22_FC_AB_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"4029AD63-E59F-5D23-E053-F662850AC19D","latestVersionIndicator":"Yes","beginDate":"2016-10-31","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-10-31","modifiedBy":"REEVESD","dateModified":"2016-11-01","changeNote":"Curated to support creation of NCI CCR Bone Marrow CRF in C3D.11.1.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5557095","version":"1","preferredName":"Bone Marrow CD22 Count Flow Cytometry Result Percentage Value","preferredDefinition":"Percentage result of the evaluation of a bone marrow specimen for CD22 cells using flow cytometry.","longName":"BM_CD22_FC_PC_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"4029AD63-E5D5-5D23-E053-F662850AC19D","latestVersionIndicator":"Yes","beginDate":"2016-10-31","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-10-31","modifiedBy":"REEVESD","dateModified":"2016-11-01","changeNote":"Curated to support creation of NCI CCR Bone Marrow CRF in C3D.11.1.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5557096","version":"1","preferredName":"Bone Marrow CD22 Count Chimeric Antigen Receptor Flow Cytometry Result Percentage Value","preferredDefinition":"Percentage result of the evaluation of a bone marrow specimen for CD22 chimeric antigen receptor (CAR) cells using flow cytometry.","longName":"BM_CD22CAR_FC_PC_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"402B04F0-29B2-4AA9-E053-F662850A11D7","latestVersionIndicator":"Yes","beginDate":"2016-10-31","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-10-31","modifiedBy":"REEVESD","dateModified":"2016-11-01","changeNote":"Curated to support creation of NCI CCR Bone Marrow CRF in C3D.11.1.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5557130","version":"1","preferredName":"Bone Marrow CD4 Count Flow Cytometry Result Value","preferredDefinition":"Numeric result of the evaluation of a bone marrow specimen for CD4 cells using flow cytometry.","longName":"BM_CD4_FC_AB_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"402B04F0-29C2-4AA9-E053-F662850A11D7","latestVersionIndicator":"Yes","beginDate":"2016-10-31","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-10-31","modifiedBy":"REEVESD","dateModified":"2016-11-01","changeNote":"Curated to support creation of NCI CCR Bone Marrow CRF in C3D.11.1.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5557131","version":"1","preferredName":"Bone Marrow CD4 Count Flow Cytometry Result Percentage Value","preferredDefinition":"Percentage result of the evaluation of a bone marrow specimen for CD4 cells using flow cytometry.","longName":"BM_CD4_FC_PC_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"4029AD63-E5E5-5D23-E053-F662850AC19D","latestVersionIndicator":"Yes","beginDate":"2016-10-31","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-10-31","modifiedBy":"REEVESD","dateModified":"2016-11-01","changeNote":"Curated to support creation of NCI CCR Bone Marrow CRF in C3D.11.1.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5557168","version":"1","preferredName":"Bone Marrow CD4 Count Chimeric Antigen Receptor Flow Cytometry Result Percentage Value","preferredDefinition":"Percentage result of the evaluation of a bone marrow specimen for CD4 chimeric antigen receptor (CAR) cells using flow cytometry.","longName":"BM_CD4CAR_FC_PC_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"402B04F0-29D2-4AA9-E053-F662850A11D7","latestVersionIndicator":"Yes","beginDate":"2016-10-31","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-10-31","modifiedBy":"REEVESD","dateModified":"2016-11-01","changeNote":"Curated to support creation of NCI CCR Bone Marrow CRF in C3D.11.1.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5557173","version":"1","preferredName":"Bone Marrow CD5 Count Flow Cytometry Result Value","preferredDefinition":"Numeric result of the evaluation of a bone marrow specimen for CD5 cells using flow cytometry.","longName":"BM_CD5_FC_AB_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"402B04F0-29E2-4AA9-E053-F662850A11D7","latestVersionIndicator":"Yes","beginDate":"2016-10-31","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-10-31","modifiedBy":"REEVESD","dateModified":"2016-11-01","changeNote":"Curated to support creation of NCI CCR Bone Marrow CRF in C3D.11.1.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5557174","version":"1","preferredName":"Bone Marrow CD5 Count Flow Cytometry Result Percentage Value","preferredDefinition":"Percentage result of the evaluation of a bone marrow specimen for CD5 cells using flow cytometry.","longName":"BM_CD5_FC_PC_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"402B04F0-29F2-4AA9-E053-F662850A11D7","latestVersionIndicator":"Yes","beginDate":"2016-10-31","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-10-31","modifiedBy":"REEVESD","dateModified":"2016-11-01","changeNote":"Curated to support creation of NCI CCR Bone Marrow CRF in C3D.11.1.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5557175","version":"1","preferredName":"Bone Marrow CD5 Count Chimeric Antigen Receptor Flow Cytometry Result Percentage Value","preferredDefinition":"Percentage result of the evaluation of a bone marrow specimen for CD5 chimeric antigen receptor (CAR) cells using flow cytometry.","longName":"BM_CD5CAR_FC_PC_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"4029AD63-E5F5-5D23-E053-F662850AC19D","latestVersionIndicator":"Yes","beginDate":"2016-10-31","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-10-31","modifiedBy":"REEVESD","dateModified":"2016-11-01","changeNote":"Curated to support creation of NCI CCR Bone Marrow CRF in C3D.11.1.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5557176","version":"1","preferredName":"Bone Marrow CD7 Count Flow Cytometry Result Value","preferredDefinition":"Numeric result of the evaluation of a bone marrow specimen for CD7 cells using flow cytometry.","longName":"BM_CD7_FC_AB_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"4029AD63-E605-5D23-E053-F662850AC19D","latestVersionIndicator":"Yes","beginDate":"2016-10-31","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-10-31","modifiedBy":"REEVESD","dateModified":"2016-11-01","changeNote":"Curated to support creation of NCI CCR Bone Marrow CRF in C3D.11.1.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5557231","version":"1","preferredName":"Bone Marrow CD7 Count Flow Cytometry Result Percentage Value","preferredDefinition":"Percentage result of the evaluation of a bone marrow specimen for CD7 cells using flow cytometry.","longName":"BM_CD7_FC_PC_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"402B8A28-72F9-0B01-E053-F662850A74B0","latestVersionIndicator":"Yes","beginDate":"2016-10-31","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-10-31","modifiedBy":"REEVESD","dateModified":"2016-11-01","changeNote":"Curated to support creation of NCI CCR Bone Marrow CRF in C3D.11.1.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5557232","version":"1","preferredName":"Bone Marrow CD7 Count Chimeric Antigen Receptor Flow Cytometry Result Percentage Value","preferredDefinition":"Percentage result of the evaluation of a bone marrow specimen for CD7 chimeric antigen receptor (CAR) cells using flow cytometry.","longName":"BM_CD7CAR_FC_PC_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"402B8FED-041E-2E12-E053-F662850A24B4","latestVersionIndicator":"Yes","beginDate":"2016-10-31","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-10-31","modifiedBy":"REEVESD","dateModified":"2016-11-01","changeNote":"Curated to support creation of NCI CCR Bone Marrow CRF in C3D.11.1.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5557233","version":"1","preferredName":"Bone Marrow CD8 Count Flow Cytometry Result Value","preferredDefinition":"Numeric result of the evaluation of a bone marrow specimen for CD8 cells using flow cytometry.","longName":"BM_CD8_FC_AB_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"402B8A28-7309-0B01-E053-F662850A74B0","latestVersionIndicator":"Yes","beginDate":"2016-10-31","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-10-31","modifiedBy":"REEVESD","dateModified":"2016-11-01","changeNote":"Curated to support creation of NCI CCR Bone Marrow CRF in C3D.11.1.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5557234","version":"1","preferredName":"Bone Marrow CD8 Count Flow Cytometry Result Percentage Value","preferredDefinition":"Percentage result of the evaluation of a bone marrow specimen for CD8 cells using flow cytometry.","longName":"BM_CD8_FC_PC_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"402B8A28-7319-0B01-E053-F662850A74B0","latestVersionIndicator":"Yes","beginDate":"2016-10-31","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-10-31","modifiedBy":"REEVESD","dateModified":"2016-11-01","changeNote":"Curated to support creation of NCI CCR Bone Marrow CRF in C3D.11.1.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5557260","version":"1","preferredName":"Bone Marrow CD8 Count Chimeric Antigen Receptor Flow Cytometry Result Percentage Value","preferredDefinition":"Percentage result of the evaluation of a bone marrow specimen for CD8 chimeric antigen receptor (CAR) cells using flow cytometry.","longName":"BM_CD8CAR_FC_PC_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"402B8FED-0434-2E12-E053-F662850A24B4","latestVersionIndicator":"Yes","beginDate":"2016-10-31","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-10-31","modifiedBy":"REEVESD","dateModified":"2016-11-01","changeNote":"Curated to support creation of NCI CCR Bone Marrow CRF in C3D.11.1.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5557261","version":"1","preferredName":"Bone Marrow CD10 Count Flow Cytometry Result Value","preferredDefinition":"Numeric result of the evaluation of a bone marrow specimen for CD10 cells using flow cytometry.","longName":"BM_CD10_FC_AB_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"402B8A28-7329-0B01-E053-F662850A74B0","latestVersionIndicator":"Yes","beginDate":"2016-10-31","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-10-31","modifiedBy":"REEVESD","dateModified":"2016-11-01","changeNote":"Curated to support creation of NCI CCR Bone Marrow CRF in C3D.11.1.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5557262","version":"1","preferredName":"Bone Marrow CD10 Count Flow Cytometry Result Percentage Value","preferredDefinition":"Percentage result of the evaluation of a bone marrow specimen for CD10 cells using flow cytometry.","longName":"BM_CD10_FC_PC_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"402B8A28-7339-0B01-E053-F662850A74B0","latestVersionIndicator":"Yes","beginDate":"2016-10-31","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-10-31","modifiedBy":"REEVESD","dateModified":"2016-11-01","changeNote":"Curated to support creation of NCI CCR Bone Marrow CRF in C3D.11.1.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5557263","version":"1","preferredName":"Bone Marrow CD10 Count Chimeric Antigen Receptor Flow Cytometry Result Percentage Value","preferredDefinition":"Percentage result of the evaluation of a bone marrow specimen for CD10 chimeric antigen receptor (CAR) cells using flow cytometry.","longName":"BM_CD10CAR_FC_PC_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"402B8A28-7349-0B01-E053-F662850A74B0","latestVersionIndicator":"Yes","beginDate":"2016-10-31","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-10-31","modifiedBy":"REEVESD","dateModified":"2016-11-01","changeNote":"Curated to support creation of NCI CCR Bone Marrow CRF in C3D.11.1.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5557266","version":"1","preferredName":"Bone Marrow CD45 Count Present Flow Cytometry Result Value","preferredDefinition":"Numeric result of the evaluation of a bone marrow specimen for CD45 cells using flow cytometry.","longName":"BM_CD45_FC_AB_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"402B8FED-0444-2E12-E053-F662850A24B4","latestVersionIndicator":"Yes","beginDate":"2016-10-31","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-10-31","modifiedBy":"REEVESD","dateModified":"2016-11-01","changeNote":"Curated to support creation of NCI CCR Bone Marrow CRF in C3D.11.1.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5557267","version":"1","preferredName":"Bone Marrow CD45 Count Present Flow Cytometry Result Percentage Value","preferredDefinition":"Percentage result of the evaluation of a bone marrow specimen for CD45 cells using flow cytometry.","longName":"BM_CD45_FC_PC_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"402BC3A1-0C54-4D81-E053-F662850A2E98","latestVersionIndicator":"Yes","beginDate":"2016-10-31","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-10-31","modifiedBy":"REEVESD","dateModified":"2016-11-01","changeNote":"Curated to support creation of NCI CCR Bone Marrow CRF in C3D.11.1.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5557268","version":"1","preferredName":"Bone Marrow CD45 Count Chimeric Antigen Receptor Flow Cytometry Result Percentage Value","preferredDefinition":"Percentage result of the evaluation of a bone marrow specimen for CD45 chimeric antigen receptor (CAR) cells using flow cytometry.","longName":"BM_CD45CAR_FC_PC_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"402BC3A1-0C64-4D81-E053-F662850A2E98","latestVersionIndicator":"Yes","beginDate":"2016-10-31","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-10-31","modifiedBy":"REEVESD","dateModified":"2016-11-01","changeNote":"Curated to support creation of NCI CCR Bone Marrow CRF in C3D.11.1.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5557269","version":"1","preferredName":"Bone Marrow CD56 Count Flow Cytometry Result Value","preferredDefinition":"Numeric result of the evaluation of a bone marrow specimen for CD56 cells using flow cytometry.","longName":"BM_CD56_FC_AB_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"402BC3A1-0C74-4D81-E053-F662850A2E98","latestVersionIndicator":"Yes","beginDate":"2016-10-31","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-10-31","modifiedBy":"REEVESD","dateModified":"2016-11-01","changeNote":"Curated to support creation of NCI CCR Bone Marrow CRF in C3D.11.1.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5557270","version":"1","preferredName":"Bone Marrow CD56 Count Flow Cytometry Result Percentage Value","preferredDefinition":"Percentage result of the evaluation of a bone marrow specimen for CD56 cells using flow cytometry.","longName":"BM_CD56_FC_PC_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"402B8FED-0454-2E12-E053-F662850A24B4","latestVersionIndicator":"Yes","beginDate":"2016-10-31","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-10-31","modifiedBy":"REEVESD","dateModified":"2016-11-01","changeNote":"Curated to support creation of NCI CCR Bone Marrow CRF in C3D.11.1.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5557339","version":"1","preferredName":"Bone Marrow CD56 Count Chimeric Antigen Receptor Flow Cytometry Result Percentage Value","preferredDefinition":"Percentage result of the evaluation of a bone marrow specimen for CD56 chimeric antigen receptor (CAR) cells using flow cytometry.","longName":"BM_CD56CAR_FC_PC_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"402BC3A1-0C84-4D81-E053-F662850A2E98","latestVersionIndicator":"Yes","beginDate":"2016-10-31","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-10-31","modifiedBy":"REEVESD","dateModified":"2016-11-01","changeNote":"Curated to support creation of NCI CCR Bone Marrow CRF in C3D.11.1.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5557340","version":"1","preferredName":"Bone Marrow CD57 Count Flow Cytometry Result Value","preferredDefinition":"Numeric result of the evaluation of a bone marrow specimen for CD57 cells using flow cytometry.","longName":"BM_CD57_FC_AB_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"402B8FED-0464-2E12-E053-F662850A24B4","latestVersionIndicator":"Yes","beginDate":"2016-10-31","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-10-31","modifiedBy":"REEVESD","dateModified":"2016-11-01","changeNote":"Curated to support creation of NCI CCR Bone Marrow CRF in C3D.11.1.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5557341","version":"1","preferredName":"Bone Marrow CD57 Count Flow Cytometry Result Percentage Value","preferredDefinition":"Percentage result of the evaluation of a bone marrow specimen for CD57 cells using flow cytometry.","longName":"BM_CD57_FC_PC_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"402B8FED-0474-2E12-E053-F662850A24B4","latestVersionIndicator":"Yes","beginDate":"2016-10-31","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-10-31","modifiedBy":"REEVESD","dateModified":"2016-11-01","changeNote":"Curated to support creation of NCI CCR Bone Marrow CRF in C3D.11.1.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5557342","version":"1","preferredName":"Bone Marrow CD57 Count Chimeric Antigen Receptor Flow Cytometry Result Percentage Value","preferredDefinition":"Percentage result of the evaluation of a bone marrow specimen for CD57 chimeric antigen receptor (CAR) cells using flow cytometry.","longName":"BM_CD57CAR_FC_PC_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"402BC3A1-0CA7-4D81-E053-F662850A2E98","latestVersionIndicator":"Yes","beginDate":"2016-10-31","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-10-31","modifiedBy":"REEVESD","dateModified":"2016-11-01","changeNote":"Curated to support creation of NCI CCR Bone Marrow CRF in C3D.11.1.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5557343","version":"1","preferredName":"Bone Marrow T-Lymphocyte Count Result Percentage Value","preferredDefinition":"Percentage result of the evaluation of a bone marrow specimen for T-lymphocyte cells using flow cytometry.","longName":"BM_TCELL_FC_PC_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"402B8FED-0484-2E12-E053-F662850A24B4","latestVersionIndicator":"Yes","beginDate":"2016-10-31","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-10-31","modifiedBy":"REEVESD","dateModified":"2016-11-01","changeNote":"Curated to support creation of NCI CCR Bone Marrow CRF in C3D.11.1.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5557344","version":"1","preferredName":"Bone Marrow B-Lymphocyte Count Result Percentage Value","preferredDefinition":"Percentage result of the evaluation of a bone marrow specimen for B-lymphocyte cells using flow cytometry.","longName":"BM_BCELL_FC_PC_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"402BC3A1-0CCB-4D81-E053-F662850A2E98","latestVersionIndicator":"Yes","beginDate":"2016-10-31","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-10-31","modifiedBy":"REEVESD","dateModified":"2016-11-01","changeNote":"Curated to support creation of NCI CCR Bone Marrow CRF in C3D.11.1.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5557345","version":"1","preferredName":"Bone Marrow Natural Killer Cell Count Result Percentage Value","preferredDefinition":"Percentage result of the evaluation of a bone marrow specimen for Natural Killer (NK) cells using flow cytometry.","longName":"BM_NKCELL_FC_PC_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"402BC3A1-0CF0-4D81-E053-F662850A2E98","latestVersionIndicator":"Yes","beginDate":"2016-10-31","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-10-31","modifiedBy":"REEVESD","dateModified":"2016-11-01","changeNote":"Curated to support creation of NCI CCR Bone Marrow CRF in C3D.11.1.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5557346","version":"1","preferredName":"Flow Cytometry Performed Descriptive Text","preferredDefinition":"Text to describe the interpretation of a flow cytometry evaluation.","longName":"FC_PERF_DESC_TXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"402C01D6-7FFF-6F09-E053-F662850A516F","latestVersionIndicator":"Yes","beginDate":"2016-10-31","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-10-31","modifiedBy":"SOKKERL","dateModified":"2018-08-21","changeNote":"Curated to support creation of NCI CCR Bone Marrow CRF in C3D.11.1.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5580452","version":"1","preferredName":"Chronic Graft Versus Host Disease Organ NIH Score Type","preferredDefinition":"Text term that represents the kind of organ associated with the Chronic Graft Versus Host Disease NIH score.","longName":"CGVHD_ORG_SCR_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Application","id":"41C23560-FC04-3FE1-E053-F662850A0773","latestVersionIndicator":"Yes","beginDate":"2016-11-20","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-11-20","modifiedBy":"COOPERM","dateModified":"2016-12-05","changeNote":"Created for NIH Score CRF as requested by Y. Yakovlev. mc 11/18/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5580453","version":"1","preferredName":"Chronic Graft Versus Host Disease Skin Involvement Final Score","preferredDefinition":"Final score that represents the percentage of body surface area involved by disease signs and the cutaneous features scale associated with cGVHD (chronic Graft vs. Host Disease).","longName":"CGVHD_SKN_FNL_SCR","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Application","id":"41C23ECD-7080-3FE3-E053-F662850AB9B3","latestVersionIndicator":"Yes","beginDate":"2016-11-20","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-11-20","modifiedBy":"MAESKEB","dateModified":"2022-03-31","changeNote":"Created for NIH Score CRF as requested by Y. Yakovlev. mc 11/18/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5580454","version":"1","preferredName":"Abnormality Other Cause Not Chronic Graft Versus Host Disease Text","preferredDefinition":"Text description of any abnormality explained by a documented cause other than cGVHD (chronic Graft vs. Host Disease).","longName":"ABN_NCGVHD_TXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Application","id":"41C24865-37CD-3FDB-E053-F662850AD473","latestVersionIndicator":"Yes","beginDate":"2016-11-20","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-11-20","modifiedBy":"COOPERM","dateModified":"2016-12-05","changeNote":"Created for NIH Score CRF as requested by Y. Yakovlev. mc 11/18/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5580455","version":"1","preferredName":"Chronic Graft Versus Host Disease Skin Features Score","preferredDefinition":"Score that represents the type of skin features associated with chronic graft vs. host disease.","longName":"CGVHD_SKIN_FTR_SCR","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Application","id":"41C23560-FC31-3FE1-E053-F662850A0773","latestVersionIndicator":"Yes","beginDate":"2016-11-20","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-11-20","modifiedBy":"MAESKEB","dateModified":"2022-03-31","changeNote":"Created for NIH Score CRF as requested by Y. Yakovlev. mc 11/18/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5580456","version":"1","preferredName":"Chronic Graft Versus Host Disease Lichen Planus Indicator","preferredDefinition":"Indicator of whether or not features that resemble Lichen planus are present.","longName":"CGVHD_LICHNPLN_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Application","id":"41C2570F-7013-3FE5-E053-F662850A4622","latestVersionIndicator":"Yes","beginDate":"2016-11-20","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-11-20","modifiedBy":"COOPERM","dateModified":"2016-12-08","changeNote":"Created for NIH Score CRF as requested by Y. Yakovlev. mc 11/18/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5580459","version":"1","preferredName":"Chronic Graft Versus Host Disease Ophthalmologist Confirmed Dry Eye Syndrome Indicator","preferredDefinition":"Indicator of whether or not Keratoconjunctivitis sicca (Dry Eye Syndrome) was confirmed by an ophthalmologist.","longName":"KCS_OPHTH_CONF_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Application","id":"41C2768F-5C4A-6400-E053-F662850A1E40","latestVersionIndicator":"Yes","beginDate":"2016-11-20","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-11-20","modifiedBy":"COOPERM","dateModified":"2016-12-05","changeNote":"Created for NIH Score CRF as requested by Y. Yakovlev. mc 11/18/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5580460","version":"1","preferredName":"Chronic Graft Versus Host Disease Lung Involvement Final Score","preferredDefinition":"Final score that represents the lung symptom and FEV1 scores associated with cGVHD (chronic Graft vs. Host Disease).","longName":"CGVHD_LUNG_FNL_SCR","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Application","id":"41C36DC8-6369-6402-E053-F662850A7925","latestVersionIndicator":"Yes","beginDate":"2016-11-20","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-11-20","modifiedBy":"COOPERM","dateModified":"2016-12-06","changeNote":"Created for NIH Score CRF as requested by Y. Yakovlev. mc 11/18/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5580461","version":"1","preferredName":"Chronic Graft Versus Host Disease Genital Tract Features Type","preferredDefinition":"Text term that represents the kind of genital tract feature associated with the Chronic Graft Versus Host Disease.","longName":"CGVHD_GENITAL_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Application","id":"41C37F2B-1601-7042-E053-F662850A1127","latestVersionIndicator":"Yes","beginDate":"2016-11-20","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-11-20","modifiedBy":"MALUMK","dateModified":"2021-08-12","changeNote":"Created for NIH Score CRF as requested by Y. Yakovlev. mc 11/18/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5580465","version":"1","preferredName":"Abnormality Other Cause And Chronic Graft Versus Host Disease Specify Text","preferredDefinition":"Text description of any abnormality explained by another cause plus cGVHD (chronic Graft vs. Host Disease).","longName":"ABN_OTHAND_CGVHD_TXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Application","id":"41C39000-A0F7-0791-E053-F662850AD792","latestVersionIndicator":"Yes","beginDate":"2016-11-20","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-11-20","modifiedBy":"COOPERM","dateModified":"2016-12-05","changeNote":"Created for NIH Score CRF as requested by Y. Yakovlev. mc 11/18/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5580473","version":"1","preferredName":"Chronic Graft Versus Host Disease Previous Biopsy Evaluation Change Response Type","preferredDefinition":"Text term that represents the change in disease response from a previous biopsy evaluation of cGVHD (chronic Graft vs. Host Disease).","longName":"CGVHD_RESP_CHG_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Application","id":"41C434A7-F4E3-0789-E053-F662850A2161","latestVersionIndicator":"Yes","beginDate":"2016-11-20","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-11-20","modifiedBy":"COOPERM","dateModified":"2016-12-05","changeNote":"Created for NIH Score CRF as requested by Y. Yakovlev. mc 11/18/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5583847","version":"1","preferredName":"NCI Center for Cancer Research Adverse Drug Experience Reporting System Submission Yes No Indicator","preferredDefinition":"Text term to represent submission of expedited notification that a subject has experienced an adverse event to the National Cancer Institute (NCI) Center for Cancer Research (CCR).","longName":"CCR_EP_AE_SUBM_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Application","id":"429B5A82-A581-796C-E053-F662850A6674","latestVersionIndicator":"Yes","beginDate":"2016-12-01","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-12-01","modifiedBy":"REEVESD","dateModified":"2017-02-11","changeNote":"Curated to support NCI CCR clinical trial reporting requirements.12.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5596079","version":"1","preferredName":"Activity Card Sort Instrumental Activities Total Score","preferredDefinition":"Numeric representation of the total score for the Instrumental Activities section of the Activity Card Sort.","longName":"ACS_INST_ACT_TSCR","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"ACS:Activity Card Sort, 2nd Edition, Carolyn M. Baum, PhD, OTR/L, FAOTA, and Dorothy Edwards, PhD. 2008","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4313E6D7-4AF8-788C-E053-F662850ADD1D","latestVersionIndicator":"Yes","beginDate":"2016-12-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-12-07","modifiedBy":"COOPERM","dateModified":"2016-12-08","changeNote":"Created for CCR study 16C0094 in C3D as requested by P. Asangong. mc 12/7/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5596083","version":"1","preferredName":"Activity Card Sort Low-Demand Leisure Activities Total Score","preferredDefinition":"Numeric representation of the total score for the Low Demand Leisure Activities section of the Activity Card Sort.","longName":"ACS_LOW_ACT_TSCR","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"ACS:Activity Card Sort, 2nd Edition, Carolyn M. Baum, PhD, OTR/L, FAOTA, and Dorothy Edwards, PhD. 2008","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4313E6D7-4B1F-788C-E053-F662850ADD1D","latestVersionIndicator":"Yes","beginDate":"2016-12-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-12-07","modifiedBy":"COOPERM","dateModified":"2016-12-08","changeNote":"Created for CCR study 16C0094 in C3D as requested by P. Asangong. mc 12/7/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5596084","version":"1","preferredName":"Activity Card Sort High-Demand Leisure Activities Total Score","preferredDefinition":"Numeric representation of the total score for the High Demand Leisure Activities section of the Activity Card Sort.","longName":"ACS_HIGH_ACT_TSCR","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"ACS:Activity Card Sort, 2nd Edition, Carolyn M. Baum, PhD, OTR/L, FAOTA, and Dorothy Edwards, PhD. 2008","workflowStatus":"RELEASED","registrationStatus":"Application","id":"43137719-FADC-1777-E053-F662850A6D12","latestVersionIndicator":"Yes","beginDate":"2016-12-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-12-07","modifiedBy":"COOPERM","dateModified":"2016-12-08","changeNote":"Created for CCR study 16C0094 in C3D as requested by P. Asangong. mc 12/7/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5596085","version":"1","preferredName":"Activity Card Sort Social Activities Total Score","preferredDefinition":"Numeric representation of the total score for the Social Activities section of the Activity Card Sort.","longName":"ACS_SOC_ACT_TSCR","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"ACS:Activity Card Sort, 2nd Edition, Carolyn M. Baum, PhD, OTR/L, FAOTA, and Dorothy Edwards, PhD. 2008","workflowStatus":"RELEASED","registrationStatus":"Application","id":"43137719-FB09-1777-E053-F662850A6D12","latestVersionIndicator":"Yes","beginDate":"2016-12-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-12-07","modifiedBy":"COOPERM","dateModified":"2016-12-08","changeNote":"Created for CCR study 16C0094 in C3D as requested by P. Asangong. mc 12/7/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5596086","version":"1","preferredName":"Health Assessment Questionnaire Disability Index Past Week Difficulty Ability to Dress Yourself 4 Point Scale","preferredDefinition":"A person's stated observation of the difficulty they had dressing themselves, including shoelaces and buttons, over the past week, using a 4 point Likert scale.","longName":"HAQDI_PWD_DRESS_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"HAQ-DI:Health Assessment Questionnaire Disability Index, James F. Fries, MD. 1978","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4313E6D7-4B4C-788C-E053-F662850ADD1D","latestVersionIndicator":"Yes","beginDate":"2016-12-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-12-07","modifiedBy":"COOPERM","dateModified":"2016-12-08","changeNote":"Created for CCR study 16C0094 in C3D as requested by P. Asangong. mc 12/7/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5596087","version":"1","preferredName":"Health Assessment Questionnaire Disability Index Past Week Difficulty Ability to Shampoo Hair 4 Point Scale","preferredDefinition":"A person's stated observation of the difficulty they had shampooing their hair over the past week, using a 4 point Likert scale.","longName":"HAQDI_PWD_SHAM_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"HAQ-DI:Health Assessment Questionnaire Disability Index, James F. Fries, MD. 1978","workflowStatus":"RELEASED","registrationStatus":"Application","id":"43137719-FB36-1777-E053-F662850A6D12","latestVersionIndicator":"Yes","beginDate":"2016-12-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-12-07","modifiedBy":"COOPERM","dateModified":"2016-12-08","changeNote":"Created for CCR study 16C0094 in C3D as requested by P. Asangong. mc 12/7/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5596088","version":"1","preferredName":"Health Assessment Questionnaire Disability Index Past Week Difficulty Ability to Stand Up From a Straight Chair 4 Point Scale","preferredDefinition":"A person's stated observation of the difficulty they had standing up from a straight chair over the past week, using a 4 point Likert scale.","longName":"HAQDI_PWD_STND_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"HAQ-DI:Health Assessment Questionnaire Disability Index, James F. Fries, MD. 1978","workflowStatus":"RELEASED","registrationStatus":"Application","id":"43137719-FB63-1777-E053-F662850A6D12","latestVersionIndicator":"Yes","beginDate":"2016-12-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-12-07","modifiedBy":"COOPERM","dateModified":"2016-12-08","changeNote":"Created for CCR study 16C0094 in C3D as requested by P. Asangong. mc 12/7/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5596089","version":"1","preferredName":"Health Assessment Questionnaire Disability Index Past Week Difficulty Ability to Get In and Out of Bed 4 Point Scale","preferredDefinition":"A person's stated observation of the difficulty they had getting in and out of bed over the past week, using a 4 point Likert scale.","longName":"HAQDI_PWD_BED_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"HAQ-DI:Health Assessment Questionnaire Disability Index, James F. Fries, MD. 1978","workflowStatus":"RELEASED","registrationStatus":"Application","id":"43151845-8D91-55DD-E053-F662850AE4D5","latestVersionIndicator":"Yes","beginDate":"2016-12-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-12-07","modifiedBy":"COOPERM","dateModified":"2016-12-08","changeNote":"Created for CCR study 16C0094 in C3D as requested by P. Asangong. mc 12/7/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5596094","version":"1","preferredName":"Health Assessment Questionnaire Disability Index Past Week Difficulty Ability to Cut Own Meat 4 Point Scale","preferredDefinition":"A person's stated observation of the difficulty they had cutting their own meat over the past week, using a 4 point Likert scale.","longName":"HAQDI_PWD_CUT_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"HAQ-DI:Health Assessment Questionnaire Disability Index, James F. Fries, MD. 1978","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4313E6D7-4BB5-788C-E053-F662850ADD1D","latestVersionIndicator":"Yes","beginDate":"2016-12-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-12-07","modifiedBy":"COOPERM","dateModified":"2016-12-08","changeNote":"Created for CCR study 16C0094 in C3D as requested by P. Asangong. mc 12/7/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5596095","version":"1","preferredName":"Health Assessment Questionnaire Disability Index Past Week Difficulty Ability to Lift Full Cup or Glass to Mouth 4 Point Scale","preferredDefinition":"A person's stated observation of the difficulty they had lifting a full cup or glass to their mouth over the past week, using a 4 point Likert scale.","longName":"HAQDI_PWD_LIFT_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"HAQ-DI:Health Assessment Questionnaire Disability Index, James F. Fries, MD. 1978","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4313E6D7-4BE2-788C-E053-F662850ADD1D","latestVersionIndicator":"Yes","beginDate":"2016-12-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-12-07","modifiedBy":"COOPERM","dateModified":"2016-12-08","changeNote":"Created for CCR study 16C0094 in C3D as requested by P. Asangong. mc 12/7/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5596096","version":"1","preferredName":"Health Assessment Questionnaire Disability Index Past Week Difficulty Ability to Open New Milk Carton 4 Point Scale","preferredDefinition":"A person's stated observation of the difficulty they had opening a new milk carton over the past week, using a 4 point Likert scale.","longName":"HAQDI_PWD_OPEN_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"HAQ-DI:Health Assessment Questionnaire Disability Index, James F. Fries, MD. 1978","workflowStatus":"RELEASED","registrationStatus":"Application","id":"43152066-4CC0-650F-E053-F662850A59E3","latestVersionIndicator":"Yes","beginDate":"2016-12-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-12-07","modifiedBy":"COOPERM","dateModified":"2016-12-08","changeNote":"Created for CCR study 16C0094 in C3D as requested by P. Asangong. mc 12/7/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5596097","version":"1","preferredName":"Health Assessment Questionnaire Disability Index Past Week Difficulty Ability to Walk Outdoors on Flat Ground 4 Point Scale","preferredDefinition":"A person's stated observation of the difficulty they had walking outdoors on flat ground over the past week, using a 4 point Likert scale.","longName":"HAQDI_PWD_WALK_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"HAQ-DI:Health Assessment Questionnaire Disability Index, James F. Fries, MD. 1978","workflowStatus":"RELEASED","registrationStatus":"Application","id":"43152066-4CED-650F-E053-F662850A59E3","latestVersionIndicator":"Yes","beginDate":"2016-12-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-12-07","modifiedBy":"COOPERM","dateModified":"2016-12-08","changeNote":"Created for CCR study 16C0094 in C3D as requested by P. Asangong. mc 12/7/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5596098","version":"1","preferredName":"Health Assessment Questionnaire Disability Index Past Week Difficulty Ability to Climb Up 5 Steps 4 Point Scale","preferredDefinition":"A person's stated observation of the difficulty they had climbing five steps over the past week, using a 4 point Likert scale.","longName":"HAQDI_PWD_CLMB_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"HAQ-DI:Health Assessment Questionnaire Disability Index, James F. Fries, MD. 1978","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4313E6D7-4C0F-788C-E053-F662850ADD1D","latestVersionIndicator":"Yes","beginDate":"2016-12-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-12-07","modifiedBy":"COOPERM","dateModified":"2016-12-08","changeNote":"Created for CCR study 16C0094 in C3D as requested by P. Asangong. mc 12/7/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5596100","version":"1","preferredName":"Health Assessment Questionnaire Disability Index Past Week Use Aid or Device for Activity Type","preferredDefinition":"A person's stated observation of the kind of aids or devices they usually used over the past week, using a 4 point Likert scale.","longName":"HAQDI_PW_AID_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"HAQ-DI:Health Assessment Questionnaire Disability Index, James F. Fries, MD. 1978","workflowStatus":"RELEASED","registrationStatus":"Application","id":"43152066-4D3A-650F-E053-F662850A59E3","latestVersionIndicator":"Yes","beginDate":"2016-12-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-12-07","modifiedBy":"COOPERM","dateModified":"2016-12-08","changeNote":"Created for CCR study 16C0094 in C3D as requested by P. Asangong. mc 12/7/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5596101","version":"1","preferredName":"Health Assessment Questionnaire Disability Index Past Week Need Help from Another Person Category","preferredDefinition":"A person's stated observation of the kind of activity for which they usually needed help from another person over the past week, using a 4 point Likert scale.","longName":"HAQDI_PW_HELP_CAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"HAQ-DI:Health Assessment Questionnaire Disability Index, James F. Fries, MD. 1978","workflowStatus":"RELEASED","registrationStatus":"Application","id":"43152066-4D67-650F-E053-F662850A59E3","latestVersionIndicator":"Yes","beginDate":"2016-12-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-12-07","modifiedBy":"COOPERM","dateModified":"2016-12-08","changeNote":"Created for CCR study 16C0094 in C3D as requested by P. Asangong. mc 12/7/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5596102","version":"1","preferredName":"Health Assessment Questionnaire Disability Index Past Week Difficulty Ability to Wash and Dry Body 4 Point Scale","preferredDefinition":"A person's stated observation of the difficulty they had washing and drying their body over the past week, using a 4 point Likert scale.","longName":"HAQDI_PWD_WASH_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"HAQ-DI:Health Assessment Questionnaire Disability Index, James F. Fries, MD. 1978","workflowStatus":"RELEASED","registrationStatus":"Application","id":"43152066-4D94-650F-E053-F662850A59E3","latestVersionIndicator":"Yes","beginDate":"2016-12-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-12-07","modifiedBy":"COOPERM","dateModified":"2016-12-08","changeNote":"Created for CCR study 16C0094 in C3D as requested by P. Asangong. mc 12/7/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5596103","version":"1","preferredName":"Health Assessment Questionnaire Disability Index Past Week Difficulty Ability to Take Tub Bath  4 Point Scale","preferredDefinition":"A person's stated observation of the difficulty they had taking a tub bath over the past week, using a 4 point Likert scale.","longName":"HAQDI_PWD_BATH_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"HAQ-DI:Health Assessment Questionnaire Disability Index, James F. Fries, MD. 1978","workflowStatus":"RELEASED","registrationStatus":"Application","id":"43152066-4DC1-650F-E053-F662850A59E3","latestVersionIndicator":"Yes","beginDate":"2016-12-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-12-07","modifiedBy":"COOPERM","dateModified":"2016-12-08","changeNote":"Created for CCR study 16C0094 in C3D as requested by P. Asangong. mc 12/7/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5596104","version":"1","preferredName":"Health Assessment Questionnaire Disability Index Past Week Difficulty Ability to Get On and Off Toilet  4 Point Scale","preferredDefinition":"A person's stated observation of the difficulty they had getting on and off the toilet over the past week, using a 4 point Likert scale.","longName":"HAQDI_PWD_TOIL_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"HAQ-DI:Health Assessment Questionnaire Disability Index, James F. Fries, MD. 1978","workflowStatus":"RELEASED","registrationStatus":"Application","id":"43152066-4DEE-650F-E053-F662850A59E3","latestVersionIndicator":"Yes","beginDate":"2016-12-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-12-07","modifiedBy":"COOPERM","dateModified":"2016-12-08","changeNote":"Created for CCR study 16C0094 in C3D as requested by P. Asangong. mc 12/7/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5596105","version":"1","preferredName":"Health Assessment Questionnaire Disability Index Past Week Difficulty Ability to Reach and Get Down 5 Pound Object From Above Head 4 Point Scale","preferredDefinition":"A person's stated observation of the difficulty they had reaching and getting down a five pound object, such as a bag of sugar, from above their head over the past week, using a 4 point Likert scale.","longName":"HAQDI_PWD_RCH5_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"HAQ-DI:Health Assessment Questionnaire Disability Index, James F. Fries, MD. 1978","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4313E6D7-4C3F-788C-E053-F662850ADD1D","latestVersionIndicator":"Yes","beginDate":"2016-12-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-12-07","modifiedBy":"COOPERM","dateModified":"2016-12-08","changeNote":"Created for CCR study 16C0094 in C3D as requested by P. Asangong. mc 12/7/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5596106","version":"1","preferredName":"Health Assessment Questionnaire Disability Index Past Week Difficulty Ability to Bend Down to Pick up Clothing from the Floor 4 Point Scale","preferredDefinition":"A person's stated observation of the difficulty they had bending down to pick up clothing from the floor over the past week, using a 4 point Likert scale.","longName":"HAQDI_PWD_BEND_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"HAQ-DI:Health Assessment Questionnaire Disability Index, James F. Fries, MD. 1978","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4313E6D7-4C6C-788C-E053-F662850ADD1D","latestVersionIndicator":"Yes","beginDate":"2016-12-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-12-07","modifiedBy":"COOPERM","dateModified":"2016-12-08","changeNote":"Created for CCR study 16C0094 in C3D as requested by P. Asangong. mc 12/7/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5596107","version":"1","preferredName":"Health Assessment Questionnaire Disability Index Past Week Difficulty Ability to Open Car Door 4 Point Scale","preferredDefinition":"A person's stated observation of the difficulty they had opening car doors over the past week, using a 4 point Likert scale.","longName":"HAQDI_PWD_OCAR_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"HAQ-DI:Health Assessment Questionnaire Disability Index, James F. Fries, MD. 1978","workflowStatus":"RELEASED","registrationStatus":"Application","id":"43152066-4E1B-650F-E053-F662850A59E3","latestVersionIndicator":"Yes","beginDate":"2016-12-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-12-07","modifiedBy":"COOPERM","dateModified":"2016-12-08","changeNote":"Created for CCR study 16C0094 in C3D as requested by P. Asangong. mc 12/7/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5596108","version":"1","preferredName":"Health Assessment Questionnaire Disability Index Past Week Difficulty Ability to Open Previously Opened Jar 4 Point Scale","preferredDefinition":"A person's stated observation of the difficulty they had opening previously opened jars over the past week, using a 4 point Likert scale.","longName":"HAQDI_PWD_JAR_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"HAQ-DI:Health Assessment Questionnaire Disability Index, James F. Fries, MD. 1978","workflowStatus":"RELEASED","registrationStatus":"Application","id":"43152066-4E48-650F-E053-F662850A59E3","latestVersionIndicator":"Yes","beginDate":"2016-12-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-12-07","modifiedBy":"COOPERM","dateModified":"2016-12-08","changeNote":"Created for CCR study 16C0094 in C3D as requested by P. Asangong. mc 12/7/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5596109","version":"1","preferredName":"Health Assessment Questionnaire Disability Index Past Week Difficulty Ability to Turn Faucets On and Off 4 Point Scale","preferredDefinition":"A person's stated observation of the difficulty they had turning faucets on and off over the past week, using a 4 point Likert scale.","longName":"HAQDI_PWD_FCET_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"HAQ-DI:Health Assessment Questionnaire Disability Index, James F. Fries, MD. 1978","workflowStatus":"RELEASED","registrationStatus":"Application","id":"43152066-4E75-650F-E053-F662850A59E3","latestVersionIndicator":"Yes","beginDate":"2016-12-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-12-07","modifiedBy":"COOPERM","dateModified":"2016-12-08","changeNote":"Created for CCR study 16C0094 in C3D as requested by P. Asangong. mc 12/7/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5596110","version":"1","preferredName":"Health Assessment Questionnaire Disability Index Past Week Difficulty Ability to Run Errands and Shop 4 Point Scale","preferredDefinition":"A person's stated observation of the difficulty they had running errands and shopping over the past week, using a 4 point Likert scale.","longName":"HAQDI_PWD_ERND_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"HAQ-DI:Health Assessment Questionnaire Disability Index, James F. Fries, MD. 1978","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4313E6D7-4C99-788C-E053-F662850ADD1D","latestVersionIndicator":"Yes","beginDate":"2016-12-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-12-07","modifiedBy":"COOPERM","dateModified":"2016-12-08","changeNote":"Created for CCR study 16C0094 in C3D as requested by P. Asangong. mc 12/7/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5596111","version":"1","preferredName":"Health Assessment Questionnaire Disability Index Questionnaire Past Week Difficulty Ability to Get In and Out of a Car Activity Difficulty 4 Point Scale","preferredDefinition":"A person's stated observation of the difficulty they had getting in and out of a car over the past week, using a 4 point Likert scale.","longName":"HAQDI_PWD_IOCR_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"HAQ-DI:Health Assessment Questionnaire Disability Index, James F. Fries, MD. 1978","workflowStatus":"RELEASED","registrationStatus":"Application","id":"43152066-4EA2-650F-E053-F662850A59E3","latestVersionIndicator":"Yes","beginDate":"2016-12-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-12-07","modifiedBy":"COOPERM","dateModified":"2017-03-10","changeNote":"Created for CCR study 16C0094 in C3D as requested by P. Asangong. mc 12/7/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5596112","version":"1","preferredName":"Health Assessment Questionnaire Disability Index Past Week Difficulty Ability to Do Chores 4 Point Scale","preferredDefinition":"A person's stated observation of the difficulty they had doing chores over the past week, using a 4 point Likert scale.","longName":"HAQDI_PWD_CHOR_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"HAQ-DI:Health Assessment Questionnaire Disability Index, James F. Fries, MD. 1978","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4313E6D7-4CC6-788C-E053-F662850ADD1D","latestVersionIndicator":"Yes","beginDate":"2016-12-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-12-07","modifiedBy":"COOPERM","dateModified":"2016-12-08","changeNote":"Created for CCR study 16C0094 in C3D as requested by P. Asangong. mc 12/7/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5596113","version":"1","preferredName":"Health Assessment Questionnaire Disability Index Past Week Extent Ability to Carry Out Everyday Physical Activity 5 Point Scale","preferredDefinition":"A person's stated observation of the extent to which they carried out their everyday physical activities, such as walking, climbing stairs, carrying groceries or moving a chair, over the past week, using a 4 point Likert scale.","longName":"HAQDI_PHYS_ACT_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"HAQ-DI:Health Assessment Questionnaire Disability Index, James F. Fries, MD. 1978","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4313E6D7-4CF3-788C-E053-F662850ADD1D","latestVersionIndicator":"Yes","beginDate":"2016-12-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-12-07","modifiedBy":"COOPERM","dateModified":"2016-12-08","changeNote":"Created for CCR study 16C0094 in C3D as requested by P. Asangong. mc 12/7/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5596114","version":"1","preferredName":"Health Assessment Questionnaire Disability Index Past Week How Much Pain Scale","preferredDefinition":"A person's stated observation of how much pain they had over the past week, using a visual analogue scale where zero represents no pain and 100 represents severe pain.","longName":"HAQDI_PW_PAIN_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"HAQ-DI:Health Assessment Questionnaire Disability Index, James F. Fries, MD. 1978","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4313E6D7-4D20-788C-E053-F662850ADD1D","latestVersionIndicator":"Yes","beginDate":"2016-12-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-12-07","modifiedBy":"COOPERM","dateModified":"2016-12-08","changeNote":"Created for CCR study 16C0094 in C3D as requested by P. Asangong. mc 12/7/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5596115","version":"1","preferredName":"Health Assessment Questionnaire Disability Index Past Week How Well Doing Health Rating Scale","preferredDefinition":"A person's stated rating of how well they were doing related to their health over the past week, using a visual analogue scale where zero represents very well and 100 represents very poor.","longName":"HAQDI_HEALTH_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"HAQ-DI:Health Assessment Questionnaire Disability Index, James F. Fries, MD. 1978","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4313E6D7-4D4D-788C-E053-F662850ADD1D","latestVersionIndicator":"Yes","beginDate":"2016-12-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-12-07","modifiedBy":"COOPERM","dateModified":"2016-12-08","changeNote":"Created for CCR study 16C0094 in C3D as requested by P. Asangong. mc 12/7/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5596116","version":"1","preferredName":"Multidimensional Fatigue Inventory 1 How True Feel Fit Score 5 Point Scale","preferredDefinition":"A person's stated agreement with how true a statement of I feel fit is to them, using a 5 point visual analogue scale.","longName":"MFI_1_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"MFI:Multi-dimensional Fatigue Inventory, Smets EM, Garssen B, Bonke B, De Haes JC. J Psychosom Res., April 1995","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4315C76A-CBF7-2ADD-E053-F662850AC831","latestVersionIndicator":"Yes","beginDate":"2016-12-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-12-07","modifiedBy":"COOPERM","dateModified":"2016-12-08","changeNote":"Created for CCR study 16C0094 in C3D as requested by P. Asangong. mc 12/7/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5596117","version":"1","preferredName":"Multidimensional Fatigue Inventory 2 How True Feel Physically Able to Only Do a Little Score 5 Point Scale","preferredDefinition":"A person's stated agreement with how true a statement of physically I feel only able to do a little is, using a 5 point visual analogue scale.","longName":"MFI_2_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"MFI:Multi-dimensional Fatigue Inventory, Smets EM, Garssen B, Bonke B, De Haes JC. J Psychosom Res., April 1995","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4313E6D7-4D7A-788C-E053-F662850ADD1D","latestVersionIndicator":"Yes","beginDate":"2016-12-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-12-07","modifiedBy":"COOPERM","dateModified":"2016-12-08","changeNote":"Created for CCR study 16C0094 in C3D as requested by P. Asangong. mc 12/7/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5596118","version":"1","preferredName":"Multidimensional Fatigue Inventory 3 How True Feel Very Active Score 5 Point Scale","preferredDefinition":"A person's stated agreement with how true a statement of I feel very active is, using a 5 point visual analogue scale.","longName":"MFI_3_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"MFI:Multi-dimensional Fatigue Inventory, Smets EM, Garssen B, Bonke B, De Haes JC. J Psychosom Res., April 1995","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4313E6D7-4DA7-788C-E053-F662850ADD1D","latestVersionIndicator":"Yes","beginDate":"2016-12-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-12-07","modifiedBy":"COOPERM","dateModified":"2016-12-08","changeNote":"Created for CCR study 16C0094 in C3D as requested by P. Asangong. mc 12/7/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5596119","version":"1","preferredName":"Multidimensional Fatigue Inventory 4 How True Feel Like Doing All Sorts of Nice Things Score 5 Point Scale","preferredDefinition":"A person's stated agreement with how true a statement of I feel like doing all sorts of nice things is, using a 5 point visual analogue scale.","longName":"MFI_4_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"MFI:Multi-dimensional Fatigue Inventory, Smets EM, Garssen B, Bonke B, De Haes JC. J Psychosom Res., April 1995","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4313E6D7-4DF2-788C-E053-F662850ADD1D","latestVersionIndicator":"Yes","beginDate":"2016-12-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-12-07","modifiedBy":"COOPERM","dateModified":"2016-12-08","changeNote":"Created for CCR study 16C0094 in C3D as requested by P. Asangong. mc 12/7/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5596120","version":"1","preferredName":"Multidimensional Fatigue Inventory 5 How True Feel Tired Score 5 Point Scale","preferredDefinition":"A person's stated agreement with how true a statement of I feel tired is, using a 5 point visual analogue scale.","longName":"MFI_5_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"MFI:Multi-dimensional Fatigue Inventory, Smets EM, Garssen B, Bonke B, De Haes JC. J Psychosom Res., April 1995","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4315C76A-CC6A-2ADD-E053-F662850AC831","latestVersionIndicator":"Yes","beginDate":"2016-12-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-12-07","modifiedBy":"COOPERM","dateModified":"2016-12-08","changeNote":"Created for CCR study 16C0094 in C3D as requested by P. Asangong. mc 12/7/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5596121","version":"1","preferredName":"Multidimensional Fatigue Inventory 6 How True Think I Do a Lot in a Day Score 5 Point Scale","preferredDefinition":"A person's stated agreement with how true a statement of I think I do a lot in a day is, using a 5 point visual analogue scale.","longName":"MFI_6_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"MFI:Multi-dimensional Fatigue Inventory, Smets EM, Garssen B, Bonke B, De Haes JC. J Psychosom Res., April 1995","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4315C76A-CC97-2ADD-E053-F662850AC831","latestVersionIndicator":"Yes","beginDate":"2016-12-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-12-07","modifiedBy":"COOPERM","dateModified":"2016-12-08","changeNote":"Created for CCR study 16C0094 in C3D as requested by P. Asangong. mc 12/7/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5596122","version":"1","preferredName":"Multidimensional Fatigue Inventory 7 How True When Doing Something Can Keep Thoughts on It Score 5 Point Scale","preferredDefinition":"A person's stated agreement with how true a statement of when I am doing something, I can keep my thoughts on it is, using a 5 point visual analogue scale.","longName":"MFI_7_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"MFI:Multi-dimensional Fatigue Inventory, Smets EM, Garssen B, Bonke B, De Haes JC. J Psychosom Res., April 1995","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4313E6D7-4EB3-788C-E053-F662850ADD1D","latestVersionIndicator":"Yes","beginDate":"2016-12-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-12-07","modifiedBy":"COOPERM","dateModified":"2016-12-08","changeNote":"Created for CCR study 16C0094 in C3D as requested by P. Asangong. mc 12/7/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5596123","version":"1","preferredName":"Multidimensional Fatigue Inventory 9 How True Dread Having to do Things Score 5 Point Scale","preferredDefinition":"A person's stated agreement with how true a statement of I dread having to do things is, using a 5 point visual analogue scale.","longName":"MFI_9_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"MFI:Multi-dimensional Fatigue Inventory, Smets EM, Garssen B, Bonke B, De Haes JC. J Psychosom Res., April 1995","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4313E6D7-4EE0-788C-E053-F662850ADD1D","latestVersionIndicator":"Yes","beginDate":"2016-12-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-12-07","modifiedBy":"COOPERM","dateModified":"2016-12-08","changeNote":"Created for CCR study 16C0094 in C3D as requested by P. Asangong. mc 12/7/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5596124","version":"1","preferredName":"Multidimensional Fatigue Inventory 10 How True Do Very Little in a Day Score 5 Point Scale","preferredDefinition":"A person's stated agreement with how true a statement of I think I do very little in a day is, using a 5 point visual analogue scale.","longName":"MFI_10_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"MFI:Multi-dimensional Fatigue Inventory, Smets EM, Garssen B, Bonke B, De Haes JC. J Psychosom Res., April 1995","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4313E6D7-4F0D-788C-E053-F662850ADD1D","latestVersionIndicator":"Yes","beginDate":"2016-12-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-12-07","modifiedBy":"COOPERM","dateModified":"2016-12-08","changeNote":"Created for CCR study 16C0094 in C3D as requested by P. Asangong. mc 12/7/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5596125","version":"1","preferredName":"Multidimensional Fatigue Inventory 11 How True Concentrate Well Score 5 Point Scale","preferredDefinition":"A person's stated agreement with how true a statement of I can concentrate well is, using a 5 point visual analogue scale.","longName":"MFI_11_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"MFI:Multi-dimensional Fatigue Inventory, Smets EM, Garssen B, Bonke B, De Haes JC. J Psychosom Res., April 1995","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4313E6D7-4F3A-788C-E053-F662850ADD1D","latestVersionIndicator":"Yes","beginDate":"2016-12-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-12-07","modifiedBy":"COOPERM","dateModified":"2016-12-08","changeNote":"Created for CCR study 16C0094 in C3D as requested by P. Asangong. mc 12/7/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5596126","version":"1","preferredName":"Multidimensional Fatigue Inventory 12 How True Am Rested Score 5 Point Scale","preferredDefinition":"A person's stated agreement with how true a statement of I am rested is, using a 5 point visual analogue scale.","longName":"MFI_12_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"MFI:Multi-dimensional Fatigue Inventory, Smets EM, Garssen B, Bonke B, De Haes JC. J Psychosom Res., April 1995","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4313E6D7-4F6A-788C-E053-F662850ADD1D","latestVersionIndicator":"Yes","beginDate":"2016-12-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-12-07","modifiedBy":"COOPERM","dateModified":"2016-12-08","changeNote":"Created for CCR study 16C0094 in C3D as requested by P. Asangong. mc 12/7/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5596127","version":"1","preferredName":"Multidimensional Fatigue Inventory 13 How True Takes a Lot of Effort to Concentrate on Things Score 5 Point Scale","preferredDefinition":"A person's stated agreement with how true a statement of it takes a lot of effort to concentrate on things is to them, using a 5 point visual analogue scale.","longName":"MFI_13_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"MFI:Multi-dimensional Fatigue Inventory, Smets EM, Garssen B, Bonke B, De Haes JC. J Psychosom Res., April 1995","workflowStatus":"RELEASED","registrationStatus":"Application","id":"43162F91-E8A0-0F4D-E053-F662850A2397","latestVersionIndicator":"Yes","beginDate":"2016-12-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-12-07","modifiedBy":"COOPERM","dateModified":"2016-12-08","changeNote":"Created for CCR study 16C0094 in C3D as requested by P. Asangong. mc 12/7/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5596128","version":"1","preferredName":"Multidimensional Fatigue Inventory 14 How True Physically Feel in Bad Condition Score 5 Point Scale","preferredDefinition":"A person's stated agreement with how true a statement of physically I feel I am in a bad condition is, using a 5 point visual analogue scale.","longName":"MFI_14_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"MFI:Multi-dimensional Fatigue Inventory, Smets EM, Garssen B, Bonke B, De Haes JC. J Psychosom Res., April 1995","workflowStatus":"RELEASED","registrationStatus":"Application","id":"43162F91-E8CD-0F4D-E053-F662850A2397","latestVersionIndicator":"Yes","beginDate":"2016-12-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-12-07","modifiedBy":"COOPERM","dateModified":"2016-12-08","changeNote":"Created for CCR study 16C0094 in C3D as requested by P. Asangong. mc 12/7/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5596129","version":"1","preferredName":"Multidimensional Fatigue Inventory 15 How True Have Lots of Plans Score 5 Point Scale","preferredDefinition":"A person's stated agreement with how true a statement of I have a lot of plans is, using a 5 point visual analogue scale.","longName":"MFI_15_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"MFI:Multi-dimensional Fatigue Inventory, Smets EM, Garssen B, Bonke B, De Haes JC. J Psychosom Res., April 1995","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4313E6D7-4FE2-788C-E053-F662850ADD1D","latestVersionIndicator":"Yes","beginDate":"2016-12-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-12-07","modifiedBy":"COOPERM","dateModified":"2016-12-08","changeNote":"Created for CCR study 16C0094 in C3D as requested by P. Asangong. mc 12/7/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5596130","version":"1","preferredName":"Multidimensional Fatigue Inventory 16 How True Tire Easily Score 5 Point Scale","preferredDefinition":"A person's stated agreement with how true a statement of I tire easily is, using a 5 point visual analogue scale.","longName":"MFI_16_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"MFI:Multi-dimensional Fatigue Inventory, Smets EM, Garssen B, Bonke B, De Haes JC. J Psychosom Res., April 1995","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4313E6D7-500F-788C-E053-F662850ADD1D","latestVersionIndicator":"Yes","beginDate":"2016-12-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-12-07","modifiedBy":"COOPERM","dateModified":"2016-12-08","changeNote":"Created for CCR study 16C0094 in C3D as requested by P. Asangong. mc 12/7/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5596136","version":"1","preferredName":"Multidimensional Fatigue Inventory 17 How True Get Little Done Score 5 Point Scale","preferredDefinition":"A person's stated agreement with how true a statement of I get little done is, using a 5 point visual analogue scale.","longName":"MFI_17_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"MFI:Multi-dimensional Fatigue Inventory, Smets EM, Garssen B, Bonke B, De Haes JC. J Psychosom Res., April 1995","workflowStatus":"RELEASED","registrationStatus":"Application","id":"43175978-A1FF-1E21-E053-F662850AB300","latestVersionIndicator":"Yes","beginDate":"2016-12-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-12-07","modifiedBy":"COOPERM","dateModified":"2016-12-08","changeNote":"Created for CCR study 16C0094 in C3D as requested by P. Asangong. mc 12/7/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5596137","version":"1","preferredName":"Multidimensional Fatigue Inventory 18 How True Don't Feel Like Doing Anything Score 5 Point Scale","preferredDefinition":"A person's stated agreement with how true a statement of I don't feel like doing anything is, using a 5 point visual analogue scale.","longName":"MFI_18_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"MFI:Multi-dimensional Fatigue Inventory, Smets EM, Garssen B, Bonke B, De Haes JC. J Psychosom Res., April 1995","workflowStatus":"RELEASED","registrationStatus":"Application","id":"431765D8-B020-2C64-E053-F662850A73C2","latestVersionIndicator":"Yes","beginDate":"2016-12-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-12-07","modifiedBy":"COOPERM","dateModified":"2016-12-08","changeNote":"Created for CCR study 16C0094 in C3D as requested by P. Asangong. mc 12/7/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5596138","version":"1","preferredName":"Multidimensional Fatigue Inventory 19 How True Thoughts Easily Wander Score 5 Point Scale","preferredDefinition":"A person's stated agreement with how true a statement of my thoughts easily wander is, using a 5 point visual analogue scale.","longName":"MFI_19_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"MFI:Multi-dimensional Fatigue Inventory, Smets EM, Garssen B, Bonke B, De Haes JC. J Psychosom Res., April 1995","workflowStatus":"RELEASED","registrationStatus":"Application","id":"431765D8-B04D-2C64-E053-F662850A73C2","latestVersionIndicator":"Yes","beginDate":"2016-12-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-12-07","modifiedBy":"COOPERM","dateModified":"2016-12-08","changeNote":"Created for CCR study 16C0094 in C3D as requested by P. Asangong. mc 12/7/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5596139","version":"1","preferredName":"Multidimensional Fatigue Inventory 20 How True Physically Feel in Excellent Condition Score 5 Point Scale","preferredDefinition":"A person's stated agreement with how true a statement of physically I feel I am in an excellent condition is, using a 5 point visual analogue scale.","longName":"MFI_20_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"MFI:Multi-dimensional Fatigue Inventory, Smets EM, Garssen B, Bonke B, De Haes JC. J Psychosom Res., April 1995","workflowStatus":"RELEASED","registrationStatus":"Application","id":"43176BEF-FA1B-3270-E053-F662850A801F","latestVersionIndicator":"Yes","beginDate":"2016-12-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-12-07","modifiedBy":"COOPERM","dateModified":"2016-12-08","changeNote":"Created for CCR study 16C0094 in C3D as requested by P. Asangong. mc 12/7/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5597223","version":"1","preferredName":"Multidimensional Fatigue Inventory 8 How True Physically Can Take on a Lot Score 5 Point Scale","preferredDefinition":"A person's stated agreement with how true a statement of physically I can take on a lot is, using a 5 point visual analogue scale.","longName":"MFI_8_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"MFI:Multi-dimensional Fatigue Inventory, Smets EM, Garssen B, Bonke B, De Haes JC. J Psychosom Res., April 1995","workflowStatus":"RELEASED","registrationStatus":"Application","id":"43193300-5288-512C-E053-F662850A715E","latestVersionIndicator":"Yes","beginDate":"2016-12-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-12-07","modifiedBy":"COOPERM","dateModified":"2016-12-08","changeNote":"Created for CCR study 16C0094 in C3D as requested by P. Asangong. mc 12/7/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5598543","version":"1","preferredName":"Multidimensional Fatigue Inventory Total Global Score","preferredDefinition":"Numeric representation of the total global score for the Multidimensional Fatigue Inventory.","longName":"MFI_TTL_GLB_SCR","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"MFI:Multi-dimensional Fatigue Inventory, Smets EM, Garssen B, Bonke B, De Haes JC. J Psychosom Res., April 1995","workflowStatus":"RELEASED","registrationStatus":"Application","id":"432C08A8-9A3B-5D5C-E053-F662850A8D1C","latestVersionIndicator":"Yes","beginDate":"2016-12-08","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-12-08","modifiedBy":"COOPERM","dateModified":"2017-03-06","changeNote":"Created for CCR study 16C0094 in C3D as requested by P. Asangong. mc 12/8/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5607580","version":"1","preferredName":"Glioblastoma RANO Criteria Response Type","preferredDefinition":"Response status based on Glioblastoma Response Assessment in Neuro-Oncology Criteria (RANO).","longName":"GBM_RANO_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4405383D-EEAE-7588-E053-F662850A313B","latestVersionIndicator":"Yes","beginDate":"2016-12-19","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-12-19","modifiedBy":"COOPERM","dateModified":"2017-03-10","changeNote":"Created for GBM Pembro HSPPC protocol as requested by Y. Yakovlev. mc 12/19/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5607584","version":"1","preferredName":"Glioblastoma RANO Criteria Response Date","preferredDefinition":"Date of response based on Response Assessment in Neuro-Oncology Criteria Response (RANO) criteria for Glioblastoma.","longName":"GBM_RANO_DT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4404FDC6-821A-0F30-E053-F662850ADAC1","latestVersionIndicator":"Yes","beginDate":"2016-12-19","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-12-19","modifiedBy":"COOPERM","dateModified":"2017-03-10","changeNote":"Created for GBM Pembro HSPPC protocol as requested by Y. Yakovlev. mc 12/19/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5607585","version":"1","preferredName":"Glioblastoma iRANO Criteria Response Status","preferredDefinition":"Response status based on Glioblastoma Immunotherapy Response Assessment in Neuro-Oncology Criteria (iRANO).","longName":"GBM_IRANO_ST","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"44064941-DCF1-3255-E053-F662850A158D","latestVersionIndicator":"Yes","beginDate":"2016-12-19","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-12-19","modifiedBy":"COOPERM","dateModified":"2016-12-30","changeNote":"Created for GBM Pembro HSPPC protocol as requested by Y. Yakovlev. mc 12/19/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5607586","version":"1","preferredName":"Glioblastoma iRANO Criteria Response Date","preferredDefinition":"Date of response based on iRANO criteria for Glioblastoma.","longName":"GBM_IRANO_DT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"44064FF9-3D29-324B-E053-F662850A78C7","latestVersionIndicator":"Yes","beginDate":"2016-12-19","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-12-19","modifiedBy":"COOPERM","dateModified":"2016-12-30","changeNote":"Created for GBM Pembro HSPPC protocol as requested by Y. Yakovlev. mc 12/19/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5607587","version":"1","preferredName":"Glioblastoma iRANO Criteria Actual Progression Date","preferredDefinition":"Date of disease progression response status based on iRANO criteria for Glioblastoma.","longName":"GBM_IRANO_ACTL_PD_DT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"440643B5-309D-324D-E053-F662850A781B","latestVersionIndicator":"Yes","beginDate":"2016-12-19","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-12-19","modifiedBy":"COOPERM","dateModified":"2016-12-30","changeNote":"Created for GBM Pembro HSPPC protocol as requested by Y. Yakovlev. mc 12/19/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5626393","version":"1","preferredName":"Organ System Skin Symptom Type","preferredDefinition":"Text term that represents the kind of skin symptom.","longName":"ORGSYS_SKIN_SYMP_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"45E7631A-4318-6CCF-E053-F662850AE353","latestVersionIndicator":"Yes","beginDate":"2017-01-12","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-01-12","modifiedBy":"COOPERM","dateModified":"2017-01-20","changeNote":"Created for 17-C-0027 Chronic GVHD Review of Systems History Screening form. mc 1/12/17","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5626394","version":"1","preferredName":"Organ System Skin Symptom Indicator","preferredDefinition":"Indicator of whether or not there is a history of skin symptoms.","longName":"ORGSYS_SKIN_SYMP_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"45E7631A-4345-6CCF-E053-F662850AE353","latestVersionIndicator":"Yes","beginDate":"2017-01-12","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-01-12","modifiedBy":"COOPERM","dateModified":"2017-01-20","changeNote":"Created for 17-C-0027 Chronic GVHD Review of Systems History Screening form. mc 1/12/17","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5626395","version":"1","preferredName":"Organ System Eye Symptom Indicator","preferredDefinition":"Indicator of whether or not there is a history of eye symptoms.","longName":"ORGSYS_EYE_SYMP_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"45E7EAC1-C928-39E1-E053-F662850A7672","latestVersionIndicator":"Yes","beginDate":"2017-01-12","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-01-12","modifiedBy":"COOPERM","dateModified":"2017-01-20","changeNote":"Created for 17-C-0027 Chronic GVHD Review of Systems History Screening form. mc 1/12/17","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5626396","version":"1","preferredName":"Organ System Eye Symptom Type","preferredDefinition":"Text term that represents the kind of eye symptom.","longName":"ORGSYS_EYE_SYMP_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"45E7E809-AFCF-241A-E053-F662850A1E0C","latestVersionIndicator":"Yes","beginDate":"2017-01-12","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-01-12","modifiedBy":"COOPERM","dateModified":"2017-01-20","changeNote":"Created for 17-C-0027 Chronic GVHD Review of Systems History Screening form. mc 1/12/17","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5626401","version":"1","preferredName":"Organ System Mouth Symptom Type","preferredDefinition":"Text term that represents the kind of mouth symptom.","longName":"ORGSYS_MTH_SYMP_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"45E7EAC1-C96A-39E1-E053-F662850A7672","latestVersionIndicator":"Yes","beginDate":"2017-01-12","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-01-12","modifiedBy":"COOPERM","dateModified":"2017-01-20","changeNote":"Created for 17-C-0027 Chronic GVHD Review of Systems History Screening form. mc 1/12/17","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5626402","version":"1","preferredName":"Organ System Mouth Symptom Indicator","preferredDefinition":"Indicator of whether or not there is a history of mouth symptoms.","longName":"ORGSYS_MTH_SYMP_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"45E7EAC1-C997-39E1-E053-F662850A7672","latestVersionIndicator":"Yes","beginDate":"2017-01-12","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-01-12","modifiedBy":"COOPERM","dateModified":"2017-01-20","changeNote":"Created for 17-C-0027 Chronic GVHD Review of Systems History Screening form. mc 1/12/17","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5626407","version":"1","preferredName":"Organ System Nasal Sinus Symptom Type","preferredDefinition":"Text term that represents the kind of nasal sinus symptom.","longName":"ORGSYS_SNS_SYMP_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"45E7EAC1-C9CF-39E1-E053-F662850A7672","latestVersionIndicator":"Yes","beginDate":"2017-01-12","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-01-12","modifiedBy":"COOPERM","dateModified":"2017-01-20","changeNote":"Created for 17-C-0027 Chronic GVHD Review of Systems History Screening form. mc 1/12/17","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5626408","version":"1","preferredName":"Organ System Nasal Sinus Symptom Indicator","preferredDefinition":"Indicator of whether or not there is a history of nasal sinus symptoms.","longName":"ORGSYS_SNS_SYMP_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"45E80FE3-40C3-4852-E053-F662850AC27A","latestVersionIndicator":"Yes","beginDate":"2017-01-12","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-01-12","modifiedBy":"COOPERM","dateModified":"2017-01-20","changeNote":"Created for 17-C-0027 Chronic GVHD Review of Systems History Screening form. mc 1/12/17","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5626409","version":"1","preferredName":"Organ System Gastrointestinal Tract Symptom Type","preferredDefinition":"Text term that represents the kind of gastrointestinal symptom.","longName":"ORGSYS_GI_SYMP_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"45E828CE-0DAD-5A38-E053-F662850A37C6","latestVersionIndicator":"Yes","beginDate":"2017-01-12","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-01-12","modifiedBy":"COOPERM","dateModified":"2017-01-20","changeNote":"Created for 17-C-0027 Chronic GVHD Review of Systems History Screening form. mc 1/12/17","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5626410","version":"1","preferredName":"Organ System Gastrointestinal Tract Symptom Indicator","preferredDefinition":"Indicator of whether or not there is a history of gastrointestinal tract symptoms.","longName":"ORGSYS_GI_SYMP_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"45E83254-FB6A-5FF6-E053-F662850A88CF","latestVersionIndicator":"Yes","beginDate":"2017-01-12","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-01-12","modifiedBy":"COOPERM","dateModified":"2017-01-20","changeNote":"Created for 17-C-0027 Chronic GVHD Review of Systems History Screening form. mc 1/12/17","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5626415","version":"1","preferredName":"Organ System Musculoskeletal Symptom Type","preferredDefinition":"Text term that represents the kind of musculoskeletal symptom.","longName":"ORGSYS_MSKL_SYMP_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"45E83D1F-9F74-64BD-E053-F662850AFF5B","latestVersionIndicator":"Yes","beginDate":"2017-01-12","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-01-12","modifiedBy":"COOPERM","dateModified":"2017-01-20","changeNote":"Created for 17-C-0027 Chronic GVHD Review of Systems History Screening form. mc 1/12/17","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5626417","version":"1","preferredName":"Organ System Musculoskeletal Symptom Indicator","preferredDefinition":"Indicator of whether or not there is a history of musculoskeletal symptoms.","longName":"ORGSYS_MSKL_SYMP_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"45E83D1F-9FA3-64BD-E053-F662850AFF5B","latestVersionIndicator":"Yes","beginDate":"2017-01-12","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-01-12","modifiedBy":"COOPERM","dateModified":"2017-01-20","changeNote":"Created for 17-C-0027 Chronic GVHD Review of Systems History Screening form. mc 1/12/17","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5626418","version":"1","preferredName":"Organ System Lung Symptom Type","preferredDefinition":"Text term that represents the kind of lung symptom.","longName":"ORGSYS_LUNG_SYMP_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"45E83D1F-9FD2-64BD-E053-F662850AFF5B","latestVersionIndicator":"Yes","beginDate":"2017-01-12","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-01-12","modifiedBy":"COOPERM","dateModified":"2017-01-20","changeNote":"Created for 17-C-0027 Chronic GVHD Review of Systems History Screening form. mc 1/12/17","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5626419","version":"1","preferredName":"Organ System Lung Symptom Indicator","preferredDefinition":"Indicator of whether or not there is a history of lung symptoms.","longName":"ORGSYS_LUNG_SYMP_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"45E83254-FBA1-5FF6-E053-F662850A88CF","latestVersionIndicator":"Yes","beginDate":"2017-01-12","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-01-12","modifiedBy":"COOPERM","dateModified":"2017-01-20","changeNote":"Created for 17-C-0027 Chronic GVHD Review of Systems History Screening form. mc 1/12/17","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5626423","version":"1","preferredName":"Gastrointestinal Tract Past Week Frequency of Diarrhea Scale","preferredDefinition":"Text term that describes the frequency of loose or liquid stools occurring during the past week.","longName":"GI_SYMP_DIRRH_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"45E83D1F-A08B-64BD-E053-F662850AFF5B","latestVersionIndicator":"Yes","beginDate":"2017-01-12","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-01-12","modifiedBy":"COOPERM","dateModified":"2017-01-20","changeNote":"Created for 17-C-0027 Chronic GVHD Review of Systems History Screening form. mc 1/12/17","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5626425","version":"1","preferredName":"Person Weight Loss Percent Number","preferredDefinition":"Numeric representation of the percentage of weight loss.","longName":"WT_LOSS_PRCT_NUM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"45E83254-FBF8-5FF6-E053-F662850A88CF","latestVersionIndicator":"Yes","beginDate":"2017-01-12","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-01-12","modifiedBy":"COOPERM","dateModified":"2017-01-20","changeNote":"Created for 17-C-0027 Chronic GVHD Review of Systems History Screening form. mc 1/12/17","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5626426","version":"1","preferredName":"Gastrointestinal Tract Past Week How Often Swallowing Difficulty Scale","preferredDefinition":"Text term that represents how often during the past week swallowing difficulties occurred.","longName":"GI_SWALL_DIF_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"45E83D1F-A0E5-64BD-E053-F662850AFF5B","latestVersionIndicator":"Yes","beginDate":"2017-01-12","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-01-12","modifiedBy":"COOPERM","dateModified":"2017-01-20","changeNote":"Created for 17-C-0027 Chronic GVHD Review of Systems History Screening form. mc 1/12/17","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5626459","version":"1","preferredName":"Musculoskeletal Symptom How Much Activity of Daily Living Affected Scale","preferredDefinition":"Text term that represents how much activities of daily living are affected by musculoskeletal symptoms.","longName":"MSKL_SYMP_ADL_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"45E8B213-3497-278F-E053-F662850AAE70","latestVersionIndicator":"Yes","beginDate":"2017-01-12","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-01-12","modifiedBy":"COOPERM","dateModified":"2017-01-20","changeNote":"Created for 17-C-0027 Chronic GVHD Review of Systems History Screening form. mc 1/12/17","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5626490","version":"1","preferredName":"Organ System Genital Dryness Or Discomfort Symptom Indicator","preferredDefinition":"Indicator of whether or not an individual experiences vaginal or penile, foreskin dryness and/or discomfort.","longName":"GEN_DRY_DSCM_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"45E83254-FCB1-5FF6-E053-F662850A88CF","latestVersionIndicator":"Yes","beginDate":"2017-01-12","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-01-12","modifiedBy":"COOPERM","dateModified":"2017-01-20","changeNote":"Created for 17-C-0027 Chronic GVHD Review of Systems History Screening form. mc 1/12/17","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5626534","version":"1","preferredName":"Organ System Genital Dryness or Discomfort Symptom Severity Scale","preferredDefinition":"Text term that represents the severity of vaginal or penile, foreskin dryness/discomfort.","longName":"GEN_DRY_SEV_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"45E8B213-34D0-278F-E053-F662850AAE70","latestVersionIndicator":"Yes","beginDate":"2017-01-12","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-01-12","modifiedBy":"COOPERM","dateModified":"2017-01-20","changeNote":"Created for 17-C-0027 Chronic GVHD Review of Systems History Screening form. mc 1/12/17","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5626563","version":"1","preferredName":"Organ System Lung Symptom Shortness of Breath Scale","preferredDefinition":"Text term that describes what activities cause an individual to have shortness of breath.","longName":"SHRT_BREATH_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"45E8B213-350B-278F-E053-F662850AAE70","latestVersionIndicator":"Yes","beginDate":"2017-01-12","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-01-12","modifiedBy":"COOPERM","dateModified":"2017-01-20","changeNote":"Created for 17-C-0027 Chronic GVHD Review of Systems History Screening form. mc 1/12/17","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5697857","version":"1","preferredName":"Multidimensional Fatigue Inventory Total General Fatigue Score","preferredDefinition":"Numeric representation of the total general fatigue dimension score for the Multidimensional Fatigue Inventory.","longName":"MFI_TTL_GFATG_SCR","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"MFI:Multi-dimensional Fatigue Inventory, Smets EM, Garssen B, Bonke B, De Haes JC. J Psychosom Res., April 1995","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4A1B3BA1-6BD2-5DAC-E053-F662850A6A05","latestVersionIndicator":"Yes","beginDate":"2017-03-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-03-06","modifiedBy":"COOPERM","dateModified":"2017-03-27","changeNote":"Created for CCR study 16C0094 in C3D as requested by P. Asangong. mc 3/6/17","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5697858","version":"1","preferredName":"Multidimensional Fatigue Inventory Total Physical Fatigue Score","preferredDefinition":"Numeric representation of the total physical fatigue dimension score for the Multidimensional Fatigue Inventory.","longName":"MFI_TTL_PHYS_SCR","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"MFI:Multi-dimensional Fatigue Inventory, Smets EM, Garssen B, Bonke B, De Haes JC. J Psychosom Res., April 1995","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4A1B3BA1-6BFF-5DAC-E053-F662850A6A05","latestVersionIndicator":"Yes","beginDate":"2017-03-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-03-06","modifiedBy":"COOPERM","dateModified":"2017-03-27","changeNote":"Created for CCR study 16C0094 in C3D as requested by P. Asangong. mc 3/6/17","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5697859","version":"1","preferredName":"Multidimensional Fatigue Inventory Total Reduced Activity Score","preferredDefinition":"Numeric representation of the total reduced activity dimension score for the Multidimensional Fatigue Inventory.","longName":"MFI_TTL_RACTV_SCR","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"MFI:Multi-dimensional Fatigue Inventory, Smets EM, Garssen B, Bonke B, De Haes JC. J Psychosom Res., April 1995","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4A16F550-743A-1FE8-E053-F662850ACCE5","latestVersionIndicator":"Yes","beginDate":"2017-03-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-03-06","modifiedBy":"COOPERM","dateModified":"2017-03-27","changeNote":"Created for CCR study 16C0094 in C3D as requested by P. Asangong. mc 3/6/17","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5697860","version":"1","preferredName":"Multidimensional Fatigue Inventory Total Reduced Motivation Score","preferredDefinition":"Numeric representation of the total reduced motivation dimension score for the Multidimensional Fatigue Inventory.","longName":"MFI_TTL_RMOTV_SCR","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"MFI:Multi-dimensional Fatigue Inventory, Smets EM, Garssen B, Bonke B, De Haes JC. J Psychosom Res., April 1995","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4A1A23AA-0BD7-2AD8-E053-F662850AC8C1","latestVersionIndicator":"Yes","beginDate":"2017-03-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-03-06","modifiedBy":"COOPERM","dateModified":"2017-03-27","changeNote":"Created for CCR study 16C0094 in C3D as requested by P. Asangong. mc 3/6/17","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5697861","version":"1","preferredName":"Multidimensional Fatigue Inventory Total Mental Fatigue Score","preferredDefinition":"Numeric representation of the total mental fatigue dimension score for the Multidimensional Fatigue Inventory.","longName":"MFI_TTL_TMENTL_SCR","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"MFI:Multi-dimensional Fatigue Inventory, Smets EM, Garssen B, Bonke B, De Haes JC. J Psychosom Res., April 1995","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4A1B3BA1-6C2C-5DAC-E053-F662850A6A05","latestVersionIndicator":"Yes","beginDate":"2017-03-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-03-06","modifiedBy":"COOPERM","dateModified":"2017-03-27","changeNote":"Created for CCR study 16C0094 in C3D as requested by P. Asangong. mc 3/6/17","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5697862","version":"1","preferredName":"Manual Ability Measure Raw Score","preferredDefinition":"Numeric representation of the raw score for the Manual Ability Measure.","longName":"MAM_RAW_SCR","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"MFI:Multi-dimensional Fatigue Inventory, Smets EM, Garssen B, Bonke B, De Haes JC. J Psychosom Res., April 1995","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4A1BE07A-C2DB-2312-E053-F662850A8262","latestVersionIndicator":"Yes","beginDate":"2017-03-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-03-06","modifiedBy":"COOPERM","dateModified":"2017-03-10","changeNote":"Created for CCR study 16C0094 in C3D as requested by P. Asangong. mc 3/6/17","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5697863","version":"1","preferredName":"HAQ-DI Total Functional Disability Index Score","preferredDefinition":"Numeric representation of the total functional disability index.","longName":"HAQDI_FNCT_DISAB_SCR","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"HAQ-DI:Health Assessment Questionnaire Disability Index, James F. Fries, MD. 1978","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4A1BE07A-C308-2312-E053-F662850A8262","latestVersionIndicator":"Yes","beginDate":"2017-03-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-03-06","modifiedBy":"COOPERM","dateModified":"2017-03-10","changeNote":"Created for CCR study 16C0094 in C3D as requested by P. Asangong. mc 3/6/17","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5709942","version":"1","preferredName":"MD Anderson Symptom Inventory Not Complete Reason","preferredDefinition":"Text term that represents the reason why the MD Anderson Symptom Inventory was not completed.","longName":"MDASI_NOT_COMPL_RSN","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4AA8D4D4-C2F8-438B-E053-F662850ACABF","latestVersionIndicator":"Yes","beginDate":"2017-03-13","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-03-13","modifiedBy":"COOPERM","dateModified":"2017-03-27","changeNote":"Curated to support NCI CCR study. mc 3/13/17","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5709943","version":"1","preferredName":"MD Anderson Symptom Inventory Instrument Complete Name","preferredDefinition":"Text term that represents the name of the MD Anderson Symptom Inventory instrument completed by the patient.","longName":"MDASI_COMPL_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4AA8E0A0-5B11-34A6-E053-F662850A10CC","latestVersionIndicator":"Yes","beginDate":"2017-03-13","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-03-13","modifiedBy":"COOPERM","dateModified":"2017-03-27","changeNote":"Curated to support NCI CCR study. mc 3/13/17","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5709944","version":"1","preferredName":"MD Anderson Symptom Inventory Person Complete by Type","preferredDefinition":"Text term that describes the person who filled out the MD Anderson Symptom Inventory instrument.","longName":"MDASI_COMPL_BY_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4AA8EEBB-23C5-5B33-E053-F662850A2071","latestVersionIndicator":"Yes","beginDate":"2017-03-13","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-03-13","modifiedBy":"COOPERM","dateModified":"2017-03-27","changeNote":"Curated to support NCI CCR study. mc 3/13/17","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5709945","version":"1","preferredName":"Glioblastoma RANO Progression Date","preferredDefinition":"Date of disease progression response status based on RANO criteria for Glioblastoma.","longName":"GBM_RANO_PD_DT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4AA8FD67-76AD-3A47-E053-F662850AF8CB","latestVersionIndicator":"Yes","beginDate":"2017-03-13","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-03-13","modifiedBy":"COOPERM","dateModified":"2017-03-27","changeNote":"Curated to support NCI CCR study. mc 3/13/17","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5724471","version":"1","preferredName":"PROMIS-29 Adult Profile v1.0 21 Past Week Satisfied with How Much Work I Can Do Score 5 Point Scale","preferredDefinition":"Persons' stated observation of how satisfied they are with the amount of work they can do, including work at home in the past 7 days, using a five-point Likert scale.","longName":"PROMIS29V1_21_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"PROMIS:Patient Reported Outcomes Measurement Information System, PROMIS Health Organization and PROMIS Cooperative Group, 2008-2012","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4B67E377-02A5-0476-E053-F662850AE1CD","latestVersionIndicator":"Yes","beginDate":"2017-03-23","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-03-23","modifiedBy":"COOPERM","dateModified":"2017-03-23","changeNote":"Created for C3D use of PROMIS Adult Profile. mc 3/23/17","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5724472","version":"1","preferredName":"PROMIS-29 Adult Profile v1.0 22 Past Week Satisfied with Ability to Work Score 5 Point Scale","preferredDefinition":"Persons' stated observation of how satisfied they are with their ability to work, including work at home in the past 7 days, using a five-point Likert scale.","longName":"PROMIS29V1_22_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"PROMIS:Patient Reported Outcomes Measurement Information System, PROMIS Health Organization and PROMIS Cooperative Group, 2008-2012","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4B69C136-EC04-0283-E053-F662850A11B0","latestVersionIndicator":"Yes","beginDate":"2017-03-23","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-03-23","modifiedBy":"COOPERM","dateModified":"2017-03-23","changeNote":"Created for C3D use of PROMIS Adult Profile. mc 3/23/17","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5724473","version":"1","preferredName":"PROMIS-29 Adult Profile v1.0 23 Past Week Satisfied with Ability to do Regular Personal and Household Responsibilities Score 5 Point Scale","preferredDefinition":"Persons' stated observation of how satisfied they are with their ability to do regular personal and household responsibilities in the past 7 days, using a five-point Likert scale.","longName":"PROMIS29V1_23_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"PROMIS:Patient Reported Outcomes Measurement Information System, PROMIS Health Organization and PROMIS Cooperative Group, 2008-2012","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4B6A19EC-4D44-72AE-E053-F662850A8964","latestVersionIndicator":"Yes","beginDate":"2017-03-23","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-03-23","modifiedBy":"COOPERM","dateModified":"2017-03-23","changeNote":"Created for C3D use of PROMIS Adult Profile. mc 3/23/17","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5724474","version":"1","preferredName":"PROMIS-29 Adult Profile v1.0 24 Past Week Satisfied with Ability to Perform Daily Routine Score 5 Point Scale","preferredDefinition":"Persons' stated observation of how satisfied they are with their ability to perform their daily routine in the past 7 days, using a five-point Likert scale.","longName":"PROMIS29V1_24_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"PROMIS:Patient Reported Outcomes Measurement Information System, PROMIS Health Organization and PROMIS Cooperative Group, 2008-2012","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4B69C136-EC32-0283-E053-F662850A11B0","latestVersionIndicator":"Yes","beginDate":"2017-03-23","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-03-23","modifiedBy":"COOPERM","dateModified":"2017-03-23","changeNote":"Created for C3D use of PROMIS Adult Profile. mc 3/23/17","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5724475","version":"1","preferredName":"PROMIS-29 Adult Profile v1.0 28 Past Week Pain Interferes with Enjoyment of Life Score 5 Point Scale","preferredDefinition":"Persons' stated observation of how pain interfered with their enjoyment of life in the past 7 days, using a five-point Likert scale.","longName":"PROMIS29V1_28_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"PROMIS:Patient Reported Outcomes Measurement Information System, PROMIS Health Organization and PROMIS Cooperative Group, 2008-2012","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4B699681-719E-5D12-E053-F662850A14F4","latestVersionIndicator":"Yes","beginDate":"2017-03-23","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-03-23","modifiedBy":"COOPERM","dateModified":"2017-03-23","changeNote":"Created for C3D use of PROMIS Adult Profile. mc 3/23/17","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5731475","version":"1","preferredName":"Molecular Analysis Laboratory Procedure Ig Gene Rearrangement PCR Result","preferredDefinition":"Text term that represents the gene rearrangement pattern for Immunoglobulin (Ig) found through molecular analysis using PCR.","longName":"IG_PCR_RSLT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4C0CCDE5-4357-1D95-E053-F662850A6F4F","latestVersionIndicator":"Yes","beginDate":"2017-03-31","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-03-31","modifiedBy":"COOPERM","dateModified":"2017-03-31","changeNote":"Created for 16C0003 Molecular Pathology CRF request by Y.Yakovlev. mc 3/31/17","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5731476","version":"1","preferredName":"Molecular Analysis Laboratory Procedure TRG PCR Result","preferredDefinition":"Text term that represents the gene rearrangement pattern for T-Cell Receptor Gamma Gene (TRG) found through molecular analysis using PCR.","longName":"TRG_PCR_RSLT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4C0C8539-3AEB-3499-E053-F662850AD520","latestVersionIndicator":"Yes","beginDate":"2017-03-31","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-03-31","modifiedBy":"COOPERM","dateModified":"2017-03-31","changeNote":"Created for 16C0003 Molecular Pathology CRF request by Y.Yakovlev. mc 3/31/17","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5731477","version":"1","preferredName":"Molecular Analysis Laboratory Procedure EBNA-2 PCR Finding Type","preferredDefinition":"Text term that represents the result for Epstein-Barr Nuclear Antigen 2 (EBNA-2) found through molecular analysis using PCR.","longName":"EBNA2_PCR_FND_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4C0C74FA-AAAD-1D8F-E053-F662850AE775","latestVersionIndicator":"Yes","beginDate":"2017-03-31","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-03-31","modifiedBy":"COOPERM","dateModified":"2017-03-31","changeNote":"Created for 16C0003 Molecular Pathology CRF request by Y.Yakovlev. mc 3/31/17","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5731478","version":"1","preferredName":"Molecular Analysis Laboratory Procedure Ig Gene Rearrangement PCR Result Text","preferredDefinition":"Text that describes the gene rearrangement pattern for Immunoglobulin G (Ig) found through molecular analysis using PCR.","longName":"IG_PCR_FND_TXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4C0DA752-759E-2DE9-E053-F662850AAADE","latestVersionIndicator":"Yes","beginDate":"2017-03-31","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-03-31","modifiedBy":"COOPERM","dateModified":"2017-03-31","changeNote":"Created for 16C0003 Molecular Pathology CRF request by Y.Yakovlev. mc 3/31/17","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5731479","version":"1","preferredName":"Molecular Analysis Laboratory Procedure TRG PCR Result Text","preferredDefinition":"Text that describes the gene rearrangement pattern for  T-Cell Receptor Gamma Gene (TRG) found through molecular analysis using PCR.","longName":"TRG_PCR_FND_TXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4C0DA752-75CB-2DE9-E053-F662850AAADE","latestVersionIndicator":"Yes","beginDate":"2017-03-31","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-03-31","modifiedBy":"COOPERM","dateModified":"2017-03-31","changeNote":"Created for 16C0003 Molecular Pathology CRF request by Y.Yakovlev. mc 3/31/17","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5731480","version":"1","preferredName":"Molecular Analysis Laboratory Procedure EBNA-2 PCR Finding Text","preferredDefinition":"Text that describes the result for Epstein-Barr Nuclear Antigen 2 (EBNA-2) found through molecular analysis using PCR.","longName":"EBNA2_PCR_FND_TXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4C0CC691-D5A6-2C53-E053-F662850AF12C","latestVersionIndicator":"Yes","beginDate":"2017-03-31","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-03-31","modifiedBy":"COOPERM","dateModified":"2017-03-31","changeNote":"Created for 16C0003 Molecular Pathology CRF request by Y.Yakovlev. mc 3/31/17","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5751659","version":"1","preferredName":"Gastrointestinal Tract Past Week How Often Eat Less Scale","preferredDefinition":"Text term that describes how often an individual's lack of appetite, early fullness when eating, nausea or vomiting caused them to eat less during the past week.","longName":"GI_HIST_EAT_LESS_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4CF9B198-52A2-044B-E053-F662850AA56E","latestVersionIndicator":"Yes","beginDate":"2017-04-12","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-04-12","modifiedBy":"COOPERM","dateModified":"2017-04-12","changeNote":"Created new to correct VD error for 17-C-0027 Chronic GVHD Review of Systems History Screening form. mc 1/12/17","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5880680","version":"1","preferredName":"Paraganglioma Description Type","preferredDefinition":"Text term that represents the kind of paraganglioma.","longName":"PGL_DESC_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"528E50DE-C08B-4EB9-E053-F662850A4C3D","latestVersionIndicator":"Yes","beginDate":"2017-06-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-06-22","modifiedBy":"COOPERM","dateModified":"2017-07-05","changeNote":"Created for 17-C-0087 PHEO/PGL form. 6.22.17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5880681","version":"1","preferredName":"Pheochromocytoma or Paraganglioma Genetic Subtype","preferredDefinition":"Text term that represents the genetic subtype of the pheochromocytoma or paraganglioma.","longName":"PHEO_PGL_GENE_SUB_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"528DF760-315C-609B-E053-F662850A9B11","latestVersionIndicator":"Yes","beginDate":"2017-06-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-06-22","modifiedBy":"COOPERM","dateModified":"2017-07-05","changeNote":"Created for 17-C-0087 PHEO/PGL form. 6.22.17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5880683","version":"1","preferredName":"Pheochromocytoma or Paraganglioma Other Genetic Subtype Text","preferredDefinition":"Text term that represents another genetic subtype of the pheochromocytoma or paraganglioma not previously specified.","longName":"PHEO_PGL_OTH_GENE_TX","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"528E67A5-D3C2-4885-E053-F662850ADC1D","latestVersionIndicator":"Yes","beginDate":"2017-06-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-06-22","modifiedBy":"COOPERM","dateModified":"2017-07-05","changeNote":"Created for 17-C-0087 PHEO/PGL form. 6.22.17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5880684","version":"1","preferredName":"Pheochromocytoma or Paraganglioma Operable Indicator","preferredDefinition":"Indicator of whether or not the pheochromocytoma or paraganglioma is operable.","longName":"PHEO_PGL_OPER_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"528E6E4B-BBE8-087B-E053-F662850A9702","latestVersionIndicator":"Yes","beginDate":"2017-06-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-06-22","modifiedBy":"COOPERM","dateModified":"2017-07-05","changeNote":"Created for 17-C-0087 PHEO/PGL form. 6.22.17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5880685","version":"1","preferredName":"Disease Response PET Scan Standardized Uptake Value Anatomic Site","preferredDefinition":"Text term that represents the tumor location response based on PET scan standardized uptake value.","longName":"PET_RESP_SITE","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"528E7995-E9BD-3648-E053-F662850AAE06","latestVersionIndicator":"Yes","beginDate":"2017-06-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-06-22","modifiedBy":"COOPERM","dateModified":"2017-07-05","changeNote":"Created for 17-C-0087 PHEO/PGL form. 6.22.17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5892279","version":"1","preferredName":"Neck Pain Quantity Score 11 Point Visual Analogue Scale","preferredDefinition":"Person's observation of the amount of neck pain they experience using an 11 point visual analogue scale.","longName":"NECK_PAIN_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"530603FA-35FD-3591-E053-F662850ADD89","latestVersionIndicator":"Yes","beginDate":"2017-06-28","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-06-28","modifiedBy":"COOPERM","dateModified":"2017-06-28","changeNote":"Created for 15-C-0105 Amendment D as requested by P.Asangong on 6/19/17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5892451","version":"1","preferredName":"Swallowing Impairment Scale 1 How Often Requires Great Effort to Swallow Score 5 Point Scale","preferredDefinition":"Person's stated observation of how frequently it requires great effort for them to swallow, using a 5 point Likert scale.","longName":"SIS_Q1_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"SIS-6:Swallowing Impairment Scale","workflowStatus":"RELEASED","registrationStatus":"Application","id":"530737F4-4B9A-0ABD-E053-F662850ABB6A","latestVersionIndicator":"Yes","beginDate":"2017-06-28","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-06-28","modifiedBy":"COOPERM","dateModified":"2017-06-28","changeNote":"Created for 15-C-0105 Amendment D as requested by P.Asangong on 6/19/17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5892452","version":"1","preferredName":"Swallowing Impairment Scale 2 How Often Feel Throat Obstacle During Swallowing Score 5 Point Scale","preferredDefinition":"Person's stated observation of how frequently they feel a throat obstacle during swallowing, using a 5 point Likert scale.","longName":"SIS_Q2_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"SIS-6:Swallowing Impairment Scale","workflowStatus":"RELEASED","registrationStatus":"Application","id":"530737F4-4BC7-0ABD-E053-F662850ABB6A","latestVersionIndicator":"Yes","beginDate":"2017-06-28","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-06-28","modifiedBy":"COOPERM","dateModified":"2017-06-28","changeNote":"Created for 15-C-0105 Amendment D as requested by P.Asangong on 6/19/17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5892453","version":"1","preferredName":"Swallowing Impairment Scale 3 How Often Feel Pharyngeal Annoyance During Bolus Transit Score 5 Point Scale","preferredDefinition":"Person's stated observation of how frequently they feel pharyngeal annoyance during bolus transit, using a 5 point Likert scale.","longName":"SIS_Q3_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"SIS-6:Swallowing Impairment Scale","workflowStatus":"RELEASED","registrationStatus":"Application","id":"530737F4-4BF4-0ABD-E053-F662850ABB6A","latestVersionIndicator":"Yes","beginDate":"2017-06-28","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-06-28","modifiedBy":"COOPERM","dateModified":"2017-06-28","changeNote":"Created for 15-C-0105 Amendment D as requested by P.Asangong on 6/19/17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5892457","version":"1","preferredName":"Swallowing Impairment Scale 4 How Often Cough During Bolus Transit Score 5 Point Scale","preferredDefinition":"Person's stated observation of how frequently they cough during bolus transit, using a 5 point Likert scale.","longName":"SIS_Q4_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"SIS-6:Swallowing Impairment Scale","workflowStatus":"RELEASED","registrationStatus":"Application","id":"53071E34-7202-6DEF-E053-F662850AB5B0","latestVersionIndicator":"Yes","beginDate":"2017-06-28","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-06-28","modifiedBy":"COOPERM","dateModified":"2017-06-28","changeNote":"Created for 15-C-0105 Amendment D as requested by P.Asangong on 6/19/17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5892459","version":"1","preferredName":"Swallowing Impairment Scale 5 How Often Feel Sensation of Foreign Body In Pharynx Score 5 Point Scale","preferredDefinition":"Person's stated observation of how frequently they feel a sensation of a foreign body in my pharynx, using a 5 point Likert scale.","longName":"SIS_Q5_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"SIS-6:Swallowing Impairment Scale","workflowStatus":"RELEASED","registrationStatus":"Application","id":"53071E34-722F-6DEF-E053-F662850AB5B0","latestVersionIndicator":"Yes","beginDate":"2017-06-28","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-06-28","modifiedBy":"COOPERM","dateModified":"2017-06-28","changeNote":"Created for 15-C-0105 Amendment D as requested by P.Asangong on 6/19/17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5892460","version":"1","preferredName":"Swallowing Impairment Scale 6 How Often Have Some Difficulties Swallowing Fluids Score 5 Point Scale","preferredDefinition":"Person's stated observation of how frequently they have some difficulties swallowing fluids, using a 5 point Likert scale.","longName":"SIS_Q6_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"SIS-6:Swallowing Impairment Scale","workflowStatus":"RELEASED","registrationStatus":"Application","id":"53074E59-A00F-2903-E053-F662850A6527","latestVersionIndicator":"Yes","beginDate":"2017-06-28","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-06-28","modifiedBy":"COOPERM","dateModified":"2017-06-28","changeNote":"Created for 15-C-0105 Amendment D as requested by P.Asangong on 6/19/17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5893239","version":"1","preferredName":"Pheochromocytoma Or Paraganglioma Inoperable Reason Text","preferredDefinition":"Text term to explain why the pheochromocytoma or paraganglioma is not operable.","longName":"PHEO_PGL_INOPER_TXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"532E2CF8-A200-46F7-E053-F662850A7CA9","latestVersionIndicator":"Yes","beginDate":"2017-06-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-06-30","modifiedBy":"COOPERM","dateModified":"2017-07-05","changeNote":"Created for 17-C-0087 PHEO/PGL form. 6.22.17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5895914","version":"1","preferredName":"PET Mean Liver SUV Value","preferredDefinition":"A numeric value to represent the mean liver Standard Uptake Value (SUV) measured by Positron Emission Tomography (PET) imaging.","longName":"PET_MEAN_LIVR_SUV","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"53BD8A6F-CBA8-2B25-E053-F662850A29E2","latestVersionIndicator":"Yes","beginDate":"2017-07-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-07-07","modifiedBy":"COOPERM","dateModified":"2017-07-07","changeNote":"Created for 17C0087 study in C3D as requested by Y. Yakovlev. 7/7/17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5895915","version":"1","preferredName":"PET Mean Aorta SUV Value","preferredDefinition":"Numeric value to represent the mean aorta Standard Uptake Value (SUV) measured by Positron Emission Tomography (PET) imaging.","longName":"PET_MEAN_AORTA_SUV","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"53BF10EE-418F-2B1D-E053-F662850A5919","latestVersionIndicator":"Yes","beginDate":"2017-07-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-07-07","modifiedBy":"COOPERM","dateModified":"2017-07-07","changeNote":"Created for 17C0087 study in C3D as requested by Y. Yakovlev. 7/7/17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5895916","version":"1","preferredName":"PET Maximum Muscle SUV Value","preferredDefinition":"Numeric value to represent the maximum muscle Standard Uptake Value (SUV) measured by Positron Emission Tomography (PET) imaging.","longName":"PET_MAX_MUSCLE_SUV","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"53BEE0FA-DE91-47C5-E053-F662850A9BB7","latestVersionIndicator":"Yes","beginDate":"2017-07-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-07-07","modifiedBy":"COOPERM","dateModified":"2017-07-07","changeNote":"Created for 17C0087 study in C3D as requested by Y. Yakovlev. 7/7/17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5895917","version":"1","preferredName":"PET Mean Muscle SUV Value","preferredDefinition":"Numeric value to represent the mean muscle Standard Uptake Value (SUV) measured by Positron Emission Tomography (PET) imaging.","longName":"PET_MEAN_MUSCLE_SUV","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"53BEC6FB-50E3-2B15-E053-F662850A0CAE","latestVersionIndicator":"Yes","beginDate":"2017-07-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-07-07","modifiedBy":"COOPERM","dateModified":"2017-07-07","changeNote":"Created for 17C0087 study in C3D as requested by Y. Yakovlev. 7/7/17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5913764","version":"1","preferredName":"PET Deauville Criteria Scale Result Score","preferredDefinition":"Numeric score that represents the response to treatment of Hodgkins and Aggressive Non-Hodgkins Lymphoma using the London Deauville Criteria Scale.","longName":"PET_DEAUVL_SCR","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"Deauville Criteria:London Deauville Criteria Point Scale","workflowStatus":"RELEASED","registrationStatus":"Application","id":"549DB537-85C8-6C9B-E053-F662850A82CE","latestVersionIndicator":"Yes","beginDate":"2017-07-18","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-07-18","modifiedBy":"NYCHM","dateModified":"2017-12-19","changeNote":"Created for 17C0127 import to GLIB requested on 7/13/17. mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5914455","version":"1","preferredName":"Oral Lesion Present Indicator Description Type","preferredDefinition":"Text term that represents whether or not an oral lesion is present and a description of the gross appearance.","longName":"ORAL_LESN_IND_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"54C1F10B-477A-3474-E053-F662850AD024","latestVersionIndicator":"Yes","beginDate":"2017-07-20","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-07-20","modifiedBy":"COOPERM","dateModified":"2017-07-21","changeNote":"Created for 16c0171 requested by Y.Yakovlev 7/17/17. mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5914457","version":"1","preferredName":"Visceral Lesion Present Indicator Anatomic Site","preferredDefinition":"Text term that represents whether or not a visceral lesion is present and the anatomic location.","longName":"VISC_LESN_IND_AN_ST","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"54B403C3-8BB2-6E80-E053-F662850A461A","latestVersionIndicator":"Yes","beginDate":"2017-07-20","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-07-20","modifiedBy":"COOPERM","dateModified":"2017-07-21","changeNote":"Created for 16c0171 requested by Y.Yakovlev 7/17/17. mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5914509","version":"1","preferredName":"Visceral Lesion Present Other Location Text","preferredDefinition":"Text description of another anatomic location for a visceral lesion not already specified.","longName":"VISC_LESN_OTHR_AN_ST","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"54C23EB9-AA21-449D-E053-F662850AA9C0","latestVersionIndicator":"Yes","beginDate":"2017-07-20","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-07-20","modifiedBy":"COOPERM","dateModified":"2017-07-21","changeNote":"Created for 16c0171 requested by Y.Yakovlev 7/17/17. mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5914516","version":"1","preferredName":"Follicular Lymphoma FLIPI Overall Survival Score","preferredDefinition":"Number or range of numbers that represents the Follicular Lymphoma International Prognostic Index (FLIPI) score to predict overall survival.","longName":"FLIPI_OS_SCR","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"54C46327-A8BD-231D-E053-F662850A0E46","latestVersionIndicator":"Yes","beginDate":"2017-07-20","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-07-20","modifiedBy":"COOPERM","dateModified":"2017-07-21","changeNote":"Created for 17C0127 requested by Y.Yakovlev 7/13/17. mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5916920","version":"1","preferredName":"Follicular Lymphoma F2 Progression-free Survival Score","preferredDefinition":"Number or range of numbers that represents the Follicular Lymphoma International Prognostic Index 2 (FLIPI-2) score to predict progression-free survival.","longName":"F2_OS_SCR","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"55B6501B-C964-6E50-E053-F662850AA5C9","latestVersionIndicator":"Yes","beginDate":"2017-08-01","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-08-01","modifiedBy":"COOPERM","dateModified":"2017-08-04","changeNote":"Created for 17C0127 requested by Y.Yakovlev 7/20/17. mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5935925","version":"1","preferredName":"Pediatric Height Percentile Value","preferredDefinition":"Number that represents the rank of what percent of the reference population a child would equal or exceed as related to height.","longName":"PEDS_HT_PRCNTL_VL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Application","id":"570CFAB5-E9CF-6A5E-E053-F662850AF038","latestVersionIndicator":"Yes","beginDate":"2017-08-18","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-08-18","modifiedBy":"TSESU","dateModified":"2017-08-29","changeNote":"Created to support CCR 11C0161 clinical trial. 8/18/17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5935926","version":"1","preferredName":"Pediatric Weight Percentile Value","preferredDefinition":"Number that represents the rank of what percent of the reference population a child would equal or exceed as related to weight.","longName":"PEDS_WT_PRCNTL_VL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Application","id":"570CFAB5-E9FD-6A5E-E053-F662850AF038","latestVersionIndicator":"Yes","beginDate":"2017-08-18","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-08-18","modifiedBy":"TSESU","dateModified":"2017-08-29","changeNote":"Created to support CCR 11C0161 clinical trial. 8/18/17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5935927","version":"1","preferredName":"Pediatric Oncologist Consultation Post Last Visit Occurrence Specify Text","preferredDefinition":"Text description of why the patient/patient's parents visited a pediatric oncologist since the last clinical trials team visit.","longName":"PED_ONC_VST_OCC_TXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Application","id":"570CFAB5-EA2B-6A5E-E053-F662850AF038","latestVersionIndicator":"Yes","beginDate":"2017-08-18","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-08-18","modifiedBy":"COOPERM","dateModified":"2017-08-18","changeNote":"Created to support CCR 11C0161 clinical trial. 8/18/17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5969527","version":"1","preferredName":"Cordonnier Infectious Complications Grading Scale Assessment Grade","preferredDefinition":"Text terms that represent classification of the severity of infections in three grades, using the Cordonnier scale.","longName":"CORDNR_INF_SCL_GRD","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"Cordonnier Scale:Cordonnier Infectious Complications Grading Scale, Catherine Cordonnier, et..al., Transplantation, Volume 82, Number 1, July 15, 2006","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5899C382-F86F-11B0-E053-F662850AC703","latestVersionIndicator":"Yes","beginDate":"2017-09-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-09-07","modifiedBy":"COOPERM","dateModified":"2017-10-03","changeNote":"Created for 15C0067 study AE CRF in C3D. 8.15.17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6011773","version":"1","preferredName":"Reconstructive Surgery Jejunostomy Performed Indicator","preferredDefinition":"Indicator of whether or not surgical creation of an external opening into the jejunum was performed.","longName":"RCN_SRG_JEJNSTMY_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5C758DEA-6729-378B-E053-F662850AF004","latestVersionIndicator":"Yes","beginDate":"2017-10-26","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-10-26","modifiedBy":"COOPERM","dateModified":"2017-10-26","changeNote":"Created for protocol 17C0135 request 10.18.17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6011774","version":"1","preferredName":"Surgical Procedure Esophagectomy Performed Type","preferredDefinition":"Text term that represents the kind of esophagectomy performed.","longName":"SURG_ESOPHCTMY_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5C759821-F57B-3E41-E053-F662850A86C9","latestVersionIndicator":"Yes","beginDate":"2017-10-26","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-10-26","modifiedBy":"COOPERM","dateModified":"2017-10-26","changeNote":"Created for protocol 17C0135 request 10.18.17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6011775","version":"1","preferredName":"Surgical Procedure Robotic Resection Performed Indicator","preferredDefinition":"Indicator of whether or not a robotic assisted resection was performed.","longName":"SURG_RBT_RESCT_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5C757E17-9E54-729A-E053-F662850A8498","latestVersionIndicator":"Yes","beginDate":"2017-10-26","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-10-26","modifiedBy":"COOPERM","dateModified":"2017-10-26","changeNote":"Created for protocol 17C0135 request 10.18.17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6011792","version":"1","preferredName":"Gastrointestinal Cancer Post Neoadjuvant Treatment Mandard Grade","preferredDefinition":"Number that represents the Mandard tumor regression grade used for upper gastrointestinal carcinomas.","longName":"GI_CA_PNADJ_MND_GRD","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5C725AB5-C369-1B07-E053-F662850A8C3E","latestVersionIndicator":"Yes","beginDate":"2017-10-26","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-10-26","modifiedBy":"COOPERM","dateModified":"2017-10-26","changeNote":"Created for protocol 17C0135 request 10.18.17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6013151","version":"1","preferredName":"Dysphagia Assessment Score 5 Point Scale","preferredDefinition":"Numeric value that represents the assessment of an individual's ability to swallow.","longName":"DYSPHG_ASMT_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5CC657DE-9188-6CDF-E053-F662850A1319","latestVersionIndicator":"Yes","beginDate":"2017-10-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-10-30","modifiedBy":"COOPERM","dateModified":"2017-10-30","changeNote":"Created for protocol 17C0135 request 10.19.17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6032885","version":"1","preferredName":"Prostate Cancer Dominant Disease Indicator","preferredDefinition":"Indicator of whether or not prostate cancer is the dominant disease.","longName":"PCA_DOM_DIS_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F038289-62E9-3955-E053-F662850A5E90","latestVersionIndicator":"Yes","beginDate":"2017-11-28","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-11-28","modifiedBy":"COOPERM","dateModified":"2017-12-04","changeNote":"Created for Dr. Turkbey P173316 request 11.21.17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6032886","version":"1","preferredName":"Clinical Testing Sensitivity or Contraindication Indicator","preferredDefinition":"Indicator of whether or not sensitivity or contraindication for testing is present.","longName":"TEST_SEN_COMRB_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F038289-6317-3955-E053-F662850A5E90","latestVersionIndicator":"Yes","beginDate":"2017-11-28","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-11-28","modifiedBy":"COOPERM","dateModified":"2017-12-04","changeNote":"Created for Dr. Turkbey P173316 request 11.21.17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6032887","version":"1","preferredName":"Prostate Cancer History Family Member Relationship Type","preferredDefinition":"Text term that represents the kind of family member relationship to an individual with a history of prostate cancer.","longName":"PCA_HIST_FAM_REL_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F0C3D6A-B53A-2540-E053-F662850AB2EB","latestVersionIndicator":"Yes","beginDate":"2017-11-28","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-11-28","modifiedBy":"COOPERM","dateModified":"2017-12-04","changeNote":"Created for Dr. Turkbey P173316 request 11.21.17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6032888","version":"1","preferredName":"Cancer History Family Member Relationship Type","preferredDefinition":"Text term that represents the kind of family member relationship to an individual with a history of cancer.","longName":"CA_HIST_FAM_REL_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F0C451C-9244-47B0-E053-F662850A412A","latestVersionIndicator":"Yes","beginDate":"2017-11-28","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-11-28","modifiedBy":"KUMMEROA","dateModified":"2022-05-10","changeNote":"Created for Dr. Turkbey P173316 request 11.21.17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6032889","version":"1","preferredName":"Non-Cancer History with Significant Comorbidity Family Member Relationship Type","preferredDefinition":"Text term that represents the kind of family member relationship to an individual with no history of cancer and significant comorbidity.","longName":"NCA_SG_CMRB_FM_RL_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F0B82B0-6B21-25AB-E053-F662850A4853","latestVersionIndicator":"Yes","beginDate":"2017-11-28","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-11-28","modifiedBy":"COOPERM","dateModified":"2017-12-04","changeNote":"Created for Dr. Turkbey P173316 request 11.21.17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6032890","version":"1","preferredName":"Deceased Family Member Father Indicator","preferredDefinition":"Indicator of whether or not an individual's father is deceased.","longName":"DCSD_FMMEM_FATHR_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F0C6D2B-9F1D-354C-E053-F662850A4B6E","latestVersionIndicator":"Yes","beginDate":"2017-11-28","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-11-28","modifiedBy":"COOPERM","dateModified":"2017-12-04","changeNote":"Created for Dr. Turkbey P173316 request 11.21.17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6032891","version":"1","preferredName":"Deceased Family Member Father Cause of Death Text","preferredDefinition":"Text to describe the cause of death to an individual's father.","longName":"FATHR_CAUSE_DTH_TXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F0C7806-2985-2346-E053-F662850ACD5F","latestVersionIndicator":"Yes","beginDate":"2017-11-28","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-11-28","modifiedBy":"SOKKERL","dateModified":"2018-07-31","changeNote":"Created for Dr. Turkbey P173316 request 11.21.17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6032892","version":"1","preferredName":"Deceased Family Member Father Age of Death Value","preferredDefinition":"Numeric representation of the age of an individual's father at death.","longName":"FATHR_DTH_AGE_VL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F0C81BE-8A6E-065B-E053-F662850A4AED","latestVersionIndicator":"Yes","beginDate":"2017-11-28","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-11-28","modifiedBy":"COOPERM","dateModified":"2017-12-04","changeNote":"Created for Dr. Turkbey P173316 request 11.21.17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6032897","version":"1","preferredName":"Deceased Family Member Mother Indicator","preferredDefinition":"Indicator of whether or not an individual's mother is deceased.","longName":"DCSD_FMMEM_MOTHR_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F0C8B09-E59C-38A8-E053-F662850AA61C","latestVersionIndicator":"Yes","beginDate":"2017-11-28","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-11-28","modifiedBy":"COOPERM","dateModified":"2017-12-04","changeNote":"Created for Dr. Turkbey P173316 request 11.21.17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6032898","version":"1","preferredName":"Deceased Family Member Mother Cause of Death Text","preferredDefinition":"Text to describe the cause of death to an individual's mother.","longName":"MOTHR_CAUSE_DTH_TXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F0C9044-37BE-3511-E053-F662850A17DB","latestVersionIndicator":"Yes","beginDate":"2017-11-28","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-11-28","modifiedBy":"SOKKERL","dateModified":"2018-07-31","changeNote":"Created for Dr. Turkbey P173316 request 11.21.17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6032899","version":"1","preferredName":"Deceased Family Member Mother Age of Death Number","preferredDefinition":"Numeric representation of the age of an individual's mother at death.","longName":"MOTHR_DTH_AGE_VL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F0C9603-9CBF-34BE-E053-F662850A573E","latestVersionIndicator":"Yes","beginDate":"2017-11-28","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-11-28","modifiedBy":"COOPERM","dateModified":"2017-12-04","changeNote":"Created for Dr. Turkbey P173316 request 11.21.17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6032900","version":"1","preferredName":"NIH Clinic Visit Count","preferredDefinition":"Numeric representation of the number of times an individual was seen at the National Institutes of Health (NIH) clinic.","longName":"NIH_CLIN_VISIT_CT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F0C9044-37EC-3511-E053-F662850A17DB","latestVersionIndicator":"Yes","beginDate":"2017-11-28","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-11-28","modifiedBy":"COOPERM","dateModified":"2017-12-04","changeNote":"Created for Dr. Turkbey P173316 request 11.21.17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6032901","version":"1","preferredName":"Active Surveillance Time Duration Value","preferredDefinition":"Numeric representation of the time an individual was on active surveillance.","longName":"AS_TIME_DUR_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F0C8885-1052-23FB-E053-F662850A858F","latestVersionIndicator":"Yes","beginDate":"2017-11-28","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-11-28","modifiedBy":"COOPERM","dateModified":"2017-12-04","changeNote":"Created for Dr. Turkbey P173316 request 11.21.17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6032903","version":"1","preferredName":"Prior Testing Cancer Center Number","preferredDefinition":"Numeric representation of the number of centers involved in prior testing.","longName":"PR_TEST_CC_NUM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F0C9603-9D0E-34BE-E053-F662850A573E","latestVersionIndicator":"Yes","beginDate":"2017-11-28","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-11-28","modifiedBy":"COOPERM","dateModified":"2017-12-04","changeNote":"Created for Dr. Turkbey P173316 request 11.21.17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6032917","version":"1","preferredName":"Gleason Original Assessment Score","preferredDefinition":"Numeric representation of the original Gleason score.","longName":"ORIG_GLEASON_SCR","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F0B665C-55C5-23DE-E053-F662850AA0D1","latestVersionIndicator":"Yes","beginDate":"2017-11-28","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-11-28","modifiedBy":"ZHANGWE","dateModified":"2018-09-28","changeNote":"Created for Dr. Turkbey P173316 request 11.21.17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6032921","version":"1","preferredName":"Gleason Score Percent Core of Original Number","preferredDefinition":"Numeric representation of the percent core of the original Gleason score.","longName":"GLSN_SCR_PCR_ORG_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F0CF9EF-9FC6-2505-E053-F662850A8049","latestVersionIndicator":"Yes","beginDate":"2017-11-28","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-11-28","modifiedBy":"COOPERM","dateModified":"2017-12-04","changeNote":"Created for Dr. Turkbey P173316 request 11.21.17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6032922","version":"1","preferredName":"Patient Visit Most Recent Interval Value","preferredDefinition":"Numeric representation of the interval from the most recent visit.","longName":"PTVST_MSTRCT_INTV_VL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F0B665C-55F3-23DE-E053-F662850AA0D1","latestVersionIndicator":"Yes","beginDate":"2017-11-28","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-11-28","modifiedBy":"COOPERM","dateModified":"2017-12-04","changeNote":"Created for Dr. Turkbey P173316 request 11.21.17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6032924","version":"1","preferredName":"Prostate Cancer Prior Therapy Location and/or Extent Text","preferredDefinition":"Text description of the prior therapy location and/or extent for prostate cancer.","longName":"PCA_PRTX_LOC_EXT_TXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F0CF9EF-9FF4-2505-E053-F662850A8049","latestVersionIndicator":"Yes","beginDate":"2017-11-28","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-11-28","modifiedBy":"COOPERM","dateModified":"2017-12-04","changeNote":"Created for Dr. Turkbey P173316 request 11.21.17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6032927","version":"1","preferredName":"First Metastatic Tumor Diagnosis Date","preferredDefinition":"Date of the first metastatic tumor diagnosis.","longName":"FIRST_METS_DX_DT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F0C81BE-8A9C-065B-E053-F662850A4AED","latestVersionIndicator":"Yes","beginDate":"2017-11-28","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-11-28","modifiedBy":"COOPERM","dateModified":"2020-07-27","changeNote":"Created for Dr. Turkbey P173316 request 11.21.17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6032936","version":"1","preferredName":"First Metastatic Tumor Anatomic Site","preferredDefinition":"Text term that represents the anatomic site of the first metastatic tumor.","longName":"FIRST_METS_ANAT_ST","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F0D4F0B-FE76-3F61-E053-F662850A67FC","latestVersionIndicator":"Yes","beginDate":"2017-11-28","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-11-28","modifiedBy":"COOPERM","dateModified":"2017-12-04","changeNote":"Created for Dr. Turkbey P173316 request 11.21.17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6032941","version":"1","preferredName":"Prostate Cancer Prior Therapy Administered Code","preferredDefinition":"Code abbreviation for the type of prior therapy given for prostate cancer.","longName":"PCA_PR_TX_CD","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F0DE0D5-2849-4352-E053-F662850AD839","latestVersionIndicator":"Yes","beginDate":"2017-11-28","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-11-28","modifiedBy":"COOPERM","dateModified":"2017-12-04","changeNote":"Created for Dr. Turkbey P173316 request 11.21.17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6032942","version":"1","preferredName":"Outside Institution Treatment Recommendation Code","preferredDefinition":"Code abbreviation for the type of prior therapy recommended for prostate cancer by an outside institution.","longName":"OUT_INST_TX_RECM_CD","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F0DF252-630A-350F-E053-F662850A0AF1","latestVersionIndicator":"Yes","beginDate":"2017-11-28","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-11-28","modifiedBy":"COOPERM","dateModified":"2017-12-04","changeNote":"Created for Dr. Turkbey P173316 request 11.21.17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6035031","version":"1","preferredName":"Test Aversion Indicator","preferredDefinition":"Indicator of whether or not an individual has an aversion to additional testing.","longName":"TEST_AVRSN_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F34E43E-9F44-756D-E053-F662850AF65F","latestVersionIndicator":"Yes","beginDate":"2017-11-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-11-30","modifiedBy":"COOPERM","dateModified":"2017-12-04","changeNote":"Created for Dr. Turkbey P173316 request 11.21.17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6035032","version":"1","preferredName":"Trial Enrollment NIH Visit Indicator","preferredDefinition":"Indicator of whether or not an individual visited the National Institutes of Health (NIH) specifically to enroll in a clinical trial.","longName":"TRL_ENRL_NIH_VST_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F35D590-D05B-6627-E053-F662850A7ECE","latestVersionIndicator":"Yes","beginDate":"2017-11-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-11-30","modifiedBy":"COOPERM","dateModified":"2017-12-04","changeNote":"Created for Dr. Turkbey P173316 request 11.21.17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6035033","version":"1","preferredName":"Prostate Cancer Treatment or Active Surveillance Preference Code","preferredDefinition":"Text abbreviation for the preference of treatment or active surveillance for prostate cancer.","longName":"PCA_TX_AS_PREF_CD","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F34F484-1775-77A2-E053-F662850AC643","latestVersionIndicator":"Yes","beginDate":"2017-11-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-11-30","modifiedBy":"COOPERM","dateModified":"2017-12-04","changeNote":"Created for Dr. Turkbey P173316 request 11.21.17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6035045","version":"1","preferredName":"Prostate Cancer Treatment Preference Code","preferredDefinition":"Text abbreviation for the preferred treatment of prostate cancer.","longName":"PCA_TX_PREF_CD","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F361211-1D20-4177-E053-F662850AF9D1","latestVersionIndicator":"Yes","beginDate":"2017-11-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-11-30","modifiedBy":"COOPERM","dateModified":"2017-12-04","changeNote":"Created for Dr. Turkbey P173316 request 11.21.17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6035047","version":"1","preferredName":"Prostate Cancer Aversion Treatment Type","preferredDefinition":"Text term for the kind of treatment an individual has an aversion to for prostate cancer.","longName":"PCA_AVRSN_TX_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F33EFA9-B3C4-7201-E053-F662850A8D50","latestVersionIndicator":"Yes","beginDate":"2017-11-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-11-30","modifiedBy":"COOPERM","dateModified":"2017-12-04","changeNote":"Created for Dr. Turkbey P173316 request 11.21.17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6035049","version":"1","preferredName":"Prostate Cancer Treatment Aversion Reason","preferredDefinition":"Text term that represents the reason an individual has an aversion to prostate cancer treatment.","longName":"PCA_TX_AVRSN_RSN","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F361211-1D4E-4177-E053-F662850AF9D1","latestVersionIndicator":"Yes","beginDate":"2017-11-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-11-30","modifiedBy":"COOPERM","dateModified":"2017-12-04","changeNote":"Created for Dr. Turkbey P173316 request 11.21.17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6035050","version":"1","preferredName":"Prostate Cancer Treatment Decision Urgency Indicator","preferredDefinition":"Indicator of whether or not an urgent decision is needed for prostate cancer treatment.","longName":"PCA_TX_DECSN_URG_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F344D29-2163-7542-E053-F662850A5472","latestVersionIndicator":"Yes","beginDate":"2017-11-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-11-30","modifiedBy":"COOPERM","dateModified":"2017-12-04","changeNote":"Created for Dr. Turkbey P173316 request 11.21.17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6035052","version":"1","preferredName":"Treatment Center and/or Physician Location Type","preferredDefinition":"Text term that represents the kind of cancer center for treatment and or physician.","longName":"TX_CNTR_PHYS_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F3607BC-FE7C-3C03-E053-F662850A6B93","latestVersionIndicator":"Yes","beginDate":"2017-11-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-11-30","modifiedBy":"COOPERM","dateModified":"2017-12-04","changeNote":"Created for Dr. Turkbey P173316 request 11.21.17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6035053","version":"1","preferredName":"Outside Institution Patient Visit Count","preferredDefinition":"The number of times an individual visited or is visiting an institution other than the National Institutes of Health.","longName":"OUT_INST_VISIT_CT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F361211-1D7C-4177-E053-F662850AF9D1","latestVersionIndicator":"Yes","beginDate":"2017-11-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-11-30","modifiedBy":"COOPERM","dateModified":"2017-12-04","changeNote":"Created for Dr. Turkbey P173316 request 11.21.17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6035054","version":"1","preferredName":"Prostate Cancer Symptoms Present Indicator","preferredDefinition":"Indicator of whether or not an individual has symptoms of prostate cancer.","longName":"PCA_SYMPT_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F361211-1DAA-4177-E053-F662850AF9D1","latestVersionIndicator":"Yes","beginDate":"2017-11-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-11-30","modifiedBy":"COOPERM","dateModified":"2017-12-04","changeNote":"Created for Dr. Turkbey P173316 request 11.21.17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6035074","version":"1","preferredName":"Pathology Special Stain Indicator","preferredDefinition":"Indicator of whether or not special staining was used.","longName":"PATH_SP_STN_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F367B86-2963-4672-E053-F662850AB638","latestVersionIndicator":"Yes","beginDate":"2017-11-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-11-30","modifiedBy":"COOPERM","dateModified":"2017-12-04","changeNote":"Created for Dr. Turkbey P173316 request 11.21.17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6035075","version":"1","preferredName":"Finding PSA Measurement and Clinical Response Agreement Indicator","preferredDefinition":"Indicator of whether or not the findings for prostate specific antigen (PSA) and the clinical response are in agreement.","longName":"PSA_RESP_AGREE_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F367B86-2991-4672-E053-F662850AB638","latestVersionIndicator":"Yes","beginDate":"2017-11-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-11-30","modifiedBy":"COOPERM","dateModified":"2017-12-04","changeNote":"Created for Dr. Turkbey P173316 request 11.21.17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6035076","version":"1","preferredName":"Finding PSA and Clinical Response Prior Discordance Indicator","preferredDefinition":"Indicator of whether or not the findings for prior prostate specific antigen (PSA) and the clinical response disagree.","longName":"PR_PSA_RSP_DSAGR_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F33EFA9-B409-7201-E053-F662850A8D50","latestVersionIndicator":"Yes","beginDate":"2017-11-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-11-30","modifiedBy":"COOPERM","dateModified":"2017-12-04","changeNote":"Created for Dr. Turkbey P173316 request 11.21.17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6035077","version":"1","preferredName":"Finding Prior and/or Outside Read Outcome","preferredDefinition":"Text term that represents the agreement result of the finding for the prior and/or outside reading.","longName":"PRIOR_OUT_RD_RESULT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F343497-9B37-7687-E053-F662850A032A","latestVersionIndicator":"Yes","beginDate":"2017-11-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-11-30","modifiedBy":"COOPERM","dateModified":"2017-12-04","changeNote":"Created for Dr. Turkbey P173316 request 11.21.17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6035078","version":"1","preferredName":"Prostate Cancer Prior Outcome of Therapy Text","preferredDefinition":"Text description of the prior outcome of therapy for prostate cancer.","longName":"PRIOR_OUTC_THRP_TXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F3974CC-E386-687A-E053-F662850A7039","latestVersionIndicator":"Yes","beginDate":"2017-11-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-11-30","modifiedBy":"COOPERM","dateModified":"2017-12-04","changeNote":"Created for Dr. Turkbey P173316 request 11.21.17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6035079","version":"1","preferredName":"Benign Prostatic Hyperplasia Burden and/or Inflammation Outcome","preferredDefinition":"Text term that represents the burden of benign prostatic hyperplasia or inflammation results.","longName":"BPH_BRDN_INFLM_RSLT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F344D29-2215-7542-E053-F662850A5472","latestVersionIndicator":"Yes","beginDate":"2017-11-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-11-30","modifiedBy":"COOPERM","dateModified":"2017-12-04","changeNote":"Created for Dr. Turkbey P173316 request 11.21.17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6035086","version":"1","preferredName":"Image Patchy Appearance Indicator","preferredDefinition":"Indicator of whether or not the image has a patchy appearance.","longName":"IMG_PATCHY_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F367B86-29C8-4672-E053-F662850AB638","latestVersionIndicator":"Yes","beginDate":"2017-11-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-11-30","modifiedBy":"COOPERM","dateModified":"2017-12-04","changeNote":"Created for Dr. Turkbey P173316 request 11.21.17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6035087","version":"1","preferredName":"Patient Condition Stability Type","preferredDefinition":"Text term that represents the kind of stability over time of an individual's condition.","longName":"PT_COND_STBL_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F35010E-B3BF-55FE-E053-F662850AE46B","latestVersionIndicator":"Yes","beginDate":"2017-11-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-11-30","modifiedBy":"COOPERM","dateModified":"2017-12-04","changeNote":"Created for Dr. Turkbey P173316 request 11.21.17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6035088","version":"1","preferredName":"Index Lesion Concern Indicator","preferredDefinition":"Indicator of whether or not the concerning lesion is the index lesion.","longName":"INX_LSN_CRN_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F3A6C61-DEB6-0FF9-E053-F662850A2F33","latestVersionIndicator":"Yes","beginDate":"2017-11-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-11-30","modifiedBy":"COOPERM","dateModified":"2017-12-04","changeNote":"Created for Dr. Turkbey P173316 request 11.21.17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6035093","version":"1","preferredName":"Index Lesion Largest Indicator","preferredDefinition":"Indicator of whether or not the largest lesion is the index lesion.","longName":"INX_LSN_LRG_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F3A3E6D-A52F-7972-E053-F662850A88C4","latestVersionIndicator":"Yes","beginDate":"2017-11-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-11-30","modifiedBy":"COOPERM","dateModified":"2017-12-04","changeNote":"Created for Dr. Turkbey P173316 request 11.21.17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6035094","version":"1","preferredName":"New Primary Lesion Retrospective Appearance and/or Detection Type","preferredDefinition":"Text term that represents the kind of appearance and/or detection for the new primary lesion.","longName":"NPLSN_RTRO_AP_DT_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F3AA332-B356-3DE8-E053-F662850A4238","latestVersionIndicator":"Yes","beginDate":"2017-11-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-11-30","modifiedBy":"COOPERM","dateModified":"2017-12-04","changeNote":"Created for Dr. Turkbey P173316 request 11.21.17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6035095","version":"1","preferredName":"Metastatic Disease and/or Recurrence Retrospective Identification Type","preferredDefinition":"Text term that represents the kind of retrospective identification of recurrence and/or metastatic disease.","longName":"MET_RTRO_RC_ID_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F3AB66A-CA7C-541D-E053-F662850A1D59","latestVersionIndicator":"Yes","beginDate":"2017-11-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-11-30","modifiedBy":"COOPERM","dateModified":"2017-12-04","changeNote":"Created for Dr. Turkbey P173316 request 11.21.17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6035098","version":"1","preferredName":"Multiple Small Lesion Appearance and/or Disappearance Indicator","preferredDefinition":"Indicator of whether or not there are multiple appearance or disappearance of small lesions.","longName":"MULT_SM_LSN_APDP_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F3A6C61-DEE4-0FF9-E053-F662850A2F33","latestVersionIndicator":"Yes","beginDate":"2017-11-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-11-30","modifiedBy":"COOPERM","dateModified":"2017-12-04","changeNote":"Created for Dr. Turkbey P173316 request 11.21.17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6035099","version":"1","preferredName":"Image Poor Quality Reason","preferredDefinition":"Text term or abbreviation that represents the main reason why an image is of poor quality.","longName":"IMG_POOR_QL_RSN","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F35010E-B3F1-55FE-E053-F662850AE46B","latestVersionIndicator":"Yes","beginDate":"2017-11-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-11-30","modifiedBy":"COOPERM","dateModified":"2017-12-04","changeNote":"Created for Dr. Turkbey P173316 request 11.21.17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6035100","version":"1","preferredName":"Image Easy Delineation Indicator","preferredDefinition":"Indicator of whether or not the image can be easily delineated.","longName":"IMG_EASY_DELIN_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F3AF61E-7A86-67D7-E053-F662850A28D3","latestVersionIndicator":"Yes","beginDate":"2017-11-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-11-30","modifiedBy":"COOPERM","dateModified":"2017-12-04","changeNote":"Created for Dr. Turkbey P173316 request 11.21.17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6035101","version":"1","preferredName":"Index Lesion Growth and/or Changes Compared to Other Finding Type","preferredDefinition":"Text term that represents the growth and/or changes to the index lesion as compared to others.","longName":"INX_LSN_GRW_CMP_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F3B007E-87B2-7386-E053-F662850ADB9A","latestVersionIndicator":"Yes","beginDate":"2017-11-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-11-30","modifiedBy":"COOPERM","dateModified":"2017-12-04","changeNote":"Created for Dr. Turkbey P173316 request 11.21.17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6035102","version":"1","preferredName":"Rare Finding Description Text","preferredDefinition":"Text description of the rare finding.","longName":"RARE_FND_DSCP_TXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F367B86-29F6-4672-E053-F662850AB638","latestVersionIndicator":"Yes","beginDate":"2017-11-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-11-30","modifiedBy":"COOPERM","dateModified":"2017-12-04","changeNote":"Created for Dr. Turkbey P173316 request 11.21.17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6035103","version":"1","preferredName":"Multimodal Imaging Finding Outcome","preferredDefinition":"Text term that represents the agreement result of the finding for the multimodal image.","longName":"MULTMDL_IMG_RESLT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F3AB66A-CAAE-541D-E053-F662850A1D59","latestVersionIndicator":"Yes","beginDate":"2017-11-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-11-30","modifiedBy":"COOPERM","dateModified":"2017-12-04","changeNote":"Created for Dr. Turkbey P173316 request 11.21.17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6035104","version":"1","preferredName":"Hemorrhage Present Indicator","preferredDefinition":"Indicator of whether or not a hemorrhage is present.","longName":"HMRG_PRST_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F3B1E76-915A-5B72-E053-F662850ADCFB","latestVersionIndicator":"Yes","beginDate":"2017-11-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-11-30","modifiedBy":"MORENOC","dateModified":"2018-05-07","changeNote":"Created for Dr. Turkbey P173316 request 11.21.17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6035105","version":"1","preferredName":"Radiological Finding Other Description Text","preferredDefinition":"Text description of another radiological finding not already specified.","longName":"RAD_FND_OTH_DSC_TXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F3B27D6-0E33-620C-E053-F662850AEDD4","latestVersionIndicator":"Yes","beginDate":"2017-11-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-11-30","modifiedBy":"COOPERM","dateModified":"2017-12-04","changeNote":"Created for Dr. Turkbey P173316 request 11.21.17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6035106","version":"1","preferredName":"Metastatic Tumor Location Anatomic Site","preferredDefinition":"Text term that represents the anatomic site of the metastatic tumor.","longName":"METS_LOC_ANAT_ST","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F3B2EFA-D5A3-68FD-E053-F662850A5183","latestVersionIndicator":"Yes","beginDate":"2017-11-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-11-30","modifiedBy":"COOPERM","dateModified":"2017-12-04","changeNote":"Created for Dr. Turkbey P173316 request 11.21.17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6035111","version":"1","preferredName":"Metastatic Tumor Assessment Count","preferredDefinition":"Number of all metastatic tumors assessed.","longName":"METS_ASMT_CT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F3B69F5-7082-1E38-E053-F662850AA234","latestVersionIndicator":"Yes","beginDate":"2017-11-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-11-30","modifiedBy":"COOPERM","dateModified":"2017-12-04","changeNote":"Created for Dr. Turkbey P173316 request 11.21.17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6035112","version":"1","preferredName":"Metastatic Tumor Burden and/or Volume Value","preferredDefinition":"Number that represents the measurement of the metastatic tumor burden and/or tumor volume.","longName":"METS_BRDN_VOL_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F3B2EFA-D600-68FD-E053-F662850A5183","latestVersionIndicator":"Yes","beginDate":"2017-11-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-11-30","modifiedBy":"COOPERM","dateModified":"2017-12-04","changeNote":"Created for Dr. Turkbey P173316 request 11.21.17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6036486","version":"1","preferredName":"Prostate Cancer Family Member Relationship Other Specify","preferredDefinition":"Text term not previously mentioned that represents the kind of family member relationship to an individual with a history of prostate cancer.","longName":"PCA_HIST_FAM_REL_SPE","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F8E8B23-2B27-5917-E053-F662850A871E","latestVersionIndicator":"Yes","beginDate":"2017-12-04","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2017-12-04","modifiedBy":"COOPERM","dateModified":"2017-12-06","changeNote":"Created for Dr. Turkbey P173316 request 12.04.17 ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6036487","version":"1","preferredName":"Cancer Family Member Relationship Other Specify","preferredDefinition":"Text term not previously mentioned that represents the kind of family member relationship to an individual with a history of cancer.","longName":"CA_HIST_FAM_REL_SPEC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F89D91E-70E7-211C-E053-F662850AA3DB","latestVersionIndicator":"Yes","beginDate":"2017-12-04","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2017-12-04","modifiedBy":"COOPERM","dateModified":"2017-12-06","changeNote":"Created for Dr. Turkbey P173316 request 12.04.17 ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6036488","version":"1","preferredName":"Non-Cancer History With Significant Comorbidity Family Member Relationship Other Specify","preferredDefinition":"Text term not previously mentioned that represents the kind of family member relationship to an individual with no history of cancer and significant comorbidity.","longName":"NCA_SG_CMRB_FM_RL_SP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F8BD6D2-1AAC-4D04-E053-F662850A6B61","latestVersionIndicator":"Yes","beginDate":"2017-12-04","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2017-12-04","modifiedBy":"COOPERM","dateModified":"2017-12-06","changeNote":"Created for Dr. Turkbey P173316 request 12.04.17 ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6036489","version":"1","preferredName":"Prostate Cancer Prior Therapy Administered Other Specify","preferredDefinition":"Text term not previously mentioned that represents the type of prior therapy given for prostate cancer.","longName":"PCA_PR_TX_SPEC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F89D91E-7109-211C-E053-F662850AA3DB","latestVersionIndicator":"Yes","beginDate":"2017-12-04","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2017-12-04","modifiedBy":"COOPERM","dateModified":"2017-12-06","changeNote":"Created for Dr. Turkbey P173316 request 12.04.17 ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6036490","version":"1","preferredName":"First Metastatic Tumor Anatomic Site Other Specify","preferredDefinition":"Text term not previously mentioned that represents the anatomic site of the first metastatic tumor.","longName":"FIRST_METS_ANAT_SPEC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F861E61-D5B1-6851-E053-F662850AC560","latestVersionIndicator":"Yes","beginDate":"2017-12-04","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2017-12-04","modifiedBy":"COOPERM","dateModified":"2017-12-06","changeNote":"Created for Dr. Turkbey P173316 request 12.04.17 ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6036491","version":"1","preferredName":"Outside Institution Treatment Recommendation Other Specify","preferredDefinition":"Text term not previously mentioned that represents the type of prior therapy recommended for prostate cancer by an outside institution.","longName":"OUT_INST_TX_RECM_SP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F861E61-D5D3-6851-E053-F662850AC560","latestVersionIndicator":"Yes","beginDate":"2017-12-04","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2017-12-04","modifiedBy":"COOPERM","dateModified":"2017-12-06","changeNote":"Created for Dr. Turkbey P173316 request 12.04.17 ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6036492","version":"1","preferredName":"Prostate Cancer Treatment Preference Other Specify","preferredDefinition":"Text term not previously mentioned that represents the preferred treatment for prostate cancer.","longName":"PCA_TX_PREF_SPEC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F8EB2D6-E560-05CF-E053-F662850AFA5E","latestVersionIndicator":"Yes","beginDate":"2017-12-04","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2017-12-04","modifiedBy":"COOPERM","dateModified":"2017-12-06","changeNote":"Created for Dr. Turkbey P173316 request 12.04.17 ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6036493","version":"1","preferredName":"Prostate Cancer Aversion Treatment Other Specify","preferredDefinition":"Text term not previously mentioned that represents the kind of treatment an individual has an aversion to for prostate cancer.","longName":"PCA_AVRSN_TX_SPEC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F8EB6BB-93B6-091A-E053-F662850AFF25","latestVersionIndicator":"Yes","beginDate":"2017-12-04","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2017-12-04","modifiedBy":"COOPERM","dateModified":"2017-12-06","changeNote":"Created for Dr. Turkbey P173316 request 12.04.17 ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6036494","version":"1","preferredName":"Treatment Center And/Or Physician Location Other Specify","preferredDefinition":"Text term not previously mentioned that represents the kind of cancer center for treatment and or physician.","longName":"TX_CNTR_PHYS_SPEC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F8EBFD7-5AF3-0F91-E053-F662850AFE47","latestVersionIndicator":"Yes","beginDate":"2017-12-04","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2017-12-04","modifiedBy":"COOPERM","dateModified":"2017-12-06","changeNote":"Created for Dr. Turkbey P173316 request 12.04.17 ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6036495","version":"1","preferredName":"Metastatic Tumor Location Other Specify","preferredDefinition":"Text term not previously mentioned that represents the anatomic site of the metastatic tumor.","longName":"METS_LOC_ANAT_SPEC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F8EC63A-4857-1228-E053-F662850AA679","latestVersionIndicator":"Yes","beginDate":"2017-12-04","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2017-12-04","modifiedBy":"COOPERM","dateModified":"2017-12-06","changeNote":"Created for Dr. Turkbey P173316 request 12.04.17 ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6036496","version":"1","preferredName":"Treatment Regimen Intent Other Specify","preferredDefinition":"Text term not previously mentioned to identify the reason for the administration of a treatment regimen.","longName":"TX_REG_INTENT_SPEC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F8ED118-38B5-190D-E053-F662850A8575","latestVersionIndicator":"Yes","beginDate":"2017-12-04","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2017-12-04","modifiedBy":"COOPERM","dateModified":"2017-12-06","changeNote":"Created for Dr. Turkbey P173316 request 12.04.17 ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6036497","version":"1","preferredName":"Finding Result Pathology and Imaging Concordance Type","preferredDefinition":"Text term that represents the concordance of results between pathology and imaging findings.","longName":"FND_PATH_IMG_CND_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F8BD6D2-1ACE-4D04-E053-F662850A6B61","latestVersionIndicator":"Yes","beginDate":"2017-12-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-12-04","modifiedBy":"COOPERM","dateModified":"2017-12-06","changeNote":"Created for Dr. Turkbey P173316 request 11.21.17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6036498","version":"1","preferredName":"Image Lesion Sample Collection Indicator","preferredDefinition":"Indicator of whether or not all lesions on imaging have been sampled.","longName":"IMG_LESN_SMPL_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F8EF4F5-C38E-2C38-E053-F662850AFF9D","latestVersionIndicator":"Yes","beginDate":"2017-12-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-12-04","modifiedBy":"COOPERM","dateModified":"2017-12-06","changeNote":"Created for Dr. Turkbey P173316 request 11.21.17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6036499","version":"1","preferredName":"Image Lesion Biopsy Type","preferredDefinition":"Text term that represents the kind of biopsy done based on the lesion on imaging.","longName":"IMG_LESN_BX_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F907AFB-A39E-4477-E053-F662850ADEB4","latestVersionIndicator":"Yes","beginDate":"2017-12-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-12-04","modifiedBy":"COOPERM","dateModified":"2017-12-06","changeNote":"Created for Dr. Turkbey P173316 request 11.21.17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6036500","version":"1","preferredName":"Random Biopsy Pathology to Imaging Finding Mapping Indicator","preferredDefinition":"Indicator of whether or not or the likelihood that the pathology report is mappable to the imaging report for a random biopsy.","longName":"RMBX_PTH2IMG_MAP_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F8ED118-38D9-190D-E053-F662850A8575","latestVersionIndicator":"Yes","beginDate":"2017-12-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-12-04","modifiedBy":"COOPERM","dateModified":"2017-12-06","changeNote":"Created for Dr. Turkbey P173316 request 11.21.17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6036501","version":"1","preferredName":"Index Lesion Biopsy Saturation Indicator","preferredDefinition":"Indicator of whether or not there was biopsy saturation of the index lesion.","longName":"INX_LSN_BX_SAT_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F8EC63A-487C-1228-E053-F662850AA679","latestVersionIndicator":"Yes","beginDate":"2017-12-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-12-04","modifiedBy":"COOPERM","dateModified":"2017-12-06","changeNote":"Created for Dr. Turkbey P173316 request 11.21.17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6036502","version":"1","preferredName":"Metastatic Lesion Biopsy Performed Indicator","preferredDefinition":"Indicator of whether or not the metastatic lesions were biopsied.","longName":"MET_LSN_BX_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F8ED118-3907-190D-E053-F662850A8575","latestVersionIndicator":"Yes","beginDate":"2017-12-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-12-04","modifiedBy":"COOPERM","dateModified":"2017-12-06","changeNote":"Created for Dr. Turkbey P173316 request 11.21.17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6036504","version":"1","preferredName":"Finding Result Pathology and Imaging Poor Correlation Reason Text","preferredDefinition":"Text description of why the pathology and imaging results correlated poorly.","longName":"PATH_IMG_POORCOR_TXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F861E61-D5F5-6851-E053-F662850AC560","latestVersionIndicator":"Yes","beginDate":"2017-12-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-12-04","modifiedBy":"COOPERM","dateModified":"2017-12-06","changeNote":"Created for Dr. Turkbey P173316 request 11.21.17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6036506","version":"1","preferredName":"Healthcare Facility Geographic Location and Travel Ease Type","preferredDefinition":"Text term that represents the healthcare facility location and ease of transportation.","longName":"GEO_LOC_EASE_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F9100AA-F1F3-201A-E053-F662850A6ACD","latestVersionIndicator":"Yes","beginDate":"2017-12-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-12-04","modifiedBy":"COOPERM","dateModified":"2017-12-06","changeNote":"Created for Dr. Turkbey P173316 request 11.21.17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6036508","version":"1","preferredName":"Other Institution Practice Reference Text","preferredDefinition":"Text description of other institutional practices referenced.","longName":"OTH_INST_REF_TXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F8EBFD7-5B15-0F91-E053-F662850AFE47","latestVersionIndicator":"Yes","beginDate":"2017-12-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-12-04","modifiedBy":"COOPERM","dateModified":"2017-12-06","changeNote":"Created for Dr. Turkbey P173316 request 11.21.17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6036509","version":"1","preferredName":"Scientific Work Reference Text","preferredDefinition":"Text description of scientific works referenced","longName":"SCIENC_REF_TXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F8EB6BB-93E5-091A-E053-F662850AFF25","latestVersionIndicator":"Yes","beginDate":"2017-12-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-12-04","modifiedBy":"COOPERM","dateModified":"2017-12-06","changeNote":"Created for Dr. Turkbey P173316 request 11.21.17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6036510","version":"1","preferredName":"Additional Test Required Prior to Decision Indicator","preferredDefinition":"Indicator of whether or not additional testing is required before a decision is made.","longName":"AD_TST_RQ_PR_DSN_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F8BD6D2-1AFC-4D04-E053-F662850A6B61","latestVersionIndicator":"Yes","beginDate":"2017-12-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-12-04","modifiedBy":"COOPERM","dateModified":"2017-12-06","changeNote":"Created for Dr. Turkbey P173316 request 11.21.17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6036511","version":"1","preferredName":"Additional Testing Future Performance Type","preferredDefinition":"Text term that represents the kind of additional testing to be done.","longName":"AD_TST_FUTR_PERF_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F8F01C8-1C40-386A-E053-F662850A5CE8","latestVersionIndicator":"Yes","beginDate":"2017-12-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-12-04","modifiedBy":"COOPERM","dateModified":"2017-12-06","changeNote":"Created for Dr. Turkbey P173316 request 11.21.17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6036512","version":"1","preferredName":"Prostate Cancer Ancillary Test Performed Type","preferredDefinition":"Text term that represents the kind of ancillary testing performed for prostate cancer.","longName":"ANCL_TST_PRF_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F90CE7D-F3C6-23C5-E053-F662850A7010","latestVersionIndicator":"Yes","beginDate":"2017-12-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-12-04","modifiedBy":"COOPERM","dateModified":"2017-12-06","changeNote":"Created for Dr. Turkbey P173316 request 11.21.17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6036514","version":"1","preferredName":"Eligibility Clarification Testing Review Indicator","preferredDefinition":"Indicator of whether or not a review of testing to clarify eligibility was done.","longName":"ELIG_CLR_TEST_RW_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F861E61-D623-6851-E053-F662850AC560","latestVersionIndicator":"Yes","beginDate":"2017-12-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-12-04","modifiedBy":"COOPERM","dateModified":"2017-12-06","changeNote":"Created for Dr. Turkbey P173316 request 11.21.17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6036515","version":"1","preferredName":"Eligibility Change Additional Testing Indicator","preferredDefinition":"Indicator of whether or not additional testing would change the determination of eligibility.","longName":"ELIG_AD_TST_CHG_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F861E61-D653-6851-E053-F662850AC560","latestVersionIndicator":"Yes","beginDate":"2017-12-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-12-04","modifiedBy":"COOPERM","dateModified":"2017-12-06","changeNote":"Created for Dr. Turkbey P173316 request 11.21.17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6036516","version":"1","preferredName":"Enrollment Concern Type","preferredDefinition":"Text term that represents the kind of trial enrollment concern.","longName":"ENROL_CONCRN_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F8F01C8-1C6E-386A-E053-F662850A5CE8","latestVersionIndicator":"Yes","beginDate":"2017-12-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-12-04","modifiedBy":"COOPERM","dateModified":"2017-12-06","changeNote":"Created for Dr. Turkbey P173316 request 11.21.17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6036517","version":"1","preferredName":"Non-Progression Contraindication Report Type","preferredDefinition":"Text term that represents the kind report used to contraindicate calling non-progression.","longName":"NPROG_CTRIND_RPT_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F91A8BD-E056-40F7-E053-F662850AD3B4","latestVersionIndicator":"Yes","beginDate":"2017-12-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-12-04","modifiedBy":"COOPERM","dateModified":"2017-12-06","changeNote":"Created for Dr. Turkbey P173316 request 11.21.17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6036518","version":"1","preferredName":"Disease Progression Status","preferredDefinition":"Text term that describes the state of the disease progression.","longName":"DIS_PROG_STAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F91A8BD-E084-40F7-E053-F662850AD3B4","latestVersionIndicator":"Yes","beginDate":"2017-12-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-12-05","modifiedBy":"COOPERM","dateModified":"2017-12-06","changeNote":"Created for Dr. Turkbey P173316 request 11.21.17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6036519","version":"1","preferredName":"Prostate Specific Antigen Pathology and/or Imaging Report Concordance Indicator","preferredDefinition":"Indicator of whether or not the Prostate Specific Antigen (PSA) was concordant with the pathology and/or imaging report.","longName":"PSA_PATH_IMG_CNC_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F8F01C8-1C9C-386A-E053-F662850A5CE8","latestVersionIndicator":"Yes","beginDate":"2017-12-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-12-05","modifiedBy":"COOPERM","dateModified":"2017-12-06","changeNote":"Created for Dr. Turkbey P173316 request 11.21.17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6036520","version":"1","preferredName":"Cancer Progression Indeterminate Finding Basis Report Type","preferredDefinition":"Text term that represents the kind report used as the basis for a finding of indeterminate progression.","longName":"CAPROG_INDT_RPT_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F8EC63A-48AA-1228-E053-F662850AA679","latestVersionIndicator":"Yes","beginDate":"2017-12-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-12-05","modifiedBy":"COOPERM","dateModified":"2017-12-06","changeNote":"Created for Dr. Turkbey P173316 request 11.21.17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6037627","version":"1","preferredName":"Prostate Cancer Treatment Aversion Reason Other Specify","preferredDefinition":"Text term not previously mentioned that represents the reason an individual has an aversion to prostate cancer treatment.","longName":"PCA_TX_AVRSN_RSN_SPE","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F9F7552-C1ED-06B0-E053-F662850AF9D4","latestVersionIndicator":"Yes","beginDate":"2017-12-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2017-12-05","modifiedBy":"COOPERM","dateModified":"2017-12-06","changeNote":"Created for Dr. Turkbey P173316 request 12.05.17 ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6037640","version":"1","preferredName":"Additional Testing Future Performance Other Specify","preferredDefinition":"Text term not previously mentioned that represents the kind of additional testing to be done.","longName":"AD_TST_FUTR_PERF_SPE","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F9DC2E1-39DF-257E-E053-F662850A5E99","latestVersionIndicator":"Yes","beginDate":"2017-12-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2017-12-05","modifiedBy":"COOPERM","dateModified":"2017-12-06","changeNote":"Created for Dr. Turkbey P173316 request 12.05.17 ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6037645","version":"1","preferredName":"Prostate Cancer Ancillary Testing Performed Other Specify","preferredDefinition":"Text term not previously mentioned that represents the kind of ancillary testing performed for prostate cancer.","longName":"ANCL_TST_PRF_SPEC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F9F85E1-1F5E-76DE-E053-F662850A148B","latestVersionIndicator":"Yes","beginDate":"2017-12-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2017-12-05","modifiedBy":"COOPERM","dateModified":"2017-12-06","changeNote":"Created for Dr. Turkbey P173316 request 12.05.17 ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6037646","version":"1","preferredName":"Enrollment Concern Other Specify","preferredDefinition":"Text term not previously mentioned that represents the kind of trial enrollment concern.","longName":"ENROL_CONCRN_SPEC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F9F8C2A-3577-7A2A-E053-F662850A6DFA","latestVersionIndicator":"Yes","beginDate":"2017-12-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2017-12-05","modifiedBy":"COOPERM","dateModified":"2017-12-06","changeNote":"Created for Dr. Turkbey P173316 request 12.05.17 ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6037653","version":"1","preferredName":"Non-Progression Contraindication Report Other Specify","preferredDefinition":"Text term not previously mentioned that represents the kind report used to contraindicate calling non-progression.","longName":"NPROG_CTRIND_RPT_SPE","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F9DCC08-7464-6CA3-E053-F662850A9DAF","latestVersionIndicator":"Yes","beginDate":"2017-12-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2017-12-05","modifiedBy":"COOPERM","dateModified":"2017-12-06","changeNote":"Created for Dr. Turkbey P173316 request 12.05.17 ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6037660","version":"1","preferredName":"Disease Progression Assessment Other Specify","preferredDefinition":"Text term not previously mentioned that describes the state of the disease progression.","longName":"DIS_PROG_ASMT_SPEC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F9DB814-78E4-77EE-E053-F662850A199D","latestVersionIndicator":"Yes","beginDate":"2017-12-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2017-12-05","modifiedBy":"COOPERM","dateModified":"2017-12-06","changeNote":"Created for Dr. Turkbey P173316 request 12.05.17 ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6037674","version":"1","preferredName":"Cancer Progression Indeterminate Finding Basis Report Other Specify","preferredDefinition":"Text term not previously mentioned that represents the kind report used as the basis for a finding of indeterminate progression.","longName":"CAPROG_INDT_RPT_SPEC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F9FA14E-7893-7909-E053-F662850AD0D7","latestVersionIndicator":"Yes","beginDate":"2017-12-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2017-12-05","modifiedBy":"COOPERM","dateModified":"2017-12-06","changeNote":"Created for Dr. Turkbey P173316 request 12.05.17 ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6037736","version":"1","preferredName":"Surgical Procedure Combined Treatment Preference Other Specify","preferredDefinition":"Text term not previously mentioned that represents the kind of combined treatment preference with surgery.","longName":"SURG_CMB_TX_PREF_SPE","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F9DB814-7906-77EE-E053-F662850A199D","latestVersionIndicator":"Yes","beginDate":"2017-12-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2017-12-05","modifiedBy":"COOPERM","dateModified":"2017-12-06","changeNote":"Created for Dr. Turkbey P173316 request 12.05.17 ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6037741","version":"1","preferredName":"Surgical Procedure Imaging Based Contraindication Other Specify","preferredDefinition":"Text term not previously mentioned that represents the kind of surgical contraindication based on the imaging report.","longName":"SURG_IMGBS_CNTRND_SP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F9FBABE-74D8-7881-E053-F662850A4C7E","latestVersionIndicator":"Yes","beginDate":"2017-12-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2017-12-05","modifiedBy":"COOPERM","dateModified":"2017-12-06","changeNote":"Created for Dr. Turkbey P173316 request 12.05.17 ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6037746","version":"1","preferredName":"Medical Oncology First Other Treatment Preference Specify","preferredDefinition":"Text term not previously mentioned that represents the kind of first other treatment preference with medical oncology.","longName":"MONC_FOTH_TX_PRF_SPE","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F9FBABE-74FA-7881-E053-F662850A4C7E","latestVersionIndicator":"Yes","beginDate":"2017-12-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2017-12-05","modifiedBy":"COOPERM","dateModified":"2017-12-06","changeNote":"Created for Dr. Turkbey P173316 request 12.05.17 ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6037751","version":"1","preferredName":"Medical Oncology Combined Treatment Preference Other Specify","preferredDefinition":"Text term not previously mentioned that represents the kind of combined treatment preference with medical oncology.","longName":"MONC_CMB_TX_PRF_SP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F9FBABE-751C-7881-E053-F662850A4C7E","latestVersionIndicator":"Yes","beginDate":"2017-12-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2017-12-05","modifiedBy":"COOPERM","dateModified":"2017-12-06","changeNote":"Created for Dr. Turkbey P173316 request 12.05.17 ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6037757","version":"1","preferredName":"Medical Oncology Imaging Based Contraindication Other Specify","preferredDefinition":"Text term not previously mentioned that represents the kind of medical oncology contraindication based on the imaging report.","longName":"MONC_IMGBS_CNTRND_SP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F9CE14F-33D5-732B-E053-F662850A6503","latestVersionIndicator":"Yes","beginDate":"2017-12-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2017-12-05","modifiedBy":"COOPERM","dateModified":"2017-12-06","changeNote":"Created for Dr. Turkbey P173316 request 12.05.17 ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6037766","version":"1","preferredName":"Radiation Oncology Imaging Based Contraindication Other Specify","preferredDefinition":"Text term not previously mentioned that represents the kind of radiation oncology contraindication based on the imaging report.","longName":"RT_IMGBS_CNTRND_SPEC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F9FD71F-0C88-78C8-E053-F662850A33B0","latestVersionIndicator":"Yes","beginDate":"2017-12-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2017-12-05","modifiedBy":"COOPERM","dateModified":"2017-12-06","changeNote":"Created for Dr. Turkbey P173316 request 12.05.17 ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6037771","version":"1","preferredName":"Hormone Therapy Recommendation Medical Science Division Other Specify","preferredDefinition":"Text term not previously mentioned that represents the name of the division that provided the recommendation for hormone therapy.","longName":"HT_TX_RECOM_DIV_SPEC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F9EB0FF-75CA-0245-E053-F662850A01CA","latestVersionIndicator":"Yes","beginDate":"2017-12-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2017-12-05","modifiedBy":"COOPERM","dateModified":"2017-12-06","changeNote":"Created for Dr. Turkbey P173316 request 12.05.17 ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6037776","version":"1","preferredName":"Hormone Therapy Combined Preference Other Specify","preferredDefinition":"Text term not previously mentioned that represents the kind of combined treatment preference with hormone therapy.","longName":"HT_CMB_TX_PRF_SPEC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F9FE1D1-ABD6-7F38-E053-F662850A8046","latestVersionIndicator":"Yes","beginDate":"2017-12-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2017-12-05","modifiedBy":"COOPERM","dateModified":"2017-12-06","changeNote":"Created for Dr. Turkbey P173316 request 12.05.17 ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6037781","version":"1","preferredName":"Active Survelliance Candidate Recommendation Medical Science Division Other Specify","preferredDefinition":"Text term not previously mentioned that represents the name of the division that provided the recommendation for active surveillance (AS).","longName":"AS_RECOM_DIV_SPEC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F9EB0FF-75EC-0245-E053-F662850A01CA","latestVersionIndicator":"Yes","beginDate":"2017-12-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2017-12-05","modifiedBy":"COOPERM","dateModified":"2017-12-06","changeNote":"Created for Dr. Turkbey P173316 request 12.05.17 ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6037784","version":"1","preferredName":"Active Surveillance Imaging Based Contraindication Other Specify","preferredDefinition":"Text term not previously mentioned that represents the kind of active surveillance contraindication based on the imaging report.","longName":"AS_IMGBS_CNTRND_SPEC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F9CE14F-33F7-732B-E053-F662850A6503","latestVersionIndicator":"Yes","beginDate":"2017-12-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2017-12-05","modifiedBy":"COOPERM","dateModified":"2017-12-06","changeNote":"Created for Dr. Turkbey P173316 request 12.05.17 ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6038226","version":"1","preferredName":"Surgical Procedure Overall Recommendation Type","preferredDefinition":"Text term that represents the kind of overall recommendation for surgery.","longName":"SURG_OVR_RECOMD_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5FAD0D2F-1197-7427-E053-F662850A272F","latestVersionIndicator":"Yes","beginDate":"2017-12-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-12-06","modifiedBy":"COOPERM","dateModified":"2017-12-06","changeNote":"Created for Dr. Turkbey P173316 request 11.21.17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6038227","version":"1","preferredName":"Surgical Procedure Favorable Characteristics Text","preferredDefinition":"Text description of the favorable characteristics for surgery.","longName":"SURG_FAV_CHAR_TXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5FAD1478-D80C-742B-E053-F662850AD795","latestVersionIndicator":"Yes","beginDate":"2017-12-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-12-06","modifiedBy":"COOPERM","dateModified":"2017-12-06","changeNote":"Created for Dr. Turkbey P173316 request 11.21.17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6038228","version":"1","preferredName":"Surgical Procedure Nerve Concern and/or Risk Present Indicator","preferredDefinition":"Indicator of whether or not there is surgical nerve concern or risk.","longName":"SURG_NRV_RSK_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5FACAC5B-6109-7423-E053-F662850AAF61","latestVersionIndicator":"Yes","beginDate":"2017-12-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-12-06","modifiedBy":"COOPERM","dateModified":"2017-12-06","changeNote":"Created for Dr. Turkbey P173316 request 11.21.17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6038229","version":"1","preferredName":"Surgical Procedure Combined Treatment Preference Type","preferredDefinition":"Text term that represents the kind of combined treatment preference with surgery.","longName":"SURG_CMB_TX_PREF_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5FAD1478-D83A-742B-E053-F662850AD795","latestVersionIndicator":"Yes","beginDate":"2017-12-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-12-06","modifiedBy":"COOPERM","dateModified":"2017-12-06","changeNote":"Created for Dr. Turkbey P173316 request 11.21.17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6038230","version":"1","preferredName":"Surgical Procedure Imaging Based Contraindication Type","preferredDefinition":"Text term that represents the kind of surgical contraindication based on the imaging report.","longName":"SURG_IMGBS_CNTRND_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5FAD1478-D868-742B-E053-F662850AD795","latestVersionIndicator":"Yes","beginDate":"2017-12-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-12-06","modifiedBy":"COOPERM","dateModified":"2017-12-06","changeNote":"Created for Dr. Turkbey P173316 request 11.21.17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6038231","version":"1","preferredName":"Surgical Procedure Pathology Based Contraindication Text","preferredDefinition":"Text term that represents the kind of surgical contraindication based on the pathology report.","longName":"SURG_PTHBS_CNTRND_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5FACAB24-702C-742F-E053-F662850A2D29","latestVersionIndicator":"Yes","beginDate":"2017-12-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-12-06","modifiedBy":"COOPERM","dateModified":"2017-12-06","changeNote":"Created for Dr. Turkbey P173316 request 11.21.17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6038232","version":"1","preferredName":"Surgical Procedure Comorbidity Based Contraindication Text","preferredDefinition":"Text term that represents the kind of surgical contraindication based on the comorbidities.","longName":"SURG_CMBD_CNTRND_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5FAD1478-D896-742B-E053-F662850AD795","latestVersionIndicator":"Yes","beginDate":"2017-12-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-12-06","modifiedBy":"COOPERM","dateModified":"2017-12-06","changeNote":"Created for Dr. Turkbey P173316 request 11.21.17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6038233","version":"1","preferredName":"Surgical Procedure Unusual Requirement Indicator","preferredDefinition":"Indicator of whether or not surgery would require an unusual procedure.","longName":"SURG_UNSL_REQ_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5FAD1478-D8C4-742B-E053-F662850AD795","latestVersionIndicator":"Yes","beginDate":"2017-12-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-12-06","modifiedBy":"COOPERM","dateModified":"2017-12-06","changeNote":"Created for Dr. Turkbey P173316 request 11.21.17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6038234","version":"1","preferredName":"Medical Oncology Overall Recommendation Type","preferredDefinition":"Text term that represents the kind of overall recommendation for medical oncology.","longName":"MONC_OVR_RECOMD_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5FAD4629-A24F-65E6-E053-F662850A0B32","latestVersionIndicator":"Yes","beginDate":"2017-12-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-12-06","modifiedBy":"COOPERM","dateModified":"2017-12-06","changeNote":"Created for Dr. Turkbey P173316 request 11.21.17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6038235","version":"1","preferredName":"Medical Oncology Favorable Characteristics Text","preferredDefinition":"Text description of the favorable characteristics for medical oncology.","longName":"MONC_FAV_CHAR_TXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5FACAB24-705A-742F-E053-F662850A2D29","latestVersionIndicator":"Yes","beginDate":"2017-12-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-12-06","modifiedBy":"COOPERM","dateModified":"2017-12-06","changeNote":"Created for Dr. Turkbey P173316 request 11.21.17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6038236","version":"1","preferredName":"Medical Oncology First Other Treatment Preference Type","preferredDefinition":"Text term that represents the kind of first other treatment preference with medical oncology.","longName":"MONC_FOTH_TX_PRF_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5FACAC5B-6137-7423-E053-F662850AAF61","latestVersionIndicator":"Yes","beginDate":"2017-12-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-12-06","modifiedBy":"COOPERM","dateModified":"2017-12-06","changeNote":"Created for Dr. Turkbey P173316 request 11.21.17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6038237","version":"1","preferredName":"Medical Oncology Combined Treatment Preference Type","preferredDefinition":"Text term that represents the kind of combined treatment preference with medical oncology.","longName":"MONC_CMB_TX_PRF_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5FAD5FFB-C289-741B-E053-F662850A61C0","latestVersionIndicator":"Yes","beginDate":"2017-12-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-12-06","modifiedBy":"COOPERM","dateModified":"2017-12-06","changeNote":"Created for Dr. Turkbey P173316 request 11.21.17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6038238","version":"1","preferredName":"Medical Oncology Imaging Based Contraindication Type","preferredDefinition":"Text term that represents the kind of medical oncology contraindication based on the imaging report.","longName":"MONC_IMGBS_CNTRND_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5FAD4629-A27D-65E6-E053-F662850A0B32","latestVersionIndicator":"Yes","beginDate":"2017-12-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-12-06","modifiedBy":"COOPERM","dateModified":"2017-12-06","changeNote":"Created for Dr. Turkbey P173316 request 11.21.17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6038239","version":"1","preferredName":"Medical Oncology Pathology Based Contraindication Text","preferredDefinition":"Text term that represents the kind of medical oncology contraindication based on the pathology report.","longName":"MONC_PTHBS_CNTRND_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5FAD1478-D8F2-742B-E053-F662850AD795","latestVersionIndicator":"Yes","beginDate":"2017-12-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-12-06","modifiedBy":"COOPERM","dateModified":"2017-12-06","changeNote":"Created for Dr. Turkbey P173316 request 11.21.17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6038240","version":"1","preferredName":"Medical Oncology Comorbidity Based Contraindication Text","preferredDefinition":"Text term that represents the kind of medical oncology contraindication based on the comorbidities.","longName":"MONC_CMBD_CNTRND_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5FAD70EF-63B7-615B-E053-F662850A1552","latestVersionIndicator":"Yes","beginDate":"2017-12-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-12-06","modifiedBy":"COOPERM","dateModified":"2017-12-06","changeNote":"Created for Dr. Turkbey P173316 request 11.21.17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6038242","version":"1","preferredName":"Radiation Oncology Overall Recommendation Type","preferredDefinition":"Text term that represents the kind of overall recommendation for radiation oncology.","longName":"RT_OVR_RECOMD_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5FAD1478-D920-742B-E053-F662850AD795","latestVersionIndicator":"Yes","beginDate":"2017-12-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-12-06","modifiedBy":"COOPERM","dateModified":"2017-12-06","changeNote":"Created for Dr. Turkbey P173316 request 11.21.17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6038243","version":"1","preferredName":"Radiation Oncology Favorable Characteristics Text","preferredDefinition":"Text description of the favorable characteristics for radiation oncology.","longName":"RT_FAV_CHAR_TXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5FAD99B9-2F7B-71AF-E053-F662850ACE11","latestVersionIndicator":"Yes","beginDate":"2017-12-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-12-06","modifiedBy":"COOPERM","dateModified":"2017-12-06","changeNote":"Created for Dr. Turkbey P173316 request 11.21.17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6038244","version":"1","preferredName":"Radiation Oncology Imaging Based Contraindication Type","preferredDefinition":"Text term that represents the kind of radiation oncology contraindication based on the imaging report.","longName":"RT_IMGBS_CNTRND_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5FAD1478-D94E-742B-E053-F662850AD795","latestVersionIndicator":"Yes","beginDate":"2017-12-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-12-06","modifiedBy":"COOPERM","dateModified":"2017-12-06","changeNote":"Created for Dr. Turkbey P173316 request 11.21.17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6038245","version":"1","preferredName":"Radiation Oncology Pathology Based Contraindication Text","preferredDefinition":"Text term that represents the kind of radiation oncology contraindication based on the pathology report.","longName":"RT_PTHBS_CNTRND_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5FAD1478-D97C-742B-E053-F662850AD795","latestVersionIndicator":"Yes","beginDate":"2017-12-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-12-06","modifiedBy":"COOPERM","dateModified":"2017-12-06","changeNote":"Created for Dr. Turkbey P173316 request 11.21.17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6038246","version":"1","preferredName":"Hormone Therapy Recommendation Medical Science Division Name","preferredDefinition":"Text term that represents the name of the division that provided the recommendation for hormone therapy.","longName":"HT_TX_RECOM_DIV_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5FAD1478-D9AA-742B-E053-F662850AD795","latestVersionIndicator":"Yes","beginDate":"2017-12-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-12-06","modifiedBy":"COOPERM","dateModified":"2017-12-06","changeNote":"Created for Dr. Turkbey P173316 request 11.21.17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6038247","version":"1","preferredName":"Hormone Therapy Combined Treatment Preference Type","preferredDefinition":"Text term that represents the kind of combined treatment preference with hormone therapy.","longName":"HT_CMB_TX_PRF_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5FAD1478-D9D8-742B-E053-F662850AD795","latestVersionIndicator":"Yes","beginDate":"2017-12-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-12-06","modifiedBy":"COOPERM","dateModified":"2017-12-06","changeNote":"Created for Dr. Turkbey P173316 request 11.21.17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6038248","version":"1","preferredName":"Active Surveillance Candidate Recommendation Division Name","preferredDefinition":"Text term that represents the name of the division that provided the recommendation for active surveillance (AS).","longName":"AS_RECOM_DIV_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5FAD1478-DA06-742B-E053-F662850AD795","latestVersionIndicator":"Yes","beginDate":"2017-12-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-12-06","modifiedBy":"COOPERM","dateModified":"2017-12-06","changeNote":"Created for Dr. Turkbey P173316 request 11.21.17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6038249","version":"1","preferredName":"Active Surveillance Imaging Based Contraindication Type","preferredDefinition":"Text term that represents the kind of active surveillance contraindication based on the imaging report.","longName":"AS_IMGBS_CNTRND_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5FAD1478-DA34-742B-E053-F662850AD795","latestVersionIndicator":"Yes","beginDate":"2017-12-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-12-06","modifiedBy":"COOPERM","dateModified":"2017-12-06","changeNote":"Created for Dr. Turkbey P173316 request 11.21.17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6038250","version":"1","preferredName":"Active Surveillance Pathology Based Contraindication Text","preferredDefinition":"Text term that represents the kind of active surveillance contraindication based on the pathology report.","longName":"AS_PTHBS_CNTRND_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5FAD1478-DA62-742B-E053-F662850AD795","latestVersionIndicator":"Yes","beginDate":"2017-12-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-12-06","modifiedBy":"COOPERM","dateModified":"2017-12-06","changeNote":"Created for Dr. Turkbey P173316 request 11.21.17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6038251","version":"1","preferredName":"Active Surveillance Comorbidity Based Contraindication Text","preferredDefinition":"Text term that represents the kind of active surveillance contraindication based on the comorbidities.","longName":"AS_CMBD_CNTRND_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5FADE2A7-F7F3-08A2-E053-F662850A52D1","latestVersionIndicator":"Yes","beginDate":"2017-12-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-12-06","modifiedBy":"COOPERM","dateModified":"2017-12-06","changeNote":"Created for Dr. Turkbey P173316 request 11.21.17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6044778","version":"1","preferredName":"Cancer Follow-up Last Radiology Assessment Date","preferredDefinition":"The date on which the cancer is assessed by radiology during the follow-up period of a study.","longName":"CA_FU_LST_RAD_DT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"60C9D092-2670-7E61-E053-F662850A2259","latestVersionIndicator":"Yes","beginDate":"2017-12-20","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-12-20","modifiedBy":"COOPERM","dateModified":"2017-12-20","changeNote":"Created for NCI-INC0243804 for 16C0011 curation. 12.20.17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6270379","version":"1","preferredName":"Infusion Catheter Placement Location Other Specify","preferredDefinition":"Text description of another vessel location, not previously specified, in which an infusion catheter tip is placed.","longName":"INF_CATH_OTH_PLCM_SP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6BA0B745-517A-39E8-E053-F662850AF65E","latestVersionIndicator":"Yes","beginDate":"2018-05-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-05-07","modifiedBy":"COOPERM","dateModified":"2018-05-09","changeNote":"Created for HAIP request 4.25.18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6270380","version":"1","preferredName":"Hepatic Artery Infusion Pump Vessels Ligated During Placement Type","preferredDefinition":"Text term that represents the kind of vessel ligated during hepatic artery infusion pump (HAIP) placement.","longName":"HAIP_PLC_VESL_LIG_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6BA086A3-329A-2D10-E053-F662850AEE9F","latestVersionIndicator":"Yes","beginDate":"2018-05-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-05-07","modifiedBy":"COOPERM","dateModified":"2018-05-09","changeNote":"Created for HAIP request 4.25.18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6270381","version":"1","preferredName":"Hepatic Artery Infusion Pump Other Vessels Ligated During Placement Specify","preferredDefinition":"Text term that represents another kind of vessel ligated during hepatic artery infusion pump (HAIP) placement not previously specified.","longName":"HAIP_OTH_VESL_LIG_SP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6BA0C6A7-F94D-2357-E053-F662850A0112","latestVersionIndicator":"Yes","beginDate":"2018-05-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-05-07","modifiedBy":"COOPERM","dateModified":"2018-05-09","changeNote":"Created for HAIP request 4.25.18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6270431","version":"1","preferredName":"Methylene Blue Dye Outside of Liver Visualized Indicator","preferredDefinition":"Indicator of whether or not the methylene blue dye was visualized outside the liver.","longName":"METHBLU_OUT_LIVR_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6BA0D03D-D8F3-2333-E053-F662850ADBB9","latestVersionIndicator":"Yes","beginDate":"2018-05-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-05-07","modifiedBy":"COOPERM","dateModified":"2018-05-09","changeNote":"Created for HAIP request 4.25.18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6270432","version":"1","preferredName":"Methylene Blue Outside of Liver Visualized Specify Text","preferredDefinition":"Text description of the location of methylene blue dye that was visualized outside the liver.","longName":"METHBLU_OUTLIVR_SPTX","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6BA0D8CC-876F-237D-E053-F662850A25E9","latestVersionIndicator":"Yes","beginDate":"2018-05-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-05-07","modifiedBy":"COOPERM","dateModified":"2018-05-09","changeNote":"Created for HAIP request 4.25.18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6270433","version":"1","preferredName":"Methylene Blue Dye Within Liver Perfusion Type","preferredDefinition":"Text term that represents the kind of perfusion of methylene blue dye visualized in the liver.","longName":"METHBLU_INLVR_PRF_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6BA0F899-E103-62FC-E053-F662850A4E6D","latestVersionIndicator":"Yes","beginDate":"2018-05-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-05-07","modifiedBy":"COOPERM","dateModified":"2018-05-09","changeNote":"Created for HAIP request 4.25.18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6270434","version":"1","preferredName":"Methylene Blue Dye in Liver Heterogeneous Perfusion Location Specify Text","preferredDefinition":"Text description of the location of the heterogeneous perfusion of methylene blue dye in the liver.","longName":"METHBLU_IN_LIVR_SPTX","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6BA0F899-E125-62FC-E053-F662850A4E6D","latestVersionIndicator":"Yes","beginDate":"2018-05-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-05-07","modifiedBy":"COOPERM","dateModified":"2018-05-09","changeNote":"Created for HAIP request 4.25.18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6270441","version":"1","preferredName":"Postoperative Nuclear Radiology Imaging Hepatic Perfusion or Location Type","preferredDefinition":"Text term that represents the location or perfusion of radioisotope determined by nuclear medicine scan after surgical placement of the hepatic artery infusion pump.","longName":"POSTOP_STDY_PERF_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6BA134A4-E7AC-22FE-E053-F662850A9F65","latestVersionIndicator":"Yes","beginDate":"2018-05-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-05-07","modifiedBy":"COOPERM","dateModified":"2018-05-09","changeNote":"Created for HAIP request 4.25.18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6270442","version":"1","preferredName":"Postoperative Nuclear Radiology Imaging Hepatic Perfusion Other Organ Specify","preferredDefinition":"Text description of another organ not previously mentioned perfused by radioisotope as determined by nuclear medicine scan after surgical placement of the hepatic artery infusion pump.","longName":"POSTOP_STDY_ORG_SP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6BA134A4-E7CE-22FE-E053-F662850A9F65","latestVersionIndicator":"Yes","beginDate":"2018-05-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-05-07","modifiedBy":"COOPERM","dateModified":"2018-05-09","changeNote":"Created for HAIP request 4.25.18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6270443","version":"1","preferredName":"Postoperative Nuclear Radiology Imaging Hepatic Heterogeneous Perfusion Other Location Specify Text","preferredDefinition":"Text description of another organ or tissues, not previously mentioned, heterogeneously perfused by radioisotope as determined by nuclear medicine scan after surgical placement of the hepatic artery infusion pump.","longName":"POSTOP_STDY_HETRO_TX","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6BA144DA-4060-6AA9-E053-F662850A23B7","latestVersionIndicator":"Yes","beginDate":"2018-05-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-05-07","modifiedBy":"COOPERM","dateModified":"2018-05-09","changeNote":"Created for HAIP request 4.25.18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6270444","version":"1","preferredName":"Repeat Nuclear Radiology Imaging Hepatic Perfusion or Location Type","preferredDefinition":"Text term that represents the location or perfusion of radioisotope determined by a repeat of nuclear medicine scan.","longName":"REPT_STDY_PERF_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6BA14F76-ACED-79C9-E053-F662850AED5F","latestVersionIndicator":"Yes","beginDate":"2018-05-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-05-07","modifiedBy":"COOPERM","dateModified":"2018-05-09","changeNote":"Created for HAIP request 4.25.18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6270445","version":"1","preferredName":"Repeat Nuclear Radiology Imaging Hepatic Perfusion Other Organ Specify","preferredDefinition":"Text description of another organ not previously mentioned perfused by radioisotope as determined by a repeat of nuclear medicine scan.","longName":"REPT_STDY_ORG_SP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6BA14F76-AD0F-79C9-E053-F662850AED5F","latestVersionIndicator":"Yes","beginDate":"2018-05-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-05-07","modifiedBy":"COOPERM","dateModified":"2018-05-09","changeNote":"Created for HAIP request 4.25.18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6270446","version":"1","preferredName":"Repeat Nuclear Radiology Imaging Hepatic Heterogeneous Perfusion Other Location Specify Text","preferredDefinition":"Text description of another organ or tissues, not previously mentioned, heterogeneously perfused by radioisotope as determined by a repeat of nuclear medicine scan.","longName":"REPT_STDY_HETERO_TX","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6BA14F76-AD31-79C9-E053-F662850AED5F","latestVersionIndicator":"Yes","beginDate":"2018-05-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-05-07","modifiedBy":"COOPERM","dateModified":"2018-05-09","changeNote":"Created for HAIP request 4.25.18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6290003","version":"1","preferredName":"Liquid Enzalutamide Formulation Finish Taking Indicator","preferredDefinition":"Indicator of whether or not the patient completed taking the liquid enzalutamide formulation.","longName":"EZLTMD_LQ_COMP_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6C573E68-F7C5-3F01-E053-F662850A3E61","latestVersionIndicator":"Yes","beginDate":"2018-05-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-05-16","modifiedBy":"COOPERM","dateModified":"2018-05-17","changeNote":"Created for 18C0070 Tolerability Assessment of Liquid 5.10.18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6290004","version":"1","preferredName":"Liquid Enzalutamide Formulation Not Finish Taking Reason","preferredDefinition":"Text to describe the reason why the patient did not complete taking the liquid enzalutamide formulation.","longName":"EZLTMD_LQ_NCOMP_RSN","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6C56AF06-A18B-78A3-E053-F662850A65FB","latestVersionIndicator":"Yes","beginDate":"2018-05-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-05-16","modifiedBy":"COOPERM","dateModified":"2018-05-17","changeNote":"Created for 18C0070 Tolerability Assessment of Liquid 5.10.18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6290028","version":"1","preferredName":"Liquid Enzalutamide Formulation Overall Taste Rating Scale","preferredDefinition":"The patient's overall rating of the taste of the liquid enzalutamide formulation, using a 4 point scale.","longName":"EZLTMD_LQ_OVR_TST_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6C578161-824E-3360-E053-F662850A75C7","latestVersionIndicator":"Yes","beginDate":"2018-05-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-05-16","modifiedBy":"COOPERM","dateModified":"2018-05-17","changeNote":"Created for 18C0070 Tolerability Assessment of Liquid 5.10.18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6290029","version":"1","preferredName":"Liquid Enzalutamide Formulation Taste Description Type","preferredDefinition":"Text term that best describes the taste of the liquid enzalutamide formulation.","longName":"EZLTMD_LQ_TST_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6C570EAC-F623-0AF2-E053-F662850AC73E","latestVersionIndicator":"Yes","beginDate":"2018-05-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-05-16","modifiedBy":"COOPERM","dateModified":"2018-05-17","changeNote":"Created for 18C0070 Tolerability Assessment of Liquid 5.10.18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6290030","version":"1","preferredName":"Liquid Enzalutamide Formulation Other Taste Description Text","preferredDefinition":"Text term that best describes another taste of the liquid enzalutamide formulation not previously specified.","longName":"EZLTMD_LQ_OTH_TST_TX","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6C578DFB-7121-06CB-E053-F662850A1EA2","latestVersionIndicator":"Yes","beginDate":"2018-05-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-05-16","modifiedBy":"COOPERM","dateModified":"2018-05-17","changeNote":"Created for 18C0070 Tolerability Assessment of Liquid 5.10.18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6290031","version":"1","preferredName":"Liquid Dosage Form Enzalutamide Encounter Use Problem Yes No Indicator","preferredDefinition":"encountered any problems with the use of the liquid enzalutamide formulation.","longName":"EZLTMD_LQ_PROB_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6C5792EF-68C7-0AE2-E053-F662850A9055","latestVersionIndicator":"Yes","beginDate":"2018-05-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-05-16","modifiedBy":"COOPERM","dateModified":"2018-05-17","changeNote":"Created for 18C0070 Tolerability Assessment of Liquid 5.10.18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6290094","version":"1","preferredName":"Liquid Enzalutamide Formulation Encounter Usage Problem Text","preferredDefinition":"Text description of the problem encountered with the use of the liquid enzalutamide formulation.","longName":"EZLTMD_LQ_PROB_TXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6C578161-827E-3360-E053-F662850A75C7","latestVersionIndicator":"Yes","beginDate":"2018-05-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-05-16","modifiedBy":"COOPERM","dateModified":"2018-05-17","changeNote":"Created for 18C0070 Tolerability Assessment of Liquid 5.10.18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6290103","version":"1","preferredName":"Liquid Enzalutamide Formulation Acceptable Method Taking Medication if Have Difficulty Swallowing Indicator","preferredDefinition":"Indicator of whether or not the liquid formulation would be an acceptable way of taking enzalutamide if the patient had difficulty swallowing.","longName":"EZLTMD_LQ_ACPT_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6C56AF06-A1AD-78A3-E053-F662850A65FB","latestVersionIndicator":"Yes","beginDate":"2018-05-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-05-16","modifiedBy":"COOPERM","dateModified":"2018-05-17","changeNote":"Created for 18C0070 Tolerability Assessment of Liquid 5.10.18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6414101","version":"1","preferredName":"Lesion Malignant Tumor Type","preferredDefinition":"Text term that represents the kind of malignant lesion.","longName":"LESN_TMR_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"746EC0B4-364B-4174-E053-F662850AABE2","latestVersionIndicator":"Yes","beginDate":"2018-08-27","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-08-27","modifiedBy":"COOPERM","dateModified":"2018-08-27","changeNote":"Created for NCI-INC0306453 - Picklist addition 8.21.18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6545712","version":"1","preferredName":"Hallucination Severity Scale","preferredDefinition":"Text term that represents the rating of severity of hallucinations.","longName":"HALUCIN_SEVRT_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"79632523-7735-39EB-E053-F662850AA854","latestVersionIndicator":"Yes","beginDate":"2018-10-29","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-10-29","modifiedBy":"COOPERM","dateModified":"2018-11-01","changeNote":"Created for P173255 request NCI-INC0324033 10.24.18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6606277","version":"1","preferredName":"Pulmonary Function Test Forced Expiratory Volume in 1 Second Effort Result","preferredDefinition":"Text term that represents the effort expended during the Forced Expiratory Volume in one Second (FEV1) exam.","longName":"FEV1_EFRT_RSLT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7EDF5178-3243-46C9-E053-F662850A52D0","latestVersionIndicator":"Yes","beginDate":"2019-01-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-01-07","modifiedBy":"COOPERM","dateModified":"2019-01-14","changeNote":"Created for 16C0003 qn Curation 12.28.18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6606390","version":"1","preferredName":"Pulmonary Function Test Forced Expiratory Volume in 1 Second Reproducibility Result","preferredDefinition":"Text term that represents the reproducibility of the Forced Expiratory Volume in one second (FEV1) exam.","longName":"FEV1_REPR_RSLT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7EE3E4A7-CDFE-41D1-E053-F662850AD488","latestVersionIndicator":"Yes","beginDate":"2019-01-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-01-07","modifiedBy":"COOPERM","dateModified":"2019-01-14","changeNote":"Created for 16C0003 qn Curation 12.28.18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6606392","version":"1","preferredName":"Pulmonary Function Test Carbon Monoxide Diffusing Capability Test Effort Result","preferredDefinition":"Text term that represents the effort expended during the Carbon Monoxide Diffusing Capability (DLCO) exam.","longName":"DLCO_EFRT_RSLT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7EE3EF47-0D77-1BE4-E053-F662850AD0C7","latestVersionIndicator":"Yes","beginDate":"2019-01-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-01-07","modifiedBy":"COOPERM","dateModified":"2019-01-14","changeNote":"Created for 16C0003 qn Curation 12.28.18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6606395","version":"1","preferredName":"Pulmonary Function Test Carbon Monoxide Diffusing Capability Test Reproducibility Result","preferredDefinition":"Text term that represents the reproducibility of the Carbon Monoxide Diffusing Capability (DLCO) exam.","longName":"DLCO_REPR_RSLT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7EE3F824-A03F-4A18-E053-F662850A8C40","latestVersionIndicator":"Yes","beginDate":"2019-01-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-01-07","modifiedBy":"COOPERM","dateModified":"2019-01-14","changeNote":"Created for 16C0003 qn Curation 12.28.18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6606543","version":"1","preferredName":"Central Nervous System Adverse Event Present Indicator","preferredDefinition":"Indicator of whether or not an adverse event was observed related to the central nervous system.","longName":"CNS_AE_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7EE62050-5056-35B6-E053-F662850A5F49","latestVersionIndicator":"Yes","beginDate":"2019-01-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-01-07","modifiedBy":"COOPERM","dateModified":"2019-01-14","changeNote":"Created for 19C0011 qns curation 12.28.18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6649500","version":"1","preferredName":"Maternal Ethnic Group Category Text","preferredDefinition":"Text field to describe the ethnic group category of a person's mother.","longName":"MOTHR_ETHNC_CAT_TXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"82430F7C-E11B-4809-E053-F662850AA13F","latestVersionIndicator":"Yes","beginDate":"2019-02-19","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-02-19","modifiedBy":"COOPERM","dateModified":"2019-02-20","changeNote":"Created for Curation Family History 19C0040 request. 2.11.19","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6649537","version":"1","preferredName":"Paternal Ethnic Group Category Text","preferredDefinition":"Text field to describe the ethnic category of a person's father.","longName":"PATRNL_ETHNC_CAT_TXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"82433365-9E2E-5703-E053-F662850AED55","latestVersionIndicator":"Yes","beginDate":"2019-02-19","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-02-19","modifiedBy":"COOPERM","dateModified":"2019-02-20","changeNote":"Created for Curation Family History 19C0040 request. 2.11.19","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6649563","version":"1","preferredName":"Cancer or Medical Condition Diagnosis Indicator","preferredDefinition":"Indicator of whether or not a person has been diagnosed with cancer or another medical condition.","longName":"CA_MED_COND_DX_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"824210FF-9406-0295-E053-F662850A646B","latestVersionIndicator":"Yes","beginDate":"2019-02-19","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-02-19","modifiedBy":"COOPERM","dateModified":"2019-02-20","changeNote":"Created for Curation Family History 19C0040 request. 2.11.19","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6650826","version":"1","preferredName":"Cancer Diagnosis Type","preferredDefinition":"Text term that represents the kind of malignant neoplasm or cancer.","longName":"CA_DX_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8245CC61-FC41-5033-E053-F662850AE908","latestVersionIndicator":"Yes","beginDate":"2019-02-19","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-02-19","modifiedBy":"COOPERM","dateModified":"2019-02-20","changeNote":"Created for Curation Family History 19C0040 request. 2.11.19","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6650860","version":"1","preferredName":"Patient Medical History Condition Type","preferredDefinition":"Text term that represents the kind of medical condition.","longName":"PT_MED_HX_COND_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8247640F-C99B-16A9-E053-F662850AE641","latestVersionIndicator":"Yes","beginDate":"2019-02-19","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-02-19","modifiedBy":"COOPERM","dateModified":"2019-02-20","changeNote":"Created for Curation Family History 19C0040 request. 2.11.19","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6650869","version":"1","preferredName":"Cancer or Medical Condition Treatment Text","preferredDefinition":"Text field to describe the kind of treatment used for cancer or medical condition.","longName":"CA_MED_COND_TX_TXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"82476F2E-BDF0-166B-E053-F662850A7608","latestVersionIndicator":"Yes","beginDate":"2019-02-19","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-02-19","modifiedBy":"COOPERM","dateModified":"2019-02-20","changeNote":"Created for Curation Family History 19C0040 request. 2.11.19","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6650878","version":"1","preferredName":"Laboratory Procedure Past Genetic Testing Performed Indicator","preferredDefinition":"Indicator of whether or not a genetic test was performed in the past.","longName":"LAB_PAST_GENTEST_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"82474FE0-7A60-1871-E053-F662850A4103","latestVersionIndicator":"Yes","beginDate":"2019-02-19","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-02-19","modifiedBy":"COOPERM","dateModified":"2019-02-20","changeNote":"Created for Curation Family History 19C0040 request. 2.11.19","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6650879","version":"1","preferredName":"Laboratory Procedure Genetic Test Performed Name","preferredDefinition":"The name of a genetic test performed.","longName":"LAB_GENTEST_PERF_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8247B33C-2CAA-16A1-E053-F662850AE1D5","latestVersionIndicator":"Yes","beginDate":"2019-02-19","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-02-19","modifiedBy":"COOPERM","dateModified":"2019-02-20","changeNote":"Created for Curation Family History 19C0040 request. 2.11.19","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6650880","version":"1","preferredName":"Laboratory Procedure Genetic Finding Result","preferredDefinition":"A laboratory test result that indicates the outcome of a genetic test.","longName":"LAB_GENTEST_RESLT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"824755E0-20BB-1F4E-E053-F662850ADAE4","latestVersionIndicator":"Yes","beginDate":"2019-02-19","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-02-19","modifiedBy":"COOPERM","dateModified":"2019-02-20","changeNote":"Created for Curation Family History 19C0040 request. 2.11.19","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6681415","version":"1","preferredName":"Physician's Global Assessment  of Epidermal cGVHD Score 5 Point Scale","preferredDefinition":"A clinical outcome instrument to measure the severity of epidermal chronic graft versus host disease using a 5-point scale.","longName":"PGA_EPIDRM_CGVHD_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"84EE7E41-810B-4F53-E053-F662850A045F","latestVersionIndicator":"Yes","beginDate":"2019-03-25","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-03-25","modifiedBy":"COOPERM","dateModified":"2019-03-26","changeNote":"Created for NCI-INC0362757 - 18AR0035 request 3.20.19 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6692748","version":"1","preferredName":"Bone Marrow Adequate Biopsy Indicator","preferredDefinition":"Indicator of whether the bone marrow biopsy sample is adequate.","longName":"BM_ADEQ_BX_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"86992E29-DF0B-0AF6-E053-F662850AC18C","latestVersionIndicator":"Yes","beginDate":"2019-04-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-04-15","modifiedBy":"COOPERM","dateModified":"2019-04-17","changeNote":"Created for NCI-INC0368225 - FW: 19C0042 BM Bx and Aspirate Disease Assessment CRF curation request. 4/10/19 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6692749","version":"1","preferredName":"Bone Marrow Adequate Aspirate Indicator","preferredDefinition":"Indicator of whether the bone marrow aspirate sample is adequate.","longName":"BM_ADEQ_ASPR_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8699502A-7AD7-09CB-E053-F662850AF898","latestVersionIndicator":"Yes","beginDate":"2019-04-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-04-15","modifiedBy":"COOPERM","dateModified":"2019-04-17","changeNote":"Created for NCI-INC0368225 - FW: 19C0042 BM Bx and Aspirate Disease Assessment CRF curation request. 4/10/19 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6692788","version":"1","preferredName":"Bone Marrow Aspirate Leukemia Cell Infiltration Percentage Value","preferredDefinition":"Numeric value for the percent of leukemia cells infiltrating the bone marrow aspirate.","longName":"BMASP_LEUK_INFIL_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"86997BB4-565B-7FF2-E053-F662850A722D","latestVersionIndicator":"Yes","beginDate":"2019-04-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-04-15","modifiedBy":"COOPERM","dateModified":"2019-04-17","changeNote":"Created for NCI-INC0368225 - FW: 19C0042 BM Bx and Aspirate Disease Assessment CRF curation request. 4/10/19 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6692789","version":"1","preferredName":"Bone Marrow Biopsy Cellularity Percentage Value","preferredDefinition":"Numeric representation of percent cellularity in a bone marrow biopsy sample.","longName":"BM_BX_CELL_PRCNT_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"86997FD9-9019-6558-E053-F662850AD141","latestVersionIndicator":"Yes","beginDate":"2019-04-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-04-15","modifiedBy":"COOPERM","dateModified":"2019-04-17","changeNote":"Created for NCI-INC0368225 - FW: 19C0042 BM Bx and Aspirate Disease Assessment CRF curation request. 4/10/19 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6692790","version":"1","preferredName":"Bone Marrow Leukemia Cell Present Indicator","preferredDefinition":"Indicator of whether or not leukemia cells are present in bone marrow.","longName":"BM_LEUK_CELL_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"869A224B-E91C-4E8C-E053-F662850A7FEC","latestVersionIndicator":"Yes","beginDate":"2019-04-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-04-15","modifiedBy":"COOPERM","dateModified":"2019-04-17","changeNote":"Created for NCI-INC0368225 - FW: 19C0042 BM Bx and Aspirate Disease Assessment CRF curation request. 4/10/19 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6692791","version":"1","preferredName":"Bone Marrow Leukemia Cell Low Range Percentage Value","preferredDefinition":"Number that represents the low range of leukemia cells measured in bone marrow.","longName":"BM_LEUK_LOW_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"86997FD9-9047-6558-E053-F662850AD141","latestVersionIndicator":"Yes","beginDate":"2019-04-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-04-15","modifiedBy":"COOPERM","dateModified":"2019-04-17","changeNote":"Created for NCI-INC0368225 - FW: 19C0042 BM Bx and Aspirate Disease Assessment CRF curation request. 4/10/19 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6692792","version":"1","preferredName":"Bone Marrow Leukemia Cell High Range Percentage Value","preferredDefinition":"Number that represents the high range of leukemia cells measured in bone marrow.","longName":"BM_LEUK_HIGH_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"869931C6-6688-08F2-E053-F662850AC2B3","latestVersionIndicator":"Yes","beginDate":"2019-04-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-04-15","modifiedBy":"COOPERM","dateModified":"2019-04-17","changeNote":"Created for NCI-INC0368225 - FW: 19C0042 BM Bx and Aspirate Disease Assessment CRF curation request. 4/10/19 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6699942","version":"1","preferredName":"Bone Marrow Specimen Collection Type","preferredDefinition":"Text term that represents the kind of sample collected from bone marrow.","longName":"BM_SPEC_COLL_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"86B9C340-36C1-7D29-E053-F662850A33DA","latestVersionIndicator":"Yes","beginDate":"2019-04-17","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-04-17","modifiedBy":"TSESU","dateModified":"2022-08-03","changeNote":"Created for NCI-INC0368225 - FW: 19C0042 BM Bx and Aspirate Disease Assessment CRF curation request. 4/10/19 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6701192","version":"1","preferredName":"Therapy Description Type","preferredDefinition":"Text term that describes the kind of treatment in the study design.","longName":"TX_DESC_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"86C00008-581C-1E08-E053-F662850AC584","latestVersionIndicator":"Yes","beginDate":"2019-04-17","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-04-17","modifiedBy":"COOPERM","dateModified":"2019-11-04","changeNote":"Created for 19C0030 Therapy Type qn curation request. 4.9.19 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6719434","version":"1","preferredName":"Bone Marrow Leukemia Cell Percentage Value","preferredDefinition":"Numeric value for the percent of leukemia cells found in bone marrow.","longName":"BM_LEUK_PRCNT_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"873D277E-284E-072C-E053-F662850A9030","latestVersionIndicator":"Yes","beginDate":"2019-04-23","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-04-23","modifiedBy":"COOPERM","dateModified":"2019-04-25","changeNote":"Created for NCI-INC0368225 - FW: 19C0042 BM Bx and Aspirate Disease Assessment CRF curation request add-on. 4/22/19 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6729501","version":"1","preferredName":"Response Evaluation Criteria In Lymphoma (RECIL) 2017 Assessment Code","preferredDefinition":"Code that represents the assessment of response to treatment for lymphoma using the Response Evaluation Criteria in Lymphoma (RECIL) 2017.","longName":"RECIL2017_ASMT_CD","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"87491500-12D1-575E-E053-F662850A3604","latestVersionIndicator":"Yes","beginDate":"2019-04-24","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-04-24","modifiedBy":"COOPERM","dateModified":"2019-05-07","changeNote":"Created for NCI-INC0370865 19C0076 qns curation request. 4.17.19 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6738976","version":"1","preferredName":"Disease Response International Myeloma Working Group Minimal Residual Disease Criteria Category","preferredDefinition":"Categorization of response to treatment for minimal residual disease (MRD) based on criteria created by the International Myeloma Working Group (IMWG).","longName":"RESP_IMWG_MRD_CAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"87C4DBE6-6741-3B8F-E053-F662850A164D","latestVersionIndicator":"Yes","beginDate":"2019-04-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-04-30","modifiedBy":"COOPERM","dateModified":"2019-05-01","changeNote":"Created for NCI-INC0371350-19C0078 IMWG curation 4.19.19 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6738977","version":"1","preferredName":"Disease Response International Myeloma Working Group Standard Response Criteria Category","preferredDefinition":"Categorization of response to treatment based on criteria created by the International Myeloma Working Group (IMWG).","longName":"RESP_IMWG_STD_CAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"87C52E17-A446-490C-E053-F662850A01E6","latestVersionIndicator":"Yes","beginDate":"2019-04-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-04-30","modifiedBy":"COOPERM","dateModified":"2019-05-01","changeNote":"Created for NCI-INC0371350-19C0078 IMWG curation 4.19.19 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6739015","version":"1","preferredName":"Bone Marrow Immunophenotype Flow Cytometry Aberrant Clonal Plasma Cell Percent Value","preferredDefinition":"Numeric representation for the percentage of clonal plasma cells in bone marrow aspirate by immunophenotype flow cytometry.","longName":"BM_IMPH_AB_PLAS_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"87C6F424-B5B7-7250-E053-F662850A3E63","latestVersionIndicator":"Yes","beginDate":"2019-04-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-04-30","modifiedBy":"COOPERM","dateModified":"2019-05-01","changeNote":"Created for NCI-INC0372441-19C0078 Flow Cytometry qn curation 4.23.19 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6741250","version":"1","preferredName":"Cutaneous T-cell Lymphoma Global Response Score Category","preferredDefinition":"Response category that describes the overall disease status based on staging and classification criteria for cutaneous T-cell lymphoma (CTCL).","longName":"CTCL_GR_SCR_CAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"883A6093-8FCD-03A5-E053-F662850A391E","latestVersionIndicator":"Yes","beginDate":"2019-05-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-05-06","modifiedBy":"COOPERM","dateModified":"2019-05-08","changeNote":"Created for NCI-INC0370865: 19C0076 qns curation request 4.17.19 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6741251","version":"1","preferredName":"Cutaneous T-cell Lymphoma Response in Skin Category","preferredDefinition":"Response category that describes the disease involvement in skin based on staging and classification criteria for cutaneous T-cell lymphoma (CTCL).","longName":"CTCL_SKIN_SCR_CAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"883A69D8-CC1A-2BF7-E053-F662850A376B","latestVersionIndicator":"Yes","beginDate":"2019-05-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-05-06","modifiedBy":"COOPERM","dateModified":"2019-05-08","changeNote":"Created for NCI-INC0370865: 19C0076 qns curation request 4.17.19 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6741255","version":"1","preferredName":"Cutaneous T-cell Lymphoma Response in Lymph Nodes Category","preferredDefinition":"Response category that describes the disease involvement in lymph nodes based on staging and classification criteria for cutaneous T-cell lymphoma (CTCL).","longName":"CTCL_NODES_SCR_CAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"883A72FE-D1E0-2F09-E053-F662850AE916","latestVersionIndicator":"Yes","beginDate":"2019-05-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-05-06","modifiedBy":"COOPERM","dateModified":"2019-05-08","changeNote":"Created for NCI-INC0370865: 19C0076 qns curation request 4.17.19 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6741256","version":"1","preferredName":"Cutaneous T-cell Lymphoma Response in Viscera Category","preferredDefinition":"Response category that describes the disease involvement in viscera based on staging and classification criteria for cutaneous T-cell lymphoma (CTCL).","longName":"CTCL_VISCERA_SCR_CAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"883A7858-453A-30B4-E053-F662850A9FFC","latestVersionIndicator":"Yes","beginDate":"2019-05-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-05-06","modifiedBy":"COOPERM","dateModified":"2019-05-08","changeNote":"Created for NCI-INC0370865: 19C0076 qns curation request 4.17.19 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6741257","version":"1","preferredName":"Cutaneous T-cell Lymphoma Response in Blood Category","preferredDefinition":"Response category that describes the disease involvement in blood based on staging and classification criteria for cutaneous T-cell lymphoma (CTCL).","longName":"CTCL_BLOOD_SCR_CAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"883A7DC3-489B-2C52-E053-F662850A0E22","latestVersionIndicator":"Yes","beginDate":"2019-05-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-05-06","modifiedBy":"COOPERM","dateModified":"2019-05-08","changeNote":"Created for NCI-INC0370865: 19C0076 qns curation request 4.17.19 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6757367","version":"1","preferredName":"Retreatment Reason","preferredDefinition":"The text response that explains the reason a patient is being retreated.","longName":"RTX_RSN","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"88F3E9D3-CE00-4EBA-E053-F662850A03C4","latestVersionIndicator":"Yes","beginDate":"2019-05-15","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-05-15","modifiedBy":"HARTLEYG","dateModified":"2019-05-15","changeNote":"11C0161","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6776853","version":"1","preferredName":"International Prognostic Index Risk Assessment Score","preferredDefinition":"Numerical representation for the assessment of predicted risk of disease recurrence and survival following therapy for non-Hodgkin lymphoma patients.","longName":"IPI_RISK_SCR","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8AFD0EE0-F127-6247-E053-F662850A7A6B","latestVersionIndicator":"Yes","beginDate":"2019-06-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-06-10","modifiedBy":"COOPERM","dateModified":"2019-06-11","changeNote":"Created for NCI-INC0386214-CDE Import - IPI Score request by Pam. 6.10.19 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6779720","version":"1","preferredName":"International Prognostic Index Risk Assessment Category","preferredDefinition":"Text term that represents the risk group description of how an individual with non-Hodgkin lymphoma patient might respond to a certain treatment or predict the risk of disease recurrence and survival following therapy.","longName":"IPI_RISK_CAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8B121B28-7353-7AC5-E053-F662850A0DA3","latestVersionIndicator":"Yes","beginDate":"2019-06-11","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-06-11","modifiedBy":"COOPERM","dateModified":"2019-06-11","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6780671","version":"1","preferredName":"Prognostic Index for PTCL Risk Assessment Score","preferredDefinition":"Numeric representation for the prediction of the risk of disease recurrence in an individual with peripheral T-cell lymphoma using the Prognostic Index for PTCL (PIT).","longName":"PIT_RISK_SCR","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8B2372B5-EC8F-0A49-E053-F662850A7CC4","latestVersionIndicator":"Yes","beginDate":"2019-06-12","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-06-12","modifiedBy":"COOPERM","dateModified":"2019-06-12","changeNote":"Created for NCI-INC0386225 - CDE Curation - Prognostic Index for PTCL patients (PIT) score request by Pam. 6.12.19 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6841442","version":"1","preferredName":"Revised International Prognostic Scoring System Risk Category","preferredDefinition":"Text term that represents the risk category for myelodysplastic syndrome progression that is derived from Revised International Prognostic Scoring System (IPSS-R) risk score.","longName":"REV_IPSS_RISK_CAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8EEDB2B7-EF50-2299-E053-F662850A7CEE","latestVersionIndicator":"Yes","beginDate":"2019-07-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-07-30","modifiedBy":"COOPERM","dateModified":"2019-07-31","changeNote":"Created for CDE request. 7.24.19 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6867758","version":"1","preferredName":"Feasibility Failure Determination Indicator","preferredDefinition":"The indication whether conditions were met that constituted a treatment feasibility failure.","longName":"FEAS_FAIL_DET_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"9144CB8F-269D-3B6B-E053-F662850ABA76","latestVersionIndicator":"Yes","beginDate":"2019-08-29","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-08-29","modifiedBy":"HARTLEYG","dateModified":"2019-09-10","changeNote":"Curated to support Protocol P19C0130","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6867759","version":"1","preferredName":"Definitive Treatment Delay Neoadjuvant Therapy Toxicity Attribution Indicator","preferredDefinition":"The indication whether definitive therapy delay was attributed to neoadjuvant therapy toxicity.","longName":"DEF_TRT_DLY_ATR_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"91448F22-865C-3B75-E053-F662850AFFA2","latestVersionIndicator":"Yes","beginDate":"2019-08-29","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-08-29","modifiedBy":"HARTLEYG","dateModified":"2019-09-10","changeNote":"Curated to support Protocol P19C0130","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6867784","version":"1","preferredName":"HPV-16 E7 TCR Expressing T-cells Neoadjuvant Therapy Greater Than 4 Weeks Post Enrollment Administered Indicator","preferredDefinition":"The indication whether HPV-16 E7 TCR Expressing T-cells were delivered 4 weeks after protocol enrollment.","longName":"E7TCR_GT4WK_ADM_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"9143BD4C-545E-3B63-E053-F662850A2031","latestVersionIndicator":"Yes","beginDate":"2019-08-29","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-08-29","modifiedBy":"HARTLEYG","dateModified":"2019-09-10","changeNote":"Curated to support Protocol P19C0130","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6867785","version":"1","preferredName":"HPV-16 E7 TCR Expressing T-cells Generation Negation Ability Indicator","preferredDefinition":"The indication whether HPV-16 E7 TCR Expressing T-cells were able to be generated.","longName":"E7TCR_GEN_INABL_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"9144CB8F-26BF-3B6B-E053-F662850ABA76","latestVersionIndicator":"Yes","beginDate":"2019-08-29","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-08-29","modifiedBy":"HARTLEYG","dateModified":"2019-09-10","changeNote":"Curated to support Protocol P19C0130","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6922129","version":"1","preferredName":"Neoplasm Post Baseline And Prior Last Disease Response Assessment T Category Or N Category Increase Yes No Indicator","preferredDefinition":"The indication whether a neoplasm has increased in T-stage or N-stage after baseline but before the last disease response assessment was completed.","longName":"TSTG_NSTG_INC_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"923C9050-D557-5647-E053-F662850ADCEA","latestVersionIndicator":"Yes","beginDate":"2019-09-10","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-09-10","modifiedBy":"COOPERM","dateModified":"2020-04-21","changeNote":"Curated to support Protocol P19C0130","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6922130","version":"1","preferredName":"Definitive Treatment Delay Induction Therapy Toxicity Attribution Indicator","preferredDefinition":"The indication whether definitive therapy delay was attributed to induction therapy toxicity.","longName":"TR_DLY_INDTX_ATR_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"923C9050-D579-5647-E053-F662850ADCEA","latestVersionIndicator":"Yes","beginDate":"2019-09-10","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-09-10","modifiedBy":"HARTLEYG","dateModified":"2019-09-19","changeNote":"Curated to support Protocol P19C0130","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6922131","version":"1","preferredName":"Transplant Conditioning Without HPV-16 E7 TCR Expressing T-cells Begin Yes No Indicator","preferredDefinition":"Indication whether the patient began the conditioning chemotherapy regimen without receiving HPV-16 E7 TCR expressing t-cells.","longName":"CND_WO_TCELL_BGN_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"92380E2F-2B48-4CD6-E053-F662850A5FE6","latestVersionIndicator":"Yes","beginDate":"2019-09-10","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-09-10","modifiedBy":"COOPERM","dateModified":"2020-04-21","changeNote":"Curated to support Protocol P19C0130","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6945943","version":"1","preferredName":"Research Comments Indicator","preferredDefinition":"Indicator of whether or not research comments are recorded.","longName":"RSCH_COMMENTS_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9374BD18-3A7E-3884-E053-F662850A3B80","latestVersionIndicator":"Yes","beginDate":"2019-09-26","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-09-26","modifiedBy":"COOPERM","dateModified":"2019-09-26","changeNote":"Created for C3D to Rave transition. 9.25.19 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7091276","version":"1","preferredName":"Disease Risk Index for Allogeneic Stem Cell Transplantation Assessment Category","preferredDefinition":"The response indicating the overall survival risk group category of a stem cell transplant patient based on disease type and disease status at the time of transplantation.","longName":"DZ_RISK_INDEX_CAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"9977D747-1B65-52F0-E053-F662850A4DDC","latestVersionIndicator":"Yes","beginDate":"2019-12-11","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-12-11","modifiedBy":"KUMMEROA","dateModified":"2022-07-18","changeNote":"Curated to support 19C0112 database build_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7098605","version":"1","preferredName":"SF-36v2 Health Survey Past 4 Weeks How Much of the Time Have You Been Very Nervous Person Score 5 Point Scale","preferredDefinition":"A person's stated perception of how much of the time during the past four weeks they have been very nervous, using a 5 point Likert scale.","longName":"SF36V2_NERVOUS_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"SF-36v2:Short Form 36 Health Survey Standard, US Version 2.0 Questionnaire, Sherbourne Cathy D; Ware John E., 1998","workflowStatus":"RELEASED","registrationStatus":"Application","id":"9A116C35-CF6B-3F64-E053-F662850A2DB0","latestVersionIndicator":"Yes","beginDate":"2019-12-19","endDate":null,"createdBy":"TSESU","dateCreated":"2019-12-19","modifiedBy":"COOPERM","dateModified":"2020-08-21","changeNote":"smt created in error; 12/19/19 smt created for Alliance A021804  1/15/2020 - smt created in error. 8.21.20 Transferred to CCR and released for use with NCI-INC0513328-20C0058 SF36 form request. mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7098613","version":"1","preferredName":"SF-36v2 Health Survey Past 4 Weeks How Much of the Time Have You Felt So Down in the Dumps That Nothing Could Cheer You Up Score 5 Point Scale","preferredDefinition":"A person's stated perception of how much of the time during the past four weeks they have felt so down in the dumps that nothing could cheer them up, using a 5 point Likert scale.","longName":"SF36v2_DOWN_DUMP_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"SF-36v2:Short Form 36 Health Survey Standard, US Version 2.0 Questionnaire, Sherbourne Cathy D; Ware John E., 1998","workflowStatus":"RELEASED","registrationStatus":"Application","id":"9A009341-6D92-0942-E053-F662850A6729","latestVersionIndicator":"Yes","beginDate":"2019-12-19","endDate":null,"createdBy":"TSESU","dateCreated":"2019-12-19","modifiedBy":"COOPERM","dateModified":"2020-08-21","changeNote":"smt created in error; 12/19/19 smt created for Alliance A021804. 8.21.20 Transferred to CCR and released for use with NCI-INC0513328-20C0058 SF36 form request. mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7098625","version":"1","preferredName":"SF-36v2 Health Survey Past 4 Weeks How Much of the Time Have You Felt Calm and Peaceful Score 5 Point Scale","preferredDefinition":"A person's stated perception of how much of the time during the past four weeks they have felt calm and peaceful, using a 5 point Likert scale.","longName":"SF36v2_CALMPEACE_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"SF-36v2:Short Form 36 Health Survey Standard, US Version 2.0 Questionnaire, Sherbourne Cathy D; Ware John E., 1998","workflowStatus":"RELEASED","registrationStatus":"Application","id":"9A041F46-BD96-3EFA-E053-F662850A81B2","latestVersionIndicator":"Yes","beginDate":"2019-12-19","endDate":null,"createdBy":"TSESU","dateCreated":"2019-12-19","modifiedBy":"COOPERM","dateModified":"2020-08-21","changeNote":"smt created in error; 12/19/19 smt created for Alliance A021804. 8.21.20 Transferred to CCR and released for use with NCI-INC0513328-20C0058 SF36 form request. mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7098629","version":"1","preferredName":"SF-36v2 Health Survey Past 4 Weeks How Much of the Time Have You Felt Downhearted and Blue Score 5 Point Scale","preferredDefinition":"A person's stated perception of how much of the time during the past four weeks they have felt downhearted and blue (or depressed), using a 5 point Likert scale.","longName":"SF36v2_DOWN_BLUE_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"SF-36v2:Short Form 36 Health Survey Standard, US Version 2.0 Questionnaire, Sherbourne Cathy D; Ware John E., 1998","workflowStatus":"RELEASED","registrationStatus":"Application","id":"9A15BFA8-BE0C-3329-E053-F662850AB60E","latestVersionIndicator":"Yes","beginDate":"2019-12-19","endDate":null,"createdBy":"TSESU","dateCreated":"2019-12-19","modifiedBy":"COOPERM","dateModified":"2020-08-21","changeNote":"smt created in error; 12/19/19 smt created for Alliance A021804. 8.21.20 Transferred to CCR and released for use with NCI-INC0513328-20C0058 SF36 form request. mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7098631","version":"1","preferredName":"SF-36v2 Health Survey Past 4 Weeks How Much of the Time Have You Been Happy Score 5 Point Scale","preferredDefinition":"A person's stated perception of how much of the time during the past four weeks they have been happy, using a 5 point Likert scale.","longName":"SF36V2_HAPPY_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"SF-36v2:Short Form 36 Health Survey Standard, US Version 2.0 Questionnaire, Sherbourne Cathy D; Ware John E., 1998","workflowStatus":"RELEASED","registrationStatus":"Application","id":"9A15D3C9-4F48-207C-E053-F662850A4E2A","latestVersionIndicator":"Yes","beginDate":"2019-12-19","endDate":null,"createdBy":"TSESU","dateCreated":"2019-12-19","modifiedBy":"COOPERM","dateModified":"2020-08-21","changeNote":"12/19/19 smt created for Alliance A021804 smt created in error. 8.21.20 Transferred to CCR and released for use with NCI-INC0513328-20C0058 SF36 form request. mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7154805","version":"2","preferredName":"Registering Institution Identifier Code","preferredDefinition":"The name of the institution registering patients for a clinical trial.","longName":"REG_INST_ID_CD","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A58ABC8C-DDAA-7942-E053-F662850A7603","latestVersionIndicator":"Yes","beginDate":"2020-05-13","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-05-13","modifiedBy":"COOPERM","dateModified":"2020-05-13","changeNote":"Curated to support CCR registering institutions_ghd Versioned to support change in PV names to include NCI. mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7165624","version":"1","preferredName":"Germline Variant Pathogenicity Category","preferredDefinition":"Classification category that describes the likelihood that germline variant is causally related to a heritable disease.","longName":"GRMLN_VAR_PTHGNC_CAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"9E010F8E-B00C-5730-E053-F662850AA1A4","latestVersionIndicator":"Yes","beginDate":"2020-02-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-02-07","modifiedBy":"COOPERM","dateModified":"2020-10-21","changeNote":"Created for NCI-INC0454031 - potential new CDE and PVs request from Liz on 2/4/20","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7186559","version":"1","preferredName":"Surgical Procedure Delay Indicator","preferredDefinition":"Indicator of whether or not a surgical procedure is or was delayed.","longName":"SURG_PROC_DELAY_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"9FAB50E1-F373-50A1-E053-F662850ACBAB","latestVersionIndicator":"Yes","beginDate":"2020-02-28","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-02-28","modifiedBy":"MMADDINENI","dateModified":"2023-05-15","changeNote":"Created for NCI-INC0461408: 20C0024 Import and curation request by Y.Yakovlev. 2/27/20 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7187104","version":"1","preferredName":"Tumor Clinical To Pathologic Response Downstaging Indicator","preferredDefinition":"Indicator of whether the tumor decreased in size and extent of metastases, and/or lymph node involvement, to a lower pathologic than clinical stage.","longName":"CLN_PATH_DOWNSTG_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"9FE4B6F0-0BCC-23C7-E053-F662850A5848","latestVersionIndicator":"Yes","beginDate":"2020-03-02","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-03-02","modifiedBy":"COOPERM","dateModified":"2020-04-21","changeNote":"Created for NCI-INC0461408: 20C0024 Import and curation request by Y.Yakovlev. 2/27/20 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7239646","version":"1","preferredName":"UGT1A1 Gene Status Result Type","preferredDefinition":"Text to represent the status of UGT1A1 Gene testing result.","longName":"UGT1A1_ST_RES_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A269F6E1-3DFC-3A13-E053-F662850ADF9D","latestVersionIndicator":"Yes","beginDate":"2020-04-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-04-03","modifiedBy":"COOPERM","dateModified":"2020-04-06","changeNote":"Created for NCI-INC0474687: 20C0013 qn curation. mc 4/3/20","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7293067","version":"1","preferredName":"Drug Accumulation Index Dose-Limiting Toxicity Risk Category","preferredDefinition":"Values and text that represent dose limiting toxicities defined by the risk of drug accumulation determined by accumulation index (AI).","longName":"DRUG_AI_RISK_CAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A59CC15F-7143-1658-E053-F662850A85C1","latestVersionIndicator":"Yes","beginDate":"2020-05-14","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-05-14","modifiedBy":"COOPERM","dateModified":"2020-08-13","changeNote":"Created for NCI-INC0484835 - 20C0023 Drug accumulation Index request 5.11.2020 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7309038","version":"1","preferredName":"Global Longitudinal Strain Percent Value","preferredDefinition":"Negative number that represents the Global Longitudinal Strain measurement of left ventricular function.","longName":"GLS_PCT_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A6B85C8A-D25B-771E-E053-4EBD850AD4C6","latestVersionIndicator":"Yes","beginDate":"2020-05-28","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-05-28","modifiedBy":"COOPERM","dateModified":"2020-06-12","changeNote":"Created for NCI-INC0486863 - 20C0056 GLS and Breast Cancer staging request 5.18.2020","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7330137","version":"1","preferredName":"Post Clinical Trial Treatment Other Specify","preferredDefinition":"Text to describe another type of treatment administered to an individual after going off the treatment portion of a clinical trial not previously mentioned.","longName":"POST_PROT_TX_OTH_SP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A7C390F3-2A73-5EC7-E053-4EBD850A4B3C","latestVersionIndicator":"Yes","beginDate":"2020-06-11","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-06-11","modifiedBy":"COOPERM","dateModified":"2020-06-12","changeNote":"Added for NCI-INC0492132 - 19C0040 request. 6.8.2020 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7340578","version":"1","preferredName":"Gene Pathogenic Variant Name","preferredDefinition":"Name of the genetic variant that is known to directly contribute to the development of disease.","longName":"GENE_PATH_VAR_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A8AC5A89-665A-2312-E053-4EBD850A16BD","latestVersionIndicator":"Yes","beginDate":"2020-06-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-06-22","modifiedBy":"NIKITAP","dateModified":"2022-02-23","changeNote":"Created for NCI-INC0494856 - FW: need help with database 19C0040 6.17.20 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7346856","version":"1","preferredName":"Capsule a.m. Medication Taken Number","preferredDefinition":"Number that represents the count of capsules taken in the a.m.","longName":"CAP_AM_MED_TAKN_NUM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A96498FC-9F72-550C-E053-4EBD850AD01F","latestVersionIndicator":"Yes","beginDate":"2020-07-01","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-07-01","modifiedBy":"COOPERM","dateModified":"2020-07-01","changeNote":"Created for NCI-INC0498328-20C0121 Patient's Medication Diary per Tania Glushchak request. mc 7/1/20","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7346857","version":"1","preferredName":"Capsule p.m. Medication Taken Number","preferredDefinition":"Number that represents the count of capsules taken in the p.m.","longName":"CAP_PM_MED_TAKN_NUM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A962F766-274C-5512-E053-4EBD850A1D2E","latestVersionIndicator":"Yes","beginDate":"2020-07-01","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-07-01","modifiedBy":"COOPERM","dateModified":"2020-07-01","changeNote":"Created for NCI-INC0498328-20C0121 Patient's Medication Diary per Tania Glushchak request. mc 7/1/20","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7374104","version":"1","preferredName":"RAS Gene Mutation Status Result","preferredDefinition":"Text term that represents the RAS gene mutation status.","longName":"RAS_MUT_STAT_RESLT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB9C2571-7804-2EE3-E053-4EBD850ADBD5","latestVersionIndicator":"Yes","beginDate":"2020-07-29","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-07-29","modifiedBy":"COOPERM","dateModified":"2020-08-06","changeNote":"Created for NCI-INC0507000 20C0138 RAS mutation status request 7.29.20 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7405995","version":"1","preferredName":"SF-36v2 Health Survey Past 4 Weeks How Much Pain Has Interfered with Normal Work Score 5 Point Scale","preferredDefinition":"A person's stated perception of how much in the past four weeks pain interfered with their normal work (including both work outside the home and housework), using a 5 point Likert scale.","longName":"SF36V2_PAIN_WRK_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"SF-36v2:Short Form 36 Health Survey Standard, US Version 2.0 Questionnaire, Sherbourne Cathy D; Ware John E., 1998","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AD6B136F-F734-4097-E053-4EBD850AA0AE","latestVersionIndicator":"Yes","beginDate":"2020-08-21","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-08-21","modifiedBy":"COOPERM","dateModified":"2020-08-21","changeNote":"Created for NCI-INC0513328-20C0058 SF36 form request. mc 8/21/20","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7415490","version":"1","preferredName":"BK Virus Infection Hemorrhagic Cystitis Event Indicator","preferredDefinition":"Indicator of whether or not a BK virus infection event happened.","longName":"BKV_INF_HEM_CYST_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AF100E19-CF75-7D4E-E053-4EBD850A9B79","latestVersionIndicator":"Yes","beginDate":"2020-09-11","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-09-11","modifiedBy":"BROWNTY","dateModified":"2022-04-08","changeNote":"Created for NCI-INC0519249 - BK and CMV qns curation 9.11.20","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7415491","version":"1","preferredName":"Continuous Bladder Irrigation Required Indicator","preferredDefinition":"Indicator of whether or not continuous bladder irrigation was required.","longName":"CONT_BLDR_IRG_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AF1018D4-0245-1F3B-E053-4EBD850A1576","latestVersionIndicator":"Yes","beginDate":"2020-09-11","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-09-11","modifiedBy":"HARTLEYG","dateModified":"2020-10-02","changeNote":"Created for NCI-INC0519249 - BK and CMV qns curation 9.11.20","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7415499","version":"1","preferredName":"Cystoscopy Required Indicator","preferredDefinition":"Indicator of whether or not cytoscopy was required.","longName":"CYSTOSCOPY_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AF104004-A163-741F-E053-4EBD850AD9D5","latestVersionIndicator":"Yes","beginDate":"2020-09-11","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-09-11","modifiedBy":"HARTLEYG","dateModified":"2020-10-02","changeNote":"Created for NCI-INC0519249 - BK and CMV qns curation 9.11.20","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7415500","version":"1","preferredName":"Blood Transfusion Required Indicator","preferredDefinition":"Indicator of whether or not transfusion was required.","longName":"TRANSFUSION_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AF104470-3B2B-0618-E053-4EBD850A5973","latestVersionIndicator":"Yes","beginDate":"2020-09-11","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-09-11","modifiedBy":"HARTLEYG","dateModified":"2020-10-02","changeNote":"Created for NCI-INC0519249 - BK and CMV qns curation 9.11.20","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7415502","version":"1","preferredName":"Intravenous Patient-Controlled Analgesia Required Indicator","preferredDefinition":"Indicator of whether or not intravenous patient-controlled analgesia was required.","longName":"PCA_REQ_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AF104F5E-E804-1D24-E053-4EBD850A3303","latestVersionIndicator":"Yes","beginDate":"2020-09-11","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-09-11","modifiedBy":"HARTLEYG","dateModified":"2020-10-02","changeNote":"Created for NCI-INC0519249 - BK and CMV qns curation 9.11.20","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7415503","version":"1","preferredName":"BK Virus Infection Neuropathy Present Indicator","preferredDefinition":"Indicator of whether or not nephropathy was present with BK virus infection.","longName":"BKV_NEUROP_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AF10601F-B18B-0B7B-E053-4EBD850A37CB","latestVersionIndicator":"Yes","beginDate":"2020-09-11","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-09-11","modifiedBy":"HARTLEYG","dateModified":"2020-10-02","changeNote":"Created for NCI-INC0519249 - BK and CMV qns curation 9.11.20","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7415507","version":"1","preferredName":"BK Virus Infection Kidney Biopsy Performed Indicator","preferredDefinition":"Indicator of whether or not renal biopsy was performed.","longName":"KIDNEY_BIOP_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AF106EA9-25E2-4C54-E053-4EBD850AC1B0","latestVersionIndicator":"Yes","beginDate":"2020-09-11","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-09-11","modifiedBy":"HARTLEYG","dateModified":"2020-10-02","changeNote":"Created for NCI-INC0519249 - BK and CMV qns curation 9.11.20","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7415512","version":"1","preferredName":"BK Virus Infection Treatment Performed Indicator","preferredDefinition":"Indicator of whether or not treatment for BK virus infection was performed.","longName":"BKV_TRMT_PERF_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AF100E19-CFB7-7D4E-E053-4EBD850A9B79","latestVersionIndicator":"Yes","beginDate":"2020-09-11","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-09-11","modifiedBy":"HARTLEYG","dateModified":"2020-10-02","changeNote":"Created for NCI-INC0519249 - BK and CMV qns curation 9.11.20","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7415514","version":"1","preferredName":"BK Virus Infection Hemorrhagic Cystitis Symptom Onset Date","preferredDefinition":"The date of symptom onset when supportive care medication for BK virus cystitis began.","longName":"BKV_CYSTITS_ONSET_DT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AF107C7B-2116-267D-E053-4EBD850AD778","latestVersionIndicator":"Yes","beginDate":"2020-09-11","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-09-11","modifiedBy":"HARTLEYG","dateModified":"2020-10-02","changeNote":"Created for NCI-INC0519249 - BK and CMV qns curation 9.11.20","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7415521","version":"1","preferredName":"BK Virus Infection Hemorrhagic Cystitis Symptom Resolution Date","preferredDefinition":"The date of symptom resolution when supportive care medication for BK virus infection stopped.","longName":"BKV_CYSTITS_RSLVD_DT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AF10601F-B1B9-0B7B-E053-4EBD850A37CB","latestVersionIndicator":"Yes","beginDate":"2020-09-11","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-09-11","modifiedBy":"HARTLEYG","dateModified":"2020-10-02","changeNote":"Created for NCI-INC0519249 - BK and CMV qns curation 9.11.20","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7415527","version":"1","preferredName":"Gross Hematuria Onset Date","preferredDefinition":"The date of onset of gross hematuria.","longName":"GRS_HMTURIA_ONSET_DT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AF10B4B3-84A0-7888-E053-4EBD850A07E1","latestVersionIndicator":"Yes","beginDate":"2020-09-11","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-09-11","modifiedBy":"HARTLEYG","dateModified":"2020-10-02","changeNote":"Created for NCI-INC0519249 - BK and CMV qns curation 9.11.20","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7415529","version":"1","preferredName":"Gross Hematuria Resolution Date","preferredDefinition":"The date of resolution of gross hematuria.","longName":"GRS_HMTURIA_RSLVD_DT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AF10BC42-3B53-76A7-E053-4EBD850AE7BF","latestVersionIndicator":"Yes","beginDate":"2020-09-11","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-09-11","modifiedBy":"HARTLEYG","dateModified":"2020-10-02","changeNote":"Created for NCI-INC0519249 - BK and CMV qns curation 9.11.20","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7415533","version":"1","preferredName":"Microscopic Hematuria Onset  Date","preferredDefinition":"The date of onset of microscopic hematuria.","longName":"MIC_HMTURIA_ONSET_DT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AF1066D9-6312-7F7C-E053-4EBD850AD382","latestVersionIndicator":"Yes","beginDate":"2020-09-11","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-09-11","modifiedBy":"HARTLEYG","dateModified":"2020-10-02","changeNote":"Created for NCI-INC0519249 - BK and CMV qns curation 9.11.20","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7415534","version":"1","preferredName":"Microscopic Hematuria Resolution Date","preferredDefinition":"The date of resolution of microscopic hematuria.","longName":"MIC_HMTURIA_RSVLD_DT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AF0FC00D-8E0E-393B-E053-4EBD850A5E4C","latestVersionIndicator":"Yes","beginDate":"2020-09-11","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-09-11","modifiedBy":"HARTLEYG","dateModified":"2020-10-02","changeNote":"Created for NCI-INC0519249 - BK and CMV qns curation 9.11.20","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7415536","version":"1","preferredName":"Continue Bladder Irrigation Start Date","preferredDefinition":"The start date of continuous bladder irrigation.","longName":"CNT_BLDR_IRG_BGN_DT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AF0F7D48-09DA-6E30-E053-4EBD850A8BBE","latestVersionIndicator":"Yes","beginDate":"2020-09-11","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-09-11","modifiedBy":"HARTLEYG","dateModified":"2020-10-02","changeNote":"Created for NCI-INC0519249 - BK and CMV qns curation 9.11.20","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7415537","version":"1","preferredName":"Continue Bladder Irrigation Stop Date","preferredDefinition":"The stop date of continuous bladder irrigation.","longName":"CNT_BLDR_IRG_END_DT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AF102B98-BCA5-6E5D-E053-4EBD850AAD42","latestVersionIndicator":"Yes","beginDate":"2020-09-11","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-09-11","modifiedBy":"HARTLEYG","dateModified":"2020-10-02","changeNote":"Created for NCI-INC0519249 - BK and CMV qns curation 9.11.20","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7415542","version":"1","preferredName":"BK Virus Infection Nephropathy Probability Type","preferredDefinition":"Text term that represents the likelihood of BK virus nephropathy.","longName":"BKV_NEPHRP_PROB_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AF107C7B-2147-267D-E053-4EBD850AD778","latestVersionIndicator":"Yes","beginDate":"2020-09-11","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-09-11","modifiedBy":"HARTLEYG","dateModified":"2020-10-02","changeNote":"Created for NCI-INC0519249 - BK and CMV qns curation 9.11.20","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7415543","version":"1","preferredName":"BK Virus Infection Non-Renal Organ Type","preferredDefinition":"Text term that represents the non-renal diseased organ related to BK virus infection.","longName":"BKV_NRENL_ORGAN_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AF107F88-C82E-0178-E053-4EBD850A6381","latestVersionIndicator":"Yes","beginDate":"2020-09-11","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-09-11","modifiedBy":"COOPERM","dateModified":"2021-02-24","changeNote":"Created for NCI-INC0519249 - BK and CMV qns curation 9.11.20","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7418095","version":"1","preferredName":"Symptom BK Virus Viral Load Event Type","preferredDefinition":"Text that represents the event related to symptom status associated with BK Virus Viral Load testing.","longName":"SYM_BKV_EVNT_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AF463B7D-2471-1CCE-E053-4EBD850A8844","latestVersionIndicator":"Yes","beginDate":"2020-09-14","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-09-14","modifiedBy":"HARTLEYG","dateModified":"2020-10-02","changeNote":"Created for NCI-INC0519249 - BK and CMV qns curation 9.11.20","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7421770","version":"1","preferredName":"Cytomegalovirus Reactivation During Conditioning Indicator","preferredDefinition":"Indicator of whether or not CMV reactivation was found during transfusion conditioning.","longName":"CMV_RCTV_DUR_CND_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AF6EDE2F-6DCB-207D-E053-4EBD850A0345","latestVersionIndicator":"Yes","beginDate":"2020-09-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-09-16","modifiedBy":"HARTLEYG","dateModified":"2020-10-02","changeNote":"Created for NCI-INC0519249 - BK and CMV qns curation 9.11.20","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7421774","version":"1","preferredName":"Cytomegalovirus Reactivation Day 4 Conditioning Indicator","preferredDefinition":"Indicator of whether or not CMV reactivation was found through day 4 of transfusion conditioning.","longName":"CMV_RCTV_D4_CND_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AF6EE7F4-DA9D-01C2-E053-4EBD850A2FE9","latestVersionIndicator":"Yes","beginDate":"2020-09-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-09-16","modifiedBy":"HARTLEYG","dateModified":"2020-10-02","changeNote":"Created for NCI-INC0519249 - BK and CMV qns curation 9.11.20","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7421780","version":"1","preferredName":"Cytomegalovirus Reactivation First Event Indicator","preferredDefinition":"Indicator of whether or not CMV reactivation was the first event.","longName":"CMV_RCTV_FST_EVT_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AF6EF1DD-37A7-1521-E053-4EBD850A97E8","latestVersionIndicator":"Yes","beginDate":"2020-09-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-09-16","modifiedBy":"HARTLEYG","dateModified":"2020-10-02","changeNote":"Created for NCI-INC0519249 - BK and CMV qns curation 9.11.20","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7421781","version":"1","preferredName":"Cytomegaloviral Infection Present Indicator","preferredDefinition":"Indicator of whether or not CMV infection occurred.","longName":"CMV_PRSNT_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AF6EF698-9165-507C-E053-4EBD850A094B","latestVersionIndicator":"Yes","beginDate":"2020-09-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-09-16","modifiedBy":"HARTLEYG","dateModified":"2020-10-02","changeNote":"Created for NCI-INC0519249 - BK and CMV qns curation 9.11.20","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7421782","version":"1","preferredName":"Cytomegaloviral Infection Biopsy Performed Indicator","preferredDefinition":"Indicator of whether or not a biopsy related to CMV infection was performed.","longName":"CMV_BIOP_PERF_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AF6EFBF0-23FF-5726-E053-4EBD850A83D9","latestVersionIndicator":"Yes","beginDate":"2020-09-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-09-16","modifiedBy":"HARTLEYG","dateModified":"2020-10-02","changeNote":"Created for NCI-INC0519249 - BK and CMV qns curation 9.11.20","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7421783","version":"1","preferredName":"Letermovir Primary Prophylaxis Indicator","preferredDefinition":"Indicator of whether or not primary Letermovir prophylaxis was given.","longName":"LTRMVR_PRIM_PROX_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AF6EE7F4-DACB-01C2-E053-4EBD850A2FE9","latestVersionIndicator":"Yes","beginDate":"2020-09-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-09-16","modifiedBy":"HARTLEYG","dateModified":"2020-10-02","changeNote":"Created for NCI-INC0519249 - BK and CMV qns curation 9.11.20","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7421786","version":"1","preferredName":"Letermovir Secondary Prophylaxis Indicator","preferredDefinition":"Indicator of whether or not secondary letermovir prophylaxis was given.","longName":"LTRMVR_SCND_PROX_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AF6F0A4E-F99D-4543-E053-4EBD850A19BE","latestVersionIndicator":"Yes","beginDate":"2020-09-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-09-16","modifiedBy":"HARTLEYG","dateModified":"2020-10-02","changeNote":"Created for NCI-INC0519249 - BK and CMV qns curation 9.11.20","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7421793","version":"1","preferredName":"Cytomegalovirus Reactivation Second Event Indicator","preferredDefinition":"Indicator of whether or not CMV infection reactivation was the second event.","longName":"CMV_RCTV_SCND_EV_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AF6EEB6F-2C1C-5289-E053-4EBD850AC351","latestVersionIndicator":"Yes","beginDate":"2020-09-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-09-16","modifiedBy":"HARTLEYG","dateModified":"2020-10-02","changeNote":"Created for NCI-INC0519249 - BK and CMV qns curation 9.11.20","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7421794","version":"1","preferredName":"Cytomegalovirus Reactivation Third Event Indicator","preferredDefinition":"Indicator of whether or not CMV reactivation was the third event.","longName":"CMV_RCTV_THRD_EV_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AF6EDE2F-6E06-207D-E053-4EBD850A0345","latestVersionIndicator":"Yes","beginDate":"2020-09-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-09-16","modifiedBy":"HARTLEYG","dateModified":"2020-10-02","changeNote":"Created for NCI-INC0519249 - BK and CMV qns curation 9.11.20","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7421799","version":"1","preferredName":"Cytomegalovirus Reactivation First Event Treatment Start Date","preferredDefinition":"Start date of treatment related to the first CMV reactivation event.","longName":"CMVRCTV_FST_TX_ST_DT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AF6F9A91-2C0F-2D94-E053-4EBD850AD248","latestVersionIndicator":"Yes","beginDate":"2020-09-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-09-16","modifiedBy":"HARTLEYG","dateModified":"2020-10-02","changeNote":"Created for NCI-INC0519249 - BK and CMV qns curation 9.11.20","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7421800","version":"1","preferredName":"Cytomegaloviral Infection Treatment Start Date","preferredDefinition":"Start date of treatment related to CMV infection.","longName":"CMV_TRMT_ST_DT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AF6F6001-D92C-186A-E053-4EBD850A1B07","latestVersionIndicator":"Yes","beginDate":"2020-09-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-09-16","modifiedBy":"HARTLEYG","dateModified":"2020-10-02","changeNote":"Created for NCI-INC0519249 - BK and CMV qns curation 9.11.20","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7421801","version":"1","preferredName":"Letermovir Primary Prophylaxix Start Date","preferredDefinition":"Start date of Letermovir primary prophylaxis.","longName":"LTRMV_PR_PROX_ST_DT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AF6F6001-D95A-186A-E053-4EBD850A1B07","latestVersionIndicator":"Yes","beginDate":"2020-09-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-09-16","modifiedBy":"HARTLEYG","dateModified":"2020-10-02","changeNote":"Created for NCI-INC0519249 - BK and CMV qns curation 9.11.20","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7421806","version":"1","preferredName":"Letermovir Secondary Prophylaxix Start Date","preferredDefinition":"Start date of Letermovir secondary prophylaxis.","longName":"LTRMV_SCND_PRX_ST_DT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AF6FCC4C-D11C-580E-E053-4EBD850A90F2","latestVersionIndicator":"Yes","beginDate":"2020-09-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-09-16","modifiedBy":"HARTLEYG","dateModified":"2020-10-02","changeNote":"Created for NCI-INC0519249 - BK and CMV qns curation 9.11.20","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7421807","version":"1","preferredName":"Cytomegalovirus Reactivation Second Event Treatment Start Date","preferredDefinition":"Start date of treatment related to the second CMV reactivation event.","longName":"CMVRCT_SCEV_TX_ST_DT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AF6F9A91-2C76-2D94-E053-4EBD850AD248","latestVersionIndicator":"Yes","beginDate":"2020-09-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-09-16","modifiedBy":"HARTLEYG","dateModified":"2020-10-02","changeNote":"Created for NCI-INC0519249 - BK and CMV qns curation 9.11.20","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7421808","version":"1","preferredName":"Cytomegalovirus Reactivation Third Event Treatment Start Date","preferredDefinition":"Start date of treatment related to the third CMV reactivation event.","longName":"CMVRCT_TREV_TX_ST_DT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AF6EDE2F-6E34-207D-E053-4EBD850A0345","latestVersionIndicator":"Yes","beginDate":"2020-09-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-09-16","modifiedBy":"HARTLEYG","dateModified":"2020-10-02","changeNote":"Created for NCI-INC0519249 - BK and CMV qns curation 9.11.20","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7421810","version":"1","preferredName":"Cytomegaloviral Infection Treatment End Date","preferredDefinition":"End date of treatment related to CMV infection.","longName":"CMV_TRMT_END_DT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AF6EDE2F-6E62-207D-E053-4EBD850A0345","latestVersionIndicator":"Yes","beginDate":"2020-09-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-09-16","modifiedBy":"HARTLEYG","dateModified":"2020-10-02","changeNote":"Created for NCI-INC0519249 - BK and CMV qns curation 9.11.20","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7421817","version":"1","preferredName":"Cytomegalovirus Reactivation First Event Treatment End Date","preferredDefinition":"End date of treatment related to the first CMV reactivation event.","longName":"CMVRCT_1EV_TX_END_DT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AF702002-326F-33E9-E053-4EBD850ACBF1","latestVersionIndicator":"Yes","beginDate":"2020-09-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-09-16","modifiedBy":"HARTLEYG","dateModified":"2020-10-02","changeNote":"Created for NCI-INC0519249 - BK and CMV qns curation 9.11.20","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7421963","version":"1","preferredName":"Letermovir Primary Prophylaxis Stop Date","preferredDefinition":"Date on which Letermovir primary prophylaxis was stopped.","longName":"LTRMV_PRM_PRX_STP_DT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AF717933-0E40-58F8-E053-4EBD850ACA27","latestVersionIndicator":"Yes","beginDate":"2020-09-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-09-16","modifiedBy":"HARTLEYG","dateModified":"2020-10-02","changeNote":"Created for NCI-INC0519249 - BK and CMV qns curation 9.11.20","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7421964","version":"1","preferredName":"Letermovir Secondary Prophylaxis Stop Date","preferredDefinition":"End date of Letermovir secondary prophylaxis.","longName":"LTRMV_SEC_PRX_STP_DT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AF71876A-D7F8-715D-E053-4EBD850AB161","latestVersionIndicator":"Yes","beginDate":"2020-09-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-09-16","modifiedBy":"HARTLEYG","dateModified":"2020-10-02","changeNote":"Created for NCI-INC0519249 - BK and CMV qns curation 9.11.20","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7421968","version":"1","preferredName":"Cytomegalovirus Reactivation Second Event Treatment End Date","preferredDefinition":"End date of treatment related to the second CMV reactivation event.","longName":"CMVRC_SCEV_TX_END_DT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AF71876A-D826-715D-E053-4EBD850AB161","latestVersionIndicator":"Yes","beginDate":"2020-09-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-09-16","modifiedBy":"HARTLEYG","dateModified":"2020-10-02","changeNote":"Created for NCI-INC0519249 - BK and CMV qns curation 9.11.20","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7421971","version":"1","preferredName":"Cytomegalovirus Reactivation Third Event Treatment End Date","preferredDefinition":"End date of treatment related to the third CMV reactivation event.","longName":"CMVRC_TREV_TX_END_DT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AF71876A-D854-715D-E053-4EBD850AB161","latestVersionIndicator":"Yes","beginDate":"2020-09-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-09-16","modifiedBy":"HARTLEYG","dateModified":"2020-10-02","changeNote":"Created for NCI-INC0519249 - BK and CMV qns curation 9.11.20","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7423118","version":"1","preferredName":"First Cytomegalovirus Reactivation Start Immunosuppressive Therapy Type","preferredDefinition":"Text that represents the kind of immunosuppression agent used at the start of the first CMV reactivation event.","longName":"CMVRC1_IMM_TRMT_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AF717933-0EB6-58F8-E053-4EBD850ACA27","latestVersionIndicator":"Yes","beginDate":"2020-09-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-09-16","modifiedBy":"HARTLEYG","dateModified":"2020-10-02","changeNote":"Created for NCI-INC0519249 - BK and CMV qns curation 9.11.20","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7423119","version":"1","preferredName":"First Cytomegalovirus Reactivation End Immunosuppressive Therapy Type","preferredDefinition":"Text that represents the kind of immunosuppression agent used at the end of the first CMV reactivation event.","longName":"CMVRC1_END_IMM_TX_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AF71263D-C08A-1831-E053-4EBD850A951D","latestVersionIndicator":"Yes","beginDate":"2020-09-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-09-16","modifiedBy":"HARTLEYG","dateModified":"2020-10-02","changeNote":"Created for NCI-INC0519249 - BK and CMV qns curation 9.11.20","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7423120","version":"1","preferredName":"Second Cytomegalovirus Reactivation Start Immunosuppressive Therapy Type","preferredDefinition":"Text that represents the kind of immunosuppression agent used at the start of the second CMV reactivation event.","longName":"CMVRC2_IMM_TRMT_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AF71263D-C0B8-1831-E053-4EBD850A951D","latestVersionIndicator":"Yes","beginDate":"2020-09-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-09-16","modifiedBy":"HARTLEYG","dateModified":"2020-10-02","changeNote":"Created for NCI-INC0519249 - BK and CMV qns curation 9.11.20","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7423121","version":"1","preferredName":"Second Cytomegalovirus Reactivation End Immunosuppressive Therapy Type","preferredDefinition":"Text that represents the kind of immunosuppression agent used at the end of the second CMV reactivation event.","longName":"CMVRC2_END_IMM_TX_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AF713BDA-107D-5195-E053-4EBD850A3C6E","latestVersionIndicator":"Yes","beginDate":"2020-09-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-09-16","modifiedBy":"HARTLEYG","dateModified":"2020-10-02","changeNote":"Created for NCI-INC0519249 - BK and CMV qns curation 9.11.20","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7423122","version":"1","preferredName":"Third Cytomegalovirus Reactivation Start Immunosuppressive Therapy Type","preferredDefinition":"Text that represents the kind of immunosuppression agent used at the start of the third CMV reactivation event.","longName":"CMVRC3_IMM_TRMT_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AF713BDA-10AB-5195-E053-4EBD850A3C6E","latestVersionIndicator":"Yes","beginDate":"2020-09-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-09-16","modifiedBy":"HARTLEYG","dateModified":"2020-10-02","changeNote":"Created for NCI-INC0519249 - BK and CMV qns curation 9.11.20","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7423123","version":"1","preferredName":"Third Cytomegalovirus Reactivation End Immunosuppressive Therapy Type","preferredDefinition":"Text that represents the kind of immunosuppression agent used at the end of the third CMV reactivation event.","longName":"CMVRC3_END_IMM_TX_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AF71876A-D8A7-715D-E053-4EBD850AB161","latestVersionIndicator":"Yes","beginDate":"2020-09-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-09-16","modifiedBy":"HARTLEYG","dateModified":"2020-10-02","changeNote":"Created for NCI-INC0519249 - BK and CMV qns curation 9.11.20","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7424280","version":"1","preferredName":"First Cytomegalovirus Reactivation Start Immunosuppressive Therapy Other Specify","preferredDefinition":"Text that represents another immunosuppression agent used at the start of the first CMV reactivation event not previously mentioned.","longName":"CMVRC1_IMM_OTHTX_SP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AF725FD1-534B-12F5-E053-4EBD850A804A","latestVersionIndicator":"Yes","beginDate":"2020-09-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-09-16","modifiedBy":"HARTLEYG","dateModified":"2020-10-02","changeNote":"Created for NCI-INC0519249 - BK and CMV qns curation 9.11.20","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7424281","version":"1","preferredName":"First Cytomegalovirus Reactivation End Immunosuppressive Therapy Other Specify","preferredDefinition":"Text that represents another immunosuppression agent used at the end of the first CMV reactivation event not previously mentioned.","longName":"CMVRC1_END_IM_OTH_SP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AF725413-2657-6D45-E053-4EBD850AB061","latestVersionIndicator":"Yes","beginDate":"2020-09-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-09-16","modifiedBy":"HARTLEYG","dateModified":"2020-10-02","changeNote":"Created for NCI-INC0519249 - BK and CMV qns curation 9.11.20","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7424282","version":"1","preferredName":"Second Cytomegalovirus Reactivation Start Immunosuppressive Therapy Other Specify","preferredDefinition":"Text that represents another immunosuppression agent used at the end of the second CMV reactivation event not previously mentioned.","longName":"CMVRC2_IMM_OTHTX_SP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AF725413-2685-6D45-E053-4EBD850AB061","latestVersionIndicator":"Yes","beginDate":"2020-09-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-09-16","modifiedBy":"HARTLEYG","dateModified":"2020-10-02","changeNote":"Created for NCI-INC0519249 - BK and CMV qns curation 9.11.20","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7424283","version":"1","preferredName":"Second Cytomegalovirus Reactivation End Immunosuppressive Therapy Other Specify","preferredDefinition":"Text that represents another immunosuppression agent used at the end of the second CMV reactivation event not previously mentioned.","longName":"CMVRC2_END_IM_OTH_SP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AF725FD1-5379-12F5-E053-4EBD850A804A","latestVersionIndicator":"Yes","beginDate":"2020-09-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-09-16","modifiedBy":"HARTLEYG","dateModified":"2020-10-02","changeNote":"Created for NCI-INC0519249 - BK and CMV qns curation 9.11.20","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7424284","version":"1","preferredName":"Third Cytomegalovirus Reactivation Start Immunosuppressive Therapy Other Specify","preferredDefinition":"Text that represents another immunosuppression agent used at the start of the third CMV reactivation event not previously mentioned.","longName":"CMVRC3_IMM_OTHTX_SP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AF727A7B-B66F-2680-E053-4EBD850A021B","latestVersionIndicator":"Yes","beginDate":"2020-09-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-09-16","modifiedBy":"HARTLEYG","dateModified":"2020-10-02","changeNote":"Created for NCI-INC0519249 - BK and CMV qns curation 9.11.20","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7424285","version":"1","preferredName":"Third Cytomegalovirus Reactivation End Immunosuppressive Therapy Other Specify","preferredDefinition":"Text that represents another immunosuppression agent used at the end of the third CMV reactivation event not previously mentioned.","longName":"CMVRC3_END_IM_OTH_SP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AF725FD1-53A7-12F5-E053-4EBD850A804A","latestVersionIndicator":"Yes","beginDate":"2020-09-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-09-16","modifiedBy":"HARTLEYG","dateModified":"2020-10-02","changeNote":"Created for NCI-INC0519249 - BK and CMV qns curation 9.11.20","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7424286","version":"1","preferredName":"Cytomegaloviral Infection Hematopoietic Stem Cells Given Indicator","preferredDefinition":"Indicator of whether or not cells were given for CMV infection.","longName":"CMV_HSC_ADM_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AF72C926-8444-1E85-E053-4EBD850A818B","latestVersionIndicator":"Yes","beginDate":"2020-09-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-09-16","modifiedBy":"HARTLEYG","dateModified":"2020-10-02","changeNote":"Created for NCI-INC0519249 - BK and CMV qns curation 9.11.20","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7424287","version":"1","preferredName":"Cytomegaloviral Infection Hematopoietic Stem Cell Given Date","preferredDefinition":"The date cells were given for CMV infection.","longName":"CMV_HSC_ADM_DT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AF727FAC-008C-2154-E053-4EBD850A3C06","latestVersionIndicator":"Yes","beginDate":"2020-09-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-09-16","modifiedBy":"HARTLEYG","dateModified":"2020-10-02","changeNote":"Created for NCI-INC0519249 - BK and CMV qns curation 9.11.20","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7424288","version":"1","preferredName":"Cytomegaloviral Infection Organ Involvement Type","preferredDefinition":"Text that represents the organ involved in CMV infection.","longName":"CMV_ORGAN_INV_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AF72C926-8472-1E85-E053-4EBD850A818B","latestVersionIndicator":"Yes","beginDate":"2020-09-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-09-16","modifiedBy":"COOPERM","dateModified":"2021-02-24","changeNote":"Created for NCI-INC0519249 - BK and CMV qns curation 9.11.20","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7429667","version":"1","preferredName":"MRI Computed Tomography Mesothelioma Probability Score","preferredDefinition":"The score related to suspicion of malignancy, including mesothelioma, as measured by magnetic resonance imaging (MRI).","longName":"MRI_CT_MESO_PRB_SCR","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AFED7454-F5EE-23FF-E053-4EBD850A6220","latestVersionIndicator":"Yes","beginDate":"2020-09-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-09-22","modifiedBy":"COOPERM","dateModified":"2020-09-23","changeNote":"Created for NCI-INC0521046 20C0106 new questions 9.16.20 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7429668","version":"1","preferredName":"High Resolution and Photon Counting Computed Tomography Mesothelioma Probability Score","preferredDefinition":"The score related to suspicion of malignancy, including mesothelioma, as measured by high resolution and photon counting computed tomography imaging.","longName":"HRCT_PCCT_MS_PRB_SCR","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AFEF3108-F7B2-6291-E053-4EBD850A3808","latestVersionIndicator":"Yes","beginDate":"2020-09-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-09-22","modifiedBy":"COOPERM","dateModified":"2020-09-23","changeNote":"Created for NCI-INC0521046 20C0106 new questions 9.16.20 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7430767","version":"1","preferredName":"Videothoracoscopy and Laparoscopy Surveillance Result Score","preferredDefinition":"The score related to suspicion of malignancy, including mesothelioma, as detected by surveillance videothoracoscopy and laparoscopy.","longName":"VATS_LAP_SURV_RS_SCR","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AFEBCBE4-21F4-28D7-E053-4EBD850A040A","latestVersionIndicator":"Yes","beginDate":"2020-09-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-09-22","modifiedBy":"COOPERM","dateModified":"2020-09-23","changeNote":"Created for NCI-INC0521046 20C0106 new questions 9.16.20 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7437708","version":"1","preferredName":"Prior High Dose Steroids Received Immune-Related Side Effect Indicator","preferredDefinition":"Indicator of whether a patient previously received high dose steroids for any immune related side effects.","longName":"PR_HDS_STRD_IRAE_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B029334E-DAA8-10B7-E053-4EBD850A9D16","latestVersionIndicator":"Yes","beginDate":"2020-09-25","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-09-25","modifiedBy":"COOPERM","dateModified":"2020-09-25","changeNote":"Created for NCI-INC0523148 - High Dose steroid qn 9.24.20 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7449444","version":"1","preferredName":"Prior Therapeutic Procedure Cohort Category","preferredDefinition":"The text response indicating the patient cohort based on prior therapeutic procedures.","longName":"PR_TX_COHORT_CAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B08EBB16-094A-59EC-E053-4EBD850A7A9C","latestVersionIndicator":"Yes","beginDate":"2020-09-30","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2020-09-30","modifiedBy":"HARTLEYG","dateModified":"2020-09-30","changeNote":"Curated to support Protocol 17C0102","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7476426","version":"1","preferredName":"Tumor Panel Sequencing Performed TruSight Oncology 500 Assay Gene Code","preferredDefinition":"Code that represents the gene identified using a next-generation sequencing assay that enables comprehensive genomic profiling of tumor samples.","longName":"TUMR_GENE_SEQ_TSO_CD","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2341633-A626-2E0B-E053-4EBD850AEDA0","latestVersionIndicator":"Yes","beginDate":"2020-10-21","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-10-21","modifiedBy":"COOPERM","dateModified":"2020-11-05","changeNote":"10.20.20 Created for 20C0106 TSO 500 gene panel request. mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7477359","version":"1","preferredName":"High Resolution Computed Tomography Performed Indicator","preferredDefinition":"Indicator of whether a high resolution computed tomography (HRCT) procedure was performed.","longName":"HRCT_PERF_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B248D67A-9D7D-2C39-E053-4EBD850A6872","latestVersionIndicator":"Yes","beginDate":"2020-10-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-10-22","modifiedBy":"COOPERM","dateModified":"2020-10-22","changeNote":"Created for NCI-INC0530815 RE:20C0106 new questions 10.22.20 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7477360","version":"1","preferredName":"Photon Counting Computed Tomography Performed Indicator","preferredDefinition":"Indicator of whether a photon counting computed tomography (PCCT) procedure was performed.","longName":"PCCT_PERF_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B24925D4-274C-3408-E053-4EBD850A1810","latestVersionIndicator":"Yes","beginDate":"2020-10-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-10-22","modifiedBy":"COOPERM","dateModified":"2020-10-22","changeNote":"Created for NCI-INC0530815 RE:20C0106 new questions 10.22.20 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7477361","version":"1","preferredName":"Videothoracoscopy And Laparoscopy Performed Indicator","preferredDefinition":"Indicator of whether video-assisted thoracoscopy (VATS) and laparoscopy procedures were performed.","longName":"VATS_LAPSCP_PERF_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2498D3E-4E1D-2C45-E053-4EBD850A2688","latestVersionIndicator":"Yes","beginDate":"2020-10-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-10-22","modifiedBy":"COOPERM","dateModified":"2020-10-22","changeNote":"Created for NCI-INC0530815 RE:20C0106 new questions 10.22.20 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7498767","version":"1","preferredName":"Toxoplasmosis Antibody Test Status","preferredDefinition":"Text term that represents the toxoplasmosis antibody test status.","longName":"TOXOPLAS_AB_TST_STAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B3C6A64C-046F-73CA-E053-4EBD850A799E","latestVersionIndicator":"Yes","beginDate":"2020-11-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-11-10","modifiedBy":"COOPERM","dateModified":"2020-11-10","changeNote":"Created for NCI-INC0536652 - 20C0070 Curation and import request. mc 11/10/2020","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7507211","version":"1","preferredName":"Gastrointestinal Stromal Tumor Gene Mutation Name","preferredDefinition":"The name of the gene associated with Gastrointestinal Stromal Tumor (GIST).","longName":"GIST_GENE_MUT_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B4648A18-3CDC-5E66-E053-4EBD850A0245","latestVersionIndicator":"Yes","beginDate":"2020-11-18","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-11-18","modifiedBy":"COOPERM","dateModified":"2020-11-18","changeNote":"Created for NCI-INC0538595 20C0161 Exon and codon request. 11.17.2020 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7507212","version":"1","preferredName":"KIT Gene Mutation Exon Specify","preferredDefinition":"A molecular genetic abnormality indicating the presence of a mutation specified by the KIT gene exon.","longName":"KIT_MUT_EXON_SP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B464DF2C-D263-6042-E053-4EBD850A7CDD","latestVersionIndicator":"Yes","beginDate":"2020-11-18","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-11-18","modifiedBy":"COOPERM","dateModified":"2020-11-18","changeNote":"Created for NCI-INC0538595 20C0161 Exon and codon request. 11.17.2020 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7507213","version":"1","preferredName":"NF1 Gene Mutation Exon Specify","preferredDefinition":"A molecular genetic abnormality indicating the presence of a mutation specified by the NF1 gene exon.","longName":"NF1_MUT_EXON_SP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B464E43A-1EC5-48C0-E053-4EBD850AB683","latestVersionIndicator":"Yes","beginDate":"2020-11-18","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-11-18","modifiedBy":"COOPERM","dateModified":"2020-11-18","changeNote":"Created for NCI-INC0538595 20C0161 Exon and codon request. 11.17.2020 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7507214","version":"1","preferredName":"Other Gene Mutation Exon Specify","preferredDefinition":"A molecular genetic abnormality indicating the presence of a mutation specified by another gene exon not previously identified.","longName":"OTH_MUT_EXON_SP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B45D6AEF-600B-0F85-E053-4EBD850AD7D5","latestVersionIndicator":"Yes","beginDate":"2020-11-18","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-11-18","modifiedBy":"COOPERM","dateModified":"2020-11-18","changeNote":"Created for NCI-INC0538595 20C0161 Exon and codon request. 11.17.2020 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7507215","version":"1","preferredName":"PDGFRA Gene Mutation Exon Specify","preferredDefinition":"A molecular genetic abnormality indicating the presence of a mutation specified by the PDGFRA gene exon.","longName":"PDGFRA_MUT_EXON_SP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B464F299-94C8-6F3B-E053-4EBD850A86F8","latestVersionIndicator":"Yes","beginDate":"2020-11-18","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-11-18","modifiedBy":"COOPERM","dateModified":"2020-11-18","changeNote":"Created for NCI-INC0538595 20C0161 Exon and codon request. 11.17.2020 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7507216","version":"1","preferredName":"KIT Gene Mutation Codon Specify","preferredDefinition":"The specified KIT codon where a mutation was identified.","longName":"KIT_MUT_CODON_SP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B4648A18-3D0A-5E66-E053-4EBD850A0245","latestVersionIndicator":"Yes","beginDate":"2020-11-18","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-11-18","modifiedBy":"COOPERM","dateModified":"2020-11-18","changeNote":"Created for NCI-INC0538595 20C0161 Exon and codon request. 11.17.2020 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7507217","version":"1","preferredName":"NF1 Gene Mutation Codon Specify","preferredDefinition":"The specified NF1 codon where a mutation was identified.","longName":"NF1_MUT_CODON_SP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B4644DF9-648F-48C6-E053-4EBD850A328D","latestVersionIndicator":"Yes","beginDate":"2020-11-18","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-11-18","modifiedBy":"COOPERM","dateModified":"2020-11-18","changeNote":"Created for NCI-INC0538595 20C0161 Exon and codon request. 11.17.2020 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7507218","version":"1","preferredName":"Other Gene Mutation Codon Specify","preferredDefinition":"The specified gene codon where a mutation was identified in a gene not previously identified.","longName":"OTH_MUT_CODON_SP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B4650D34-EEB1-6054-E053-4EBD850A99F1","latestVersionIndicator":"Yes","beginDate":"2020-11-18","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-11-18","modifiedBy":"COOPERM","dateModified":"2020-11-18","changeNote":"Created for NCI-INC0538595 20C0161 Exon and codon request. 11.17.2020 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7507219","version":"1","preferredName":"PDGFRA Gene Mutation Codon Specify","preferredDefinition":"The specified PDGFRA codon where a mutation was identified.","longName":"PDGFRA_MUT_CODON_SP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B464F299-94F6-6F3B-E053-4EBD850A86F8","latestVersionIndicator":"Yes","beginDate":"2020-11-18","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-11-18","modifiedBy":"COOPERM","dateModified":"2020-11-18","changeNote":"Created for NCI-INC0538595 20C0161 Exon and codon request. 11.17.2020 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7507223","version":"1","preferredName":"SDH Gene Mutation Protein Subunit Specify","preferredDefinition":"The specified subunit in the succinate dehydrogenase (SDH) complex where the gene mutation occurs.","longName":"SDH_MUT_SUBUNIT_SP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B46439AE-CAB5-48CB-E053-4EBD850AD3E2","latestVersionIndicator":"Yes","beginDate":"2020-11-18","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-11-18","modifiedBy":"COOPERM","dateModified":"2020-11-18","changeNote":"Created for NCI-INC0538595 20C0161 Exon and codon request. 11.17.2020 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7507232","version":"1","preferredName":"Gastrointestinal Stromal Tumor Other Gene Mutation Name","preferredDefinition":"The name of another gene associated with Gastrointestinal Stromal Tumor (GIST) not previously specified.","longName":"GIST_OTH_GENE_MUT_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B4653A6A-E97E-6086-E053-4EBD850A0A0B","latestVersionIndicator":"Yes","beginDate":"2020-11-18","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-11-18","modifiedBy":"COOPERM","dateModified":"2020-11-18","changeNote":"Created for NCI-INC0538595 20C0161 Exon and codon request. 11.17.2020 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7507242","version":"1","preferredName":"Gastrointestinal Stromal Tumor Mutation Abnormality Type","preferredDefinition":"Text term that represents the kind of tissue or cell mutation abnormality associated with gastrointestinal stromal tumors.","longName":"GIST_MUT_ABN_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B465E6E8-DB6E-0328-E053-4EBD850A758C","latestVersionIndicator":"Yes","beginDate":"2020-11-18","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-11-18","modifiedBy":"COOPERM","dateModified":"2020-11-18","changeNote":"Created for NCI-INC0538595 20C0161 Exon and codon request. 11.17.2020 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7513391","version":"1","preferredName":"Infectious Disorder Response or Outcome Type","preferredDefinition":"Term that describes the response to treatment or outcome of the infection.","longName":"INFECT_OUTCOME_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B47ECCAA-76FF-25DD-E053-4EBD850AB3DC","latestVersionIndicator":"Yes","beginDate":"2020-11-19","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-11-19","modifiedBy":"COOPERM","dateModified":"2020-11-20","changeNote":"11.18.2020 Created for NCI-INC0538950 20C0070 Curation and import_02 request. mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7513392","version":"1","preferredName":"T-Cell Receptor Signaling Defect Description Text","preferredDefinition":"Text description of the T-Cell Receptor (TCR) signaling defect.","longName":"TCR_SIG_DEF_TXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B47F1570-41E7-5B5B-E053-4EBD850AE132","latestVersionIndicator":"Yes","beginDate":"2020-11-19","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-11-19","modifiedBy":"COOPERM","dateModified":"2020-11-20","changeNote":"11.18.2020 Created for NCI-INC0538950 20C0070 Curation and import_02 request. mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7515013","version":"1","preferredName":"Gene Mutation Detection Type","preferredDefinition":"Text term to represent the detected gene mutation.","longName":"GENE_MUTATE_DTCT_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B4C8B94F-573A-7A4D-E053-4EBD850AB3BA","latestVersionIndicator":"Yes","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"COOPERM","dateModified":"2021-02-16","changeNote":"Approved for import and released. mc 12.23.2020; Created for NCI-INC0536652 - 20C0070 Curation and import 11.10.2020. AK 2020-11-23","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7515746","version":"1","preferredName":"Gene Mutation Abnormality Type","preferredDefinition":"Text term to represent the gene mutation abnormality.","longName":"GENE_MUTATE_ABN_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B4CD76C6-807E-61FA-E053-4EBD850A9D05","latestVersionIndicator":"Yes","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"NIKITAP","dateModified":"2022-02-24","changeNote":"Approved for import and released. mc 12.23.2020; Created for NCI-INC0536652 - 20C0070 Curation and import 11.10.2020. AK 2020-11-23","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7516342","version":"1","preferredName":"HSCT Timepoint Name","preferredDefinition":"Text term to represent the timepoint associated with allogenic hematopoietic stem cell transplantation (HSCT).","longName":"HSCT_TIMEPOINT_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B4F073C7-6C63-69A7-E053-4EBD850A63A8","latestVersionIndicator":"Yes","beginDate":"2020-11-25","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-11-25","modifiedBy":"COOPERM","dateModified":"2020-12-23","changeNote":"Created for NCI-INC0536652 - 20C0070 Curation and import 11.10.2020 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7516343","version":"1","preferredName":"Post HSCT Timepoint Name","preferredDefinition":"Text term for the specific point in time after allogenic hematopoietic stem cell transplantation (HSCT).","longName":"POST_HSCT_TIMEPT_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B4EFE894-F76B-2DCA-E053-4EBD850AD89C","latestVersionIndicator":"Yes","beginDate":"2020-11-25","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-11-25","modifiedBy":"COOPERM","dateModified":"2020-12-23","changeNote":"Created for NCI-INC0536652 - 20C0070 Curation and import 11.10.2020 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7516344","version":"1","preferredName":"Primary Immunodeficiency Syndrome Infection Type","preferredDefinition":"Text term that represents the kind of infection associated with primary immunodeficiency disease (PID).","longName":"PID_INFECT_TYP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B4F08FFE-1197-69A9-E053-4EBD850ABFD7","latestVersionIndicator":"Yes","beginDate":"2020-11-25","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-11-25","modifiedBy":"COOPERM","dateModified":"2021-01-28","changeNote":"Created for NCI-INC0536652 - 20C0070 Curation and import 11.10.2020 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7516345","version":"1","preferredName":"Infection Pathogen Name","preferredDefinition":"Text term to represent the name of the disease agent associated with the infection.","longName":"INFECT_PATHOG_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B4F08FFE-11C5-69A9-E053-4EBD850ABFD7","latestVersionIndicator":"Yes","beginDate":"2020-11-25","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-11-25","modifiedBy":"COOPERM","dateModified":"2021-01-28","changeNote":"Created for NCI-INC0536652 - 20C0070 Curation and import 11.10.2020 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7516346","version":"1","preferredName":"Infection Pathogen Other Specify","preferredDefinition":"Text description of another disease agent not previously mentioned or listed related to the infection.","longName":"INFECT_OTH_PATHOG_SP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B4F08FFE-11F3-69A9-E053-4EBD850ABFD7","latestVersionIndicator":"Yes","beginDate":"2020-11-25","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-11-25","modifiedBy":"COOPERM","dateModified":"2021-01-28","changeNote":"Created for NCI-INC0536652 - 20C0070 Curation and import 11.10.2020 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7516347","version":"1","preferredName":"Specimen Positive Finding Source Name","preferredDefinition":"Text term that describes the source of the specimen (site) associated with a positive result.","longName":"SPEC_POS_SOURCE_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B4F0305F-3327-69AF-E053-4EBD850AE5CB","latestVersionIndicator":"Yes","beginDate":"2020-11-25","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-11-25","modifiedBy":"COOPERM","dateModified":"2021-01-28","changeNote":"Created for NCI-INC0536652 - 20C0070 Curation and import 11.10.2020 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7516348","version":"1","preferredName":"Specimen Positive Finding Source Other Specify","preferredDefinition":"Text term that describes another source of the specimen (site) not previously mentioned or listed associated with a positive result.","longName":"SPEC_POS_OTH_SRC_SP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B4F02EE3-B569-69AD-E053-4EBD850AF07C","latestVersionIndicator":"Yes","beginDate":"2020-11-25","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-11-25","modifiedBy":"COOPERM","dateModified":"2021-01-28","changeNote":"Created for NCI-INC0536652 - 20C0070 Curation and import 11.10.2020 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7516349","version":"1","preferredName":"Laboratory Test Result Finding Type","preferredDefinition":"Text term that represents the finding of laboratory test.","longName":"LAB_RSLT_TYP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B4F0C383-84F2-5408-E053-4EBD850AB5A8","latestVersionIndicator":"Yes","beginDate":"2020-11-25","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-11-25","modifiedBy":"COOPERM","dateModified":"2021-01-28","changeNote":"Created for NCI-INC0536652 - 20C0070 Curation and import 11.10.2020 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7516350","version":"1","preferredName":"Laboratory Procedure PCR Viral Load Value","preferredDefinition":"The numerical quantity that represents the viral load as measured by polymerase chain reaction (PCR) laboratory testing.","longName":"LAB_PCR_VIR_LD_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B4F0DE19-4066-530A-E053-4EBD850AEFEB","latestVersionIndicator":"Yes","beginDate":"2020-11-25","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-11-25","modifiedBy":"COOPERM","dateModified":"2021-01-28","changeNote":"Created for NCI-INC0536652 - 20C0070 Curation and import 11.10.2020 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7516351","version":"1","preferredName":"Infection Category","preferredDefinition":"Text term that represents a qualifier used to describe whether the infection is disseminated or localized.","longName":"INFECTION_CAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B4F02EE3-B59F-69AD-E053-4EBD850AF07C","latestVersionIndicator":"Yes","beginDate":"2020-11-25","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-11-25","modifiedBy":"COOPERM","dateModified":"2021-01-28","changeNote":"Created for NCI-INC0536652 - 20C0070 Curation and import 11.10.2020 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7516352","version":"1","preferredName":"Infection Treatment Description Text","preferredDefinition":"Text field to capture the description of the treatment used for the infection.","longName":"INFECTION_TRMT_TXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B4F078E9-664C-2DE8-E053-4EBD850A7F97","latestVersionIndicator":"Yes","beginDate":"2020-11-25","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-11-25","modifiedBy":"COOPERM","dateModified":"2021-01-28","changeNote":"Created for NCI-INC0536652 - 20C0070 Curation and import 11.10.2020 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7518853","version":"1","preferredName":"Histology Immunophenotype HSCT Timepoint Name","preferredDefinition":"Text term to represent the HSCT timepoint for the immunophenotype histology.","longName":"IMMUNTP_HSCT_TP_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B567459F-6AC3-0C72-E053-4EBD850A9EBD","latestVersionIndicator":"Yes","beginDate":"2020-12-01","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-12-01","modifiedBy":"COOPERM","dateModified":"2021-01-05","changeNote":"2020-12-1 AK Created for NCI-INC0536652 - 20C0070 Curation and import 11.10.2020","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7518854","version":"1","preferredName":"Histology Immunophenotype Post HSCT Timepoint Name","preferredDefinition":"Text term to represent the post HSCT timepoint for the immunophenotype histology.","longName":"IMMU_PST_HSCT_TP_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B56858F7-F063-0C6C-E053-4EBD850ADEA0","latestVersionIndicator":"Yes","beginDate":"2020-12-01","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-12-01","modifiedBy":"COOPERM","dateModified":"2021-01-05","changeNote":"2020-12-1 AK Created for NCI-INC0536652 - 20C0070 Curation and import 11.10.2020","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7518859","version":"1","preferredName":"Flow Cytometry Primary Immunodeficiency Syndrome Performed Indicator","preferredDefinition":"The response indicating whether flow cytometry for primary immunodeficiency syndrome was performed.","longName":"FLOW_PID_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B5694CA4-BEC2-571F-E053-4EBD850A774C","latestVersionIndicator":"Yes","beginDate":"2020-12-01","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-12-01","modifiedBy":"COOPERM","dateModified":"2021-01-05","changeNote":"2020-12-1 AK Created for NCI-INC0536652 - 20C0070 Curation and import 11.10.2020","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7518870","version":"1","preferredName":"Analysis Lymphocyte Phenotype Performed Indicator","preferredDefinition":"The response indicating whether an analysis for the lymphocyte phenotype was performed.","longName":"ANA_LYM_PNTP_PFM_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B5694CA4-BEF6-571F-E053-4EBD850A774C","latestVersionIndicator":"Yes","beginDate":"2020-12-01","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-12-01","modifiedBy":"COOPERM","dateModified":"2021-01-05","changeNote":"2020-12-1 AK Created for NCI-INC0536652 - 20C0070 Curation and import 11.10.2020","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7518881","version":"1","preferredName":"Immunoglobulin Level Present Indicator","preferredDefinition":"The response indicating whether an immunoglobulin level was present.","longName":"IG_LEVEL_PRSNT_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B569998B-1A6A-7FEB-E053-4EBD850AC7B0","latestVersionIndicator":"Yes","beginDate":"2020-12-01","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-12-01","modifiedBy":"COOPERM","dateModified":"2021-01-05","changeNote":"2020-12-1 AK Created for NCI-INC0536652 - 20C0070 Curation and import 11.10.2020","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7518886","version":"1","preferredName":"Isohemagglutinin Titer Present Indicator","preferredDefinition":"The response indicating whether an isohemagglutinin titer was present.","longName":"ISOMAG_TTR_PRSNT_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B569E701-232C-571B-E053-4EBD850AB125","latestVersionIndicator":"Yes","beginDate":"2020-12-01","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-12-01","modifiedBy":"COOPERM","dateModified":"2021-01-05","changeNote":"2020-12-1 AK Created for NCI-INC0536652 - 20C0070 Curation and import 11.10.2020","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7518896","version":"1","preferredName":"Measurable Defect Assay Performed Name","preferredDefinition":"Text term to represent the name of the measurable defect assay that was performed.","longName":"MSR_DFT_ASSY_PFRM_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B56858F7-F165-0C6C-E053-4EBD850ADEA0","latestVersionIndicator":"Yes","beginDate":"2020-12-01","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-12-01","modifiedBy":"COOPERM","dateModified":"2021-01-05","changeNote":"2020-12-1 AK Created for NCI-INC0536652 - 20C0070 Curation and import 11.10.2020","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7518899","version":"1","preferredName":"Measurable Defect Assay Performed Results Text","preferredDefinition":"Text term to represent the measurable defect assay results.","longName":"MSR_DFT_ASY_PFRM_RSL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B56858F7-F1AE-0C6C-E053-4EBD850ADEA0","latestVersionIndicator":"Yes","beginDate":"2020-12-01","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-12-01","modifiedBy":"COOPERM","dateModified":"2021-01-05","changeNote":"2020-12-1 AK Created for NCI-INC0536652 - 20C0070 Curation and import 11.10.2020","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7522014","version":"1","preferredName":"Malignant Neoplasm Diagnosis Name","preferredDefinition":"Text term to represent the malignant neoplasm diagnosis.","longName":"MLGN_NEO_DX_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B5949761-1A31-351E-E053-4EBD850A1604","latestVersionIndicator":"Yes","beginDate":"2020-12-03","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-12-03","modifiedBy":"COOPERM","dateModified":"2021-01-08","changeNote":"2020-12-2-3 AK Created for NCI-INC0536652 - 20C0070 Curation and import 11.10.2020","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7522018","version":"1","preferredName":"Associated Virus Present Pathogen Name","preferredDefinition":"Text term to represent the associated virus pathogen.","longName":"ASSC_VRS_PATH_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B593EFD3-FCAF-0CE5-E053-4EBD850A572A","latestVersionIndicator":"Yes","beginDate":"2020-12-03","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-12-03","modifiedBy":"COOPERM","dateModified":"2021-01-08","changeNote":"2020-12-3 AK Created for NCI-INC0536652 - 20C0070 Curation and import 11.10.2020","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7522031","version":"1","preferredName":"Karyotype Description Name","preferredDefinition":"Text term to represent the karyotype.","longName":"KARYO_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B594B022-AD89-4955-E053-4EBD850A28C4","latestVersionIndicator":"Yes","beginDate":"2020-12-03","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-12-03","modifiedBy":"COOPERM","dateModified":"2021-01-08","changeNote":"2020-12-3 AK Created for NCI-INC0536652 - 20C0070 Curation and import 11.10.2020","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7522036","version":"1","preferredName":"New Malignant Neoplasm Post Transplantation Occurrence Descriptive Text","preferredDefinition":"Free text description of the post transplant new malignant neoplasm.","longName":"NW_MLGN_NEO_PST_TX","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B59378AE-9EC7-7443-E053-4EBD850A1F9C","latestVersionIndicator":"Yes","beginDate":"2020-12-03","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-12-03","modifiedBy":"COOPERM","dateModified":"2021-01-08","changeNote":"2020-12-3 AK Created for NCI-INC0536652 - 20C0070 Curation and import 11.10.2020","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7522037","version":"1","preferredName":"Malignant Disease or Disorder Status Descriptive Text","preferredDefinition":"Free text description of the malignant disease or status.","longName":"MLNG_DIS_STAT_TXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B5929EAB-4078-215C-E053-4EBD850A9136","latestVersionIndicator":"Yes","beginDate":"2020-12-03","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-12-03","modifiedBy":"COOPERM","dateModified":"2021-01-08","changeNote":"2020-12-3 AK Created for NCI-INC0536652 - 20C0070 Curation and import 11.10.2020","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7522038","version":"1","preferredName":"Associated Virus Present Descriptive Text","preferredDefinition":"Free text description of the associated virus.","longName":"ASSC_VIRS_TX","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B594B022-ADB7-4955-E053-4EBD850A28C4","latestVersionIndicator":"Yes","beginDate":"2020-12-03","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-12-03","modifiedBy":"COOPERM","dateModified":"2021-01-08","changeNote":"2020-12-3 AK Created for NCI-INC0536652 - 20C0070 Curation and import 11.10.2020","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7522039","version":"1","preferredName":"Karyotype Description Text","preferredDefinition":"Free text description of the karyotype.","longName":"KARYO_DSCR_TXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B595919C-E063-4C51-E053-4EBD850A10F7","latestVersionIndicator":"Yes","beginDate":"2020-12-03","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-12-03","modifiedBy":"COOPERM","dateModified":"2021-01-08","changeNote":"2020-12-3 AK Created for NCI-INC0536652 - 20C0070 Curation and import 11.10.2020","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7525210","version":"1","preferredName":"Non-Hodgkin Lymphoma Present Stage","preferredDefinition":"Stage related to non-hodgkin lymphoma.","longName":"NHL_STAGE","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B5E26465-2448-6F9E-E053-4EBD850A0E89","latestVersionIndicator":"Yes","beginDate":"2020-12-07","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-12-07","modifiedBy":"COOPERM","dateModified":"2021-01-08","changeNote":"2020-12-7 AK Created for NCI-INC0536652 - 20C0070 Curation and import 11.10.2020","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7525215","version":"1","preferredName":"Cervical Adenocarcinoma Present Finding Grade","preferredDefinition":"Grade to signify the cervical adenocarcinoma finding.","longName":"CERV_ADENO_FDN_GRD","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B5E2AF08-AAA3-69EF-E053-4EBD850AFAB6","latestVersionIndicator":"Yes","beginDate":"2020-12-07","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-12-07","modifiedBy":"COOPERM","dateModified":"2021-01-08","changeNote":"2020-12-7 AK Created for NCI-INC0536652 - 20C0070 Curation and import 11.10.2020","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7525217","version":"1","preferredName":"Cervical Adenocarcinoma Present Stage","preferredDefinition":"Stage related to cervical adenocarcinoma.","longName":"CERV_ADENO_STG","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B5DA7913-E921-6F96-E053-4EBD850A97B4","latestVersionIndicator":"Yes","beginDate":"2020-12-07","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-12-07","modifiedBy":"COOPERM","dateModified":"2021-01-08","changeNote":"2020-12-7 AK Created for NCI-INC0536652 - 20C0070 Curation and import 11.10.2020","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7525223","version":"1","preferredName":"Vulvar Squamous Cell Carcinoma Present Finding Grade","preferredDefinition":"Grade to signify the vulvar squamous cell carcinoma finding.","longName":"VULV_SCC_FND_GRD","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B5DA57BE-5027-6F92-E053-4EBD850AF212","latestVersionIndicator":"Yes","beginDate":"2020-12-07","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-12-07","modifiedBy":"COOPERM","dateModified":"2021-01-08","changeNote":"2020-12-7 AK Created for NCI-INC0536652 - 20C0070 Curation and import 11.10.2020","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7525224","version":"1","preferredName":"Vulvar Squamous Cell Carcinoma Present Stage","preferredDefinition":"Stage related to vulvar squamous cell carcinoma.","longName":"VULV_SCC_STG","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B5E264EB-E0A8-6F98-E053-4EBD850A9151","latestVersionIndicator":"Yes","beginDate":"2020-12-07","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-12-07","modifiedBy":"COOPERM","dateModified":"2021-01-08","changeNote":"2020-12-7 AK Created for NCI-INC0536652 - 20C0070 Curation and import 11.10.2020","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7525227","version":"1","preferredName":"Squamous Cell Carcinoma Present Stage","preferredDefinition":"Stage related to squamous cell carcinoma.","longName":"SCC_STG","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B5E25D80-58A2-2E07-E053-4EBD850A0F49","latestVersionIndicator":"Yes","beginDate":"2020-12-07","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-12-07","modifiedBy":"COOPERM","dateModified":"2021-01-08","changeNote":"2020-12-7 AK Created for NCI-INC0536652 - 20C0070 Curation and import 11.10.2020","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7525228","version":"1","preferredName":"Squamous Cell Carcinoma Present Site Name","preferredDefinition":"A text description of the squamous cell carcinoma site.","longName":"SCC_SITE_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B5DA4551-F047-6F9A-E053-4EBD850A6680","latestVersionIndicator":"Yes","beginDate":"2020-12-07","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-12-07","modifiedBy":"COOPERM","dateModified":"2021-01-08","changeNote":"2020-12-7 AK Created for NCI-INC0536652 - 20C0070 Curation and import 11.10.2020","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7525231","version":"1","preferredName":"Hodgkin Lymphoma Present Stage","preferredDefinition":"Stage related to hodgkin lymphoma.","longName":"HL_STG","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B5E26465-2485-6F9E-E053-4EBD850A0E89","latestVersionIndicator":"Yes","beginDate":"2020-12-07","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-12-07","modifiedBy":"COOPERM","dateModified":"2021-01-08","changeNote":"2020-12-7 AK Created for NCI-INC0536652 - 20C0070 Curation and import 11.10.2020","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7525253","version":"1","preferredName":"Malignant Disease or Disorder Status","preferredDefinition":"A text description of the malignant neoplasm status.","longName":"MALGNT_NEO_STAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B5E49150-89AD-6D8F-E053-4EBD850ADD11","latestVersionIndicator":"Yes","beginDate":"2020-12-07","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-12-07","modifiedBy":"COOPERM","dateModified":"2021-01-08","changeNote":"2020-12-7 AK Created for NCI-INC0536652 - 20C0070 Curation and import 11.10.2020","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7532266","version":"1","preferredName":"Autoimmune Disease Type Other Specify","preferredDefinition":"Text that describes another autoimmune disorders not previously specified or mentioned.","longName":"AUTOIMM_DZ_OTH_SP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B6827379-6440-5D1C-E053-4EBD850A32F2","latestVersionIndicator":"Yes","beginDate":"2020-12-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-12-15","modifiedBy":"COOPERM","dateModified":"2020-12-23","changeNote":"Created for NCI-INC0536652 - 20C0070 Curation and import 11.10.2020 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7532267","version":"1","preferredName":"Laboratory Procedure Antibody or Titer Name","preferredDefinition":"The name of the autoimmune antibody or titer laboratory test.","longName":"LAB_AUTOIMM_AB_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B6827FBB-C046-5DC8-E053-4EBD850A4A38","latestVersionIndicator":"Yes","beginDate":"2020-12-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-12-15","modifiedBy":"COOPERM","dateModified":"2020-12-23","changeNote":"Created for NCI-INC0536652 - 20C0070 Curation and import 11.10.2020 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7532268","version":"1","preferredName":"Laboratory Procedure Antibody Titer Performed Measurement","preferredDefinition":"The result of the autoimmune antibody or titer measurement.","longName":"LAB_AUTOIM_AB_TTR_MS","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B6827FBB-C079-5DC8-E053-4EBD850A4A38","latestVersionIndicator":"Yes","beginDate":"2020-12-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-12-15","modifiedBy":"COOPERM","dateModified":"2020-12-23","changeNote":"Created for NCI-INC0536652 - 20C0070 Curation and import 11.10.2020 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7532269","version":"1","preferredName":"Autoinflammatory Disorder Present Name","preferredDefinition":"Text term that represents the name of the autoinflammatory syndrome or disorder.","longName":"AUTOINFL_DS_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B68286CE-E4C5-6BDC-E053-4EBD850AA51C","latestVersionIndicator":"Yes","beginDate":"2020-12-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-12-15","modifiedBy":"COOPERM","dateModified":"2020-12-23","changeNote":"Created for NCI-INC0536652 - 20C0070 Curation and import 11.10.2020 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7532270","version":"1","preferredName":"Autoimmune Disorder Status","preferredDefinition":"Text term that represents the status of the autoimmune disorder.","longName":"AUTOIMM_DS_STATUS","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B6829B3A-79A1-705F-E053-4EBD850A94C5","latestVersionIndicator":"Yes","beginDate":"2020-12-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-12-15","modifiedBy":"COOPERM","dateModified":"2020-12-23","changeNote":"Created for NCI-INC0536652 - 20C0070 Curation and import 11.10.2020 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7533445","version":"1","preferredName":"Disease or Disorder Primary Immunodeficiency Syndrome Or Primary Immune Regulatory Disorder Classification Name","preferredDefinition":"Text term to represent the primary immunodeficiency syndrome or primary immune regulatory disorder classification.","longName":"PID_PIRD_CLASS_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B6841741-B18A-6D86-E053-4EBD850AC78E","latestVersionIndicator":"Yes","beginDate":"2020-12-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-12-15","modifiedBy":"COOPERM","dateModified":"2020-12-23","changeNote":"Approved for import and released. mc 12.23.2020; 2020-12-15 AK Created for NCI-INC0536652 - 20C0070 Curation and import 11.10.2020","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7533462","version":"1","preferredName":"Severe Combined Immunodeficiency Description Name","preferredDefinition":"Text term to describe the severe combined immunodeficiency.","longName":"SCID_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B6846E55-A8D6-6BDA-E053-4EBD850ADAE6","latestVersionIndicator":"Yes","beginDate":"2020-12-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-12-15","modifiedBy":"COOPERM","dateModified":"2020-12-23","changeNote":"Approved for import and released. mc 12.23.2020; 2020-12-15 AK Created for NCI-INC0536652 - 20C0070 Curation and import 11.10.2020","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7533480","version":"1","preferredName":"Primary Immune Regulatory Disorder Description Name","preferredDefinition":"Text term to describe the primary immune regulatory disorder.","longName":"PIRD_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B684A897-C943-6B77-E053-4EBD850ADE0E","latestVersionIndicator":"Yes","beginDate":"2020-12-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-12-15","modifiedBy":"COOPERM","dateModified":"2020-12-23","changeNote":"Approved for import and released. mc 12.23.2020; 2020-12-15 AK Created for NCI-INC0536652 - 20C0070 Curation and import 11.10.2020","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7533488","version":"1","preferredName":"Congenital Defects of Phagocyte Description Type","preferredDefinition":"Text term to describe the congenital defects of phagocytes.","longName":"CONG_DFCT_PHAG_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B684E05F-3493-4E88-E053-4EBD850A7545","latestVersionIndicator":"Yes","beginDate":"2020-12-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-12-15","modifiedBy":"COOPERM","dateModified":"2020-12-23","changeNote":"Approved for import and released. mc 12.23.2020; 2020-12-15 AK Created for NCI-INC0536652 - 20C0070 Curation and import 11.10.2020","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7533503","version":"1","preferredName":"Defects of Intrinsic and Innate Immunity Description Name","preferredDefinition":"Text term to describe the defects of intrinsic and innate immunity.","longName":"DFCT_INT_INN_IMM_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B684FB38-6AC8-4E80-E053-4EBD850A9415","latestVersionIndicator":"Yes","beginDate":"2020-12-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-12-15","modifiedBy":"COOPERM","dateModified":"2020-12-23","changeNote":"Approved for import and released. mc 12.23.2020; 2020-12-15 AK Created for NCI-INC0536652 - 20C0070 Curation and import 11.10.2020","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7533518","version":"1","preferredName":"Disease or Disorder Primary Immunodeficiency Syndrome Or Primary Immune Regulatory Disorder Description Name","preferredDefinition":"Text term to describe the primary immunodeficiency syndrome or primary immune regulatory disorder.","longName":"PID_PIRD_DIS_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B6853381-5D9A-06D5-E053-4EBD850A0E44","latestVersionIndicator":"Yes","beginDate":"2020-12-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-12-15","modifiedBy":"COOPERM","dateModified":"2020-12-23","changeNote":"Approved for import and released. mc 12.23.2020; 2020-12-15 AK Created for NCI-INC0536652 - 20C0070 Curation and import 11.10.2020","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7533528","version":"1","preferredName":"Inheritance Pattern Description Type","preferredDefinition":"Text term to describe the inheritance pattern.","longName":"INH_PATT_DSCPT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B684FB38-6AF7-4E80-E053-4EBD850A9415","latestVersionIndicator":"Yes","beginDate":"2020-12-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-12-15","modifiedBy":"COOPERM","dateModified":"2020-12-23","changeNote":"Approved for import and released. mc 12.23.2020; 2020-12-15 AK Created for NCI-INC0536652 - 20C0070 Curation and import 11.10.2020","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7533684","version":"1","preferredName":"Autoimmune Cytopenia Type","preferredDefinition":"Text term that represents the kind of autoimmune cytopenia.","longName":"AUTOIMM_CYTOPN_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B6AAFAAC-B0E6-2DB1-E053-4EBD850A3D8F","latestVersionIndicator":"Yes","beginDate":"2020-12-17","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-12-17","modifiedBy":"COOPERM","dateModified":"2020-12-23","changeNote":"Created for NCI-INC0536652 - 20C0070 Curation and import 11.10.2020 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7533687","version":"1","preferredName":"Autoimmune Hepatitis Type","preferredDefinition":"Text term that represents the kind of autoimmune hepatitis.","longName":"AUTOIMM_HEPATITS_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B697BB91-3672-3C93-E053-4EBD850A2F84","latestVersionIndicator":"Yes","beginDate":"2020-12-17","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-12-17","modifiedBy":"COOPERM","dateModified":"2020-12-23","changeNote":"Created for NCI-INC0536652 - 20C0070 Curation and import 11.10.2020 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7533689","version":"1","preferredName":"Autoimmune Endocrinopathy Type","preferredDefinition":"Text term that represents the kind of autoimmune endocrinopathy.","longName":"AUTOIMM_ENDOCRINE_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B6AB0565-AD54-2D4A-E053-4EBD850A93F0","latestVersionIndicator":"Yes","beginDate":"2020-12-17","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-12-17","modifiedBy":"COOPERM","dateModified":"2020-12-23","changeNote":"Created for NCI-INC0536652 - 20C0070 Curation and import 11.10.2020 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7533692","version":"1","preferredName":"Autoimmune Inflammatory Bowel Disease Type","preferredDefinition":"Text term that represents the kind of Inflammatory Bowel Disease (IBD).","longName":"AUTOIMM_IBD_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B6ADB7BE-1B64-33A6-E053-4EBD850A5A6D","latestVersionIndicator":"Yes","beginDate":"2020-12-17","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-12-17","modifiedBy":"COOPERM","dateModified":"2020-12-23","changeNote":"Created for NCI-INC0536652 - 20C0070 Curation and import 11.10.2020 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7533694","version":"1","preferredName":"Autoimmune Nephritis Type","preferredDefinition":"Text term that represents the kind of autoimmune nephritis.","longName":"AUTOIMM_NEPHRITIS_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B6ADD55E-04BE-33BD-E053-4EBD850AE930","latestVersionIndicator":"Yes","beginDate":"2020-12-17","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-12-17","modifiedBy":"COOPERM","dateModified":"2020-12-23","changeNote":"Created for NCI-INC0536652 - 20C0070 Curation and import 11.10.2020 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7539723","version":"1","preferredName":"Autoimmune Disease Other Type","preferredDefinition":"Text term that represents another autoimmune disorders not previously specified or mentioned.","longName":"AUTOIMM_DZ_OTH_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B72C8614-5968-205C-E053-4EBD850AB570","latestVersionIndicator":"Yes","beginDate":"2020-12-23","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-12-23","modifiedBy":"COOPERM","dateModified":"2020-12-23","changeNote":"Created for NCI-INC0536652 - 20C0070 Curation and import 11.10.2020 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7544811","version":"1","preferredName":"Malignant Neoplasm Stage Grouping Description Stage","preferredDefinition":"Text description of the stage of the malignancy.","longName":"MLGN_NEO_GRP_DSC_STG","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B82F5789-D36D-28AA-E053-4EBD850A1600","latestVersionIndicator":"Yes","beginDate":"2021-01-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2021-01-05","modifiedBy":"COOPERM","dateModified":"2021-01-08","changeNote":"Created for NCI-INC0536652 - 20C0070 Curation and import 11.10.2020 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7545526","version":"1","preferredName":"Myelodysplastic Syndrome Assessment  Blast Cell Status","preferredDefinition":"Text term that represents the blast cell status related to myelodysplastic syndrome (MDS).","longName":"MDS_ASMT_BLAST_STS","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B865BF74-D70C-2AD8-E053-4EBD850A1EE2","latestVersionIndicator":"Yes","beginDate":"2021-01-08","endDate":null,"createdBy":"COOPERM","dateCreated":"2021-01-08","modifiedBy":"COOPERM","dateModified":"2021-01-08","changeNote":"Created for 20C0070 Curation and import Sheet6 1.7.2021","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7552057","version":"1","preferredName":"Neurofibromatosis Type 1 Pathologic Diagnosis Type","preferredDefinition":"Text term that represents the kind of Neurofibromatosis Type 1 identified by pathologic diagnosis.","longName":"NF1_PATH_DIAG_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B95A0B2A-F5EC-3953-E053-4EBD850AA9A9","latestVersionIndicator":"Yes","beginDate":"2021-01-21","endDate":null,"createdBy":"COOPERM","dateCreated":"2021-01-21","modifiedBy":"COOPERM","dateModified":"2021-01-21","changeNote":"Created for NCI-INC0551952 - Curation for 21C0011 1/19/21 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7552058","version":"1","preferredName":"Neurofibromatosis Type 1 Pathologic Diagnosis Other Specify","preferredDefinition":"Text term that represents another kind of Neurofibromatosis Type 1 identified by pathologic diagnosis not previously mentioned.","longName":"NF1_PATH_DIAG_OTH_SP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B95A0B2A-F61A-3953-E053-4EBD850AA9A9","latestVersionIndicator":"Yes","beginDate":"2021-01-21","endDate":null,"createdBy":"COOPERM","dateCreated":"2021-01-21","modifiedBy":"COOPERM","dateModified":"2021-01-21","changeNote":"Created for NCI-INC0551952 - Curation for 21C0011 1/19/21 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7552074","version":"1","preferredName":"Neurofibromatosis Type 1 Atypical Feature Type","preferredDefinition":"Text term that represents the kind of atypical feature found in Neurofibromatosis Type 1.","longName":"NF1_ATYP_FTR_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B96AABCF-F8D7-4F3A-E053-4EBD850A4096","latestVersionIndicator":"Yes","beginDate":"2021-01-21","endDate":null,"createdBy":"COOPERM","dateCreated":"2021-01-21","modifiedBy":"COOPERM","dateModified":"2021-01-21","changeNote":"Created for NCI-INC0551952 - Curation for 21C0011 1/19/21 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7552143","version":"1","preferredName":"Target Atypical Neurofibromatosis Type 1 Clinical Trial Enrollment Disease Status","preferredDefinition":"Disease status term to capture the screening assessment of the progression status of Neurofibromatosis Type I (NF1) target atypical neurofibromas.","longName":"TRG_ATYP_NF1_ENR_ST","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B96CCB02-23E4-5569-E053-4EBD850A96E5","latestVersionIndicator":"Yes","beginDate":"2021-01-21","endDate":null,"createdBy":"COOPERM","dateCreated":"2021-01-21","modifiedBy":"COOPERM","dateModified":"2021-01-21","changeNote":"Created for NCI-INC0552327 - 21C0011 ANF enrollment status 1/20/21 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7564871","version":"1","preferredName":"Primary Immunodeficiency Syndrome Infection Status","preferredDefinition":"Text term that represents the status of the infection associated with Primary Immunodeficiency Syndrome (PID).","longName":"PID_INFECT_STATUS","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B9FD956A-0F94-10B0-E053-4EBD850AAB73","latestVersionIndicator":"Yes","beginDate":"2021-01-28","endDate":null,"createdBy":"COOPERM","dateCreated":"2021-01-28","modifiedBy":"COOPERM","dateModified":"2021-01-29","changeNote":"Created for NCI-INC0536652 - 20C0070 Curation and import 11.10.2020 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7574366","version":"1","preferredName":"Residual Disease Assessment CRS/HIPEC Completeness of Cytoreduction Score","preferredDefinition":"Term that represents the assessment of residual disease after cytoreduction surgery and heated intraperitoneal chemotherapy.","longName":"CRS_HIPEC_CC_SCR","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"BA629EDD-6E7E-7FE0-E053-4EBD850A040C","latestVersionIndicator":"Yes","beginDate":"2021-02-02","endDate":null,"createdBy":"COOPERM","dateCreated":"2021-02-02","modifiedBy":"COOPERM","dateModified":"2021-02-04","changeNote":"Created for NCI-INC0554138 21C0012 CC score request. 1/27/21 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7576067","version":"1","preferredName":"Hepatitis A Status","preferredDefinition":"Text term that represents the status of Hepatitis A viral infection.","longName":"HEP_A_STATUS","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BA990C1F-9278-6995-E053-4EBD850AE68C","latestVersionIndicator":"Yes","beginDate":"2021-02-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2021-02-05","modifiedBy":"COOPERM","dateModified":"2021-02-05","changeNote":"Created for NCI-INC0556390 - 20C0070 curation / import to glib 02/04 request. mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7576068","version":"1","preferredName":"Human Immunodeficiency Virus Status","preferredDefinition":"Text term that represents the status of Human Immunodeficiency Virus (HIV) infection.","longName":"HIV_1_2_STATUS","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BA9A2A07-288A-129E-E053-4EBD850A752E","latestVersionIndicator":"Yes","beginDate":"2021-02-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2021-02-05","modifiedBy":"COOPERM","dateModified":"2021-02-05","changeNote":"Created for NCI-INC0556390 - 20C0070 curation / import to glib 02/04 request. mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7576478","version":"1","preferredName":"Immune System Disease or Disorder Atopy Diagnosis Name","preferredDefinition":"Text term that represents the atopy condition.","longName":"IMM_DZ_ATOPY_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BB01635F-926B-4290-E053-4EBD850AA322","latestVersionIndicator":"Yes","beginDate":"2021-02-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2021-02-10","modifiedBy":"COOPERM","dateModified":"2021-02-10","changeNote":"Created for NCI-INC0557438 - 20C0070 curation request. mc 2.9.21","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7584548","version":"2","preferredName":"Adverse Event Commercial Agent Attribution Category","preferredDefinition":"Text term representing the causal relationship between commercial agent(s) and a specific adverse event.","longName":"AE_COM_AGT_ATRB_CAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BF77669B-5CCC-34B8-E053-4EBD850A6DC4","latestVersionIndicator":"Yes","beginDate":"2021-04-08","endDate":null,"createdBy":"COOPERM","dateCreated":"2021-04-08","modifiedBy":"COOPERM","dateModified":"2021-04-08","changeNote":"Created for help with AE attribution request. mc 2.17.21 VD/CDE versioned to change VM names. 4.8.21 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7587035","version":"2","preferredName":"Adverse Event Investigational New Drug Attribution Category","preferredDefinition":"Text term representing the causal relationship between investigational new drug(s) and a specific adverse event.","longName":"AE_IND_ATRB_CAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BF771EAB-0D5D-5B15-E053-4EBD850AF1B7","latestVersionIndicator":"Yes","beginDate":"2021-04-08","endDate":null,"createdBy":"COOPERM","dateCreated":"2021-04-08","modifiedBy":"COOPERM","dateModified":"2021-04-08","changeNote":"Created for help with AE attribution request. mc 2.17.21 VD/CDE versioned to change VM names. 4.8.21 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7587036","version":"2","preferredName":"Adverse Event Surgery Attribution Category","preferredDefinition":"Text term representing the causal relationship between surgery/surgical procedure(s) and a specific adverse event.","longName":"AE_SURG_ATRB_CAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BF76EAB4-5582-2378-E053-4EBD850A7E06","latestVersionIndicator":"Yes","beginDate":"2021-04-08","endDate":null,"createdBy":"COOPERM","dateCreated":"2021-04-08","modifiedBy":"COOPERM","dateModified":"2021-04-08","changeNote":"Created for help with AE attribution request. mc 2.17.21 VD/CDE versioned to change VM names. 4.8.21 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7587037","version":"2","preferredName":"Adverse Event Concomitant Medication Attribution Category","preferredDefinition":"Text term representing the causal relationship between a concomitant measure or medication, and the specific adverse event.","longName":"AE_CONMED_ATRB_CAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BF7745B7-7F9B-2544-E053-4EBD850A7FF5","latestVersionIndicator":"Yes","beginDate":"2021-04-08","endDate":null,"createdBy":"COOPERM","dateCreated":"2021-04-08","modifiedBy":"COOPERM","dateModified":"2021-04-08","changeNote":"Created for help with AE attribution request. mc 2.17.21 VD/CDE versioned to change VM names. 4.8.21 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7587038","version":"2","preferredName":"Adverse Event Investigational Medical Device Exemption Attribution Category","preferredDefinition":"Text term representing the causal relationship between an Investigational Device Exemption (IDE) and a specific adverse event.","longName":"AE_IDE_ATRB_CAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BF76FDBC-B88B-4013-E053-4EBD850A230A","latestVersionIndicator":"Yes","beginDate":"2021-04-08","endDate":null,"createdBy":"COOPERM","dateCreated":"2021-04-08","modifiedBy":"COOPERM","dateModified":"2021-04-08","changeNote":"Created for help with AE attribution request. mc 2.17.21 VD/CDE versioned to change VM names. 4.8.21 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7587042","version":"2","preferredName":"Adverse Event Procedure Attribution Category","preferredDefinition":"Text term representing the causal relationship between a procedure and the specific adverse event.","longName":"AE_PROC_ATRB_CAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BF76FDBC-B845-4013-E053-4EBD850A230A","latestVersionIndicator":"Yes","beginDate":"2021-04-08","endDate":null,"createdBy":"COOPERM","dateCreated":"2021-04-08","modifiedBy":"COOPERM","dateModified":"2021-04-08","changeNote":"Created for help with AE attribution request. mc 2.17.21 VD/CDE versioned to change VM names. 4.8.21 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7587043","version":"2","preferredName":"Adverse Event Other Condition Attribution Category","preferredDefinition":"Text term representing the causal relationship between a health condition that is different than the one(s) previously specified or mentioned, and a specific adverse event.","longName":"AE_OTH_COND_ATRB_CAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BF770915-B659-459C-E053-4EBD850AB1D5","latestVersionIndicator":"Yes","beginDate":"2021-04-08","endDate":null,"createdBy":"COOPERM","dateCreated":"2021-04-08","modifiedBy":"COOPERM","dateModified":"2021-04-08","changeNote":"Created for help with AE attribution request. mc 2.17.21 VD/CDE versioned to change VM names. 4.8.21 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7587044","version":"2","preferredName":"Adverse Event Radiation Therapy Attribution Category","preferredDefinition":"Text term representing the causal relationship between radiation therapy and a specific adverse event.","longName":"AE_RT_ATRB_CAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BF770915-B627-459C-E053-4EBD850AB1D5","latestVersionIndicator":"Yes","beginDate":"2021-04-08","endDate":null,"createdBy":"COOPERM","dateCreated":"2021-04-08","modifiedBy":"COOPERM","dateModified":"2021-04-08","changeNote":"Created for help with AE attribution request. mc 2.17.21 VD/CDE versioned to change VM names. 4.8.21 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7587045","version":"2","preferredName":"Adverse Event Clinical Study Procedure Attribution Category","preferredDefinition":"Text term representing the causal relationship between the clinical study procedure and the specific adverse event.","longName":"AE_STD_PROC_ATRB_CAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BF77669B-5CFE-34B8-E053-4EBD850A6DC4","latestVersionIndicator":"Yes","beginDate":"2021-04-08","endDate":null,"createdBy":"COOPERM","dateCreated":"2021-04-08","modifiedBy":"COOPERM","dateModified":"2021-04-08","changeNote":"Created for help with AE attribution request. mc 2.17.21 VD/CDE versioned to change VM names. 4.8.21 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7587181","version":"2","preferredName":"Adverse Event Disease or Disorder Attribution Category","preferredDefinition":"Text term representing the causal relationship between the disease under investigation and a specific adverse event.","longName":"AE_DZ_ATRB_CAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BF7745B7-7F66-2544-E053-4EBD850A7FF5","latestVersionIndicator":"Yes","beginDate":"2021-04-08","endDate":null,"createdBy":"COOPERM","dateCreated":"2021-04-08","modifiedBy":"COOPERM","dateModified":"2021-04-08","changeNote":"Created for help with AE attribution request. mc 2.17.21 VD/CDE versioned to change VM names. 4.8.21 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7587192","version":"2","preferredName":"Adverse Event Medical Device Attribution Category","preferredDefinition":"Text term representing the causal relationship between a medical device and the specific adverse event.","longName":"AE_MED_DVC_ATRB_CAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BF7714AE-3588-5BE2-E053-4EBD850A51B5","latestVersionIndicator":"Yes","beginDate":"2021-04-08","endDate":null,"createdBy":"COOPERM","dateCreated":"2021-04-08","modifiedBy":"COOPERM","dateModified":"2021-04-08","changeNote":"Created for help with AE attribution request. mc 2.17.21 VD/CDE versioned to change VM names. 4.8.21 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7587206","version":"2","preferredName":"Adverse Event Research Attribution Category","preferredDefinition":"Text term representing the causal relationship between a subject's participation in a study, including study-related therapy and procedures, and a specific adverse event.","longName":"AE_RESRCH_ATRB_CAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BF76EAB4-55BD-2378-E053-4EBD850A7E06","latestVersionIndicator":"Yes","beginDate":"2021-04-08","endDate":null,"createdBy":"COOPERM","dateCreated":"2021-04-08","modifiedBy":"COOPERM","dateModified":"2021-04-08","changeNote":"Created for help with AE attribution request. mc 2.17.21 VD/CDE versioned to change VM names. 4.8.21 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7588896","version":"1","preferredName":"Cytogenetic Analysis of Hematologic Neoplasm Summary Result Text","preferredDefinition":"Text to provide a summary results of hematologic neoplasm chromosome analysis.","longName":"CHRM_HEM_SM_RSLT_TXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BC948E49-4D8C-10F3-E053-4EBD850A4FFF","latestVersionIndicator":"Yes","beginDate":"2021-03-02","endDate":null,"createdBy":"COOPERM","dateCreated":"2021-03-02","modifiedBy":"COOPERM","dateModified":"2021-03-10","changeNote":"Created for NCI-INC0560707 - Sent from Snipping Tool 20C0070 request. 2.22.21 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7588903","version":"1","preferredName":"Cytogenetic Analysis of Hematologic Neoplasm Result Interpretation Text","preferredDefinition":"Text to provide an interpretation of hematologic neoplasm chromosome analysis.","longName":"CHRM_HEM_INTRP_TXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BC948E49-4E4B-10F3-E053-4EBD850A4FFF","latestVersionIndicator":"Yes","beginDate":"2021-03-02","endDate":null,"createdBy":"COOPERM","dateCreated":"2021-03-02","modifiedBy":"COOPERM","dateModified":"2021-03-10","changeNote":"Created for NCI-INC0560707 - Sent from Snipping Tool 20C0070 request. 2.22.21 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7588904","version":"1","preferredName":"Cytogenetic Analysis of Hematologic Neoplasm Referral Reason Text","preferredDefinition":"Text to describe the reason for the referral for hematologic neoplasm chromosome analysis.","longName":"CHRM_HEM_REF_RSN_TXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BC948E49-4E81-10F3-E053-4EBD850A4FFF","latestVersionIndicator":"Yes","beginDate":"2021-03-02","endDate":null,"createdBy":"COOPERM","dateCreated":"2021-03-02","modifiedBy":"COOPERM","dateModified":"2021-03-10","changeNote":"Created for NCI-INC0560707 - Sent from Snipping Tool 20C0070 request. 2.22.21 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7588905","version":"1","preferredName":"Cytogenetic Analysis of Hematologic Neoplasm Method Name","preferredDefinition":"Text term representing the name of the method used in the hematologic neoplasm chromosome analysis laboratory test.","longName":"CHRM_LB_METHD_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BC948E49-4EB2-10F3-E053-4EBD850A4FFF","latestVersionIndicator":"Yes","beginDate":"2021-03-02","endDate":null,"createdBy":"COOPERM","dateCreated":"2021-03-02","modifiedBy":"COOPERM","dateModified":"2021-03-10","changeNote":"Created for NCI-INC0560707 - Sent from Snipping Tool 20C0070 request. 2.22.21 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7588906","version":"1","preferredName":"Cytogenetic Analysis of Hematologic Neoplasm Chromosome Band Resolution Value","preferredDefinition":"Numeric representation of the chromosome band pattern resolution obtained in the hematologic neoplasm chromosome analysis testing.","longName":"CHRM_BAND_RESL_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BC948E49-4EE0-10F3-E053-4EBD850A4FFF","latestVersionIndicator":"Yes","beginDate":"2021-03-02","endDate":null,"createdBy":"COOPERM","dateCreated":"2021-03-02","modifiedBy":"COOPERM","dateModified":"2021-03-10","changeNote":"Created for NCI-INC0560707 - Sent from Snipping Tool 20C0070 request. 2.22.21 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7591527","version":"1","preferredName":"Flow Cytometry Peripheral Blood Testing Performed Status","preferredDefinition":"Text representing the status of flow cytometry testing on peripheral blood.","longName":"FLOW_CYTO_BLD_TST_ST","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BCCD470F-9DBC-40A5-E053-4EBD850A7D6D","latestVersionIndicator":"Yes","beginDate":"2021-03-08","endDate":null,"createdBy":"COOPERM","dateCreated":"2021-03-08","modifiedBy":"COOPERM","dateModified":"2021-03-08","changeNote":"Created for NCI-INC0563162-20C0169 CDE migration request. 3/3/2021 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7591532","version":"1","preferredName":"Malignant Lymphocyte Count Bone Marrow Percentage Value","preferredDefinition":"Numeric value in percentage for the count of all lymphocytes as malignant cells.","longName":"MLGNT_LYMPH_PCNT_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BD0933BA-2A4D-72C5-E053-4EBD850A9A1D","latestVersionIndicator":"Yes","beginDate":"2021-03-08","endDate":null,"createdBy":"COOPERM","dateCreated":"2021-03-08","modifiedBy":"COOPERM","dateModified":"2021-03-08","changeNote":"Created for NCI-INC0563162-20C0169 CDE migration request. 3/3/2021 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7611101","version":"1","preferredName":"Metastatic Prostate Cancer Type","preferredDefinition":"Text term representing the kind of metastatic prostate cancer.","longName":"MET_PCA_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BE37A54C-34A0-625A-E053-4EBD850A6C38","latestVersionIndicator":"Yes","beginDate":"2021-03-23","endDate":null,"createdBy":"COOPERM","dateCreated":"2021-03-23","modifiedBy":"COOPERM","dateModified":"2021-03-23","changeNote":"Created for NCI-INC0567536 21C0001 metastatic prostate cancer request. mc 3.23.21","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7639231","version":"1","preferredName":"Solicited Adverse Event Occurrence Indicator","preferredDefinition":"Indicator of whether or not a solicited adverse event was present.","longName":"SOLICIT_AE_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C06B9402-A70A-5277-E053-4EBD850A50DC","latestVersionIndicator":"Yes","beginDate":"2021-04-20","endDate":null,"createdBy":"COOPERM","dateCreated":"2021-04-20","modifiedBy":"COOPERM","dateModified":"2021-04-30","changeNote":"Created for 000115 Solicited AE qn curation request. 4.19.21 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7639627","version":"1","preferredName":"Diffusion Weighted MRI with Background Subtraction Diffusion Restriction Performed Indicator","preferredDefinition":"Indicator of whether or not diffusion weighted magnetic resonance imaging with background subtraction and diffusion restriction was performed.","longName":"DWIBS_PERF_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C082671F-827C-69E9-E053-4EBD850A6E95","latestVersionIndicator":"Yes","beginDate":"2021-04-21","endDate":null,"createdBy":"COOPERM","dateCreated":"2021-04-21","modifiedBy":"COOPERM","dateModified":"2021-05-04","changeNote":"Created for NCI-INC0570307 - FW: Dr. Abdul Sater protocol 21C0007 BEST Trial - C3D Draft Specification Document request 4/5/2021 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7639631","version":"1","preferredName":"Multiphasic Magnetic Resonance Imaging Performed Indicator","preferredDefinition":"Indicator of whether or not multiphase magnetic resonance imaging was performed.","longName":"MPHS_MRI_PERF_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C0838C67-32C4-58A1-E053-4EBD850A359B","latestVersionIndicator":"Yes","beginDate":"2021-04-21","endDate":null,"createdBy":"COOPERM","dateCreated":"2021-04-21","modifiedBy":"COOPERM","dateModified":"2021-05-04","changeNote":"Created for NCI-INC0570307 - FW: Dr. Abdul Sater protocol 21C0007 BEST Trial - C3D Draft Specification Document request 4/5/2021 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7639632","version":"1","preferredName":"Multiphasic Magnetic Resonance Imaging Phase Type","preferredDefinition":"Text term representing the phase used in the multiphase magnetic resonance imaging.","longName":"MPHS_MRI_PHASE_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C082DB7F-F9D5-55F0-E053-4EBD850A4133","latestVersionIndicator":"Yes","beginDate":"2021-04-21","endDate":null,"createdBy":"COOPERM","dateCreated":"2021-04-21","modifiedBy":"COOPERM","dateModified":"2021-05-04","changeNote":"Created for NCI-INC0570307 - FW: Dr. Abdul Sater protocol 21C0007 BEST Trial - C3D Draft Specification Document request 4/5/2021 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7639635","version":"1","preferredName":"Multiphasic Magnetic Resonance Imaging Enhancement Type","preferredDefinition":"Text term representing the kind of enhancement used in the multiphase magnetic resonance imaging.","longName":"MPHS_MRI_ENH_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C0812025-DA08-7D97-E053-4EBD850A51C2","latestVersionIndicator":"Yes","beginDate":"2021-04-21","endDate":null,"createdBy":"COOPERM","dateCreated":"2021-04-21","modifiedBy":"COOPERM","dateModified":"2021-05-04","changeNote":"Created for NCI-INC0570307 - FW: Dr. Abdul Sater protocol 21C0007 BEST Trial - C3D Draft Specification Document request 4/5/2021 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7639712","version":"1","preferredName":"Fever Vital Signs Measurement Performed Indicator","preferredDefinition":"Indicator of whether or not fever vital signs measurement was performed.","longName":"FEV_VSM_PRFMD_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C0871E61-40E7-7D58-E053-4EBD850A128F","latestVersionIndicator":"Yes","beginDate":"2021-04-22","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-04-22","modifiedBy":"KUMMEROA","dateModified":"2021-04-23","changeNote":"Approved and released. 2021-4-23 ak.; Created for NCI-INC0574290 - Reactogenicity Grading Scale Tables 000115. 2021-4-22 ak","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7639713","version":"1","preferredName":"Tachycardia Vital Signs Measurement Performed Indicator","preferredDefinition":"Indicator of whether or not tachycardia vital signs measurement was performed.","longName":"TACHY_VSM_PRFMD_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C08F0CD7-3AFB-525F-E053-4EBD850AD704","latestVersionIndicator":"Yes","beginDate":"2021-04-22","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-04-22","modifiedBy":"KUMMEROA","dateModified":"2021-04-23","changeNote":"Approved and released. 2021-4-23 ak.; Created for NCI-INC0574290 - Reactogenicity Grading Scale Tables 000115. 2021-4-22 ak","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7639714","version":"1","preferredName":"Bradycardia Vital Signs Measurement Performed Indicator","preferredDefinition":"Indicator of whether or not bradycardia vital signs measurement was performed.","longName":"BRADY_VSM_PRFMD_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCI:Charlson Comorbidity Index, Charlson, ME, 1987","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C08F73D9-3BBC-598A-E053-4EBD850A683A","latestVersionIndicator":"Yes","beginDate":"2021-04-22","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-04-22","modifiedBy":"KUMMEROA","dateModified":"2021-04-23","changeNote":"Approved and released. 2021-4-23 ak.; Created for NCI-INC0574290 - Reactogenicity Grading Scale Tables 000115. 2021-4-22 ak","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7639715","version":"1","preferredName":"Systolic Hypertension Vital Signs Measurement Performed Indicator","preferredDefinition":"Indicator of whether or not systolic hypertension vital signs measurement was performed.","longName":"SY_HTN_VSM_PRFMD_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C08F8D1C-6C22-7665-E053-4EBD850A0C58","latestVersionIndicator":"Yes","beginDate":"2021-04-22","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-04-22","modifiedBy":"KUMMEROA","dateModified":"2021-04-23","changeNote":"Approved and released. 2021-4-23 ak.; Created for NCI-INC0574290 - Reactogenicity Grading Scale Tables 000115. 2021-4-22 ak","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7639716","version":"1","preferredName":"Diastolic Hypertension Vital Signs Measurement Performed Indicator","preferredDefinition":"Indicator of whether or not diastolic hypertension vital signs measurement was performed.","longName":"DS_HTN_VSM_PRFMD_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C0876252-3968-5CD6-E053-4EBD850A2617","latestVersionIndicator":"Yes","beginDate":"2021-04-22","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-04-22","modifiedBy":"KUMMEROA","dateModified":"2021-04-23","changeNote":"Approved and released. 2021-4-23 ak.; Created for NCI-INC0574290 - Reactogenicity Grading Scale Tables 000115. 2021-4-22 ak","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7639717","version":"1","preferredName":"Respiratory Rate Vital Signs Measurement Performed Indicator","preferredDefinition":"Indicator of whether or not respiratory rate vital signs measurement was performed.","longName":"RSP_RT_VSM_PRFMD_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C086E7DB-6F37-29F9-E053-4EBD850A4227","latestVersionIndicator":"Yes","beginDate":"2021-04-22","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-04-22","modifiedBy":"KUMMEROA","dateModified":"2021-04-23","changeNote":"Approved and released. 2021-4-23 ak.; Created for NCI-INC0574290 - Reactogenicity Grading Scale Tables 000115. 2021-4-22 ak","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7639766","version":"1","preferredName":"Local Pain Injectable Product-Related Reaction Occurrence Indicator","preferredDefinition":"Indicator of whether or not local pain reaction to the injectable product occurred.","longName":"LC_PN_INJ_RCT_OC_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C091C796-C379-4735-E053-4EBD850A30B6","latestVersionIndicator":"Yes","beginDate":"2021-04-22","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-04-22","modifiedBy":"KUMMEROA","dateModified":"2021-04-23","changeNote":"Approved and released. 2021-4-23 ak.; Created for NCI-INC0574290 - Reactogenicity Grading Scale Tables 000115. 2021-4-22 ak","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7639767","version":"1","preferredName":"Local Tenderness Injectable Product-Related Reaction Occurrence Indicator","preferredDefinition":"Indicator of whether or not local tenderness reaction to the injectable product occurred.","longName":"LC_TN_INJ_RCT_OC_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C09219D4-B823-2C02-E053-4EBD850A2BAE","latestVersionIndicator":"Yes","beginDate":"2021-04-22","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-04-22","modifiedBy":"KUMMEROA","dateModified":"2021-04-23","changeNote":"Approved and released. 2021-4-23 ak.; Created for NCI-INC0574290 - Reactogenicity Grading Scale Tables 000115. 2021-4-22 ak","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7639768","version":"1","preferredName":"Local Erythema/Redness Injectable Product-Related Reaction Occurrence Indicator","preferredDefinition":"Indicator of whether or not local erythema/redness reaction to the injectable product occurred.","longName":"LC_ET_INJ_RCT_OC_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C091ABA9-6715-1D5C-E053-4EBD850ABD42","latestVersionIndicator":"Yes","beginDate":"2021-04-22","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-04-22","modifiedBy":"KUMMEROA","dateModified":"2021-04-23","changeNote":"Approved and released. 2021-4-23 ak.; Created for NCI-INC0574290 - Reactogenicity Grading Scale Tables 000115. 2021-4-22 ak","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7639769","version":"1","preferredName":"Local Induration/Swelling Injectable Product-Related Reaction Occurrence Indicator","preferredDefinition":"Indicator of whether or not local induration/swelling reaction to the injectable product occurred.","longName":"LC_SW_INJ_RCT_OC_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C091ABA9-6743-1D5C-E053-4EBD850ABD42","latestVersionIndicator":"Yes","beginDate":"2021-04-22","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-04-22","modifiedBy":"KUMMEROA","dateModified":"2021-04-23","changeNote":"Approved and released. 2021-4-23 ak.; Created for NCI-INC0574290 - Reactogenicity Grading Scale Tables 000115. 2021-4-22 ak","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7639785","version":"1","preferredName":"Local Pain Injectable Product-Related Reaction Occurrence Reactogenicity Grade","preferredDefinition":"The grade of the severity of local pain associated to the reaction to the injectable product.","longName":"LC_PN_INJ_RCT_OC_GRD","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C091ABA9-68AA-1D5C-E053-4EBD850ABD42","latestVersionIndicator":"Yes","beginDate":"2021-04-22","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-04-22","modifiedBy":"KUMMEROA","dateModified":"2021-04-23","changeNote":"Approved and released. 2021-4-23 ak.; Created for NCI-INC0574290 - Reactogenicity Grading Scale Tables 000115. 2021-4-22 ak","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7639789","version":"1","preferredName":"Local Tenderness Injectable Product-Related Reaction Occurrence Reactogenicity Grade","preferredDefinition":"The grade of the severity of local tenderness associated to the reaction to the injectable product.","longName":"LC_TN_INJ_RCT_OC_GRD","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C092F70A-7EB1-5536-E053-4EBD850A759A","latestVersionIndicator":"Yes","beginDate":"2021-04-22","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-04-22","modifiedBy":"KUMMEROA","dateModified":"2021-04-23","changeNote":"Approved and released. 2021-4-23 ak.; Created for NCI-INC0574290 - Reactogenicity Grading Scale Tables 000115. 2021-4-22 ak","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7639791","version":"1","preferredName":"Local Erythema/Redness Injectable Product-Related Reaction Occurrence Reactogenicity Grade","preferredDefinition":"The grade of the severity of local erythema/redness associated to the reaction to the injectable product.","longName":"LC_ET_INJ_RCT_OC_GRD","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C09329E7-7EC7-305B-E053-4EBD850A5435","latestVersionIndicator":"Yes","beginDate":"2021-04-22","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-04-22","modifiedBy":"KUMMEROA","dateModified":"2021-04-23","changeNote":"Approved and released. 2021-4-23 ak.; Created for NCI-INC0574290 - Reactogenicity Grading Scale Tables 000115. 2021-4-22 ak","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7639797","version":"1","preferredName":"Local Induration/Swelling Injectable Product-Related Reaction Occurrence Reactogenicity Grade","preferredDefinition":"The grade of the severity of local induration/swelling associated to the reaction to the injectable product.","longName":"LC_SW_INJ_RCT_OC_GRD","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C0932074-0A45-277E-E053-4EBD850A0E31","latestVersionIndicator":"Yes","beginDate":"2021-04-22","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-04-22","modifiedBy":"KUMMEROA","dateModified":"2021-04-23","changeNote":"Approved and released. 2021-4-23 ak.; Created for NCI-INC0574290 - Reactogenicity Grading Scale Tables 000115. 2021-4-22 ak","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7639802","version":"1","preferredName":"Local Erythema/Redness Injectable Product-Related Reaction Occurrence Measurement Centimeter Value","preferredDefinition":"Numeric centimeter value to represent the measurement of the local erythema/redness associated to the reaction to the injectable product.","longName":"LC_ET_INJ_RCT_OC_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C0935BCA-338B-7A09-E053-4EBD850AF271","latestVersionIndicator":"Yes","beginDate":"2021-04-22","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-04-22","modifiedBy":"KUMMEROA","dateModified":"2021-04-23","changeNote":"Approved and released. 2021-4-23 ak.; Created for NCI-INC0574290 - Reactogenicity Grading Scale Tables 000115. 2021-4-22 ak","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7639803","version":"1","preferredName":"Local Induration/Swelling Injectable Product-Related Reaction Occurrence Measurement Centimeter Value","preferredDefinition":"Numeric centimeter value to represent the measurement of the local induration/swelling associated to the reaction to the injectable product.","longName":"LC_SW_INJ_RCT_OC_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C09370E4-9FD2-1530-E053-4EBD850A461A","latestVersionIndicator":"Yes","beginDate":"2021-04-22","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-04-22","modifiedBy":"KUMMEROA","dateModified":"2021-04-23","changeNote":"Approved and released. 2021-4-23 ak.; Created for NCI-INC0574290 - Reactogenicity Grading Scale Tables 000115. 2021-4-22 ak","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7639810","version":"1","preferredName":"Systolic Hypotension Vital Signs Measurement Performed Indicator","preferredDefinition":"Indicator of whether or not systolic hypotension vital signs measurement was performed.","longName":"SY_HOTN_VS_PRFMD_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C093A759-EA42-16CA-E053-4EBD850A03B7","latestVersionIndicator":"Yes","beginDate":"2021-04-22","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-04-22","modifiedBy":"KUMMEROA","dateModified":"2021-04-23","changeNote":"Approved and released. 2021-4-23 ak.; Created for NCI-INC0574290 - Reactogenicity Grading Scale Tables 000115. 2021-4-22 ak","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7639978","version":"1","preferredName":"Diastolic Hypotension Vital Signs Measurement Performed Indicator","preferredDefinition":"Indicator of whether or not diastolic hypotension vital signs measurement was performed.","longName":"DS_HOTN_VS_PRFMD_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C0935BCA-33B9-7A09-E053-4EBD850AF271","latestVersionIndicator":"Yes","beginDate":"2021-04-22","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-04-22","modifiedBy":"KUMMEROA","dateModified":"2021-04-23","changeNote":"Approved and released. 2021-4-23 ak.; Created for NCI-INC0574290 - Reactogenicity Grading Scale Tables 000115. 2021-4-22 ak","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7640022","version":"1","preferredName":"Fever Vital Signs Measurement Performed Reactogenicity Grade","preferredDefinition":"The grade of the severity of fever associated to the vital signs measurement.","longName":"FEV_VSM_REACT_GRD","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C0940822-3410-239A-E053-4EBD850A5A30","latestVersionIndicator":"Yes","beginDate":"2021-04-22","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-04-22","modifiedBy":"KUMMEROA","dateModified":"2021-04-23","changeNote":"Approved and released. 2021-4-23 ak.; Created for NCI-INC0574290 - Reactogenicity Grading Scale Tables 000115. 2021-4-22 ak","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7640028","version":"1","preferredName":"Tachycardia Vital Signs Measurement Performed Reactogenicity Grade","preferredDefinition":"The grade of the severity of tachycardia associated to the vital signs measurement.","longName":"TACHY_VSM_REACT_GRD","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C093BEFD-7EF9-1945-E053-4EBD850A2CE2","latestVersionIndicator":"Yes","beginDate":"2021-04-22","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-04-22","modifiedBy":"KUMMEROA","dateModified":"2021-04-23","changeNote":"Approved and released. 2021-4-23 ak.; Created for NCI-INC0574290 - Reactogenicity Grading Scale Tables 000115. 2021-4-22 ak","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7640034","version":"1","preferredName":"Bradycardia Vital Signs Measurement Performed Reactogenicity Grade","preferredDefinition":"The grade of the severity of bradycardia associated to the vital signs measurement.","longName":"BRADY_VSM_REACT_GRD","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C093A759-EA70-16CA-E053-4EBD850A03B7","latestVersionIndicator":"Yes","beginDate":"2021-04-22","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-04-22","modifiedBy":"HARTLEYG","dateModified":"2021-04-23","changeNote":"Approved and released. 2021-4-23 ak.; Created for NCI-INC0574290 - Reactogenicity Grading Scale Tables 000115. 2021-4-22 ak","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7640038","version":"1","preferredName":"Systolic Hypertension Vital Signs Measurement Performed Reactogenicity Grade","preferredDefinition":"The grade of the severity of systolic hypertension associated to the vital signs measurement.","longName":"SY_HTN_VSM_REACT_GRD","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C0944C31-7057-2A9F-E053-4EBD850A38C4","latestVersionIndicator":"Yes","beginDate":"2021-04-22","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-04-22","modifiedBy":"KUMMEROA","dateModified":"2021-04-23","changeNote":"Approved and released. 2021-4-23 ak.; Created for NCI-INC0574290 - Reactogenicity Grading Scale Tables 000115. 2021-4-22 ak","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7640040","version":"1","preferredName":"Diastolic Hypertension Vital Signs Measurement Performed Reactogenicity Grade","preferredDefinition":"The grade of the severity of diastolic hypertension associated to the vital signs measurement.","longName":"DS_HTN_VSM_REACT_GRD","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C0935BCA-33E7-7A09-E053-4EBD850AF271","latestVersionIndicator":"Yes","beginDate":"2021-04-22","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-04-22","modifiedBy":"KUMMEROA","dateModified":"2021-04-23","changeNote":"Approved and released. 2021-4-23 ak.; Created for NCI-INC0574290 - Reactogenicity Grading Scale Tables 000115. 2021-4-22 ak","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7640041","version":"1","preferredName":"Systolic Hypotension Vital Signs Measurement Performed Reactogenicity Grade","preferredDefinition":"The grade of the severity of systolic hypotension associated to the vital signs measurement.","longName":"SY_HOTN_VS_REACT_GRD","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C0940822-343E-239A-E053-4EBD850A5A30","latestVersionIndicator":"Yes","beginDate":"2021-04-22","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-04-22","modifiedBy":"KUMMEROA","dateModified":"2021-04-23","changeNote":"Approved and released. 2021-4-23 ak.; Created for NCI-INC0574290 - Reactogenicity Grading Scale Tables 000115. 2021-4-22 ak","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7640042","version":"1","preferredName":"Diastolic Hypotension Vital Signs Measurement Performed Reactogenicity Grade","preferredDefinition":"The grade of the severity of diastolic hypotension associated to the vital signs measurement.","longName":"DS_HOTN_VS_REACT_GRD","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C09329E7-7EFA-305B-E053-4EBD850A5435","latestVersionIndicator":"Yes","beginDate":"2021-04-22","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-04-22","modifiedBy":"KUMMEROA","dateModified":"2021-04-23","changeNote":"Approved and released. 2021-4-23 ak.; Created for NCI-INC0574290 - Reactogenicity Grading Scale Tables 000115. 2021-4-22 ak","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7640046","version":"1","preferredName":"Respiratory Rate Vital Signs Measurement Performed Reactogenicity Grade","preferredDefinition":"The grade of the severity of respiratory rate associated to the vital signs measurement.","longName":"RSP_RT_VSM_REACT_GRD","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C09329E7-7F28-305B-E053-4EBD850A5435","latestVersionIndicator":"Yes","beginDate":"2021-04-22","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-04-22","modifiedBy":"KUMMEROA","dateModified":"2021-04-23","changeNote":"Approved and released. 2021-4-23 ak.; Created for NCI-INC0574290 - Reactogenicity Grading Scale Tables 000115. 2021-4-22 ak","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7642139","version":"1","preferredName":"Nausea Or Vomiting Sign or Symptom Occurrence Indicator","preferredDefinition":"Indicator of whether or not nausea or vomiting occurred.","longName":"NAU_VOM_OCC_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C0E01527-ED78-67AF-E053-4EBD850A27BE","latestVersionIndicator":"Yes","beginDate":"2021-04-26","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-04-26","modifiedBy":"KUMMEROA","dateModified":"2021-04-26","changeNote":"Created for NCI-INC0574290 - Reactogenicity Grading Scale Tables 000115. 2021-4-26 ak","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7642140","version":"1","preferredName":"Diarrhea Sign or Symptom Occurrence Indicator","preferredDefinition":"Indicator of whether or not diarrhea occurred.","longName":"DIARR_OCC_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C0E01527-EDA6-67AF-E053-4EBD850A27BE","latestVersionIndicator":"Yes","beginDate":"2021-04-26","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-04-26","modifiedBy":"KUMMEROA","dateModified":"2021-04-26","changeNote":"Created for NCI-INC0574290 - Reactogenicity Grading Scale Tables 000115. 2021-4-26 ak","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7642141","version":"1","preferredName":"Headache Sign or Symptom Occurrence Indicator","preferredDefinition":"Indicator of whether or not headaches occurred.","longName":"HDACH_OCC_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C0E036BA-59E2-2D5D-E053-4EBD850ACB44","latestVersionIndicator":"Yes","beginDate":"2021-04-26","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-04-26","modifiedBy":"KUMMEROA","dateModified":"2021-04-26","changeNote":"Created for NCI-INC0574290 - Reactogenicity Grading Scale Tables 000115. 2021-4-26 ak","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7642142","version":"1","preferredName":"Fatigue Sign or Symptom Occurrence Indicator","preferredDefinition":"Indicator of whether or not fatigue occurred.","longName":"FTGU_OCC_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C0E00147-A47A-67A9-E053-4EBD850A4B44","latestVersionIndicator":"Yes","beginDate":"2021-04-26","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-04-26","modifiedBy":"KUMMEROA","dateModified":"2021-04-26","changeNote":"Created for NCI-INC0574290 - Reactogenicity Grading Scale Tables 000115. 2021-4-26 ak","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7642144","version":"1","preferredName":"Myalgia Sign or Symptom Occurrence Indicator","preferredDefinition":"Indicator of whether or not myalgia occurred.","longName":"MYLG_OCC_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C0E00147-A4A8-67A9-E053-4EBD850A4B44","latestVersionIndicator":"Yes","beginDate":"2021-04-26","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-04-26","modifiedBy":"KUMMEROA","dateModified":"2021-04-26","changeNote":"Created for NCI-INC0574290 - Reactogenicity Grading Scale Tables 000115. 2021-4-26 ak","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7642145","version":"1","preferredName":"Sickness Or Clinical Adverse Event Sign or Symptom Occurrence Indicator","preferredDefinition":"Indicator of whether or not sickness of clinical adverse events occurred.","longName":"SCK_CLN_AE_OCC_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C0E06EF3-7663-148E-E053-4EBD850AD929","latestVersionIndicator":"Yes","beginDate":"2021-04-26","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-04-26","modifiedBy":"KUMMEROA","dateModified":"2021-04-26","changeNote":"Created for NCI-INC0574290 - Reactogenicity Grading Scale Tables 000115. 2021-4-26 ak","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7642146","version":"1","preferredName":"Nausea Or Vomiting Sign or Symptom Occurrence Reactogenicity Grade","preferredDefinition":"The grade of the severity of nausea or vomiting.","longName":"NAU_VOM_REACT_GRD","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C0DFD5FF-2181-0F5E-E053-4EBD850A89C5","latestVersionIndicator":"Yes","beginDate":"2021-04-26","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-04-26","modifiedBy":"KUMMEROA","dateModified":"2021-04-26","changeNote":"Created for NCI-INC0574290 - Reactogenicity Grading Scale Tables 000115. 2021-4-26 ak","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7642147","version":"1","preferredName":"Diarrhea Sign or Symptom Occurrence Reactogenicity Grade","preferredDefinition":"The grade of the severity of diarrhea.","longName":"DIARR_REACT_GRD","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C0DFDE1C-D82C-2FFE-E053-4EBD850A25ED","latestVersionIndicator":"Yes","beginDate":"2021-04-26","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-04-26","modifiedBy":"KUMMEROA","dateModified":"2021-04-26","changeNote":"Created for NCI-INC0574290 - Reactogenicity Grading Scale Tables 000115. 2021-4-26 ak","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7642148","version":"1","preferredName":"Headache Sign or Symptom Occurrence Reactogenicity Grade","preferredDefinition":"The grade of the severity of headaches.","longName":"HDACH_REACT_GRD","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C0DFEEB9-8F12-5137-E053-4EBD850A8513","latestVersionIndicator":"Yes","beginDate":"2021-04-26","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-04-26","modifiedBy":"KUMMEROA","dateModified":"2021-04-26","changeNote":"Created for NCI-INC0574290 - Reactogenicity Grading Scale Tables 000115. 2021-4-26 ak","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7642149","version":"1","preferredName":"Fatigue Sign or Symptom Occurrence Reactogenicity Grade","preferredDefinition":"The grade of the severity of fatigue.","longName":"FTGU_REACT_GRD","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C0DFE825-398B-3834-E053-4EBD850ACF2C","latestVersionIndicator":"Yes","beginDate":"2021-04-26","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-04-26","modifiedBy":"KUMMEROA","dateModified":"2021-04-26","changeNote":"Created for NCI-INC0574290 - Reactogenicity Grading Scale Tables 000115. 2021-4-26 ak","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7642150","version":"1","preferredName":"Myalgia Sign or Symptom Occurrence Reactogenicity Grade","preferredDefinition":"The grade of the severity of myalgia.","longName":"MYLG_REACT_GRD","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C0DFDE1C-D85A-2FFE-E053-4EBD850A25ED","latestVersionIndicator":"Yes","beginDate":"2021-04-26","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-04-26","modifiedBy":"KUMMEROA","dateModified":"2021-04-26","changeNote":"Created for NCI-INC0574290 - Reactogenicity Grading Scale Tables 000115. 2021-4-26 ak","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7642151","version":"1","preferredName":"Sickness Or Clinical Adverse Event Sign or Symptom Occurrence Reactogenicity Grade","preferredDefinition":"The grade of the severity of sickness or clinical adverse event.","longName":"SCK_CLN_AE_REACT_GRD","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C0DFE825-39B9-3834-E053-4EBD850ACF2C","latestVersionIndicator":"Yes","beginDate":"2021-04-26","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-04-26","modifiedBy":"KUMMEROA","dateModified":"2021-04-26","changeNote":"Created for NCI-INC0574290 - Reactogenicity Grading Scale Tables 000115. 2021-4-26 ak","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7671016","version":"1","preferredName":"Arthralgia Occurrence Indicator","preferredDefinition":"Indicator of whether or not arthralgia occurred.","longName":"ARTHRLG_OCR_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C341B5EA-4F95-0334-E053-4EBD850AF01B","latestVersionIndicator":"Yes","beginDate":"2021-05-26","endDate":null,"createdBy":"COOPERM","dateCreated":"2021-05-26","modifiedBy":"COOPERM","dateModified":"2021-05-27","changeNote":"Created for NCI-INC0582796 - Reactogenicity Grading Scale Tables 000115 additions request. mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7671017","version":"1","preferredName":"Chills Occurrence Indicator","preferredDefinition":"Indicator of whether or not chills occurred.","longName":"CHILL_OCR_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C341B5EA-4FC3-0334-E053-4EBD850AF01B","latestVersionIndicator":"Yes","beginDate":"2021-05-26","endDate":null,"createdBy":"COOPERM","dateCreated":"2021-05-26","modifiedBy":"COOPERM","dateModified":"2021-05-27","changeNote":"Created for NCI-INC0582796 - Reactogenicity Grading Scale Tables 000115 additions request. mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7671018","version":"1","preferredName":"Arthralgia Occurrence Reactogenicity Grade","preferredDefinition":"The grade of the severity of arthralgia associated to reactogenicity.","longName":"ARTHRLG_REACT_GRD","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C341B5EA-4FF1-0334-E053-4EBD850AF01B","latestVersionIndicator":"Yes","beginDate":"2021-05-26","endDate":null,"createdBy":"COOPERM","dateCreated":"2021-05-26","modifiedBy":"COOPERM","dateModified":"2021-05-27","changeNote":"Created for NCI-INC0582796 - Reactogenicity Grading Scale Tables 000115 additions request. mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7671019","version":"1","preferredName":"Chills Occurrence Reactogenicity Grade","preferredDefinition":"The grade of the severity of chills associated to reactogenicity.","longName":"CHILL_REACT_GRD","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C341B5EA-501F-0334-E053-4EBD850AF01B","latestVersionIndicator":"Yes","beginDate":"2021-05-26","endDate":null,"createdBy":"COOPERM","dateCreated":"2021-05-26","modifiedBy":"COOPERM","dateModified":"2021-05-27","changeNote":"Created for NCI-INC0582796 - Reactogenicity Grading Scale Tables 000115 additions request. mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7715608","version":"1","preferredName":"Human Immunodeficiency Virus Viral Load Enrollment Result Value","preferredDefinition":"Number to represent the numeric value for a human immunodeficiency virus viral load (the number of HIV viral particles in a sample of blood plasma) assay performed on an individual at the time of enrollment.","longName":"HIV_VRLD_ENR_RSL_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C5D7B963-879F-6F71-E053-4EBD850AFEF8","latestVersionIndicator":"Yes","beginDate":"2021-06-28","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2021-06-28","modifiedBy":"HARTLEYG","dateModified":"2021-06-28","changeNote":"Curated to support 21C0026_06.28.21_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7715612","version":"1","preferredName":"Oral Lesion Present Other Location Descriptive Short Text","preferredDefinition":"Text description of another anatomic location for an oral lesion not already specified.","longName":"ORAL_LESN_OTHR_AN_ST","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C5D7D4B7-6E23-708B-E053-4EBD850A8045","latestVersionIndicator":"Yes","beginDate":"2021-06-28","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2021-06-28","modifiedBy":"HARTLEYG","dateModified":"2021-06-28","changeNote":"Created for 21C0026_06.28.21_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7781976","version":"1","preferredName":"Weight Loss Past Year Occurrence Indicator","preferredDefinition":"The indicator of whether or not, in the past year, an individual has lost weight.","longName":"WT_LS_PST_YR_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CBF4D9B6-3522-514A-E053-4EBD850A8AD4","latestVersionIndicator":"Yes","beginDate":"2021-09-14","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-09-14","modifiedBy":"KUMMEROA","dateModified":"2021-09-30","changeNote":"2021-9-14 ak Created for Protocol 00359.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7781978","version":"1","preferredName":"Weight Change Past Year Occurrence Indicator","preferredDefinition":"The indicator of whether, in the past year, an individual tried to lose/gain weight.","longName":"WT_CHNG_PST_YR_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CBF4C953-9F7C-2FDD-E053-4EBD850A6F7C","latestVersionIndicator":"Yes","beginDate":"2021-09-14","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-09-14","modifiedBy":"KUMMEROA","dateModified":"2021-09-30","changeNote":"2021-9-14 ak Created for Protocol 00359.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7781982","version":"1","preferredName":"Montreal Cognitive Assessment Version 7.1 Visuospatial/Executive Test Score","preferredDefinition":"The score of the Visuospatial/Executive test.","longName":"MOCA_VISPAC_V7_1_SCR","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"MoCA:Montreal Cognitive Assessment; Z.S.Nasreddine et al., J AM Geriatric Society (2005)","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CBF49E17-B598-394B-E053-4EBD850A5119","latestVersionIndicator":"Yes","beginDate":"2021-09-14","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-09-14","modifiedBy":"KUMMEROA","dateModified":"2021-11-30","changeNote":"2021-9-14 ak Created for Protocol 00359.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7781984","version":"1","preferredName":"Montreal Cognitive Assessment Version 7.1 Naming Test Score","preferredDefinition":"The score of the Naming test.","longName":"MOCA_NAMING_V7_1_SCR","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"MoCA:Montreal Cognitive Assessment; Z.S.Nasreddine et al., J AM Geriatric Society (2005)","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CBF4C953-9FAA-2FDD-E053-4EBD850A6F7C","latestVersionIndicator":"Yes","beginDate":"2021-09-14","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-09-14","modifiedBy":"KUMMEROA","dateModified":"2021-11-30","changeNote":"2021-9-14 ak Created for Protocol 00359.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7781985","version":"1","preferredName":"Montreal Cognitive Assessment Version 7.1 Attention - Digits Test Score","preferredDefinition":"The score of the Attention - Digits test","longName":"MOCA_ATTN_D_V7_1_SCR","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"MoCA:Montreal Cognitive Assessment; Z.S.Nasreddine et al., J AM Geriatric Society (2005)","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CBF7DE34-A06B-21D8-E053-4EBD850A2759","latestVersionIndicator":"Yes","beginDate":"2021-09-14","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-09-14","modifiedBy":"KUMMEROA","dateModified":"2021-11-30","changeNote":"2021-9-14 ak Created for Protocol 00359.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7781986","version":"1","preferredName":"Montreal Cognitive Assessment Version 7.1 Attention - Letters Test Score","preferredDefinition":"The score of the Attention - Letters test.","longName":"MOCA_ATTN_L_V7_1_SCR","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"MoCA:Montreal Cognitive Assessment; Z.S.Nasreddine et al., J AM Geriatric Society (2005)","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CBF4B271-DCC6-0731-E053-4EBD850A2189","latestVersionIndicator":"Yes","beginDate":"2021-09-14","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-09-14","modifiedBy":"KUMMEROA","dateModified":"2021-11-30","changeNote":"2021-9-14 ak Created for Protocol 00359.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7781987","version":"1","preferredName":"Montreal Cognitive Assessment Version 7.1 Attention - Subtraction Test Score","preferredDefinition":"The score of the Attention - Subtraction test.","longName":"MOCA_ATTN_S_V7_1_SCR","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"MoCA:Montreal Cognitive Assessment; Z.S.Nasreddine et al., J AM Geriatric Society (2005)","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CBF7ED9C-2D31-4D3B-E053-4EBD850ADDC9","latestVersionIndicator":"Yes","beginDate":"2021-09-14","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-09-14","modifiedBy":"KUMMEROA","dateModified":"2021-11-30","changeNote":"2021-9-14 ak Created for Protocol 00359.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7781988","version":"1","preferredName":"Montreal Cognitive Assessment Version 7.1 Language - Repeat Test Score","preferredDefinition":"The score of the Language - Repeat test.","longName":"MOCA_LANG_R_V7_1_SCR","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"MoCA:Montreal Cognitive Assessment; Z.S.Nasreddine et al., J AM Geriatric Society (2005)","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CBF7ED9C-2D5E-4D3B-E053-4EBD850ADDC9","latestVersionIndicator":"Yes","beginDate":"2021-09-14","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-09-14","modifiedBy":"KUMMEROA","dateModified":"2021-11-30","changeNote":"2021-9-14 ak Created for Protocol 00359.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7781989","version":"1","preferredName":"Montreal Cognitive Assessment Version 7.1 Language - Fluency Test Score","preferredDefinition":"The score of the Language - Fluency test.","longName":"MOCA_LANG_F_V7_1_SCR","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"MoCA:Montreal Cognitive Assessment; Z.S.Nasreddine et al., J AM Geriatric Society (2005)","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CBF43096-105E-0727-E053-4EBD850AD10F","latestVersionIndicator":"Yes","beginDate":"2021-09-14","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-09-14","modifiedBy":"KUMMEROA","dateModified":"2021-11-30","changeNote":"2021-9-14 ak Created for Protocol 00359.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7781990","version":"1","preferredName":"Montreal Cognitive Assessment Version 7.1 Abstraction Test Score","preferredDefinition":"The score of the Abstraction test.","longName":"MOCA_ABSTRC_V7_1_SCR","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"MoCA:Montreal Cognitive Assessment; Z.S.Nasreddine et al., J AM Geriatric Society (2005)","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CBF804DD-8ECA-2FEB-E053-4EBD850A290A","latestVersionIndicator":"Yes","beginDate":"2021-09-14","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-09-14","modifiedBy":"KUMMEROA","dateModified":"2021-11-30","changeNote":"2021-9-14 ak Created for Protocol 00329.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7781991","version":"1","preferredName":"Montreal Cognitive Assessment Version 7.1 Orientation Test Score","preferredDefinition":"The score of the Orientation test.","longName":"MOCA_ORIENT_V7_1_SCR","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"MoCA:Montreal Cognitive Assessment; Z.S.Nasreddine et al., J AM Geriatric Society (2005)","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CBF49E17-B5C6-394B-E053-4EBD850A5119","latestVersionIndicator":"Yes","beginDate":"2021-09-14","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-09-14","modifiedBy":"KUMMEROA","dateModified":"2021-11-30","changeNote":"2021-9-14 ak Created for Protocol 003259.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7784400","version":"1","preferredName":"Johns Hopkins Frailty Assessment Calculator Past 30 Days Average Amount Have Felt Unusually Tired During the Day Indicator","preferredDefinition":"A person's stated response, over the past month, on average, of how they have been feeling unusually tired during the day.","longName":"JHFAC_TIRED_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CC09D53A-FAE0-282C-E053-4EBD850AAC52","latestVersionIndicator":"Yes","beginDate":"2021-09-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-09-15","modifiedBy":"KUMMEROA","dateModified":"2021-09-30","changeNote":"2021-9-15 ak Created for Protocol 00359.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7784404","version":"1","preferredName":"Johns Hopkins Frailty Assessment Calculator Past 30 Days Average Amount Have Felt Unusually Tired During the Day Indicator Scale","preferredDefinition":"A person's stated response, over the past month, on average, of how they have been feeling unusually tired during the day, using a 5 point Likert scale.","longName":"JHFAC_TIRED_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CC0E2BA3-7FCA-4610-E053-4EBD850A81AE","latestVersionIndicator":"Yes","beginDate":"2021-09-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-09-15","modifiedBy":"KUMMEROA","dateModified":"2021-09-30","changeNote":"2021-9-15 ak Created for Protocol 00359.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7784425","version":"1","preferredName":"Johns Hopkins Frailty Assessment Calculator Past 30 Days Average Amount Have Felt Unusually Weak Indicator","preferredDefinition":"A person's stated response, over the past month, on average, of how they have been feeling unusually weak.","longName":"JHFAC_WEAK_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CC09B468-8516-70D3-E053-4EBD850AB071","latestVersionIndicator":"Yes","beginDate":"2021-09-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-09-15","modifiedBy":"KUMMEROA","dateModified":"2021-09-30","changeNote":"2021-9-15 ak Created for Protocol 00359.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7784426","version":"1","preferredName":"Johns Hopkins Frailty Assessment Calculator Past 30 Days Average Amount Have Felt Unusually Weak Indicator Scale","preferredDefinition":"A person's stated response, over the past month, on average, of how they have been feeling unusually weak, using a 5 point Likert scale.","longName":"JHFAC_WEAK_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CC0E8F7E-8C01-1772-E053-4EBD850A41AD","latestVersionIndicator":"Yes","beginDate":"2021-09-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-09-15","modifiedBy":"KUMMEROA","dateModified":"2021-09-30","changeNote":"2021-9-15 ak Created for Protocol 00359.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7784430","version":"1","preferredName":"Johns Hopkins Frailty Assessment Calculator Past 30 Days Usual Energy While Awake Score 11 Point  Visual Analog Scale","preferredDefinition":"A person's stated response, over the past month of their usual energy level while awake, using an 11 point visual analog scale.","longName":"JHFAC_ENG_LV_11P_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CC0EB31C-6FA5-529E-E053-4EBD850A6A81","latestVersionIndicator":"Yes","beginDate":"2021-09-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-09-15","modifiedBy":"KUMMEROA","dateModified":"2021-09-30","changeNote":"2021-9-15 ak Created for Protocol 00359.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7784435","version":"1","preferredName":"Johns Hopkins Frailty Assessment Calculator During Past 2 Weeks Walked for Exercise Indicator","preferredDefinition":"A person's stated response, during the past two weeks, whether they have walked for exercise.","longName":"JHFAC_WALK_EXCSE_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CC0ECE61-96B8-39C9-E053-4EBD850A655C","latestVersionIndicator":"Yes","beginDate":"2021-09-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-09-15","modifiedBy":"KUMMEROA","dateModified":"2021-09-30","changeNote":"2021-9-15 ak Created for Protocol 00359.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7784436","version":"1","preferredName":"Johns Hopkins Frailty Assessment Calculator During Past 2 Weeks Walked for Exercise Indicator How Often Specify","preferredDefinition":"A person's stated response, during the past two weeks, of how often they have walked for exercise.","longName":"JHFAC_WALK_EXCSE_SP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CC09D53A-FB0E-282C-E053-4EBD850AAC52","latestVersionIndicator":"Yes","beginDate":"2021-09-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-09-15","modifiedBy":"KUMMEROA","dateModified":"2021-09-30","changeNote":"2021-9-15 ak Created for Protocol 00359.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7784437","version":"1","preferredName":"Johns Hopkins Frailty Assessment Calculator During Past Two Weeks Walked For Exercise Indicator Average  Hours Time","preferredDefinition":"A person's stated response, during the past two weeks, of the average amount of hours they have walked for exercise.","longName":"JHFAC_WALK_EXCSE_HRS","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CC0E2BA3-7FF8-4610-E053-4EBD850A81AE","latestVersionIndicator":"Yes","beginDate":"2021-09-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-09-15","modifiedBy":"KUMMEROA","dateModified":"2021-09-30","changeNote":"2021-9-15 ak Created for Protocol 00359.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7784438","version":"1","preferredName":"Johns Hopkins Frailty Assessment Calculator During Past 2 Weeks Walked for Exercise Indicator Average Minute Time","preferredDefinition":"A person's stated response, during the past two weeks, of the average amount of minutes they have walked for exercise.","longName":"JHFAC_WALK_EXCSE_MIN","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CC09D53A-FB3C-282C-E053-4EBD850AAC52","latestVersionIndicator":"Yes","beginDate":"2021-09-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-09-15","modifiedBy":"KUMMEROA","dateModified":"2021-09-30","changeNote":"2021-9-15 ak Created for Protocol 00359.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7784439","version":"1","preferredName":"Johns Hopkins Frailty Assessment Calculator During Past 2 Weeks Walked for Exercise Indicator Monthly Frequency","preferredDefinition":"A person's stated response, during the past two weeks, of the frequency of months per year they have walked for exercise.","longName":"JHFAC_WALK_EXCSE_MTH","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CC0E9FB0-DF76-579A-E053-4EBD850A1D8B","latestVersionIndicator":"Yes","beginDate":"2021-09-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-09-15","modifiedBy":"KUMMEROA","dateModified":"2021-09-30","changeNote":"2021-9-15 ak Created for Protocol 00359.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7784476","version":"1","preferredName":"Johns Hopkins Frailty Assessment Calculator During Past 2 Weeks Have Done Moderately Strenuous Household Chores Indicator","preferredDefinition":"A person's stated response, during the past two weeks, whether they have done moderately strenuous household chores, like scrubbing and vacuuming.","longName":"JHFAC_MD_STN_CHR_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CC0F5AD8-5F40-67F0-E053-4EBD850A1787","latestVersionIndicator":"Yes","beginDate":"2021-09-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-09-15","modifiedBy":"KUMMEROA","dateModified":"2021-09-30","changeNote":"2021-9-15 ak Created for Protocol 00359.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7784477","version":"1","preferredName":"Johns Hopkins Frailty Assessment Calculator During Past 2 Weeks Have Done Moderately Strenuous Household Chores Indicator How Often Specify","preferredDefinition":"A person's stated response, during the past two weeks, of how often they have done moderately strenuous household chores, like scrubbing and vacuuming.","longName":"JHFAC_MD_STN_CHR_SP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CC0A73E3-35E1-5652-E053-4EBD850ACFAB","latestVersionIndicator":"Yes","beginDate":"2021-09-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-09-15","modifiedBy":"KUMMEROA","dateModified":"2021-09-30","changeNote":"2021-9-15 ak Created for Protocol 00359.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7784478","version":"1","preferredName":"Johns Hopkins Frailty Assessment Calculator During Past 2 Weeks Have Done Moderately Strenuous Household Chores Indicator Average Hour Time","preferredDefinition":"A person's stated response, during the past two weeks, of the average amount of hours they have done moderately strenuous household chores, like scrubbing and vacuuming.","longName":"JHFAC_MD_STN_CHR_HRS","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CC0F7B52-18E7-57F1-E053-4EBD850A97F7","latestVersionIndicator":"Yes","beginDate":"2021-09-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-09-15","modifiedBy":"KUMMEROA","dateModified":"2021-09-30","changeNote":"2021-9-15 ak Created for Protocol 00359.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7784479","version":"1","preferredName":"Johns Hopkins Frailty Assessment Calculator During Past 2 Weeks Have Done Moderately Strenuous Household Chores Indicator Average Minute Time","preferredDefinition":"A person's stated response, during the past two weeks, of the average amount of minutes they have done moderately strenuous household chores, like scrubbing and vacuuming.","longName":"JHFAC_MD_STN_CHR_MIN","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CC09D53A-FB8E-282C-E053-4EBD850AAC52","latestVersionIndicator":"Yes","beginDate":"2021-09-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-09-15","modifiedBy":"KUMMEROA","dateModified":"2021-09-30","changeNote":"2021-9-15 ak Created for Protocol 00359.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7784480","version":"1","preferredName":"Johns Hopkins Frailty Assessment Calculator During Past 2 Weeks Have Done Moderately Strenuous Household Chores Indicator Monthly Frequency","preferredDefinition":"A person's stated response, during the past two weeks, of the frequency of months per year they have done moderately strenuous household chores, like scrubbing and vacuuming.","longName":"JHFAC_MD_STN_CHR_MTH","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CC0F907C-4AF2-3543-E053-4EBD850A46D3","latestVersionIndicator":"Yes","beginDate":"2021-09-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-09-15","modifiedBy":"KUMMEROA","dateModified":"2021-09-30","changeNote":"2021-9-15 ak Created for Protocol 00359.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7784519","version":"1","preferredName":"Johns Hopkins Frailty Assessment Calculator During Past 2 Weeks Have Done Moderately Strenuous Outdoor Chores Indicator","preferredDefinition":"A person's stated response, during the past two weeks, whether they have done moderately strenuous  outdoor chores, like raking or mowing the lawn, shoveling snow, or working in the garden.","longName":"JHFAC_MD_STN_ODC_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CC1C84B5-0391-7E77-E053-4EBD850AE864","latestVersionIndicator":"Yes","beginDate":"2021-09-16","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-09-16","modifiedBy":"KUMMEROA","dateModified":"2021-09-30","changeNote":"2021-9-16 ak Created for Protocol 00359.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7784520","version":"1","preferredName":"Johns Hopkins Frailty Assessment Calculator During Past 2 Weeks Have Done Moderately Strenuous Outdoor Chores Indicator How Often Specify","preferredDefinition":"A person's stated response, during the past two weeks, of how often they have done moderately strenuous  outdoor chores, like raking or mowing the lawn, shoveling snow, or working in the garden.","longName":"JHFAC_MD_STN_ODC_SP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CC1C9059-6899-4EC4-E053-4EBD850A23F2","latestVersionIndicator":"Yes","beginDate":"2021-09-16","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-09-16","modifiedBy":"KUMMEROA","dateModified":"2021-09-30","changeNote":"2021-9-16 ak Created for Protocol 00359.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7784521","version":"1","preferredName":"Johns Hopkins Frailty Assessment Calculator During Past 2 Weeks Have Done Moderately Strenuous Outdoor Chores Indicator Average Hour Time","preferredDefinition":"A person's stated response, during the past two weeks, of the average amount of hours they have done moderately strenuous  outdoor chores, like raking or mowing the lawn, shoveling snow, or working in the garden.","longName":"JHFAC_MD_STN_ODC_HRS","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CC1C9B88-EB30-508E-E053-4EBD850A1866","latestVersionIndicator":"Yes","beginDate":"2021-09-16","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-09-16","modifiedBy":"KUMMEROA","dateModified":"2021-09-30","changeNote":"2021-9-16 ak Created for Protocol 00359.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7784522","version":"1","preferredName":"Johns Hopkins Frailty Assessment Calculator During Past 2 Weeks Have Done Moderately Strenuous Outdoor Chores Indicator Average Minute Time","preferredDefinition":"A person's stated response, during the past two weeks, of the average amount of minutes they have done moderately strenuous  outdoor chores, like raking or mowing the lawn, shoveling snow, or working in the garden.","longName":"JHFAC_MD_STN_ODC_MIN","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CC1CA767-89D5-5223-E053-4EBD850A3E6B","latestVersionIndicator":"Yes","beginDate":"2021-09-16","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-09-16","modifiedBy":"KUMMEROA","dateModified":"2021-09-30","changeNote":"2021-9-16 ak Created for Protocol 00359.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7784523","version":"1","preferredName":"Johns Hopkins Frailty Assessment Calculator During Past 2 Weeks Have Done Moderately Strenuous Outdoor Chores Indicator Monthly Frequency","preferredDefinition":"A person's stated response, during the past two weeks, of the frequency of months per year they have done moderately strenuous  outdoor chores, like raking or mowing the lawn, shoveling snow, or working in the garden.","longName":"JHFAC_MD_STN_ODC_MTH","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CC1CB174-5C14-1C79-E053-4EBD850ACE37","latestVersionIndicator":"Yes","beginDate":"2021-09-16","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-09-16","modifiedBy":"KUMMEROA","dateModified":"2021-09-30","changeNote":"2021-9-16 ak Created for Protocol 00359.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7784527","version":"1","preferredName":"Johns Hopkins Frailty Assessment Calculator During Past 2 Weeks Have Been Dancing Indicator","preferredDefinition":"A person's stated response, during the past two weeks, whether they have been dancing.","longName":"JHFAC_DNCNG_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CC1CD247-2E05-5A5C-E053-4EBD850A412B","latestVersionIndicator":"Yes","beginDate":"2021-09-16","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-09-16","modifiedBy":"KUMMEROA","dateModified":"2021-09-30","changeNote":"2021-9-16 ak Created for Protocol 00359.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7784528","version":"1","preferredName":"Johns Hopkins Frailty Assessment Calculator During Past 2 Weeks Have Been Dancing Indicator How Often Specify","preferredDefinition":"A person's stated response, during the past two weeks, of how often they have been dancing.","longName":"JHFAC_DNCNG_IND_SP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CC1CDC2B-84B4-4F6B-E053-4EBD850A3000","latestVersionIndicator":"Yes","beginDate":"2021-09-16","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-09-16","modifiedBy":"KUMMEROA","dateModified":"2021-09-30","changeNote":"2021--16 ak Created for Protocol 00359.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7784529","version":"1","preferredName":"Johns Hopkins Frailty Assessment Calculator During Past 2 Weeks Have Been Dancing Indicator Average Hour Time","preferredDefinition":"A person's stated response, during the past two weeks, of the average amount of hours they have been dancing.","longName":"JHFAC_DNCNG_IND_HRS","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CC1CE651-1165-5119-E053-4EBD850ABDFD","latestVersionIndicator":"Yes","beginDate":"2021-09-16","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-09-16","modifiedBy":"KUMMEROA","dateModified":"2021-09-30","changeNote":"2021-9-16 ak Created for Protocol 00359.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7784530","version":"1","preferredName":"Johns Hopkins Frailty Assessment Calculator During Past 2 Weeks Have Been Dancing Indicator Average Minute Time","preferredDefinition":"A person's stated response, during the past two weeks, of the average amount of minutes they have been dancing.","longName":"JHFAC_DNCNG_IND_MIN","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CC1CF06E-0443-1BFC-E053-4EBD850AE554","latestVersionIndicator":"Yes","beginDate":"2021-09-16","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-09-16","modifiedBy":"KUMMEROA","dateModified":"2021-09-30","changeNote":"2021-9-16 ak Created for Protocol 00359.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7784531","version":"1","preferredName":"Johns Hopkins Frailty Assessment Calculator During Past 2 Weeks Have Been Dancing Indicator Monthly Frequency","preferredDefinition":"A person's stated response, during the past two weeks, of the frequency of months per year they have been dancing.","longName":"JHFAC_DNCNG_IND_MTH","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CC1CF991-1E56-1D65-E053-4EBD850A65D9","latestVersionIndicator":"Yes","beginDate":"2021-09-16","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-09-16","modifiedBy":"KUMMEROA","dateModified":"2021-09-30","changeNote":"2021-9-16 ak Created for Protocol 00359.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7784535","version":"1","preferredName":"Johns Hopkins Frailty Assessment Calculator During Past 2 Weeks Have Been Bowling Indicator","preferredDefinition":"A person's stated response, during the past two weeks, whether they have been bowling.","longName":"JHFAC_BWLNG_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CC1C84B5-03BF-7E77-E053-4EBD850AE864","latestVersionIndicator":"Yes","beginDate":"2021-09-16","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-09-16","modifiedBy":"KUMMEROA","dateModified":"2021-09-30","changeNote":"2021-9-16 ak Created for Protocol 00359.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7784536","version":"1","preferredName":"Johns Hopkins Frailty Assessment Calculator During Past 2 Weeks Have Been Bowling Indicator How Often Specify","preferredDefinition":"A person's stated response, during the past two weeks, of how often they have been bowling.","longName":"JHFAC_BWLNG_IND_SP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CC1C9059-68C7-4EC4-E053-4EBD850A23F2","latestVersionIndicator":"Yes","beginDate":"2021-09-16","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-09-16","modifiedBy":"KUMMEROA","dateModified":"2021-09-30","changeNote":"2021-9-16 ak Created for Protocol 00359.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7784537","version":"1","preferredName":"Johns Hopkins Frailty Assessment Calculator During Past 2 Weeks Have Been Bowling Indicator Average Hour Time","preferredDefinition":"A person's stated response, during the past two weeks, of the average amount of hours they have been bowling.","longName":"JHFAC_BWLNG_IND_HRS","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CC1C9B88-EB5E-508E-E053-4EBD850A1866","latestVersionIndicator":"Yes","beginDate":"2021-09-16","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-09-16","modifiedBy":"KUMMEROA","dateModified":"2021-09-30","changeNote":"2021-9-16 ak Created for Protocol 00359.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7784538","version":"1","preferredName":"Johns Hopkins Frailty Assessment Calculator During Past 2 Weeks Have Been Bowling Indicator Average Minute Time","preferredDefinition":"A person's stated response, during the past two weeks, of the average amount of minutes they have been bowling.","longName":"JHFAC_BWLNG_IND_MIN","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CC1D2DC8-43C7-51CE-E053-4EBD850A9DCD","latestVersionIndicator":"Yes","beginDate":"2021-09-16","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-09-16","modifiedBy":"KUMMEROA","dateModified":"2021-09-30","changeNote":"2021-9-16 ak Created for Protocol 00359.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7784539","version":"1","preferredName":"Johns Hopkins Frailty Assessment Calculator During Past 2 Weeks Have Been Bowling Indicator Monthly Frequency","preferredDefinition":"A person's stated response, during the past two weeks, of the frequency of months per year they have been bowling.","longName":"JHFAC_BWLNG_IND_MTH","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CC1D36AF-DD16-1C69-E053-4EBD850AA970","latestVersionIndicator":"Yes","beginDate":"2021-09-16","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-09-16","modifiedBy":"KUMMEROA","dateModified":"2021-09-30","changeNote":"2021-9-16 ak Created for Protocol 00359.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7784543","version":"1","preferredName":"Johns Hopkins Frailty Assessment Calculator During Past 2 Weeks Have Participated in Regular Exercise Program Indicator","preferredDefinition":"A person's stated response, during the past two weeks, whether they have participated in any regular exercise program, such as stretching or strengthening exercises, swimming or any other regular exercise program.","longName":"JHFAC_EXCRSE_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CC1D546D-436A-2305-E053-4EBD850ADF4F","latestVersionIndicator":"Yes","beginDate":"2021-09-16","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-09-16","modifiedBy":"KUMMEROA","dateModified":"2021-09-30","changeNote":"2021-9-16 ak Created for Protocol 00359.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7784544","version":"1","preferredName":"Johns Hopkins Frailty Assessment Calculator During Past 2 Weeks Have Participated in Regular Exercise Program Indicator How Often Specify","preferredDefinition":"A person's stated response, during the past two weeks, of how often they have participated in any regular exercise program, such as stretching or strengthening exercises, swimming or any other regular exercise program.","longName":"JHFAC_EXCRSE_IND_SP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CC1CD247-2E33-5A5C-E053-4EBD850A412B","latestVersionIndicator":"Yes","beginDate":"2021-09-16","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-09-16","modifiedBy":"KUMMEROA","dateModified":"2021-09-30","changeNote":"2021-9-16 ak Created for Protocol 00359.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7784545","version":"1","preferredName":"Johns Hopkins Frailty Assessment Calculator During Past 2 Weeks Have Participated in Regular Exercise Program Indicator Average Hour Time","preferredDefinition":"A person's stated response, during the past two weeks, of the average amount of hours they have participated in any regular exercise program, such as stretching or strengthening exercises, swimming or any other regular exercise program.","longName":"JHFAC_EXCRSE_IND_HRS","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CC1D6717-946F-4EE2-E053-4EBD850A1A72","latestVersionIndicator":"Yes","beginDate":"2021-09-16","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-09-16","modifiedBy":"KUMMEROA","dateModified":"2021-09-30","changeNote":"2021-9-16 ak Created for Protocol 00359.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7784546","version":"1","preferredName":"Johns Hopkins Frailty Assessment Calculator During Past 2 Weeks Have Participated in Regular Exercise Program Indicator Average Minute Time","preferredDefinition":"A person's stated response, during the past two weeks, of the average amount of minutes they have participated in any regular exercise program, such as stretching or strengthening exercises, swimming or any other regular exercise program.","longName":"JHFAC_EXCRSE_IND_MIN","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CC1D7128-9137-509D-E053-4EBD850A47CD","latestVersionIndicator":"Yes","beginDate":"2021-09-16","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-09-16","modifiedBy":"KUMMEROA","dateModified":"2021-09-30","changeNote":"2021-9-16 ak Created for Protocol 00359.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7784547","version":"1","preferredName":"Johns Hopkins Frailty Assessment Calculator During Past 2 Weeks Have Participated in Regular Exercise Program Indicator Monthly Frequency","preferredDefinition":"A person's stated response, during the past two weeks, of the frequency of months per year they have participated in any regular exercise program, such as stretching or strengthening exercises, swimming or any other regular exercise program.","longName":"JHFAC_EXCRSE_IND_MTH","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CC1D7A59-A94E-1B44-E053-4EBD850AC415","latestVersionIndicator":"Yes","beginDate":"2021-09-16","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-09-16","modifiedBy":"KUMMEROA","dateModified":"2021-09-30","changeNote":"2021-9-16 ak Created for Protocol 00359.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7784557","version":"1","preferredName":"Johns Hopkins Frailty Assessment Calculator Grip Strength Dominant Hand First Measurement Indicator Kilogram Value","preferredDefinition":"Numeric value to represent an individual's first grip strength in the dominant hand as measured in kilograms.","longName":"JHFAC_GSDH_MSR_1_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CC1D7128-9165-509D-E053-4EBD850A47CD","latestVersionIndicator":"Yes","beginDate":"2021-09-16","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-09-16","modifiedBy":"KUMMEROA","dateModified":"2021-09-30","changeNote":"2021-9-16 ak Created for Protocol 00359.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7784558","version":"1","preferredName":"Johns Hopkins Frailty Assessment Calculator Grip Strength Dominant Hand Second Measurement Indicator Kilogram Value","preferredDefinition":"Numeric value to represent an individual's second grip strength in the dominant hand as measured in kilograms.","longName":"JHFAC_GSDH_MSR_2_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CC1DC839-0CCE-1BD1-E053-4EBD850A5201","latestVersionIndicator":"Yes","beginDate":"2021-09-16","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-09-16","modifiedBy":"KUMMEROA","dateModified":"2021-09-30","changeNote":"2021-9-16 ak Created for Protocol 00359.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7784559","version":"1","preferredName":"Johns Hopkins Frailty Assessment Calculator Grip Strength Dominant Hand Third Measurement Indicator Kilogram Value","preferredDefinition":"Numeric value to represent an individual's third grip strength in the dominant hand as measured in kilograms.","longName":"JHFAC_GSDH_MSR_3_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CC1DD23F-AE2E-1D01-E053-4EBD850A706E","latestVersionIndicator":"Yes","beginDate":"2021-09-16","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-09-16","modifiedBy":"KUMMEROA","dateModified":"2021-09-30","changeNote":"2021-9-16 ak Created for Protocol 00359.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7784563","version":"1","preferredName":"Johns Hopkins Frailty Assessment Calculator Grip Strength Test Not Complete Indicator Reason","preferredDefinition":"A person's stated response of why the grip strength test was not completed.","longName":"JHFAC_GRST_NT_CMP_RS","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CC1CB62C-B7F5-1F15-E053-4EBD850A75FC","latestVersionIndicator":"Yes","beginDate":"2021-09-16","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-09-16","modifiedBy":"KUMMEROA","dateModified":"2021-09-30","changeNote":"2021-9-6 ak Created for Protocol 00359.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7784564","version":"1","preferredName":"Johns Hopkins Frailty Assessment Calculator Grip Strength Test Not Complete Indicator Other Specify","preferredDefinition":"Text term not previously mentioned that represents why the grip strength test was not completed.","longName":"JHFAC_GRST_NT_CMP_SP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CC1E075B-5C0C-20ED-E053-4EBD850A5EB2","latestVersionIndicator":"Yes","beginDate":"2021-09-16","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-09-16","modifiedBy":"KUMMEROA","dateModified":"2021-09-30","changeNote":"2021-9-16 ak Created for Protocol 00359.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7784577","version":"1","preferredName":"Johns Hopkins Frailty Assessment Calculator Four Meter Have Completed Walking Test Indicator","preferredDefinition":"A person's stated response of whether they have completed the four meter walking test.","longName":"JHFAC_WK_TST_CPT_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CC1E4A11-9AE4-5040-E053-4EBD850AFD0B","latestVersionIndicator":"Yes","beginDate":"2021-09-16","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-09-16","modifiedBy":"KUMMEROA","dateModified":"2021-09-30","changeNote":"2021-9-16 ak Created for Protocol 00359.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7784593","version":"1","preferredName":"Johns Hopkins Frailty Assessment Calculator Four Meter First Usual Pace Walk Time Duration","preferredDefinition":"The first period of time walking 4 meters at usual pace in seconds.","longName":"JHFAC_1ST_4_M_PC_DRN","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CC1CDC2B-84E2-4F6B-E053-4EBD850A3000","latestVersionIndicator":"Yes","beginDate":"2021-09-16","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-09-16","modifiedBy":"KUMMEROA","dateModified":"2021-10-01","changeNote":"2021-9-16 ak Created for Protocol 00359.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7784597","version":"1","preferredName":"Johns Hopkins Frailty Assessment Calculator Four Meter Second Usual Pace Walk Time Duration","preferredDefinition":"The second period of time walking 4 meters at usual pace in seconds.","longName":"JHFAC_2ND_4_M_PC_DRN","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CC1EEFE0-CC3F-1C50-E053-4EBD850A653E","latestVersionIndicator":"Yes","beginDate":"2021-09-16","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-09-16","modifiedBy":"KUMMEROA","dateModified":"2021-10-01","changeNote":"2021-9-16 ak Created for Protocol 00359.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7784601","version":"1","preferredName":"Johns Hopkins Frailty Assessment Calculator Not Have Completed Walking Test Indicator Reason","preferredDefinition":"A person's stated response of why the walking test was not completed.","longName":"JHFAC_WLK_NT_CMP_RS","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CC1DF47E-7A95-1EC3-E053-4EBD850A358D","latestVersionIndicator":"Yes","beginDate":"2021-09-16","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-09-16","modifiedBy":"KUMMEROA","dateModified":"2021-09-30","changeNote":"2021-9-16 ak Created for Protocol 003529.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7784602","version":"1","preferredName":"Johns Hopkins Frailty Assessment Calculator Not Have Completed Walking Test Indicator Other Specify","preferredDefinition":"Text term not previously mentioned that represents why the walking test was not completed.","longName":"JHFAC_WLK_NT_CMP_SP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CC1E3ECC-4E87-21B0-E053-4EBD850A2D8F","latestVersionIndicator":"Yes","beginDate":"2021-09-16","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-09-16","modifiedBy":"KUMMEROA","dateModified":"2021-09-30","changeNote":"2021-9-16 ak Created for Protocol 00359.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7784606","version":"1","preferredName":"Montreal Cognitive Assessment Version 7.1 Delayed Recall With No Cue Test Score","preferredDefinition":"The score of the Delayed Recall test with no cue.","longName":"MOCA_DELRNC_V7_1_SCR","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"MoCA:Montreal Cognitive Assessment; Z.S.Nasreddine et al., J AM Geriatric Society (2005)","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CC1D546D-4398-2305-E053-4EBD850ADF4F","latestVersionIndicator":"Yes","beginDate":"2021-09-16","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-09-16","modifiedBy":"KUMMEROA","dateModified":"2021-11-30","changeNote":"2021-9-16 ak Created for Protocol 00359.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7784610","version":"1","preferredName":"Montreal Cognitive Assessment Version 7.1 Delayed Cue Test Score","preferredDefinition":"The score of the Delayed Recall test with category cue.","longName":"MOCA_DELCUE_V7_1_SCR","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"MoCA:Montreal Cognitive Assessment; Z.S.Nasreddine et al., J AM Geriatric Society (2005)","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CC2049B6-5C13-2235-E053-4EBD850A6BF0","latestVersionIndicator":"Yes","beginDate":"2021-09-16","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-09-16","modifiedBy":"KUMMEROA","dateModified":"2021-11-30","changeNote":"2021-9-16 ak Created for Protocol 00359.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7784614","version":"1","preferredName":"Montreal Cognitive Assessment Version 7.1 Delayed Recall With Muliple Choice Cue Test Score","preferredDefinition":"The score of the Delayed Recall test with multiple choice cue.","longName":"MOCA_DELMCC_V7_1_SCR","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"MoCA:Montreal Cognitive Assessment; Z.S.Nasreddine et al., J AM Geriatric Society (2005)","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CC1EE601-0A71-1FAF-E053-4EBD850A56AD","latestVersionIndicator":"Yes","beginDate":"2021-09-16","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-09-16","modifiedBy":"KUMMEROA","dateModified":"2021-11-30","changeNote":"2021-9-16 ak Created for Protocol 00359.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7784735","version":"1","preferredName":"Tumor Volume Change From Baseline Percentage Value","preferredDefinition":"The numerical response that indicates the percentage change of tumor volume as compared at some baseline event or timepoint.","longName":"VOL_CHANGE_PCT_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CC25D68A-FD92-27EA-E053-4EBD850A38BA","latestVersionIndicator":"Yes","beginDate":"2021-09-16","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2021-09-16","modifiedBy":"HARTLEYG","dateModified":"2021-09-23","changeNote":"Curated to support protocol 000080_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7784736","version":"1","preferredName":"Standardized Uptake Value Maximum Change From Baseline Percentage Value","preferredDefinition":"The numerical response that indicates the percentage change in the maximum standardized uptake value compared at some baseline event or timepoint.","longName":"SUV_MAX_CHNG_PCT_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CC286EF6-40B0-269D-E053-4EBD850A74E4","latestVersionIndicator":"Yes","beginDate":"2021-09-16","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2021-09-16","modifiedBy":"HARTLEYG","dateModified":"2021-09-23","changeNote":"Curated to support protocol 000080_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7784790","version":"1","preferredName":"Lawton-Brody Instrumental Activities of Daily Living Scale 1 Ability Use the Telephone Score 4 Point Scale","preferredDefinition":"A person's stated response about their ability to use the telephone, using a 4 point Likert scale.","longName":"LB_IADL_1_PHONE_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CC3147CB-241C-4BBA-E053-4EBD850A1CA4","latestVersionIndicator":"Yes","beginDate":"2021-09-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-09-17","modifiedBy":"KUMMEROA","dateModified":"2021-09-30","changeNote":"2021-9-17 ak Created for Protocol 00359.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7784794","version":"1","preferredName":"Lawton-Brody Instrumental Activities of Daily Living Scale 2 Ability to Go Shopping Score 4 Point Scale","preferredDefinition":"A person's stated response about their ability to go shopping, using a 4 point Likert scale.","longName":"LB_IADL_2_SHOP_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CC313938-804A-76C8-E053-4EBD850AA120","latestVersionIndicator":"Yes","beginDate":"2021-09-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-09-17","modifiedBy":"KUMMEROA","dateModified":"2021-09-30","changeNote":"2021-9-17 ak Created for Protocol 00359.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7784798","version":"1","preferredName":"Lawton-Brody Instrumental Activities of Daily Living Scale 3 Ability Prepare Your Meals Score 4 Point Scale","preferredDefinition":"A person's stated response about their ability to prepare food, using a 4 point Likert scale.","longName":"LB_IADL_3_FOOD_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CC313938-8078-76C8-E053-4EBD850AA120","latestVersionIndicator":"Yes","beginDate":"2021-09-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-09-17","modifiedBy":"KUMMEROA","dateModified":"2021-09-30","changeNote":"2021-9-17 ak Created for Protocol 00359.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7784802","version":"1","preferredName":"Lawton-Brody Instrumental Activities of Daily Living Scale 4 Ability Do Housework Score  5 Point Scale","preferredDefinition":"A person's stated response about their ability to do housekeeping, using a 5 point Likert scale.","longName":"LB_IADL_4_HSWK_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CC315B7A-1380-75F1-E053-4EBD850AA7FA","latestVersionIndicator":"Yes","beginDate":"2021-09-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-09-17","modifiedBy":"KUMMEROA","dateModified":"2021-09-30","changeNote":"2021-9-17 ak Created for Protocol 00359.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7784806","version":"1","preferredName":"Lawton-Brody Instrumental Activities of Daily Living Scale 5 Ability to Do Laundry Score 3 Point Scale","preferredDefinition":"A person's stated response about their ability to do laundry, using a 3 point Likert scale.","longName":"LB_IADL_5_LNDRY_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CC314A2B-C163-0592-E053-4EBD850A8F72","latestVersionIndicator":"Yes","beginDate":"2021-09-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-09-17","modifiedBy":"KUMMEROA","dateModified":"2021-09-30","changeNote":"2021-9-17 ak Created for Protocol 00359.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7784814","version":"1","preferredName":"Lawton-Brody Instrumental Activities of Daily Living Scale 6 Ability Mode of Transportation Score  5 Point Scale","preferredDefinition":"A person's stated response about their ability to travel independently, using a 5 point Likert scale.","longName":"LB_IADL_6_TRVL_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CC31603C-EF5A-3457-E053-4EBD850A0EA9","latestVersionIndicator":"Yes","beginDate":"2021-09-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-09-17","modifiedBy":"KUMMEROA","dateModified":"2021-09-30","changeNote":"2021-9-17 ak Created for Protocol 00359.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7784822","version":"1","preferredName":"Lawton-Brody Instrumental Activities of Daily Living Scale 7 Ability Responsibility for Own Medications Score 3 Point Scale","preferredDefinition":"A person's stated response about their ability to be responsible for their own medictions, using a 3 point Likert scale.","longName":"LB_IADL_7_TRVL_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CC312A4C-0608-4C39-E053-4EBD850A07F1","latestVersionIndicator":"Yes","beginDate":"2021-09-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-09-17","modifiedBy":"KUMMEROA","dateModified":"2021-09-30","changeNote":"2021-9-17 ak Created for Protocol 00359.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7784826","version":"1","preferredName":"Lawton-Brody Instrumental Activities of Daily Living Scale 8 Ability to Handle Finances Score 3 Point Scale","preferredDefinition":"A person's stated response about their ability to handle their finances, using a 3 point Likert scale.","longName":"LB_IADL_8_TRVL_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CC31433C-6BBF-7AC0-E053-4EBD850A003E","latestVersionIndicator":"Yes","beginDate":"2021-09-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-09-17","modifiedBy":"KUMMEROA","dateModified":"2021-09-30","changeNote":"2021-9-17 ak Created for Protocol 00359.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7786736","version":"1","preferredName":"Short Physical Performance Battery 1 Side-by-Side Score SPPB Seconds Score","preferredDefinition":"Short Physical Performance Battery V1.2 (SPPB V1.2) (Guralnik JM, Ferrucci L, Pieper CF, Leveille SG, Markides KS, Ostir GV, Studenski S, Berkman LF, Wallace RB. Lower extremity function and subsequent disability: consistency across studies, predictive models, and value of gait speed alone compared with the short physical performance battery. J Gerontol A Biol Sci Med Sci 2000 April;55(4):M221-M231)._Short Physical Performance Battery Version 1.2 (SPPB Version 1.2) Side-By-Side Stand: Side-by-side score._An ordered reference standard used to measure incremental changes._A number or range of numeric values measuring performance, function, quality, or ability.","longName":"SPPB_1_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"SPPB:Short Physical Performance Battery, Guralnik JM, Simonsick EM, Ferrucci L, et al.J Gerontol. 1994;49(2):M85-94.","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CC6D323D-DDFF-19EF-E053-4EBD850AEECC","latestVersionIndicator":"Yes","beginDate":"2021-09-20","endDate":null,"createdBy":"TSESU","dateCreated":"2021-09-20","modifiedBy":"KUMMEROA","dateModified":"2021-09-30","changeNote":"Created for CCR protocol 000359 per E. Lyalka - smt","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7786737","version":"1","preferredName":"Short Physical Performance Battery 2 Did Not Attempt or Failed Side-by-Side-Stand Reason","preferredDefinition":"The reason that a participant did not attempt or failed the side-by-side stand test.","longName":"SPPB_2_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"SPPB:Short Physical Performance Battery, Guralnik JM, Simonsick EM, Ferrucci L, et al.J Gerontol. 1994;49(2):M85-94.","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CC6F30D3-2360-1DCA-E053-4EBD850A88E6","latestVersionIndicator":"Yes","beginDate":"2021-09-20","endDate":null,"createdBy":"TSESU","dateCreated":"2021-09-20","modifiedBy":"KUMMEROA","dateModified":"2021-09-30","changeNote":"Created for CCR protocol 000359 per E. Lyalka - smt","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7786738","version":"1","preferredName":"Short Physical Performance Battery 3 Did Not Attempt or Failed Side-by-Side-Stand Other Specify Text","preferredDefinition":"Text to describe other reason than those previously listed to describe reason that participant did not attempt or failed the side-by-side stand balance test.","longName":"SPPB_3_TXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"SPPB:Short Physical Performance Battery, Guralnik JM, Simonsick EM, Ferrucci L, et al.J Gerontol. 1994;49(2):M85-94.","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CC6FDC8C-D380-121F-E053-4EBD850AA073","latestVersionIndicator":"Yes","beginDate":"2021-09-20","endDate":null,"createdBy":"TSESU","dateCreated":"2021-09-20","modifiedBy":"TSESU","dateModified":"2021-09-29","changeNote":"Created for CCR protocol 000359 per E. Lyalka - smt","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7786739","version":"1","preferredName":"Short Physical Performance Battery 4 Side-by-Side Seconds Held If Less Than 10 Seconds Value","preferredDefinition":"The number value of seconds held by a participant for the side-by-side stand balance test, if less than 10 seconds.","longName":"SPPB_4_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"SPPB:Short Physical Performance Battery, Guralnik JM, Simonsick EM, Ferrucci L, et al.J Gerontol. 1994;49(2):M85-94.","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CC6F621A-7F42-77A2-E053-4EBD850A7BC5","latestVersionIndicator":"Yes","beginDate":"2021-09-20","endDate":null,"createdBy":"TSESU","dateCreated":"2021-09-20","modifiedBy":"TSESU","dateModified":"2021-09-29","changeNote":"Created for CCR protocol 000359 per E. Lyalka - smt","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7786740","version":"1","preferredName":"Short Physical Performance Battery 5 Semi-Tandem Stand Score","preferredDefinition":"Short Physical Performance Battery V1.2 (SPPB V1.2) (Guralnik JM, Ferrucci L, Pieper CF, Leveille SG, Markides KS, Ostir GV, Studenski S, Berkman LF, Wallace RB. Lower extremity function and subsequent disability: consistency across studies, predictive models, and value of gait speed alone compared with the short physical performance battery. J Gerontol A Biol Sci Med Sci 2000 April;55(4):M221-M231)._Short Physical Performance Battery Version 1.2 (SPPB Version 1.2) Semi-Tandem Stand: Semi-tandem stand score._A number or range of numeric values measuring performance, function, quality, or ability._An ordered reference standard used to measure incremental changes._A number or range of numeric values measuring performance, function, quality, or ability.","longName":"SPPB_5_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"SPPB:Short Physical Performance Battery, Guralnik JM, Simonsick EM, Ferrucci L, et al.J Gerontol. 1994;49(2):M85-94.","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CC704453-6FB6-1EB9-E053-4EBD850AD5F7","latestVersionIndicator":"Yes","beginDate":"2021-09-20","endDate":null,"createdBy":"TSESU","dateCreated":"2021-09-20","modifiedBy":"KUMMEROA","dateModified":"2021-09-30","changeNote":"Created for CCR protocol 000359 per E. Lyalka - smt","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7786741","version":"1","preferredName":"Short Physical Performance Battery 6 Did Not Attempt or Failed Semi-Tandem Stand Reason","preferredDefinition":"The reason that a participant did not attempt or failed the semi-tandem stand test.","longName":"SPPB_6_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"SPPB:Short Physical Performance Battery, Guralnik JM, Simonsick EM, Ferrucci L, et al.J Gerontol. 1994;49(2):M85-94.","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CC6FDC8C-D3AE-121F-E053-4EBD850AA073","latestVersionIndicator":"Yes","beginDate":"2021-09-20","endDate":null,"createdBy":"TSESU","dateCreated":"2021-09-20","modifiedBy":"KUMMEROA","dateModified":"2021-09-30","changeNote":"Created for CCR protocol 000359 per E. Lyalka - smt","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7786742","version":"1","preferredName":"Short Physical Performance Battery 7 Did Not Attempt or Failed Semi-Tandem Stand  Other Specify Text","preferredDefinition":"Text to describe other reason than those previously listed to describe the reason that participant did not attempt or failed the semi-tandem stand balance test.","longName":"SPPB_7_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"SPPB:Short Physical Performance Battery, Guralnik JM, Simonsick EM, Ferrucci L, et al.J Gerontol. 1994;49(2):M85-94.","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CC6F30D3-238E-1DCA-E053-4EBD850A88E6","latestVersionIndicator":"Yes","beginDate":"2021-09-20","endDate":null,"createdBy":"TSESU","dateCreated":"2021-09-20","modifiedBy":"TSESU","dateModified":"2021-09-29","changeNote":"Created for CCR protocol 000359 per E. Lyalka - smt","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7786743","version":"1","preferredName":"Short Physical Performance Battery 8 Semi-Tandem Seconds Held If Less Than 10 Seconds Value","preferredDefinition":"The number value of seconds held by a participant for the semi-tandem stand balance test, if less than 10 seconds.","longName":"SPPB_8_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"SPPB:Short Physical Performance Battery, Guralnik JM, Simonsick EM, Ferrucci L, et al.J Gerontol. 1994;49(2):M85-94.","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CC704453-6FE4-1EB9-E053-4EBD850AD5F7","latestVersionIndicator":"Yes","beginDate":"2021-09-20","endDate":null,"createdBy":"TSESU","dateCreated":"2021-09-20","modifiedBy":"TSESU","dateModified":"2021-09-29","changeNote":"Created for CCR protocol 000359 per E. Lyalka - smt","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7786772","version":"1","preferredName":"Short Physical Performance Battery 9 Tandem Stand Score","preferredDefinition":"The score of a participant's tandem stand balance test.","longName":"SPPB_9_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"SPPB:Short Physical Performance Battery, Guralnik JM, Simonsick EM, Ferrucci L, et al.J Gerontol. 1994;49(2):M85-94.","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CC71B6B2-041C-1897-E053-4EBD850A3CD3","latestVersionIndicator":"Yes","beginDate":"2021-09-20","endDate":null,"createdBy":"TSESU","dateCreated":"2021-09-20","modifiedBy":"KUMMEROA","dateModified":"2021-09-30","changeNote":"Created for CCR protocol 000359 per E. Lyalka - smt","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7786773","version":"1","preferredName":"Short Physical Performance Battery 10 Did Not Attempt or Failed Tandem Stand Reason","preferredDefinition":"The reason that a participant did not attempt or failed the tandem stand test.","longName":"SPPB_10_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"SPPB:Short Physical Performance Battery, Guralnik JM, Simonsick EM, Ferrucci L, et al.J Gerontol. 1994;49(2):M85-94.","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CC71BDF1-066C-2A68-E053-4EBD850AB2A5","latestVersionIndicator":"Yes","beginDate":"2021-09-20","endDate":null,"createdBy":"TSESU","dateCreated":"2021-09-20","modifiedBy":"KUMMEROA","dateModified":"2021-09-30","changeNote":"Created for CCR protocol 000359 per E. Lyalka - smt","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7786774","version":"1","preferredName":"Short Physical Performance Battery 11 Did Not Attempt or Failed Tandem Stand Other Specify Text","preferredDefinition":"Text to describe other reason than those previously listed to describe reason that participant did not attempt or failed the tandem stand balance test.","longName":"SPPB_10_TXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"SPPB:Short Physical Performance Battery, Guralnik JM, Simonsick EM, Ferrucci L, et al.J Gerontol. 1994;49(2):M85-94.","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CC6F30D3-23BC-1DCA-E053-4EBD850A88E6","latestVersionIndicator":"Yes","beginDate":"2021-09-20","endDate":null,"createdBy":"TSESU","dateCreated":"2021-09-20","modifiedBy":"TSESU","dateModified":"2021-09-29","changeNote":"Created for CCR protocol 000359 per E. Lyalka - smt","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7786775","version":"1","preferredName":"Short Physical Performance Battery 12 Tandem If Less than 10 Seconds Score Value","preferredDefinition":"The number value in seconds held by a participant for the tandem stand balance test, if less than 10 seconds.","longName":"SPPB_12_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"SPPB:Short Physical Performance Battery, Guralnik JM, Simonsick EM, Ferrucci L, et al.J Gerontol. 1994;49(2):M85-94.","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CC71D274-0328-7010-E053-4EBD850AFF27","latestVersionIndicator":"Yes","beginDate":"2021-09-20","endDate":null,"createdBy":"TSESU","dateCreated":"2021-09-20","modifiedBy":"TSESU","dateModified":"2021-09-29","changeNote":"Created for CCR protocol 000359 per E. Lyalka - smt","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7786783","version":"1","preferredName":"Short Physical Performance Battery 13 Total Balance Test Text","preferredDefinition":"Text field for Total Balance Tests.","longName":"SPPB_13_TXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"SPPB:Short Physical Performance Battery, Guralnik JM, Simonsick EM, Ferrucci L, et al.J Gerontol. 1994;49(2):M85-94.","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CC704453-7012-1EB9-E053-4EBD850AD5F7","latestVersionIndicator":"Yes","beginDate":"2021-09-20","endDate":null,"createdBy":"TSESU","dateCreated":"2021-09-20","modifiedBy":"TSESU","dateModified":"2021-09-29","changeNote":"Created for CCR protocol 000359 per E. Lyalka - smt","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7786788","version":"1","preferredName":"Short Physical Performance Battery 14 Gait Assessment Test Distance","preferredDefinition":"The length of the gait speed test course.","longName":"SPPB_14_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"SPPB:Short Physical Performance Battery, Guralnik JM, Simonsick EM, Ferrucci L, et al.J Gerontol. 1994;49(2):M85-94.","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CC723E3B-58BD-3A51-E053-4EBD850A422F","latestVersionIndicator":"Yes","beginDate":"2021-09-20","endDate":null,"createdBy":"TSESU","dateCreated":"2021-09-20","modifiedBy":"TSESU","dateModified":"2021-09-29","changeNote":"Created for CCR protocol 000359 per E. Lyalka - smt","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7786789","version":"1","preferredName":"Short Physical Performance Battery 15 Time for 3 or 4 Meters 1st Gait Score Value","preferredDefinition":"The number value for participant's completion time to walk 3 or 4 meters in the first Gait Speed Test.","longName":"SPPB_15_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"SPPB:Short Physical Performance Battery, Guralnik JM, Simonsick EM, Ferrucci L, et al.J Gerontol. 1994;49(2):M85-94.","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CC723E3B-58EB-3A51-E053-4EBD850A422F","latestVersionIndicator":"Yes","beginDate":"2021-09-20","endDate":null,"createdBy":"TSESU","dateCreated":"2021-09-20","modifiedBy":"TSESU","dateModified":"2021-09-29","changeNote":"Created for CCR protocol 000359 per E. Lyalka - smt","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7786790","version":"1","preferredName":"Short Physical Performance Battery 16 Did Not Attempt 1st Gait Reason","preferredDefinition":"The reason that a participant did not attempt or failed the first gait speed test.","longName":"SPPB_16_RSN","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"SPPB:Short Physical Performance Battery, Guralnik JM, Simonsick EM, Ferrucci L, et al.J Gerontol. 1994;49(2):M85-94.","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CC72743E-44B1-6F72-E053-4EBD850A8458","latestVersionIndicator":"Yes","beginDate":"2021-09-20","endDate":null,"createdBy":"TSESU","dateCreated":"2021-09-20","modifiedBy":"KUMMEROA","dateModified":"2021-09-30","changeNote":"Created for CCR protocol 000359 per E. Lyalka - smt","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7786792","version":"1","preferredName":"Short Physical Performance Battery 17 Did Not Attempt 1st Gait Other Specify Text","preferredDefinition":"Text to describe other reason than those previously listed to describe reason that participant did not attempt or failed the first gait speed test.","longName":"SPPB_17_TXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"SPPB:Short Physical Performance Battery, Guralnik JM, Simonsick EM, Ferrucci L, et al.J Gerontol. 1994;49(2):M85-94.","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CC727CB3-FF67-7B2E-E053-4EBD850A9205","latestVersionIndicator":"Yes","beginDate":"2021-09-20","endDate":null,"createdBy":"TSESU","dateCreated":"2021-09-20","modifiedBy":"TSESU","dateModified":"2021-09-29","changeNote":"Created for CCR protocol 000359 per E. Lyalka - smt","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7786796","version":"1","preferredName":"Short Physical Performance Battery 18 Aids Used 1st Gait Type","preferredDefinition":"Walking aids used in first gait speed test.","longName":"SPPB_18_TXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"SPPB:Short Physical Performance Battery, Guralnik JM, Simonsick EM, Ferrucci L, et al.J Gerontol. 1994;49(2):M85-94.","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CC7282FD-AA0C-7544-E053-4EBD850A01D0","latestVersionIndicator":"Yes","beginDate":"2021-09-20","endDate":null,"createdBy":"TSESU","dateCreated":"2021-09-20","modifiedBy":"TSESU","dateModified":"2021-09-29","changeNote":"Created for CCR protocol 000359 per E. Lyalka - smt","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7786799","version":"1","preferredName":"Short Physical Performance Battery 19 Time for 3 or 4 Meters 2nd Gait Duration Value","preferredDefinition":"The number value for participant's completion time to walk 3 or 4 meters in the first gait speed test.","longName":"SPPB_19_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"SPPB:Short Physical Performance Battery, Guralnik JM, Simonsick EM, Ferrucci L, et al.J Gerontol. 1994;49(2):M85-94.","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CC728B13-658C-771C-E053-4EBD850A9DCE","latestVersionIndicator":"Yes","beginDate":"2021-09-20","endDate":null,"createdBy":"TSESU","dateCreated":"2021-09-20","modifiedBy":"TSESU","dateModified":"2021-09-29","changeNote":"Created for CCR protocol 000359 per E. Lyalka - smt","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7786800","version":"1","preferredName":"Short Physical Performance Battery 20 Did Not Attempt or Failed 2nd Gait Reason","preferredDefinition":"The reason that a participant did not attempt or failed the second gait speed test.","longName":"SPPB_20_RSN","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"SPPB:Short Physical Performance Battery, Guralnik JM, Simonsick EM, Ferrucci L, et al.J Gerontol. 1994;49(2):M85-94.","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CC729300-8CD7-79E8-E053-4EBD850A55A3","latestVersionIndicator":"Yes","beginDate":"2021-09-20","endDate":null,"createdBy":"TSESU","dateCreated":"2021-09-20","modifiedBy":"KUMMEROA","dateModified":"2021-09-30","changeNote":"Created for CCR protocol 000359 per E. Lyalka - smt","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7786801","version":"1","preferredName":"Short Physical Performance Battery 21 Did Not Attempt 2nd Gait Other Specify Text","preferredDefinition":"Text to describe other reason than those previously listed to describe reason that participant did not attempt or failed the second gait speed test.","longName":"SPPB_21_TXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"SPPB:Short Physical Performance Battery, Guralnik JM, Simonsick EM, Ferrucci L, et al.J Gerontol. 1994;49(2):M85-94.","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CC71D274-03D1-7010-E053-4EBD850AFF27","latestVersionIndicator":"Yes","beginDate":"2021-09-20","endDate":null,"createdBy":"TSESU","dateCreated":"2021-09-20","modifiedBy":"TSESU","dateModified":"2021-09-29","changeNote":"Created for CCR protocol 000359 per E. Lyalka - smt","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7786802","version":"1","preferredName":"Short Physical Performance Battery 22 Aids Used 2nd Gait Type","preferredDefinition":"Walking aids used in second gait speed test.","longName":"SPPB_22_TXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"SPPB:Short Physical Performance Battery, Guralnik JM, Simonsick EM, Ferrucci L, et al.J Gerontol. 1994;49(2):M85-94.","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CC6F5F59-9808-1CFA-E053-4EBD850A124C","latestVersionIndicator":"Yes","beginDate":"2021-09-20","endDate":null,"createdBy":"TSESU","dateCreated":"2021-09-20","modifiedBy":"TSESU","dateModified":"2021-09-29","changeNote":"Created for CCR protocol 000359 per E. Lyalka - smt","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7786805","version":"1","preferredName":"Short Physical Performance Battery 26 4-Meter Walk Score","preferredDefinition":"The score for a participant's 4-meter walk completion time.","longName":"SPPB_26_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"SPPB:Short Physical Performance Battery, Guralnik JM, Simonsick EM, Ferrucci L, et al.J Gerontol. 1994;49(2):M85-94.","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CC72BD03-8697-77CB-E053-4EBD850AD5BA","latestVersionIndicator":"Yes","beginDate":"2021-09-20","endDate":null,"createdBy":"TSESU","dateCreated":"2021-09-20","modifiedBy":"KUMMEROA","dateModified":"2021-09-30","changeNote":"Created for CCR protocol 000359 per E. Lyalka - smt","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7786806","version":"1","preferredName":"Short Physical Performance Battery 27 3-Meter Walk Duration Score","preferredDefinition":"The score for a participant's 3-meter walk completion time.","longName":"SPPB_27_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"SPPB:Short Physical Performance Battery, Guralnik JM, Simonsick EM, Ferrucci L, et al.J Gerontol. 1994;49(2):M85-94.","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CC71D274-03FF-7010-E053-4EBD850AFF27","latestVersionIndicator":"Yes","beginDate":"2021-09-20","endDate":null,"createdBy":"TSESU","dateCreated":"2021-09-20","modifiedBy":"TSESU","dateModified":"2021-09-29","changeNote":"Created for CCR protocol 000359 per E. Lyalka - smt","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7786807","version":"1","preferredName":"Short Physical Performance Battery 28 Safe to Stand Without Help Indicator","preferredDefinition":"Indicator of whether or not conditions were safe for a participant to stand without help.","longName":"SPPB_28_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"SPPB:Short Physical Performance Battery, Guralnik JM, Simonsick EM, Ferrucci L, et al.J Gerontol. 1994;49(2):M85-94.","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CC72BD03-86C5-77CB-E053-4EBD850AD5BA","latestVersionIndicator":"Yes","beginDate":"2021-09-20","endDate":null,"createdBy":"TSESU","dateCreated":"2021-09-20","modifiedBy":"TSESU","dateModified":"2021-09-29","changeNote":"Created for CCR protocol 000359 per E. Lyalka - smt","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7786808","version":"1","preferredName":"Short Physical Performance Battery 29 Results Single Chair Score","preferredDefinition":"The score of a participant's single chair stand test result.","longName":"SPPB_29_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"SPPB:Short Physical Performance Battery, Guralnik JM, Simonsick EM, Ferrucci L, et al.J Gerontol. 1994;49(2):M85-94.","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CC723E3B-5919-3A51-E053-4EBD850A422F","latestVersionIndicator":"Yes","beginDate":"2021-09-20","endDate":null,"createdBy":"TSESU","dateCreated":"2021-09-20","modifiedBy":"TSESU","dateModified":"2021-09-29","changeNote":"Created for CCR protocol 000359 per E. Lyalka - smt","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7786809","version":"1","preferredName":"Short Physical Performance Battery 30 Did Not Attempt Single Chair Reason","preferredDefinition":"The reason that a participant did not attempt or failed the single chair stand test.","longName":"SPPB_30_RSN","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"SPPB:Short Physical Performance Battery, Guralnik JM, Simonsick EM, Ferrucci L, et al.J Gerontol. 1994;49(2):M85-94.","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CC71B6B2-044A-1897-E053-4EBD850A3CD3","latestVersionIndicator":"Yes","beginDate":"2021-09-20","endDate":null,"createdBy":"TSESU","dateCreated":"2021-09-20","modifiedBy":"KUMMEROA","dateModified":"2021-09-30","changeNote":"Created for CCR protocol 000359 per E. Lyalka - smt","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7786810","version":"1","preferredName":"Short Physical Performance Battery 31 Not Attempt Single Chair Other Specify Text","preferredDefinition":"Text to describe other reason than those previously listed to describe reason that participant did not attempt or failed the single chair stand test.","longName":"SPPB_31_TXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"SPPB:Short Physical Performance Battery, Guralnik JM, Simonsick EM, Ferrucci L, et al.J Gerontol. 1994;49(2):M85-94.","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CC732E7B-B36E-7A6D-E053-4EBD850A8026","latestVersionIndicator":"Yes","beginDate":"2021-09-20","endDate":null,"createdBy":"TSESU","dateCreated":"2021-09-20","modifiedBy":"TSESU","dateModified":"2021-09-29","changeNote":"Created for CCR protocol 000359 per E. Lyalka - smt","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7786811","version":"1","preferredName":"Short Physical Performance Battery 32 Safe to Stand Five Times Indicator","preferredDefinition":"Indicator of whether or not conditions were safe for participant to stand five times during the repeated chair stand test.","longName":"SPPB_32_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"SPPB:Short Physical Performance Battery, Guralnik JM, Simonsick EM, Ferrucci L, et al.J Gerontol. 1994;49(2):M85-94.","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CC6F30D3-23EE-1DCA-E053-4EBD850A88E6","latestVersionIndicator":"Yes","beginDate":"2021-09-20","endDate":null,"createdBy":"TSESU","dateCreated":"2021-09-20","modifiedBy":"TSESU","dateModified":"2021-09-29","changeNote":"Created for CCR protocol 000359 per E. Lyalka - smt","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7786812","version":"1","preferredName":"Short Physical Performance Battery 33 Time to Complete Five Stands Duration Time Value","preferredDefinition":"Number value of the time for participant to complete five stands during repeated chair stand test.","longName":"SPPB_33_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"SPPB:Short Physical Performance Battery, Guralnik JM, Simonsick EM, Ferrucci L, et al.J Gerontol. 1994;49(2):M85-94.","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CC733D8B-8411-59AF-E053-4EBD850AF513","latestVersionIndicator":"Yes","beginDate":"2021-09-20","endDate":null,"createdBy":"TSESU","dateCreated":"2021-09-20","modifiedBy":"TSESU","dateModified":"2021-09-29","changeNote":"Created for CCR protocol 000359 per E. Lyalka - smt","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7786819","version":"1","preferredName":"Short Physical Performance Battery 34 Did Not Attempt Repeated Chair Reason","preferredDefinition":"The reason that a participant did not attempt or failed the repeated chair stand test.","longName":"SPPB_34_RSN","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"SPPB:Short Physical Performance Battery, Guralnik JM, Simonsick EM, Ferrucci L, et al.J Gerontol. 1994;49(2):M85-94.","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CC72BCF2-1A39-091A-E053-4EBD850A801C","latestVersionIndicator":"Yes","beginDate":"2021-09-20","endDate":null,"createdBy":"TSESU","dateCreated":"2021-09-20","modifiedBy":"KUMMEROA","dateModified":"2021-09-30","changeNote":"Created for CCR protocol 000359 per E. Lyalka - smt","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7786820","version":"1","preferredName":"Short Physical Performance Battery 35 Not Attempt Repeated Chair Other Specify Text","preferredDefinition":"Text to describe other reason than those previously listed to describe reason that participant did not attempt or failed the repeated chair stand test.","longName":"SPPB_35_TXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"SPPB:Short Physical Performance Battery, Guralnik JM, Simonsick EM, Ferrucci L, et al.J Gerontol. 1994;49(2):M85-94.","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CC72BCF2-1A67-091A-E053-4EBD850A801C","latestVersionIndicator":"Yes","beginDate":"2021-09-20","endDate":null,"createdBy":"TSESU","dateCreated":"2021-09-20","modifiedBy":"TSESU","dateModified":"2021-09-29","changeNote":"Created for CCR protocol 000359 per E. Lyalka - smt","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7786822","version":"1","preferredName":"Short Physical Performance Battery 36 Chair Stand Repeated Chair Test Score","preferredDefinition":"Score for participant's repeated chair test.","longName":"SPPB_36_SC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"SPPB:Short Physical Performance Battery, Guralnik JM, Simonsick EM, Ferrucci L, et al.J Gerontol. 1994;49(2):M85-94.","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CC72BCF2-1AC3-091A-E053-4EBD850A801C","latestVersionIndicator":"Yes","beginDate":"2021-09-20","endDate":null,"createdBy":"TSESU","dateCreated":"2021-09-20","modifiedBy":"TSESU","dateModified":"2021-09-29","changeNote":"Created for CCR protocol 000359 per E. Lyalka - smt","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7786823","version":"1","preferredName":"Short Physical Performance Battery 37 Total Balance Tests Score Text","preferredDefinition":"Text field for Total Balance Test Score.","longName":"SPPB_37_TXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"SPPB:Short Physical Performance Battery, Guralnik JM, Simonsick EM, Ferrucci L, et al.J Gerontol. 1994;49(2):M85-94.","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CC7362B3-6313-1405-E053-4EBD850AD650","latestVersionIndicator":"Yes","beginDate":"2021-09-20","endDate":null,"createdBy":"TSESU","dateCreated":"2021-09-20","modifiedBy":"TSESU","dateModified":"2021-09-29","changeNote":"Created for CCR protocol 000359 per E. Lyalka - smt","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7786824","version":"1","preferredName":"Short Physical Performance Battery 38 Gait Speed Test Score Text","preferredDefinition":"Text field for gait speed test score.","longName":"SPPB_38_TXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"SPPB:Short Physical Performance Battery, Guralnik JM, Simonsick EM, Ferrucci L, et al.J Gerontol. 1994;49(2):M85-94.","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CC7362B3-6341-1405-E053-4EBD850AD650","latestVersionIndicator":"Yes","beginDate":"2021-09-20","endDate":null,"createdBy":"TSESU","dateCreated":"2021-09-20","modifiedBy":"TSESU","dateModified":"2021-09-29","changeNote":"Created for CCR protocol 000359 per E. Lyalka - smt","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7786825","version":"1","preferredName":"Short Physical Performance Battery 39 Ability to Rise from a Chair Score Text","preferredDefinition":"Text field for chair stand test score.","longName":"SPPB_39_TXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"SPPB:Short Physical Performance Battery, Guralnik JM, Simonsick EM, Ferrucci L, et al.J Gerontol. 1994;49(2):M85-94.","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CC7362B3-636F-1405-E053-4EBD850AD650","latestVersionIndicator":"Yes","beginDate":"2021-09-20","endDate":null,"createdBy":"TSESU","dateCreated":"2021-09-20","modifiedBy":"TSESU","dateModified":"2021-09-29","changeNote":"Created for CCR protocol 000359 per E. Lyalka - smt","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7786826","version":"1","preferredName":"Short Physical Performance Battery 40 Complete SPPB Total Score Text","preferredDefinition":"Text field for the complete Short Physical Performance Battery total score.","longName":"SPPB_40_TXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"SPPB:Short Physical Performance Battery, Guralnik JM, Simonsick EM, Ferrucci L, et al.J Gerontol. 1994;49(2):M85-94.","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CC737BEA-DC98-4100-E053-4EBD850A8200","latestVersionIndicator":"Yes","beginDate":"2021-09-20","endDate":null,"createdBy":"TSESU","dateCreated":"2021-09-20","modifiedBy":"TSESU","dateModified":"2021-09-29","changeNote":"Created for CCR protocol 000359 per E. Lyalka - smt","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7786837","version":"1","preferredName":"Total Lesion Contrast Enhanced PET-CT Scan Percent Change From Baseline Percentage Value","preferredDefinition":"The numerical response that indicates the percentage change of total lesion contrast enhanced PET-CT scan as compared at some baseline event or timepoint.","longName":"TOT_LSN_CHG_PCT_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CC75837F-28B1-7482-E053-4EBD850A2300","latestVersionIndicator":"Yes","beginDate":"2021-09-20","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2021-09-20","modifiedBy":"HARTLEYG","dateModified":"2021-09-23","changeNote":"Curated to support protocol 000080_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7788419","version":"1","preferredName":"Short Physical Performance Battery 23 Shorter of Two Times for Gait Speed Test Value","preferredDefinition":"The number value in seconds of the shorter of the two times for the gait speed test.","longName":"SPPB_23_TXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"SPPB:Short Physical Performance Battery, Guralnik JM, Simonsick EM, Ferrucci L, et al.J Gerontol. 1994;49(2):M85-94.","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CC9C7B8B-CC90-1839-E053-4EBD850AFDFE","latestVersionIndicator":"Yes","beginDate":"2021-09-22","endDate":null,"createdBy":"TSESU","dateCreated":"2021-09-22","modifiedBy":"TSESU","dateModified":"2021-09-29","changeNote":"Created for CCR protocol 000359 per E. Lyalka - smt","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7788420","version":"1","preferredName":"Short Physical Performance Battery 24 Gait Speed Test Time if Only One Walk Completed Value","preferredDefinition":"The number value in seconds if only one of the two gait speed tests were completed.","longName":"SPPB_24_TXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"SPPB:Short Physical Performance Battery, Guralnik JM, Simonsick EM, Ferrucci L, et al.J Gerontol. 1994;49(2):M85-94.","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CC975616-F502-3C8F-E053-4EBD850AAFD0","latestVersionIndicator":"Yes","beginDate":"2021-09-22","endDate":null,"createdBy":"TSESU","dateCreated":"2021-09-22","modifiedBy":"TSESU","dateModified":"2021-09-29","changeNote":"Created for CCR protocol 000359 per E. Lyalka - smt","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7788421","version":"1","preferredName":"Short Physical Performance Battery 25 Unable to Complete Gait Speed Test Score","preferredDefinition":"Patient was unable to complete the gait speed test.","longName":"SPPB_25_TXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"SPPB:Short Physical Performance Battery, Guralnik JM, Simonsick EM, Ferrucci L, et al.J Gerontol. 1994;49(2):M85-94.","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CC9CF874-962E-55E4-E053-4EBD850A16C3","latestVersionIndicator":"Yes","beginDate":"2021-09-22","endDate":null,"createdBy":"TSESU","dateCreated":"2021-09-22","modifiedBy":"TSESU","dateModified":"2021-09-29","changeNote":"Created for CCR protocol 000359 per E. Lyalka - smt","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7794952","version":"1","preferredName":"Opportunistic Infection Onset Date","preferredDefinition":"The date of the onset of opportunistic infection.","longName":"OPP_INFECT_ONSET_DT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CDA0A38F-823C-0777-E053-4EBD850A35CD","latestVersionIndicator":"Yes","beginDate":"2021-10-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2021-10-05","modifiedBy":"HARTLEYG","dateModified":"2021-10-07","changeNote":"Curated to support protocol 21C0026_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7794954","version":"1","preferredName":"Neoplasm Edema Laterality Name","preferredDefinition":"The response indicating the laterality of the edema due to a neoplasm.","longName":"NEO_EDEMA_LAT_NAME","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CDA05739-19A7-795A-E053-4EBD850A1CE3","latestVersionIndicator":"Yes","beginDate":"2021-10-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2021-10-05","modifiedBy":"HARTLEYG","dateModified":"2021-10-07","changeNote":"Curated to support protocol 21C0026_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7794955","version":"1","preferredName":"Edema Anatomic Site Name","preferredDefinition":"The anatomic site where edema was measured.","longName":"EDEMA_ANATSITE_NAME","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CDA40369-1602-7C07-E053-4EBD850A3A92","latestVersionIndicator":"Yes","beginDate":"2021-10-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2021-10-05","modifiedBy":"HARTLEYG","dateModified":"2021-10-07","changeNote":"Curated to support protocol 21C0026_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7794956","version":"1","preferredName":"Edema Anatomic Site Diameter Measurement","preferredDefinition":"The numeric response indicating the diameter of the anatomic site affected by edema.","longName":"EDEMA_DIAM_MSMT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CD9F32F1-7CFA-2439-E053-4EBD850ACFFF","latestVersionIndicator":"Yes","beginDate":"2021-10-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2021-10-05","modifiedBy":"HARTLEYG","dateModified":"2021-10-07","changeNote":"Curated to support protocol 21C0026_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7794957","version":"1","preferredName":"Edema Anatomic Site Distance Measurement","preferredDefinition":"The numeric response indicating the distance between anatomic sites measured for edema.","longName":"EDEMA_DIST_MSMT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CDA0C499-1A6A-6799-E053-4EBD850A004C","latestVersionIndicator":"Yes","beginDate":"2021-10-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2021-10-05","modifiedBy":"HARTLEYG","dateModified":"2021-10-07","changeNote":"Curated to support protocol 21C0026_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7801224","version":"1","preferredName":"Malignant Neoplasm Diagnosis Histology Name","preferredDefinition":"The histologic cell type used to diagnosis the abnormal morphologic characteristics of a tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues.","longName":"MLG_NPL_HX_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CF6DFBF2-CF08-5F7B-E053-4EBD850AF61A","latestVersionIndicator":"Yes","beginDate":"2021-10-28","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2021-10-28","modifiedBy":"HARTLEYG","dateModified":"2021-12-02","changeNote":"Curated to support import into C3D based on the NCI Standard_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7801246","version":"1","preferredName":"Montreal Cognitive Assessment Version 7.1 Total Score","preferredDefinition":"The total sum of the scores.","longName":"MOCA_V7_1_TOTAL_SCR","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"MoCA:Montreal Cognitive Assessment; Z.S.Nasreddine et al., J AM Geriatric Society (2005)","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CF807F3C-242E-47C7-E053-4EBD850AEBC0","latestVersionIndicator":"Yes","beginDate":"2021-10-29","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-10-29","modifiedBy":"KUMMEROA","dateModified":"2021-11-30","changeNote":"2021-10-29 ak Created for Protocol 00359.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7801844","version":"1","preferredName":"Montreal Cognitive Assessment Version 7.1 Memory, 1st Trial Test Score","preferredDefinition":"The score of the Memory - 1st Trial test.","longName":"MOCA_MEM_1_V7_1_SCR","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CFE15CE0-7BF0-4BBA-E053-4EBD850A9385","latestVersionIndicator":"Yes","beginDate":"2021-11-03","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-11-03","modifiedBy":"KUMMEROA","dateModified":"2021-11-30","changeNote":"2021-11-3 ak Created for Protocol 00359.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7801848","version":"1","preferredName":"Montreal Cognitive Assessment Version 7.1 Memory, 2nd Trial Test Score","preferredDefinition":"The score of the Memory - 2nd Trial test.","longName":"MOCA_MEM_2_V7_1_SCR","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CFE1447A-BCE9-4BAC-E053-4EBD850AB108","latestVersionIndicator":"Yes","beginDate":"2021-11-03","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-11-03","modifiedBy":"KUMMEROA","dateModified":"2021-11-30","changeNote":"2021-11-3 ak Created for Protocol 00359.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7801852","version":"1","preferredName":"Lawton-Brody Instrumental Activities of Daily Living Scale Total Score","preferredDefinition":"The total sum of the scores.","longName":"LB_IADL_TOTAL_SCR","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CFE15CE0-7C57-4BBA-E053-4EBD850A9385","latestVersionIndicator":"Yes","beginDate":"2021-11-03","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-11-03","modifiedBy":"KUMMEROA","dateModified":"2021-11-03","changeNote":"2021-11-3 ak Created for Protocol 00359.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7826385","version":"1","preferredName":"Mantle Cell Lymphoma International Prognostic Index Risk Assessment Score","preferredDefinition":"Prognostic index score predictive of outcome in advanced mantle cell lymphoma based on four factors that have independent prognostic relevance including age, performance status, LDH, and white blood cell count (WBC).","longName":"MIPI_RISK_SCORE","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D071FCAC-BA64-5EDA-E053-4EBD850AE820","latestVersionIndicator":"Yes","beginDate":"2021-11-10","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2021-11-10","modifiedBy":"HARTLEYG","dateModified":"2021-12-02","changeNote":"Curated to support C3D Trial_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7974902","version":"1","preferredName":"Polygenic Risk Score Assessment Number","preferredDefinition":"Numeric value to represent the polygenic risk assessment score.","longName":"PRS_ASSMT_NUM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"D2CC1A47-F5CF-1DAD-E053-4EBD850AB280","latestVersionIndicator":"Yes","beginDate":"2021-12-10","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-12-10","modifiedBy":"KUMMEROA","dateModified":"2021-12-10","changeNote":"2021-12-10 ak Created for 19C0040 study.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7974928","version":"1","preferredName":"Reference Object Sequence Identifier","preferredDefinition":"The string of characters used to identify the reference object sequence.","longName":"REF_SEQU_IDENTFY","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"D2CD4E5C-7110-3957-E053-4EBD850ACB82","latestVersionIndicator":"Yes","beginDate":"2021-12-10","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-12-10","modifiedBy":"KUMMEROA","dateModified":"2021-12-10","changeNote":"2021-12-10 ak Created for 19C0040 study.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7974929","version":"1","preferredName":"Reference Object Sequence Name","preferredDefinition":"A textual description of the reference object sequence name.","longName":"RFNC_SEQU_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"D2CD5B84-9A53-296B-E053-4EBD850AE486","latestVersionIndicator":"Yes","beginDate":"2021-12-10","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-12-10","modifiedBy":"KUMMEROA","dateModified":"2021-12-10","changeNote":"2021-12-10 ak Created for 19C0040 study.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7974930","version":"1","preferredName":"Protein Sequence Change Identifier","preferredDefinition":"The string of characters used to identify the protein sequence change.","longName":"PRTN_SEQU_CHNG_IDENT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"D2CD6C4A-9C7B-69DD-E053-4EBD850AD5EE","latestVersionIndicator":"Yes","beginDate":"2021-12-10","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-12-10","modifiedBy":"KUMMEROA","dateModified":"2021-12-10","changeNote":"2021-12-10 ak Created for 19C0040 study.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7979585","version":"1","preferredName":"Treatment Cohort Study Name","preferredDefinition":"The text response that represents the name of a patient's cohort.","longName":"COHORT_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D35B7258-DD64-377A-E053-4EBD850AE87E","latestVersionIndicator":"Yes","beginDate":"2021-12-17","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2021-12-17","modifiedBy":"HARTLEYG","dateModified":"2021-12-17","changeNote":"Curated to support CCR_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7979586","version":"1","preferredName":"Treatment Cohort Study Description Text","preferredDefinition":"The text response that describes the patient's cohort.","longName":"COHORT_DESC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D35B8F5F-EAE7-1C99-E053-4EBD850ACDF9","latestVersionIndicator":"Yes","beginDate":"2021-12-17","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2021-12-17","modifiedBy":"HARTLEYG","dateModified":"2021-12-17","changeNote":"Curated to support CCR_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7979587","version":"1","preferredName":"Protocol Treatment Arm Description Text","preferredDefinition":"The text response that describes the patient's protocol treatment arm.","longName":"ARM_DESC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D35B7A9B-4A7C-031E-E053-4EBD850A4B3B","latestVersionIndicator":"Yes","beginDate":"2021-12-17","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2021-12-17","modifiedBy":"HARTLEYG","dateModified":"2021-12-17","changeNote":"Curated to support CCR_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7979588","version":"1","preferredName":"Protocol Treatment Arm Description Text Name","preferredDefinition":"The text response that represents the name of a patient's protocol treatment arm.","longName":"ARM_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D35BD003-CB34-37A1-E053-4EBD850A501C","latestVersionIndicator":"Yes","beginDate":"2021-12-17","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2021-12-17","modifiedBy":"HARTLEYG","dateModified":"2021-12-17","changeNote":"Curated to support CCR_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7994638","version":"1","preferredName":"High Risk Prostate Cancer Feature Present Indicator","preferredDefinition":"Text term to signify whether high risk prostate cancer features were present.","longName":"HG_RSK_PST_CA_FT_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"D4B32F77-8C85-5EDE-E053-4EBD850A5365","latestVersionIndicator":"Yes","beginDate":"2022-01-03","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-01-03","modifiedBy":"KUMMEROA","dateModified":"2022-01-03","changeNote":"2022-1-3 ak Created for High Genetic Risk for Prostate Cancer.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8027586","version":"1","preferredName":"EORTC Quality of Life Questionnaire-Core 30 Administered Yes No Indicator","preferredDefinition":"The response indicating whether or not the EORTC-C30 Quality of Life questionnaire was administered to the patient.","longName":"EORTC_C30_ADM_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D71DFA76-7C69-4B80-E053-4EBD850A425A","latestVersionIndicator":"Yes","beginDate":"2022-02-03","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2022-02-03","modifiedBy":"HARTLEYG","dateModified":"2022-02-07","changeNote":"Curated to support protocol 000356_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8027587","version":"1","preferredName":"National Institutes of Health Myelodysplastic Syndrome Adult Psychosocial Assessment Administered Yes No Indicator","preferredDefinition":"The response indicating whether or not the NIH Myelodysplastic Adult Psychosocial Assessment was administered to the patient.","longName":"NIH_MDS_PSCSL_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D71E0336-A6BC-66FE-E053-4EBD850A8F93","latestVersionIndicator":"Yes","beginDate":"2022-02-03","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2022-02-03","modifiedBy":"HARTLEYG","dateModified":"2022-02-07","changeNote":"Curated to support protocol 000356_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8029004","version":"1","preferredName":"Clinical Frailty Scale Assessment Score","preferredDefinition":"The numeric value representing an elderly patient's fitness and frailty.","longName":"CNCL_FRLT_SC_SCORE","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D770F865-DA89-3D13-E053-4EBD850AD217","latestVersionIndicator":"Yes","beginDate":"2022-02-07","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2022-02-07","modifiedBy":"HARTLEYG","dateModified":"2022-02-07","changeNote":"Curated to support protocol 000356_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8029005","version":"1","preferredName":"Myelodysplastic Syndrome-Specific Comorbidity Index Risk Status Category","preferredDefinition":"The text term assigned to represent the predictive effect of commodities on outcomes in myelodysplastic syndromes combining the effect of five comorbidity factors and identifying three groups of MDS patients with probabilities of non-leukemic death and survival.","longName":"MDS_CI_RSK_STS_CAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D772CCB9-E304-0445-E053-4EBD850A7EE8","latestVersionIndicator":"Yes","beginDate":"2022-02-07","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2022-02-07","modifiedBy":"HARTLEYG","dateModified":"2022-02-07","changeNote":"Curated to support protocol 000356_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8029219","version":"1","preferredName":"Mutation Abnormality Clinical Significance Identification Name","preferredDefinition":"The text used to identify a variation in a genetic sequence whose association with disease risk is clinically significant.","longName":"MUT_ABN_CLSIG_NAME","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D7729366-73F3-148A-E053-4EBD850AE0DD","latestVersionIndicator":"Yes","beginDate":"2022-02-07","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2022-02-07","modifiedBy":"HARTLEYG","dateModified":"2022-02-11","changeNote":"Curated to support protocol 000302","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8029229","version":"1","preferredName":"Genetic Variation Unknown Clinical Significance Identification Name","preferredDefinition":"The text used to identify a variation in a genetic sequence whose association with disease risk is unknown.","longName":"GEN_VAR_UNK_ID_NAME","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D7736C07-5CA3-135A-E053-4EBD850ABAB2","latestVersionIndicator":"Yes","beginDate":"2022-02-07","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2022-02-07","modifiedBy":"GDEEN","dateModified":"2022-07-14","changeNote":"Curated to support protocol 000302","administrativeNotes":"07.14.22_Released as part of quarterly metrics updates_ghd","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8029261","version":"1","preferredName":"PD-L1 Positive Identification Test Method Type","preferredDefinition":"The response that indicates the test method used to identity positive PD-L1 expression.","longName":"PDL1_POS_ID_MTH_TYP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D773E05D-266A-776E-E053-4EBD850ABC44","latestVersionIndicator":"Yes","beginDate":"2022-02-07","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2022-02-07","modifiedBy":"HARTLEYG","dateModified":"2022-02-11","changeNote":"Curated to support protocol 000302_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8038400","version":"1","preferredName":"PD-L1 Positive Identification Test Method Other Specify","preferredDefinition":"The response that indicates the test method used to identity positive PD-L1 expression not previously listed.","longName":"PDL1_POS_MTH_SPEC","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D7C566F9-1B9E-553C-E053-4EBD850A3AB9","latestVersionIndicator":"Yes","beginDate":"2022-02-11","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2022-02-11","modifiedBy":"GDEEN","dateModified":"2022-07-14","changeNote":"Curated to support protocol 000302_ghd","administrativeNotes":"07.14.22_Released as part of quarterly metrics updates_ghd","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8070680","version":"1","preferredName":"Target Lesion Response ITMIG MRECIST Criteria Type","preferredDefinition":"Text term to represent disease response in a target lesion using the ITMIG MRECIST criteria.","longName":"LES_ITMIG_MRECIST_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"D9685735-0966-249A-E053-4EBD850A19ED","latestVersionIndicator":"Yes","beginDate":"2022-03-04","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-03-04","modifiedBy":"KUMMEROA","dateModified":"2022-03-04","changeNote":"2022-3-4 ak Created for CCR.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8177930","version":"1","preferredName":"Agent Administration Unit of Measure Other Specify","preferredDefinition":"The free-text description of the agent's other unit of measure.","longName":"AGNT_ADMN_UOM_SP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DDB66F1B-B6E1-2817-E053-4EBD850AE11F","latestVersionIndicator":"Yes","beginDate":"2022-04-28","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-04-28","modifiedBy":"GDEEN","dateModified":"2022-07-14","changeNote":null,"administrativeNotes":"07.14.22_Released as part of quarterly metrics updates_ghd","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10148707","version":"1","preferredName":"Data Field Record Indicator","preferredDefinition":"Text term to signify whether the recorded data field was estimated.","longName":"DATA_FLD_EST_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DDE5A4E5-4B5E-5E37-E053-731AD00A299D","latestVersionIndicator":"Yes","beginDate":"2022-05-10","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-05-10","modifiedBy":"KUMMEROA","dateModified":"2022-05-24","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10148806","version":"1","preferredName":"Cause of Death Malignant Neoplasm Related Indicator","preferredDefinition":"Text term to signify whether the cause of death was cancer related.","longName":"COD_CA_REL_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DDE5A4E5-4BC4-5E37-E053-731AD00A299D","latestVersionIndicator":"Yes","beginDate":"2022-05-10","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-05-10","modifiedBy":"KUMMEROA","dateModified":"2022-05-24","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10148807","version":"1","preferredName":"Employment Outside Of Home Status Indicator","preferredDefinition":"Text term to signify whether there was employment outside of the home.","longName":"EMPLY_OTSD_HM_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DDE5A4E5-4BC7-5E37-E053-731AD00A299D","latestVersionIndicator":"Yes","beginDate":"2022-05-10","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-05-10","modifiedBy":"KUMMEROA","dateModified":"2022-05-24","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10150288","version":"1","preferredName":"Cancer Diagnosis Indicator","preferredDefinition":"Text term to signify whether there was cancer diagnosis.","longName":"CA_DX_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DDE5F7A4-7433-5D7D-E053-731AD00AA191","latestVersionIndicator":"Yes","beginDate":"2022-05-10","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-05-10","modifiedBy":"DWARZEL","dateModified":"2022-05-24","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10151975","version":"1","preferredName":"Person Birth Order Number","preferredDefinition":"Numeric number of the person's birth order.","longName":"PRSN_BRTH_ORD_NUM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DDE5F7A4-7AD3-5D7D-E053-731AD00AA191","latestVersionIndicator":"Yes","beginDate":"2022-05-10","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-05-10","modifiedBy":"KUMMEROA","dateModified":"2022-05-24","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10151980","version":"1","preferredName":"Person Children Indicator","preferredDefinition":"Text term to signify whether or not a person has children.","longName":"PRSN_CHLDRN_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DDE5F7A4-7ADC-5D7D-E053-731AD00AA191","latestVersionIndicator":"Yes","beginDate":"2022-05-10","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-05-10","modifiedBy":"KUMMEROA","dateModified":"2022-05-24","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10151984","version":"1","preferredName":"Person Sibling Indicator","preferredDefinition":"Text term to signify whether a person has siblings.","longName":"PER_SIBLNG_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DDE5F7A4-7AE0-5D7D-E053-731AD00AA191","latestVersionIndicator":"Yes","beginDate":"2022-05-10","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-05-10","modifiedBy":"KUMMEROA","dateModified":"2022-05-24","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10151987","version":"1","preferredName":"Person Full Sibling Count","preferredDefinition":"The number of full siblings a person has.","longName":"PRSN_FULL_SIB_CT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DDE5F7A4-7AE2-5D7D-E053-731AD00AA191","latestVersionIndicator":"Yes","beginDate":"2022-05-10","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-05-10","modifiedBy":"KUMMEROA","dateModified":"2022-11-07","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10151990","version":"1","preferredName":"Person Sibling Yes No Indicator","preferredDefinition":"Text term to signify whether or not a person has any siblings.","longName":"PRSN_SIB_Y_N_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DE1DD1B6-F925-5D79-E053-731AD00A650C","latestVersionIndicator":"Yes","beginDate":"2022-05-10","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-05-10","modifiedBy":"KUMMEROA","dateModified":"2022-05-24","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10152620","version":"1","preferredName":"Multiple Neoplasm Diagnosis Indicator","preferredDefinition":"Text term to signify whether there was more than one cancer diagnosis.","longName":"MULT_CA_DX_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DE1DD1B6-FB9E-5D79-E053-731AD00A650C","latestVersionIndicator":"Yes","beginDate":"2022-05-10","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-05-10","modifiedBy":"KUMMEROA","dateModified":"2022-05-24","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10152635","version":"1","preferredName":"Malignant Neoplasm Parent Related Indicator","preferredDefinition":"Text term to signify whether a diagnosed malignant neoplasm was related to a parent.","longName":"CA_PRNT_REL_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DEAE2982-8872-5D6D-E053-731AD00AC1B5","latestVersionIndicator":"Yes","beginDate":"2022-05-10","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-05-10","modifiedBy":"KUMMEROA","dateModified":"2022-05-24","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10152637","version":"1","preferredName":"Malignant Neoplasm Other Biological Relative Diagnosis Indicator","preferredDefinition":"Text term to signify whether other biological family members were diagnosed with a malignant neoplasm.","longName":"OT_BIO_REL_CA_DX_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DEAE2982-8877-5D6D-E053-731AD00AC1B5","latestVersionIndicator":"Yes","beginDate":"2022-05-10","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-05-10","modifiedBy":"KUMMEROA","dateModified":"2022-05-24","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10152638","version":"1","preferredName":"Malignant Neoplasm Other Biological Relative Diagnosis Count","preferredDefinition":"The number of other biological relatives that have been diagnosed with a malignant neoplasm.","longName":"OT_BIO_REL_CA_DX_CNT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DEAED41F-23BE-5D71-E053-731AD00A2B4D","latestVersionIndicator":"Yes","beginDate":"2022-05-10","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-05-10","modifiedBy":"KUMMEROA","dateModified":"2022-05-24","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10156012","version":"1","preferredName":"Person Half Sibling Count","preferredDefinition":"The number of half siblings a person has.","longName":"PRSN_HALF_SIB_CT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DEBD4660-EF19-1FBB-E053-731AD00A3827","latestVersionIndicator":"Yes","beginDate":"2022-05-11","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-05-11","modifiedBy":"DWARZEL","dateModified":"2022-05-24","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10156341","version":"1","preferredName":"Person Parent Unknown Adopted Indicator","preferredDefinition":"Text term to signify whether a person was  adopted and parents are unknown.","longName":"PRS_ADPT_PNT_UNK_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DEBD4660-EF69-1FBB-E053-731AD00A3827","latestVersionIndicator":"Yes","beginDate":"2022-05-11","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-05-11","modifiedBy":"DWARZEL","dateModified":"2022-05-24","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10156751","version":"1","preferredName":"Person Occupation Category","preferredDefinition":"The text term that describes a person's occupation.","longName":"PRSN_OCCUPTN_CAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DEAED41F-2811-5D71-E053-731AD00A2B4D","latestVersionIndicator":"Yes","beginDate":"2022-05-11","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-05-11","modifiedBy":"GDEEN","dateModified":"2023-11-14","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10348376","version":"1","preferredName":"Personal Medical History Disease or Disorder Diagnosis Type","preferredDefinition":"A textual description of a person's disease diagnosis.","longName":"PRSN_DS_DX_TY","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DFA627E9-B85A-49F8-E053-731AD00A5194","latestVersionIndicator":"Yes","beginDate":"2022-05-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-05-23","modifiedBy":"DWARZEL","dateModified":"2022-05-24","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10348381","version":"1","preferredName":"Biological Parent Half Sibling Relationship Type","preferredDefinition":"A textual description of the biological parent the half sibling is related to.","longName":"PRNT_HALF_SIB_REL_TP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DFAE79AA-04FE-49F6-E053-731AD00A614B","latestVersionIndicator":"Yes","beginDate":"2022-05-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-05-23","modifiedBy":"KUMMEROA","dateModified":"2022-05-24","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10457626","version":"1","preferredName":"PROMIS Short Form v1.0 Fatigue 10a Administered Yes No Indicator","preferredDefinition":"The response indicating whether or not the PROMIS Fatigue Short Form 10a assessment was administered.","longName":"PROMIS_FTGSF_10A_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DFC1DD82-7D89-2FB8-E053-731AD00AE15F","latestVersionIndicator":"Yes","beginDate":"2022-06-09","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-06-09","modifiedBy":"GDEEN","dateModified":"2022-07-18","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10457627","version":"1","preferredName":"PROMIS Pediatric Short Form - Pain Interference Administered Yes No Indicator","preferredDefinition":"The response indicating whether or not the PROMIS Pediatric Short Form - Pain Interference assessment was administered.","longName":"PROMIS_PEDPAINSF_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DFC1DD82-7D8B-2FB8-E053-731AD00AE15F","latestVersionIndicator":"Yes","beginDate":"2022-06-09","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-06-09","modifiedBy":"GDEEN","dateModified":"2022-07-18","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10457628","version":"1","preferredName":"PROMIS Global Health Questionnaire Administered Yes No Indicator","preferredDefinition":"The response indicating whether or not the PROMIS Global Health Questionnaire was administered.","longName":"PROMIS_GHQ_ADM_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DFC1DD82-7D8D-2FB8-E053-731AD00AE15F","latestVersionIndicator":"Yes","beginDate":"2022-06-09","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-06-09","modifiedBy":"GDEEN","dateModified":"2022-07-18","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10457640","version":"1","preferredName":"Psychosocial Assessment Administered Yes No Indicator","preferredDefinition":"The response indicating whether or not the psychosocial assessment was administered.","longName":"PSYSOC_ASMT_ADM_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E10A6ABC-4AE1-2FAE-E053-731AD00A4F5C","latestVersionIndicator":"Yes","beginDate":"2022-06-09","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-06-09","modifiedBy":"GDEEN","dateModified":"2022-07-18","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10576715","version":"1","preferredName":"Adverse Event Multi-agent Therapeutic Regimens Attribution Two Tier Category","preferredDefinition":"Text term representing the causal relationship between the multi-agent therapeutic regimen and the specific adverse event.","longName":"AE_ATRB_CAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E3B7C935-425C-658A-E053-731AD00A5972","latestVersionIndicator":"Yes","beginDate":"2022-07-13","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-07-13","modifiedBy":"GDEEN","dateModified":"2022-07-18","changeNote":"Created for help with AE attribution request. mc 2.17.21 VD/CDE versioned to change VM names. 4.8.21 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"11251171","version":"1","preferredName":"Adverse Event Graft Versus Host Disease Relationship Yes No Indicator","preferredDefinition":"The indication of whether or not the adverse event is related to the disease/disorder of graft versus host disease.","longName":"AE_GVHD_REL_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E8BBFEBE-FB09-3B83-E053-731AD00A314C","latestVersionIndicator":"Yes","beginDate":"2022-09-15","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-09-15","modifiedBy":"GDEEN","dateModified":"2022-09-16","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"11253448","version":"1","preferredName":"Adverse Event BK Virus Infection Relationship Yes No Indicator","preferredDefinition":"The indication of whether or not the adverse event is related to the BK virus infection.","longName":"AE_BK_REL_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E8C0CE77-1AEE-5C2E-E053-731AD00A16A5","latestVersionIndicator":"Yes","beginDate":"2022-09-15","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-09-15","modifiedBy":"GDEEN","dateModified":"2022-09-16","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"11253449","version":"1","preferredName":"Adverse Event Cytomegaloviral Infection Relationship Yes No Indicator","preferredDefinition":"The indication of whether or not the adverse event is related to the cytomegaloviral infection.","longName":"AE_CMV_REL_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E8C0D8D9-1FE9-5D53-E053-731AD00ACDB5","latestVersionIndicator":"Yes","beginDate":"2022-09-15","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-09-15","modifiedBy":"GDEEN","dateModified":"2022-09-16","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"11253450","version":"1","preferredName":"Adverse Event HIV Infection Relationship Yes No Indicator","preferredDefinition":"The indication of whether or not the adverse event is related to the HIV infection.","longName":"AE_HIV_REL_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E8C0DEAE-0CF8-5DF8-E053-731AD00A991E","latestVersionIndicator":"Yes","beginDate":"2022-09-15","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-09-15","modifiedBy":"GDEEN","dateModified":"2022-09-16","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"11253451","version":"1","preferredName":"Adverse Event Immune Reconstitution Inflammatory Syndrome Associated with Kaposi Sarcoma Relationship Yes No Indicator","preferredDefinition":"The indication of whether or not the adverse event is related to the immune reconstitution inflammatory syndrome associated with Kaposi sarcoma.","longName":"AE_IRIS_REL_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E8C0E624-B748-5EE2-E053-731AD00AEFA2","latestVersionIndicator":"Yes","beginDate":"2022-09-15","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-09-15","modifiedBy":"GDEEN","dateModified":"2022-09-16","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"11495706","version":"1","preferredName":"Pharmacologic Substance Manufacture Dose Fulfill Yes No Indicator","preferredDefinition":"The response indicating whether or not the drug manufacturing met the dose level requirements.","longName":"MANU_DOSE_FUFILL_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EBF3C6B3-28F5-5AE8-E053-731AD00AD5ED","latestVersionIndicator":"Yes","beginDate":"2022-10-26","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-10-26","modifiedBy":"GDEEN","dateModified":"2022-10-26","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"11495710","version":"1","preferredName":"Patient Anakinra Receive Yes No Indicator","preferredDefinition":"The response indicating whether a not a patient received anakinra.","longName":"PT_ANKNR_RCV_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EBF3CFB0-EB15-5BE8-E053-731AD00A2774","latestVersionIndicator":"Yes","beginDate":"2022-10-26","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-10-26","modifiedBy":"GDEEN","dateModified":"2022-10-26","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"11529113","version":"1","preferredName":"Assessment Estimated Right Atrial Pressure Blood Pressure Value","preferredDefinition":"Numeric representation of the estimated blood pressure in milligrams of mercury within the right atrium measured in millimeters of mercury. It is determined by the interaction of the heart's pumping ability (cardiac function) and the return of blood to the heart (return function).","longName":"EST_RAP_VAL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EC9C7746-DE21-5212-E053-731AD00A3148","latestVersionIndicator":"Yes","beginDate":"2022-11-03","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-11-03","modifiedBy":"GDEEN","dateModified":"2022-11-07","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"11532092","version":"1","preferredName":"Systemic Corticosteroid First-Line Therapy Start Date","preferredDefinition":"The month, day, and year of the start of systemic corticosteroid first-line therapy.","longName":"SYS_CRTSTRD_TX_ST_DT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"ECA87D3A-0C3F-0C03-E053-731AD00AED33","latestVersionIndicator":"Yes","beginDate":"2022-11-04","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-11-04","modifiedBy":"GDEEN","dateModified":"2022-11-15","changeNote":null,"administrativeNotes":"Curated to support Protocol 15C0067","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"11532093","version":"1","preferredName":"Second-Line Therapy Post Failure After First Systemic Corticosteroid Therapy Start Date","preferredDefinition":"The month, day, and year of the start of second-line therapy after failure of systemic corticosteroid first-line therapy.","longName":"SCDLN_TX_ ST_DT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"ECA89683-690E-0EB9-E053-731AD00A33FA","latestVersionIndicator":"Yes","beginDate":"2022-11-04","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-11-04","modifiedBy":"GDEEN","dateModified":"2022-11-15","changeNote":null,"administrativeNotes":"Curated to support Protocol 15C0067","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12400025","version":"1","preferredName":"Adverse Event Associated with Serious Medical Event Yes No Indicator","preferredDefinition":"Any unfavorable or unintended disease, sign, or symptom (including an abnormal laboratory finding) that is temporally associated with the use of a medical treatment or procedure, and that may or may not be considered related to the medical treatment or procedure. Such events can be related to the intervention, dose, route of administration, patient, or caused by an interaction with another drug(s) or procedure(s)._An indication or description of an adverse event associated with a critical medical event.:The preferred Value Domain to indicate a question with permissible values of yes/no.","longName":"MEDEVENT_YN","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F29604E8-7776-4AC8-E053-731AD00A4C56","latestVersionIndicator":"Yes","beginDate":"2023-01-18","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-01-18","modifiedBy":"GDEEN","dateModified":"2023-05-31","changeNote":null,"administrativeNotes":"01/18/23_Curated to support AE_SURV_ghd","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12492610","version":"1","preferredName":"Primary Cause of Death Principal Investigator Reported Information Descriptive Text","preferredDefinition":"The first significant event which ultimately led to death.:An investigator who is responsible for all aspects of the conduct of a study._Information given about something.:The text that provides a description of a topic.","longName":"PRI_CSDTH_RPT_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F3859E82-2CAF-610C-E053-731AD00A1753","latestVersionIndicator":"Yes","beginDate":"2023-01-30","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-01-30","modifiedBy":"GDEEN","dateModified":"2023-02-13","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12914463","version":"1","preferredName":"Questionnaire Administered Name Text","preferredDefinition":"The name of the questionnaire administered to an individual.","longName":"QUST_ADM_NM_TEXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F526570C-665A-29A2-E053-731AD00A8661","latestVersionIndicator":"Yes","beginDate":"2023-02-20","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-02-20","modifiedBy":"GDEEN","dateModified":"2023-02-20","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12916875","version":"1","preferredName":"NCI Center for Cancer Research Diagnosis Name","preferredDefinition":"The response indicating the diagnosis name for a subject participating in CCR research.","longName":"CCR_DGNS_NAME","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"F5412F86-921B-4219-E053-731AD00A9696","latestVersionIndicator":"Yes","beginDate":"2023-02-21","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-02-21","modifiedBy":"GDEEN","dateModified":"2023-02-21","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12928555","version":"1","preferredName":"Radiation Surgery Radiation Arc Method Number","preferredDefinition":"The number of arcs in radiation therapy technique that delivers radiation directly to the tumor while sparing the healthy tissue.","longName":"RAD_ARC_NUM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F57C500D-6A6F-601B-E053-731AD00AF167","latestVersionIndicator":"Yes","beginDate":"2023-02-24","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-02-24","modifiedBy":"KUMMEROA","dateModified":"2023-03-03","changeNote":null,"administrativeNotes":"2023.3.3 Released per CCR review. ak","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12943959","version":"1","preferredName":"Prostate Carcinoma Combined Clinical Evaluation T Category","preferredDefinition":"Based on combined clinical observation, the extent of the primary prostate carcinoma based on information obtained from the date of cancer diagnosis until the start of definitive treatment, or within four months (whichever is shorter).","longName":"PC_CCLIN_T_CAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5D1185E-4C40-0A5C-E053-731AD00ADA9F","latestVersionIndicator":"Yes","beginDate":"2023-03-01","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-03-01","modifiedBy":"KUMMEROA","dateModified":"2023-03-03","changeNote":null,"administrativeNotes":"2023.3.3 Released per CCR review. ak","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12943960","version":"1","preferredName":"Prostate Carcinoma Digital Rectal Examination T Category","preferredDefinition":"Based on digital rectal examination, the extent of the primary prostate carcinoma based on information obtained from the date of cancer diagnosis until the start of definitive treatment, or within four months (whichever is shorter).","longName":"PC_DRE_T_CAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5D1185E-4C41-0A5C-E053-731AD00ADA9F","latestVersionIndicator":"Yes","beginDate":"2023-03-01","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-03-01","modifiedBy":"KUMMEROA","dateModified":"2023-03-03","changeNote":null,"administrativeNotes":"2023.3.3 Released per CCR review. ak","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12943961","version":"1","preferredName":"Prostate Carcinoma Magnetic Resonance Imaging T Category","preferredDefinition":"Based on MRI, the extent of the primary prostate carcinoma based on information obtained from the date of cancer diagnosis until the start of definitive treatment, or within four months (whichever is shorter).","longName":"PC_MRI_T_CAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5D1185E-4C42-0A5C-E053-731AD00ADA9F","latestVersionIndicator":"Yes","beginDate":"2023-03-01","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-03-01","modifiedBy":"KUMMEROA","dateModified":"2023-03-03","changeNote":null,"administrativeNotes":"2023.3.3 Released per CCR review. ak","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12943962","version":"1","preferredName":"Prostate Carcinoma PSMA PET Scan T Category","preferredDefinition":"Based on PSMA Pet scan, the extent of the primary prostate carcinoma based on information obtained from the date of cancer diagnosis until the start of definitive treatment, or within four months (whichever is shorter).","longName":"PC_PSMA_T_CAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5D1185E-4C43-0A5C-E053-731AD00ADA9F","latestVersionIndicator":"Yes","beginDate":"2023-03-01","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-03-01","modifiedBy":"KUMMEROA","dateModified":"2023-03-03","changeNote":null,"administrativeNotes":"2023.3.3 Released per CCR review. ak","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12943963","version":"1","preferredName":"Prostate Carcinoma PSMA-targeting Agent-Technetium Tc99m EC0652 PET Scan Category","preferredDefinition":"Based on PSMA-targeting Agent-Technetium Tc99m EC0652 PET scan, the extent of the primary prostate carcinoma based on information obtained from the date of cancer diagnosis until the start of definitive treatment, or within four months (whichever is shorter).","longName":"PC_TC99M_T_CAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5D1185E-4C44-0A5C-E053-731AD00ADA9F","latestVersionIndicator":"Yes","beginDate":"2023-03-01","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-03-01","modifiedBy":"KUMMEROA","dateModified":"2023-03-03","changeNote":null,"administrativeNotes":"2023.3.3 Released per CCR review. ak","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12943964","version":"1","preferredName":"Prostate Carcinoma Diagnostic Imaging Computed Tomography T Category","preferredDefinition":"Based on diagnostic CT scan, the extent of the primary prostate carcinoma based on information obtained from the date of cancer diagnosis until the start of definitive treatment, or within four months (whichever is shorter).","longName":"PC_DXCT_T_CAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5D11947-7F40-0A77-E053-731AD00A68A3","latestVersionIndicator":"Yes","beginDate":"2023-03-01","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-03-01","modifiedBy":"KUMMEROA","dateModified":"2023-03-03","changeNote":null,"administrativeNotes":"2023.3.3 Released per CCR review. ak","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12943965","version":"1","preferredName":"Prostate Carcinoma Clinical Observation N Stage Category","preferredDefinition":"Based on clinical observation, the extent of the regional lymph node involvement for prostate carcinoma based on evidence obtained from the date of cancer diagnosis until the start of definitive treatment, or within four months (whichever is shorter)","longName":"PC_CLIN_N_CAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5D11947-7F41-0A77-E053-731AD00A68A3","latestVersionIndicator":"Yes","beginDate":"2023-03-01","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-03-01","modifiedBy":"KUMMEROA","dateModified":"2023-03-03","changeNote":null,"administrativeNotes":"2023.3.3 Released per CCR review. ak","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12943966","version":"1","preferredName":"Prostate Carcinoma Magnetic Resonance Imaging N Stage Category","preferredDefinition":"Based on MRI, the extent of the regional lymph node involvement for prostate carcinoma based on evidence obtained from the date of cancer diagnosis until the start of definitive treatment, or within four months (whichever is shorter)","longName":"PC_MRI_N_CAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5D11947-7F42-0A77-E053-731AD00A68A3","latestVersionIndicator":"Yes","beginDate":"2023-03-01","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-03-01","modifiedBy":"KUMMEROA","dateModified":"2023-03-03","changeNote":null,"administrativeNotes":"2023.3.3 Released per CCR review. ak","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12943967","version":"1","preferredName":"Prostate Carcinoma PSMA PET Scan N Stage Category","preferredDefinition":"Based on PSMA PET scan, the extent of the regional lymph node involvement for prostate carcinoma based on evidence obtained from the date of cancer diagnosis until the start of definitive treatment, or within four months (whichever is shorter)","longName":"PC_PSMA_N_CAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5D11947-7F43-0A77-E053-731AD00A68A3","latestVersionIndicator":"Yes","beginDate":"2023-03-01","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-03-01","modifiedBy":"KUMMEROA","dateModified":"2023-03-03","changeNote":null,"administrativeNotes":"2023.3.3 Released per CCR review. ak","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12943968","version":"1","preferredName":"Prostate Carcinoma 99mTc-based PSMA-targeting Agent-Technetium Tc99m EC0652 PET Scan Category","preferredDefinition":"Based on  PSMA-targeting Agent-Technetium Tc99m EC0652 PET scan, the extent of the regional lymph node involvement for prostate carcinoma based on evidence obtained from the date of cancer diagnosis until the start of definitive treatment, or within four months (whichever is shorter)","longName":"PC_TC99M_N_CAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5D11947-7F44-0A77-E053-731AD00A68A3","latestVersionIndicator":"Yes","beginDate":"2023-03-01","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-03-01","modifiedBy":"KUMMEROA","dateModified":"2023-03-03","changeNote":null,"administrativeNotes":"2023.3.3 Released per CCR review. ak","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12943969","version":"1","preferredName":"Prostate Carcinoma Diagnostic Imaging Computed Tomography N Stage Category","preferredDefinition":"Based on diagnostic CT scan, the extent of the regional lymph node involvement for prostate carcinoma based on evidence obtained from the date of cancer diagnosis until the start of definitive treatment, or within four months (whichever is shorter)","longName":"PC_DXCT_N_CAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5D11947-7F4A-0A77-E053-731AD00A68A3","latestVersionIndicator":"Yes","beginDate":"2023-03-01","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-03-01","modifiedBy":"KUMMEROA","dateModified":"2023-03-03","changeNote":null,"administrativeNotes":"2023.3.3 Released per CCR review. ak","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12943970","version":"1","preferredName":"Prostate Carcinoma Clinical Observation M Stage Category","preferredDefinition":"Based on clinical observation, the extent of the distant metastasis for prostate carcinoma based on information obtained from the date of cancer diagnosis until the start of definitive treatment, or within four months (whichever is shorter).","longName":"PC_CLIN_M_CAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5D11947-7F4B-0A77-E053-731AD00A68A3","latestVersionIndicator":"Yes","beginDate":"2023-03-01","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-03-01","modifiedBy":"KUMMEROA","dateModified":"2023-03-03","changeNote":null,"administrativeNotes":"2023.3.3 Released per CCR review. ak","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12943971","version":"1","preferredName":"Prostate Carcinoma Magnetic Resonance Imaging M Stage Category","preferredDefinition":"Based on MRI, the extent of the distant metastasis for prostate carcinoma based on information obtained from the date of cancer diagnosis until the start of definitive treatment, or within four months (whichever is shorter).","longName":"PC_MRI_M_CAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5D11947-7F4C-0A77-E053-731AD00A68A3","latestVersionIndicator":"Yes","beginDate":"2023-03-01","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-03-01","modifiedBy":"KUMMEROA","dateModified":"2023-03-03","changeNote":null,"administrativeNotes":"2023.3.3 Released per CCR review. ak","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12943972","version":"1","preferredName":"Prostate Carcinoma PSMA PET Scan M Stage Category","preferredDefinition":"Based on PSMA PET scan, the clinical observation of the extent of the distant metastasis for prostate carcinoma based on information obtained from the date of cancer diagnosis until the start of definitive treatment, or within four months (whichever is shorter).","longName":"PC_PSMA_M_CAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5D11947-7F4D-0A77-E053-731AD00A68A3","latestVersionIndicator":"Yes","beginDate":"2023-03-01","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-03-01","modifiedBy":"KUMMEROA","dateModified":"2023-03-03","changeNote":null,"administrativeNotes":"2023.3.3 Released per CCR review. ak","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12943973","version":"1","preferredName":"Prostate Carcinoma PSMA-targeting Agent-Technetium Tc99m EC0652 PET Scan Category","preferredDefinition":"Based on PSMA-targeting Agent-Technetium Tc99m EC0652 PET scan, the clinical observation of the extent of the distant metastasis for prostate carcinoma based on information obtained from the date of cancer diagnosis until the start of definitive treatment, or within four months (whichever is shorter).","longName":"PC_TC99M_M_CAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5D11947-7F4E-0A77-E053-731AD00A68A3","latestVersionIndicator":"Yes","beginDate":"2023-03-01","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-03-01","modifiedBy":"KUMMEROA","dateModified":"2023-03-03","changeNote":null,"administrativeNotes":"2023.3.3 Released per CCR review. ak","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12943974","version":"1","preferredName":"Prostate Carcinoma Diagnostic Imaging Computed Tomography M Stage Category","preferredDefinition":"Based on diagnostic CT scan, the clinical observation of the extent of the distant metastasis for prostate carcinoma based on information obtained from the date of cancer diagnosis until the start of definitive treatment, or within four months (whichever is shorter).","longName":"PC_DXCT_M_CAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5D11AA2-3A16-0AB5-E053-731AD00A3B8E","latestVersionIndicator":"Yes","beginDate":"2023-03-01","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-03-01","modifiedBy":"KUMMEROA","dateModified":"2023-03-03","changeNote":null,"administrativeNotes":"2023.3.3 Released per CCR review. ak","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12943975","version":"1","preferredName":"Systematic Prostate Biopsy NCCN Prostate Cancer Risk Stratification Clinical Evaluation Category","preferredDefinition":"The NCCN prostate cancer risk stratification group using systematic prostate biopsy as determined by clinical observation.","longName":"SYSTBX_NCCN_CCLN_CAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5D11AA2-3A17-0AB5-E053-731AD00A3B8E","latestVersionIndicator":"Yes","beginDate":"2023-03-01","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-03-01","modifiedBy":"KUMMEROA","dateModified":"2023-03-03","changeNote":null,"administrativeNotes":"2023.3.3 Released per CCR review. ak","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12943976","version":"1","preferredName":"Systematic Prostate Biopsy NCCN Prostate Cancer Risk Stratification Magnetic Resonance Imaging Category","preferredDefinition":"The NCCN prostate cancer risk stratification group using systematic prostate biopsy as determined by magnetic resonance imaging.","longName":"SYSTBX_NCCN_MRI_CAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5D11AA2-3A18-0AB5-E053-731AD00A3B8E","latestVersionIndicator":"Yes","beginDate":"2023-03-01","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-03-01","modifiedBy":"KUMMEROA","dateModified":"2023-03-03","changeNote":null,"administrativeNotes":"2023.3.3 Released per CCR review. ak","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12943977","version":"1","preferredName":"Systematic Prostate Biopsy NCCN Prostate Cancer Risk Stratification PSMA PET Scan Category","preferredDefinition":"The NCCN prostate cancer risk stratification group using systematic prostate biopsy as determined by PSMA PET scan.","longName":"SYSTBX_NCCN_PSMA_CAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5D11AA2-3A19-0AB5-E053-731AD00A3B8E","latestVersionIndicator":"Yes","beginDate":"2023-03-01","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-03-01","modifiedBy":"KUMMEROA","dateModified":"2023-03-03","changeNote":null,"administrativeNotes":"2023.3.3 Released per CCR review. ak","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12943978","version":"1","preferredName":"Systematic Prostate Biopsy NCCN Prostate Cancer Risk Stratification PSMA-targeting Agent-Technetium Tc99m EC0652 PET Category","preferredDefinition":"The NCCN prostate cancer risk stratification group using systematic prostate biopsy as determined by PSMA-targeted agent-Technetium Tc99m EC0652 PET scan.","longName":"SYSTBX_NCCN_TC99M_CT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5D11AA2-3A1A-0AB5-E053-731AD00A3B8E","latestVersionIndicator":"Yes","beginDate":"2023-03-01","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-03-01","modifiedBy":"KUMMEROA","dateModified":"2023-03-06","changeNote":null,"administrativeNotes":"2023.3.6 Shortened (PET) LN due to Import issues. ak 2023.3.3 Released per CCR review. ak","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12943979","version":"1","preferredName":"Systematic Prostate Biopsy NCCN Prostate Cancer Risk Stratification Diagnostic Imaging Computed Tomography Category","preferredDefinition":"The NCCN prostate cancer risk stratification group using systematic prostate biopsy as determined by diagnostic CT scan.","longName":"SYSTBX_NCCN_DXCT_CAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5D11B44-0E21-0AD0-E053-731AD00A29A8","latestVersionIndicator":"Yes","beginDate":"2023-03-01","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-03-01","modifiedBy":"KUMMEROA","dateModified":"2023-03-03","changeNote":null,"administrativeNotes":"2023.3.3 Released per CCR review. ak","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12943980","version":"1","preferredName":"Targeted Prostate Biopsy NCCN Prostate Cancer Risk Stratification Clinical Evaluation Category","preferredDefinition":"The NCCN prostate cancer risk stratification group using targeted prostate biopsy as determined by clinical observation.","longName":"TGTBX_NCCN_CCLIN_CAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5D11B44-0E22-0AD0-E053-731AD00A29A8","latestVersionIndicator":"Yes","beginDate":"2023-03-01","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-03-01","modifiedBy":"KUMMEROA","dateModified":"2023-03-03","changeNote":null,"administrativeNotes":"2023.3.3 Released per CCR review. ak","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12943981","version":"1","preferredName":"Targeted Prostate Biopsy NCCN Prostate Cancer Risk Stratification Magnetic Resonance Imaging Category","preferredDefinition":"The NCCN prostate cancer risk stratification group using targeted prostate biopsy as determined by magnetic resonance imaging.","longName":"TGTBX_NCCN_MRI_CAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5D11B44-0E23-0AD0-E053-731AD00A29A8","latestVersionIndicator":"Yes","beginDate":"2023-03-01","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-03-01","modifiedBy":"KUMMEROA","dateModified":"2023-03-03","changeNote":null,"administrativeNotes":"2023.3.3 Released per CCR review. ak","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12943982","version":"1","preferredName":"Targeted Prostate Biopsy NCCN Prostate Cancer Risk Stratification PSMA PET Scan Category","preferredDefinition":"The NCCN prostate cancer risk stratification group using targeted prostate biopsy as determined by PSMA PET scan.","longName":"TGTBX_NCCN_PSMA_CAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5D11B44-0E24-0AD0-E053-731AD00A29A8","latestVersionIndicator":"Yes","beginDate":"2023-03-01","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-03-01","modifiedBy":"KUMMEROA","dateModified":"2023-03-03","changeNote":null,"administrativeNotes":"2023.3.3 Released per CCR review. ak","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12943983","version":"1","preferredName":"Targeted Prostate Biopsy NCCN Prostate Cancer Risk Stratification PSMA-targeting Agent-Technetium Tc99m EC0652 PET Category","preferredDefinition":"The NCCN prostate cancer risk stratification group using targeted prostate biopsy as determined by PSMA-targeted agent-Technetium Tc99m EC0652 PET scan.","longName":"TGTBX_NCCN_TC99M_CAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5D11B44-0E25-0AD0-E053-731AD00A29A8","latestVersionIndicator":"Yes","beginDate":"2023-03-01","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-03-01","modifiedBy":"KUMMEROA","dateModified":"2023-03-06","changeNote":null,"administrativeNotes":"2023.3.6 Shortened (PET) LN due to Import issues. ak 2023.3.3 Released per CCR review. ak","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12943984","version":"1","preferredName":"Targeted Prostate Biopsy NCCN Prostate Cancer Risk Stratification Diagnostic Imaging Computed Tomography Category","preferredDefinition":"The NCCN prostate cancer risk stratification group using targeted prostate biopsy as determined by diagnostic CT scan.","longName":"TGTBX_NCCN_DXCT_CAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5D11BE0-74AC-0B07-E053-731AD00AF816","latestVersionIndicator":"Yes","beginDate":"2023-03-01","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-03-01","modifiedBy":"KUMMEROA","dateModified":"2023-03-03","changeNote":null,"administrativeNotes":"2023.3.3 Released per CCR review. ak","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12943985","version":"1","preferredName":"Combination Prostate Biopsy NCCN Prostate Cancer Risk Stratification Clinical Evaluation Category","preferredDefinition":"The NCCN prostate cancer risk stratification group using combination prostate biopsy as determined by clinical observation.","longName":"COMBX_NCCN_CCLIN_CAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5D11BE0-74AD-0B07-E053-731AD00AF816","latestVersionIndicator":"Yes","beginDate":"2023-03-01","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-03-01","modifiedBy":"KUMMEROA","dateModified":"2023-03-03","changeNote":null,"administrativeNotes":"2023.3.3 Released per CCR review. ak","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12943986","version":"1","preferredName":"Combination Prostate Biopsy NCCN Prostate Cancer Risk Stratification Magnetic Resonance Imaging Category","preferredDefinition":"The NCCN prostate cancer risk stratification group using combination prostate biopsy as determined by magnetic resonance imaging.","longName":"COMBX_NCCN_MRI_CAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5D11BE0-74AE-0B07-E053-731AD00AF816","latestVersionIndicator":"Yes","beginDate":"2023-03-01","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-03-01","modifiedBy":"KUMMEROA","dateModified":"2023-03-03","changeNote":null,"administrativeNotes":"2023.3.3 Released per CCR review. ak","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12943987","version":"1","preferredName":"Combination Prostate Biopsy NCCN Prostate Cancer Risk Stratification PSMA PET Scan Category","preferredDefinition":"The NCCN prostate cancer risk stratification group using combination prostate biopsy as determined by PSMA PET scan.","longName":"COMBX_NCCN_PSMA_CAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5D11BE0-74AF-0B07-E053-731AD00AF816","latestVersionIndicator":"Yes","beginDate":"2023-03-01","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-03-01","modifiedBy":"KUMMEROA","dateModified":"2023-03-03","changeNote":null,"administrativeNotes":"2023.3.3 Released per CCR review. ak","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12943988","version":"1","preferredName":"Combination Prostate Biopsy NCCN Prostate Cancer Risk Stratification PSMA-targeting Agent-Technetium Tc99m EC0652 PET Category","preferredDefinition":"The NCCN prostate cancer risk stratification group using combination prostate biopsy as determined by PSMA-targeted agent-Technetium Tc99m EC0652 PET scan.","longName":"COMBX_NCCN_TC99M_CAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5D11BE0-74B0-0B07-E053-731AD00AF816","latestVersionIndicator":"Yes","beginDate":"2023-03-01","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-03-01","modifiedBy":"KUMMEROA","dateModified":"2023-03-06","changeNote":null,"administrativeNotes":"2023.3.6 Shortened (PET) LN due to Import issues. ak2023.3.3 Released per CCR review. ak","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12943989","version":"1","preferredName":"Combination Prostate Biopsy NCCN Prostate Cancer Risk Stratification Diagnostic Imaging Computed Tomography Category","preferredDefinition":"The NCCN prostate cancer risk stratification group using combination prostate biopsy as determined by diagnostic CT scan.","longName":"COMBX_NCCN_DXCT_CAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5D11BE0-74B1-0B07-E053-731AD00AF816","latestVersionIndicator":"Yes","beginDate":"2023-03-01","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-03-01","modifiedBy":"KUMMEROA","dateModified":"2023-03-03","changeNote":null,"administrativeNotes":"2023.3.3 Released per CCR review. ak","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12951419","version":"1","preferredName":"Linear Accelerator Radiation Dose Administered Monitor Unit Unit of Measure","preferredDefinition":"The monitor unit of measure of the linear accelerator radiation dose administered.","longName":"LA_RD_DS_ADMN_MU_UOM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5DE0F00-D502-508E-E053-731AD00ACA9B","latestVersionIndicator":"Yes","beginDate":"2023-03-01","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-03-01","modifiedBy":"KUMMEROA","dateModified":"2023-03-03","changeNote":null,"administrativeNotes":"2023.3.3 Released per CCR review. ak","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12951619","version":"1","preferredName":"Intracavity Hydrogel Packing Spacer Device Use Yes No Indicator","preferredDefinition":"The indication of whether or not a hydrogel spacer was used.","longName":"HYGEL_SPAC_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5DFC51E-F1F2-1DC6-E053-731AD00AA44B","latestVersionIndicator":"Yes","beginDate":"2023-03-01","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-03-01","modifiedBy":"KUMMEROA","dateModified":"2023-03-03","changeNote":null,"administrativeNotes":"2023.3.3 Released per CCR review. ak","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12951620","version":"1","preferredName":"Intracavity Hydrogel Packing Spacer Device Use Text","preferredDefinition":"The free text field for general notes describing hydrogel spacer use.","longName":"HYGEL_SPAC_USE _TXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5DFC51E-F1F3-1DC6-E053-731AD00AA44B","latestVersionIndicator":"Yes","beginDate":"2023-03-01","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-03-01","modifiedBy":"KUMMEROA","dateModified":"2023-03-03","changeNote":null,"administrativeNotes":"2023.3.3 Released per CCR review. ak","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12951621","version":"1","preferredName":"Antiandrogen Therapy Current Protocol Treatment Course Use Yes No Indicator","preferredDefinition":"The indication of whether or not antiandrogen therapy was used in the current course.","longName":"ADT_USE_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5DFC51E-F1F4-1DC6-E053-731AD00AA44B","latestVersionIndicator":"Yes","beginDate":"2023-03-01","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-03-01","modifiedBy":"KUMMEROA","dateModified":"2023-03-03","changeNote":null,"administrativeNotes":"2023.3.3 Released per CCR review. ak","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12951622","version":"1","preferredName":"Antiandrogent Therapy Expected Use Duration","preferredDefinition":"The text response indicating the anticipated duration of antiandrogen therapy.","longName":"ADT_USE_DUR","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5DFC51E-F1F5-1DC6-E053-731AD00AA44B","latestVersionIndicator":"Yes","beginDate":"2023-03-01","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-03-01","modifiedBy":"KUMMEROA","dateModified":"2023-03-03","changeNote":null,"administrativeNotes":"2023.3.3 Released per CCR review. ak","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12951623","version":"1","preferredName":"Fiducial Marker Image Guided Radiation Therapy Use Number","preferredDefinition":"The text field indicating the number of fiducial markers used for guided radiation therapy.","longName":"FIDMK_GUID_USE_NUM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5DFC51E-F1F6-1DC6-E053-731AD00AA44B","latestVersionIndicator":"Yes","beginDate":"2023-03-01","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-03-01","modifiedBy":"KUMMEROA","dateModified":"2023-03-03","changeNote":null,"administrativeNotes":"2023.3.3 Released per CCR review. ak","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12951624","version":"1","preferredName":"Fiducial Marker Within Neoplasm Location Yes No Indicator","preferredDefinition":"The indication of whether or not fiducial markers were inside the neoplasm.","longName":"FIDMK_NEO_LOC_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5DFC51E-F1F7-1DC6-E053-731AD00AA44B","latestVersionIndicator":"Yes","beginDate":"2023-03-01","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-03-01","modifiedBy":"KUMMEROA","dateModified":"2023-03-03","changeNote":null,"administrativeNotes":"2023.3.3 Released per CCR review. ak","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12951625","version":"1","preferredName":"Foley Catheter Radiation Therapy Treatment and Planning Simulation Use Yes No Indicator","preferredDefinition":"The indication of whether or not a foley catheter was used during radiation simulation.","longName":"FOLEY_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5DFC51E-F1F8-1DC6-E053-731AD00AA44B","latestVersionIndicator":"Yes","beginDate":"2023-03-01","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-03-01","modifiedBy":"KUMMEROA","dateModified":"2023-03-03","changeNote":null,"administrativeNotes":"2023.3.3 Released per CCR review. ak","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12951626","version":"1","preferredName":"Foley Catheter Second Treatment Use Yes No Indicator","preferredDefinition":"The indication of whether or not a foley catheter was used at the second treatment.","longName":"FOLEY_TRT2_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5DFC51E-F1F9-1DC6-E053-731AD00AA44B","latestVersionIndicator":"Yes","beginDate":"2023-03-01","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-03-01","modifiedBy":"KUMMEROA","dateModified":"2023-03-03","changeNote":null,"administrativeNotes":"2023.3.3 Released per CCR review. ak","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12951627","version":"1","preferredName":"Genitourinary System Protocol Treatment Course Maximum Adverse Event Severity Grade","preferredDefinition":"The maximum grade of genitourinary adverse events experienced during treatment.","longName":"GU_MAX_ADV_EVT_GRD","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5DFC51E-F1FA-1DC6-E053-731AD00AA44B","latestVersionIndicator":"Yes","beginDate":"2023-03-01","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-03-01","modifiedBy":"KUMMEROA","dateModified":"2023-03-03","changeNote":null,"administrativeNotes":"2023.3.3 Released per CCR review. ak","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12951628","version":"1","preferredName":"Digestive System Protocol Treatment Course Maximum Adverse Event Severity Grade","preferredDefinition":"The maximum grade of gastrointestinal adverse events experienced during treatment.","longName":"GI_MAX_ADV_EVT_GRD","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5DFC51E-F1FB-1DC6-E053-731AD00AA44B","latestVersionIndicator":"Yes","beginDate":"2023-03-01","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-03-01","modifiedBy":"KUMMEROA","dateModified":"2023-03-03","changeNote":null,"administrativeNotes":"2023.3.3 Released per CCR review. ak","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12951629","version":"1","preferredName":"Male Reproductive System Protocol Treatment Course Maximum Adverse Event Severity Grade","preferredDefinition":"The maximum grade of male reproductive system adverse events experienced during treatment.","longName":"MSEX_MAX_ADV_EVT_GRD","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5DFC51E-F1FC-1DC6-E053-731AD00AA44B","latestVersionIndicator":"Yes","beginDate":"2023-03-01","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-03-01","modifiedBy":"KUMMEROA","dateModified":"2023-03-03","changeNote":null,"administrativeNotes":"2023.3.3 Released per CCR review. ak","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12951630","version":"1","preferredName":"Foley Catheter First Treatment Use Yes No Indicator","preferredDefinition":"The indication of whether or not a foley catheter was used at the first treatment.","longName":"FOLEY_TRT1_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5DFD04F-61BF-1EE5-E053-731AD00AB005","latestVersionIndicator":"Yes","beginDate":"2023-03-01","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-03-01","modifiedBy":"KUMMEROA","dateModified":"2023-03-03","changeNote":null,"administrativeNotes":"2023.3.3 Released per CCR review. ak","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12951680","version":"1","preferredName":"First Therapeutic Procedure Administered Time","preferredDefinition":"The time the first treatment was administered.","longName":"FIRST_TX_ADM_TIME","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5DFFCDE-74E3-2742-E053-731AD00A0B57","latestVersionIndicator":"Yes","beginDate":"2023-03-01","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-03-01","modifiedBy":"KUMMEROA","dateModified":"2023-03-03","changeNote":null,"administrativeNotes":"2023.3.3 Released per CCR review. ak","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12951721","version":"1","preferredName":"Second Therapeutic Procedure Administered Time","preferredDefinition":"The time the second treatment was administered.","longName":"SEC_TRT_ADM_TIME","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5E0023F-ED80-27F7-E053-731AD00A6457","latestVersionIndicator":"Yes","beginDate":"2023-03-01","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-03-01","modifiedBy":"KUMMEROA","dateModified":"2023-03-03","changeNote":null,"administrativeNotes":"2023.3.3 Released per CCR review. ak","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12951724","version":"1","preferredName":"Intrafraction Motion Monitoring Diagnostic Imaging Type","preferredDefinition":"The indication of the type of diagnostic imaging that was monitored for intrafraction motion.","longName":"INTRFRC_MTN_MON_TYPE","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5E079CB-2EAE-4194-E053-731AD00AEE18","latestVersionIndicator":"Yes","beginDate":"2023-03-01","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-03-01","modifiedBy":"KUMMEROA","dateModified":"2023-03-03","changeNote":null,"administrativeNotes":"2023.3.3 Added CS/CSI. Released per CCR review. ak","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12952389","version":"1","preferredName":"Baseline Assessment Digestive System Toxicity Adverse Event Severity Grade","preferredDefinition":"The adverse event baseline assessment toxicity severity grade of the digestive system.","longName":"BL_GI_TOX_AE_SEV_GRD","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5EB8937-C3CF-0D36-E053-731AD00A8591","latestVersionIndicator":"Yes","beginDate":"2023-03-02","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-03-02","modifiedBy":"KUMMEROA","dateModified":"2023-03-03","changeNote":null,"administrativeNotes":"2023.3.3 Released per CCR review. ak","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12952390","version":"1","preferredName":"Maximum Digestive System Therapy-Related Toxicity Adverse Event Severity Grade","preferredDefinition":"The maximum severity grade of the therapy related toxicity to the digestive system.","longName":"MX_GI_TX_TOX_AE_GR","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5EBC113-0885-1D1A-E053-731AD00AE55E","latestVersionIndicator":"Yes","beginDate":"2023-03-02","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-03-02","modifiedBy":"KUMMEROA","dateModified":"2023-03-03","changeNote":null,"administrativeNotes":"2023.3.3 Released per CCR review. ak","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12952391","version":"1","preferredName":"Maximum Therapy-Related Toxicity Digestive System Adverse Experience Severity Grade","preferredDefinition":"The maximum therapy related toxicity severity grade to the digestive system.","longName":"MX_TX_TOX_GI_AE_GR","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5EBF17B-288C-2656-E053-731AD00A13A2","latestVersionIndicator":"Yes","beginDate":"2023-03-02","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-03-02","modifiedBy":"KUMMEROA","dateModified":"2023-03-03","changeNote":null,"administrativeNotes":"2023.3.3 Released per CCR review. ak","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12952392","version":"1","preferredName":"Increase Digestive System Therapy-Related Toxicity Adverse Event Severity Grade","preferredDefinition":"The increased therapy related toxicity severity grade to the digestive system.","longName":"INC_GI_TX_TOX_AE_GR","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5EC1B9E-6228-2B79-E053-731AD00AD313","latestVersionIndicator":"Yes","beginDate":"2023-03-02","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-03-02","modifiedBy":"KUMMEROA","dateModified":"2023-03-03","changeNote":null,"administrativeNotes":"2023.3.3 Released per CCR review. ak","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12952393","version":"1","preferredName":"Total Adverse Experience Digestive System Toxicity Burden Adverse Event Severity Grade","preferredDefinition":"The total adverse experienced toxicity burden to the digestive system.","longName":"TTL_AE_GI_TOX_BRD_GR","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5EC37E4-5D0A-2E4D-E053-731AD00AA50A","latestVersionIndicator":"Yes","beginDate":"2023-03-02","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-03-02","modifiedBy":"KUMMEROA","dateModified":"2023-03-03","changeNote":null,"administrativeNotes":"2023.3.3 Released per CCR review. ak","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12952394","version":"1","preferredName":"Baseline Assessment Genitourinary System Toxicity Adverse Event Severity Grade","preferredDefinition":"The adverse event baseline assessment toxicity severity grade of the genitourinary system.","longName":"BL_GU_TOX_AE_SEV_GRD","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5EC504A-3757-31CC-E053-731AD00AB24D","latestVersionIndicator":"Yes","beginDate":"2023-03-02","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-03-02","modifiedBy":"KUMMEROA","dateModified":"2023-03-03","changeNote":null,"administrativeNotes":"2023.3.3 Released per CCR review. ak","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12952395","version":"1","preferredName":"Maximum Genitourinary System Therapy-Related Toxicity Adverse Event Severity Grade","preferredDefinition":"The maximum severity grade of the therapy related toxicity to the genitourinary system.","longName":"MX_GU_TX_TOX_AE_GR","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5EC6661-6F97-37AD-E053-731AD00A7C29","latestVersionIndicator":"Yes","beginDate":"2023-03-02","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-03-02","modifiedBy":"KUMMEROA","dateModified":"2023-03-03","changeNote":null,"administrativeNotes":"2023.3.3 Released per CCR review. ak","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12952396","version":"1","preferredName":"Maximum Therapy-Related Toxicity Genitourinary System Adverse Experience Adverse Event Severity Grade","preferredDefinition":"The maximum therapy related toxicity severity grade to the genitourinary system.","longName":"MX_TX_TOX_GU_AE_GR","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5EC7F7C-F2E3-3AF5-E053-731AD00AE201","latestVersionIndicator":"Yes","beginDate":"2023-03-02","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-03-02","modifiedBy":"KUMMEROA","dateModified":"2023-03-03","changeNote":null,"administrativeNotes":"2023.3.3 Released per CCR review. ak","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12952397","version":"1","preferredName":"Increase Genitourinary System Therapy-Related Toxicity Adverse Event Severity Grade","preferredDefinition":"The increased therapy related toxicity severity grade to the genitourinary system.","longName":"INC_GU_TX_TOX_AE_GR","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5ECA412-4D1A-3F4E-E053-731AD00A6936","latestVersionIndicator":"Yes","beginDate":"2023-03-02","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-03-02","modifiedBy":"KUMMEROA","dateModified":"2023-03-03","changeNote":null,"administrativeNotes":"2023.3.3 Released per CCR review. ak","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12952398","version":"1","preferredName":"Total Adverse Experience Genitourinary System Toxicity Burden Adverse Event Severity Grade","preferredDefinition":"The total adverse experienced toxicity burden to the genitourinary system.","longName":"TTL_AE_GU_TOX_BRD_GR","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5ECB709-1236-41EA-E053-731AD00AF0AD","latestVersionIndicator":"Yes","beginDate":"2023-03-02","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-03-02","modifiedBy":"KUMMEROA","dateModified":"2023-03-03","changeNote":null,"administrativeNotes":"2023.3.3 Released per CCR review. ak","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12952399","version":"1","preferredName":"Baseline Assessment Male Reproductive System Toxicity Adverse Event Severity Grade","preferredDefinition":"The adverse event baseline assessment toxicity severity grade of the male reproductive system.","longName":"BL_MR_TOX_AE_SEV_GR","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5ECCE14-B623-47DC-E053-731AD00A2F81","latestVersionIndicator":"Yes","beginDate":"2023-03-02","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-03-02","modifiedBy":"KUMMEROA","dateModified":"2023-03-03","changeNote":null,"administrativeNotes":"2023.3.3 Released per CCR review. ak","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12953031","version":"1","preferredName":"Maximum Male Reproductive System Therapy-Related Toxicity Adverse Event Severity Grade","preferredDefinition":"The maximum severity grade of the therapy related toxicity to the male reproductive system.","longName":"MX_MR_TX_TOX_AE_GR","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5ED68C7-7978-66F2-E053-731AD00A4BE6","latestVersionIndicator":"Yes","beginDate":"2023-03-02","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-03-02","modifiedBy":"KUMMEROA","dateModified":"2023-03-03","changeNote":null,"administrativeNotes":"2023.3.3 Released per CCR review. ak","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12953032","version":"1","preferredName":"Maximum Therapy-Related Toxicity Male Reproductive System Adverse Experience Severity Grade","preferredDefinition":"The maximum therapy related toxicity severity grade to the male reproductive system.","longName":"MX_TX_TOX_MR_AE_GR","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5ED7E7D-676A-6972-E053-731AD00A6317","latestVersionIndicator":"Yes","beginDate":"2023-03-02","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-03-02","modifiedBy":"KUMMEROA","dateModified":"2023-03-03","changeNote":null,"administrativeNotes":"2023.3.3 Released per CCR review. ak","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12953033","version":"1","preferredName":"Increase Male Reproductive System Therapy-Related Toxicity Adverse Event Severity Grade","preferredDefinition":"The increased therapy related toxicity severity grade to the male reproductive system.","longName":"INC_MR_TX_TOX_AE_GR","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5ED919E-BEAD-6C46-E053-731AD00AE1CD","latestVersionIndicator":"Yes","beginDate":"2023-03-02","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-03-02","modifiedBy":"KUMMEROA","dateModified":"2023-03-03","changeNote":null,"administrativeNotes":"2023.3.3 Released per CCR review. ak","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12953034","version":"1","preferredName":"Total Adverse Experience Male Reproductive System Toxicity Burden Adverse Event Severity Grade","preferredDefinition":"The total adverse experienced toxicity burden to the male reproductive system.","longName":"TTL_AE_MR_TOX_BRD_GR","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5EDA170-DB78-715E-E053-731AD00AE046","latestVersionIndicator":"Yes","beginDate":"2023-03-02","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-03-02","modifiedBy":"KUMMEROA","dateModified":"2023-03-03","changeNote":null,"administrativeNotes":"2023.3.3 Released per CCR review. ak","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12960092","version":"1","preferredName":"Loperamide At Baseline Use Yes No Indicator","preferredDefinition":"The indicator of whether or not loperamide was used at baseline.","longName":"LPMD_BSLN_USE_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5F1182B-50FD-0A53-E053-731AD00A236F","latestVersionIndicator":"Yes","beginDate":"2023-03-02","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-03-02","modifiedBy":"KUMMEROA","dateModified":"2023-03-03","changeNote":null,"administrativeNotes":"2023.3.3 Released per CCR review. ak","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12960095","version":"1","preferredName":"Tamsulosin Hydrochloride At Baseline Use Yes No Indicator","preferredDefinition":"The indicator of whether or not tamsulosin hydrochloride was used at baseline.","longName":"TMSL_BSLN_USE_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5F1320E-6D04-161C-E053-731AD00AFA9E","latestVersionIndicator":"Yes","beginDate":"2023-03-02","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-03-02","modifiedBy":"KUMMEROA","dateModified":"2023-03-03","changeNote":null,"administrativeNotes":"2023.3.3 Released per CCR review. ak","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12960103","version":"1","preferredName":"Oxybutynin Chloride At Baseline Use Yes No Indicator","preferredDefinition":"The indicator of whether or not oxybutynin chloride was used at baseline.","longName":"OXBTN_BSLN_USE_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5F14F40-0FB4-1A00-E053-731AD00A7381","latestVersionIndicator":"Yes","beginDate":"2023-03-02","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-03-02","modifiedBy":"KUMMEROA","dateModified":"2023-03-03","changeNote":null,"administrativeNotes":"2023.3.3 Released per CCR review. ak","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12960104","version":"1","preferredName":"Phosphodiesterase Inhibitor At Baseline Use Yes No Indicator","preferredDefinition":"The indicator of whether or not phosphodiesterase inhibitors were used at baseline.","longName":"PDE_INH_BSLN_USE_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5F1687C-8532-1D7B-E053-731AD00A722B","latestVersionIndicator":"Yes","beginDate":"2023-03-02","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-03-02","modifiedBy":"KUMMEROA","dateModified":"2023-03-03","changeNote":null,"administrativeNotes":"2023.3.3 Released per CCR review. ak","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12960108","version":"1","preferredName":"Digestive System Medication Agent Name","preferredDefinition":"The digestive system medication agent's name.","longName":"GI_MED_AGNT_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5F194CF-2EC9-2EB5-E053-731AD00A2038","latestVersionIndicator":"Yes","beginDate":"2023-03-02","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-03-02","modifiedBy":"KUMMEROA","dateModified":"2023-03-03","changeNote":null,"administrativeNotes":"2023.3.3 Released per CCR review. ak","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12960109","version":"1","preferredName":"Genitourinary System Medication Agent Name","preferredDefinition":"The genitourinary system medication agent's name.","longName":"GU_MED_AGNT_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5F1AE47-90D1-31A4-E053-731AD00A56D6","latestVersionIndicator":"Yes","beginDate":"2023-03-02","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-03-02","modifiedBy":"KUMMEROA","dateModified":"2023-03-03","changeNote":null,"administrativeNotes":"2023.3.3 Released per CCR review. ak","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12960110","version":"1","preferredName":"Male Reproductive System Medication Agent Name","preferredDefinition":"The male reproductive system medication agent's name.","longName":"MR_MED_AGNT_NM","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5F1BF34-AAC8-3412-E053-731AD00AB2DC","latestVersionIndicator":"Yes","beginDate":"2023-03-02","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-03-02","modifiedBy":"KUMMEROA","dateModified":"2023-03-03","changeNote":null,"administrativeNotes":"2023.3.3 Released per CCR review. ak","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12960112","version":"1","preferredName":"Digestive System Medication Comments Text","preferredDefinition":"The free text field for general notes related to the digestive system medication.","longName":"GI_MED_CMNT_TXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5F1EAEE-41D1-3C96-E053-731AD00ADCF6","latestVersionIndicator":"Yes","beginDate":"2023-03-02","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-03-02","modifiedBy":"KUMMEROA","dateModified":"2023-03-03","changeNote":null,"administrativeNotes":"2023.3.3 Released per CCR review. ak","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12960114","version":"1","preferredName":"Genitourinary System Medication Comments Text","preferredDefinition":"The free text field for general notes related to the genitourinary system medication.","longName":"GU_MED_CMNT_TXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5F1FB54-7838-3E98-E053-731AD00A00EE","latestVersionIndicator":"Yes","beginDate":"2023-03-02","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-03-02","modifiedBy":"KUMMEROA","dateModified":"2023-03-03","changeNote":null,"administrativeNotes":"2023.3.3 Released per CCR review. ak","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12960119","version":"1","preferredName":"Male Reproductive System Medication Comments Text","preferredDefinition":"The free text field for general notes related to the male reproductive system medication.","longName":"MR_MED_CMNT_TXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5F20AB1-37B8-4088-E053-731AD00ABAAD","latestVersionIndicator":"Yes","beginDate":"2023-03-02","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-03-02","modifiedBy":"KUMMEROA","dateModified":"2023-03-03","changeNote":null,"administrativeNotes":"2023.3.3 Released per CCR review. ak","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12960552","version":"1","preferredName":"Loperamide Administered Yes No Indicator","preferredDefinition":"The indicator of whether or not loperamide was administered.","longName":"LPMD_ADMIN_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5F21FB1-FF52-432D-E053-731AD00A16CD","latestVersionIndicator":"Yes","beginDate":"2023-03-02","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-03-02","modifiedBy":"KUMMEROA","dateModified":"2023-03-03","changeNote":null,"administrativeNotes":"2023.3.3 Released per CCR review. ak","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12960564","version":"1","preferredName":"Tamsulosin Hydrochloride At Timepoint Use Yes No Indicator","preferredDefinition":"The indicator of whether or not tamsulosin hydrochloride was used at a specific timepoint.","longName":"TMSL_TMPT_USE_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5F277F7-6E65-5277-E053-731AD00A4AB3","latestVersionIndicator":"Yes","beginDate":"2023-03-02","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-03-02","modifiedBy":"KUMMEROA","dateModified":"2023-03-03","changeNote":null,"administrativeNotes":"2023.3.3 Released per CCR review. ak","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12960567","version":"1","preferredName":"Oxybutynin Chloride At Timepoint Use Yes No Indicator","preferredDefinition":"The indicator of whether or not oxybutynin chloride was used at a specific timepoint.","longName":"OXBTN_TMPT_USE_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5F28A5E-4B88-5490-E053-731AD00A7602","latestVersionIndicator":"Yes","beginDate":"2023-03-02","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-03-02","modifiedBy":"KUMMEROA","dateModified":"2023-03-03","changeNote":null,"administrativeNotes":"2023.3.3 Released per CCR review. ak","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12960568","version":"1","preferredName":"Mirabegron At Timepoint Use Yes No Indicator","preferredDefinition":"The indicator of whether or not mirabegron was used at a specific timepoint.","longName":"MBG_TMPT_USE_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5F2994A-2C27-56D2-E053-731AD00A597F","latestVersionIndicator":"Yes","beginDate":"2023-03-02","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-03-02","modifiedBy":"KUMMEROA","dateModified":"2023-03-03","changeNote":null,"administrativeNotes":"2023.3.3 Released per CCR review. ak","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12960573","version":"1","preferredName":"Pentosan Polysulfate Sodium At Timepoint Use Yes No Indicator","preferredDefinition":"The indicator of whether or not pentosan polysulfate sodium was used at a specific timepoint.","longName":"PPS_TMPT_USE_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5F2A808-5E98-5915-E053-731AD00AA8BD","latestVersionIndicator":"Yes","beginDate":"2023-03-02","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-03-02","modifiedBy":"KUMMEROA","dateModified":"2023-03-03","changeNote":null,"administrativeNotes":"2023.3.3 Released per CCR review. ak","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12960577","version":"1","preferredName":"Nonsteroidal Antiinflammatory Drug At Timepoint Use Yes No Indicator","preferredDefinition":"The indicator of whether or not a nonsteroidal antiinflammatory drug was used at a specific timepoint.","longName":"NSAID_TMPT_USE_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5F2BDCC-379D-5ECF-E053-731AD00A0734","latestVersionIndicator":"Yes","beginDate":"2023-03-02","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-03-02","modifiedBy":"KUMMEROA","dateModified":"2023-03-03","changeNote":null,"administrativeNotes":"2023.3.3 Released per CCR review. ak","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12960583","version":"1","preferredName":"Phosphodiesterase Inhibitor At Timepoint Use Yes No Indicator","preferredDefinition":"The indicator of whether or not a phosphodiesterase inhibitor was used at a specific timepoint.","longName":"PDE_TMPT_USE_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5F2CDDC-C5F4-6106-E053-731AD00A876F","latestVersionIndicator":"Yes","beginDate":"2023-03-02","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-03-02","modifiedBy":"KUMMEROA","dateModified":"2023-03-03","changeNote":null,"administrativeNotes":"2023.3.3 Released per CCR review. ak","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12961431","version":"1","preferredName":"Urinary Medication At Timepoint Use Count","preferredDefinition":"The number of urinary medications used at a specific timepoint.","longName":"URN_MED_TMPT_USE_CNT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5F2E737-4FCC-6C9F-E053-731AD00A776E","latestVersionIndicator":"Yes","beginDate":"2023-03-02","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-03-02","modifiedBy":"KUMMEROA","dateModified":"2023-03-03","changeNote":null,"administrativeNotes":"2023.3.3 Released per CCR review. ak","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"13397506","version":"1","preferredName":"Memorial Symptom Assessment Scale Section One Symptom Type","preferredDefinition":"The symptom assessed in Section I of the Memorial Symptom Assessment Scale.","longName":"MSAS_S1_SYMP_TYP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F9CCB091-1E88-7ECF-E053-731AD00A108C","latestVersionIndicator":"Yes","beginDate":"2023-04-20","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-04-20","modifiedBy":"GDEEN","dateModified":"2023-05-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"13397507","version":"1","preferredName":"Memorial Symptom Assessment Scale Section Two Symptom Type","preferredDefinition":"The symptom assessed in Section II of the Memorial Symptom Assessment Scale.","longName":"MSAS_S2_SYMP_TYP","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F9CCB091-1E89-7ECF-E053-731AD00A108C","latestVersionIndicator":"Yes","beginDate":"2023-04-20","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-04-20","modifiedBy":"GDEEN","dateModified":"2023-05-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"13397508","version":"1","preferredName":"Memorial Symptom Assessment Scale Symptom Indicator","preferredDefinition":"A persons stated observation of whether or not they were experiencing a symptom, using a yes or no response.","longName":"MSAS_SYMP_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F9CCB091-1E8A-7ECF-E053-731AD00A108C","latestVersionIndicator":"Yes","beginDate":"2023-04-20","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-04-20","modifiedBy":"GDEEN","dateModified":"2023-05-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"13397509","version":"1","preferredName":"Memorial Symptom Assessment Scale Distress Criterion 5 Point Scale","preferredDefinition":"A persons stated observation how much distress they had from a symptom, using a five-point Likert scale.","longName":"MSAS_DIST_CRIT_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F9CCB091-1E8B-7ECF-E053-731AD00A108C","latestVersionIndicator":"Yes","beginDate":"2023-04-20","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-04-20","modifiedBy":"GDEEN","dateModified":"2023-05-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"13397510","version":"1","preferredName":"Memorial Symptom Assessment Scale Frequency Criterion Score 4 Point Scale","preferredDefinition":"A persons stated observation of how often they had problems with a symptom, using a four-point Likert scale.","longName":"MSAS_FREQ_CRIT_SCL","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F9CCB091-1E8C-7ECF-E053-731AD00A108C","latestVersionIndicator":"Yes","beginDate":"2023-04-20","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-04-20","modifiedBy":"GDEEN","dateModified":"2023-05-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"13552922","version":"1","preferredName":"Chronic Graft Versus Host Disease Skin Features National Institutes of Health Score","preferredDefinition":"Score that represents the type of skin features associated with chronic graft vs. host disease.","longName":"CGVHD_SKIN_NIH_SCORE","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FB485A95-DDD6-1663-E053-731AD00A8CDA","latestVersionIndicator":"Yes","beginDate":"2023-05-09","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-05-09","modifiedBy":"GDEEN","dateModified":"2023-05-10","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"13552923","version":"1","preferredName":"Chronic Graft Versus Host Disease Body Surface Area Percent National Institutes of Health Score","preferredDefinition":"Score that represents the type of skin percentage of body surface area associated with chronic graft vs. host disease.","longName":"CGVHD_BSA_NIH_SCORE","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FB485A95-DDD7-1663-E053-731AD00A8CDA","latestVersionIndicator":"Yes","beginDate":"2023-05-09","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-05-09","modifiedBy":"GDEEN","dateModified":"2023-05-10","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"13552924","version":"1","preferredName":"Chronic Graft Versus Host Disease Performance National Institutes of Health Score","preferredDefinition":"Score that represents the type of performance characteristics associated with chronic graft vs. host disease.","longName":"CGVHD_PFM_NIH_SCORE","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FB485A95-DDD8-1663-E053-731AD00A8CDA","latestVersionIndicator":"Yes","beginDate":"2023-05-09","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-05-09","modifiedBy":"GDEEN","dateModified":"2023-05-10","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"13552925","version":"1","preferredName":"Chronic Graft Versus Host Disease Mouth National Institutes of Health Score","preferredDefinition":"Score that represents the type of  mouth characteristics associated with chronic graft vs. host disease.","longName":"CGVHD_MOUTH_NIH_SCORE","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FB485A95-DDD9-1663-E053-731AD00A8CDA","latestVersionIndicator":"Yes","beginDate":"2023-05-09","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-05-09","modifiedBy":"GDEEN","dateModified":"2023-05-10","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"13552926","version":"1","preferredName":"Chronic Graft Versus Host Disease Lung Symptom National Institutes of Health Score","preferredDefinition":"Score that represents the type of lung characteristics associated with chronic graft vs. host disease.","longName":"CGVHD_LUNG_NIH_SCORE","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FB485A95-DDDA-1663-E053-731AD00A8CDA","latestVersionIndicator":"Yes","beginDate":"2023-05-09","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-05-09","modifiedBy":"GDEEN","dateModified":"2023-05-10","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"13552927","version":"1","preferredName":"Chronic Graft Versus Host Disease FEV1 National Institutes of Health Score","preferredDefinition":"Score that represents the type of FEV1 characteristics associated with chronic graft vs. host disease.","longName":"CGVHD_FEV1_NIH_SCORE","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FB485A95-DDDB-1663-E053-731AD00A8CDA","latestVersionIndicator":"Yes","beginDate":"2023-05-09","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-05-09","modifiedBy":"GDEEN","dateModified":"2023-05-10","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"13552928","version":"1","preferredName":"Chronic Graft Versus Host Disease Liver National Institutes of Health Score","preferredDefinition":"Score that represents the type of liver characteristics associated with chronic graft vs. host disease.","longName":"CGVHD_LIVER_NIH_SCORE","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FB485A95-DDDC-1663-E053-731AD00A8CDA","latestVersionIndicator":"Yes","beginDate":"2023-05-09","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-05-09","modifiedBy":"GDEEN","dateModified":"2023-05-10","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"13552929","version":"1","preferredName":"Chronic Graft Versus Host Disease Joint And Fascia National Institutes of Health Score","preferredDefinition":"Score that represents the type of joint and fascia characteristics associated with chronic graft vs. host disease.","longName":"CGVHD_JOINT_NIH_SCORE","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FB485A95-DDDD-1663-E053-731AD00A8CDA","latestVersionIndicator":"Yes","beginDate":"2023-05-09","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-05-09","modifiedBy":"GDEEN","dateModified":"2023-05-10","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"13552930","version":"1","preferredName":"Chronic Graft Versus Host Disease Gynecologic Feature National Institutes of Health Score","preferredDefinition":"Score that represents the type of gynecologic features associated with chronic graft vs. host disease.","longName":"CGVHD_GYN_NIH_SCORE","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FB485A95-DDDE-1663-E053-731AD00A8CDA","latestVersionIndicator":"Yes","beginDate":"2023-05-09","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-05-09","modifiedBy":"GDEEN","dateModified":"2023-05-10","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"13552931","version":"1","preferredName":"Chronic Graft Versus Host Disease Gastrointestinal Tract National Institutes of Health Score","preferredDefinition":"Score that represents the type of gastrointestinal features associated with chronic graft vs. host disease.","longName":"CGVHD_GI_NIH_SCORE","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FB485A95-DDDF-1663-E053-731AD00A8CDA","latestVersionIndicator":"Yes","beginDate":"2023-05-09","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-05-09","modifiedBy":"GDEEN","dateModified":"2023-05-10","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"13552932","version":"1","preferredName":"Chronic Graft Versus Host Disease Reproductive System National Institutes of Health Score","preferredDefinition":"Score that represents the type of genital tract features associated with chronic graft vs. host disease.","longName":"CGVHD_GNTL_NIH_SCORE","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FB485A95-DDE0-1663-E053-731AD00A8CDA","latestVersionIndicator":"Yes","beginDate":"2023-05-09","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-05-09","modifiedBy":"GDEEN","dateModified":"2023-05-10","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"13552933","version":"1","preferredName":"Chronic Graft Versus Host Disease Eye National Institutes of Health Score","preferredDefinition":"Score that represents the type of eye features associated with chronic graft vs. host disease.","longName":"CGVHD_EYE_NIH_SCORE","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FB485A95-DDE1-1663-E053-731AD00A8CDA","latestVersionIndicator":"Yes","beginDate":"2023-05-09","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-05-09","modifiedBy":"GDEEN","dateModified":"2023-05-10","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"13560107","version":"1","preferredName":"De Novo Onset of Chronic Graft Versus Host Disease Occurrence Yes No Indicator","preferredDefinition":"The indication of whether or not chronic GVHD occurred in a patient who did not previously experience acute GVHD.","longName":"DE_NOVO_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FB5B5137-5AF1-6DFC-E053-731AD00AD134","latestVersionIndicator":"Yes","beginDate":"2023-05-10","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-05-10","modifiedBy":"GDEEN","dateModified":"2023-05-10","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"13560108","version":"1","preferredName":"Progressive Onset of Chronic Graft Versus Host Disease Occurrence Yes No Indicator","preferredDefinition":"The indication of whether or not the initial presentation of chronic GVHD occurred while acute GVHD symptoms are still active.","longName":"PROG_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FB5B5137-5AF2-6DFC-E053-731AD00AD134","latestVersionIndicator":"Yes","beginDate":"2023-05-10","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-05-10","modifiedBy":"GDEEN","dateModified":"2023-05-10","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"13560109","version":"1","preferredName":"Quiescent Onset of Chronic Graft Versus Host Disease Occurrence Yes No Indicator","preferredDefinition":"The indication of whether or not the occurrence of chronic GVHD occurred after all acute GVHD was controlled, inactive or resolved.","longName":"QUIESC_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FB5B5137-5AF3-6DFC-E053-731AD00AD134","latestVersionIndicator":"Yes","beginDate":"2023-05-10","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-05-10","modifiedBy":"GDEEN","dateModified":"2023-05-10","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"13660191","version":"1","preferredName":"Clinical Study Subject Type","preferredDefinition":"The response describing the target biological entity registered or enrolled in the clinical trial.","longName":"CLSDY_SUBJ_TYPE","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"FC7AABA5-64F7-58DA-E053-731AD00A09B9","latestVersionIndicator":"Yes","beginDate":"2023-05-24","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-05-24","modifiedBy":"GDEEN","dateModified":"2023-05-24","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"14428750","version":"1","preferredName":"Participant Dose Limiting Toxicity Evaluable Yes No Indicator","preferredDefinition":"The response indicating whether or not a participant is able to be evaluated for a toxicity that necessitates a dose modification.","longName":"PPT_DLT_EVAL_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"03857A10-C270-4A6B-E063-731AD00A2D92","latestVersionIndicator":"Yes","beginDate":"2023-08-22","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-08-22","modifiedBy":"GDEEN","dateModified":"2023-08-22","changeNote":null,"administrativeNotes":"08.22.23_Curated to support DSMB reporting_ghd","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"14479404","version":"1","preferredName":"KSHV Inflammatory Cytokine Syndrome Disease Response Category","preferredDefinition":"Code assigned to describe the KSHV inflammatory cytokine syndrome patient's disease response or outcome to treatment.","longName":"KSHV_KICS_DS_RSP_CAT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"05AB308C-0E5C-38C3-E063-731AD00A2CDD","latestVersionIndicator":"Yes","beginDate":"2023-09-18","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-09-18","modifiedBy":"GDEEN","dateModified":"2023-09-18","changeNote":null,"administrativeNotes":"09.18.23_Curated to support IRB001538_GHD","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"14599795","version":"1","preferredName":"Recreational Drug Use Yes No Indicator","preferredDefinition":"Text term to indicate the use of any recreational drugs (cocaine, heroin, methamphetamine, ecstasy)","longName":"REC_DRUG_USE_IND","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0A26F280-037B-1AAA-E063-731AD00A953A","latestVersionIndicator":"Yes","beginDate":"2023-11-14","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-11-14","modifiedBy":"GDEEN","dateModified":"2023-11-14","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"14599797","version":"1","preferredName":"Recreational Drug Name","preferredDefinition":"Text term to identify a recreational drugs (cocaine, heroin, methamphetamine, ecstasy).","longName":"REC_DRUG_NAME","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0A270AA6-76B2-1E8C-E063-731AD00A343A","latestVersionIndicator":"Yes","beginDate":"2023-11-14","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-11-14","modifiedBy":"GDEEN","dateModified":"2023-11-14","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"14640574","version":"1","preferredName":"Contrast Enhanced PET-CT Scan Volume of Interest Value","preferredDefinition":"The value representing the user-selected volume from a contrast enhanced PET-CT scan image.","longName":"CE_PET_CT_VOI","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0B69B166-B80B-5B30-E063-731AD00AA76C","latestVersionIndicator":"Yes","beginDate":"2023-11-30","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-11-30","modifiedBy":"GDEEN","dateModified":"2023-11-30","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"14640575","version":"1","preferredName":"Contrast Enhanced PET-CT Scan Total Lesion Uptake Value","preferredDefinition":"The value representing the lesional mean uptake of a radioactive marker multiplied by the lesion volume and expressed as a percentage of the injected dose obtained from a contrast enhanced PET-CT scan.","longName":"CE_PET_CT_TLU","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0B69B166-B80C-5B30-E063-731AD00AA76C","latestVersionIndicator":"Yes","beginDate":"2023-11-30","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-11-30","modifiedBy":"GDEEN","dateModified":"2023-11-30","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"14640576","version":"1","preferredName":"Contrast Enhanced PET-CT Scan Total Metabolic Tumor Value","preferredDefinition":"The value representing the uptake of a radioactive tracer by metabolically active tumor segments obtained from a contrast enhanced PET-CT scan.","longName":"CE_PET_CT_TMTV","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0B69B166-B80D-5B30-E063-731AD00AA76C","latestVersionIndicator":"Yes","beginDate":"2023-11-30","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-11-30","modifiedBy":"GDEEN","dateModified":"2023-11-30","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"14651983","version":"1","preferredName":"Disease or Disorder Secondary Diagnosis Text","preferredDefinition":"The text response that indicates the name of the secondary diagnosis.","longName":"SECOND_DIAG_TXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0BF6D821-22B1-69CA-E063-731AD00AE9B2","latestVersionIndicator":"Yes","beginDate":"2023-12-07","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-12-07","modifiedBy":"GDEEN","dateModified":"2023-12-07","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"14651984","version":"1","preferredName":"Disease or Disorder Tertiary Diagnosis Text","preferredDefinition":"The text response that indicates the name of the tertiary diagnosis.","longName":"TERT_DIAG_TXT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0BF6E176-5DF8-6B53-E063-731AD00AD3E7","latestVersionIndicator":"Yes","beginDate":"2023-12-07","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-12-07","modifiedBy":"GDEEN","dateModified":"2023-12-07","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"14651985","version":"1","preferredName":"Disease or Disorder Secondary Diagnosis Date","preferredDefinition":"The date of the procedure or evaluation used to determine the secondary diagnosis.","longName":"SECOND_DX_DT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0BF6F7C5-8137-71AB-E063-731AD00AE8BE","latestVersionIndicator":"Yes","beginDate":"2023-12-07","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-12-07","modifiedBy":"GDEEN","dateModified":"2023-12-07","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"14651986","version":"1","preferredName":"Disease or Disorder Tertiary Diagnosis Date","preferredDefinition":"The date of the procedure or evaluation used to determine the tertiary diagnosis.","longName":"TERT_DX_DT","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0BF703F3-325D-737F-E063-731AD00AC6A2","latestVersionIndicator":"Yes","beginDate":"2023-12-07","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-12-07","modifiedBy":"GDEEN","dateModified":"2023-12-07","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"14679124","version":"1","preferredName":"B-Lymphocyte Biomarker Present Type","preferredDefinition":"The response indicating the B-lymphocyte biomarker expression been detected in a biospecimen.","longName":"BLYMPH_BIOMK_TYPE","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0F27032D-520F-3608-E063-731AD00A54CC","latestVersionIndicator":"Yes","beginDate":"2024-01-17","endDate":null,"createdBy":"GDEEN","dateCreated":"2024-01-17","modifiedBy":"GDEEN","dateModified":"2024-01-17","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"14776915","version":"1","preferredName":"Overall Lesion Response RECIP 1.0 Type","preferredDefinition":"Text term to represent the overall disease response in the prostate-specific membrane antigen (PSMA)-positive total tumor volume and the occurrence of new lesions using the RECIP criteria.","longName":"OVR_RECIP_TYPE","contextName":"CCR","contextVersion":"1","dataElementConceptPublicId":"2010794","dataElementConceptVersion":"2.31","valueDomainPublicId":"2018777","valueDomainVersion":"1","origin":"RECIP: Gafita, A., et al., Novel framework for treatment response evaluation using PSMA-PET/CT in patients with metastatic castration-resistant prostate cancer (RECIP 1.0):an international multicenter study. European Journal of Nuclear Medicine and Molecular Imaging, 2022. 49(Suppl 1): p. S269-S269.","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1211B94C-9DED-2AB3-E063-731AD00AE03E","latestVersionIndicator":"Yes","beginDate":"2024-02-23","endDate":null,"createdBy":"GDEEN","dateCreated":"2024-02-23","modifiedBy":"GDEEN","dateModified":"2024-02-23","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}]}